Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA single nuclei brain specificity"	"RNA single nuclei brain distribution"	"RNA single nuclei brain specificity score"	"RNA single nuclei brain specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA tissue cell type enrichment"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Secretome function"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Brain expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	Interactions	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Cancer prognostics - Bladder Urothelial Carcinoma (TCGA)"	"Cancer prognostics - Breast Invasive Carcinoma (TCGA)"	"Cancer prognostics - Breast Invasive Carcinoma (validation)"	"Cancer prognostics - Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA)"	"Cancer prognostics - Colon Adenocarcinoma (TCGA)"	"Cancer prognostics - Colon Adenocarcinoma (validation)"	"Cancer prognostics - Glioblastoma Multiforme (TCGA)"	"Cancer prognostics - Glioblastoma Multiforme (validation)"	"Cancer prognostics - Head and Neck Squamous Cell Carcinoma (TCGA)"	"Cancer prognostics - Kidney Chromophobe (TCGA)"	"Cancer prognostics - Kidney Renal Clear Cell Carcinoma (TCGA)"	"Cancer prognostics - Kidney Renal Clear Cell Carcinoma (validation)"	"Cancer prognostics - Kidney Renal Papillary Cell Carcinoma (TCGA)"	"Cancer prognostics - Liver Hepatocellular Carcinoma (TCGA)"	"Cancer prognostics - Liver Hepatocellular Carcinoma (validation)"	"Cancer prognostics - Lung Adenocarcinoma (TCGA)"	"Cancer prognostics - Lung Adenocarcinoma (validation)"	"Cancer prognostics - Lung Squamous Cell Carcinoma (TCGA)"	"Cancer prognostics - Lung Squamous Cell Carcinoma (validation)"	"Cancer prognostics - Ovary Serous Cystadenocarcinoma (TCGA)"	"Cancer prognostics - Ovary Serous Cystadenocarcinoma (validation)"	"Cancer prognostics - Pancreatic Adenocarcinoma (TCGA)"	"Cancer prognostics - Pancreatic Adenocarcinoma (validation)"	"Cancer prognostics - Prostate Adenocarcinoma (TCGA)"	"Cancer prognostics - Rectum Adenocarcinoma (TCGA)"	"Cancer prognostics - Rectum Adenocarcinoma (validation)"	"Cancer prognostics - Skin Cuteneous Melanoma (TCGA)"	"Cancer prognostics - Stomach Adenocarcinoma (TCGA)"	"Cancer prognostics - Testicular Germ Cell Tumor (TCGA)"	"Cancer prognostics - Thyroid Carcinoma (TCGA)"	"Cancer prognostics - Uterine Corpus Endometrial Carcinoma (TCGA)"
ABAT	"GABA-T, GABAT"	ENSG00000183044	"4-aminobutyrate aminotransferase"	P80404	16	8674596-8784575	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Neurotransmitter degradation"	"Aminotransferase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 127.6;kidney: 128.6;liver: 335.3;pancreas: 134.0"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 263.2;Horizontal cells: 67.4;Inhibitory neurons: 91.1;Oligodendrocyte precursor cells: 72.2;Proximal tubular cells: 76.0"	"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"Glioblastoma Multiforme (TCGA): 88.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Kidney - Proximal tubular cells, Liver - Hepatocytes, Pancreas - Exocrine glandular cells, Prostate - Prostate glandular cells, Testis - Sertoli cells, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041528, HPA041690"	Enhanced	Supported	Supported	Mitochondria			No	No		1600000	"Cluster 21: Neutrophils - Unknown function"	"Cluster 69: Liver - Oxidoreductase activity"	"Cluster 40: Astrocytes - Astrocyte-neuron interactions"	"Cluster 33: Sarcoma - Muscle contraction"	"Cluster 62: Hepatocytes - Metabolism"	6	Mitochondria		"HPA041528: AB_10795690, HPA041690: AB_10794674"	"unprognostic (5.62e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.31e-3)"	"unprognostic (3.90e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.66e-1)"	"unprognostic (3.07e-1)"	"potential prognostic favorable (5.11e-8)"	"unprognostic (4.54e-2)"	"potential prognostic favorable (2.14e-5)"	"potential prognostic favorable (5.42e-4)"	"unprognostic (2.22e-3)"	"potential prognostic favorable (6.68e-5)"	"unprognostic (7.12e-3)"	"unprognostic (1.97e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.24e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.52e-1)"	"unprognostic (4.48e-1)"	"unprognostic (5.41e-2)"	"unprognostic (7.31e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.88e-2)"
ABCA1	"ABC1, HDLDT1, TGD"	ENSG00000165029	"ATP binding cassette subfamily A member 1"	O95477	9	104781006-104928155	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transport"	Translocase	"Atherosclerosis, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"granulocytes: 147.1;Hepatocytes: 135.0;Kupffer cells: 149.2;Langerhans cells: 126.1;Macrophages: 114.3"	"Cell type enhanced"	"Detected in all"		"astrocyte: 485.5;fibroblast: 338.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"eosinophil: 13.1;neutrophil: 10.7"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 13.1"	"Low cancer specificity"	"Detected in many"			"Adrenal gland - Adrenal cortex cells, Minor Salivary Gland - Macrophages"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB069889, HPA075201"	Approved		Supported	"Golgi apparatus,Plasma membrane"			NA	NA			"Cluster 22: Eosinophils - Transcription"	"Cluster 11: Liver - Plasma proteins"	"Cluster 39: Astrocytes - Mixed function"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 58: Macrophages - Innate immune response"	16	"Plasma membrane"	"Golgi apparatus"	"CAB069889: AB_10002789, HPA075201: "	"unprognostic (1.04e-2)"	"unprognostic (2.61e-2)"	"unprognostic (9.75e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.28e-1)"	"unprognostic (8.23e-2)"	"unprognostic (7.72e-2)"	"unprognostic (8.66e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.87e-2)"	"potential prognostic favorable (4.66e-4)"	"unprognostic (6.71e-3)"	"unprognostic (9.94e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.68e-1)"	"unprognostic (8.55e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.09e-3)"	"potential prognostic unfavorable (1.19e-4)"	"unprognostic (3.06e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.73e-1)"	"potential prognostic unfavorable (7.46e-4)"	"unprognostic (5.47e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.14e-1)"
ABCC1	"GS-X, MRP, MRP1"	ENSG00000103222	"ATP binding cassette subfamily C member 1"	P33527	16	15949138-16143257	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	"Hydrolase, Translocase"	"Cancer-related genes, Deafness, FDA approved drug targets, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Breast - Fibroblasts, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002380, HPA076011"	Uncertain		Supported	"Plasma membrane,Cell Junctions"			NA	NA				"Cluster 66: Non-specific - Transcription"	"Cluster 21: Non-specific - Metabolism"	"Cluster 7: Liver cancer - Metabolism"	"Cluster 78: NK-cells & T-cells - Immune system & Transcription"	13	"Plasma membrane"	"Cell Junctions"	"HPA002380: AB_1844432, HPA076011: "	"unprognostic (9.49e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.60e-2)"	"unprognostic (6.27e-2)"	"unprognostic (7.13e-2)"		"unprognostic (1.71e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.04e-1)"	"potential prognostic favorable (1.30e-5)"	"unprognostic (3.17e-1)"	"unprognostic (1.47e-1)"		"unprognostic (1.12e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.77e-2)"	"unprognostic (4.25e-2)"	"unprognostic (3.61e-2)"	"unprognostic (9.51e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.58e-3)"	"unprognostic (4.55e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.35e-1)"	"unprognostic (7.70e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.06e-1)"
ABCC2	"CMOAT, cMRP, DJS, MRP2"	ENSG00000023839	"ATP binding cassette subfamily C member 2"	Q92887	10	99782640-99852594	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 39.1;liver: 118.0"	"Cell type enriched"	"Detected in many"	6	"Hepatocytes: 213.3"	"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in many"		"Liver Hepatocellular Carcinoma (TCGA): 29.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"liver cancer: 63.3;Rhabdoid: 79.2"	"Kidney - Proximal tubular cells, Testis - Early spermatids"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA071145	Enhanced						NA	NA				"Cluster 37: Liver & Intestine - Lipid metabolism"	"Cluster 6: Non-specific - Immune response"	"Cluster 7: Liver cancer - Metabolism"	"Cluster 43: Hepatocytes - Metabolism"	15			"HPA071145: "	"unprognostic (6.73e-3)"		"unprognostic (2.25e-1)"		"unprognostic (3.38e-1)"	"unprognostic (8.66e-2)"		"unprognostic (3.75e-3)"			"unprognostic (6.93e-3)"	"unprognostic (1.93e-2)"	"potential prognostic unfavorable (5.54e-5)"	"unprognostic (2.14e-1)"	"unprognostic (6.60e-2)"	"potential prognostic unfavorable (5.77e-7)"	"unprognostic (3.62e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.11e-3)"				"unprognostic (1.92e-2)"		"unprognostic (1.93e-1)"	"unprognostic (1.43e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.71e-1)"		
ABCC8	"ABC36, HHF1, HI, HRINS, MRP8, PHHI, SUR, SUR1, TNDM2"	ENSG00000006071	"ATP binding cassette subfamily C member 8"	Q09428	11	17392498-17476894	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	Transport	Receptor	"Diabetes mellitus, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 42.2;pancreas: 19.5;pituitary gland: 33.4"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 18.6;Bipolar cells: 47.0;Endometrial stromal cells: 16.4;Enteroendocrine cells: 16.5;Excitatory neurons: 46.6;Horizontal cells: 18.9;Inhibitory neurons: 37.6;Oligodendrocyte precursor cells: 36.8;Pancreatic endocrine cells: 30.6"	"Low cell type specificity"	"Detected in many"			"Cancer enriched"	"Detected in some"	7	"Pancreatic Adenocarcinoma (TCGA): 23.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	9	"thyroid cancer: 3.4"	"Adrenal gland - Adrenal medulla cells, Heart muscle - Cardiomyocytes, Pancreas - Alpha cells, Pancreas - Beta cells, Pituitary gland - Corticotropes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011451, HPA042318"	Approved		Approved	"Nucleoli,Golgi apparatus,Cytosol,Principal piece"			No	NA				"Cluster 65: Cerebellum - Nervous system development"	"Cluster 24: Neurons - Mixed function"	"Cluster 16: Thyroid cancer - Neuronal signaling"	"Cluster 25: Bipolar cells - Visual perception"		"Nucleoli, Golgi apparatus"	"Cytosol, Principal piece"	"CAB011451: , HPA042318: AB_2677947"		"unprognostic (2.97e-1)"	"unprognostic (2.51e-2)"				"unprognostic (3.41e-2)"	"unprognostic (1.26e-2)"														"unprognostic (1.79e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.62e-2)"						"unprognostic (4.12e-2)"	
ABCC9	"CMD1O, SUR2"	ENSG00000069431	"ATP binding cassette subfamily C member 9"	O60706	12	21797389-21942543	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	Transport	Receptor	"Atrial fibrillation, Cardiomyopathy, Disease variant, FDA approved drug targets, Intellectual disability"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 39.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 68.4;Cardiomyocytes: 37.0;Fibroblasts: 30.5;Hepatocytes: 83.2;Sertoli cells: 46.2;Skeletal myocytes: 53.7;Smooth muscle cells: 84.8"	"Cell type enhanced"	"Detected in many"		"ependymal cell: 194.8;pericyte: 470.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Kidney - Fibroblasts, Pituitary gland - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007279	Uncertain		Approved	"Nucleoplasm,Plasma membrane"			NA	NA				"Cluster 83: Liver - Metabolism"	"Cluster 23: Choroid plexus - Mixed function"	"Cluster 71: Lymphoma - Inflammatory response"	"Cluster 48: Smooth muscle cells - Signal transduction"		"Nucleoplasm, Plasma membrane"		"HPA007279: AB_1844435"	"unprognostic (1.79e-1)"	"potential prognostic unfavorable (9.88e-4)"	"unprognostic (1.25e-1)"	"unprognostic (4.91e-2)"	"potential prognostic unfavorable (7.23e-4)"	"unprognostic (2.47e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.90e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.62e-1)"	"potential prognostic favorable (1.68e-4)"	"unprognostic (5.46e-3)"	"unprognostic (1.39e-1)"	"unprognostic (8.16e-3)"	"unprognostic (2.68e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.55e-1)"	"unprognostic (5.70e-2)"	"unprognostic (8.19e-2)"	"unprognostic (9.97e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.56e-1)"	"unprognostic (7.50e-3)"	"unprognostic (7.75e-3)"	"unprognostic (9.45e-3)"	"unprognostic (1.92e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.72e-3)"	"unprognostic (1.75e-2)"
ABL1	"ABL, c-ABL, JTK7, p150"	ENSG00000097007	"ABL proto-oncogene 1, non-receptor tyrosine kinase"	P00519	9	130713043-130887675	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Autophagy, Cell adhesion, DNA damage, DNA repair, Endocytosis"	"DNA-binding, Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 108.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Breast - Fibroblasts, Spleen - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002686, HPA027251, HPA027280, HPA028409"	Supported		Supported	"Nucleoplasm,Nuclear bodies"			Yes	No			"Cluster 30: Non-specific - DNA binding"	"Cluster 41: Smooth muscle tissue - ECM organization"	"Cluster 6: Non-specific - Immune response"	"Cluster 43: Non-specific - Basic cellular processes"	"Cluster 53: Fibroblasts - ECM organization"	160	Nucleoplasm	"Nuclear bodies"	"CAB002686: , HPA027251: AB_1844453, HPA027280: AB_1844454, HPA028409: AB_10601011"	"unprognostic (1.53e-1)"	"unprognostic (2.66e-2)"	"unprognostic (4.09e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.40e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.22e-1)"	"potential prognostic favorable (2.76e-4)"	"unprognostic (7.92e-3)"	"unprognostic (4.17e-1)"	"unprognostic (7.37e-3)"	"unprognostic (5.27e-2)"	"unprognostic (2.14e-2)"	"unprognostic (7.30e-2)"	"unprognostic (1.14e-2)"	"unprognostic (3.64e-3)"	"unprognostic (1.42e-2)"	"unprognostic (2.99e-3)"	"unprognostic (9.06e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.66e-2)"	"unprognostic (3.38e-1)"	"unprognostic (9.73e-2)"	"unprognostic (3.41e-2)"
ACAT1	"ACAT, THIL"	ENSG00000075239	"Acetyl-CoA acetyltransferase 1"	P24752	11	108116695-108147603	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 599.8;liver: 939.5"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 814.6;Distal tubular cells: 556.3;Hepatocytes: 776.1;Proximal tubular cells: 1447.9"	"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"Kidney Chromophobe (TCGA): 542.4"	"Region enriched"	"Detected in all"	4	"choroid plexus: 124.0"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Adrenal gland - Adrenal cortex cells, Breast - Adipocytes (Breast), Heart muscle - Cardiomyocytes, Kidney - Proximal tubular cells, Kidney - Proximal tubular cells, Liver - Hepatocytes, Skeletal muscle - Skeletal myocytes, Spleen - Macrophages, Testis - Early spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004428, HPA007569"	Enhanced		Enhanced	Mitochondria			NA	NA		660000	"Cluster 33: Non-specific - ATP binding"	"Cluster 1: Liver & Kidney - Metabolism"	"Cluster 21: Non-specific - Metabolism"	"Cluster 24: Non-specific - Unknown function"	"Cluster 56: Proximal tubular cells - Amino acid metabolism"	14	Mitochondria		"HPA004428: AB_1078088, HPA007569: AB_1844482"	"unprognostic (9.86e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.32e-2)"	"unprognostic (2.05e-2)"	"unprognostic (4.08e-1)"	"unprognostic (3.01e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.29e-1)"	"potential prognostic favorable (1.55e-11)"	"unprognostic (9.23e-3)"	"potential prognostic favorable (3.02e-5)"	"potential prognostic favorable (4.27e-4)"	"unprognostic (1.04e-3)"	"unprognostic (5.77e-3)"	"unprognostic (3.21e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.18e-2)"	"unprognostic (3.99e-2)"	"unprognostic (4.19e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.78e-1)"	"unprognostic (4.64e-2)"	"unprognostic (6.88e-2)"
ACE	"ACE1, CD143, DCP1"	ENSG00000159640	"Angiotensin I converting enzyme"	P12821	17	63477061-63498380	"Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Calmodulin-binding, Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 257.7;testis: 99.0"	"Group enriched"	"Detected in many"	20	"Early spermatids: 373.5;Late spermatids: 1317.0;Proximal enterocytes: 1039.2"	"Cell type enhanced"	"Detected in many"		"endothelial cell: 5.9;medium spiny neuron: 7.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"memory B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cancer enhanced"	"Detected in many"		"Neuroblastoma: 17.2"	"Adipose subcutaneous - Adipose progenitor cells, Kidney - Proximal tubular cells, Kidney - Proximal tubular cells, Pituitary gland - Corticotropes, Skin - Fibroblast_1, Testis - Late spermatids, Thyroid gland - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002426, CAB002921, HPA029298, HPA069790"	Enhanced		Approved	Vesicles	"Secreted to blood"	Enzyme	NA	NA	104000000	130000000	"Cluster 14: Non-specific - Unknown function"	"Cluster 25: Small intestine - Absorption"	"Cluster 33: Neurons - Mixed function"	"Cluster 11: Neuronal - Sensory perception"	"Cluster 22: Proximal enterocytes - Digestion"	4	Vesicles		"CAB002426: AB_442052, CAB002921: , HPA029298: AB_10960255, HPA069790: AB_2686197"	"unprognostic (2.23e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.07e-2)"	"unprognostic (4.01e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.68e-1)"	"unprognostic (4.46e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.90e-1)"	"validated prognostic favorable (2.65e-5)"	"validated prognostic favorable (2.01e-4)"	"unprognostic (4.85e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.62e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.69e-3)"	"unprognostic (1.32e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.71e-1)"	"unprognostic (6.94e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.92e-2)"
ACHE	YT	ENSG00000087085	"Acetylcholinesterase (Cartwright blood group)"	P22303	7	100889994-100896974	"Blood group antigen proteins, Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Neurotransmitter degradation"	"Blood group antigen, Hydrolase, Serine esterase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 104.5;skeletal muscle: 157.4;tongue: 46.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 35.1;Erythroid cells: 33.0;Exocrine glandular cells: 63.2;Horizontal cells: 59.2;Paneth cells: 39.8;Proximal enterocytes: 39.3;Skeletal myocytes: 80.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Colon - Colon enteroendocrine cells, Heart muscle - Fibroblasts, Pituitary gland - Gonadotropes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027098			Approved	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	Enzyme	NA	NA		1200000		"Cluster 79: Non-specific - Transcription"	"Cluster 41: Monoamines - Neurotransmitter signalling"	"Cluster 47: Leukemia - Hemostasis"	"Cluster 5: Enterocytes - Absorption"	3	"Golgi apparatus"	Vesicles	"HPA027098: AB_2672111"	"unprognostic (8.14e-3)"		"unprognostic (2.08e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.35e-2)"	"potential prognostic unfavorable (2.24e-5)"	"unprognostic (7.48e-2)"	"unprognostic (1.68e-1)"		"potential prognostic unfavorable (5.51e-5)"	"unprognostic (1.66e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.02e-1)"	"potential prognostic unfavorable (2.58e-5)"	"potential prognostic favorable (5.01e-4)"	"unprognostic (1.15e-1)"	"unprognostic (3.29e-2)"				"unprognostic (1.00e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.58e-1)"	"unprognostic (4.15e-2)"		"unprognostic (7.51e-3)"
ACLY	"ACL, ATPCL, CLATP"	ENSG00000131473	"ATP citrate lyase"	P53396	17	41866917-41930542	"Cancer-related genes, Citric acid cycle related proteins, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Colon - Macrophages, Prostate - Prostate glandular cells, Testis - Spermatogonia"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007783, HPA022434, HPA022953, HPA022959, HPA028758"	Enhanced		Supported	"Nucleoplasm,Primary cilium transition zone,Basal body,Cytosol,Principal piece"			No	No		3600000	"Cluster 37: Monocytes & Neutrophils - Innate immune response"	"Cluster 51: Thyroid gland - Unknown function"	"Cluster 43: Hindbrain - Mixed function"	"Cluster 1: Neuronal - Visual perception"	"Cluster 38: Proximal tubular cells - Transmembrane transport"	37	Cytosol	"Nucleoplasm, Primary cilium transition zone, Basal body, Principal piece"	"CAB007783: AB_562242, HPA022434: AB_1844513, HPA022953: AB_1844514, HPA022959: AB_1844515, HPA028758: AB_10603575"	"unprognostic (1.22e-1)"	"unprognostic (3.18e-2)"	"unprognostic (5.18e-2)"	"potential prognostic unfavorable (5.56e-4)"	"unprognostic (1.55e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.33e-2)"	"potential prognostic unfavorable (4.59e-5)"	"potential prognostic favorable (1.58e-6)"	"unprognostic (1.50e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.90e-3)"	"unprognostic (6.07e-3)"	"unprognostic (5.74e-3)"	"unprognostic (2.90e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.26e-1)"	"unprognostic (4.50e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.16e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.31e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.67e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.45e-1)"
ACP3	"ACP-3, ACPP, PAP, TM-PAP"	ENSG00000014257	"Acid phosphatase 3"	P15309	3	132317369-132368302	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Lipid metabolism"	Hydrolase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	76	"prostate: 3512.4"	"Cell type enriched"	"Detected in many"	443	"Prostatic glandular cells: 16688.0"	"Cell type enriched"	"Detected in some"	4	"central nervous system macrophage: 55.6"	"Cancer enriched"	"Detected in many"	268	"Prostate Adenocarcinoma (TCGA): 2890.7"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 139.9"	"Lineage enhanced"	"Detected in many"		"granulocytes: 139.9"	"Cancer enriched"	"Detected in many"	36	"prostate cancer: 250.9"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Adrenal cortex cells, Breast - Breast glandular cells, Lung - Alveolar cells type 2, Prostate - Prostate glandular cells, Spleen - Neutrophils"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB000071, HPA004335, HPA063916"	Enhanced				"Secreted to blood"	Enzyme	NA	NA	460000	470000	"Cluster 7: Non-specific - Innate immune response"	"Cluster 64: Neuronal - Transcription"	"Cluster 55: Non-specific - Transcription"	"Cluster 60: Prostate cancer - Unknown function"	"Cluster 40: Prostatic glandular cells - Transcription"	2			"CAB000071: , HPA004335: AB_1079684, HPA063916: AB_2685152"	"unprognostic (7.88e-2)"	"unprognostic (1.70e-1)"		"unprognostic (2.87e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.42e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.36e-1)"		"unprognostic (1.54e-1)"				"unprognostic (7.46e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.14e-1)"	"unprognostic (4.84e-2)"	"unprognostic (3.99e-2)"	"unprognostic (4.19e-1)"	"unprognostic (8.01e-2)"	"unprognostic (9.41e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.26e-3)"	"unprognostic (7.95e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.68e-1)"
ACTN1		ENSG00000072110	"Actinin alpha 1"	P12814	14	68874128-68979440	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 515.0"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 369.9;Pancreatic endocrine cells: 336.2"	"Cell type enhanced"	"Detected in all"		"vascular associated smooth muscle cell: 424.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 346.0"	"Low lineage specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"Adrenocortical cancer: 1086.0"	"Colon - Smooth muscle cells, Lung - Smooth muscle cells, Minor Salivary Gland - Minor salivary glandular cells, Pituitary gland - Endothelial cells, Prostate - Smooth muscle cells, Skin - Outer root sheath cells, Spleen - Fibroblast_1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004303, HPA006035"	Approved		Approved	"Plasma membrane,Actin filaments,Focal adhesion sites,Primary cilium,Primary cilium transition zone,Cytosol"			NA	NA		260000000	"Cluster 21: Neutrophils - Unknown function"	"Cluster 41: Smooth muscle tissue - ECM organization"	"Cluster 23: Choroid plexus - Mixed function"	"Cluster 30: Non-specific - Gene expression regulation"	"Cluster 32: Smooth muscle cells - Muscle contraction"	93	"Plasma membrane, Actin filaments, Focal adhesion sites"	"Primary cilium, Primary cilium transition zone, Cytosol"	"CAB004303: AB_626633, HPA006035: AB_1078095"	"unprognostic (1.11e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.73e-2)"	"potential prognostic unfavorable (1.49e-4)"	"unprognostic (2.42e-1)"	"unprognostic (3.28e-2)"	"unprognostic (4.79e-2)"	"unprognostic (8.30e-2)"	"unprognostic (1.86e-3)"	"unprognostic (2.64e-2)"	"unprognostic (2.47e-3)"	"unprognostic (2.33e-1)"	"potential prognostic unfavorable (1.38e-5)"	"unprognostic (2.64e-3)"	"unprognostic (3.88e-3)"	"unprognostic (1.87e-3)"	"potential prognostic unfavorable (3.40e-4)"	"unprognostic (5.31e-2)"	"unprognostic (4.19e-3)"	"unprognostic (1.87e-2)"	"unprognostic (3.56e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.57e-1)"	"unprognostic (4.07e-1)"	"unprognostic (4.24e-3)"	"unprognostic (6.92e-2)"	"unprognostic (8.09e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.71e-2)"	"unprognostic (2.14e-1)"
ADA	ADA1	ENSG00000196839	"Adenosine deaminase"	P00813	20	44584896-44652252	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Nucleotide metabolism"	Hydrolase	"Disease variant, FDA approved drug targets, Hereditary hemolytic anemia, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"intestine: 468.5;lymphoid tissue: 238.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 107.6;Extravillous trophoblasts: 152.2;monocytes: 104.5;Oocytes: 77.9"	"Cell type enhanced"	"Detected in some"		"committed oligodendrocyte precursor: 9.8;leukocyte: 24.5;oligodendrocyte: 12.4;pericyte: 12.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"intermediate monocyte: 163.0;NK-cell: 90.4;non-classical monocyte: 351.2;plasmacytoid DC: 211.2"	"Group enriched"	"Detected in all"	4	"dendritic cells: 211.2;monocytes: 351.2;NK-cells: 90.4"	"Cancer enhanced"	"Detected in all"		"Leukemia: 168.9"	"Minor Salivary Gland - Endothelial cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001399, CAB004307, HPA023884, CAB080432"	Enhanced		Supported	"Plasma membrane,Cytosol"			No	No		590000	"Cluster 10: Non-specific - Membrane trafficking"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 34: Non-specific - Mixed function"	"Cluster 59: Leukemia - T-cell receptor"	"Cluster 4: Extravillous trophoblasts - Unknown function"	4	"Plasma membrane"	Cytosol	"CAB004307: AB_626634, CAB080432: , HPA001399: AB_1078099, HPA023884: AB_1844573"	"unprognostic (2.37e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.18e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.95e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.97e-1)"	"potential prognostic unfavorable (1.73e-5)"	"unprognostic (3.05e-2)"	"potential prognostic unfavorable (5.82e-5)"	"potential prognostic unfavorable (1.35e-6)"	"unprognostic (2.20e-2)"	"potential prognostic unfavorable (6.28e-6)"	"unprognostic (1.13e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.90e-1)"	"unprognostic (6.99e-2)"	"unprognostic (3.57e-3)"	"unprognostic (1.22e-3)"	"unprognostic (7.92e-2)"	"unprognostic (2.84e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.41e-3)"
ADH1A	ADH1	ENSG00000187758	"Alcohol dehydrogenase 1A (class I), alpha polypeptide"	P07327	4	99276369-99291003	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	305	"liver: 2653.7"	"Cell type enriched"	"Detected in some"	11	"Hepatocytes: 208.0"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	229	"Liver Hepatocellular Carcinoma (TCGA): 407.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Adipose subcutaneous - Adipocytes (Subcutaneous), Liver - Hepatocytes, Minor Salivary Gland - Adipocytes (Minor salivary gland)"									"CAB009562, HPA047814, HPA060902"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Primary cilium,Primary cilium transition zone,Basal body,Cytosol"			NA	NA		28000000		"Cluster 31: Liver - Plasma proteins"		"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 43: Hepatocytes - Metabolism"		"Plasma membrane, Cytosol"	"Nucleoplasm, Primary cilium, Primary cilium transition zone, Basal body"	"CAB009562: AB_2257984, HPA047814: AB_2680163, HPA060902: AB_2684384"														"potential prognostic favorable (1.95e-4)"	"unprognostic (2.75e-3)"							"unprognostic (1.50e-3)"						"unprognostic (3.22e-2)"			
ADH1B	ADH2	ENSG00000196616	"Alcohol dehydrogenase 1B (class I), beta polypeptide"	P00325	4	99304971-99352760	"Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 1449.1;liver: 5678.8"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 761.6;Hepatocytes: 4180.2;Mesothelial cells: 1146.2"	"Group enriched"	"Detected in some"	39	"fibroblast: 44.1;pericyte: 47.6;vascular associated smooth muscle cell: 15.1"	"Cancer enriched"	"Detected in many"	27	"Liver Hepatocellular Carcinoma (TCGA): 832.6"	"Region enhanced"	"Detected in many"		"choroid plexus: 24.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Adipose subcutaneous - Adipocytes (Subcutaneous), Adrenal gland - Fibroblasts, Breast - Adipocytes (Breast), Kidney - Fibroblasts, Liver - Hepatocytes, Pancreas - Fibroblasts, Spleen - Fibroblast_2, Testis - Endothelial cells"									"HPA047814, HPA060902"	Supported		Approved	"Nucleoplasm,Plasma membrane,Primary cilium,Primary cilium transition zone,Basal body,Cytosol"			NA	NA		30000000		"Cluster 83: Liver - Metabolism"	"Cluster 8: Immune cells - Immune response"	"Cluster 44: Connective tissue cells - ECM organization"	"Cluster 43: Hepatocytes - Metabolism"	1	"Plasma membrane, Cytosol"	"Nucleoplasm, Primary cilium, Primary cilium transition zone, Basal body"	"HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (1.36e-2)"	"unprognostic (5.62e-2)"	"potential prognostic favorable (9.38e-5)"		"unprognostic (4.06e-2)"	"unprognostic (1.40e-1)"				"unprognostic (1.17e-1)"	"unprognostic (9.45e-2)"	"unprognostic (2.29e-1)"	"potential prognostic unfavorable (1.19e-4)"	"validated prognostic favorable (6.15e-4)"	"validated prognostic favorable (6.43e-4)"	"potential prognostic favorable (2.37e-4)"	"unprognostic (2.02e-2)"	"unprognostic (8.00e-3)"	"unprognostic (8.33e-2)"	"unprognostic (9.62e-3)"	"unprognostic (9.31e-2)"	"unprognostic (2.70e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.86e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.95e-3)"	"unprognostic (4.10e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.91e-3)"
ADH1C	ADH3	ENSG00000248144	"Alcohol dehydrogenase 1C (class I), gamma polypeptide"	P00326	4	99336497-99352746	"Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	21	"intestine: 581.0;liver: 1997.6;stomach 1: 555.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 230.3;Enteroendocrine cells: 216.1;Exocrine glandular cells: 344.5;Gastric mucus-secreting cells: 669.1;Hepatocytes: 514.4;Undifferentiated cells: 339.5"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	7	"Liver Hepatocellular Carcinoma (TCGA): 461.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"liver cancer: 53.7"	"Liver - Hepatocytes, Minor Salivary Gland - Minor salivary gland ductal cells, Stomach - Gastric mucous cells"									"HPA047814, HPA060902"	Supported		Approved	"Nucleoplasm,Plasma membrane,Primary cilium,Primary cilium transition zone,Basal body,Cytosol"			NA	NA		22000000		"Cluster 83: Liver - Metabolism"		"Cluster 7: Liver cancer - Metabolism"	"Cluster 43: Hepatocytes - Metabolism"	11	"Plasma membrane, Cytosol"	"Nucleoplasm, Primary cilium, Primary cilium transition zone, Basal body"	"HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (6.19e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.94e-2)"	"unprognostic (6.65e-2)"	"unprognostic (4.46e-3)"	"unprognostic (1.12e-1)"			"unprognostic (5.87e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.68e-1)"		"unprognostic (1.40e-3)"	"validated prognostic favorable (3.38e-4)"	"validated prognostic favorable (5.73e-9)"	"unprognostic (1.07e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.17e-2)"	"unprognostic (8.99e-2)"			"unprognostic (1.74e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.82e-1)"		"unprognostic (9.15e-2)"	"unprognostic (1.95e-1)"		"unprognostic (2.53e-1)"
ADORA1	RDC7	ENSG00000163485	"Adenosine A1 receptor"	P30542	1	203090654-203167405	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 44.2;testis: 20.9"	"Cell type enhanced"	"Detected in some"		"Ductal cells: 12.9;Excitatory neurons: 17.5;Muller glia cells: 40.9;Oligodendrocyte precursor cells: 33.0;Oligodendrocytes: 29.3"	"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in many"		"Glioblastoma Multiforme (TCGA): 66.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Kidney cancer: 51.9"	"Adipose subcutaneous - Adipocytes (Subcutaneous), Heart muscle - Cardiomyocytes, Kidney - Podocytes, Skin - Eccrine sweat gland cells, Testis - Sertoli cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044383, CAB080543"	Uncertain		Supported	"Plasma membrane,Primary cilium"			NA	NA				"Cluster 9: Oligodendrocytes - Myelination"	"Cluster 49: Hindbrain - Mixed function"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 10: Muller glia cells - Visual perception"	9	"Plasma membrane"	"Primary cilium"	"CAB080543: , HPA044383: AB_2678921"	"unprognostic (1.90e-2)"	"unprognostic (7.77e-3)"	"unprognostic (6.77e-2)"	"unprognostic (6.62e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.55e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.60e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.16e-3)"	"unprognostic (8.88e-2)"	"potential prognostic unfavorable (4.46e-4)"	"unprognostic (3.10e-2)"	"unprognostic (2.84e-1)"	"unprognostic (5.65e-3)"	"unprognostic (1.94e-3)"	"potential prognostic unfavorable (8.41e-4)"	"unprognostic (8.47e-2)"	"unprognostic (1.06e-3)"	"unprognostic (5.04e-2)"	"unprognostic (3.75e-2)"	"unprognostic (9.22e-2)"		"unprognostic (1.41e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.51e-2)"	"unprognostic (9.36e-2)"	"unprognostic (2.44e-2)"	"unprognostic (2.23e-2)"
ADORA2A	"ADORA2, RDC8"	ENSG00000128271	"Adenosine A2a receptor"	P29274	22	24417879-24442357	"Cancer-related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 40.1;brain: 111.0;lymphoid tissue: 52.7"	"Cell type enhanced"	"Detected in some"		"B-cells: 6.1;Gastric mucus-secreting cells: 1.8;Plasma cells: 9.1;T-cells: 3.0"	"Cell type enhanced"	"Detected in many"		"medium spiny neuron: 46.3;pericyte: 95.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	8	"basal ganglia: 200.5"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"lymphoma: 45.6;Myeloma: 39.1"	"Kidney - Endothelial cells"	"Region enriched"	"Detected in many"	9	"basal ganglia: 399.9"	"Region enriched"	"Detected in many"	50	"basal ganglia: 187.1"	"CAB001943, HPA065566, HPA075997"	Enhanced	Supported					NA	NA			"Cluster 43: Non-specific - Transcription & Translation"	"Cluster 5: Brain & Testis - Signal transduction"	"Cluster 33: Neurons - Mixed function"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 7: T-cells - T-cell receptor"	16			"CAB001943: , HPA065566: , HPA075997: AB_2732298"	"unprognostic (6.30e-2)"	"unprognostic (9.31e-2)"	"unprognostic (1.67e-1)"	"unprognostic (8.72e-3)"	"unprognostic (1.52e-1)"	"unprognostic (8.94e-2)"	"unprognostic (1.67e-1)"		"potential prognostic favorable (3.96e-4)"	"unprognostic (5.64e-3)"	"potential prognostic favorable (8.35e-4)"	"unprognostic (3.52e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.03e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.24e-3)"	"unprognostic (9.51e-2)"	"unprognostic (2.79e-2)"	"unprognostic (3.59e-2)"	"potential prognostic favorable (2.01e-4)"	"unprognostic (1.40e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.46e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.73e-2)"	"unprognostic (4.08e-1)"	"unprognostic (3.40e-1)"
ADORA2B		ENSG00000170425	"Adenosine A2b receptor"	P29275	17	15945130-15975746	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"urinary bladder: 16.1"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 46.2;Basal respiratory cells: 69.1;Basal squamous epithelial cells: 31.2;Langerhans cells: 31.5;Suprabasal keratinocytes: 36.4"	"Cell type enhanced"	"Detected in many"		"bergmann glia: 42.2;pericyte: 75.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 17.3;myeloid DC: 10.5"	"Group enriched"	"Detected in many"	113	"dendritic cells: 10.5;granulocytes: 17.3;monocytes: 5.9"	"Low cancer specificity"	"Detected in many"			"Prostate - Urothelial cells, Skin - Keratinocyte (other)"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073747			Uncertain	Cytosol			NA	Yes			"Cluster 26: Monocytes - Plasma membrane proteins"	"Cluster 60: Choroid plexus - Transmembrane transport"	"Cluster 40: Astrocytes - Astrocyte-neuron interactions"	"Cluster 49: HMC-1 - Innate immune response"	"Cluster 12: Squamous epithelial cells - Keratinization"	28	Cytosol		"HPA073747: "	"unprognostic (7.71e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.21e-3)"		"potential prognostic unfavorable (3.29e-11)"	"unprognostic (1.43e-2)"			"unprognostic (5.82e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.63e-3)"	"unprognostic (6.40e-2)"	"unprognostic (9.42e-2)"			"unprognostic (1.31e-3)"	"unprognostic (1.98e-2)"		"unprognostic (1.83e-1)"	"unprognostic (5.14e-1)"	"unprognostic (2.00e-1)"	"unprognostic (8.92e-2)"	"unprognostic (3.43e-1)"		"unprognostic (4.79e-2)"
ADORA3	"A3AR, AD026"	ENSG00000282608	"Adenosine A3 receptor"	P0DMS8	1	111499429-111503633	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.7"	"Cell type enhanced"	"Detected in some"		"granulocytes: 13.8;Hofbauer cells: 16.7;Kupffer cells: 62.2;Late spermatids: 17.7;Macrophages: 31.4"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in all"		"Glioblastoma Multiforme (TCGA): 37.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	40	"eosinophil: 602.8"	"Lineage enriched"	"Detected in many"	40	"granulocytes: 602.8"	"Cancer enriched"	"Detected in single"	6	"Leukemia: 1.9"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Colon - Macrophages, Heart muscle - Macrophages, Kidney - Macrophages, Liver - Kupffer cells, Lung - Macrophages, Minor Salivary Gland - Macrophages, Pancreas - Macrophages, Pituitary gland - Macrophages, Prostate - Macrophages, Skeletal muscle - Macrophages, Skin - Macrophages, Stomach - Macrophages, Thyroid gland - Macrophages"	"Low region specificity"	"Detected in many"														NA	NA			"Cluster 19: Eosinophils - Unknown function"	"Cluster 9: Oligodendrocytes - Myelination"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 49: HMC-1 - Innate immune response"	"Cluster 58: Macrophages - Innate immune response"					"unprognostic (6.22e-3)"	"unprognostic (1.21e-3)"	"unprognostic (1.64e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.49e-2)"	"unprognostic (9.09e-3)"	"unprognostic (7.27e-2)"		"unprognostic (2.59e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.78e-3)"	"unprognostic (2.30e-1)"	"potential prognostic favorable (2.48e-4)"	"unprognostic (7.41e-3)"	"unprognostic (2.24e-1)"	"unprognostic (6.85e-3)"	"unprognostic (2.27e-3)"	"unprognostic (3.93e-2)"	"unprognostic (2.38e-2)"	"unprognostic (5.51e-3)"		"unprognostic (7.31e-2)"		"unprognostic (3.36e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.31e-2)"	"potential prognostic favorable (1.67e-5)"	"unprognostic (6.36e-3)"
ADRA1A	"ADRA1C, ADRA1L1"	ENSG00000120907	"Adrenoceptor alpha 1A"	P35348	8	26748150-26867278	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 21.0;liver: 58.3"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 100.0;Early spermatids: 34.5;Inhibitory neurons: 117.6;Late spermatids: 38.2;Oligodendrocyte precursor cells: 107.1"	"Cell type enhanced"	"Detected in many"		"bergmann glia: 455.0;hippocampal dentate gyrus: 910.2"	"Cancer enhanced"	"Detected in some"		"Liver Hepatocellular Carcinoma (TCGA): 2.9;Prostate Adenocarcinoma (TCGA): 2.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	7	"Bone cancer: 4.1"	"Adipose subcutaneous - Adipocytes (Subcutaneous), Breast - Adipocytes (Breast), Prostate - Smooth muscle cells, Skin - Smooth muscle cells, Testis - Late spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA029678, HPA029679, HPA076693"	Approved	Supported	Approved	Nucleoplasm,Vesicles,Cytosol			NA	NA				"Cluster 83: Liver - Metabolism"	"Cluster 29: Forebrain - Mixed function"	"Cluster 12: Bone cancer - Neuronal signaling"	"Cluster 69: Neurons - Neuronal signaling"	4	Cytosol	"Nucleoplasm, Vesicles"	"HPA029678: AB_10602108, HPA029679: AB_2673143, HPA076693: "							"unprognostic (1.16e-1)"	"unprognostic (1.79e-1)"						"unprognostic (1.31e-3)"	"potential prognostic favorable (1.35e-4)"								"unprognostic (3.35e-2)"	"unprognostic (4.83e-2)"							
ADRA1B		ENSG00000170214	"Adrenoceptor alpha 1B"	P35368	5	159865080-159973012	"Cancer-related genes, FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 8.9;liver: 11.2;lymphoid tissue: 11.3"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 40.1;Hepatocytes: 13.5;Horizontal cells: 8.2;Inhibitory neurons: 31.2;Mesothelial cells: 12.5"	"Cell type enhanced"	"Detected in many"		"CGE interneuron: 144.7;hippocampal dentate gyrus: 115.4"	"Cancer enhanced"	"Detected in many"		"Kidney Renal Clear Cell Carcinoma (TCGA): 7.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Adrenal gland - Fibroblasts, Spleen - Fibroblast_2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA074416			Supported	"Plasma membrane"			NA	NA				"Cluster 69: Liver - Oxidoreductase activity"	"Cluster 14: Neurons - Synaptic function"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 34: Neurons - Neuronal signaling"	3	"Plasma membrane"		"HPA074416: AB_2686688"			"unprognostic (1.98e-1)"				"unprognostic (2.28e-3)"	"unprognostic (2.30e-1)"		"unprognostic (1.79e-2)"	"unprognostic (3.25e-3)"	"unprognostic (1.17e-2)"	"unprognostic (9.60e-3)"	"unprognostic (1.26e-3)"	"unprognostic (5.80e-3)"	"unprognostic (5.16e-2)"				"unprognostic (7.14e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.88e-1)"	"unprognostic (6.17e-3)"				"unprognostic (9.64e-3)"			"potential prognostic favorable (7.74e-4)"	"potential prognostic unfavorable (7.17e-4)"
ADRA1D	"ADRA1, ADRA1A, ADRA1R"	ENSG00000171873	"Adrenoceptor alpha 1D"	P25100	20	4220630-4249287	"FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 6.8;cervix: 7.0"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 2.0;Inhibitory neurons: 2.3;Sertoli cells: 8.2;Smooth muscle cells: 6.8"	"Group enriched"	"Detected in many"	4	"CGE interneuron: 14.8;deep-layer near-projecting: 6.0;hippocampal CA1-3: 12.2;hippocampal CA4: 8.7;LAMP5-LHX6 and Chandelier: 15.6;mammillary body: 9.3;MGE interneuron: 5.0;splatter: 6.0;thalamic excitatory: 10.6;vascular associated smooth muscle cell: 3.9"	"Cancer enhanced"	"Detected in some"		"Glioblastoma Multiforme (TCGA): 2.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	5	"Bone cancer: 27.8"	"Adipose visceral - Smooth muscle cells, Minor Salivary Gland - Endothelial cells, Prostate - Smooth muscle cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA038789	Uncertain						NA	NA				"Cluster 64: Neuronal - Transcription"	"Cluster 38: Sub-cortical - Mixed function"	"Cluster 12: Bone cancer - Neuronal signaling"	"Cluster 48: Smooth muscle cells - Signal transduction"	13			"HPA038789: AB_10673475"			"unprognostic (6.41e-2)"				"unprognostic (4.95e-2)"																	"unprognostic (4.86e-2)"				"unprognostic (2.05e-3)"			
ADRA2A	"ADRA2, ADRA2R, ADRAR"	ENSG00000150594	"Adrenoceptor alpha 2A"	P08913	10	111077029-111080907	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 48.9;cervix: 45.1"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 66.8;Glandular and luminal cells: 31.5;Paneth cells: 128.1;Smooth muscle cells: 84.9"	"Cell type enhanced"	"Detected in many"		"vascular associated smooth muscle cell: 15.1"	"Cancer enhanced"	"Detected in many"		"Pancreatic Adenocarcinoma (TCGA): 23.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"prostate cancer: 11.9"	"Adipose visceral - Adipocytes (Visceral), Kidney - Fibroblasts, Minor Salivary Gland - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"										NA	NA				"Cluster 62: Connective tissue - ECM organization"	"Cluster 41: Monoamines - Neurotransmitter signalling"	"Cluster 57: Stomach & Colon cancer - Digestion"	"Cluster 48: Smooth muscle cells - Signal transduction"	2				"unprognostic (2.37e-3)"	"unprognostic (2.18e-1)"	"unprognostic (6.18e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.54e-3)"	"unprognostic (9.50e-2)"		"unprognostic (7.08e-3)"	"unprognostic (3.36e-3)"	"unprognostic (1.83e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.54e-3)"	"potential prognostic favorable (2.96e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.14e-3)"	"unprognostic (2.52e-1)"	"unprognostic (4.78e-2)"	"potential prognostic favorable (2.03e-4)"	"unprognostic (3.11e-2)"	"unprognostic (5.96e-3)"	"unprognostic (1.14e-1)"	"unprognostic (8.70e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.17e-2)"	"unprognostic (3.15e-3)"	"unprognostic (1.87e-1)"
ADRA2B	"ADRA2L1, ADRA2RL1, ADRARL1"	ENSG00000274286	"Adrenoceptor alpha 2B"	P18089	2	96112876-96116571	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Glandular and luminal cells: 6.7;Ionocytes: 12.9;Langerhans cells: 12.0;Sertoli cells: 8.2;Smooth muscle cells: 11.9"	"Cell type enhanced"	"Detected in some"		"choroid plexus epithelial cell: 2.1;eccentric medium spiny neuron: 1.9;medium spiny neuron: 1.8;vascular associated smooth muscle cell: 2.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Colon - Endothelial cells"	"Group enriched"	"Detected in some"	6	"basal ganglia: 2.5;cerebellum: 1.0;thalamus: 3.2"	"Low region specificity"	"Detected in many"			"HPA066029, HPA074948"	Approved		Supported	Vesicles,Cytosol			NA	NA				"Cluster 43: Non-specific - Mitochondrial translation"	"Cluster 42: Choroid plexus - Mitochondria"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 48: Smooth muscle cells - Signal transduction"	3	Vesicles	Cytosol	"HPA066029: AB_2685599, HPA074948: "			"unprognostic (9.15e-3)"							"unprognostic (2.65e-3)"	"validated prognostic favorable (3.02e-4)"	"validated prognostic favorable (7.50e-7)"						"unprognostic (2.27e-2)"		"unprognostic (9.88e-3)"									"unprognostic (2.19e-1)"		
ADRA2C	"ADRA2L2, ADRA2RL2, ADRARL2"	ENSG00000184160	"Adrenoceptor alpha 2C"	P18825	4	3766348-3768526	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 82.1;endometrium 1: 55.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 24.5;Endometrial stromal cells: 133.1;Fibroblasts: 15.7;Secretory cells: 33.6;Smooth muscle cells: 26.0"	"Cell type enhanced"	"Detected in many"		"fibroblast: 19.1;pericyte: 42.4"	"Cancer enhanced"	"Detected in many"		"Ovary Serous Cystadenocarcinoma (TCGA): 30.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Adrenocortical cancer: 18.1"	"Minor Salivary Gland - Endothelial cells, Spleen - Fibroblast_2, Thyroid gland - Smooth muscle cells"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"basal ganglia: 45.2"	HPA057688	Uncertain						NA	NA				"Cluster 62: Connective tissue - ECM organization"	"Cluster 33: Neurons - Mixed function"	"Cluster 32: Non-specific - Cell proliferation"	"Cluster 9: Endometrial stromal cells - Transcription"	10			"HPA057688: AB_2683503"	"unprognostic (7.13e-2)"	"unprognostic (2.93e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.62e-2)"			"unprognostic (6.00e-2)"	"unprognostic (6.62e-2)"	"unprognostic (5.71e-2)"	"unprognostic (8.75e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.82e-2)"		"unprognostic (1.44e-1)"		"unprognostic (1.34e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.95e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.18e-2)"
ADRB1	ADRB1R	ENSG00000043591	"Adrenoceptor beta 1"	P08588	10	114043866-114046904	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 22.9;lung: 12.7;placenta: 28.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 24.6;Cardiomyocytes: 74.7;Cytotrophoblasts: 79.8;Sertoli cells: 24.5;Syncytiotrophoblasts: 34.7"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Kidney Chromophobe (TCGA): 4.9;Prostate Adenocarcinoma (TCGA): 15.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	4	"Bone cancer: 7.9"	"Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Prostate - Prostate glandular cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA067972	Enhanced						NA	NA				"Cluster 34: Non-specific - Mixed function"	"Cluster 53: Neurons - Mixed function"	"Cluster 12: Bone cancer - Neuronal signaling"	"Cluster 24: Cytotrophoblasts - Mitochondria"	7			"HPA067972: AB_2685936"	"unprognostic (6.91e-3)"		"unprognostic (1.45e-3)"	"unprognostic (2.88e-3)"		"potential prognostic unfavorable (3.97e-4)"	"unprognostic (2.39e-1)"	"unprognostic (1.21e-1)"		"unprognostic (9.13e-3)"						"unprognostic (4.93e-3)"	"unprognostic (8.06e-2)"	"unprognostic (2.72e-2)"					"unprognostic (9.33e-2)"	"unprognostic (8.22e-2)"		"unprognostic (5.76e-2)"		"unprognostic (7.28e-2)"			
ADRB2	"ADRB2R, ADRBR, B2AR, BAR"	ENSG00000169252	"Adrenoceptor beta 2"	P07550	5	148826611-148828623	"FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 191.0;Basal keratinocytes: 282.8;Basal respiratory cells: 137.6;Basal squamous epithelial cells: 174.8;granulocytes: 187.1;Squamous epithelial cells: 272.6;Suprabasal keratinocytes: 166.8"	"Cell type enhanced"	"Detected in some"		"central nervous system macrophage: 63.3;leukocyte: 27.5"	"Cancer enhanced"	"Detected in many"		"Prostate Adenocarcinoma (TCGA): 22.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"head and neck cancer: 50.9"	"Colon - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075322			Supported	"Plasma membrane,Microtubules,Cytokinetic bridge,Mitotic spindle,Primary cilium,Basal body"			Yes	NA			"Cluster 25: Non-specific - Unknown function"	"Cluster 75: Epithelium - Extracellular exosomes"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 12: Squamous epithelial cells - Keratinization"	88	"Plasma membrane"	"Microtubules, Cytokinetic bridge, Mitotic spindle, Primary cilium, Basal body"	"HPA075322: "	"unprognostic (4.34e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.49e-1)"	"unprognostic (5.93e-2)"		"unprognostic (1.66e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.35e-1)"	"unprognostic (5.14e-3)"	"potential prognostic favorable (6.64e-7)"	"unprognostic (3.59e-2)"	"unprognostic (1.34e-3)"	"unprognostic (1.11e-2)"	"potential prognostic favorable (8.63e-4)"	"unprognostic (4.60e-3)"	"unprognostic (1.35e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.19e-1)"			"unprognostic (2.08e-2)"	"unprognostic (7.70e-3)"	"unprognostic (2.20e-1)"		"unprognostic (2.45e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.00e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.16e-1)"	
ADRB3		ENSG00000188778	"Adrenoceptor beta 3"	P13945	8	37962990-37966599	"FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Diabetes mellitus, FDA approved drug targets, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 3.9;ovary: 11.3;urinary bladder: 4.5"	"Cell type enriched"	"Detected in some"	8	"Ovarian stromal cells: 14.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	169	"Bone cancer: 17.7"	"Prostate - Fibroblasts"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA061969, HPA065408"	Uncertain		Approved	"Basal body"			NA	NA				"Cluster 62: Connective tissue - ECM organization"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 12: Bone cancer - Neuronal signaling"	"Cluster 50: Connective tissue cells - ECM organization"	1	"Basal body"		"HPA061969: AB_2732674, HPA065408: "																															
AGTR1	"AG2S, AGTR1A, AGTR1B, AT1, AT1B, AT2R1, AT2R1A, AT2R1B, HAT1R"	ENSG00000144891	"Angiotensin II receptor type 1"	P30556	3	148697784-148743008	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 93.7;placenta: 137.0"	"Cell type enhanced"	"Detected in some"		"Fibroblasts: 44.5;Hepatocytes: 28.4;Leydig cells: 139.1;Sertoli cells: 51.7;Smooth muscle cells: 57.7"	"Cell type enhanced"	"Detected in some"		"bergmann glia: 25.1;pericyte: 13.7;vascular associated smooth muscle cell: 30.6"	"Group enriched"	"Detected in many"	8	"Breast Invasive Carcinoma (TCGA): 24.3;Kidney Renal Clear Cell Carcinoma (TCGA): 10.4;Liver Hepatocellular Carcinoma (TCGA): 19.2;Prostate Adenocarcinoma (TCGA): 14.7"	"Region enriched"	"Detected in many"	4	"midbrain: 17.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"liver cancer: 9.3;Rhabdoid: 6.8"	"Adrenal gland - Adrenal cortex cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA003596	Enhanced		Uncertain	Vesicles			NA	NA				"Cluster 11: Liver - Plasma proteins"	"Cluster 41: Monoamines - Neurotransmitter signalling"	"Cluster 44: Connective tissue cells - ECM organization"	"Cluster 53: Fibroblasts - ECM organization"	18	Vesicles		"HPA003596: AB_1845163"	"unprognostic (3.27e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.59e-1)"					"potential prognostic unfavorable (3.98e-5)"		"unprognostic (1.71e-1)"	"validated prognostic favorable (7.11e-7)"	"validated prognostic favorable (3.45e-4)"		"unprognostic (4.30e-1)"	"unprognostic (5.90e-3)"	"unprognostic (9.52e-3)"	"unprognostic (1.55e-2)"		"unprognostic (1.40e-1)"			"unprognostic (7.83e-3)"	"unprognostic (3.49e-2)"	"unprognostic (1.03e-1)"		"unprognostic (1.18e-2)"		"unprognostic (2.01e-3)"	"unprognostic (3.30e-2)"	"unprognostic (2.41e-1)"	
AHR	bHLHe76	ENSG00000106546	"Aryl hydrocarbon receptor"	P35869	7	16916359-17346152	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"	"Cancer-related genes, FDA approved drug targets, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"granulocytes: 187.3;Langerhans cells: 269.5;monocytes: 146.6;Schwann cells: 255.1"	"Cell type enhanced"	"Detected in many"		"hippocampal dentate gyrus: 46.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Skeletal muscle - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005072, HPA029722, HPA029723"	Enhanced		Supported	Nucleoplasm,Cytosol			NA	NA			"Cluster 33: Non-specific - ATP binding"	"Cluster 11: Liver - Plasma proteins"	"Cluster 30: White matter - Myelination"	"Cluster 57: Stomach & Colon cancer - Digestion"	"Cluster 29: Monocytes - Innate immune response"	60	Cytosol	Nucleoplasm	"CAB005072: AB_633731, HPA029722: AB_10599189, HPA029723: AB_10599025"	"potential prognostic favorable (7.65e-4)"	"unprognostic (1.73e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.24e-3)"	"unprognostic (2.07e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.07e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.81e-2)"	"potential prognostic favorable (1.68e-6)"	"unprognostic (1.34e-1)"	"potential prognostic favorable (7.81e-4)"	"unprognostic (1.19e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.47e-1)"	"unprognostic (7.75e-2)"	"unprognostic (2.82e-1)"	"unprognostic (8.88e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.11e-3)"	"unprognostic (2.25e-3)"	"unprognostic (5.04e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.69e-2)"
AKR1B1	"ALDR1, AR"	ENSG00000085662	"Aldo-keto reductase family 1 member B"	P15121	7	134442356-134459284	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism"	Oxidoreductase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"adrenal gland: 2944.0"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 1220.3;Collecting duct cells: 657.4;Cytotrophoblasts: 1189.2;Extravillous trophoblasts: 1344.0;Syncytiotrophoblasts: 2081.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"Kidney cancer: 1445.2"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Adrenal cortex cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026425, CAB027391, CAB047353, HPA052751"	Enhanced		Supported	Nucleoplasm,Cytosol			No	No		1500000	"Cluster 39: T-cells - T-cell receptor"	"Cluster 26: Adrenal gland - Steroid metabolism"	"Cluster 49: Hindbrain - Mixed function"	"Cluster 7: Liver cancer - Metabolism"	"Cluster 3: Basal prostatic cells - Lipid metabolism"	9	Cytosol	Nucleoplasm	"CAB027391: , CAB047353: , HPA026425: AB_10601563, HPA052751: AB_2681935"	"unprognostic (3.13e-3)"	"unprognostic (9.62e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.93e-2)"	"unprognostic (8.67e-2)"	"unprognostic (2.05e-1)"	"potential prognostic unfavorable (1.19e-5)"	"unprognostic (2.06e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.61e-3)"	"unprognostic (2.98e-2)"	"unprognostic (6.42e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.89e-1)"	"unprognostic (6.93e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.75e-2)"	"unprognostic (2.89e-2)"	"potential prognostic unfavorable (6.55e-6)"	"unprognostic (2.72e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.25e-2)"
AKR1C2	"BABP, DD, DD2, DDH2, HAKRD, MCDR2, TDD"	ENSG00000151632	"Aldo-keto reductase family 1 member C2"	P52895	10	4987775-5018031	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Oxidoreductase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 330.8;liver: 469.5"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 123.2;Basal respiratory cells: 143.0;Club cells: 131.5;Exocrine glandular cells: 158.7;Hepatocytes: 471.5;Squamous epithelial cells: 115.4"	"Cell type enriched"	"Detected in many"	8	"fibroblast: 183.3"	"Cancer enhanced"	"Detected in all"		"Lung Squamous Cell Carcinoma (TCGA): 964.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"Bladder cancer: 359.3;Esophageal cancer: 1222.9;Gallbladder cancer: 1184.3;liver cancer: 557.1;lung cancer: 433.6"	"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast)"									"CAB047304, HPA068265"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"			NA	NA				"Cluster 83: Liver - Metabolism"	"Cluster 45: Non-specific - Mixed function"	"Cluster 7: Liver cancer - Metabolism"	"Cluster 43: Hepatocytes - Metabolism"	10	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center, Endoplasmic reticulum"	"CAB047304: , HPA068265: AB_2685966"	"unprognostic (1.84e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.61e-2)"	"unprognostic (9.47e-3)"	"unprognostic (2.40e-2)"	"unprognostic (4.82e-2)"	"unprognostic (3.08e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.86e-1)"	"potential prognostic favorable (7.86e-6)"	"unprognostic (1.17e-1)"	"unprognostic (3.16e-2)"	"unprognostic (7.97e-3)"	"unprognostic (1.20e-1)"	"unprognostic (7.17e-2)"	"unprognostic (5.92e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.86e-1)"	"unprognostic (1.46e-1)"	"unprognostic (8.34e-2)"	"unprognostic (3.96e-2)"	"unprognostic (9.16e-3)"	"unprognostic (3.91e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.34e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.58e-3)"	"unprognostic (6.35e-3)"
AKR1D1	SRD5B1	ENSG00000122787	"Aldo-keto reductase family 1 member D1"	P51857	7	138002324-138118305	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Bile acid catabolism, Lipid degradation, Lipid metabolism, Steroid metabolism"	Oxidoreductase	"Disease variant, FDA approved drug targets, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	82	"liver: 413.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 48.8;Hepatocytes: 210.9;Late spermatids: 112.1"	"Low cell type specificity"	"Detected in some"			"Cancer enriched"	"Detected in single"	53	"Liver Hepatocellular Carcinoma (TCGA): 34.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	10	"liver cancer: 2.4"	"Liver - Hepatocytes, Minor Salivary Gland - Plasma cells, Testis - Early spermatids, Testis - Late spermatids"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA057002	Enhanced		Approved	Nucleoplasm,Cytosol			No	NA		54000		"Cluster 31: Liver - Plasma proteins"	"Cluster 48: Non-specific - Mixed function"	"Cluster 18: Liver cancer - Metabolism"	"Cluster 43: Hepatocytes - Metabolism"	5	Nucleoplasm	Cytosol	"HPA057002: AB_2683308"														"potential prognostic favorable (8.12e-4)"	"unprognostic (2.27e-3)"																
ALAD	"ALADH, PBGS"	ENSG00000148218	"Aminolevulinate dehydratase"	P13716	9	113386312-113401290	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	"Allosteric enzyme, Lyase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 203.4"	"Cell type enhanced"	"Detected in all"		"Erythroid cells: 139.7;Hepatocytes: 80.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Adrenal cortex cells, Liver - Hepatocytes, Testis - Sertoli cells, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021023, HPA022124"	Enhanced		Approved	Cytosol			NA	NA		36000000	"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 43: Non-specific - Mitochondrial translation"	"Cluster 19: Astrocytes - Mixed function"	"Cluster 47: Leukemia - Hemostasis"	"Cluster 1: Erythroid cells - Oxygen transport"		Cytosol		"HPA021023: AB_1844716, HPA022124: AB_1844717"	"unprognostic (6.93e-2)"	"unprognostic (4.58e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.01e-3)"	"potential prognostic unfavorable (7.44e-5)"	"unprognostic (7.13e-2)"	"unprognostic (2.36e-1)"	"unprognostic (7.97e-2)"	"unprognostic (2.49e-1)"	"validated prognostic favorable (4.80e-10)"	"validated prognostic favorable (2.67e-4)"	"unprognostic (3.39e-2)"	"validated prognostic favorable (3.62e-4)"	"validated prognostic favorable (1.72e-5)"	"unprognostic (6.19e-3)"	"unprognostic (1.94e-1)"	"unprognostic (3.44e-2)"	"potential prognostic favorable (5.01e-4)"	"unprognostic (5.76e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.69e-3)"	"unprognostic (2.57e-1)"	"unprognostic (5.72e-2)"	"unprognostic (8.66e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.71e-2)"
ALB		ENSG00000163631	Albumin	P02768	4	73397114-73421482	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	136	"liver: 205952.1"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 59612.0"	"Low cell type specificity"	"Detected in many"			"Cancer enriched"	"Detected in many"	407	"Liver Hepatocellular Carcinoma (TCGA): 38403.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	24	"liver cancer: 1846.4"	"Kidney - Proximal tubular cells, Liver - Hepatocytes"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB006262, HPA031024, HPA031025"	Enhanced		Approved	"Endoplasmic reticulum,Golgi apparatus"	"Secreted to blood"	Transport	NA	NA	40000000000000			"Cluster 31: Liver - Plasma proteins"	"Cluster 33: Neurons - Mixed function"	"Cluster 18: Liver cancer - Metabolism"	"Cluster 43: Hepatocytes - Metabolism"	24	"Endoplasmic reticulum, Golgi apparatus"		"CAB006262: AB_425297, HPA031024: AB_2673703, HPA031025: AB_2673704"	"unprognostic (6.95e-3)"	"unprognostic (2.77e-1)"	"unprognostic (7.30e-2)"	"unprognostic (6.46e-2)"							"validated prognostic favorable (3.80e-4)"	"validated prognostic favorable (3.74e-4)"	"unprognostic (2.18e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.17e-3)"	"unprognostic (1.17e-2)"	"unprognostic (7.56e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.17e-1)"			"unprognostic (4.51e-2)"	"potential prognostic unfavorable (8.71e-4)"	"unprognostic (3.58e-2)"	"unprognostic (2.35e-1)"		"unprognostic (3.31e-1)"	"unprognostic (1.95e-3)"	"unprognostic (5.35e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.59e-1)"
ALDH2		ENSG00000111275	"Aldehyde dehydrogenase 2 family member"	P05091	12	111766887-111817532	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, Dwarfism, FDA approved drug targets, Intellectual disability"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 831.4"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 982.7;Proximal tubular cells: 647.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 212.7;myeloid DC: 213.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 213.7;monocytes: 212.7"	"Low cancer specificity"	"Detected in many"			"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Adrenal gland - Adrenal cortex cells, Breast - Adipocytes (Breast), Heart muscle - Cardiomyocytes, Kidney - Proximal tubular cells, Liver - Hepatocytes, Spleen - Fibroblast_2, Thyroid gland - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051065	Approved						NA	NA		1700000	"Cluster 10: Non-specific - Membrane trafficking"	"Cluster 83: Liver - Metabolism"	"Cluster 19: Astrocytes - Mixed function"	"Cluster 57: Stomach & Colon cancer - Digestion"	"Cluster 58: Macrophages - Innate immune response"	12			"HPA051065: AB_2681332"	"unprognostic (4.33e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.80e-1)"	"unprognostic (8.86e-3)"	"potential prognostic favorable (8.20e-4)"	"unprognostic (1.16e-2)"	"unprognostic (8.93e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.24e-3)"	"unprognostic (2.57e-2)"	"unprognostic (1.15e-3)"	"unprognostic (7.74e-3)"	"potential prognostic favorable (1.56e-4)"	"validated prognostic favorable (4.95e-7)"	"validated prognostic favorable (3.12e-4)"	"unprognostic (1.39e-3)"	"unprognostic (3.69e-2)"	"unprognostic (2.62e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.60e-2)"	"potential prognostic favorable (1.61e-4)"	"unprognostic (9.65e-2)"	"unprognostic (1.28e-1)"	"unprognostic (9.83e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.26e-2)"	"unprognostic (2.86e-2)"
ALDH3B2	ALDH8	ENSG00000132746	"Aldehyde dehydrogenase 3 family member B2"	P48448	11	67662155-67681224	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"breast: 70.8;esophagus: 147.9;skin 1: 119.0;vagina: 39.8"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 21.3;Glandular and luminal cells: 27.0;Squamous epithelial cells: 63.5;Suprabasal keratinocytes: 47.2;Syncytiotrophoblasts: 18.1"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Breast Invasive Carcinoma (TCGA): 81.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	7	"breast cancer: 104.9"	"Breast - Breast glandular cells, Breast - Breast glandular cells"	"Region enriched"	"Detected in single"	8	"olfactory bulb: 1.0"	"Not detected"	"Not detected"			HPA045132	Approved						NA	NA				"Cluster 27: Squamous epithelium - Keratinization"		"Cluster 27: Breast cancer - Unknown function"	"Cluster 59: Suprabasal keratinocytes - Cornification"	14			"HPA045132: AB_10795993"	"unprognostic (2.72e-1)"	"unprognostic (2.04e-1)"	"unprognostic (9.65e-2)"	"unprognostic (9.11e-3)"	"unprognostic (1.78e-1)"	"unprognostic (2.05e-1)"			"unprognostic (2.35e-1)"	"unprognostic (1.42e-1)"			"unprognostic (1.41e-1)"			"unprognostic (1.99e-2)"	"unprognostic (4.68e-2)"	"unprognostic (8.00e-2)"	"unprognostic (2.77e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.88e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.75e-2)"	"unprognostic (2.26e-3)"	"unprognostic (2.46e-2)"	"unprognostic (4.37e-2)"			"unprognostic (7.22e-2)"
ALK	"ALK1, CD246"	ENSG00000171094	"ALK receptor tyrosine kinase"	Q9UM73	2	29192774-29921586	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.7;pituitary gland: 1.2;testis: 1.2"	"Group enriched"	"Detected in some"	5	"Inhibitory neurons: 262.0;Oligodendrocyte precursor cells: 407.0"	"Cell type enhanced"	"Detected in all"		"LAMP5-LHX6 and Chandelier: 876.2"	"Group enriched"	"Detected in some"	4	"Glioblastoma Multiforme (TCGA): 2.1;Ovary Serous Cystadenocarcinoma (TCGA): 1.2;Skin Cuteneous Melanoma (TCGA): 2.9;Thyroid Carcinoma (TCGA): 1.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	9	"Neuroblastoma: 84.2"	"Colon - Enteric glia cells, Pituitary gland - Lactotropes, Testis - Early spermatids, Testis - Late spermatids"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010694	Approved		Supported	"Plasma membrane"			NA	NA				"Cluster 17: Neuronal - Synaptic function"	"Cluster 41: Monoamines - Neurotransmitter signalling"	"Cluster 17: Neuroblastoma - Neuronal signaling"	"Cluster 65: Neurons - Synaptic function"	36	"Plasma membrane"		"HPA010694: AB_1078133"							"unprognostic (8.98e-2)"	"unprognostic (9.10e-2)"												"unprognostic (1.61e-1)"	"unprognostic (2.25e-1)"						"unprognostic (2.65e-3)"			"unprognostic (2.35e-1)"	
ALOX5	5-LOX	ENSG00000012779	"Arachidonate 5-lipoxygenase"	P09917	10	45374176-45446119	"Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Leukotriene biosynthesis, Lipid metabolism"	"Dioxygenase, Hydrolase, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 70.6;lymphoid tissue: 91.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 61.6;granulocytes: 184.4;Hofbauer cells: 91.7;Kupffer cells: 98.1;Macrophages: 93.5;monocytes: 70.2"	"Cell type enriched"	"Detected in many"	6	"central nervous system macrophage: 355.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cancer enhanced"	"Detected in many"		"lymphoma: 26.3;pancreatic cancer: 12.6"	"Adipose subcutaneous - Macrophages, Adrenal gland - Macrophages, Breast - Breast glandular cells, Colon - Macrophages, Liver - Neutrophils, Pituitary gland - Macrophages, Skeletal muscle - Macrophages, Spleen - Neutrophils, Thyroid gland - Macrophages"	"Region enriched"	"Detected in single"	4	"white matter: 2.9"	"Low region specificity"	"Detected in all"			HPA071285	Enhanced		Supported	Nucleoplasm			NA	NA			"Cluster 20: Non-specific - DNA binding"	"Cluster 47: Spleen - Immune response"	"Cluster 25: Non-specific - Transcription"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 58: Macrophages - Innate immune response"	21	Nucleoplasm		"HPA071285: AB_2686379"	"unprognostic (6.67e-3)"	"unprognostic (5.50e-3)"	"unprognostic (9.23e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.22e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.56e-3)"	"potential prognostic unfavorable (1.86e-4)"	"unprognostic (4.00e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.80e-2)"	"unprognostic (9.16e-2)"	"unprognostic (2.64e-2)"	"unprognostic (7.18e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.97e-2)"	"unprognostic (4.34e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.98e-3)"	"unprognostic (2.44e-2)"	"unprognostic (9.11e-2)"
ALPG	"ALPPL2, GCAP"	ENSG00000163286	"Alkaline phosphatase, germ cell"	P10696	2	232406844-232410714	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 2.3;Spermatogonia: 1.0"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Testicular Germ Cell Tumor (TCGA): 100.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Gastric cancer: 20.0;testis cancer: 35.3"										"CAB020698, HPA038764, HPA038765, HPA051699"	Approved		Approved	"Plasma membrane"	"Intracellular and membrane"	Enzyme	NA	NA						"Cluster 57: Stomach & Colon cancer - Digestion"	"Cluster 5: Enterocytes - Absorption"	13	"Plasma membrane"		"CAB020698: , HPA038764: AB_2676194, HPA038765: AB_2676195, HPA051699: AB_2681577"	"unprognostic (5.07e-1)"			"unprognostic (8.06e-2)"	"unprognostic (1.42e-2)"	"unprognostic (4.44e-2)"										"unprognostic (7.13e-2)"	"unprognostic (1.42e-2)"			"unprognostic (8.34e-2)"	"unprognostic (1.53e-2)"	"potential prognostic unfavorable (5.30e-4)"	"unprognostic (1.14e-1)"		"unprognostic (3.39e-2)"	"unprognostic (2.99e-2)"		"unprognostic (8.51e-2)"	"unprognostic (2.89e-1)"		"unprognostic (1.99e-1)"
AMY2A	AMY2	ENSG00000243480	"Amylase alpha 2A"	P04746	1	103617427-103625780	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted secreted proteins"	"Carbohydrate metabolism"	"Glycosidase, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4638	"pancreas: 148982.6"	"Cell type enriched"	"Detected in some"	135	"Exocrine glandular cells: 251.1"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	1678	"Pancreatic Adenocarcinoma (TCGA): 1235.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Pancreas - Exocrine glandular cells"									"HPA045394, HPA045399, CAB045960, HPA046980"	Enhanced		Approved	"Golgi apparatus,Cytosol"	"Secreted to digestive system"	Enzyme	NA	NA				"Cluster 15: Pancreas - Proteolysis"	"Cluster 51: Neurons - Mixed function"	"Cluster 24: Non-specific - Unknown function"	"Cluster 60: Pancreatic exocrine cells - Proteolysis"	6	"Golgi apparatus, Cytosol"		"CAB045960: AB_2226891, HPA045394: AB_2679311, HPA045399: AB_2679313, HPA046980: AB_2679889"			"unprognostic (3.64e-1)"																			"unprognostic (1.95e-1)"	"unprognostic (1.01e-1)"								
ANGPT2	Ang2	ENSG00000091879	"Angiopoietin 2"	O15123	8	6499632-6563409	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation"	"Developmental protein"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Lymphatic endothelial cells: 498.2"	"Cell type enhanced"	"Detected in all"		"endothelial cell: 236.5"	"Cancer enhanced"	"Detected in all"		"Kidney Renal Clear Cell Carcinoma (TCGA): 44.7"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Cancer enhanced"	"Detected in many"		"ovarian cancer: 10.4"	"Breast - Endothelial cells, Colon - Endothelial cells, Heart muscle - Endothelial cells, Liver - Vascular Endothelial cells, Prostate - Endothelial cells, Skeletal muscle - Endothelial cells, Skin - Endothelial cells, Testis - Endothelial cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB011437, CAB017626"	Approved				"Secreted to blood"	"Developmental protein"	NA	NA	3780000	130000	"Cluster 34: B-cells - Unknown function"	"Cluster 34: Non-specific - Mixed function"	"Cluster 49: Hindbrain - Mixed function"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 54: Lymphatic endothelial cells - Lymph vessel development"	5			"CAB011437: , CAB017626: AB_1118956"	"unprognostic (8.64e-2)"	"unprognostic (6.31e-2)"	"unprognostic (3.30e-2)"	"potential prognostic unfavorable (2.43e-4)"	"unprognostic (2.31e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.94e-3)"	"unprognostic (9.20e-3)"	"unprognostic (1.42e-2)"	"potential prognostic unfavorable (1.27e-4)"	"validated prognostic unfavorable (7.06e-5)"	"validated prognostic unfavorable (4.83e-5)"	"unprognostic (2.51e-2)"	"unprognostic (2.45e-3)"	"unprognostic (3.96e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.85e-2)"	"unprognostic (2.02e-3)"	"unprognostic (4.40e-3)"	"unprognostic (3.32e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.78e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.11e-3)"	"potential prognostic unfavorable (4.53e-4)"	"unprognostic (2.59e-1)"	"unprognostic (8.48e-3)"	"unprognostic (4.03e-2)"
ANGPTL3	ANGPT5	ENSG00000132855	"Angiopoietin like 3"	Q9Y5C1	1	62597520-62606313	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Cell adhesion, Lipid metabolism"	Heparin-binding	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"liver: 655.3"	"Group enriched"	"Detected in some"	22	"Hepatocytes: 694.2;Proximal tubular cells: 210.2"	"Cell type enhanced"	"Detected in single"		"astrocyte: 1.4"	"Cancer enriched"	"Detected in some"	24	"Liver Hepatocellular Carcinoma (TCGA): 124.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	39	"liver cancer: 9.2"	"Kidney - Proximal tubular cells, Liver - Hepatocytes, Liver - Hepatocytes, Stomach - Parietal cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA038097	Approved				"Secreted to blood"	"Cell adhesion"	NA	NA	225000000	88000000		"Cluster 1: Liver & Kidney - Metabolism"	"Cluster 31: Non-specific - Transcription"	"Cluster 18: Liver cancer - Metabolism"	"Cluster 43: Hepatocytes - Metabolism"				"HPA038097: AB_10675628"											"validated prognostic favorable (7.27e-6)"	"validated prognostic favorable (4.89e-5)"	"unprognostic (2.32e-2)"	"unprognostic (6.44e-2)"	"potential prognostic favorable (6.81e-5)"								"unprognostic (8.64e-2)"	"unprognostic (7.02e-2)"							
ANO1	"DOG1, FLJ10261, ORAOV2, TAOS2, TMEM16A"	ENSG00000131620	"Anoctamin 1"	Q5XXA6	11	69985907-70189530	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Developmental protein, Ion channel"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 84.1;seminal vesicle: 85.9"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 123.4;Breast myoepithelial cells: 71.4;Hepatocytes: 118.7;Late spermatids: 79.5;Serous glandular cells: 82.6;Smooth muscle cells: 45.6"	"Cell type enhanced"	"Detected in some"		"LAMP5-LHX6 and Chandelier: 79.2;vascular associated smooth muscle cell: 45.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Esophageal cancer: 62.2;pancreatic cancer: 72.4"	"Breast - Breast myoepithelial cells, Kidney - Fibroblasts, Liver - Hepatocytes, Pituitary gland - Fibroblasts, Skin - Keratinocyte (other), Testis - Late spermatids"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"spinal cord: 8.8"	"HPA032148, HPA057356"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"			NA	NA				"Cluster 50: Epididymis - Male reproductive secretion"	"Cluster 37: Neurons - Mixed function"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 75: Serous glandular cells - Salivary secretion"	5	"Plasma membrane"	Nucleoplasm	"HPA032148: AB_2674180, HPA057356: AB_2732610"	"unprognostic (1.13e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.35e-1)"	"unprognostic (5.07e-2)"	"unprognostic (2.41e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.32e-1)"	"potential prognostic unfavorable (6.93e-5)"	"unprognostic (9.17e-2)"	"unprognostic (8.82e-2)"	"potential prognostic favorable (2.19e-4)"	"potential prognostic unfavorable (2.26e-5)"	"unprognostic (2.09e-3)"	"potential prognostic favorable (4.08e-6)"	"unprognostic (3.70e-3)"	"potential prognostic unfavorable (6.93e-4)"	"unprognostic (2.07e-2)"	"potential prognostic unfavorable (8.69e-5)"	"unprognostic (9.53e-2)"	"unprognostic (1.17e-2)"	"potential prognostic unfavorable (6.07e-5)"	"unprognostic (1.33e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.46e-2)"	"unprognostic (4.22e-2)"
ANXA1	"ANX1, LPC1"	ENSG00000135046	"Annexin A1"	P04083	9	73151865-73170393	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Adaptive immunity, Immunity, Inflammatory response, Innate immunity"	"Phospholipase A2 inhibitor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 7281.3"	"Cell type enhanced"	"Detected in many"		"granulocytes: 3470.5;Squamous epithelial cells: 3652.5;Suprabasal keratinocytes: 8372.3;Syncytiotrophoblasts: 8404.5"	"Group enriched"	"Detected in many"	13	"endothelial cell: 140.6;ependymal cell: 259.6;fibroblast: 148.8;leukocyte: 226.5;vascular associated smooth muscle cell: 74.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 2824.3"	"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011271, HPA011272, CAB013023, CAB035987, CAB058693, CAB080415"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"	Immunity	NA	Yes	17600000	1200000000	"Cluster 42: Non-specific - Vesicular transport"	"Cluster 29: Squamous epithelium - Innate immune response"	"Cluster 39: Astrocytes - Mixed function"	"Cluster 5: Rhabdoid - Unknown function"	"Cluster 59: Suprabasal keratinocytes - Cornification"	32	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB013023: AB_2533983, CAB035987: , CAB058693: AB_2665585, CAB080415: , HPA011271: AB_1844883, HPA011272: AB_1844884"	"unprognostic (2.41e-3)"	"unprognostic (9.20e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.17e-2)"	"unprognostic (5.11e-3)"	"unprognostic (8.49e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.11e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.86e-3)"	"unprognostic (3.66e-3)"	"unprognostic (3.30e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.76e-3)"	"unprognostic (1.51e-1)"	"unprognostic (3.59e-2)"	"unprognostic (4.87e-2)"	"potential prognostic favorable (8.16e-4)"	"unprognostic (2.84e-2)"
ANXA2	"ANX2, ANX2L4, CAL1H, LIP2, LPC2D"	ENSG00000182718	"Annexin A2"	P07355	15	60347134-60402883	"Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Host-virus interaction"	RNA-binding	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 2124.0"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 5295.0;Ductal cells: 3448.7;Pancreatic endocrine cells: 3363.7"	"Cell type enhanced"	"Detected in many"		"ependymal cell: 101.5;fibroblast: 169.0;vascular associated smooth muscle cell: 96.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 4446.3;classical monocyte: 2767.4;intermediate monocyte: 2404.9;myeloid DC: 4023.2;non-classical monocyte: 2699.3;T-reg: 1686.0"	"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Pancreas - Ductal cells"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 213.0"	"CAB004311, HPA046964, HPA061798"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted to blood"	Other	NA	NA	26700000000	23000000	"Cluster 10: Non-specific - Membrane trafficking"	"Cluster 75: Epithelium - Extracellular exosomes"	"Cluster 12: Non-specific - Vasculature"	"Cluster 72: Neuronal - Signal transduction"	"Cluster 45: Non-specific - Mixed function"	49	"Plasma membrane"	Cytosol	"CAB004311: AB_626677, HPA046964: AB_2732537, HPA061798: AB_2732671"	"unprognostic (3.58e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.89e-3)"	"potential prognostic unfavorable (1.89e-4)"	"unprognostic (1.41e-3)"	"unprognostic (1.44e-2)"	"potential prognostic unfavorable (4.91e-4)"	"unprognostic (3.19e-2)"	"unprognostic (5.16e-2)"	"validated prognostic unfavorable (7.78e-4)"	"validated prognostic unfavorable (5.03e-4)"	"potential prognostic unfavorable (1.13e-4)"	"unprognostic (1.89e-2)"	"unprognostic (2.44e-2)"	"unprognostic (2.35e-3)"	"unprognostic (1.67e-2)"	"unprognostic (4.36e-2)"	"potential prognostic unfavorable (1.38e-5)"	"unprognostic (9.67e-3)"	"unprognostic (5.95e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.57e-2)"	"unprognostic (2.86e-2)"	"unprognostic (8.85e-3)"
ANXA3	ANX3	ENSG00000138772	"Annexin A3"	P12429	4	78551747-78610451	"FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Phospholipase A2 inhibitor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 334.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 273.2;Alveolar cells type 1: 599.3;Ductal cells: 343.6;Pancreatic endocrine cells: 353.2"	"Cell type enriched"	"Detected in many"	5	"endothelial cell: 341.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	328	"neutrophil: 208.7"	"Lineage enriched"	"Detected in single"	328	"granulocytes: 208.7"	"Low cancer specificity"	"Detected in many"			"Lung - Alveolar cells type 1, Minor Salivary Gland - Minor salivary glandular cells, Pancreas - Ductal cells, Prostate - Prostate glandular cells, Spleen - Neutrophils"	"Low region specificity"	"Detected in all"							"HPA013398, HPA013431"	Enhanced		Supported	"Plasma membrane"			NA	NA		6700000	"Cluster 4: Neutrophils - Degranulation"	"Cluster 77: Bone marrow - Cell proliferation"	"Cluster 49: Hindbrain - Mixed function"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 45: Non-specific - Mixed function"		"Plasma membrane"		"HPA013398: AB_1844861, HPA013431: AB_1844862"	"unprognostic (3.22e-1)"	"unprognostic (4.15e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.26e-3)"	"unprognostic (1.44e-1)"	"unprognostic (3.50e-1)"	"unprognostic (7.04e-3)"	"unprognostic (4.83e-3)"	"unprognostic (7.43e-2)"	"unprognostic (1.32e-3)"	"unprognostic (2.68e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.32e-1)"	"unprognostic (4.47e-1)"	"unprognostic (3.11e-2)"	"unprognostic (2.14e-3)"	"unprognostic (5.09e-3)"	"unprognostic (3.34e-1)"	"potential prognostic unfavorable (2.29e-4)"	"unprognostic (4.35e-2)"	"unprognostic (2.65e-1)"	"unprognostic (7.54e-3)"	"unprognostic (5.99e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.24e-1)"	"unprognostic (6.40e-2)"	"unprognostic (2.71e-2)"
ANXA4	ANX4	ENSG00000196975	"Annexin A4"	P09525	2	69644425-69827112	"Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins"			"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"gallbladder: 551.0;pancreas: 345.6"	"Cell type enhanced"	"Detected in all"		"Cholangiocytes: 2319.9;Ductal cells: 1498.9;Proximal enterocytes: 674.0"	"Cell type enhanced"	"Detected in all"		"choroid plexus epithelial cell: 396.1"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	8	"choroid plexus: 85.6"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adipose visceral - Adipose progenitor cells, Adrenal gland - Adrenal cortex cells, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005076, HPA007393, CAB017560"	Enhanced		Approved	Cytosol			NA	NA		1300000	"Cluster 42: Non-specific - Vesicular transport"	"Cluster 45: Intestine - Digestion"	"Cluster 36: Choroid plexus - Mixed function"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 37: Glandular & Luminal cells - Unknown function"	9	Cytosol		"CAB005076: AB_630869, CAB017560: AB_2227370, HPA007393: AB_1078168"	"unprognostic (2.56e-1)"	"unprognostic (7.69e-3)"	"unprognostic (1.54e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.70e-3)"	"unprognostic (3.40e-1)"	"unprognostic (5.00e-1)"	"potential prognostic favorable (5.50e-6)"	"unprognostic (7.73e-2)"	"unprognostic (4.33e-3)"	"unprognostic (2.53e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.91e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.08e-1)"	"potential prognostic unfavorable (3.47e-4)"	"unprognostic (1.99e-2)"	"unprognostic (2.27e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.95e-1)"	"unprognostic (9.00e-2)"	"unprognostic (6.02e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.39e-2)"	"unprognostic (9.97e-2)"	"unprognostic (7.21e-2)"	"unprognostic (1.39e-1)"
ANXA5	"ANX5, CPB-I, ENX2, PAP-I, RPRGL3, VAC-alph"	ENSG00000164111	"Annexin A5"	P08758	4	121667946-121696995	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters"	"Blood coagulation, Hemostasis"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 1152.9;Extravillous trophoblasts: 1191.5;Syncytiotrophoblasts: 1086.8"	"Cell type enhanced"	"Detected in many"		"fibroblast: 163.7;pericyte: 160.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Breast - Adipocytes (Breast)"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003677, HPA035330"	Approved		Approved	"Nuclear membrane"			NA	NA		5900000	"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 62: Connective tissue - ECM organization"	"Cluster 21: Non-specific - Metabolism"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 58: Macrophages - Innate immune response"	18	"Nuclear membrane"		"CAB003677: AB_425305, HPA035330: AB_2674574"	"unprognostic (2.14e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.57e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.65e-1)"	"potential prognostic unfavorable (1.91e-5)"	"potential prognostic unfavorable (6.74e-4)"	"unprognostic (1.91e-3)"	"potential prognostic favorable (6.92e-4)"	"unprognostic (1.58e-1)"	"unprognostic (2.75e-1)"	"potential prognostic unfavorable (1.30e-5)"	"unprognostic (8.95e-2)"	"unprognostic (3.03e-2)"	"potential prognostic unfavorable (6.23e-4)"	"potential prognostic unfavorable (7.48e-4)"	"unprognostic (1.10e-2)"	"unprognostic (2.97e-1)"	"unprognostic (6.88e-2)"	"unprognostic (9.71e-3)"	"unprognostic (1.55e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.56e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.26e-1)"
AOC3	"HPAO, VAP-1, VAP1"	ENSG00000131471	"Amine oxidase copper containing 3"	Q16853	17	42851184-42858130	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	Oxidoreductase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 408.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 56.3;Fibroblasts: 24.1;Peritubular cells: 69.7;Sertoli cells: 54.4;Smooth muscle cells: 102.0"	"Cell type enriched"	"Detected in some"	64	"vascular associated smooth muscle cell: 85.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Colon - Smooth muscle cells, Kidney - Fibroblasts, Liver - Hepatic stellate cells, Lung - Fibroblast_1, Prostate - Smooth muscle cells, Spleen - Fibroblast_1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA000980, CAB025797"	Enhanced		Approved	"Golgi apparatus,Cytosol"			NA	NA		180000000		"Cluster 62: Connective tissue - ECM organization"	"Cluster 32: Cerebral cortex - Mixed function"	"Cluster 44: Connective tissue cells - ECM organization"	"Cluster 48: Smooth muscle cells - Signal transduction"	10	Cytosol	"Golgi apparatus"	"CAB025797: , HPA000980: AB_1078170"	"unprognostic (1.16e-3)"	"unprognostic (2.57e-1)"	"unprognostic (9.83e-3)"	"unprognostic (3.80e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.55e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.16e-2)"	"unprognostic (6.85e-3)"	"unprognostic (3.38e-3)"	"potential prognostic unfavorable (1.98e-4)"	"unprognostic (1.44e-1)"	"unprognostic (1.12e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.36e-3)"	"potential prognostic unfavorable (2.55e-5)"	"unprognostic (2.84e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.88e-3)"	"unprognostic (9.44e-2)"	"unprognostic (5.64e-3)"	"unprognostic (4.11e-2)"	"unprognostic (6.76e-2)"	"unprognostic (4.27e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.66e-2)"	"unprognostic (7.70e-3)"
APOC3	"Apo-C3, Apo-CIII, ApoC-3, ApoC-III, APOCIII"	ENSG00000110245	"Apolipoprotein C3"	P02656	11	116829706-116833072	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism, Lipid transport, Transport"		"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	25	"liver: 26980.2"	"Cell type enriched"	"Detected in some"	9	"Hepatocytes: 87587.5"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	453	"Liver Hepatocellular Carcinoma (TCGA): 11879.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	4	"liver cancer: 40.4"	"Kidney - Proximal tubular cells, Liver - Hepatocytes"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA065365, HPA073918"	Supported		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"	"Secreted to blood"	Apolipoprotein	NA	NA	106000000000	27000000000		"Cluster 31: Liver - Plasma proteins"		"Cluster 18: Liver cancer - Metabolism"	"Cluster 43: Hepatocytes - Metabolism"	8	Nucleoplasm	"Nucleoli, Cell Junctions"	"HPA065365: AB_2732733, HPA073918: "			"unprognostic (7.06e-1)"								"unprognostic (7.88e-2)"	"unprognostic (2.55e-3)"	"unprognostic (3.22e-1)"	"validated prognostic favorable (3.08e-4)"	"validated prognostic favorable (2.30e-4)"							"unprognostic (1.55e-1)"	"unprognostic (1.11e-1)"		"unprognostic (4.06e-1)"			"unprognostic (2.96e-3)"	"unprognostic (4.05e-2)"		
APP	"AD1, alpha-sAPP"	ENSG00000142192	"Amyloid beta precursor protein"	P05067	21	25880535-26171128	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Apoptosis, Cell adhesion, Endocytosis, Notch signaling pathway"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"	"Alzheimer disease, Amyloidosis, Disease variant, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 810.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"plasmacytoid DC: 36.4"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 36.4"	"Low cancer specificity"	"Detected in all"			"Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000157, HPA001462"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Secreted to blood"	"Cell adhesion"	NA	NA		96000000	"Cluster 2: Dendritic cells - Unknown function"	"Cluster 34: Non-specific - Mixed function"	"Cluster 27: Non-specific - Mixed function"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 54: Lymphatic endothelial cells - Lymph vessel development"	492	"Golgi apparatus"	Vesicles	"CAB000157: AB_323833, HPA001462: AB_1078185"	"unprognostic (5.14e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.69e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.67e-3)"	"unprognostic (1.03e-1)"	"validated prognostic favorable (8.44e-9)"	"validated prognostic favorable (1.85e-5)"	"unprognostic (1.82e-1)"	"unprognostic (1.43e-1)"	"unprognostic (9.93e-2)"	"unprognostic (8.97e-3)"	"unprognostic (3.91e-2)"	"unprognostic (6.82e-3)"	"unprognostic (9.35e-3)"	"unprognostic (5.29e-2)"	"unprognostic (6.25e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.59e-1)"	"unprognostic (4.49e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.46e-2)"
AR	"AIS, DHTR, HUMARA, NR3C4, SBMA, SMAX1"	ENSG00000169083	"Androgen receptor"	P10275	X	67544021-67730619	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"Cancer-related genes, Disease variant, FDA approved drug targets, Neurodegeneration, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 37.1"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 147.1;Hepatocytes: 244.2;Prostatic glandular cells: 462.1;Secretory cells: 149.4"	"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in many"		"Breast Invasive Carcinoma (TCGA): 24.7;Prostate Adenocarcinoma (TCGA): 21.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	11	"prostate cancer: 91.0"	"Adipose subcutaneous - Adipocytes (Subcutaneous), Liver - Hepatocytes, Pancreas - Fibroblasts, Testis - Sertoli cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB000001, HPA004733, CAB065764"	Enhanced		Supported	Cytosol			NA	NA				"Cluster 1: Liver & Kidney - Metabolism"	"Cluster 41: Monoamines - Neurotransmitter signalling"	"Cluster 60: Prostate cancer - Unknown function"	"Cluster 40: Prostatic glandular cells - Transcription"	329	Cytosol		"CAB000001: AB_2060174, CAB065764: AB_10620739, HPA004733: "	"unprognostic (1.28e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.06e-3)"		"unprognostic (1.63e-1)"	"unprognostic (5.65e-3)"	"unprognostic (2.56e-1)"		"unprognostic (1.33e-1)"	"validated prognostic favorable (2.78e-11)"	"validated prognostic favorable (9.45e-4)"	"unprognostic (2.04e-1)"	"unprognostic (4.25e-3)"	"unprognostic (9.70e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.21e-1)"		"unprognostic (1.37e-1)"	"unprognostic (7.16e-2)"	"unprognostic (8.14e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.04e-1)"		"unprognostic (1.08e-1)"				"unprognostic (2.04e-2)"	"unprognostic (2.99e-1)"
ATIC	"AICARFT, IMPCHASE, PURH"	ENSG00000138363	"5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase"	P31939	2	215311956-215349773	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Purine biosynthesis"	"Hydrolase, Multifunctional enzyme, Transferase"	"Cancer-related genes, Disease variant, Epilepsy, FDA approved drug targets, Intellectual disability"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 179.8;Extravillous trophoblasts: 164.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013462, HPA021012"	Supported		Approved	"Plasma membrane,Cytosol"			NA	NA		5900000	"Cluster 43: Non-specific - Transcription & Translation"	"Cluster 35: Non-specific - Mitochondria"	"Cluster 28: Oligodendrocytes - Mixed function"	"Cluster 26: Non-specific - Mitochondria & RNA binding"	"Cluster 4: Extravillous trophoblasts - Unknown function"	7	Cytosol	"Plasma membrane"	"CAB013462: , HPA021012: AB_1845169"	"unprognostic (1.03e-1)"	"unprognostic (2.48e-3)"	"unprognostic (1.03e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.71e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.94e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.48e-3)"	"validated prognostic unfavorable (1.07e-8)"	"validated prognostic unfavorable (1.55e-8)"	"potential prognostic unfavorable (2.86e-4)"	"unprognostic (2.74e-3)"	"unprognostic (2.35e-1)"	"unprognostic (3.67e-1)"	"unprognostic (9.19e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.95e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.09e-3)"	"unprognostic (6.19e-3)"	"unprognostic (4.06e-2)"	"unprognostic (2.84e-2)"	"unprognostic (5.04e-2)"	"unprognostic (3.82e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.80e-1)"
ATP1A1		ENSG00000163399	"ATPase Na+/K+ transporting subunit alpha 1"	P05023	1	116372668-116410261	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"	Translocase	"Cancer-related genes, Charcot-Marie-Tooth disease, Epilepsy, FDA approved drug targets, Intellectual disability, Neurodegeneration, Neuropathy, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 1433.4"	"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 1705.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Adrenal cortex cells, Lung - Alveolar cells type 2, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018702, CAB069993"	Enhanced		Approved	"Vesicles,Plasma membrane"			NA	NA		560000	"Cluster 33: Non-specific - ATP binding"	"Cluster 24: Parathyroid gland - Vesicular transport"	"Cluster 52: Neurons & Synapses - Synaptic function"	"Cluster 70: DU4475 - Unknown function"	"Cluster 22: Proximal enterocytes - Digestion"	63	"Vesicles, Plasma membrane"		"CAB018702: AB_626713, CAB069993: AB_2060979"	"unprognostic (4.76e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.64e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.16e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.44e-1)"	"unprognostic (2.06e-2)"	"potential prognostic favorable (3.15e-6)"	"unprognostic (3.56e-2)"	"unprognostic (4.24e-3)"	"potential prognostic unfavorable (2.62e-4)"	"unprognostic (1.60e-3)"	"unprognostic (1.17e-1)"	"unprognostic (8.11e-2)"	"unprognostic (9.61e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.77e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.29e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.47e-2)"
ATP2A1	"ATP2A, SERCA1"	ENSG00000196296	"ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1"	O14983	16	28878405-28904466	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	Translocase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	85	"skeletal muscle: 7952.4;tongue: 3076.1"	"Cell type enriched"	"Detected in some"	112	"Skeletal myocytes: 628.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 1.6"	"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Skeletal muscle - Skeletal myocytes"	"Region enriched"	"Detected in some"	8	"thalamus: 13.1"	"Group enriched"	"Detected in some"	6	"basal ganglia: 1.8;cerebral cortex: 2.0;hippocampal formation: 1.7"	"CAB002310, CAB032706, HPA066701"	Enhanced		Approved	"Endoplasmic reticulum"			NA	NA		2800000	"Cluster 13: Non-specific - Mitochondria"	"Cluster 2: Skeletal muscle - Striated muscle contraction"	"Cluster 6: Non-specific - Immune response"	"Cluster 33: Sarcoma - Muscle contraction"	"Cluster 2: Skeletal myocytes - Muscle contraction"	16	"Endoplasmic reticulum"		"CAB002310: AB_564139, CAB032706: AB_2061286, HPA066701: "	"unprognostic (2.31e-3)"	"unprognostic (3.01e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.26e-3)"	"unprognostic (1.89e-3)"	"unprognostic (4.78e-2)"	"unprognostic (7.22e-2)"		"unprognostic (2.21e-1)"	"unprognostic (3.07e-1)"	"validated prognostic unfavorable (1.40e-6)"	"validated prognostic unfavorable (1.25e-4)"	"unprognostic (9.87e-2)"	"unprognostic (1.74e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.95e-1)"	"unprognostic (9.97e-2)"	"unprognostic (8.37e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.49e-1)"	"potential prognostic favorable (7.68e-4)"	"unprognostic (1.73e-1)"		"unprognostic (1.04e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.66e-2)"	"unprognostic (6.30e-2)"
ATP2A2	"ATP2B, DAR, SERCA2"	ENSG00000174437	"ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2"	P16615	12	110280756-110351093	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	Translocase	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	12	"heart muscle: 970.6;skeletal muscle: 2756.0;tongue: 2661.9"	"Group enriched"	"Detected in all"	5	"Cardiomyocytes: 1835.3;Skeletal myocytes: 481.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cancer specificity"	"Detected in all"			"Skeletal muscle - Skeletal myocytes, Testis - Spermatocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062605	Enhanced		Uncertain	"Nucleoplasm,Plasma membrane,Primary cilium,Perinuclear theca,Mid piece,End piece"			NA	NA		3100000	"Cluster 33: Non-specific - ATP binding"	"Cluster 14: Skeletal muscle - Muscle contraction"	"Cluster 27: Non-specific - Mixed function"	"Cluster 38: Non-specific - Transcription"	"Cluster 68: Cardiomyocytes - Muscle contraction"	47	"Nucleoplasm, Plasma membrane"	"Primary cilium, Perinuclear theca, Mid piece, End piece"	"HPA062605: AB_2684805"	"unprognostic (2.11e-2)"	"unprognostic (5.36e-2)"	"unprognostic (4.68e-2)"	"unprognostic (2.69e-3)"	"unprognostic (2.12e-2)"	"unprognostic (4.21e-1)"	"unprognostic (4.64e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.14e-1)"	"potential prognostic favorable (3.94e-5)"	"unprognostic (1.95e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.26e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.97e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.24e-1)"	"unprognostic (4.04e-2)"	"unprognostic (6.81e-3)"	"unprognostic (3.32e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.84e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.97e-1)"	"unprognostic (7.70e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.96e-1)"
ATP2B1	PMCA1	ENSG00000070961	"ATPase plasma membrane Ca2+ transporting 1"	P20020	12	89588049-89709366	"Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calmodulin-binding, Translocase"	"Disease variant, FDA approved drug targets, Intellectual disability"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 93.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 755.2;Langerhans cells: 522.1;monocytes: 818.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Adipose progenitor cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005605, HPA011166, HPA012945"	Enhanced	Supported	Supported	"Plasma membrane"			NA	NA		7300	"Cluster 2: Dendritic cells - Unknown function"	"Cluster 17: Neuronal - Synaptic function"	"Cluster 33: Neurons - Mixed function"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 29: Monocytes - Innate immune response"	30	"Plasma membrane"		"CAB005605: AB_2061563, HPA011166: AB_1855484, HPA012945: AB_1855483"	"unprognostic (1.24e-1)"	"unprognostic (4.71e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.85e-3)"	"unprognostic (3.56e-2)"	"unprognostic (7.93e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.75e-2)"	"unprognostic (6.47e-2)"	"potential prognostic favorable (5.04e-4)"	"unprognostic (7.25e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.01e-3)"	"unprognostic (4.45e-3)"	"unprognostic (3.47e-3)"	"unprognostic (2.10e-3)"	"unprognostic (2.62e-2)"	"unprognostic (4.16e-3)"	"unprognostic (7.60e-3)"	"unprognostic (7.71e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.08e-2)"
ATP2B2	PMCA2	ENSG00000157087	"ATPase plasma membrane Ca2+ transporting 2"	Q01814	3	10324023-10708007	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calmodulin-binding, Translocase"	"Deafness, Disease variant, FDA approved drug targets, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 63.5;choroid plexus: 62.8;salivary gland: 32.2;skeletal muscle: 36.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 111.5;Bipolar cells: 80.9;Excitatory neurons: 312.4;Horizontal cells: 87.5;Inhibitory neurons: 221.2;Oligodendrocyte precursor cells: 54.7"	"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"Kidney Chromophobe (TCGA): 13.5;Liver Hepatocellular Carcinoma (TCGA): 15.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"liver cancer: 2.7;Neuroblastoma: 3.3"	"Minor Salivary Gland - Minor salivary glandular cells, Pituitary gland - Corticotropes, Skeletal muscle - Skeletal myocytes, Testis - Early spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005606	Enhanced						NA	NA				"Cluster 22: Brain - Synaptic signal transduction"	"Cluster 52: Neurons & Synapses - Synaptic function"	"Cluster 18: Liver cancer - Metabolism"	"Cluster 34: Neurons - Neuronal signaling"	1			"CAB005606: AB_2243199"			"unprognostic (5.30e-2)"				"unprognostic (3.02e-1)"	"potential prognostic favorable (2.03e-5)"		"unprognostic (2.99e-2)"	"potential prognostic favorable (7.09e-5)"	"unprognostic (9.99e-3)"	"unprognostic (1.60e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.82e-2)"					"unprognostic (1.73e-1)"	"unprognostic (2.36e-1)"										"unprognostic (2.15e-2)"
ATP2B3	"CFAP39, CLA2, PMCA3, SCAX1"	ENSG00000067842	"ATPase plasma membrane Ca2+ transporting 3"	Q16720	X	153517642-153582939	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calmodulin-binding, Translocase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"choroid plexus: 109.2"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 22.9;Extravillous trophoblasts: 12.8;Horizontal cells: 22.7;Inhibitory neurons: 29.2;Skeletal myocytes: 6.8"	"Cell type enhanced"	"Detected in many"		"choroid plexus epithelial cell: 159.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in all"		"choroid plexus: 503.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Bone cancer: 4.9;Neuroblastoma: 9.1"	"Adrenal gland - Adrenal cortex cells, Colon - Colon enteroendocrine cells, Pituitary gland - Gonadotropes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001583	Enhanced	Supported					NA	NA				"Cluster 60: Choroid plexus - Transmembrane transport"	"Cluster 23: Choroid plexus - Mixed function"	"Cluster 1: Neuronal - Visual perception"	"Cluster 69: Neurons - Neuronal signaling"	3			"HPA001583: AB_1079641"								"unprognostic (1.63e-2)"																							
ATP2B4	"ATP2B2, MXRA1, PMCA4"	ENSG00000058668	"ATPase plasma membrane Ca2+ transporting 4"	P23634	1	203626832-203744081	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calmodulin-binding, Translocase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 170.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 170.1;Oligodendrocyte precursor cells: 186.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cancer enriched"	"Detected in all"	4	"testis cancer: 204.8"	"Colon - Smooth muscle cells, Prostate - Smooth muscle cells, Skin - Keratinocyte (other)"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016118, HPA040431"	Enhanced		Supported	"Plasma membrane,Primary cilium,Mitochondria,Basal body"			NA	NA		11000	"Cluster 33: Non-specific - ATP binding"	"Cluster 62: Connective tissue - ECM organization"	"Cluster 51: Neurons - Mixed function"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 32: Smooth muscle cells - Muscle contraction"	16	"Plasma membrane, Primary cilium"	"Mitochondria, Basal body"	"CAB016118: AB_2061729, HPA040431: AB_2676980"	"unprognostic (3.94e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.30e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.92e-1)"	"potential prognostic favorable (2.76e-5)"	"unprognostic (3.87e-2)"	"unprognostic (4.62e-2)"	"unprognostic (5.16e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.91e-1)"	"unprognostic (6.45e-2)"	"unprognostic (2.55e-2)"	"unprognostic (3.33e-1)"	"unprognostic (4.89e-2)"	"unprognostic (3.97e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.94e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.37e-1)"
ATP2C1	"ATP2C1A, BCPM, KIAA1347, PMR1, SPCA1"	ENSG00000017260	"ATPase secretory pathway Ca2+ transporting 1"	P98194	3	130850595-131016712	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	Translocase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 154.2;Excitatory neurons: 166.6;Prostatic glandular cells: 187.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Adrenal cortex cells, Prostate - Prostate glandular cells, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010207, HPA035116, HPA069684"	Supported		Supported	"Golgi apparatus"			NA	NA			"Cluster 42: Non-specific - Vesicular transport"	"Cluster 61: Brain - Neuronal signaling"	"Cluster 21: Non-specific - Metabolism"	"Cluster 63: Non-specific - Protein processing"	"Cluster 34: Neurons - Neuronal signaling"	4	"Golgi apparatus"		"CAB010207: AB_2061744, HPA035116: AB_10673106, HPA069684: AB_2686169"	"unprognostic (1.66e-1)"	"unprognostic (5.05e-2)"	"unprognostic (4.18e-2)"	"unprognostic (2.42e-2)"	"unprognostic (5.00e-2)"	"unprognostic (3.67e-2)"	"unprognostic (3.53e-1)"	"unprognostic (2.02e-2)"	"unprognostic (6.72e-3)"	"unprognostic (1.40e-1)"	"potential prognostic favorable (2.61e-6)"	"unprognostic (4.18e-2)"	"unprognostic (8.12e-2)"	"potential prognostic unfavorable (6.97e-4)"	"unprognostic (2.74e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.05e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.32e-2)"	"potential prognostic unfavorable (7.01e-4)"	"unprognostic (4.51e-2)"	"unprognostic (8.48e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.68e-1)"
ATP2C2	"KIAA0703, SPCA2"	ENSG00000064270	"ATPase secretory pathway Ca2+ transporting 2"	O75185	16	84368527-84464187	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	Translocase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 36.2;skin 1: 25.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 44.4;Basal respiratory cells: 40.6;Ciliated cells: 46.1;Club cells: 39.4;Distal enterocytes: 42.7;Enteroendocrine cells: 42.7;Intestinal goblet cells: 66.4;Ionocytes: 63.7;Oligodendrocyte precursor cells: 55.2;Undifferentiated cells: 58.4"	"Cell type enhanced"	"Detected in many"		"deep-layer near-projecting: 170.4;oligodendrocyte precursor cell: 224.5"	"Cancer enhanced"	"Detected in many"		"Colon Adenocarcinoma (TCGA): 33.0;Rectum Adenocarcinoma (TCGA): 31.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"colorectal cancer: 23.0"	"Breast - Breast glandular cells, Breast - Breast glandular cells, Colon - Colon enterocytes, Lung - Alveolar cells type 2, Testis - Late spermatids"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA052262, HPA075812"	Approved		Approved	"Plasma membrane,Focal adhesion sites"			NA	NA				"Cluster 45: Intestine - Digestion"	"Cluster 24: Neurons - Mixed function"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 16: Intestinal goblet cells - Mucin production"	1	"Plasma membrane, Focal adhesion sites"		"HPA052262: AB_2681776, HPA075812: AB_2686765"	"unprognostic (5.22e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.76e-2)"	"unprognostic (9.94e-2)"			"unprognostic (2.13e-2)"	"unprognostic (3.55e-1)"					"unprognostic (3.05e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.39e-3)"	"unprognostic (4.37e-1)"	"unprognostic (4.96e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.10e-2)"	"unprognostic (6.33e-1)"	"unprognostic (7.39e-2)"	"unprognostic (2.44e-3)"	"unprognostic (1.38e-3)"		"unprognostic (1.61e-1)"		"unprognostic (8.25e-3)"	"unprognostic (4.20e-2)"
ATP4A	ATP6A	ENSG00000105675	"ATPase H+/K+ transporting subunit alpha"	P20648	19	35550031-35563658	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Potassium transport, Transport"	Translocase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	83	"stomach 1: 819.1"	"Group enriched"	"Detected in some"	11	"Gastric mucus-secreting cells: 61.9;Late spermatids: 20.3"	"Group enriched"	"Detected in some"	8	"cerebellar inhibitory: 21.1;upper rhombic lip: 12.6"	"Cancer enriched"	"Detected in single"	16	"Stomach Adenocarcinoma (TCGA): 5.4"	"Region enhanced"	"Detected in some"		"cerebellum: 2.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Adrenal gland - Adrenal cortex cells, Stomach - Parietal cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA039154, HPA076684"	Enhanced						NA	NA				"Cluster 48: Stomach - Proteolysis"	"Cluster 2: Neurons - Nucleosome"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 46: Gastric mucus-secreting cells - Digestion"	9			"HPA039154: AB_10672772, HPA076684: "																												"unprognostic (9.93e-2)"			
ATP4B	ATP6B	ENSG00000186009	"ATPase H+/K+ transporting subunit beta"	P51164	13	113648804-113658198	"FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Hydrogen ion transport, Ion transport, Potassium transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	152	"stomach 1: 1067.1"	"Cell type enriched"	"Detected in some"	89	"Gastric mucus-secreting cells: 166.8"	"Group enriched"	"Detected in some"	60	"choroid plexus epithelial cell: 11.8;ependymal cell: 14.8"	"Cancer enriched"	"Detected in some"	5	"Stomach Adenocarcinoma (TCGA): 4.7"	"Region enriched"	"Detected in some"	6	"choroid plexus: 7.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Stomach - Parietal cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA045400, HPA052649"	Enhanced		Approved	"Plasma membrane"			NA	NA				"Cluster 48: Stomach - Proteolysis"	"Cluster 3: Choroid plexus - Cilium"	"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 46: Gastric mucus-secreting cells - Digestion"	3	"Plasma membrane"		"HPA045400: AB_2679314, HPA052649: AB_2681900"																		"unprognostic (2.69e-2)"										"unprognostic (2.94e-1)"			
ATP6V1B2	"ATP6B2, HO57, VATB, Vma2, VPP3"	ENSG00000147416	"ATPase H+ transporting V1 subunit B2"	P21281	8	20197381-20226819	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"		"Deafness, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 211.0;Proximal tubular cells: 219.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1134.2"	"Group enriched"	"Detected in all"	10	"dendritic cells: 336.8;granulocytes: 1134.2;monocytes: 682.6"	"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Prostate - Macrophages, Testis - Spermatocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008147	Enhanced		Supported	Vesicles			NA	NA		220000	"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 17: Neuronal - Synaptic function"	"Cluster 14: Neurons - Synaptic function"	"Cluster 40: Non-specific - Unknown function"	"Cluster 58: Macrophages - Innate immune response"	90	Vesicles		"HPA008147: AB_1845195"	"unprognostic (1.91e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.22e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.37e-2)"	"unprognostic (6.69e-2)"	"unprognostic (2.60e-3)"	"unprognostic (1.55e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.54e-2)"	"potential prognostic favorable (1.29e-7)"	"unprognostic (1.56e-3)"	"potential prognostic favorable (3.73e-4)"	"potential prognostic unfavorable (5.23e-4)"	"unprognostic (2.00e-1)"	"unprognostic (2.39e-2)"	"unprognostic (9.31e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.33e-3)"	"unprognostic (6.08e-3)"	"unprognostic (4.85e-3)"	"unprognostic (1.95e-1)"	"unprognostic (8.60e-2)"	"unprognostic (4.95e-2)"	"unprognostic (5.84e-3)"	"unprognostic (7.50e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.37e-1)"
ATP6V1C1	"ATP6C, ATP6D, VATC, Vma5"	ENSG00000155097	"ATPase H+ transporting V1 subunit C1"	P21283	8	103021063-103073051	"FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 187.8;Late spermatids: 172.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Adrenal cortex cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023943, HPA057297"	Approved		Approved	Nucleoplasm,Cytosol			NA	NA		19000	"Cluster 40: Monocytes - Innate immune response"	"Cluster 61: Brain - Neuronal signaling"	"Cluster 14: Neurons - Synaptic function"	"Cluster 40: Non-specific - Unknown function"	"Cluster 38: Proximal tubular cells - Transmembrane transport"	32	Nucleoplasm	Cytosol	"HPA023943: AB_1845197, HPA057297: AB_2683402"	"unprognostic (1.07e-1)"	"unprognostic (1.70e-3)"	"unprognostic (1.13e-1)"	"unprognostic (4.59e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.06e-1)"	"potential prognostic unfavorable (8.98e-4)"	"potential prognostic unfavorable (3.07e-6)"	"potential prognostic favorable (1.86e-7)"	"unprognostic (1.28e-3)"	"unprognostic (1.09e-1)"	"potential prognostic unfavorable (1.07e-4)"	"unprognostic (7.57e-3)"	"unprognostic (2.36e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.42e-3)"	"unprognostic (3.98e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.58e-2)"	"potential prognostic unfavorable (3.03e-5)"	"unprognostic (6.75e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.98e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.68e-1)"
AVPR1A	AVPR1	ENSG00000166148	"Arginine vasopressin receptor 1A"	P37288	12	63142759-63151201	"FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 54.9"	"Cell type enhanced"	"Detected in some"		"Endometrial stromal cells: 22.5;Hepatocytes: 49.2;Sertoli cells: 27.2;Smooth muscle cells: 121.0"	"Group enriched"	"Detected in some"	6	"CGE interneuron: 5.1;hippocampal CA4: 3.3;LAMP5-LHX6 and Chandelier: 3.1;pericyte: 7.6;vascular associated smooth muscle cell: 9.6"	"Cancer enriched"	"Detected in many"	10	"Kidney Chromophobe (TCGA): 45.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Myeloma: 2.8;Neuroblastoma: 1.1"	"Adrenal gland - Adrenal cortex cells, Breast - Endothelial cells, Liver - Hepatocytes, Minor Salivary Gland - Endothelial cells"	"Group enriched"	"Detected in some"	5	"basal ganglia: 7.0;hypothalamus: 3.8"	"Low region specificity"	"Detected in all"										NA	NA				"Cluster 1: Liver & Kidney - Metabolism"	"Cluster 23: Choroid plexus - Mixed function"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 48: Smooth muscle cells - Signal transduction"	1				"unprognostic (1.30e-2)"	"unprognostic (6.19e-2)"	"unprognostic (3.22e-1)"			"unprognostic (2.16e-1)"		"unprognostic (1.98e-1)"		"unprognostic (1.20e-1)"	"validated prognostic favorable (4.85e-5)"	"validated prognostic favorable (8.06e-5)"		"unprognostic (5.33e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.64e-3)"					"unprognostic (4.14e-2)"	"unprognostic (1.23e-2)"			"unprognostic (6.29e-2)"	"potential prognostic unfavorable (4.02e-6)"	"unprognostic (2.52e-3)"		"unprognostic (2.99e-2)"	"unprognostic (2.37e-2)"
AVPR1B	"AVPR3, V1bR, VPR3"	ENSG00000198049	"Arginine vasopressin receptor 1B"	P47901	1	206106936-206117699	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	18	"pituitary gland: 6.6"	"Group enriched"	"Detected in some"	21	"Enteroendocrine cells: 10.6;Glandular and luminal cells: 2.7"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"Kidney Renal Clear Cell Carcinoma (TCGA): 3.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Pancreas - Alpha cells, Pituitary gland - Corticotropes"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA075404	Enhanced						NA	NA				"Cluster 49: Pituitary gland - Hormone signaling"		"Cluster 15: Kidney cancer - Membrane components"	"Cluster 20: Enteroendocrine cells - Hormone signaling"				"HPA075404: AB_2732291"											"validated prognostic favorable (1.65e-6)"	"validated prognostic favorable (1.88e-4)"																			
AVPR2	"DIR, DIR3, V2R"	ENSG00000126895	"Arginine vasopressin receptor 2"	P30518	X	153902531-153907166	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Diabetes insipidus, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 9.6;kidney: 10.7"	"Group enriched"	"Detected in some"	7	"Adipocytes: 46.0;Collecting duct cells: 40.8;Endothelial cells: 17.2"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"cerebellum: 9.3"	"Group enriched"	"Detected in some"	28	"intermediate monocyte: 3.5;non-classical monocyte: 3.2"	"Lineage enriched"	"Detected in single"	30	"monocytes: 3.5"	"Cancer enhanced"	"Detected in some"		"Adrenocortical cancer: 5.3"	"Adipose visceral - Endothelial cells, Breast - Endothelial cells, Minor Salivary Gland - Endothelial cells, Prostate - Endothelial cells, Testis - Endothelial cells"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	29	"cerebellum: 10.5"								NA	NA			"Cluster 40: Monocytes - Innate immune response"	"Cluster 7: Adipose tissue - Mixed function"	"Cluster 35: Non-specific - DNA binding"	"Cluster 70: DU4475 - Unknown function"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	4						"unprognostic (4.28e-3)"			"unprognostic (7.94e-2)"				"unprognostic (4.18e-2)"	"potential prognostic favorable (1.32e-4)"		"unprognostic (3.13e-3)"							"unprognostic (2.36e-3)"	"unprognostic (2.86e-3)"						"unprognostic (1.73e-1)"			"unprognostic (2.55e-1)"	"unprognostic (1.28e-1)"
AXL	"ARK, JTK11, Tyro7, UFO"	ENSG00000167601	"AXL receptor tyrosine kinase"	P30530	19	41219223-41261766	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins"	"Differentiation, Host-virus interaction, Immunity, Innate immunity"	"Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"FDA approved drug targets, Oncogene, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 125.3;Kupffer cells: 138.5;Langerhans cells: 188.8;Sertoli cells: 136.0;Smooth muscle cells: 124.8"	"Cell type enhanced"	"Detected in many"		"central nervous system macrophage: 193.4;pericyte: 261.6;vascular associated smooth muscle cell: 197.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 11.3;plasmacytoid DC: 25.8"	"Group enriched"	"Detected in many"	12	"dendritic cells: 25.8;NK-cells: 11.3"	"Cancer enhanced"	"Detected in many"		"Adrenocortical cancer: 812.7"	"Testis - Sertoli cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032501, HPA037422, HPA037423, HPA075217"	Uncertain		Supported	"Vesicles,Plasma membrane,Actin filaments"			NA	Yes		38000000	"Cluster 8: Plasmacytoid DCs - Unknown function"	"Cluster 62: Connective tissue - ECM organization"	"Cluster 19: Astrocytes - Mixed function"	"Cluster 72: Neuronal - Signal transduction"	"Cluster 48: Smooth muscle cells - Signal transduction"	25	"Plasma membrane"	"Vesicles, Actin filaments"	"CAB032501: AB_2062572, HPA037422: AB_10672347, HPA037423: AB_2675470, HPA075217: "	"unprognostic (1.99e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.47e-2)"	"unprognostic (9.12e-3)"	"unprognostic (1.19e-2)"	"unprognostic (4.30e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.92e-3)"	"unprognostic (1.85e-1)"	"unprognostic (9.14e-2)"	"unprognostic (8.04e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.99e-1)"	"unprognostic (8.38e-3)"	"unprognostic (1.08e-1)"	"unprognostic (9.13e-3)"	"unprognostic (6.41e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.05e-2)"	"potential prognostic unfavorable (1.07e-5)"	"unprognostic (9.85e-3)"	"unprognostic (1.20e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.69e-2)"	"unprognostic (3.56e-3)"	"unprognostic (3.87e-2)"	"unprognostic (9.23e-3)"	"unprognostic (3.06e-2)"
BCHE	"CHE1, CHE2, E1"	ENSG00000114200	Butyrylcholinesterase	P06276	3	165772904-165837462	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Serine esterase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"liver: 508.2"	"Group enriched"	"Detected in many"	7	"Hepatocytes: 505.6;Mesothelial cells: 169.6;Oligodendrocyte precursor cells: 197.2"	"Cell type enhanced"	"Detected in many"		"committed oligodendrocyte precursor: 92.9;oligodendrocyte precursor cell: 269.3"	"Group enriched"	"Detected in many"	5	"Glioblastoma Multiforme (TCGA): 72.4;Kidney Renal Papillary Cell Carcinoma (TCGA): 18.8;Liver Hepatocellular Carcinoma (TCGA): 41.4;Skin Cuteneous Melanoma (TCGA): 40.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Adipose visceral - Mesothelial cells, Kidney - Proximal tubular cells, Liver - Hepatocytes, Minor Salivary Gland - Fibroblasts, Pituitary gland - Corticotropes, Prostate - Smooth muscle cells, Testis - Early spermatids"	"Low region specificity"	"Detected in all"							HPA001560	Approved				"Secreted to blood"	Enzyme	NA	NA	3820000000	5500000000		"Cluster 83: Liver - Metabolism"	"Cluster 13: Oligodendrocytes - Mixed function"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 43: Hepatocytes - Metabolism"	8			"HPA001560: AB_1078271"	"unprognostic (1.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.03e-2)"			"unprognostic (5.73e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.61e-1)"	"potential prognostic unfavorable (3.23e-5)"		"unprognostic (7.08e-2)"	"unprognostic (1.70e-3)"	"unprognostic (2.70e-1)"	"unprognostic (1.72e-1)"	"unprognostic (9.56e-3)"	"unprognostic (1.28e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.58e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.09e-1)"		"unprognostic (7.71e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.01e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.71e-2)"
BCL2	"Bcl-2, PPP1R50"	ENSG00000171791	"BCL2 apoptosis regulator"	P10415	18	63123346-63320128	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Autophagy"		"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 257.6;Schwann cells: 119.6;T-cells: 102.3"	"Cell type enhanced"	"Detected in all"		"leukocyte: 1345.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	18	"B-cells: 5.4;T-cells: 8.6"	"Cancer enhanced"	"Detected in all"		"lymphoma: 53.5;Myeloma: 68.5"	"Adipose subcutaneous - Adipocytes (Subcutaneous), Colon - Enteric glia cells, Pituitary gland - Undifferentiated cells (Pituitary gland), Skeletal muscle - Skeletal myocytes, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000003, CAB080071, CAB080083"	Enhanced		Enhanced	Mitochondria			NA	NA			"Cluster 43: Non-specific - Transcription & Translation"	"Cluster 16: Non-specific - Transcription"	"Cluster 19: Astrocytes - Mixed function"	"Cluster 13: Non-specific - Mixed function"	"Cluster 78: NK-cells & T-cells - Immune system & Transcription"	97	Mitochondria		"CAB000003: AB_2064429, CAB080071: , CAB080083: "	"unprognostic (1.23e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.97e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.61e-1)"	"validated prognostic favorable (1.60e-11)"	"validated prognostic favorable (2.68e-4)"	"unprognostic (1.34e-1)"		"unprognostic (1.56e-2)"	"potential prognostic favorable (1.56e-4)"	"unprognostic (1.48e-1)"	"unprognostic (2.68e-2)"	"unprognostic (6.02e-3)"	"unprognostic (4.98e-1)"	"unprognostic (4.94e-2)"	"unprognostic (9.81e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.03e-1)"	"unprognostic (8.56e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.38e-2)"	"unprognostic (4.60e-3)"	"unprognostic (1.79e-1)"
BCR	"ALL, BCR1, CML, D22S11, D22S662, PHL"	ENSG00000186716	"BCR activator of RhoGEF and GTPase"	P11274	22	23179704-23318037	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins"		"GTPase activation, Guanine-nucleotide releasing factor, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 63.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Pituitary gland - Corticotropes, Testis - Sertoli cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010421, CAB018545, HPA038337"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"			NA	NA			"Cluster 24: Non-specific - Transcription"	"Cluster 33: Brain - Neuronal signaling"	"Cluster 33: Neurons - Mixed function"	"Cluster 6: Leukemia - Signal transduction"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	52	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB010421: AB_2274682, CAB018545: AB_2063918, HPA038337: AB_10675795"	"unprognostic (2.63e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.54e-1)"	"unprognostic (4.45e-2)"	"unprognostic (4.34e-3)"	"unprognostic (2.67e-1)"	"unprognostic (1.99e-2)"	"validated prognostic favorable (5.86e-10)"	"validated prognostic favorable (1.46e-4)"	"unprognostic (2.28e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.62e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.55e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.94e-2)"	"unprognostic (2.02e-1)"	"unprognostic (9.93e-3)"	"unprognostic (7.16e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.89e-3)"	"unprognostic (4.82e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.66e-1)"	"unprognostic (8.40e-2)"	"unprognostic (2.17e-1)"
BDKRB2	BK-2	ENSG00000168398	"Bradykinin receptor B2"	P30411	14	96204679-96244166	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"urinary bladder: 39.6"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 16.0;Endothelial cells: 16.7;Fibroblasts: 17.0;Ionocytes: 16.2;Langerhans cells: 19.0;Squamous epithelial cells: 15.4"	"Cell type enhanced"	"Detected in many"		"lower rhombic lip: 13.6;upper rhombic lip: 11.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"cervical cancer: 18.2"	"Kidney - Endothelial cells, Pituitary gland - Endothelial cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA003551, HPA050841"	Approved		Supported	"Vesicles,Plasma membrane,Cytokinetic bridge"			Yes	NA				"Cluster 75: Epithelium - Extracellular exosomes"	"Cluster 49: Hindbrain - Mixed function"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	2	"Vesicles, Plasma membrane"	"Cytokinetic bridge"	"HPA003551: , HPA050841: AB_2681254"	"unprognostic (9.71e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.82e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.47e-3)"	"unprognostic (5.08e-2)"	"unprognostic (2.77e-2)"	"potential prognostic favorable (3.26e-4)"	"unprognostic (2.19e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.39e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.76e-2)"	"unprognostic (2.33e-1)"	"potential prognostic unfavorable (3.28e-4)"	"unprognostic (6.00e-2)"	"unprognostic (3.79e-2)"	"unprognostic (6.90e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.16e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.07e-1)"	"unprognostic (9.48e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.51e-1)"	"unprognostic (4.02e-2)"	"unprognostic (1.64e-1)"
BGLAP	OCN	ENSG00000242252	"Bone gamma-carboxyglutamate protein"	P02818	1	156242184-156243317	"FDA approved drug targets, Predicted secreted proteins"	Biomineralization	Hormone	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 7.1;intestine: 8.3"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 3.1;Serous glandular cells: 2.3;Sertoli cells: 2.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	17	"NK-cell: 1.8;plasmacytoid DC: 1.6"	"Group enriched"	"Detected in many"	17	"dendritic cells: 1.6;NK-cells: 1.8"	"Cancer enhanced"	"Detected in some"		"Leukemia: 5.8;Myeloma: 14.4"	"Colon - Enteric glia cells"	"Region enriched"	"Detected in single"	7	"olfactory bulb: 5.3"	"Low region specificity"	"Detected in all"								"Secreted to blood"	Hormone	NA	NA	15500000	2100000	"Cluster 8: Plasmacytoid DCs - Unknown function"	"Cluster 60: Choroid plexus - Transmembrane transport"	"Cluster 30: White matter - Myelination"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 77: Plasma cells - Protein processing"					"unprognostic (1.42e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.14e-1)"	"unprognostic (7.82e-3)"		"unprognostic (1.06e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.22e-3)"	"unprognostic (9.32e-3)"	"unprognostic (1.81e-1)"			"unprognostic (1.27e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.07e-2)"					"potential prognostic favorable (1.82e-4)"	"unprognostic (4.13e-3)"	"unprognostic (3.54e-1)"		"unprognostic (1.68e-1)"		"unprognostic (2.36e-1)"	"unprognostic (1.48e-1)"	"unprognostic (8.21e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.42e-1)"	"unprognostic (7.64e-2)"
BHMT	BHMT1	ENSG00000145692	"Betaine--homocysteine S-methyltransferase"	Q93088	5	79111809-79132288	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	83	"kidney: 751.2;liver: 1107.8"	"Group enriched"	"Detected in some"	26	"Hepatocytes: 550.2;Proximal tubular cells: 637.2"	"Cell type enriched"	"Detected in many"	19	"hippocampal CA4: 58.5"	"Group enriched"	"Detected in many"	5	"Kidney Renal Clear Cell Carcinoma (TCGA): 160.6;Kidney Renal Papillary Cell Carcinoma (TCGA): 44.7;Liver Hepatocellular Carcinoma (TCGA): 167.4"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Gastric cancer: 4.2;Kidney cancer: 1.9"	"Kidney - Proximal tubular cells, Liver - Hepatocytes"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA038285, HPA058310"	Enhanced		Approved	Cytosol			No	NA		9500000		"Cluster 1: Liver & Kidney - Metabolism"	"Cluster 51: Neurons - Mixed function"	"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 56: Proximal tubular cells - Amino acid metabolism"		Cytosol		"HPA038285: AB_10675791, HPA058310: AB_2683675"	"unprognostic (1.61e-1)"									"unprognostic (2.06e-2)"	"validated prognostic favorable (3.94e-8)"	"validated prognostic favorable (2.11e-4)"	"unprognostic (3.12e-2)"	"potential prognostic favorable (8.19e-4)"	"unprognostic (1.31e-3)"	"unprognostic (9.17e-2)"													"unprognostic (3.31e-1)"		
BLVRB	"FLR, SDR43U1"	ENSG00000090013	"Biliverdin reductase B"	P30043	19	40447765-40465764	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Oxidoreductase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 615.8"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 2110.5;Hepatocytes: 827.2;Hofbauer cells: 1099.8;Proximal enterocytes: 929.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"classical monocyte: 466.2"	"Group enriched"	"Detected in all"	7	"dendritic cells: 343.8;monocytes: 466.2"	"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Macrophages, Spleen - Macrophages"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041698, HPA041937"	Enhanced		Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"			No	No		310000000	"Cluster 26: Monocytes - Plasma membrane proteins"	"Cluster 40: Non-specific - Transcription"	"Cluster 49: Hindbrain - Mixed function"	"Cluster 47: Leukemia - Hemostasis"	"Cluster 1: Erythroid cells - Oxygen transport"	9	Cytosol	"Nucleoplasm, Vesicles, Plasma membrane"	"HPA041698: AB_10796781, HPA041937: AB_10794308"	"unprognostic (2.10e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.95e-1)"	"potential prognostic favorable (3.06e-4)"	"unprognostic (1.66e-1)"	"unprognostic (2.95e-3)"	"unprognostic (3.66e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.06e-3)"	"unprognostic (5.50e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.09e-2)"	"potential prognostic unfavorable (2.26e-4)"	"unprognostic (1.27e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.15e-2)"	"unprognostic (2.38e-1)"	"potential prognostic unfavorable (7.61e-5)"	"unprognostic (8.66e-2)"	"unprognostic (2.79e-1)"	"unprognostic (5.16e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.85e-3)"	"unprognostic (9.67e-3)"	"unprognostic (5.01e-2)"
BMPR1A	"ACVRLK3, ALK3, CD292"	ENSG00000107779	"Bone morphogenetic protein receptor type 1A"	P36894	10	86756601-86932825	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 135.3;Inhibitory neurons: 76.7;Oligodendrocyte precursor cells: 114.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Kidney - Fibroblasts, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB019398	Approved		Approved	Cytosol			NA	NA				"Cluster 51: Thyroid gland - Unknown function"	"Cluster 39: Astrocytes - Mixed function"	"Cluster 5: Rhabdoid - Unknown function"	"Cluster 76: Oligodendrocyte precursor - Unknown function"	42	Cytosol		"CAB019398: "	"unprognostic (4.53e-3)"	"unprognostic (3.26e-2)"	"unprognostic (8.39e-3)"	"unprognostic (2.82e-1)"	"unprognostic (3.15e-2)"	"unprognostic (5.05e-2)"	"unprognostic (1.64e-3)"	"potential prognostic favorable (5.70e-5)"	"unprognostic (2.37e-1)"	"unprognostic (1.26e-3)"	"unprognostic (2.56e-3)"	"unprognostic (7.22e-2)"	"unprognostic (5.16e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.88e-1)"	"unprognostic (4.24e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.59e-1)"	"unprognostic (5.14e-2)"	"unprognostic (3.46e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.22e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.34e-3)"	"unprognostic (2.51e-2)"	"unprognostic (4.92e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.64e-3)"	"unprognostic (2.74e-2)"
BMPR2	"BMPR-II, BMPR3, BRK-3, PPH1, T-ALK"	ENSG00000204217	"Bone morphogenetic protein receptor type 2"	Q13873	2	202376327-202567751	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins"		"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endothelial cells: 174.0;Excitatory neurons: 195.3;Inhibitory neurons: 182.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Adipose visceral - Endothelial cells, Adrenal gland - Adrenal cortex cells, Lung - Endothelial cells, Skeletal muscle - Endothelial cells, Thyroid gland - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017385, HPA049014"	Approved		Supported	"Nucleoplasm,Plasma membrane"			NA	NA				"Cluster 34: Non-specific - Mixed function"	"Cluster 1: Neurons - Mixed function"	"Cluster 9: Skin cancer - Melanin biosynthesis"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	14	"Nucleoplasm, Plasma membrane"		"HPA017385: AB_1845397, HPA049014: AB_2680599"	"unprognostic (3.74e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.85e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.74e-1)"	"unprognostic (9.97e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.24e-2)"	"validated prognostic favorable (4.24e-6)"	"validated prognostic favorable (2.41e-4)"	"unprognostic (7.09e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.84e-1)"	"unprognostic (3.54e-1)"	"unprognostic (6.34e-2)"	"unprognostic (6.62e-2)"	"unprognostic (3.82e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.19e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.25e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.45e-2)"	"unprognostic (4.96e-2)"	"unprognostic (3.15e-2)"	"unprognostic (4.13e-2)"
BRAF	"BRAF-1, BRAF1"	ENSG00000157764	"B-Raf proto-oncogene, serine/threonine kinase"	P15056	7	140719327-140924929	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Transporters"		"Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Cardiomyopathy, Deafness, Disease variant, Ectodermal dysplasia, FDA approved drug targets, Intellectual disability, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 243.7;Inhibitory neurons: 232.1;Oligodendrocyte precursor cells: 193.4;Oligodendrocytes: 188.6;Syncytiotrophoblasts: 187.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Testis - Early spermatids, Testis - Spermatocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001328, CAB004552, HPA071048, CAB080447, CAB080451, CAB080452, CAB080531"	Supported		Supported	"Vesicles,Plasma membrane,Primary cilium,Centriolar satellite,Basal body,Cytosol,Mid piece,Principal piece,End piece"			No	No			"Cluster 20: Non-specific - DNA binding"	"Cluster 28: Neuronal - Transcription"	"Cluster 31: Non-specific - Transcription"	"Cluster 39: Non-specific - Transcription"	"Cluster 78: NK-cells & T-cells - Immune system & Transcription"	72	"Vesicles, Cytosol"	"Plasma membrane, Primary cilium, Centriolar satellite, Basal body, Mid piece, Principal piece, End piece"	"CAB004552: AB_626760, CAB080447: , CAB080451: , CAB080452: , CAB080531: , HPA001328: AB_1078296, HPA071048: AB_2686336"	"potential prognostic favorable (4.52e-4)"	"unprognostic (8.04e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.00e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.01e-2)"	"validated prognostic favorable (1.04e-4)"	"validated prognostic favorable (2.24e-4)"	"unprognostic (1.26e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.31e-2)"	"unprognostic (7.33e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.82e-1)"	"unprognostic (7.86e-2)"	"potential prognostic unfavorable (1.29e-4)"	"unprognostic (2.08e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.21e-1)"	"unprognostic (8.43e-2)"	"unprognostic (2.20e-3)"	"unprognostic (5.50e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.77e-2)"	"unprognostic (6.27e-2)"
BST1	"BST-1, cADPR2, CD157"	ENSG00000109743	"Bone marrow stromal cell antigen 1"	Q10588	4	15703065-15738313	"CD markers, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"bone marrow: 138.1;intestine: 47.2"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 61.4;Kupffer cells: 31.0;Proximal enterocytes: 79.1"	"Cell type enhanced"	"Detected in some"		"fibroblast: 14.5;pericyte: 19.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 258.3;neutrophil: 294.2"	"Group enriched"	"Detected in many"	94	"dendritic cells: 79.0;granulocytes: 294.2;monocytes: 258.3"	"Low cancer specificity"	"Detected in many"			"Prostate - Fibroblasts, Skin - Fibroblast_2, Spleen - Neutrophils, Stomach - Fibroblasts, Thyroid gland - Fibroblasts"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA050121	Uncertain				"Intracellular and membrane"	Enzyme	NA	NA		130000000	"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 77: Bone marrow - Cell proliferation"	"Cluster 48: Non-specific - Mixed function"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 29: Monocytes - Innate immune response"				"HPA050121: AB_2681025"	"unprognostic (7.12e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.33e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.55e-2)"	"potential prognostic favorable (1.66e-5)"	"unprognostic (4.49e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.83e-1)"	"unprognostic (6.64e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.35e-2)"	"unprognostic (4.75e-1)"	"unprognostic (2.09e-1)"	"unprognostic (4.43e-1)"	"unprognostic (6.22e-2)"	"unprognostic (2.92e-1)"	"unprognostic (7.84e-3)"	"unprognostic (3.98e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.67e-2)"	"potential prognostic unfavorable (2.62e-4)"	"unprognostic (2.83e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.84e-2)"
BTK	"AGMX1, ATK, IMD1, PSCTK1, XLA"	ENSG00000010671	"Bruton tyrosine kinase"	Q06187	X	101349338-101390796	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Apoptosis, Immunity, Innate immunity, Transcription, Transcription regulation"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 25.3;lymphoid tissue: 65.1"	"Cell type enhanced"	"Detected in some"		"B-cells: 78.3;dendritic cells: 57.4;granulocytes: 172.9;Hofbauer cells: 59.3;Kupffer cells: 56.4;Langerhans cells: 41.7;Macrophages: 48.7;monocytes: 87.8;Plasma cells: 50.9"	"Cell type enriched"	"Detected in some"	4	"central nervous system macrophage: 76.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in many"	4	"basophil: 515.1"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 515.1"	"Group enriched"	"Detected in some"	93	"Leukemia: 79.9;lymphoma: 84.3;Myeloma: 21.2"	"Adipose subcutaneous - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Skeletal muscle - Macrophages, Spleen - B-cells (Spleen), Stomach - Macrophages"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA001198, HPA002028, CAB016689, CAB080300"	Enhanced		Supported	"Plasma membrane,Cytosol"			NA	NA		2000000	"Cluster 32: Basophils - Transcription"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 49: HMC-1 - Innate immune response"	"Cluster 30: Granulocytes - Unknown function"	39	"Plasma membrane, Cytosol"		"CAB016689: AB_1611894, CAB080300: , HPA001198: AB_1078305, HPA002028: AB_1078306"	"unprognostic (2.58e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.72e-1)"	"potential prognostic favorable (3.57e-4)"	"unprognostic (9.42e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.52e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.15e-2)"	"unprognostic (5.15e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.20e-1)"	"potential prognostic favorable (1.03e-5)"	"unprognostic (3.35e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.52e-1)"	"unprognostic (4.26e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.66e-3)"	"unprognostic (2.23e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.51e-3)"	"unprognostic (4.04e-2)"	"unprognostic (9.55e-2)"
C1S		ENSG00000182326	"Complement C1s"	P09871	12	6988259-7071032	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease variant, Ehlers-Danlos syndrome, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 2762.6"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 717.8;Hepatocytes: 2248.0;Leydig cells: 1204.3;Mesothelial cells: 578.3;Ovarian stromal cells: 401.7;Peritubular cells: 631.2"	"Cell type enriched"	"Detected in all"	5	"fibroblast: 348.0"	"Cancer enhanced"	"Detected in all"		"Liver Hepatocellular Carcinoma (TCGA): 745.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Adipose subcutaneous - Adipose progenitor cells, Adipose visceral - Adipose progenitor cells, Breast - Fibroblasts, Liver - Hepatocytes, Lung - Fibroblast_2, Skin - Fibroblast_2, Spleen - Fibroblast_2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB016722, HPA018852"	Supported		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	"Complement pathway"	NA	NA	93000000000	20000000000		"Cluster 31: Liver - Plasma proteins"	"Cluster 39: Astrocytes - Mixed function"	"Cluster 44: Connective tissue cells - ECM organization"	"Cluster 53: Fibroblasts - ECM organization"	3	Nucleoplasm	Cytosol	"CAB016722: , HPA018852: AB_1847112"	"unprognostic (7.81e-3)"	"unprognostic (6.27e-3)"	"unprognostic (1.58e-1)"	"unprognostic (6.27e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.55e-3)"	"unprognostic (1.04e-1)"	"unprognostic (9.25e-2)"	"potential prognostic unfavorable (1.67e-5)"	"unprognostic (1.49e-3)"	"potential prognostic unfavorable (7.14e-5)"	"validated prognostic favorable (5.46e-4)"	"validated prognostic favorable (2.13e-5)"	"unprognostic (1.20e-1)"	"unprognostic (7.56e-2)"	"unprognostic (9.06e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.31e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.93e-2)"	"unprognostic (6.79e-2)"	"unprognostic (7.09e-3)"	"unprognostic (2.72e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.65e-3)"
C3	"ARMD9, C3a, C3b, CPAMD1"	ENSG00000125730	"Complement C3"	P01024	19	6677704-6730562	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Fatty acid metabolism, Immunity, Inflammatory response, Innate immunity, Lipid metabolism"		"Age-related macular degeneration, Disease variant, FDA approved drug targets, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	9	"liver: 5250.9"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 657.6;Exocrine glandular cells: 845.2;Hepatocytes: 3158.4;Mesothelial cells: 2220.5"	"Cell type enriched"	"Detected in many"	49	"central nervous system macrophage: 753.0"	"Cancer enriched"	"Detected in all"	4	"Liver Hepatocellular Carcinoma (TCGA): 2548.0"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"non-classical monocyte: 14.5"	"Lineage enriched"	"Detected in many"	5	"monocytes: 14.5"	"Cancer enhanced"	"Detected in many"		"liver cancer: 255.0"	"Adrenal gland - Adrenal cortex cells, Liver - Hepatocytes, Lung - Fibroblast_2, Pituitary gland - Macrophages, Thyroid gland - Macrophages"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003563, CAB004209, HPA020432"	Enhanced				"Secreted to blood"	"Complement pathway"	NA	NA	1260000000000	220000000000	"Cluster 40: Monocytes - Innate immune response"	"Cluster 83: Liver - Metabolism"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 62: Hepatocytes - Metabolism"	40			"CAB004209: AB_627277, HPA003563: AB_1847117, HPA020432: AB_1847118"	"potential prognostic favorable (1.46e-4)"	"unprognostic (3.99e-3)"	"unprognostic (2.04e-2)"	"unprognostic (6.44e-2)"	"unprognostic (6.78e-2)"	"unprognostic (8.30e-2)"	"unprognostic (2.71e-2)"	"unprognostic (3.60e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.25e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.64e-3)"	"potential prognostic favorable (2.99e-6)"	"unprognostic (1.82e-1)"	"unprognostic (3.09e-3)"	"unprognostic (7.40e-3)"	"unprognostic (6.78e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.19e-1)"	"unprognostic (8.47e-3)"	"unprognostic (3.71e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.27e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.35e-2)"	"unprognostic (5.99e-2)"
C4A	"C4, C4A2, C4A3, C4A4, C4A6, C4B, C4S, CO4, CPAMD2, RG"	ENSG00000244731	"Complement C4A (Rodgers blood group)"	P0C0L4	6	31982057-32002681	"Blood group antigen proteins, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Inflammatory response, Innate immunity"	"Blood group antigen"	"Disease variant, FDA approved drug targets, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 112.2;liver: 328.2"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 6.8;Mesothelial cells: 8.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"Breast Invasive Carcinoma (TCGA): 55.1;Kidney Renal Clear Cell Carcinoma (TCGA): 49.6;Kidney Renal Papillary Cell Carcinoma (TCGA): 32.8;Liver Hepatocellular Carcinoma (TCGA): 90.9;Thyroid Carcinoma (TCGA): 27.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"liver cancer: 8.8;Myeloma: 6.7"	"Breast - Breast glandular cells, Kidney - Proximal tubular cells, Liver - Hepatocytes"									"CAB009811, CAB032603, HPA046356, HPA048287, HPA050103"	Supported				"Secreted to blood"	"Complement pathway"	NA	NA	342000000	200000000000		"Cluster 83: Liver - Metabolism"	"Cluster 39: Astrocytes - Mixed function"	"Cluster 70: DU4475 - Unknown function"	"Cluster 62: Hepatocytes - Metabolism"	13			"CAB009811: AB_2066891, CAB032603: AB_2290613, HPA046356: AB_2679635, HPA048287: AB_2680341, HPA050103: AB_2681016"	"unprognostic (3.29e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.58e-1)"	"unprognostic (9.96e-2)"		"unprognostic (8.69e-2)"	"unprognostic (7.36e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.61e-3)"	"unprognostic (1.64e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.15e-3)"	"unprognostic (4.88e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.99e-2)"	"unprognostic (7.66e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.94e-1)"		"unprognostic (9.91e-2)"	"unprognostic (7.39e-2)"	"unprognostic (6.37e-2)"	"unprognostic (6.46e-2)"
C4B	"C4B1, C4B3, C4F, CH, CO4, CPAMD3"	ENSG00000224389	"Complement C4B (Chido blood group)"	P0C0L5	6	32014795-32035418	"Blood group antigen proteins, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Inflammatory response, Innate immunity"	"Blood group antigen"	"FDA approved drug targets, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 214.6;liver: 375.4"	"Group enriched"	"Detected in some"	5	"Hepatocytes: 7.1;Mesothelial cells: 13.6"	"Cell type enhanced"	"Detected in some"		"astrocyte: 1.4;vascular associated smooth muscle cell: 1.0"	"Cancer enhanced"	"Detected in all"		"Liver Hepatocellular Carcinoma (TCGA): 238.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"liver cancer: 6.7;Myeloma: 3.9"	"Liver - Hepatocytes"									"HPA046356, HPA048287, HPA050103"	Approved				"Secreted to blood"	"Complement pathway"	NA	NA	447000000000	200000000000		"Cluster 83: Liver - Metabolism"	"Cluster 39: Astrocytes - Mixed function"	"Cluster 70: DU4475 - Unknown function"	"Cluster 62: Hepatocytes - Metabolism"	2			"HPA046356: AB_2679635, HPA048287: AB_2680341, HPA050103: AB_2681016"	"unprognostic (7.64e-2)"	"unprognostic (2.28e-1)"		"unprognostic (4.09e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.70e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.36e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.34e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.61e-3)"	"unprognostic (8.48e-2)"	"unprognostic (1.16e-3)"	"unprognostic (1.30e-1)"	"potential prognostic unfavorable (7.93e-4)"	"unprognostic (2.86e-1)"	"unprognostic (2.41e-3)"	"unprognostic (2.31e-2)"	"unprognostic (3.75e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.00e-1)"	"unprognostic (6.92e-3)"	"unprognostic (4.65e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.29e-1)"
C5	"C5a, C5b, CPAMD4"	ENSG00000106804	"Complement C5"	P01031	9	120932987-121075195	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Inflammatory response, Innate immunity"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	30	"liver: 434.4"	"Cell type enriched"	"Detected in many"	14	"Hepatocytes: 435.9"	"Low cell type specificity"	"Detected in all"			"Cancer enriched"	"Detected in many"	9	"Liver Hepatocellular Carcinoma (TCGA): 102.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	5	"liver cancer: 21.1"	"Liver - Hepatocytes, Thyroid gland - Fibroblasts"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA029339	Supported				"Secreted to blood"	"Complement pathway"	NA	NA	113000000000	41000000000		"Cluster 83: Liver - Metabolism"	"Cluster 46: Brainstem - Mixed function"	"Cluster 18: Liver cancer - Metabolism"	"Cluster 62: Hepatocytes - Metabolism"	22			"HPA029339: AB_10601125"		"unprognostic (3.43e-1)"	"unprognostic (1.10e-1)"	"potential prognostic favorable (8.56e-4)"	"unprognostic (9.85e-3)"	"potential prognostic unfavorable (1.70e-4)"	"unprognostic (1.01e-1)"	"unprognostic (2.40e-1)"	"unprognostic (9.54e-3)"		"unprognostic (1.75e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.60e-3)"	"unprognostic (5.49e-3)"	"unprognostic (1.16e-3)"	"unprognostic (2.48e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.76e-2)"	"unprognostic (3.72e-1)"		"unprognostic (1.08e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.09e-2)"	"unprognostic (8.39e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.09e-1)"	
C5AR1	"C5A, C5AR, C5R1, CD88"	ENSG00000197405	"Complement C5a receptor 1"	P21730	19	47290023-47322066	"CD markers, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 124.0;lymphoid tissue: 82.5"	"Cell type enriched"	"Detected in many"	7	"monocytes: 3492.2"	"Group enriched"	"Detected in many"	5	"choroid plexus epithelial cell: 147.9;ependymal cell: 192.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 393.7"	"Group enriched"	"Detected in many"	42	"granulocytes: 393.7;monocytes: 116.2"	"Low cancer specificity"	"Detected in many"			"Adipose subcutaneous - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Colon - Neutrophils, Heart muscle - Macrophages, Kidney - Macrophages, Minor Salivary Gland - Macrophages"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB002720, HPA014520, HPA048012"	Approved		Approved	"Golgi apparatus,Vesicles"			NA	NA			"Cluster 28: Neutrophils - Unknown function"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 12: Non-specific - Vasculature"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 29: Monocytes - Innate immune response"	41	"Golgi apparatus"	Vesicles	"CAB002720: , HPA014520: AB_1846337, HPA048012: "	"unprognostic (2.00e-2)"	"unprognostic (7.55e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.13e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.64e-2)"	"unprognostic (2.08e-3)"	"unprognostic (5.45e-2)"	"unprognostic (7.28e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.00e-1)"	"unprognostic (8.75e-3)"	"unprognostic (5.35e-2)"	"unprognostic (7.23e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.30e-1)"	"potential prognostic unfavorable (3.62e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.72e-2)"	"unprognostic (9.68e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.05e-2)"	"unprognostic (9.83e-3)"	"unprognostic (6.92e-3)"	"unprognostic (5.28e-2)"	"unprognostic (5.03e-2)"	"unprognostic (4.42e-2)"
CA1	Car1	ENSG00000133742	"Carbonic anhydrase 1"	P00915	8	85327608-85379014	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Lyase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	55	"bone marrow: 1772.1;intestine: 2041.9"	"Group enriched"	"Detected in some"	21	"Distal enterocytes: 3364.7;Erythroid cells: 8876.2"	"Cell type enhanced"	"Detected in many"		"LAMP5-LHX6 and Chandelier: 125.6"	"Group enriched"	"Detected in some"	5	"Colon Adenocarcinoma (TCGA): 15.1;Rectum Adenocarcinoma (TCGA): 38.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	32	"Leukemia: 111.9"	"Colon - Colon enterocytes, Liver - Erythroid cells, Lung - Neutrophil_1, Pituitary gland - Neutrophils, Spleen - Erythrocytes"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA006558, CAB025790"	Enhanced						NA	NA		3400000000		"Cluster 77: Bone marrow - Cell proliferation"	"Cluster 37: Neurons - Mixed function"	"Cluster 47: Leukemia - Hemostasis"	"Cluster 1: Erythroid cells - Oxygen transport"	2			"CAB025790: , HPA006558: AB_1845989"					"unprognostic (1.00e-1)"	"unprognostic (1.18e-2)"					"unprognostic (1.63e-1)"												"unprognostic (2.50e-1)"		"unprognostic (2.50e-1)"	"unprognostic (8.67e-2)"		"unprognostic (9.29e-2)"			
CA12	HsT18816	ENSG00000074410	"Carbonic anhydrase 12"	O43570	15	63321378-63381846	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins"		Lyase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 149.3;kidney: 280.0;skin 1: 138.4"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 145.6;Basal squamous epithelial cells: 124.3;Distal enterocytes: 349.5;Intestinal goblet cells: 117.1;Paneth cells: 129.7;Squamous epithelial cells: 182.1;Suprabasal keratinocytes: 192.1"	"Cell type enhanced"	"Detected in many"		"choroid plexus epithelial cell: 419.9;medium spiny neuron: 120.1"	"Cancer enriched"	"Detected in all"	4	"Kidney Chromophobe (TCGA): 881.0"	"Group enriched"	"Detected in all"	5	"basal ganglia: 92.5;choroid plexus: 274.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Kidney cancer: 208.5"	"Minor Salivary Gland - Minor salivary gland basal cells, Skin - Keratinocyte (other), Testis - Late spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008773, CAB025181, CAB062549, CAB068179, HPA073203"	Enhanced						NA	NA		29000		"Cluster 52: Kidney - Transmembrane transport"	"Cluster 36: Choroid plexus - Mixed function"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 5: Enterocytes - Absorption"				"CAB025181: , CAB062549: AB_2665617, CAB068179: AB_2665616, HPA008773: AB_1078394, HPA073203: AB_2686580"	"unprognostic (9.71e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.60e-3)"	"unprognostic (2.40e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.85e-2)"	"unprognostic (3.92e-1)"	"potential prognostic favorable (1.12e-4)"	"unprognostic (1.65e-2)"	"unprognostic (1.26e-1)"	"unprognostic (7.88e-2)"	"unprognostic (2.08e-3)"	"unprognostic (3.29e-2)"	"unprognostic (4.44e-2)"	"unprognostic (9.61e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.03e-3)"	"unprognostic (2.75e-1)"	"potential prognostic unfavorable (1.26e-6)"	"unprognostic (2.05e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.97e-1)"	"potential prognostic unfavorable (3.36e-5)"	"unprognostic (2.65e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.22e-1)"
CA13	"CAXIII, FLJ37995, MGC59868"	ENSG00000185015	"Carbonic anhydrase 13"	Q8N1Q1	8	85220587-85284073	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		Lyase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 14.2"	"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 47.7"	"Cell type enhanced"	"Detected in all"		"LAMP5-LHX6 and Chandelier: 129.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Prostate - Urothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024689, CAB025567"	Enhanced		Approved	Nucleoplasm,Nucleoli,Vesicles			NA	NA		92000	"Cluster 41: Basophils - Unknown function"	"Cluster 55: Kidney & Intestine - Metabolism"	"Cluster 10: Cerebellum - Nucleic acid binding"	"Cluster 57: Stomach & Colon cancer - Digestion"	"Cluster 22: Proximal enterocytes - Digestion"	1	Nucleoli	"Nucleoplasm, Vesicles"	"CAB025567: , HPA024689: AB_1846004"	"unprognostic (1.40e-3)"	"unprognostic (1.45e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.06e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.66e-3)"	"unprognostic (6.00e-2)"	"unprognostic (9.69e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.77e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.70e-1)"		"unprognostic (9.53e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.02e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.29e-1)"	"unprognostic (7.01e-2)"	"potential prognostic unfavorable (3.19e-4)"	"unprognostic (1.06e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.53e-1)"	"unprognostic (5.16e-2)"	"unprognostic (7.39e-2)"	"unprognostic (2.90e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.23e-1)"
CA14		ENSG00000118298	"Carbonic anhydrase 14"	Q9ULX7	1	150257251-150265078	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Lyase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 116.2;retina: 38.2;tongue: 45.6"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 56.6;Melanocytes: 68.7;Muller glia cells: 151.4;Oligodendrocytes: 23.9"	"Cell type enhanced"	"Detected in some"		"choroid plexus epithelial cell: 10.7;committed oligodendrocyte precursor: 11.3;oligodendrocyte: 27.6"	"Cancer enriched"	"Detected in many"	5	"Skin Cuteneous Melanoma (TCGA): 91.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	8	"Rhabdoid: 29.1;skin cancer: 20.9;testis cancer: 13.5"	"Heart muscle - Cardiomyocytes, Liver - Hepatocytes, Skeletal muscle - Skeletal myocytes, Skin - Melanocytes, Testis - Peritubular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008482	Approved		Approved	"Plasma membrane"			NA	NA			"Cluster 14: Non-specific - Unknown function"	"Cluster 60: Choroid plexus - Transmembrane transport"	"Cluster 50: Non-specific - Nucleic acid binding"	"Cluster 9: Skin cancer - Melanin biosynthesis"	"Cluster 10: Muller glia cells - Visual perception"	25	"Plasma membrane"		"HPA008482: AB_1078395"		"unprognostic (2.74e-2)"	"unprognostic (2.78e-2)"			"unprognostic (3.71e-2)"	"unprognostic (3.62e-3)"	"unprognostic (8.41e-3)"						"unprognostic (3.79e-2)"	"unprognostic (4.06e-3)"					"unprognostic (9.38e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.70e-2)"		"unprognostic (1.21e-1)"		"unprognostic (4.29e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.87e-1)"	"unprognostic (6.40e-2)"	"unprognostic (5.47e-2)"
CA2	"CA-II, CAII, Car2"	ENSG00000104267	"Carbonic anhydrase 2"	P00918	8	85463968-85481493	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Lyase	"Disease variant, FDA approved drug targets, Osteopetrosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 971.6;intestine: 664.8;stomach 1: 1080.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 3008.5;Erythroid cells: 1660.0;Gastric mucus-secreting cells: 1234.5;Muller glia cells: 1243.1;Paneth cells: 636.5"	"Cell type enhanced"	"Detected in many"		"choroid plexus epithelial cell: 468.9;oligodendrocyte: 412.5;pericyte: 293.5"	"Cancer enriched"	"Detected in all"	4	"Kidney Chromophobe (TCGA): 753.6"	"Region enriched"	"Detected in all"	5	"choroid plexus: 825.1"	"Immune cell enhanced"	"Detected in many"		"basophil: 51.1"	"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Breast - Breast glandular cells, Colon - Colon enterocytes, Liver - Hepatocytes, Lung - Alveolar cells type 2, Minor Salivary Gland - Minor salivary glandular cells, Skin - Keratinocyte (other), Spleen - Erythrocytes, Stomach - Gastric mucous cells, Testis - Late spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001550, CAB010102"	Enhanced						NA	Yes		450000000	"Cluster 40: Monocytes - Innate immune response"	"Cluster 60: Choroid plexus - Transmembrane transport"	"Cluster 36: Choroid plexus - Mixed function"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 5: Enterocytes - Absorption"	3			"CAB010102: AB_626796, HPA001550: AB_1078393"	"unprognostic (1.08e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.18e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.13e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.58e-1)"	"validated prognostic favorable (2.13e-8)"	"validated prognostic favorable (4.11e-4)"	"unprognostic (1.33e-3)"	"unprognostic (1.88e-1)"	"unprognostic (8.04e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.53e-1)"	"potential prognostic unfavorable (2.34e-4)"	"unprognostic (1.62e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.08e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.27e-1)"	"unprognostic (8.48e-2)"	"unprognostic (3.63e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.95e-2)"
CA3	"CAIII, Car3"	ENSG00000164879	"Carbonic anhydrase 3"	P07451	8	85373436-85449040	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Lyase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 5086.3"	"Cell type enriched"	"Detected in many"	18	"Skeletal myocytes: 3095.2"	"Cell type enhanced"	"Detected in all"		"LAMP5-LHX6 and Chandelier: 230.4"	"Group enriched"	"Detected in many"	7	"Glioblastoma Multiforme (TCGA): 53.6;Prostate Adenocarcinoma (TCGA): 17.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"Kidney cancer: 6.7;Sarcoma: 6.5"	"Prostate - Fibroblasts, Skeletal muscle - Skeletal myocytes, Testis - Early spermatids, Testis - Late spermatids"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"medulla oblongata: 4.8"	"CAB004967, HPA021775, HPA026700"	Enhanced						NA	NA		40000000		"Cluster 2: Skeletal muscle - Striated muscle contraction"	"Cluster 37: Neurons - Mixed function"	"Cluster 33: Sarcoma - Muscle contraction"	"Cluster 2: Skeletal myocytes - Muscle contraction"	2			"CAB004967: AB_437014, HPA021775: AB_1845990, HPA026700: AB_1845991"		"potential prognostic favorable (2.01e-4)"	"unprognostic (1.41e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.81e-3)"	"potential prognostic unfavorable (2.89e-4)"	"unprognostic (2.15e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.11e-2)"		"unprognostic (3.86e-2)"	"unprognostic (5.45e-2)"	"unprognostic (3.15e-2)"	"unprognostic (3.91e-2)"	"potential prognostic favorable (2.08e-4)"	"unprognostic (1.07e-2)"	"unprognostic (9.94e-2)"	"unprognostic (2.98e-1)"	"unprognostic (5.85e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.96e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.12e-1)"		"unprognostic (6.30e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.48e-1)"	
CA4	"CAIV, Car4, RP17"	ENSG00000167434	"Carbonic anhydrase 4"	P22748	17	60149942-60170899	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Lyase	"Disease variant, FDA approved drug targets, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 254.9"	"Cell type enriched"	"Detected in many"	5	"Paneth cells: 4309.8"	"Group enriched"	"Detected in many"	4	"endothelial cell: 253.1;pericyte: 330.1;upper rhombic lip: 89.9"	"Cancer enhanced"	"Detected in many"		"Rectum Adenocarcinoma (TCGA): 30.9"	"Region enriched"	"Detected in all"	5	"cerebellum: 173.8"	"Immune cell enriched"	"Detected in some"	7	"neutrophil: 100.0"	"Lineage enriched"	"Detected in single"	1000	"granulocytes: 100.0"	"Cancer enhanced"	"Detected in some"		"Brain cancer: 4.3;liver cancer: 7.8;prostate cancer: 7.4"	"Adipose visceral - Endothelial cells, Colon - Colon enterocytes, Spleen - Neutrophils"	"Region enriched"	"Detected in all"	5	"cerebellum: 300.3"	"Low region specificity"	"Detected in all"			"HPA011089, HPA017258"	Enhanced		Uncertain	Vesicles,Cytosol			NA	NA		150000	"Cluster 21: Neutrophils - Unknown function"	"Cluster 80: Non-specific - Endocytosis"	"Cluster 35: Non-specific - DNA binding"	"Cluster 1: Neuronal - Visual perception"	"Cluster 5: Enterocytes - Absorption"	4	Cytosol	Vesicles	"HPA011089: AB_1845996, HPA017258: AB_1845997"	"unprognostic (4.04e-3)"		"potential prognostic favorable (1.95e-4)"		"unprognostic (3.16e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.33e-1)"		"unprognostic (5.41e-2)"	"validated prognostic favorable (8.52e-7)"	"validated prognostic favorable (2.35e-4)"	"unprognostic (2.59e-1)"	"unprognostic (5.35e-2)"		"unprognostic (1.20e-3)"	"unprognostic (1.00e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.93e-2)"		"unprognostic (2.16e-1)"		"unprognostic (2.92e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.37e-1)"		"unprognostic (3.67e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.98e-2)"
CA5A	"CA5, CAV, CAVA"	ENSG00000174990	"Carbonic anhydrase 5A"	P35218	16	87881546-87936580	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		Lyase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	43	"liver: 23.5"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 37.0"	"Cell type enriched"	"Detected in many"	11	"endothelial cell: 19.7"	"Cancer enriched"	"Detected in single"	68	"Liver Hepatocellular Carcinoma (TCGA): 12.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Gallbladder cancer: 1.1;Gastric cancer: 1.6;liver cancer: 1.7"		"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"										NA	NA				"Cluster 31: Liver - Plasma proteins"		"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 43: Hepatocytes - Metabolism"																		"unprognostic (4.46e-3)"	"unprognostic (2.03e-2)"																
CA5B		ENSG00000169239	"Carbonic anhydrase 5B"	Q9Y2D0	X	15688830-15788411	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		Lyase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Muller glia cells: 31.6;NK-cells: 43.9;T-cells: 28.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Minor Salivary Gland - Fibroblasts, Testis - Sertoli cells, Thyroid gland - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012618	Uncertain		Supported	Mitochondria			NA	NA			"Cluster 1: T-cells - Unknown function"	"Cluster 16: Non-specific - Transcription"	"Cluster 41: Monoamines - Neurotransmitter signalling"	"Cluster 27: Breast cancer - Unknown function"	"Cluster 78: NK-cells & T-cells - Immune system & Transcription"	1	Mitochondria		"HPA012618: AB_1846000"	"unprognostic (7.42e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.74e-1)"	"unprognostic (6.20e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.58e-2)"	"unprognostic (4.81e-3)"	"potential prognostic unfavorable (6.88e-4)"	"unprognostic (9.42e-3)"	"unprognostic (3.81e-2)"	"potential prognostic favorable (1.60e-7)"	"unprognostic (1.24e-3)"	"unprognostic (3.75e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.99e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.88e-2)"	"unprognostic (3.04e-1)"	"unprognostic (5.21e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.91e-3)"	"unprognostic (4.05e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.23e-2)"	"unprognostic (4.28e-2)"
CA6		ENSG00000131686	"Carbonic anhydrase 6"	P23280	1	8945867-8975092	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted secreted proteins"		Lyase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	296	"salivary gland: 9125.4"	"Cell type enriched"	"Detected in some"	51	"Serous glandular cells: 8255.0"	"Cell type enriched"	"Detected in single"	4	"leukocyte: 3.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"naive CD4 T-cell: 5.7;naive CD8 T-cell: 16.6"	"Lineage enriched"	"Detected in many"	12	"T-cells: 16.6"	"Cancer enhanced"	"Detected in some"		"Gastric cancer: 4.3"	"Breast - Breast glandular cells (progenitors)"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA028550, HPA028692"	Enhanced				"Secreted to digestive system"	Enzyme	NA	NA		11000000	"Cluster 43: Non-specific - Transcription & Translation"	"Cluster 38: Salivary gland - Salivary secretion"	"Cluster 6: Non-specific - Immune response"	"Cluster 70: DU4475 - Unknown function"	"Cluster 75: Serous glandular cells - Salivary secretion"	35			"HPA028550: AB_10600105, HPA028692: AB_10601883"		"unprognostic (8.10e-3)"	"unprognostic (3.02e-1)"			"unprognostic (1.87e-2)"										"unprognostic (9.04e-2)"										"unprognostic (4.33e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.47e-1)"			"unprognostic (1.20e-1)"
CA7		ENSG00000168748	"Carbonic anhydrase 7"	P43166	16	66844414-66854153	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		Lyase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 55.2"	"Cell type enriched"	"Detected in some"	60	"Paneth cells: 4921.6"	"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in some"		"Rectum Adenocarcinoma (TCGA): 2.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Colon - Colon enterocytes, Testis - Spermatogonia"	"Region enhanced"	"Detected in all"		"cerebellum: 67.2"	"Low region specificity"	"Detected in many"			HPA047237	Uncertain		Approved	"Golgi apparatus,Cytosol"			NA	NA				"Cluster 45: Intestine - Digestion"	"Cluster 51: Neurons - Mixed function"	"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 5: Enterocytes - Absorption"		Cytosol	"Golgi apparatus"	"HPA047237: AB_2679994"					"unprognostic (1.00e-1)"	"unprognostic (2.80e-2)"																			"unprognostic (2.16e-1)"	"unprognostic (1.49e-2)"				"unprognostic (1.06e-2)"	
CA9	"CAIX, MN"	ENSG00000107159	"Carbonic anhydrase 9"	Q16790	9	35673928-35681159	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"		Lyase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"stomach 1: 281.3"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 255.4;Early spermatids: 188.9;Gastric mucus-secreting cells: 251.7;Late spermatids: 58.5;Mesothelial cells: 59.5"	"Cell type enriched"	"Detected in some"	11	"upper rhombic lip: 12.8"	"Cancer enhanced"	"Detected in many"		"Kidney Renal Clear Cell Carcinoma (TCGA): 219.1"	"Region enriched"	"Detected in some"	9	"cerebellum: 11.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Kidney cancer: 114.9"	"Adipose visceral - Mesothelial cells, Liver - Cholangiocyte, Testis - Late spermatids"	"Region enhanced"	"Detected in many"		"cerebellum: 12.3"	"Low region specificity"	"Detected in all"			"CAB005100, CAB017107, HPA055207"	Enhanced		Supported	"Plasma membrane"			NA	NA				"Cluster 48: Stomach - Proteolysis"	"Cluster 35: Non-specific - DNA binding"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 35: Respiratory epithelial cells - Unknown function"	14	"Plasma membrane"		"CAB005100: AB_2066539, CAB017107: , HPA055207: AB_2682738"	"unprognostic (2.26e-2)"	"unprognostic (3.73e-2)"	"unprognostic (4.90e-1)"	"potential prognostic unfavorable (9.05e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.80e-3)"	"unprognostic (2.67e-1)"	"unprognostic (3.99e-2)"		"potential prognostic favorable (5.22e-8)"	"unprognostic (3.45e-2)"	"unprognostic (1.28e-2)"	"validated prognostic unfavorable (5.71e-6)"	"validated prognostic unfavorable (7.41e-4)"	"unprognostic (2.38e-3)"	"potential prognostic unfavorable (4.33e-5)"	"unprognostic (3.49e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.82e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.89e-3)"	"unprognostic (5.25e-3)"		"unprognostic (8.55e-2)"	"unprognostic (1.34e-3)"	"unprognostic (1.00e-1)"	"unprognostic (6.38e-2)"	"unprognostic (1.21e-1)"		"unprognostic (1.29e-1)"
CACNA1A	"APCA, CACNL1A4, Cav2.1, EA2, FHM, HPCA, MHP, MHP1, SCA6"	ENSG00000141837	"Calcium voltage-gated channel subunit alpha1 A"	O00555	19	13206442-13633025	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	35	"brain: 240.4"	"Group enriched"	"Detected in many"	7	"Bipolar cells: 145.9;Enteroendocrine cells: 228.5;Excitatory neurons: 307.8;Horizontal cells: 429.9;Inhibitory neurons: 356.4;Oligodendrocyte precursor cells: 255.2"	"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"Ovary Serous Cystadenocarcinoma (TCGA): 6.5"	"Region enhanced"	"Detected in all"		"cerebellum: 218.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Brain cancer: 5.2;lung cancer: 8.4;Rhabdoid: 8.2"	"Pancreas - Alpha cells, Pancreas - Beta cells, Skeletal muscle - Smooth muscle cells, Stomach - Gastric enteroendocrine cells, Thyroid gland - Smooth muscle cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064258, HPA068138, HPA071902"	Enhanced	Supported	Uncertain	"Endoplasmic reticulum"			NA	NA				"Cluster 65: Cerebellum - Nervous system development"	"Cluster 2: Neurons - Nucleosome"	"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 71: Horizontal & Bipolar cells - Neuronal signaling"	41	"Endoplasmic reticulum"		"HPA064258: AB_2685229, HPA068138: , HPA071902: "	"unprognostic (6.25e-2)"		"unprognostic (1.87e-2)"				"unprognostic (8.10e-2)"	"potential prognostic favorable (2.58e-4)"												"unprognostic (1.10e-2)"	"unprognostic (6.23e-2)"	"potential prognostic favorable (8.21e-6)"	"unprognostic (2.93e-2)"				"unprognostic (1.60e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.50e-1)"		"unprognostic (5.19e-2)"
CACNA1B	"CACNL1A5, CACNN, Cav2.2"	ENSG00000148408	"Calcium voltage-gated channel subunit alpha1 B"	Q00975	9	137877782-138124624	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets, Intellectual disability"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 22.1"	"Group enriched"	"Detected in some"	8	"Excitatory neurons: 375.5;Inhibitory neurons: 316.8"	"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in some"		"Testicular Germ Cell Tumor (TCGA): 4.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Neuroblastoma: 14.3"	"Adrenal gland - Adrenal medulla cells, Colon - Colon enteroendocrine cells, Pancreas - Alpha cells, Pancreas - Beta cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044347	Uncertain		Approved	"Cytosol,Acrosome,Equatorial segment"			NA	NA				"Cluster 65: Cerebellum - Nervous system development"	"Cluster 53: Neurons - Mixed function"	"Cluster 17: Neuroblastoma - Neuronal signaling"	"Cluster 34: Neurons - Neuronal signaling"	3	"Cytosol, Acrosome, Equatorial segment"		"HPA044347: AB_10960837"			"unprognostic (4.29e-2)"					"unprognostic (5.93e-3)"										"unprognostic (1.08e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.50e-2)"									"unprognostic (1.57e-1)"		
CACNA1C	"CACH2, CACN2, CACNL1A1, Cav1.2, CCHL1A1, LQT8, TS"	ENSG00000151067	"Calcium voltage-gated channel subunit alpha1 C"	Q13936	12	1970772-2697950	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Host-virus interaction, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel, Voltage-gated channel"	"Autism, Autism spectrum disorder, Brugada syndrome, Disease variant, Epilepsy, FDA approved drug targets, Intellectual disability, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 19.5;heart muscle: 20.2;intestine: 28.4"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 586.4;Inhibitory neurons: 456.6;Oligodendrocyte precursor cells: 182.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Brain cancer: 3.9"	"Prostate - Smooth muscle cells, Testis - Early spermatids, Testis - Late spermatids, Thyroid gland - Smooth muscle cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039796, CAB079031"	Enhanced	Approved	Approved	"Nucleoplasm,Plasma membrane,Primary cilium"			NA	NA				"Cluster 41: Smooth muscle tissue - ECM organization"	"Cluster 40: Astrocytes - Astrocyte-neuron interactions"	"Cluster 21: Lymphoma - Adaptive immune response"	"Cluster 34: Neurons - Neuronal signaling"	28	"Nucleoplasm, Plasma membrane"	"Primary cilium"	"CAB079031: , HPA039796: AB_10673019"	"unprognostic (3.73e-2)"	"unprognostic (9.56e-2)"	"unprognostic (7.20e-2)"			"unprognostic (8.22e-2)"		"unprognostic (1.22e-3)"			"validated prognostic favorable (1.04e-4)"	"validated prognostic favorable (4.50e-4)"					"unprognostic (3.90e-1)"		"unprognostic (2.10e-2)"			"unprognostic (1.43e-2)"	"unprognostic (2.39e-1)"	"unprognostic (6.39e-2)"		"unprognostic (8.77e-3)"		"unprognostic (2.07e-2)"	"unprognostic (1.10e-1)"		
CACNA1D	"CACH3, CACN4, CACNL1A2, Cav1.3, CCHL1A2"	ENSG00000157388	"Calcium voltage-gated channel subunit alpha1 D"	Q01668	3	53328963-53813733	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Cancer-related genes, Deafness, Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Excitatory neurons: 242.8;Horizontal cells: 112.0;Inhibitory neurons: 339.0;Microglial cells: 120.8;Oligodendrocyte precursor cells: 185.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	9	"basophil: 3.7"	"Lineage enriched"	"Detected in single"	20	"granulocytes: 3.7"	"Low cancer specificity"	"Detected in many"			"Breast - Breast glandular cells, Skeletal muscle - Fibroblasts, Spleen - Fibroblast_2, Testis - Peritubular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020215	Uncertain		Approved	"Nuclear membrane"			NA	NA			"Cluster 46: Basophils - Proteolysis"	"Cluster 64: Neuronal - Transcription"	"Cluster 40: Astrocytes - Astrocyte-neuron interactions"	"Cluster 50: Lymphoma - Unknown function"	"Cluster 69: Neurons - Neuronal signaling"		"Nuclear membrane"		"HPA020215: AB_1845860"	"unprognostic (1.70e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.50e-2)"		"unprognostic (3.32e-2)"	"unprognostic (8.32e-2)"		"unprognostic (7.08e-3)"		"unprognostic (2.66e-1)"	"potential prognostic favorable (1.69e-8)"	"unprognostic (3.49e-3)"	"unprognostic (1.34e-2)"		"unprognostic (1.57e-1)"	"unprognostic (2.53e-3)"	"unprognostic (6.70e-2)"					"unprognostic (7.68e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.70e-2)"			
CACNA1E	"BII, CACH6, CACNL1A6, Cav2.3"	ENSG00000198216	"Calcium voltage-gated channel subunit alpha1 E"	Q15878	1	181317690-181813262	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"brain: 16.2"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 182.2;Inhibitory neurons: 110.6;Oligodendrocyte precursor cells: 69.3;Oligodendrocytes: 31.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"cervical cancer: 2.4;lung cancer: 2.0"	"Colon - Colon enteroendocrine cells, Kidney - Proximal tubular cells, Lung - Neutrophil_2, Spleen - Neutrophils, Testis - Sertoli cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042515, CAB079032"		Approved	Approved	"Plasma membrane,Actin filaments,Cytosol"			NA	NA				"Cluster 33: Brain - Neuronal signaling"	"Cluster 51: Neurons - Mixed function"	"Cluster 32: Non-specific - Cell proliferation"	"Cluster 34: Neurons - Neuronal signaling"		"Plasma membrane"	"Actin filaments, Cytosol"	"CAB079032: , HPA042515: "							"unprognostic (3.10e-1)"	"potential prognostic favorable (5.61e-5)"			"unprognostic (1.36e-2)"	"unprognostic (8.10e-3)"								"unprognostic (8.88e-3)"						"unprognostic (1.22e-1)"		"unprognostic (3.72e-2)"	"unprognostic (3.23e-2)"		
CACNA1F	"AIED, Cav1.4, CORDX3, CSNB2, CSNB2A, CSNBX2, JM8, JMC8, OA2"	ENSG00000102001	"Calcium voltage-gated channel subunit alpha1 F"	O60840	X	49205063-49233371	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Sensory transduction, Transport, Vision"	"Calcium channel, Ion channel, Voltage-gated channel"	"Cone-rod dystrophy, Congenital stationary night blindness, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	63	"retina: 121.4"	"Group enriched"	"Detected in some"	7	"Bipolar cells: 66.4;Cone photoreceptor cells: 73.1;Rod photoreceptor cells: 91.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in single"			"Low cancer specificity"	"Detected in single"				"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA068379	Enhanced						NA	NA			"Cluster 2: Dendritic cells - Unknown function"	"Cluster 76: Retina - Visual perception"	"Cluster 48: Non-specific - Mixed function"	"Cluster 1: Neuronal - Visual perception"	"Cluster 66: Photoreceptor cells - Visual perception"				"HPA068379: AB_2732782"			"unprognostic (3.99e-2)"			"unprognostic (8.06e-2)"						"unprognostic (1.02e-2)"					"unprognostic (3.60e-2)"			"unprognostic (3.59e-1)"						"unprognostic (2.01e-2)"					"unprognostic (1.82e-1)"
CACNA1G	"Cav3.1, NBR13"	ENSG00000006283	"Calcium voltage-gated channel subunit alpha1 G"	O43497	17	50560715-50627474	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease variant, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 20.5;cervix: 9.5;retina: 8.4"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 152.8;Horizontal cells: 68.0"	"Cell type enhanced"	"Detected in many"		"midbrain-derived inhibitory: 132.5;thalamic excitatory: 98.5"	"Cancer enhanced"	"Detected in some"		"Glioblastoma Multiforme (TCGA): 3.8;Testicular Germ Cell Tumor (TCGA): 3.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Bone cancer: 6.8"	"Lung - Fibroblast_2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004714	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol,Acrosome,Equatorial segment,Perinuclear theca"			NA	NA				"Cluster 28: Neuronal - Transcription"	"Cluster 38: Sub-cortical - Mixed function"	"Cluster 1: Neuronal - Visual perception"	"Cluster 71: Horizontal & Bipolar cells - Neuronal signaling"		"Nucleoplasm, Acrosome, Equatorial segment, Perinuclear theca"	"Nuclear bodies, Cytosol"	"HPA004714: AB_1078368"			"unprognostic (2.08e-1)"				"unprognostic (2.02e-1)"	"unprognostic (3.20e-2)"																"unprognostic (2.05e-1)"		"unprognostic (5.70e-2)"			"unprognostic (4.51e-2)"		
CACNA1H	Cav3.2	ENSG00000196557	"Calcium voltage-gated channel subunit alpha1 H"	O95180	16	1153106-1221771	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 104.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 19.0;Enteroendocrine cells: 13.1;Horizontal cells: 12.0;Late spermatids: 14.5;Ovarian stromal cells: 17.9;Peritubular cells: 22.7;Smooth muscle cells: 28.7"	"Cell type enhanced"	"Detected in many"		"medium spiny neuron: 36.6;vascular associated smooth muscle cell: 48.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Adipose subcutaneous - Smooth muscle cells, Adipose visceral - Smooth muscle cells, Adrenal gland - Adrenal cortex cells, Minor Salivary Gland - Endothelial cells, Prostate - Smooth muscle cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA039125	Approved		Approved	Nucleoplasm,Vesicles			NA	NA				"Cluster 41: Smooth muscle tissue - ECM organization"	"Cluster 33: Neurons - Mixed function"	"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 48: Smooth muscle cells - Signal transduction"	2	"Nucleoplasm, Vesicles"		"HPA039125: AB_10795578"	"unprognostic (3.35e-3)"	"unprognostic (3.36e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.50e-3)"	"unprognostic (4.13e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.14e-2)"	"potential prognostic unfavorable (9.56e-5)"	"unprognostic (1.26e-1)"	"unprognostic (8.61e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.93e-3)"		"unprognostic (8.97e-2)"	"unprognostic (1.05e-2)"	"potential prognostic favorable (2.72e-5)"	"unprognostic (3.33e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.64e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.90e-1)"
CACNA1I	Cav3.3	ENSG00000100346	"Calcium voltage-gated channel subunit alpha1 I"	Q9P0X4	22	39570753-39689735	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease variant, FDA approved drug targets, Intellectual disability"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.9;thyroid gland: 5.1"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 13.5;Excitatory neurons: 16.3;Horizontal cells: 30.2;Inhibitory neurons: 11.7"	"Low cell type specificity"	"Detected in many"			"Cancer enriched"	"Detected in single"	5	"Thyroid Carcinoma (TCGA): 3.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Bone cancer: 2.8;Rhabdoid: 1.3"	"Testis - Late spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066992			Approved	"Plasma membrane,Cell Junctions,Acrosome"			NA	NA				"Cluster 22: Brain - Synaptic signal transduction"	"Cluster 24: Neurons - Mixed function"	"Cluster 12: Bone cancer - Neuronal signaling"	"Cluster 71: Horizontal & Bipolar cells - Neuronal signaling"	2	"Plasma membrane"	"Cell Junctions, Acrosome"	"HPA066992: "			"unprognostic (1.71e-1)"																											"unprognostic (1.64e-2)"	
CACNA1S	"CACNL1A3, Cav1.1, HOKPP, hypoPP, MHS5"	ENSG00000081248	"Calcium voltage-gated channel subunit alpha1 S"	Q13698	1	201039512-201112451	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel, Voltage-gated channel"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	85	"skeletal muscle: 245.8;tongue: 185.7"	"Cell type enriched"	"Detected in some"	15	"Skeletal myocytes: 106.4"	"Cell type enhanced"	"Detected in some"		"vascular associated smooth muscle cell: 5.7"	"Cancer enriched"	"Detected in single"	5	"Head and Neck Squamous Cell Carcinoma (TCGA): 1.2"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"breast cancer: 1.1"	"Adipose visceral - Smooth muscle cells, Skeletal muscle - Skeletal myocytes, Testis - Late spermatids"	"Region enhanced"	"Detected in single"		"olfactory bulb: 1.8"	"Region enriched"	"Detected in single"	5	"olfactory bulb: 3.8"	"CAB009507, HPA048892, HPA056815"	Enhanced		Approved	"Acrosome,Equatorial segment"			NA	NA				"Cluster 14: Skeletal muscle - Muscle contraction"	"Cluster 19: Astrocytes - Mixed function"	"Cluster 70: DU4475 - Unknown function"	"Cluster 2: Skeletal myocytes - Muscle contraction"	4	"Acrosome, Equatorial segment"		"CAB009507: AB_2069576, HPA048892: AB_2680548, HPA056815: AB_2683242"									"unprognostic (1.22e-2)"																						
CACNA2D1	"alpha2delta-1, CACNA2, CACNL2A, LINC01112, lncRNA-N3, MHS3"	ENSG00000153956	"Calcium voltage-gated channel auxiliary subunit alpha2delta 1"	P54289	7	81946444-82443956	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets, Intellectual disability"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 74.7;tongue: 72.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 524.8;Inhibitory neurons: 365.9;Oligodendrocyte precursor cells: 335.8;Oligodendrocytes: 616.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Neuroblastoma: 30.6"	"Minor Salivary Gland - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008213, HPA008621"	Enhanced				"Intracellular and membrane"	Transport	NA	NA		250000000		"Cluster 14: Skeletal muscle - Muscle contraction"	"Cluster 14: Neurons - Synaptic function"	"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 65: Neurons - Synaptic function"	1			"HPA008213: AB_1233654, HPA008621: AB_1845863"	"unprognostic (2.32e-1)"	"unprognostic (6.73e-3)"	"unprognostic (1.74e-1)"	"unprognostic (9.95e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.32e-1)"	"unprognostic (6.85e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.15e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.06e-2)"	"unprognostic (4.36e-3)"			"unprognostic (1.91e-1)"	"unprognostic (2.94e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.38e-2)"	"unprognostic (5.54e-2)"	"unprognostic (8.16e-3)"	"unprognostic (9.76e-3)"	"unprognostic (6.98e-3)"	"unprognostic (2.02e-1)"	"unprognostic (3.22e-3)"	"unprognostic (2.67e-1)"	"unprognostic (5.60e-2)"	
CACNA2D2	"alpha2delta-2, KIAA0558"	ENSG00000007402	"Calcium voltage-gated channel auxiliary subunit alpha2delta 2"	Q9NY47	3	50362613-50504244	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 47.6"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 39.5;Alveolar cells type 2: 127.4;Horizontal cells: 60.4;Inhibitory neurons: 34.6;Oocytes: 53.7"	"Cell type enhanced"	"Detected in many"		"cerebellar inhibitory: 112.6"	"Cancer enhanced"	"Detected in many"		"Testicular Germ Cell Tumor (TCGA): 25.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cancer enhanced"	"Detected in many"		"Neuroblastoma: 26.8;thyroid cancer: 13.2"	"Breast - Breast glandular cells, Colon - Colon enteroendocrine cells, Lung - Alveolar cells type 2, Pancreas - Alpha cells, Pancreas - Beta cells, Pituitary gland - Corticotropes, Testis - Spermatogonia"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034771	Enhanced		Approved	"Plasma membrane,Cytosol,Flagellar centriole,Mid piece"			NA	NA		6500000	"Cluster 11: T-cells - Unknown function"	"Cluster 28: Neuronal - Transcription"	"Cluster 1: Neurons - Mixed function"	"Cluster 16: Thyroid cancer - Neuronal signaling"	"Cluster 72: Alveolar cells - Lung function"	1	Cytosol	"Plasma membrane, Flagellar centriole, Mid piece"	"HPA034771: AB_10603555"		"unprognostic (3.86e-1)"	"unprognostic (1.61e-1)"		"unprognostic (1.02e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.13e-2)"		"unprognostic (2.66e-2)"						"potential prognostic favorable (1.21e-4)"	"unprognostic (2.36e-3)"	"unprognostic (6.71e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.16e-1)"	"potential prognostic favorable (2.42e-4)"	"unprognostic (2.83e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.67e-2)"		"unprognostic (2.18e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.64e-1)"	"unprognostic (5.68e-3)"
CACNA2D3	"alpha2delta-3, HSA272268"	ENSG00000157445	"Calcium voltage-gated channel auxiliary subunit alpha2delta 3"	Q8IZS8	3	54122547-55074557	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.2;skeletal muscle: 9.5;tongue: 10.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 152.7;Excitatory neurons: 800.8;Inhibitory neurons: 435.8;Oligodendrocyte precursor cells: 298.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Adipose visceral - Mesothelial cells, Heart muscle - Cardiomyocytes, Prostate - Smooth muscle cells, Testis - Early spermatids, Testis - Late spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030849			Uncertain	"Nucleoplasm,Principal piece"			NA	NA		31000		"Cluster 61: Brain - Neuronal signaling"	"Cluster 53: Neurons - Mixed function"	"Cluster 17: Neuroblastoma - Neuronal signaling"	"Cluster 34: Neurons - Neuronal signaling"		"Nucleoplasm, Principal piece"		"HPA030849: "			"unprognostic (8.69e-2)"					"unprognostic (2.46e-2)"											"unprognostic (7.21e-2)"		"unprognostic (7.72e-2)"								"unprognostic (1.40e-1)"		
CACNA2D4	alpha2delta-4	ENSG00000151062	"Calcium voltage-gated channel auxiliary subunit alpha2delta 4"	Q7Z3S7	12	1791963-1918666	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	40	"retina: 19.5"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 57.1;Cone photoreceptor cells: 79.9;Hofbauer cells: 32.6;Late spermatids: 125.0;Rod photoreceptor cells: 97.5"	"Cell type enhanced"	"Detected in many"		"central nervous system macrophage: 6.1;hippocampal dentate gyrus: 11.8"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"dendritic cells: 2.9;monocytes: 4.4;T-cells: 4.2"	"Group enriched"	"Detected in some"	4	"Leukemia: 7.5;lymphoma: 3.1;Sarcoma: 2.9"	"Adrenal gland - Macrophages, Minor Salivary Gland - Macrophages"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA031952	Uncertain		Approved	"Mid piece,Principal piece"			NA	NA			"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 76: Retina - Visual perception"		"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 11: Late spermatids - Unknown function"		"Mid piece, Principal piece"		"HPA031952: AB_10600798"			"unprognostic (1.31e-1)"					"unprognostic (2.12e-1)"		"unprognostic (7.25e-2)"					"unprognostic (1.48e-2)"						"unprognostic (2.80e-1)"		"unprognostic (1.19e-2)"								
CACNB1	CACNLB1	ENSG00000067191	"Calcium voltage-gated channel auxiliary subunit beta 1"	Q02641	17	39173453-39197702	"FDA approved drug targets, Predicted intracellular proteins"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"skeletal muscle: 312.9;tongue: 212.3"	"Cell type enriched"	"Detected in many"	7	"Skeletal myocytes: 151.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Adipose progenitor cells, Lung - Alveolar cells type 2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023343	Approved						NA	NA			"Cluster 33: Non-specific - ATP binding"	"Cluster 14: Skeletal muscle - Muscle contraction"	"Cluster 51: Neurons - Mixed function"	"Cluster 27: Breast cancer - Unknown function"	"Cluster 2: Skeletal myocytes - Muscle contraction"	5			"HPA023343: AB_1845866"	"unprognostic (2.93e-2)"	"unprognostic (3.05e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.23e-1)"	"potential prognostic unfavorable (7.01e-4)"	"unprognostic (1.54e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.60e-2)"	"unprognostic (7.60e-3)"		"potential prognostic unfavorable (3.79e-6)"	"unprognostic (7.36e-3)"	"unprognostic (4.72e-2)"		"unprognostic (1.11e-2)"	"potential prognostic favorable (2.23e-4)"	"unprognostic (1.42e-1)"	"unprognostic (3.47e-1)"	"unprognostic (2.92e-2)"	"potential prognostic unfavorable (8.20e-5)"	"unprognostic (2.18e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.58e-2)"	"unprognostic (7.52e-2)"	"unprognostic (3.81e-1)"	"unprognostic (2.40e-2)"	"unprognostic (8.54e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.79e-1)"	"unprognostic (9.44e-2)"
CACNB2	"CACNLB2, MYSB"	ENSG00000165995	"Calcium voltage-gated channel auxiliary subunit beta 2"	Q08289	10	18140424-18543557	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Brugada syndrome, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Astrocytes: 819.0;Excitatory neurons: 527.9;Inhibitory neurons: 341.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cancer specificity"	"Detected in some"			"Adipose subcutaneous - Smooth muscle cells, Breast - Fibroblasts, Heart muscle - Cardiomyocytes, Prostate - Smooth muscle cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035326	Enhanced						NA	NA				"Cluster 64: Neuronal - Transcription"	"Cluster 23: Choroid plexus - Mixed function"	"Cluster 12: Bone cancer - Neuronal signaling"	"Cluster 34: Neurons - Neuronal signaling"	3			"HPA035326: AB_10669903"	"unprognostic (8.18e-3)"	"unprognostic (5.37e-2)"	"unprognostic (4.59e-2)"		"unprognostic (2.23e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.23e-2)"	"potential prognostic favorable (9.70e-4)"		"unprognostic (4.28e-2)"	"unprognostic (3.92e-2)"	"potential prognostic favorable (7.28e-4)"	"unprognostic (1.03e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.06e-3)"	"unprognostic (3.05e-1)"	"unprognostic (1.96e-2)"		"unprognostic (1.32e-1)"			"unprognostic (6.61e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.43e-1)"		"unprognostic (1.81e-2)"	"unprognostic (5.19e-2)"		
CACNB3	CACNLB3	ENSG00000167535	"Calcium voltage-gated channel auxiliary subunit beta 3"	P54284	12	48813794-48828941	"FDA approved drug targets, Predicted intracellular proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 75.1"	"Cell type enhanced"	"Detected in many"		"Ovarian stromal cells: 29.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.8"	"Lineage enriched"	"Detected in single"	10	"T-cells: 1.8"	"Low cancer specificity"	"Detected in all"			"Heart muscle - Fibroblasts, Thyroid gland - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059515			Approved	"Golgi apparatus,Vesicles"			NA	NA				"Cluster 64: Neuronal - Transcription"	"Cluster 51: Neurons - Mixed function"	"Cluster 27: Breast cancer - Unknown function"	"Cluster 9: Endometrial stromal cells - Transcription"	15	"Golgi apparatus, Vesicles"		"HPA059515: AB_2684047"	"unprognostic (5.27e-3)"	"unprognostic (1.99e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.10e-2)"	"unprognostic (2.68e-3)"	"unprognostic (9.55e-3)"	"unprognostic (1.42e-1)"	"unprognostic (4.83e-2)"	"potential prognostic unfavorable (3.59e-4)"	"unprognostic (2.20e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.20e-2)"	"unprognostic (8.20e-2)"	"unprognostic (9.77e-3)"	"unprognostic (1.54e-1)"	"unprognostic (8.73e-2)"	"unprognostic (2.34e-1)"	"unprognostic (6.68e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.37e-2)"	"unprognostic (8.90e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.44e-3)"	"unprognostic (4.18e-2)"	"unprognostic (9.33e-2)"	"unprognostic (1.26e-1)"
CACNB4	EJM4	ENSG00000182389	"Calcium voltage-gated channel auxiliary subunit beta 4"	O00305	2	151832771-152099167	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 24.5;skin 1: 7.1"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 478.6;Horizontal cells: 107.0;Inhibitory neurons: 452.4;Microglial cells: 130.6;Oligodendrocyte precursor cells: 145.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"neutrophil: 3.4"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.4"	"Low cancer specificity"	"Detected in some"			"Adipose subcutaneous - Adipose progenitor cells, Lung - Alveolar cells type 2, Testis - Sertoli cells, Thyroid gland - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015601	Approved						NA	NA			"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 65: Cerebellum - Nervous system development"	"Cluster 15: Non-specific - Transcription"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 8: Neurons - Neuronal signaling"	3			"HPA015601: AB_1845873"			"unprognostic (1.84e-1)"				"unprognostic (1.59e-1)"	"unprognostic (2.29e-1)"		"unprognostic (1.93e-1)"							"unprognostic (1.55e-2)"		"unprognostic (1.83e-1)"				"unprognostic (2.86e-2)"	"unprognostic (1.82e-1)"					"unprognostic (1.77e-1)"		
CACNG1	CACNLG	ENSG00000108878	"Calcium voltage-gated channel auxiliary subunit gamma 1"	Q06432	17	67044554-67056797	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	55	"skeletal muscle: 316.1;tongue: 117.0"	"Cell type enriched"	"Detected in single"	228	"Skeletal myocytes: 139.5"	"Cell type enhanced"	"Detected in some"		"bergmann glia: 1.6;oligodendrocyte precursor cell: 1.9"	"Cancer enhanced"	"Detected in some"		"Breast Invasive Carcinoma (TCGA): 2.4;Head and Neck Squamous Cell Carcinoma (TCGA): 2.7"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Breast - Breast glandular cells"	"Region enriched"	"Detected in single"	6	"basal ganglia: 3.4"	"Low region specificity"	"Detected in many"										NA	NA				"Cluster 2: Skeletal muscle - Striated muscle contraction"	"Cluster 33: Neurons - Mixed function"	"Cluster 27: Breast cancer - Unknown function"	"Cluster 2: Skeletal myocytes - Muscle contraction"	15					"unprognostic (5.34e-2)"	"unprognostic (4.59e-1)"				"unprognostic (1.47e-1)"	"unprognostic (2.25e-3)"	"unprognostic (1.18e-2)"																						
CACNG2	"MGC138502, MGC138504, stargazin"	ENSG00000166862	"Calcium voltage-gated channel auxiliary subunit gamma 2"	Q9Y698	22	36560857-36703752	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease variant, FDA approved drug targets, Intellectual disability"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 11.3"	"Group enriched"	"Detected in some"	7	"Excitatory neurons: 84.6;Horizontal cells: 32.1;Inhibitory neurons: 114.8;Oligodendrocyte precursor cells: 41.0"	"Cell type enhanced"	"Detected in many"		"cerebellar inhibitory: 291.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"Neuroblastoma: 1.1"	"Adrenal gland - Adrenal medulla cells, Pituitary gland - Corticotropes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"										NA	NA				"Cluster 28: Neuronal - Transcription"	"Cluster 52: Neurons & Synapses - Synaptic function"	"Cluster 16: Thyroid cancer - Neuronal signaling"	"Cluster 8: Neurons - Neuronal signaling"	6											"unprognostic (2.62e-2)"																							
CACNG3		ENSG00000006116	"Calcium voltage-gated channel auxiliary subunit gamma 3"	O60359	16	24256335-24362412	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"brain: 42.7;retina: 17.1"	"Group enriched"	"Detected in some"	15	"Excitatory neurons: 151.9;Horizontal cells: 57.9;Inhibitory neurons: 102.8"	"Low cell type specificity"	"Detected in many"			"Cancer enriched"	"Detected in single"	12	"Glioblastoma Multiforme (TCGA): 1.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	36	"Bone cancer: 3.6"	"Adrenal gland - Adrenal medulla cells, Testis - Early spermatids, Testis - Late spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077238	Enhanced						NA	NA				"Cluster 17: Neuronal - Synaptic function"	"Cluster 51: Neurons - Mixed function"	"Cluster 12: Bone cancer - Neuronal signaling"	"Cluster 65: Neurons - Synaptic function"	5			"HPA077238: "							"unprognostic (5.35e-2)"	"unprognostic (2.06e-1)"																							
CACNG4	"MGC11138, MGC24983"	ENSG00000075461	"Calcium voltage-gated channel auxiliary subunit gamma 4"	Q9UBN1	17	66964707-67033398	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 60.8"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 1: 35.0;Oligodendrocyte precursor cells: 136.3"	"Cell type enhanced"	"Detected in many"		"medium spiny neuron: 165.2;oligodendrocyte precursor cell: 321.2"	"Cancer enhanced"	"Detected in many"		"Breast Invasive Carcinoma (TCGA): 43.6;Glioblastoma Multiforme (TCGA): 56.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Neuroblastoma: 65.6"	"Adipose visceral - Mesothelial cells, Lung - Alveolar cells type 1, Minor Salivary Gland - Minor salivary glandular cells, Pancreas - Alpha cells, Prostate - Prostate glandular cells"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 155.8"	"HPA005803, HPA065370"	Enhanced		Approved	Vesicles			NA	NA				"Cluster 33: Brain - Neuronal signaling"	"Cluster 33: Neurons - Mixed function"	"Cluster 27: Breast cancer - Unknown function"	"Cluster 76: Oligodendrocyte precursor - Unknown function"	28	Vesicles		"HPA005803: AB_2667439, HPA065370: AB_2685480"	"unprognostic (5.77e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.77e-2)"	"unprognostic (8.08e-2)"	"unprognostic (4.22e-2)"	"unprognostic (9.82e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.54e-2)"			"unprognostic (1.59e-1)"		"unprognostic (2.71e-1)"	"potential prognostic unfavorable (8.75e-4)"	"unprognostic (2.02e-2)"	"unprognostic (1.30e-1)"	"unprognostic (6.93e-3)"	"unprognostic (4.88e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.95e-3)"	"unprognostic (6.77e-2)"	"unprognostic (6.20e-3)"	"unprognostic (1.25e-1)"	"unprognostic (8.90e-2)"	"unprognostic (1.91e-1)"		"unprognostic (5.36e-3)"	"unprognostic (1.31e-1)"	"unprognostic (8.30e-2)"	"unprognostic (6.46e-2)"
CACNG5		ENSG00000075429	"Calcium voltage-gated channel auxiliary subunit gamma 5"	Q9UF02	17	66835117-66894751	"FDA approved drug targets, Predicted membrane proteins"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	19	"retina: 15.3"	"Group enriched"	"Detected in some"	4	"Horizontal cells: 91.3;Oligodendrocyte precursor cells: 70.3"	"Cell type enhanced"	"Detected in many"		"eccentric medium spiny neuron: 58.5;oligodendrocyte precursor cell: 52.4;thalamic excitatory: 32.0"	"Cancer enhanced"	"Detected in single"		"Glioblastoma Multiforme (TCGA): 1.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Bone cancer: 1.0;breast cancer: 1.5;prostate cancer: 1.0"		"Region enhanced"	"Detected in all"		"olfactory bulb: 124.3"	"Low region specificity"	"Detected in many"			HPA050115	Uncertain						NA	NA				"Cluster 76: Retina - Visual perception"	"Cluster 38: Sub-cortical - Mixed function"	"Cluster 27: Breast cancer - Unknown function"	"Cluster 71: Horizontal & Bipolar cells - Neuronal signaling"				"HPA050115: AB_2681022"							"unprognostic (6.07e-3)"	"unprognostic (3.71e-2)"																							
CACNG6		ENSG00000130433	"Calcium voltage-gated channel auxiliary subunit gamma 6"	Q9BXT2	19	53991637-54012666	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"skeletal muscle: 87.5;tongue: 28.8"	"Group enriched"	"Detected in some"	11	"Ciliated cells: 14.5;Skeletal myocytes: 32.2"	"Cell type enriched"	"Detected in some"	11	"ependymal cell: 13.3"	"Cancer enhanced"	"Detected in many"		"Uterine Corpus Endometrial Carcinoma (TCGA): 6.7"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	107	"basophil: 13.4;eosinophil: 8.0"	"Lineage enriched"	"Detected in single"	134	"granulocytes: 13.4"	"Cancer enhanced"	"Detected in many"		"Myeloma: 11.9;pancreatic cancer: 12.2"	"Lung - Respiratory ciliated cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA056615			Approved	"Nucleoli fibrillar center,Cytosol"			NA	NA			"Cluster 22: Eosinophils - Transcription"	"Cluster 2: Skeletal muscle - Striated muscle contraction"	"Cluster 46: Brainstem - Mixed function"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 42: Ciliated cells - Cilium assembly"		"Nucleoli fibrillar center"	Cytosol	"HPA056615: AB_2683192"		"unprognostic (3.73e-1)"	"unprognostic (4.22e-2)"	"potential prognostic favorable (7.35e-4)"			"unprognostic (1.12e-1)"	"unprognostic (6.41e-2)"							"unprognostic (7.26e-1)"	"unprognostic (1.43e-1)"						"unprognostic (3.19e-1)"	"unprognostic (5.01e-2)"						"unprognostic (1.84e-1)"		"unprognostic (2.85e-1)"
CACNG7		ENSG00000105605	"Calcium voltage-gated channel auxiliary subunit gamma 7"	P62955	19	53909278-53943950	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 83.4"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 11.8;Bipolar cells: 10.2;Excitatory neurons: 30.9;Horizontal cells: 43.4;Inhibitory neurons: 41.5;Oligodendrocyte precursor cells: 21.7;Oligodendrocytes: 15.2"	"Low cell type specificity"	"Detected in all"			"Cancer enriched"	"Detected in some"	16	"Glioblastoma Multiforme (TCGA): 52.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"Bile duct cancer: 18.4;Neuroblastoma: 32.0;Rhabdoid: 31.4;thyroid cancer: 10.6"	"Colon - Colon enteroendocrine cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"										NA	NA				"Cluster 33: Brain - Neuronal signaling"	"Cluster 52: Neurons & Synapses - Synaptic function"	"Cluster 17: Neuroblastoma - Neuronal signaling"	"Cluster 71: Horizontal & Bipolar cells - Neuronal signaling"	13										"unprognostic (2.57e-1)"	"unprognostic (2.33e-1)"																					"unprognostic (7.02e-2)"		
CACNG8		ENSG00000142408	"Calcium voltage-gated channel auxiliary subunit gamma 8"	Q8WXS5	19	53962937-53990215	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	41	"brain: 36.0"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 59.8;Horizontal cells: 40.3;Inhibitory neurons: 63.1;Oligodendrocyte precursor cells: 27.8;Skeletal myocytes: 13.7"	"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in single"		"Glioblastoma Multiforme (TCGA): 2.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	9	"basophil: 5.4"	"Lineage enriched"	"Detected in single"	29	"granulocytes: 5.4"	"Cancer enhanced"	"Detected in many"		"Rhabdoid: 12.8"		"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041351	Enhanced						NA	NA			"Cluster 46: Basophils - Proteolysis"	"Cluster 33: Brain - Neuronal signaling"	"Cluster 51: Neurons - Mixed function"	"Cluster 5: Rhabdoid - Unknown function"	"Cluster 69: Neurons - Neuronal signaling"				"HPA041351: AB_10796666"						"unprognostic (7.79e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.73e-2)"																		"unprognostic (2.25e-1)"					
CALCA	"CALC1, CGRP, CGRP-alpha"	ENSG00000110680	"Calcitonin related polypeptide alpha"	"P01258, P06881"	11	14966622-14972354	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins, Transporters"		Hormone	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"parathyroid gland: 172.4;thyroid gland: 149.5"	"Cell type enriched"	"Detected in some"	15	"Ionocytes: 371.5"	"Cell type enriched"	"Detected in single"	13	"thalamic excitatory: 5.3"	"Cancer enriched"	"Detected in many"	4	"Lung Adenocarcinoma (TCGA): 436.5"	"Region enhanced"	"Detected in many"		"pons: 79.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	13	"thyroid cancer: 2800.5"	"Colon - Colon enteroendocrine cells, Thyroid gland - Parafollicular cells"	"Region enriched"	"Detected in all"	5	"pons and medulla: 58.0"					"HPA059886, HPA064453"	Enhanced	Supported			"Secreted to blood"	Hormone	NA	NA	49600	150000		"Cluster 24: Parathyroid gland - Vesicular transport"	"Cluster 43: Hindbrain - Mixed function"	"Cluster 16: Thyroid cancer - Neuronal signaling"	"Cluster 35: Respiratory epithelial cells - Unknown function"	7			"HPA059886: , HPA064453: "	"unprognostic (8.93e-2)"				"unprognostic (1.74e-1)"					"unprognostic (1.97e-1)"	"unprognostic (1.03e-1)"			"unprognostic (1.24e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.14e-2)"	"unprognostic (4.91e-3)"	"unprognostic (3.87e-1)"	"unprognostic (6.91e-2)"		"unprognostic (1.10e-1)"	"unprognostic (1.91e-1)"		"unprognostic (1.79e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.60e-1)"		"unprognostic (6.63e-2)"		"unprognostic (2.99e-3)"	"unprognostic (1.55e-3)"
CALCB	"CALC2, CGRP-II, FLJ30166"	ENSG00000175868	"Calcitonin related polypeptide beta"	P10092	11	14904997-15082342	"FDA approved drug targets, Plasma proteins, Predicted secreted proteins"		Hormone	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 9.3;thyroid gland: 20.0"	"Cell type enhanced"	"Detected in some"		"Melanocytes: 3.4;Oocytes: 2.2;Spermatocytes: 1.6;Spermatogonia: 4.3;T-cells: 1.2"	"Cell type enhanced"	"Detected in many"		"thalamic excitatory: 31.5;upper rhombic lip: 50.4"	"Cancer enhanced"	"Detected in many"		"Colon Adenocarcinoma (TCGA): 13.3;Uterine Corpus Endometrial Carcinoma (TCGA): 31.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"Bone cancer: 19.8;colorectal cancer: 60.6;thyroid cancer: 62.5"	"Colon - Colon enteroendocrine cells, Thyroid gland - Parafollicular cells"	"Region enriched"	"Detected in some"	7	"pons and medulla: 9.6"	"Group enriched"	"Detected in all"	5	"amygdala: 42.9;basal ganglia: 101.5;hypothalamus: 69.1;midbrain: 47.2;pons: 56.7"	HPA059886		Supported			"Secreted to blood"	Hormone	NA	NA	4500			"Cluster 51: Thyroid gland - Unknown function"	"Cluster 41: Monoamines - Neurotransmitter signalling"	"Cluster 16: Thyroid cancer - Neuronal signaling"	"Cluster 7: T-cells - T-cell receptor"	5			"HPA059886: "	"unprognostic (3.87e-2)"				"unprognostic (5.16e-2)"	"unprognostic (2.40e-1)"				"unprognostic (3.60e-1)"						"unprognostic (2.34e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.55e-1)"			"unprognostic (1.69e-1)"					"unprognostic (2.57e-2)"			"unprognostic (1.87e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.38e-2)"
CALCRL	"CGRPR, CRLR"	ENSG00000064989	"Calcitonin receptor like receptor"	Q16602	2	187341964-187448460	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 68.3;lung: 74.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 131.7;Endometrial stromal cells: 98.4;Endothelial cells: 262.9;Lymphatic endothelial cells: 297.8;Oligodendrocyte precursor cells: 275.0"	"Cell type enhanced"	"Detected in many"		"bergmann glia: 365.9;endothelial cell: 403.4;oligodendrocyte precursor cell: 468.1"	"Cancer enhanced"	"Detected in all"		"Kidney Renal Clear Cell Carcinoma (TCGA): 41.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"classical monocyte: 2.6;myeloid DC: 9.2;plasmacytoid DC: 2.6"	"Group enriched"	"Detected in many"	6	"dendritic cells: 9.2;monocytes: 2.6"	"Cancer enhanced"	"Detected in many"		"Rhabdoid: 12.7;Sarcoma: 23.1"	"Adrenal gland - Endothelial cells, Colon - Endothelial cells, Prostate - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008070, HPA046515"	Uncertain		Supported	"Plasma membrane"			NA	NA			"Cluster 2: Dendritic cells - Unknown function"	"Cluster 7: Adipose tissue - Mixed function"	"Cluster 43: Hindbrain - Mixed function"	"Cluster 48: Adipocytes & Endothelial cells - Angiogenesis"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	5	"Plasma membrane"		"HPA008070: AB_1845912, HPA046515: AB_2679681"	"unprognostic (2.35e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.87e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.80e-3)"	"potential prognostic favorable (6.86e-6)"	"unprognostic (4.96e-2)"	"unprognostic (2.21e-1)"	"validated prognostic favorable (1.58e-10)"	"validated prognostic favorable (8.04e-4)"	"unprognostic (2.84e-3)"	"unprognostic (2.66e-2)"	"unprognostic (4.10e-3)"	"unprognostic (1.44e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.37e-3)"	"unprognostic (5.78e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.34e-2)"	"potential prognostic unfavorable (1.64e-4)"	"unprognostic (1.54e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.83e-1)"
CALM1	"CALML2, CAMI, DD132, PHKD, PHKD1"	ENSG00000198668	"Calmodulin 1"	P0DP23	14	90396502-90408268	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Host-virus interaction"		"Disease variant, FDA approved drug targets, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adipose visceral - Endothelial cells, Prostate - Smooth muscle cells"	"Low region specificity"	"Detected in all"							"CAB018558, HPA044999"	Supported		Supported	Cytosol			NA	NA		65000000	"Cluster 5: Non-specific - Cell proliferation"	"Cluster 22: Brain - Synaptic signal transduction"	"Cluster 14: Neurons - Synaptic function"	"Cluster 30: Non-specific - Gene expression regulation"	"Cluster 78: NK-cells & T-cells - Immune system & Transcription"	232	Cytosol		"CAB018558: AB_2069454, HPA044999: AB_2679177"	"unprognostic (1.09e-1)"	"unprognostic (2.96e-3)"	"unprognostic (9.90e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.66e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.81e-3)"	"unprognostic (1.17e-3)"	"potential prognostic unfavorable (7.46e-4)"	"potential prognostic favorable (1.03e-7)"	"unprognostic (2.18e-3)"	"unprognostic (2.72e-2)"	"potential prognostic unfavorable (2.01e-4)"	"unprognostic (7.46e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.89e-1)"	"unprognostic (9.64e-2)"	"unprognostic (1.34e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.48e-1)"	"unprognostic (3.10e-1)"	"unprognostic (5.19e-3)"	"unprognostic (3.89e-2)"	"unprognostic (7.67e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.71e-2)"	"unprognostic (8.05e-2)"
CALY	"CALCYON, DRD1IP, NSG3"	ENSG00000130643	"Calcyon neuron specific vesicular protein"	Q9NYX4	10	133324072-133336935	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Endocytosis		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"brain: 305.6;pituitary gland: 163.2"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 130.9;Excitatory neurons: 70.1;Horizontal cells: 95.7;Inhibitory neurons: 122.9"	"Low cell type specificity"	"Detected in all"			"Cancer enriched"	"Detected in some"	4	"Pancreatic Adenocarcinoma (TCGA): 30.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Neuroblastoma: 1.5;Rhabdoid: 2.4"	"Adrenal gland - Adrenal medulla cells, Colon - Colon enteroendocrine cells, Pancreas - Alpha cells, Thyroid gland - Parafollicular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042283	Enhanced						NA	NA				"Cluster 33: Brain - Neuronal signaling"	"Cluster 1: Neurons - Mixed function"	"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 25: Bipolar cells - Visual perception"	1			"HPA042283: AB_10794417"			"unprognostic (2.03e-2)"				"unprognostic (5.73e-2)"	"unprognostic (1.72e-1)"								"unprognostic (3.61e-1)"						"potential prognostic favorable (2.31e-4)"	"unprognostic (6.04e-2)"								
CAMLG	"CAML, GET2"	ENSG00000164615	"Calcium modulating ligand"	P49069	5	134738495-134752157	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"ER-Golgi transport, Host-virus interaction, Transport"		"Congenital disorder of glycosylation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 716.7;Late spermatids: 1729.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Testis - Early spermatids, Testis - Late spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052636, HPA056472"	Approved		Uncertain	Nucleoplasm,Nucleoli,Vesicles			NA	NA			"Cluster 3: Non-specific - Nuclear processes"	"Cluster 64: Neuronal - Transcription"	"Cluster 14: Neurons - Synaptic function"	"Cluster 25: Non-specific - Ribosome"	"Cluster 36: Late spermatids - Unknown function"	38	Vesicles	"Nucleoplasm, Nucleoli"	"HPA052636: AB_2681893, HPA056472: AB_2683143"	"unprognostic (6.16e-3)"	"unprognostic (1.14e-1)"	"unprognostic (6.72e-2)"	"unprognostic (4.37e-2)"	"unprognostic (7.98e-2)"	"unprognostic (7.27e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.10e-3)"	"unprognostic (1.25e-2)"	"potential prognostic favorable (5.43e-5)"	"unprognostic (4.39e-2)"	"unprognostic (2.71e-3)"	"unprognostic (2.64e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.84e-1)"	"unprognostic (2.79e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.03e-1)"
CARTPT	CART	ENSG00000164326	"CART prepropeptide"	Q16568	5	71719275-71721048	"FDA approved drug targets, Human disease related genes, Predicted secreted proteins"		"Neuropeptide, Neurotransmitter"	"FDA approved drug targets, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 520.9"	"Group enriched"	"Detected in some"	5	"Early spermatids: 35.6;Horizontal cells: 141.6;Spermatocytes: 44.4"	"Group enriched"	"Detected in many"	7	"hippocampal CA4: 269.3;thalamic excitatory: 361.5"	"Cancer enriched"	"Detected in many"	11	"Breast Invasive Carcinoma (TCGA): 355.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	10	"Neuroblastoma: 24.8"	"Adrenal gland - Adrenal medulla cells, Prostate - Prostate glandular cells, Testis - Early spermatids"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"hippocampal formation: 307.9"	"CAB025515, HPA046278, CAB079776"	Enhanced	Supported			"Secreted to blood"	Neuropeptide	NA	NA				"Cluster 33: Brain - Neuronal signaling"	"Cluster 41: Monoamines - Neurotransmitter signalling"	"Cluster 17: Neuroblastoma - Neuronal signaling"	"Cluster 70: Spermatocytes & Spermatids - Spermatid development"	6			"CAB025515: , CAB079776: , HPA046278: AB_10961570"		"unprognostic (1.34e-1)"	"unprognostic (2.62e-1)"					"unprognostic (4.46e-2)"												"unprognostic (3.86e-1)"		"unprognostic (2.07e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.76e-2)"	"unprognostic (2.91e-1)"	"unprognostic (4.36e-2)"		"potential prognostic unfavorable (3.21e-4)"		"unprognostic (9.82e-2)"	
CASP3	"apopain, CPP32, CPP32B, Yama"	ENSG00000164305	"Caspase 3"	P42574	4	184627696-184650062	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 111.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"basophil: 491.1;eosinophil: 332.6"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 491.1"	"Low cancer specificity"	"Detected in all"			"Prostate - Urothelial cells, Spleen - Mitotic cells (Spleen), Stomach - Mitotic cells (Stomach)"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000091, HPA002643, CAB008381"	Enhanced		Approved	Nucleoplasm,Mitochondria			NA	NA		190000	"Cluster 42: Non-specific - Vesicular transport"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 25: Non-specific - Transcription"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 61: Plasma cells - Immunoglobulins & histones"	53	Mitochondria	Nucleoplasm	"CAB000091: , CAB008381: AB_590737, HPA002643: AB_1846048"	"potential prognostic favorable (8.17e-4)"	"unprognostic (1.10e-1)"	"unprognostic (3.65e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.73e-3)"	"unprognostic (9.91e-3)"	"unprognostic (8.15e-3)"	"unprognostic (2.62e-2)"	"unprognostic (5.42e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.38e-1)"	"potential prognostic unfavorable (4.54e-4)"	"unprognostic (1.75e-2)"	"unprognostic (4.68e-3)"	"unprognostic (2.82e-2)"	"unprognostic (8.66e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.74e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.72e-2)"	"unprognostic (2.14e-1)"	"unprognostic (9.97e-2)"	"unprognostic (5.75e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.27e-1)"	"unprognostic (3.41e-1)"
CASR	"FHH, GPRC2A, HHC, HHC1, NSHPT"	ENSG00000036828	"Calcium sensing receptor"	P41180	3	122183668-122291629	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	29	"parathyroid gland: 633.2"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 47.7;Distal tubular cells: 6.1;Ductal cells: 5.3;Enteroendocrine cells: 11.8;Pancreatic endocrine cells: 17.0"	"Cell type enriched"	"Detected in some"	16	"midbrain-derived inhibitory: 136.0"	"Cancer enhanced"	"Detected in some"		"Kidney Chromophobe (TCGA): 3.9;Pancreatic Adenocarcinoma (TCGA): 8.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	10	"thyroid cancer: 7.0"	"Kidney - Ascending Loop of Henle cells, Stomach - Gastric enteroendocrine cells, Thyroid gland - Parafollicular cells"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA039686, HPA050335"	Enhanced						NA	NA				"Cluster 24: Parathyroid gland - Vesicular transport"	"Cluster 9: Non-specific - Receptor signaling"	"Cluster 16: Thyroid cancer - Neuronal signaling"	"Cluster 20: Enteroendocrine cells - Hormone signaling"	9			"HPA039686: AB_10673536, HPA050335: AB_2681092"						"unprognostic (2.25e-3)"				"unprognostic (1.41e-1)"		"unprognostic (8.25e-3)"	"unprognostic (2.81e-1)"									"unprognostic (1.61e-1)"	"unprognostic (1.26e-1)"			"unprognostic (1.86e-2)"					
CAT		ENSG00000121691	Catalase	P04040	11	34438934-34472060	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Hydrogen peroxide"	"Mitogen, Oxidoreductase, Peroxidase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 1180.2"	"Cell type enhanced"	"Detected in all"		"Erythroid cells: 444.2;Hepatocytes: 435.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	13	"eosinophil: 4747.5"	"Lineage enriched"	"Detected in all"	13	"granulocytes: 4747.5"	"Low cancer specificity"	"Detected in many"			"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Adrenal gland - Adrenal cortex cells, Breast - Adipocytes (Breast), Liver - Hepatocytes, Spleen - Macrophages"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001515, HPA051282, HPA055838"	Enhanced		Enhanced	Vesicles			NA	NA		570000000	"Cluster 36: Eosinophils - Protein ubiquitination"	"Cluster 1: Liver & Kidney - Metabolism"	"Cluster 50: Non-specific - Nucleic acid binding"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 1: Erythroid cells - Oxygen transport"	20	Vesicles		"CAB001515: AB_384710, HPA051282: AB_2681419, HPA055838: AB_2682937"	"unprognostic (1.07e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.44e-2)"	"unprognostic (3.05e-1)"	"unprognostic (8.02e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.82e-1)"	"potential prognostic favorable (9.28e-10)"	"unprognostic (4.37e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.44e-3)"	"potential prognostic favorable (1.21e-4)"	"unprognostic (1.35e-3)"	"unprognostic (2.42e-1)"	"unprognostic (2.14e-2)"	"unprognostic (9.91e-2)"	"unprognostic (3.93e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.47e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.74e-1)"	"unprognostic (4.75e-2)"	"unprognostic (7.36e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.65e-1)"
CCDC51	FLJ12436	ENSG00000164051	"Coiled-coil domain containing 51"	Q96ER9	3	48432164-48440456	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"choroid plexus: 62.0"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 43.4;Proximal tubular cells: 46.0"	"Cell type enhanced"	"Detected in all"		"choroid plexus epithelial cell: 18.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010980, HPA011408"	Supported		Supported	Nucleoplasm,Centrosome,Mitochondria			NA	NA			"Cluster 30: Non-specific - DNA binding"	"Cluster 60: Choroid plexus - Transmembrane transport"	"Cluster 42: Choroid plexus - Mitochondria"	"Cluster 8: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	6	"Nucleoplasm, Mitochondria"	Centrosome	"HPA010980: AB_1846155, HPA011408: AB_2072212"	"unprognostic (1.41e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.09e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.57e-2)"	"unprognostic (5.30e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.56e-3)"	"unprognostic (3.83e-3)"	"unprognostic (3.49e-3)"	"potential prognostic unfavorable (3.22e-4)"	"potential prognostic favorable (4.31e-4)"	"unprognostic (3.90e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.23e-2)"	"unprognostic (8.61e-2)"	"unprognostic (1.14e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.67e-3)"	"unprognostic (1.26e-1)"	"unprognostic (8.06e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.23e-2)"	"unprognostic (4.06e-2)"
CCKAR		ENSG00000163394	"Cholecystokinin A receptor"	P32238	4	26481396-26490484	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"gallbladder: 28.2;stomach 1: 16.1"	"Cell type enhanced"	"Detected in single"		"Gastric mucus-secreting cells: 1.8"	"Cell type enhanced"	"Detected in some"		"hippocampal CA1-3: 2.1;mammillary body: 3.8;oligodendrocyte precursor cell: 2.2"	"Cancer enriched"	"Detected in single"	5	"Kidney Chromophobe (TCGA): 4.0"	"Group enriched"	"Detected in many"	5	"hypothalamus: 11.0;midbrain: 14.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"Bone cancer: 4.3;liver cancer: 2.0;Neuroblastoma: 7.5"	"Stomach - Chief cells"	"Region enhanced"	"Detected in many"		"hypothalamus: 7.2"	"Region enhanced"	"Detected in many"		"midbrain: 16.5"	HPA073900			Approved	"Nucleoplasm,Plasma membrane,Cytosol"			NA	NA				"Cluster 48: Stomach - Proteolysis"	"Cluster 41: Monoamines - Neurotransmitter signalling"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 46: Gastric mucus-secreting cells - Digestion"		"Plasma membrane, Cytosol"	Nucleoplasm	"HPA073900: "								"unprognostic (3.21e-3)"		"unprognostic (2.28e-1)"													"unprognostic (5.11e-2)"								
CCKBR		ENSG00000110148	"Cholecystokinin B receptor"	P32239	11	6259806-6272127	"Cancer-related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	31	"brain: 20.8;pancreas: 26.2;stomach 1: 40.8"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 14.1;Gastric mucus-secreting cells: 15.3;Granulosa cells: 17.1;Inhibitory neurons: 3.9"	"Low cell type specificity"	"Detected in many"			"Cancer enriched"	"Detected in some"	9	"Testicular Germ Cell Tumor (TCGA): 26.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Rhabdoid: 2.5;testis cancer: 9.7"	"Stomach - Parietal cells"	"Low region specificity"	"Detected in many"							HPA079548			Uncertain	"Vesicles,Plasma membrane"			NA	NA				"Cluster 32: Endocrine & Neural - Unknown function"	"Cluster 53: Neurons - Mixed function"	"Cluster 34: Testis cancer - Unknown function"	"Cluster 34: Neurons - Neuronal signaling"	7	Vesicles	"Plasma membrane"	"HPA079548: "	"unprognostic (2.47e-1)"		"unprognostic (3.00e-2)"																	"unprognostic (1.56e-1)"		"unprognostic (2.61e-2)"							"unprognostic (5.48e-1)"		"unprognostic (3.19e-2)"
CCND1	"BCL1, D11S287E, PRAD1, U21B31"	ENSG00000110092	"Cyclin D1"	P24385	11	69641156-69654474	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, DNA damage, Transcription, Transcription regulation"	"Cyclin, Repressor"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 896.3;Basal respiratory cells: 481.5;Secretory cells: 448.0"	"Group enriched"	"Detected in many"	4	"central nervous system macrophage: 60.4;choroid plexus epithelial cell: 24.6;endothelial cell: 33.0;fibroblast: 34.7;oligodendrocyte precursor cell: 91.2;pericyte: 40.5;vascular associated smooth muscle cell: 58.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"myeloid DC: 1.1"	"Low lineage specificity"	"Detected in single"			"Low cancer specificity"	"Detected in all"			"Minor Salivary Gland - Minor salivary gland basal cells, Skeletal muscle - Fibroblasts, Skin - Keratinocyte (other), Spleen - Fibroblast_1, Stomach - Gastric mucous cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027802, CAB080462"	Supported		Supported	Nucleoplasm			Yes	No			"Cluster 32: Basophils - Transcription"	"Cluster 13: Skin - Cornification"	"Cluster 42: Choroid plexus - Mitochondria"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 45: Non-specific - Mixed function"	93	Nucleoplasm		"CAB080462: , HPA027802: AB_2672390"	"unprognostic (1.44e-1)"	"unprognostic (1.60e-1)"	"unprognostic (8.16e-3)"	"unprognostic (5.12e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.44e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.85e-2)"	"potential prognostic unfavorable (5.23e-4)"	"unprognostic (2.57e-2)"	"validated prognostic favorable (3.18e-6)"	"validated prognostic favorable (5.97e-4)"	"unprognostic (2.46e-1)"	"unprognostic (5.48e-2)"	"unprognostic (4.00e-2)"	"unprognostic (9.58e-3)"	"unprognostic (2.02e-1)"	"unprognostic (2.46e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.90e-2)"	"unprognostic (6.38e-2)"	"potential prognostic unfavorable (2.24e-4)"	"unprognostic (1.60e-2)"	"unprognostic (4.06e-2)"	"unprognostic (3.82e-2)"	"unprognostic (9.59e-2)"	"unprognostic (2.35e-1)"	"unprognostic (8.60e-2)"	"unprognostic (7.20e-2)"	"unprognostic (7.88e-3)"	"unprognostic (2.16e-2)"
CCR4	"CC-CKR-4, CD194, ChemR13, CKR4, CMKBR4, k5-5"	ENSG00000183813	"C-C motif chemokine receptor 4"	P51679	3	32951644-32956349	"CD markers, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 12.6;urinary bladder: 5.2"	"Cell type enriched"	"Detected in some"	5	"T-cells: 11.9"	"Cell type enriched"	"Detected in single"	5	"leukocyte: 2.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"T-reg: 60.8"	"Lineage enriched"	"Detected in many"	41	"T-cells: 60.8"	"Cancer enriched"	"Detected in some"	4	"lymphoma: 18.7"	"Adipose subcutaneous - T-cells, Breast - T-cells, Skin - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA031613	Approved		Supported	"Plasma membrane"			NA	NA			"Cluster 9: T-regs - Cell cycle regulation"	"Cluster 36: Lymphoid tissue - Cytokine signaling"	"Cluster 48: Non-specific - Mixed function"	"Cluster 59: Leukemia - T-cell receptor"	"Cluster 78: NK-cells & T-cells - Immune system & Transcription"	1	"Plasma membrane"		"HPA031613: AB_10601096"	"unprognostic (4.81e-3)"	"unprognostic (5.27e-3)"	"unprognostic (3.82e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.34e-1)"			"potential prognostic favorable (7.29e-7)"		"unprognostic (6.70e-3)"	"unprognostic (6.17e-2)"				"potential prognostic favorable (7.41e-4)"	"unprognostic (4.98e-1)"	"unprognostic (1.61e-2)"	"unprognostic (4.97e-2)"			"unprognostic (1.63e-1)"	"unprognostic (7.34e-3)"	"unprognostic (9.45e-2)"		"unprognostic (2.11e-2)"		"unprognostic (1.23e-1)"	"unprognostic (4.17e-3)"		"unprognostic (1.13e-2)"
CCR5	"CC-CKR-5, CD195, CKR-5, CKR5, CMKBR5, IDDM22"	ENSG00000160791	"C-C motif chemokine receptor 5"	P51681	3	46370946-46376206	"CD markers, Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"	"Host-virus interaction"	"G-protein coupled receptor, Host cell receptor for virus entry, Receptor, Transducer"	"Diabetes mellitus, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 15.0"	"Cell type enhanced"	"Detected in some"		"Kupffer cells: 7.3;Langerhans cells: 40.9;Macrophages: 14.3;T-cells: 13.0"	"Cell type enriched"	"Detected in some"	5	"leukocyte: 26.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 40.8"	"Low lineage specificity"	"Detected in many"			"Cancer enhanced"	"Detected in some"		"lymphoma: 1.5;Myeloma: 1.2"	"Lung - T-cells, Prostate - T-cells, Skin - T-cells, Spleen - T-cells, Stomach - T-cells"					"Low region specificity"	"Detected in all"										NA	NA			"Cluster 5: Non-specific - Cell proliferation"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 59: Leukemia - T-cell receptor"	"Cluster 29: Monocytes - Innate immune response"	10				"unprognostic (5.40e-2)"	"unprognostic (6.68e-3)"	"unprognostic (7.59e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.78e-1)"	"unprognostic (7.60e-2)"	"unprognostic (6.10e-2)"	"potential prognostic favorable (3.32e-4)"	"unprognostic (7.23e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.08e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.48e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.14e-2)"	"unprognostic (7.07e-2)"
CD19		ENSG00000177455	"CD19 molecule"	P15391	16	28931965-28939342	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins"	"Adaptive immunity, Immunity"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"intestine: 32.1;lymphoid tissue: 73.1"	"Cell type enhanced"	"Detected in some"		"B-cells: 128.5;Early spermatids: 52.8;Plasma cells: 27.6"	"Cell type enhanced"	"Detected in some"		"central nervous system macrophage: 1.0;endothelial cell: 1.2;leukocyte: 1.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	81	"memory B-cell: 138.6;naive B-cell: 172.5"	"Lineage enriched"	"Detected in many"	90	"B-cells: 172.5"	"Group enriched"	"Detected in some"	13	"Leukemia: 37.8;lymphoma: 71.1"	"Liver - T-cells, Lung - B-cells (Lung), Minor Salivary Gland - Plasma cells, Spleen - B-cells (Spleen), Testis - Early spermatids, Testis - Late spermatids"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB016110	Enhanced						NA	NA			"Cluster 23: B-cells - Immunoglobulins"	"Cluster 70: Lymphoid tissue - Immune response"		"Cluster 6: Leukemia - Signal transduction"	"Cluster 73: B-cells - B-cell function"	7			"CAB016110: AB_626952"	"unprognostic (3.23e-1)"	"potential prognostic favorable (7.75e-5)"	"unprognostic (3.31e-2)"			"unprognostic (1.01e-1)"			"potential prognostic favorable (1.36e-5)"						"unprognostic (3.05e-1)"	"potential prognostic favorable (1.29e-4)"	"unprognostic (4.37e-2)"	"unprognostic (3.62e-1)"	"unprognostic (3.03e-1)"			"unprognostic (1.93e-1)"						"unprognostic (2.59e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.38e-1)"	
CD2	SRBC	ENSG00000116824	"CD2 molecule"	P06729	1	116754430-116769229	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"lymphoid tissue: 243.3"	"Group enriched"	"Detected in many"	11	"NK-cells: 199.5;T-cells: 483.9"	"Cell type enriched"	"Detected in some"	242	"leukocyte: 345.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"gdT-cell: 422.7;MAIT T-cell: 403.9;memory CD4 T-cell: 611.9;memory CD8 T-cell: 713.9;naive CD4 T-cell: 317.2;naive CD8 T-cell: 487.5;NK-cell: 1110.8;T-reg: 656.9"	"Group enriched"	"Detected in all"	10	"NK-cells: 1110.8;T-cells: 713.9"	"Group enriched"	"Detected in some"	66	"Leukemia: 11.8;lymphoma: 12.5"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Adrenal gland - T-cells, Breast - T-cells, Colon - T-cells, Kidney - T-cells, Liver - T-cells, Lung - T-cells, Minor Salivary Gland - T-cells, Pancreas - T-cells, Pituitary gland - T-cells, Prostate - T-cells, Skin - T-cells, Spleen - T-cells, Stomach - T-cells, Testis - Early spermatids, Testis - Late spermatids, Thyroid gland - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB002430, HPA003883"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane"			NA	NA			"Cluster 1: T-cells - Unknown function"	"Cluster 71: Thymus - Adaptive immune response"	"Cluster 8: Immune cells - Immune response"	"Cluster 59: Leukemia - T-cell receptor"	"Cluster 78: NK-cells & T-cells - Immune system & Transcription"	15	"Plasma membrane"	"Nucleoplasm, Golgi apparatus"	"CAB002430: AB_442057, HPA003883: AB_1846263"	"unprognostic (7.62e-3)"	"unprognostic (1.57e-3)"	"unprognostic (3.33e-2)"	"unprognostic (3.23e-3)"	"unprognostic (8.33e-2)"	"unprognostic (9.51e-2)"	"unprognostic (3.03e-2)"	"unprognostic (9.52e-2)"	"potential prognostic favorable (3.95e-4)"	"unprognostic (3.29e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.54e-2)"	"unprognostic (8.61e-3)"	"unprognostic (4.64e-3)"	"unprognostic (3.01e-3)"	"unprognostic (6.71e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.74e-2)"	"unprognostic (4.93e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.87e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.49e-1)"	"potential prognostic favorable (1.87e-4)"	"unprognostic (1.35e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.15e-1)"
CD22	"SIGLEC-2, SIGLEC2"	ENSG00000012124	"CD22 molecule"	P20273	19	35319261-35347361	"CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 223.3;ovary: 123.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 155.6;granulocytes: 71.4;Granulosa cells: 52.3;Oligodendrocytes: 85.2;Ovarian stromal cells: 46.7;Secretory cells: 34.6"	"Group enriched"	"Detected in many"	30	"committed oligodendrocyte precursor: 159.9;oligodendrocyte: 290.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	24	"memory B-cell: 97.9;naive B-cell: 120.7"	"Lineage enriched"	"Detected in many"	26	"B-cells: 120.7"	"Group enriched"	"Detected in many"	9	"Leukemia: 48.4;lymphoma: 193.5"	"Colon - Mast cells, Spleen - B-cells (Spleen)"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB002418, HPA024353, HPA066523"	Enhanced						NA	NA		4400	"Cluster 23: B-cells - Immunoglobulins"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 11: White matter - Signal transduction"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 73: B-cells - B-cell function"	9			"CAB002418: AB_563529, HPA024353: AB_10600695, HPA066523: "	"unprognostic (6.63e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.65e-2)"	"unprognostic (9.99e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.33e-2)"	"unprognostic (8.98e-3)"	"unprognostic (5.14e-2)"	"unprognostic (4.21e-2)"	"unprognostic (6.39e-2)"	"unprognostic (7.23e-2)"	"unprognostic (3.04e-1)"	"unprognostic (8.42e-2)"	"unprognostic (2.48e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.32e-1)"	"unprognostic (6.57e-2)"	"unprognostic (8.29e-3)"	"potential prognostic favorable (9.77e-4)"	"unprognostic (1.09e-3)"	"unprognostic (1.52e-2)"	"unprognostic (1.88e-1)"	"unprognostic (8.74e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.93e-2)"
CD247	"CD3-ZETA, CD3H, CD3Q, CD3Z, CD3ZETA, TCRZ"	ENSG00000198821	"CD247 molecule"	P20963	1	167425027-167518640	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"bone marrow: 39.7;lymphoid tissue: 157.1"	"Group enriched"	"Detected in many"	22	"NK-cells: 775.2;T-cells: 240.6"	"Cell type enriched"	"Detected in many"	41	"leukocyte: 1073.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	20	"gdT-cell: 336.7;MAIT T-cell: 189.2;memory CD4 T-cell: 181.3;memory CD8 T-cell: 205.8;naive CD4 T-cell: 227.8;naive CD8 T-cell: 184.5;NK-cell: 213.0;T-reg: 242.5"	"Group enriched"	"Detected in all"	25	"NK-cells: 213.0;T-cells: 336.7"	"Group enriched"	"Detected in some"	11	"Leukemia: 23.4;lymphoma: 21.4;Myeloma: 16.1"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Adrenal gland - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Liver - NK-cells (Liver), Lung - NK-cells (Lung), Minor Salivary Gland - T-cells, Pancreas - T-cells, Pituitary gland - T-cells, Prostate - T-cells, Skin - T-cells, Thyroid gland - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB004651, HPA008750"	Enhanced						NA	NA			"Cluster 27: T-cells - Unknown function"	"Cluster 71: Thymus - Adaptive immune response"	"Cluster 52: Neurons & Synapses - Synaptic function"	"Cluster 59: Leukemia - T-cell receptor"	"Cluster 19: NK-cells - Adaptive immune response"	19			"CAB004651: AB_425347, HPA008750: AB_1857863"	"unprognostic (4.54e-2)"	"potential prognostic favorable (3.28e-4)"	"unprognostic (2.84e-2)"	"unprognostic (2.63e-3)"	"unprognostic (4.65e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.15e-3)"	"unprognostic (5.40e-2)"	"potential prognostic favorable (4.82e-4)"	"unprognostic (1.22e-1)"	"unprognostic (2.09e-1)"	"unprognostic (9.98e-2)"	"unprognostic (2.79e-2)"	"unprognostic (9.49e-3)"	"unprognostic (4.73e-3)"	"unprognostic (6.01e-3)"	"unprognostic (9.34e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.68e-3)"	"unprognostic (3.61e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.05e-1)"
CD274	"B7-H, B7-H1, B7H1, PD-L1, PDCD1LG1, PDL1"	ENSG00000120217	"CD274 molecule"	Q9NZQ7	9	5450503-5470566	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Adaptive immunity, Immunity"	Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 16.3"	"Group enriched"	"Detected in many"	4	"Extravillous trophoblasts: 31.3;granulocytes: 43.8;Langerhans cells: 62.7;Syncytiotrophoblasts: 54.7"	"Cell type enriched"	"Detected in many"	5	"central nervous system macrophage: 36.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 6.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.7"	"Low cancer specificity"	"Detected in many"			"Kidney - Endothelial cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003528, CAB076385, CAB080537"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Actin filaments"	"Secreted - unknown location"	Receptor	NA	NA			"Cluster 35: Neutrophils - Protein binding"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 56: Hypothalamus - Neuropeptide signaling"	"Cluster 71: Lymphoma - Inflammatory response"	"Cluster 14: Langerhans cells - Innate immune response"	54	"Plasma membrane, Actin filaments"	Nucleoplasm	"CAB076385: AB_2687655, CAB080537: , HPA003528: "	"unprognostic (1.57e-1)"	"unprognostic (6.40e-2)"	"unprognostic (9.65e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.98e-2)"	"unprognostic (4.77e-2)"	"unprognostic (9.07e-2)"	"unprognostic (8.18e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.06e-1)"	"potential prognostic favorable (5.33e-4)"	"unprognostic (9.06e-2)"	"unprognostic (1.18e-1)"		"unprognostic (3.02e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.70e-3)"	"unprognostic (3.49e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.51e-3)"	"unprognostic (3.35e-3)"	"unprognostic (9.49e-3)"	"unprognostic (3.27e-3)"		"unprognostic (3.46e-2)"	"unprognostic (3.48e-2)"	"unprognostic (5.88e-2)"	"unprognostic (6.88e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.49e-1)"	
CD33	"FLJ00391, p67, SIGLEC-3, SIGLEC3"	ENSG00000105383	"CD33 molecule"	P20138	19	51225064-51243860	"CD markers, FDA approved drug targets, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.0;lymphoid tissue: 23.4"	"Group enriched"	"Detected in some"	6	"granulocytes: 78.7;Hofbauer cells: 90.4;Kupffer cells: 95.7;Langerhans cells: 50.2;Macrophages: 55.2;monocytes: 29.3"	"Cell type enriched"	"Detected in some"	7	"central nervous system macrophage: 37.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"classical monocyte: 166.7;intermediate monocyte: 122.1;myeloid DC: 213.7;non-classical monocyte: 58.0"	"Group enriched"	"Detected in many"	9	"dendritic cells: 213.7;monocytes: 166.7"	"Cancer enriched"	"Detected in many"	8	"Leukemia: 53.6"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Colon - Macrophages, Heart muscle - Macrophages, Kidney - Macrophages, Liver - Kupffer cells, Lung - Macrophages, Minor Salivary Gland - Macrophages, Pancreas - Macrophages, Prostate - Macrophages, Skeletal muscle - Macrophages, Spleen - Macrophages, Testis - Macrophages, Thyroid gland - Macrophages"									"CAB011442, HPA035832, CAB079996, CAB080305"	Enhanced		Supported	"Plasma membrane,Cytosol"			NA	NA		12000000	"Cluster 26: Monocytes - Plasma membrane proteins"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 29: Monocytes - Innate immune response"	24	"Plasma membrane"	Cytosol	"CAB011442: , CAB079996: , CAB080305: , HPA035832: AB_2674808"	"unprognostic (1.63e-1)"	"unprognostic (1.82e-2)"	"unprognostic (5.32e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.52e-1)"	"unprognostic (5.05e-3)"	"unprognostic (3.40e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.17e-2)"	"unprognostic (7.35e-3)"	"unprognostic (1.02e-2)"	"unprognostic (9.04e-3)"	"unprognostic (8.70e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.68e-2)"	"unprognostic (6.54e-2)"	"unprognostic (2.02e-2)"	"unprognostic (5.50e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.19e-3)"	"unprognostic (6.67e-2)"	"unprognostic (1.37e-1)"
CD3D	"CD3-DELTA, CD3DELTA, T3D"	ENSG00000167286	"CD3 delta subunit of T-cell receptor complex"	P04234	11	118339075-118342705	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor	"FDA approved drug targets, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	29	"lymphoid tissue: 846.9"	"Cell type enriched"	"Detected in many"	6	"T-cells: 663.2"	"Cell type enriched"	"Detected in single"	427	"leukocyte: 121.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in all"	53	"gdT-cell: 1434.7;MAIT T-cell: 971.2;memory CD4 T-cell: 1184.7;memory CD8 T-cell: 1338.7;naive CD4 T-cell: 1071.7;naive CD8 T-cell: 1320.2;T-reg: 1629.7"	"Lineage enriched"	"Detected in all"	68	"T-cells: 1629.7"	"Cancer enriched"	"Detected in some"	8	"Leukemia: 223.2"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Adrenal gland - T-cells, Breast - T-cells, Colon - T-cells, Kidney - T-cells, Liver - T-cells, Lung - T-cells, Minor Salivary Gland - T-cells, Pancreas - T-cells, Pituitary gland - T-cells, Prostate - T-cells, Skin - T-cells, Spleen - T-cells, Thyroid gland - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB013055, HPA071778"	Enhanced		Uncertain	"Endoplasmic reticulum,Vesicles"			NA	NA			"Cluster 11: T-cells - Unknown function"	"Cluster 71: Thymus - Adaptive immune response"	"Cluster 8: Immune cells - Immune response"	"Cluster 59: Leukemia - T-cell receptor"	"Cluster 78: NK-cells & T-cells - Immune system & Transcription"	12	"Endoplasmic reticulum, Vesicles"		"CAB013055: , HPA071778: "	"unprognostic (2.77e-3)"	"potential prognostic favorable (3.36e-4)"	"unprognostic (7.81e-2)"	"unprognostic (7.80e-3)"	"unprognostic (1.81e-1)"	"unprognostic (5.22e-2)"	"unprognostic (2.93e-3)"	"unprognostic (3.59e-2)"	"potential prognostic favorable (1.09e-4)"	"unprognostic (4.86e-1)"	"unprognostic (7.80e-2)"	"unprognostic (3.65e-2)"	"unprognostic (8.36e-2)"	"unprognostic (3.98e-1)"	"unprognostic (4.81e-2)"	"unprognostic (3.94e-2)"	"unprognostic (3.27e-1)"	"unprognostic (3.02e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.63e-2)"	"unprognostic (4.30e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.32e-1)"	"unprognostic (3.32e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.91e-1)"	"unprognostic (9.92e-2)"	"unprognostic (2.65e-2)"	"unprognostic (4.68e-2)"
CD3E	"CD3-epsilon, CD3epsilon"	ENSG00000198851	"CD3 epsilon subunit of T-cell receptor complex"	P07766	11	118304730-118316175	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Adaptive immunity, Immunity"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	17	"lymphoid tissue: 623.6"	"Group enriched"	"Detected in many"	18	"NK-cells: 214.7;T-cells: 646.6"	"Cell type enriched"	"Detected in some"	179	"leukocyte: 199.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	26	"gdT-cell: 491.6;MAIT T-cell: 421.5;memory CD4 T-cell: 415.6;memory CD8 T-cell: 463.4;naive CD4 T-cell: 493.3;naive CD8 T-cell: 502.8;NK-cell: 203.3;T-reg: 427.4"	"Group enriched"	"Detected in all"	21	"NK-cells: 203.3;T-cells: 502.8"	"Cancer enriched"	"Detected in some"	8	"Leukemia: 125.7"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Adrenal gland - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Liver - T-cells, Lung - T-cells, Minor Salivary Gland - T-cells, Pancreas - T-cells, Pituitary gland - T-cells, Prostate - T-cells, Skin - T-cells, Spleen - T-cells, Stomach - T-cells, Thyroid gland - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB000010, HPA040957, HPA043955, CAB072863, CAB072864"	Enhanced		Supported	"Endoplasmic reticulum,Golgi apparatus,Plasma membrane"			NA	NA			"Cluster 11: T-cells - Unknown function"	"Cluster 71: Thymus - Adaptive immune response"	"Cluster 8: Immune cells - Immune response"	"Cluster 59: Leukemia - T-cell receptor"	"Cluster 7: T-cells - T-cell receptor"	38	"Endoplasmic reticulum, Plasma membrane"	"Golgi apparatus"	"CAB000010: AB_2631163, CAB072863: AB_2665707, CAB072864: AB_2665708, HPA040957: AB_2677222, HPA043955: AB_2678747"	"unprognostic (2.34e-2)"	"potential prognostic favorable (1.61e-4)"	"unprognostic (2.89e-2)"	"potential prognostic favorable (2.43e-4)"	"unprognostic (1.49e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.05e-3)"	"unprognostic (8.41e-2)"	"potential prognostic favorable (3.77e-4)"	"unprognostic (2.18e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.67e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.25e-1)"	"unprognostic (5.00e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.79e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.26e-1)"	"unprognostic (8.54e-3)"	"unprognostic (1.20e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.39e-2)"
CD3G	"CD3-GAMMA, CD3GAMMA"	ENSG00000160654	"CD3 gamma subunit of T-cell receptor complex"	P09693	11	118344344-118355161	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"lymphoid tissue: 92.2"	"Group enriched"	"Detected in many"	14	"NK-cells: 95.2;T-cells: 331.9"	"Cell type enriched"	"Detected in single"	470	"leukocyte: 168.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	21	"gdT-cell: 228.7;MAIT T-cell: 135.3;memory CD4 T-cell: 187.4;memory CD8 T-cell: 196.4;naive CD4 T-cell: 192.7;naive CD8 T-cell: 241.8;T-reg: 200.1"	"Lineage enriched"	"Detected in many"	26	"T-cells: 241.8"	"Cancer enriched"	"Detected in some"	6	"Leukemia: 19.9"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Adrenal gland - T-cells, Colon - T-cells, Kidney - T-cells, Liver - T-cells, Lung - T-cells, Minor Salivary Gland - T-cells, Pancreas - T-cells, Pituitary gland - T-cells, Prostate - T-cells, Skin - T-cells, Spleen - T-cells, Stomach - T-cells, Thyroid gland - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB017520, HPA038494"	Enhanced		Supported	"Plasma membrane,Cytosol"			NA	NA			"Cluster 11: T-cells - Unknown function"	"Cluster 71: Thymus - Adaptive immune response"	"Cluster 6: Non-specific - Immune response"	"Cluster 59: Leukemia - T-cell receptor"	"Cluster 78: NK-cells & T-cells - Immune system & Transcription"	10	"Plasma membrane, Cytosol"		"CAB017520: AB_831094, HPA038494: AB_2676044"	"unprognostic (3.30e-2)"	"unprognostic (1.87e-2)"	"unprognostic (4.46e-1)"	"unprognostic (3.75e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.84e-1)"		"unprognostic (4.89e-2)"	"unprognostic (2.41e-3)"		"unprognostic (3.93e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.55e-2)"		"unprognostic (4.77e-3)"	"unprognostic (9.31e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.98e-1)"	"unprognostic (5.39e-2)"	"unprognostic (5.38e-3)"		"unprognostic (7.48e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.90e-2)"	"unprognostic (2.59e-1)"	"unprognostic (5.30e-2)"	"unprognostic (8.32e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.07e-2)"	"unprognostic (8.94e-2)"
CD4		ENSG00000010610	"CD4 molecule"	P01730	12	6786858-6820799	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity"	"Host cell receptor for virus entry, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 148.3;lymphoid tissue: 213.7;parathyroid gland: 168.4"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 227.5;Hofbauer cells: 152.0;Kupffer cells: 190.2;Langerhans cells: 99.7;Macrophages: 116.7;monocytes: 150.0"	"Cell type enhanced"	"Detected in many"		"central nervous system macrophage: 162.0;fibroblast: 71.2;pericyte: 48.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	18	"classical monocyte: 247.4;intermediate monocyte: 241.4;memory CD4 T-cell: 153.8;myeloid DC: 166.4;naive CD4 T-cell: 128.5;non-classical monocyte: 205.2;plasmacytoid DC: 264.3;T-reg: 154.9"	"Group enriched"	"Detected in many"	20	"dendritic cells: 264.3;monocytes: 247.4;T-cells: 154.9"	"Group enriched"	"Detected in some"	35	"Leukemia: 40.6;lymphoma: 27.6;Myeloma: 23.9"	"Adrenal gland - Macrophages, Colon - Macrophages, Minor Salivary Gland - Macrophages, Pituitary gland - Macrophages, Skeletal muscle - Macrophages, Spleen - Macrophages, Stomach - Macrophages"	"Region enriched"	"Detected in many"	14	"basal ganglia: 46.2"	"Low region specificity"	"Detected in many"			"CAB000011, HPA004252, HPA004472, CAB068180"	Enhanced		Supported	"Plasma membrane"			NA	NA			"Cluster 2: Dendritic cells - Unknown function"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	10	"Plasma membrane"		"CAB000011: AB_442062, CAB068180: AB_2665653, HPA004252: AB_1078466, HPA004472: AB_1078465"	"unprognostic (2.67e-3)"	"unprognostic (8.77e-3)"	"unprognostic (1.16e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.78e-2)"	"unprognostic (4.32e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.83e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.49e-1)"	"unprognostic (5.33e-2)"	"unprognostic (4.32e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.59e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.52e-3)"	"unprognostic (5.86e-2)"	"unprognostic (3.27e-1)"
CD44	"CD44R, CSPG8, HCELL, IN, MC56, MDU2, MDU3, MIC4, Pgp1"	ENSG00000026508	"CD44 molecule (Indian blood group)"	P16070	11	35138882-35232402	"Blood group antigen proteins, Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Cell adhesion"	"Blood group antigen, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 484.4"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 983.9;Exocrine glandular cells: 928.7;granulocytes: 1083.6;Langerhans cells: 2343.8;monocytes: 1059.3"	"Cell type enhanced"	"Detected in many"		"astrocyte: 403.2;leukocyte: 474.2;vascular associated smooth muscle cell: 152.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"Adrenocortical cancer: 1400.7"	"Adipose subcutaneous - Adipose progenitor cells, Prostate - Urothelial cells, Skin - Keratinocyte (other)"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000112, CAB000316, HPA005785"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"	"Secreted to blood"	Receptor	NA	NA	260000000	660000000	"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 48: Stomach - Proteolysis"	"Cluster 39: Astrocytes - Mixed function"	"Cluster 72: Neuronal - Signal transduction"	"Cluster 29: Monocytes - Innate immune response"	26	"Plasma membrane"	"Golgi apparatus"	"CAB000112: , CAB000316: AB_2076596, HPA005785: AB_1078467"	"unprognostic (1.93e-3)"	"unprognostic (1.85e-1)"	"unprognostic (3.84e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.90e-2)"	"unprognostic (3.00e-2)"	"unprognostic (3.19e-1)"	"potential prognostic unfavorable (1.71e-4)"	"unprognostic (1.76e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.08e-3)"	"unprognostic (1.73e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.77e-3)"	"unprognostic (1.44e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.58e-2)"	"unprognostic (5.89e-3)"	"unprognostic (8.97e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.97e-2)"	"unprognostic (8.74e-2)"
CD52	"CDW52, EDDM5, HE5"	ENSG00000169442	"CD52 molecule"	P31358	1	26317958-26320523	"Cancer-related genes, CD markers, FDA approved drug targets, Predicted membrane proteins"			"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	29	"epididymis: 35271.0"	"Cell type enhanced"	"Detected in many"		"B-cells: 1880.8;granulocytes: 476.9;Hofbauer cells: 965.0;Langerhans cells: 740.3;Macrophages: 545.3;monocytes: 1356.6;NK-cells: 479.6;T-cells: 1189.9"	"Cell type enriched"	"Detected in some"	20	"leukocyte: 85.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"Leukemia: 303.1;lymphoma: 667.3"	"Adipose visceral - T-cells, Breast - T-cells, Lung - Macrophages, Prostate - T-cells, Spleen - B-cells (Spleen), Thyroid gland - T-cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"										NA	NA			"Cluster 3: Non-specific - Nuclear processes"	"Cluster 50: Epididymis - Male reproductive secretion"	"Cluster 23: Choroid plexus - Mixed function"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 73: B-cells - B-cell function"					"unprognostic (1.36e-1)"	"potential prognostic favorable (4.16e-4)"	"unprognostic (4.91e-2)"	"unprognostic (4.84e-3)"	"unprognostic (1.57e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.04e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.74e-3)"	"unprognostic (2.55e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.77e-1)"	"unprognostic (7.12e-2)"	"unprognostic (2.55e-2)"	"unprognostic (3.85e-3)"	"unprognostic (1.03e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.43e-1)"	"unprognostic (8.21e-2)"	"unprognostic (2.11e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.55e-2)"	"unprognostic (4.57e-2)"	"potential prognostic favorable (9.61e-4)"	"unprognostic (3.11e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.41e-1)"
CD79B	"B29, Ig-beta, IGB, Igbeta"	ENSG00000007312	"CD79b molecule"	P40259	17	63928738-63932336	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins"	"Adaptive immunity, Immunity"		"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 258.7"	"Cell type enriched"	"Detected in many"	4	"B-cells: 490.9"	"Group enriched"	"Detected in some"	5	"fibroblast: 8.8;leukocyte: 18.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in all"	4	"memory B-cell: 1119.4;naive B-cell: 1488.8"	"Lineage enriched"	"Detected in all"	5	"B-cells: 1488.8"	"Cancer enriched"	"Detected in some"	6	"lymphoma: 657.0"	"Pituitary gland - Somatotropes, Prostate - Endothelial cells, Spleen - B-cells (Spleen)"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA009178, CAB009751, HPA044107"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"			NA	NA			"Cluster 23: B-cells - Immunoglobulins"	"Cluster 70: Lymphoid tissue - Immune response"		"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 73: B-cells - B-cell function"	3	"Plasma membrane"	"Nucleoplasm, Cytosol"	"CAB009751: AB_2275844, HPA009178: AB_1078483, HPA044107: "	"unprognostic (1.46e-1)"	"unprognostic (1.55e-2)"	"potential prognostic favorable (2.92e-5)"	"potential prognostic favorable (3.09e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.67e-1)"	"potential prognostic unfavorable (4.18e-4)"	"unprognostic (1.78e-1)"	"potential prognostic favorable (4.85e-4)"	"unprognostic (1.39e-1)"	"potential prognostic favorable (2.74e-4)"	"unprognostic (1.70e-2)"	"potential prognostic unfavorable (3.33e-4)"	"unprognostic (1.82e-1)"	"unprognostic (2.64e-2)"	"potential prognostic favorable (2.91e-4)"	"unprognostic (1.02e-1)"	"unprognostic (7.09e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.06e-2)"	"unprognostic (5.15e-2)"	"unprognostic (5.97e-2)"	"unprognostic (4.42e-3)"	"unprognostic (1.85e-1)"	"unprognostic (7.89e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.47e-1)"
CD80	"B7-1, B7.1, CD28LG, CD28LG1"	ENSG00000121594	"CD80 molecule"	P33681	3	119524293-119559614	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lung: 2.9;lymphoid tissue: 6.6"	"Group enriched"	"Detected in some"	4	"B-cells: 9.1;Langerhans cells: 21.3;Macrophages: 7.2;monocytes: 19.3"	"Cell type enhanced"	"Detected in some"		"central nervous system macrophage: 4.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 1.4;T-reg: 1.3"	"Low lineage specificity"	"Detected in many"			"Cancer enriched"	"Detected in some"	5	"lymphoma: 19.6"	"Liver - Kupffer cells"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB025368, HPA050092"	Enhanced				"Intracellular and membrane"	Receptor	NA	NA			"Cluster 14: Non-specific - Unknown function"	"Cluster 36: Lymphoid tissue - Cytokine signaling"	"Cluster 8: Immune cells - Immune response"	"Cluster 55: Lymphoma - Immune response"	"Cluster 14: Langerhans cells - Innate immune response"	6			"CAB025368: , HPA050092: AB_2681012"		"unprognostic (2.18e-1)"	"unprognostic (7.63e-2)"			"unprognostic (4.98e-2)"		"unprognostic (1.46e-1)"	"unprognostic (9.23e-2)"			"unprognostic (1.86e-1)"			"unprognostic (1.93e-1)"	"unprognostic (2.59e-3)"	"unprognostic (2.58e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.04e-1)"			"unprognostic (1.83e-2)"	"potential prognostic unfavorable (9.01e-5)"			"unprognostic (1.87e-2)"		"unprognostic (3.67e-1)"	"unprognostic (1.25e-2)"		
CD86	"B7-2, B7.2, CD28LG2"	ENSG00000114013	"CD86 molecule"	P42081	3	122055362-122121139	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Host-virus interaction, Immunity"	"Host cell receptor for virus entry, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 33.5"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 151.9;Kupffer cells: 91.5;Langerhans cells: 191.7;Macrophages: 142.5;Microglial cells: 75.1;monocytes: 464.6"	"Cell type enriched"	"Detected in some"	8	"central nervous system macrophage: 472.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"classical monocyte: 80.1;intermediate monocyte: 79.2;memory B-cell: 41.1;myeloid DC: 79.0;naive B-cell: 28.7;non-classical monocyte: 85.6"	"Group enriched"	"Detected in many"	18	"B-cells: 41.1;dendritic cells: 79.0;monocytes: 85.6"	"Cancer enriched"	"Detected in some"	6	"lymphoma: 54.5"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Colon - Macrophages, Heart muscle - Macrophages, Kidney - Macrophages, Liver - Kupffer cells, Minor Salivary Gland - Macrophages, Pancreas - Macrophages, Pituitary gland - Macrophages, Prostate - Macrophages, Skeletal muscle - Macrophages, Spleen - Macrophages, Stomach - Macrophages, Thyroid gland - Macrophages"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB004319, HPA026802"	Approved		Supported	"Plasma membrane,Centriolar satellite"			NA	NA		94000	"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 21: Lymphoma - Adaptive immune response"	"Cluster 14: Langerhans cells - Innate immune response"	3	"Plasma membrane"	"Centriolar satellite"	"CAB004319: AB_627200, HPA026802: "	"unprognostic (1.96e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.93e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.50e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.98e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.75e-1)"	"unprognostic (8.71e-2)"	"unprognostic (3.25e-1)"	"unprognostic (8.71e-2)"	"unprognostic (1.02e-3)"	"unprognostic (3.57e-1)"	"unprognostic (7.46e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.03e-2)"	"unprognostic (7.84e-2)"	"unprognostic (2.94e-1)"
CDA	CDD	ENSG00000158825	"Cytidine deaminase"	P32320	1	20589086-20618903	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 191.4;esophagus: 84.6;liver: 84.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 309.9;Hepatocytes: 135.1;monocytes: 104.5;Paneth cells: 145.5;Proximal enterocytes: 117.2;Suprabasal keratinocytes: 190.8"	"Cell type enriched"	"Detected in some"	8	"endothelial cell: 44.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 1240.3"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 1240.3"	"Cancer enhanced"	"Detected in many"		"Adrenocortical cancer: 157.8"	"Lung - Neutrophil_2, Prostate - Endothelial cells, Spleen - Neutrophils"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA064202	Enhanced		Approved	Nucleoplasm			NA	NA		2900000	"Cluster 21: Neutrophils - Unknown function"	"Cluster 77: Bone marrow - Cell proliferation"	"Cluster 47: Endothelial cells - Vasculature"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 5: Enterocytes - Absorption"	19	Nucleoplasm		"HPA064202: AB_2685211"	"unprognostic (9.46e-3)"	"unprognostic (7.62e-2)"	"unprognostic (8.85e-2)"	"potential prognostic unfavorable (6.44e-4)"	"unprognostic (9.88e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.66e-2)"	"unprognostic (5.37e-3)"	"unprognostic (5.73e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.17e-2)"	"unprognostic (5.27e-2)"	"unprognostic (5.80e-2)"	"unprognostic (2.15e-2)"	"unprognostic (5.62e-3)"	"unprognostic (9.21e-3)"	"unprognostic (1.67e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.62e-2)"	"unprognostic (2.66e-1)"	"validated prognostic unfavorable (1.19e-5)"	"validated prognostic unfavorable (5.36e-4)"	"unprognostic (5.33e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.35e-3)"	"unprognostic (3.12e-1)"	"unprognostic (2.52e-3)"	"unprognostic (8.82e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.13e-2)"
CDK4	PSK-J3	ENSG00000135446	"Cyclin dependent kinase 4"	P11802	12	57747727-57756013	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Cancer enriched"	"Detected in all"	5	"Glioblastoma Multiforme (TCGA): 998.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Adrenal cortex cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006024, CAB013116, CAB069405"	Supported		Supported	"Nucleoplasm,Nuclear membrane,Nucleoli,Cytosol"			NA	NA			"Cluster 30: Non-specific - DNA binding"	"Cluster 62: Connective tissue - ECM organization"	"Cluster 25: Non-specific - Transcription"	"Cluster 38: Non-specific - Transcription"	"Cluster 1: Erythroid cells - Oxygen transport"	114	"Nucleoplasm, Cytosol"	"Nuclear membrane, Nucleoli"	"CAB013116: AB_2536376, CAB069405: AB_1613464, HPA006024: AB_2667497"	"unprognostic (1.44e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.61e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.68e-1)"	"potential prognostic unfavorable (8.12e-6)"	"potential prognostic favorable (8.58e-4)"	"unprognostic (2.61e-3)"	"potential prognostic unfavorable (5.35e-4)"	"validated prognostic unfavorable (3.43e-6)"	"validated prognostic unfavorable (2.85e-8)"	"unprognostic (2.24e-2)"	"potential prognostic unfavorable (3.19e-4)"	"unprognostic (9.36e-3)"	"unprognostic (1.85e-2)"	"unprognostic (5.25e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.44e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.36e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.11e-2)"	"unprognostic (6.45e-3)"
CDK6	PLSTIRE	ENSG00000105810	"Cyclin dependent kinase 6"	Q00534	7	92604921-92836573	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 40.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 179.2;Erythroid cells: 211.2;Late spermatids: 253.1;Oligodendrocytes: 219.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cancer specificity"	"Detected in all"			"Testis - Spermatogonia"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA002637, CAB004363"	Enhanced		Supported	Nucleoplasm,Cytosol			NA	NA		17000	"Cluster 12: Non-specific - Mitochondrial translation"	"Cluster 67: Lymphoid tissue & Bone marrow - Cell proliferation"	"Cluster 11: White matter - Signal transduction"	"Cluster 59: Leukemia - T-cell receptor"	"Cluster 11: Late spermatids - Unknown function"	68	"Nucleoplasm, Cytosol"		"CAB004363: AB_627242, HPA002637: AB_1846432"	"unprognostic (4.45e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.53e-3)"	"unprognostic (1.73e-1)"	"unprognostic (6.26e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.21e-2)"	"unprognostic (7.40e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.02e-1)"	"unprognostic (6.84e-2)"	"potential prognostic unfavorable (1.29e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.92e-1)"	"unprognostic (7.31e-3)"	"unprognostic (1.65e-1)"	"validated prognostic unfavorable (7.99e-6)"	"validated prognostic unfavorable (5.59e-6)"	"unprognostic (2.17e-2)"	"unprognostic (2.09e-1)"	"unprognostic (8.82e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.56e-1)"	"unprognostic (7.86e-2)"	"unprognostic (9.71e-3)"
CFTR	"ABC35, ABCC7, CF, CFTR/MRP, dJ760C5.1, MRP7, TNR-CFTR"	ENSG00000001626	"CF transmembrane conductance regulator"	P13569	7	117287120-117715971	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Isomerase"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 48.4;intestine: 43.6;pancreas: 192.0"	"Group enriched"	"Detected in many"	4	"Ductal cells: 590.0;Late spermatids: 149.9"	"Cell type enhanced"	"Detected in many"		"oligodendrocyte: 247.2"	"Group enriched"	"Detected in many"	4	"Colon Adenocarcinoma (TCGA): 42.5;Kidney Chromophobe (TCGA): 86.1;Pancreatic Adenocarcinoma (TCGA): 43.4;Rectum Adenocarcinoma (TCGA): 43.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"colorectal cancer: 24.2;Gastric cancer: 9.6"	"Adipose visceral - Mesothelial cells, Breast - Breast glandular cells, Colon - Colon enterocytes, Lung - Alveolar cells type 2, Minor Salivary Gland - Minor salivary glandular cells, Skin - Eccrine sweat gland cells"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB001951, HPA021939, HPA079652"	Enhanced						NA	NA				"Cluster 15: Pancreas - Proteolysis"	"Cluster 11: White matter - Signal transduction"	"Cluster 57: Stomach & Colon cancer - Digestion"	"Cluster 45: Non-specific - Mixed function"	372			"CAB001951: , HPA021939: AB_1846578, HPA079652: "			"unprognostic (3.74e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.75e-2)"	"potential prognostic favorable (1.43e-4)"				"unprognostic (5.50e-3)"	"unprognostic (8.10e-3)"		"unprognostic (6.36e-2)"	"unprognostic (5.71e-2)"	"unprognostic (4.70e-2)"	"potential prognostic favorable (3.02e-4)"	"unprognostic (3.66e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.31e-2)"	"unprognostic (5.19e-3)"	"unprognostic (2.64e-1)"		"unprognostic (1.39e-1)"	"unprognostic (2.58e-1)"		"unprognostic (1.64e-3)"
CHRM1		ENSG00000168539	"Cholinergic receptor muscarinic 1"	P11229	11	62908679-62921807	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"brain: 44.0;prostate: 28.7;salivary gland: 28.0"	"Cell type enriched"	"Detected in some"	5	"Prostatic glandular cells: 48.9"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in some"	11	"Kidney Chromophobe (TCGA): 20.6;Prostate Adenocarcinoma (TCGA): 50.4"	"Group enriched"	"Detected in many"	5	"amygdala: 42.4;basal ganglia: 59.5;cerebral cortex: 69.7;hippocampal formation: 63.2;white matter: 36.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"breast cancer: 3.4;Neuroblastoma: 8.7;prostate cancer: 2.5"	"Adrenal gland - Adrenal medulla cells, Breast - Breast glandular cells (progenitors), Colon - Colon enteroendocrine cells, Minor Salivary Gland - Minor salivary glandular cells, Prostate - Prostate glandular cells, Skin - Eccrine sweat gland cells, Testis - Late spermatids"	"Low region specificity"	"Detected in many"							HPA014101	Enhanced	Supported					NA	NA				"Cluster 33: Brain - Neuronal signaling"	"Cluster 51: Neurons - Mixed function"	"Cluster 17: Neuroblastoma - Neuronal signaling"	"Cluster 40: Prostatic glandular cells - Transcription"				"HPA014101: AB_1854210"		"unprognostic (5.10e-3)"	"unprognostic (4.49e-2)"			"unprognostic (3.23e-2)"	"unprognostic (9.83e-2)"	"unprognostic (1.02e-2)"		"unprognostic (4.48e-2)"														"unprognostic (1.07e-1)"		"potential prognostic unfavorable (9.82e-5)"	"unprognostic (1.81e-2)"				
CHRM2		ENSG00000181072	"Cholinergic receptor muscarinic 2"	P08172	7	136868652-137020255	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 34.9;intestine: 20.5"	"Group enriched"	"Detected in some"	7	"Cardiomyocytes: 71.7;Excitatory neurons: 47.5;Inhibitory neurons: 113.6"	"Cell type enhanced"	"Detected in all"		"midbrain-derived inhibitory: 1544.5"	"Cancer enhanced"	"Detected in single"		"Stomach Adenocarcinoma (TCGA): 1.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	5	"Neuroblastoma: 11.0"	"Heart muscle - Cardiomyocytes, Liver - Hepatic stellate cells, Testis - Early spermatids, Testis - Late spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB022338, HPA029795"	Approved		Approved	"Nucleoli,Golgi apparatus,Plasma membrane,Primary cilium,Basal body"			NA	NA				"Cluster 30: Heart muscle - Heart development"	"Cluster 49: Hindbrain - Mixed function"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 69: Neurons - Neuronal signaling"		"Plasma membrane"	"Nucleoli, Golgi apparatus, Primary cilium, Basal body"	"CAB022338: , HPA029795: AB_10601357"						"unprognostic (3.61e-1)"																	"unprognostic (5.88e-2)"			"unprognostic (6.31e-3)"		"unprognostic (1.78e-2)"			
CHRM3		ENSG00000133019	"Cholinergic receptor muscarinic 3"	P20309	1	239386565-239915452	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 17.0"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 776.4;Inhibitory neurons: 594.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Myeloma: 8.4"	"Heart muscle - Smooth muscle cells, Minor Salivary Gland - Minor salivary glandular cells, Skin - Eccrine sweat gland cells, Thyroid gland - Endothelial cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA024106, HPA048036"	Approved		Supported	"Plasma membrane"			NA	NA				"Cluster 38: Salivary gland - Salivary secretion"	"Cluster 40: Astrocytes - Astrocyte-neuron interactions"	"Cluster 56: Non-specific - Sensory perception"	"Cluster 34: Neurons - Neuronal signaling"	4	"Plasma membrane"		"HPA024106: AB_1854211, HPA048036: AB_2680238"	"unprognostic (2.47e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.81e-1)"		"unprognostic (9.58e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.46e-2)"	"unprognostic (8.47e-2)"	"unprognostic (3.94e-2)"		"validated prognostic favorable (2.76e-8)"	"validated prognostic favorable (8.41e-4)"					"unprognostic (4.06e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.99e-2)"			"unprognostic (9.97e-2)"	"unprognostic (9.67e-2)"	"unprognostic (6.00e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.29e-1)"		"unprognostic (5.62e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.16e-3)"
CHRM4		ENSG00000180720	"Cholinergic receptor muscarinic 4"	P08173	11	46383789-46391776	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 13.0;intestine: 5.9;lymphoid tissue: 14.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in single"			"Region enhanced"	"Detected in many"		"basal ganglia: 44.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Colon - Colon enteroendocrine cells, Skin - Keratinocyte (granular), Testis - Early spermatids, Testis - Late spermatids"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 22.1"	"CAB022444, HPA072083"	Enhanced		Uncertain	"Nucleoplasm,Golgi apparatus"			NA	NA				"Cluster 34: Non-specific - Mixed function"	"Cluster 33: Neurons - Mixed function"	"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 77: Plasma cells - Protein processing"	2	"Golgi apparatus"	Nucleoplasm	"CAB022444: , HPA072083: "			"unprognostic (2.48e-1)"				"unprognostic (4.43e-2)"	"unprognostic (1.10e-2)"																							
CHRM5		ENSG00000184984	"Cholinergic receptor muscarinic 5"	P08912	15	33968497-34067458	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 8.7"	"Cell type enriched"	"Detected in some"	7	"Oligodendrocytes: 166.1"	"Cell type enhanced"	"Detected in all"		"eccentric medium spiny neuron: 130.6;oligodendrocyte: 137.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in single"			"Testis - Early spermatids, Testis - Late spermatids"	"Region enhanced"	"Detected in many"		"hypothalamus: 13.2"	"Low region specificity"	"Detected in many"			HPA013172	Uncertain						NA	NA				"Cluster 9: Oligodendrocytes - Myelination"	"Cluster 26: Oligodendrocytes - Mixed function"	"Cluster 49: HMC-1 - Innate immune response"	"Cluster 51: Oligodendrocytes - Unknown function"	2			"HPA013172: AB_1854212"			"unprognostic (5.59e-3)"			"unprognostic (2.69e-2)"																				"potential prognostic favorable (2.33e-5)"					
CHRNA10		ENSG00000129749	"Cholinergic receptor nicotinic alpha 10 subunit"	Q9GZZ6	11	3665587-3671384	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	22	"skeletal muscle: 46.2"	"Cell type enhanced"	"Detected in some"		"Glandular and luminal cells: 3.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in single"				"Region enriched"	"Detected in some"	6	"olfactory bulb: 7.2"	"Not detected"	"Not detected"										NA	NA				"Cluster 2: Skeletal muscle - Striated muscle contraction"	"Cluster 15: Non-specific - Transcription"	"Cluster 70: DU4475 - Unknown function"	"Cluster 37: Glandular & Luminal cells - Unknown function"							"unprognostic (6.79e-2)"					"unprognostic (1.48e-2)"																		"unprognostic (6.88e-3)"			"unprognostic (1.63e-1)"		
CHRNA2		ENSG00000120903	"Cholinergic receptor nicotinic alpha 2 subunit"	Q15822	8	27459756-27479883	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"prostate: 28.1"	"Group enriched"	"Detected in some"	10	"Horizontal cells: 28.3;Inhibitory neurons: 14.1;Prostatic glandular cells: 21.4"	"Cell type enhanced"	"Detected in some"		"cerebellar inhibitory: 18.9;CGE interneuron: 27.8;thalamic excitatory: 26.3"	"Cancer enriched"	"Detected in single"	200	"Prostate Adenocarcinoma (TCGA): 51.0"	"Region enhanced"	"Detected in all"		"thalamus: 157.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	36	"prostate cancer: 26.6"	"Pituitary gland - Corticotropes, Prostate - Prostate glandular cells, Skin - Eccrine sweat gland cells, Spleen - Platelets"	"Low region specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"thalamus: 4.9"	HPA048348			Supported	"Nucleoplasm,Plasma membrane,Cytokinetic bridge"			Yes	NA				"Cluster 64: Neuronal - Transcription"	"Cluster 38: Sub-cortical - Mixed function"	"Cluster 60: Prostate cancer - Unknown function"	"Cluster 69: Neurons - Neuronal signaling"		"Plasma membrane"	"Nucleoplasm, Cytokinetic bridge"	"HPA048348: "						"unprognostic (2.40e-1)"																		"unprognostic (1.76e-1)"		"unprognostic (1.39e-2)"					
CHRNA3		ENSG00000080644	"Cholinergic receptor nicotinic alpha 3 subunit"	P32297	15	78593052-78621295	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"adrenal gland: 38.1;lymphoid tissue: 64.2;retina: 51.9"	"Cell type enriched"	"Detected in some"	6	"Cone photoreceptor cells: 407.8"	"Group enriched"	"Detected in some"	8	"cerebellar inhibitory: 55.5;midbrain-derived inhibitory: 49.0"	"Cancer enhanced"	"Detected in some"		"Testicular Germ Cell Tumor (TCGA): 3.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	20	"Neuroblastoma: 170.3"	"Adrenal gland - Adrenal medulla cells, Colon - Colon enteroendocrine cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA029430	Enhanced		Approved	"Nuclear speckles,Plasma membrane,Primary cilium tip,Primary cilium transition zone,Basal body,Cytosol"			NA	NA				"Cluster 16: Non-specific - Transcription"	"Cluster 38: Sub-cortical - Mixed function"	"Cluster 17: Neuroblastoma - Neuronal signaling"	"Cluster 66: Photoreceptor cells - Visual perception"	1	"Nuclear speckles, Plasma membrane"	"Primary cilium tip, Primary cilium transition zone, Basal body, Cytosol"	"HPA029430: AB_10603785"				"unprognostic (2.28e-1)"	"unprognostic (4.23e-2)"	"unprognostic (2.44e-1)"		"unprognostic (3.19e-2)"														"unprognostic (2.23e-1)"	"unprognostic (2.20e-1)"		"unprognostic (1.65e-2)"	"unprognostic (2.25e-1)"		"unprognostic (2.63e-3)"	"unprognostic (3.56e-1)"		
CHRNA4	"BFNC, EBN, EBN1"	ENSG00000101204	"Cholinergic receptor nicotinic alpha 4 subunit"	P43681	20	63343223-63378401	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 14.3;liver: 56.6;parathyroid gland: 12.3"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 24.4;Hepatocytes: 29.4;Horizontal cells: 49.7"	"Cell type enhanced"	"Detected in many"		"CGE interneuron: 31.8;thalamic excitatory: 33.8"	"Cancer enhanced"	"Detected in some"		"Liver Hepatocellular Carcinoma (TCGA): 3.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"Bone cancer: 1.0"	"Adrenal gland - Adrenal cortex cells, Kidney - Proximal tubular cells, Pituitary gland - Gonadotropes, Testis - Spermatogonia"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"midbrain: 36.5;pons: 34.3;thalamus: 57.0"	CAB034064	Uncertain						NA	NA				"Cluster 69: Liver - Oxidoreductase activity"	"Cluster 38: Sub-cortical - Mixed function"	"Cluster 12: Bone cancer - Neuronal signaling"	"Cluster 71: Horizontal & Bipolar cells - Neuronal signaling"	5			"CAB034064: AB_2080535"							"unprognostic (1.73e-1)"							"unprognostic (2.82e-1)"	"potential prognostic favorable (8.99e-5)"																
CHRNA5		ENSG00000169684	"Cholinergic receptor nicotinic alpha 5 subunit"	P30532	15	78565520-78595269	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Oocytes: 104.4;Spermatogonia: 27.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Adrenal medulla cells, Testis - Spermatocytes, Testis - Spermatogonia"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA054381	Approved		Approved	"Plasma membrane,Focal adhesion sites"			NA	NA				"Cluster 45: Intestine - Digestion"	"Cluster 38: Sub-cortical - Mixed function"	"Cluster 58: Non-specific - Nuclear processes"	"Cluster 44: Oocytes - Unknown function"	26	"Focal adhesion sites"	"Plasma membrane"	"HPA054381: AB_2682468"	"unprognostic (4.42e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.08e-3)"	"potential prognostic unfavorable (1.36e-4)"		"unprognostic (1.82e-1)"	"potential prognostic unfavorable (1.49e-6)"			"potential prognostic unfavorable (9.12e-5)"	"unprognostic (7.28e-3)"	"unprognostic (1.24e-1)"	"unprognostic (4.34e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.67e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.58e-2)"	"unprognostic (8.42e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.17e-1)"		"unprognostic (9.68e-3)"
CHRNA6		ENSG00000147434	"Cholinergic receptor nicotinic alpha 6 subunit"	Q15825	8	42752620-42796392	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"retina: 3.2"	"Cell type enriched"	"Detected in some"	5	"Horizontal cells: 14.5"	"Cell type enhanced"	"Detected in some"		"CGE interneuron: 10.7;upper rhombic lip: 13.3"	"Cancer enhanced"	"Detected in some"		"Lung Squamous Cell Carcinoma (TCGA): 2.7"	"Region enhanced"	"Detected in many"		"cerebellum: 20.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"lymphoma: 4.4"		"Group enriched"	"Detected in many"	7	"midbrain: 20.2;thalamus: 6.3"	"Region enriched"	"Detected in all"	6	"midbrain: 99.4"								NA	NA				"Cluster 76: Retina - Visual perception"	"Cluster 25: Non-specific - Transcription"	"Cluster 50: Lymphoma - Unknown function"	"Cluster 71: Horizontal & Bipolar cells - Neuronal signaling"	1						"unprognostic (3.27e-1)"					"unprognostic (4.79e-3)"										"unprognostic (1.75e-1)"									"unprognostic (7.47e-2)"				
CHRNA7		ENSG00000175344	"Cholinergic receptor nicotinic alpha 7 subunit"	P36544	15	31923438-32173018	"FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 7.5;intestine: 9.4"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 31.2;Horizontal cells: 29.0;Inhibitory neurons: 29.4;Intestinal goblet cells: 31.1;Proximal enterocytes: 27.3;Spermatogonia: 16.2"	"Cell type enhanced"	"Detected in many"		"CGE interneuron: 144.7;mammillary body: 168.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	7	"Neuroblastoma: 16.8"	"Adrenal gland - Adrenal medulla cells, Colon - Colon enteroendocrine cells, Pituitary gland - Thyrotropes"									"HPA029422, CAB033624"	Enhanced						NA	NA				"Cluster 55: Kidney & Intestine - Metabolism"	"Cluster 41: Monoamines - Neurotransmitter signalling"	"Cluster 17: Neuroblastoma - Neuronal signaling"	"Cluster 69: Neurons - Neuronal signaling"	9			"CAB033624: AB_784835, HPA029422: AB_10600863"			"unprognostic (5.56e-2)"		"unprognostic (2.72e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.92e-1)"										"unprognostic (9.08e-2)"	"unprognostic (6.56e-2)"			"unprognostic (1.83e-1)"	"unprognostic (1.41e-3)"			"unprognostic (1.97e-1)"		"unprognostic (1.31e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.26e-3)"	
CHRNA9	NACHRA9	ENSG00000174343	"Cholinergic receptor nicotinic alpha 9 subunit"	Q9UGM1	4	40335333-40355217	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"Breast Invasive Carcinoma (TCGA): 4.6;Glioblastoma Multiforme (TCGA): 6.2;Lung Adenocarcinoma (TCGA): 2.4"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	6	"Rhabdoid: 16.0"	"Lung - Respiratory ciliated cells"	"Region enriched"	"Detected in single"	6	"basal ganglia: 1.0"	"Low region specificity"	"Detected in some"										NA	NA					"Cluster 43: Hindbrain - Mixed function"	"Cluster 5: Rhabdoid - Unknown function"	"Cluster 50: Connective tissue cells - ECM organization"						"unprognostic (3.85e-2)"					"unprognostic (3.28e-1)"	"unprognostic (8.02e-2)"								"unprognostic (1.03e-1)"	"unprognostic (3.80e-1)"														
CHRNB2		ENSG00000160716	"Cholinergic receptor nicotinic beta 2 subunit"	P17787	1	154567778-154580013	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 14.3;pituitary gland: 3.5;retina: 8.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 11.0;Cone photoreceptor cells: 17.0;Excitatory neurons: 5.6;Horizontal cells: 21.4;Inhibitory neurons: 7.4;Late spermatids: 11.2;Rod photoreceptor cells: 5.7"	"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in some"		"Glioblastoma Multiforme (TCGA): 3.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Neuroblastoma: 18.9"	"Adrenal gland - Adrenal medulla cells, Colon - Colon enteroendocrine cells, Pancreas - Alpha cells, Pancreas - Beta cells, Pituitary gland - Corticotropes, Testis - Early spermatids, Testis - Late spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"										NA	NA				"Cluster 17: Neuronal - Synaptic function"	"Cluster 38: Sub-cortical - Mixed function"	"Cluster 17: Neuroblastoma - Neuronal signaling"	"Cluster 71: Horizontal & Bipolar cells - Neuronal signaling"	2					"unprognostic (1.98e-1)"	"unprognostic (3.23e-1)"				"unprognostic (5.52e-3)"	"unprognostic (8.35e-3)"																			"unprognostic (1.77e-1)"				
CHRNB3		ENSG00000147432	"Cholinergic receptor nicotinic beta 3 subunit"	Q05901	8	42697366-42737407	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	7	"brain: 2.7;pancreas: 1.8;retina: 3.7;testis: 1.2"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 2.1;Horizontal cells: 6.9;Inhibitory neurons: 2.8"	"Cell type enhanced"	"Detected in many"		"mammillary body: 27.8;upper rhombic lip: 32.9"	"Cancer enriched"	"Detected in single"	4	"Testicular Germ Cell Tumor (TCGA): 1.3"	"Group enriched"	"Detected in many"	4	"cerebellum: 25.9;midbrain: 22.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	8	"Rhabdoid: 2.2"	"Testis - Early spermatids"	"Region enhanced"	"Detected in many"		"midbrain: 6.9"	"Low region specificity"	"Detected in all"			HPA045555	Enhanced						NA	NA				"Cluster 39: Retina & Testis - Cilium"	"Cluster 2: Neurons - Nucleosome"	"Cluster 5: Rhabdoid - Unknown function"	"Cluster 69: Neurons - Neuronal signaling"	3			"HPA045555: AB_10960891"																													"unprognostic (1.23e-1)"		
CHRNB4		ENSG00000117971	"Cholinergic receptor nicotinic beta 4 subunit"	P30926	15	78624111-78727754	"FDA approved drug targets, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 2.4;lymphoid tissue: 2.9;retina: 2.7;testis: 5.6"	"Group enriched"	"Detected in some"	18	"Early spermatids: 37.6;Late spermatids: 55.8;Oocytes: 56.6"	"Low cell type specificity"	"Detected in some"			"Cancer enhanced"	"Detected in some"		"Testicular Germ Cell Tumor (TCGA): 6.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	35	"Neuroblastoma: 34.5"	"Colon - Colon enteroendocrine cells, Testis - Early spermatids, Testis - Late spermatids"	"Group enriched"	"Detected in some"	5	"olfactory bulb: 5.3;pons and medulla: 1.4;thalamus: 4.2"					HPA059484			Approved	"Endoplasmic reticulum,Cell Junctions"			NA	NA				"Cluster 16: Non-specific - Transcription"	"Cluster 46: Brainstem - Mixed function"	"Cluster 17: Neuroblastoma - Neuronal signaling"	"Cluster 11: Late spermatids - Unknown function"		"Endoplasmic reticulum"	"Cell Junctions"	"HPA059484: "				"unprognostic (1.45e-1)"					"unprognostic (2.40e-2)"									"unprognostic (2.24e-1)"	"unprognostic (2.03e-2)"										"unprognostic (1.67e-1)"		
CKB	CKBB	ENSG00000166165	"Creatine kinase B"	P12277	14	103519667-103522833	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 895.8"	"Cell type enhanced"	"Detected in all"		"Bipolar cells: 3270.0;Cone photoreceptor cells: 8116.8;Distal enterocytes: 9303.1;Horizontal cells: 2867.2;Muller glia cells: 3489.2;Paneth cells: 4833.1;Rod photoreceptor cells: 3285.9"	"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"Kidney Chromophobe (TCGA): 1264.0"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	10	"non-classical monocyte: 292.6"	"Lineage enriched"	"Detected in many"	18	"monocytes: 292.6"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 769.0"	"Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Heart muscle - Cardiomyocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001254, CAB047313"	Enhanced		Supported	Cytosol			No	No		23000000	"Cluster 37: Monocytes & Neutrophils - Innate immune response"	"Cluster 80: Non-specific - Endocytosis"	"Cluster 40: Astrocytes - Astrocyte-neuron interactions"	"Cluster 60: Prostate cancer - Unknown function"	"Cluster 5: Enterocytes - Absorption"	31	Cytosol		"CAB047313: , HPA001254: AB_1078528"	"unprognostic (5.35e-2)"	"unprognostic (4.14e-2)"	"unprognostic (3.77e-1)"	"unprognostic (4.27e-3)"	"unprognostic (3.61e-2)"	"potential prognostic favorable (7.02e-5)"	"unprognostic (9.28e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.83e-3)"	"unprognostic (2.72e-1)"	"potential prognostic favorable (1.36e-6)"	"unprognostic (8.86e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.62e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.82e-2)"	"unprognostic (3.69e-2)"	"unprognostic (2.11e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.45e-3)"	"unprognostic (1.25e-1)"
CKM	CKMM	ENSG00000104879	"Creatine kinase, M-type"	P06732	19	45306413-45322875	"Candidate cardiovascular disease genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"skeletal muscle: 70959.0;tongue: 25037.6"	"Group enriched"	"Detected in some"	114	"Cardiomyocytes: 3990.9;Skeletal myocytes: 7932.3"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	5	"Head and Neck Squamous Cell Carcinoma (TCGA): 103.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Sarcoma: 5.6"	"Heart muscle - Cardiomyocytes"	"Region enriched"	"Detected in single"	15	"olfactory bulb: 1.5"	"Not detected"	"Not detected"			HPA047859	Enhanced						NA	NA		110000000		"Cluster 2: Skeletal muscle - Striated muscle contraction"	"Cluster 37: Neurons - Mixed function"	"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 68: Cardiomyocytes - Muscle contraction"	21			"HPA047859: AB_2680186"	"unprognostic (1.43e-1)"	"unprognostic (1.94e-1)"							"unprognostic (4.28e-3)"							"unprognostic (1.44e-1)"								"unprognostic (1.29e-3)"					"unprognostic (8.16e-2)"	"unprognostic (3.46e-1)"	
CKMT1A	CKMT1	ENSG00000223572	"Creatine kinase, mitochondrial 1A"	P12532	15	43692886-43699222	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 64.7;esophagus: 81.5;intestine: 72.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 66.6;Distal enterocytes: 151.6;Enteroendocrine cells: 75.9;Paneth cells: 63.3;Proximal enterocytes: 79.8;Syncytiotrophoblasts: 77.2;Undifferentiated cells: 81.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Colon - Colon enterocytes, Minor Salivary Gland - Minor salivary gland basal cells, Stomach - Gastric mucous cells"									HPA043491	Uncertain				"Intracellular and membrane"	Enzyme	NA	NA		1400000		"Cluster 80: Non-specific - Endocytosis"	"Cluster 52: Neurons & Synapses - Synaptic function"	"Cluster 57: Stomach & Colon cancer - Digestion"	"Cluster 5: Enterocytes - Absorption"	18			"HPA043491: AB_2678510"	"unprognostic (5.60e-2)"	"unprognostic (5.99e-3)"	"unprognostic (2.81e-1)"	"potential prognostic favorable (2.97e-4)"	"unprognostic (6.22e-2)"	"unprognostic (6.49e-3)"	"unprognostic (2.47e-1)"	"unprognostic (4.11e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.21e-2)"	"potential prognostic favorable (1.01e-4)"	"unprognostic (2.20e-1)"	"potential prognostic unfavorable (8.42e-4)"	"unprognostic (5.39e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.91e-2)"	"unprognostic (3.24e-2)"	"unprognostic (6.42e-2)"	"unprognostic (2.84e-1)"	"unprognostic (6.87e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.84e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.23e-3)"
CKMT1B	"CKMT, CKMT1, UMTCK"	ENSG00000237289	"Creatine kinase, mitochondrial 1B"	P12532	15	43593054-43604901	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 97.7;esophagus: 72.2;intestine: 78.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 109.4;Distal enterocytes: 198.6;Enteroendocrine cells: 79.9;Intestinal goblet cells: 75.9;Paneth cells: 69.9;Proximal enterocytes: 122.2;Syncytiotrophoblasts: 107.6;Undifferentiated cells: 93.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Colon - Colon enterocytes, Minor Salivary Gland - Minor salivary gland basal cells, Stomach - Gastric mucous cells"									HPA043491	Uncertain				"Intracellular and membrane"	Enzyme	NA	NA		1400000		"Cluster 80: Non-specific - Endocytosis"	"Cluster 52: Neurons & Synapses - Synaptic function"	"Cluster 57: Stomach & Colon cancer - Digestion"	"Cluster 5: Enterocytes - Absorption"	13			"HPA043491: AB_2678510"	"unprognostic (1.50e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.27e-3)"	"potential prognostic favorable (6.90e-5)"	"unprognostic (1.23e-1)"	"unprognostic (2.20e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.83e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.60e-1)"	"unprognostic (7.41e-2)"	"unprognostic (2.12e-3)"	"unprognostic (9.25e-2)"		"unprognostic (3.47e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.19e-2)"	"unprognostic (6.88e-2)"	"unprognostic (4.52e-1)"	"unprognostic (7.22e-2)"	"unprognostic (5.31e-3)"	"unprognostic (4.06e-1)"	"unprognostic (5.32e-2)"	"unprognostic (7.58e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.23e-1)"	"potential prognostic unfavorable (4.45e-4)"
CKMT2	SMTCK	ENSG00000131730	"Creatine kinase, mitochondrial 2"	P17540	5	81233320-81266398	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	28	"heart muscle: 1199.7;skeletal muscle: 1381.6;tongue: 2229.5"	"Cell type enriched"	"Detected in many"	7	"Cardiomyocytes: 994.6"	"Cell type enhanced"	"Detected in all"		"choroid plexus epithelial cell: 117.5"	"Cancer enriched"	"Detected in many"	10	"Kidney Chromophobe (TCGA): 156.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	7	"NK-cell: 1.1"	"Lineage enriched"	"Detected in single"	7	"NK-cells: 1.1"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 7.1;thyroid cancer: 7.2"	"Adipose subcutaneous - Smooth muscle cells, Heart muscle - Cardiomyocytes, Kidney - Intercalated cells, Pituitary gland - Gonadotropes, Prostate - Smooth muscle cells, Skin - Eccrine sweat gland cells, Stomach - Parietal cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA051880	Enhanced						NA	NA		1600000		"Cluster 12: Heart muscle - Cardiac muscle contraction"	"Cluster 47: Endothelial cells - Vasculature"	"Cluster 57: Stomach & Colon cancer - Digestion"	"Cluster 68: Cardiomyocytes - Muscle contraction"	31			"HPA051880: AB_2681650"	"unprognostic (9.52e-2)"	"unprognostic (2.35e-3)"	"unprognostic (1.55e-2)"		"unprognostic (7.84e-2)"	"unprognostic (2.02e-2)"	"potential prognostic unfavorable (2.88e-4)"	"unprognostic (2.44e-3)"	"unprognostic (1.57e-2)"	"potential prognostic unfavorable (2.46e-6)"	"unprognostic (5.41e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.23e-2)"	"potential prognostic favorable (5.04e-4)"	"unprognostic (3.93e-1)"		"unprognostic (5.05e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.40e-2)"	"unprognostic (3.69e-2)"	"unprognostic (7.46e-3)"	"unprognostic (2.39e-3)"	"unprognostic (9.31e-2)"	"unprognostic (1.15e-1)"		"unprognostic (1.13e-1)"	"unprognostic (1.22e-1)"
CLCN2	"ClC-2, CLC2, EJM6"	ENSG00000114859	"Chloride voltage-gated channel 2"	P51788	3	184346185-184361650	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 15.7"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 17.2;Distal enterocytes: 76.3;Proximal enterocytes: 29.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Testis - Sertoli cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009397, HPA014545, HPA024108"	Approved		Approved	Cytosol			NA	NA				"Cluster 45: Intestine - Digestion"	"Cluster 13: Oligodendrocytes - Mixed function"	"Cluster 57: Stomach & Colon cancer - Digestion"	"Cluster 5: Enterocytes - Absorption"		Cytosol		"CAB009397: AB_2079256, HPA014545: AB_1846881, HPA024108: AB_1846883"	"unprognostic (2.43e-1)"	"unprognostic (9.91e-2)"	"unprognostic (3.38e-3)"	"unprognostic (2.99e-1)"	"unprognostic (3.71e-1)"	"unprognostic (8.19e-2)"	"unprognostic (9.94e-2)"	"unprognostic (2.97e-3)"	"unprognostic (2.25e-3)"	"unprognostic (1.14e-1)"	"potential prognostic favorable (4.90e-5)"	"unprognostic (1.10e-1)"	"unprognostic (3.12e-1)"	"potential prognostic unfavorable (4.21e-4)"	"unprognostic (3.13e-3)"	"unprognostic (2.84e-2)"	"unprognostic (1.39e-2)"	"unprognostic (7.37e-3)"	"potential prognostic favorable (2.39e-6)"	"unprognostic (4.93e-1)"	"unprognostic (5.71e-3)"	"unprognostic (4.31e-3)"	"unprognostic (3.09e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.59e-1)"	"unprognostic (5.61e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.44e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.73e-2)"
CNR1	"CANN6, CB-R, CB1, CB1A, CB1K5, CNR"	ENSG00000118432	"Cannabinoid receptor 1"	P21554	6	88139864-88166347	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets, Neurodegeneration, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 22.3;pituitary gland: 20.1"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 22.0;Excitatory neurons: 43.1;Inhibitory neurons: 192.1;Sertoli cells: 49.0;Smooth muscle cells: 22.1"	"Cell type enhanced"	"Detected in many"		"cerebellar inhibitory: 394.9;CGE interneuron: 892.7"	"Cancer enriched"	"Detected in many"	9	"Glioblastoma Multiforme (TCGA): 26.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"Brain cancer: 9.9;lymphoma: 15.1;thyroid cancer: 4.0"	"Pituitary gland - Corticotropes, Testis - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042256, HPA069945"	Enhanced	Supported	Supported	"Plasma membrane,Actin filaments"			NA	NA				"Cluster 66: Non-specific - Transcription"	"Cluster 51: Neurons - Mixed function"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 69: Neurons - Neuronal signaling"	3	"Plasma membrane"	"Actin filaments"	"HPA042256: AB_2677917, HPA069945: "		"unprognostic (8.60e-2)"	"unprognostic (1.58e-1)"			"unprognostic (1.22e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.77e-1)"		"unprognostic (2.45e-1)"		"unprognostic (3.48e-2)"	"unprognostic (1.33e-1)"			"unprognostic (1.07e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.12e-2)"			"unprognostic (1.70e-1)"	"unprognostic (9.62e-2)"			"unprognostic (1.06e-1)"	"unprognostic (2.89e-1)"	"unprognostic (4.13e-3)"	"unprognostic (3.13e-3)"		
CNR2	CB2	ENSG00000188822	"Cannabinoid receptor 2"	P34972	1	23870515-23913362	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Inflammatory response"	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 3.3;lymphoid tissue: 8.6"	"Cell type enriched"	"Detected in some"	4	"B-cells: 35.2"	"Cell type enriched"	"Detected in some"	8	"leukocyte: 8.8"	"Cancer enriched"	"Detected in single"	5	"Testicular Germ Cell Tumor (TCGA): 4.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"basophil: 49.2;eosinophil: 35.1;memory B-cell: 29.6;naive B-cell: 27.9;NK-cell: 19.4"	"Group enriched"	"Detected in many"	9	"B-cells: 29.6;granulocytes: 49.2;NK-cells: 19.4"	"Group enriched"	"Detected in some"	14	"Leukemia: 3.1;lymphoma: 6.3"	"Lung - B-cells (Lung), Spleen - B-cells (Spleen)"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB009719	Uncertain						NA	NA			"Cluster 22: Eosinophils - Transcription"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 48: Non-specific - Mixed function"	"Cluster 55: Lymphoma - Immune response"	"Cluster 73: B-cells - B-cell function"	24			"CAB009719: AB_2082784"			"potential prognostic favorable (1.39e-4)"			"unprognostic (1.33e-1)"																	"unprognostic (1.35e-2)"			"unprognostic (5.54e-3)"			"unprognostic (2.37e-1)"		
COL1A1	OI4	ENSG00000108821	"Collagen type I alpha 1 chain"	P02452	17	50184101-50201632	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Disease variant, Dwarfism, Ehlers-Danlos syndrome, FDA approved drug targets, Osteogenesis imperfecta, Osteoporosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 1284.0;gallbladder: 1170.7;ovary: 1172.9"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 1832.0;Fibroblasts: 1713.3;Leydig cells: 547.1;Ovarian stromal cells: 435.9;Pancreatic endocrine cells: 1558.7;Smooth muscle cells: 617.8"	"Group enriched"	"Detected in some"	6	"fibroblast: 118.6;vascular associated smooth muscle cell: 32.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in all"		"Brain cancer: 1387.0"	"Adipose subcutaneous - Adipose progenitor cells, Adipose visceral - Adipose progenitor cells, Breast - Fibroblasts, Heart muscle - Fibroblasts, Kidney - Fibroblasts, Lung - Fibroblast_2, Pituitary gland - Corticotropes, Skeletal muscle - Fibroblasts, Skin - Fibroblast_1, Spleen - Fibroblast_1, Stomach - Fibroblasts, Thyroid gland - Fibroblasts"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 170.5"	"HPA011795, HPA012111"	Approved		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"	"No annotated function"	NA	NA		89000000		"Cluster 62: Connective tissue - ECM organization"	"Cluster 12: Non-specific - Vasculature"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 50: Connective tissue cells - ECM organization"	44	"Endoplasmic reticulum"	Vesicles	"HPA011795: AB_1847088, HPA012111: "	"unprognostic (1.71e-2)"	"unprognostic (3.02e-1)"	"unprognostic (9.50e-2)"	"unprognostic (5.85e-3)"	"unprognostic (2.11e-2)"	"unprognostic (2.74e-1)"	"unprognostic (6.08e-2)"	"unprognostic (9.19e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.00e-1)"	"potential prognostic unfavorable (8.35e-7)"	"unprognostic (4.68e-2)"	"unprognostic (1.75e-1)"	"potential prognostic unfavorable (9.95e-4)"	"unprognostic (3.45e-2)"	"unprognostic (6.12e-2)"	"unprognostic (3.04e-1)"	"unprognostic (4.06e-3)"	"unprognostic (3.29e-2)"	"unprognostic (4.66e-2)"	"unprognostic (9.19e-2)"	"unprognostic (9.67e-2)"	"unprognostic (4.08e-2)"	"unprognostic (7.63e-3)"	"unprognostic (3.39e-2)"	"unprognostic (9.07e-3)"	"unprognostic (6.56e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.00e-1)"
COL2A1	"AOM, SEDC, STL1"	ENSG00000139219	"Collagen type II alpha 1 chain"	P02458	12	47972967-48004554	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted secreted proteins"			"Cancer-related genes, Cataract, Deafness, Disease variant, Dwarfism, FDA approved drug targets, Stickler syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"epididymis: 18.6;pituitary gland: 8.9;retina: 5.4;stomach 1: 12.2"	"Cell type enhanced"	"Detected in some"		"Breast myoepithelial cells: 6.6;Early spermatids: 11.0;Enteroendocrine cells: 27.4;Granulosa cells: 9.7;Horizontal cells: 24.5;Late spermatids: 11.5;Muller glia cells: 21.3"	"Cell type enhanced"	"Detected in some"		"fibroblast: 2.8;hippocampal dentate gyrus: 5.7"	"Group enriched"	"Detected in many"	4	"Breast Invasive Carcinoma (TCGA): 22.3;Prostate Adenocarcinoma (TCGA): 19.7;Skin Cuteneous Melanoma (TCGA): 14.8;Testicular Germ Cell Tumor (TCGA): 22.7;Uterine Corpus Endometrial Carcinoma (TCGA): 8.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	7	"liver cancer: 78.5"	"Pituitary gland - Gonadotropes, Testis - Late spermatids"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB002214, HPA055753"	Approved		Approved	Nucleoplasm	"Secreted to extracellular matrix"	"No annotated function"	No	NA		3200000		"Cluster 50: Epididymis - Male reproductive secretion"		"Cluster 34: Testis cancer - Unknown function"	"Cluster 20: Enteroendocrine cells - Hormone signaling"	3	Nucleoplasm		"CAB002214: AB_563666, HPA055753: AB_2682908"	"unprognostic (6.77e-3)"	"unprognostic (2.16e-1)"	"unprognostic (5.49e-2)"	"unprognostic (7.27e-2)"			"unprognostic (2.63e-2)"	"unprognostic (1.11e-1)"						"unprognostic (5.52e-2)"	"unprognostic (7.13e-2)"	"unprognostic (1.04e-1)"		"unprognostic (6.95e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.07e-1)"			"unprognostic (1.93e-1)"		"unprognostic (2.54e-2)"	"unprognostic (1.91e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.81e-1)"		"unprognostic (1.31e-1)"
COL3A1	EDS4A	ENSG00000168542	"Collagen type III alpha 1 chain"	P02461	2	188974373-189012746	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Aortic aneurysm, Disease variant, Ehlers-Danlos syndrome, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 2284.1;gallbladder: 2022.4;placenta: 1914.8;smooth muscle: 2059.5"	"Group enriched"	"Detected in many"	4	"Endometrial stromal cells: 2579.5;Fibroblasts: 1454.9;Smooth muscle cells: 696.2"	"Cell type enhanced"	"Detected in some"		"fibroblast: 216.1;vascular associated smooth muscle cell: 78.5"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"cerebral cortex: 21.6;choroid plexus: 22.8;thalamus: 22.8;white matter: 8.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Rhabdoid: 1300.8;Sarcoma: 607.6;testis cancer: 879.7"	"Adipose subcutaneous - Adipose progenitor cells, Adipose visceral - Adipose progenitor cells, Kidney - Fibroblasts, Liver - Hepatic stellate cells, Minor Salivary Gland - Fibroblasts, Skeletal muscle - Fibroblasts, Skin - Fibroblast_1, Spleen - Fibroblast_1"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 74.6"	"HPA007583, CAB016766, CAB059993"	Approved		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	"No annotated function"	NA	NA		28000000		"Cluster 62: Connective tissue - ECM organization"	"Cluster 12: Non-specific - Vasculature"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 50: Connective tissue cells - ECM organization"	1	"Endoplasmic reticulum"		"CAB016766: , CAB059993: AB_2314211, HPA007583: AB_1078548"	"unprognostic (5.65e-3)"	"unprognostic (2.00e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.18e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.77e-1)"	"unprognostic (3.32e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.85e-3)"	"unprognostic (2.37e-1)"	"unprognostic (4.75e-3)"	"potential prognostic unfavorable (1.93e-8)"	"unprognostic (5.86e-2)"	"unprognostic (2.07e-1)"	"unprognostic (5.82e-2)"	"unprognostic (8.53e-3)"	"unprognostic (4.80e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.43e-3)"	"potential prognostic unfavorable (8.45e-4)"	"unprognostic (3.54e-2)"	"unprognostic (4.40e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.48e-2)"	"unprognostic (4.48e-3)"	"unprognostic (3.44e-3)"	"unprognostic (1.33e-3)"	"unprognostic (4.31e-2)"	"unprognostic (7.46e-2)"	"unprognostic (4.51e-2)"
COMT		ENSG00000093010	Catechol-O-methyltransferase	P21964	22	19941371-19969975	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Catecholamine metabolism, Lipid metabolism, Neurotransmitter degradation"	"Methyltransferase, Transferase"	"FDA approved drug targets, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 896.4;Syncytiotrophoblasts: 630.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adipose visceral - Adipose progenitor cells, Adrenal gland - Adrenal cortex cells, Kidney - Fibroblasts, Spleen - Macrophages"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001169, CAB011233"	Enhanced		Enhanced	"Endoplasmic reticulum,Vesicles"			NA	NA		17000	"Cluster 2: Dendritic cells - Unknown function"	"Cluster 43: Non-specific - Mitochondrial translation"	"Cluster 39: Astrocytes - Mixed function"	"Cluster 66: Non-specific - Mitochondria"	"Cluster 24: Cytotrophoblasts - Mitochondria"	60	Vesicles	"Endoplasmic reticulum"	"CAB011233: , HPA001169: AB_1078402"	"unprognostic (2.62e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.81e-2)"	"unprognostic (9.85e-2)"	"unprognostic (3.77e-2)"	"unprognostic (8.65e-3)"	"unprognostic (8.37e-2)"	"unprognostic (3.21e-2)"	"unprognostic (8.07e-2)"	"unprognostic (8.59e-2)"	"unprognostic (7.46e-2)"	"unprognostic (3.92e-2)"	"unprognostic (7.29e-3)"	"unprognostic (2.52e-1)"	"unprognostic (3.53e-1)"	"unprognostic (4.07e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.77e-2)"	"unprognostic (7.39e-3)"	"unprognostic (9.19e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.83e-2)"	"unprognostic (5.78e-2)"	"unprognostic (9.93e-3)"	"unprognostic (9.36e-2)"	"unprognostic (1.59e-1)"
CPB2	"CPU, PCPB, TAFI"	ENSG00000080618	"Carboxypeptidase B2"	Q96IY4	13	46053186-46105033	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis"	"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	84	"liver: 1439.0"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 1226.7"	"Cell type enhanced"	"Detected in many"		"oligodendrocyte: 87.4"	"Cancer enriched"	"Detected in some"	57	"Liver Hepatocellular Carcinoma (TCGA): 350.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	6	"liver cancer: 11.2"	"Liver - Hepatocytes, Lung - Alveolar cells type 2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA004146	Approved				"Secreted to blood"	"Blood coagulation"	NA	NA		6100000000		"Cluster 31: Liver - Plasma proteins"	"Cluster 28: Oligodendrocytes - Mixed function"	"Cluster 18: Liver cancer - Metabolism"	"Cluster 43: Hepatocytes - Metabolism"				"HPA004146: AB_1078397"						"unprognostic (1.22e-1)"								"potential prognostic favorable (2.55e-4)"	"unprognostic (2.42e-3)"	"unprognostic (1.94e-2)"	"unprognostic (7.95e-2)"		"unprognostic (3.87e-1)"				"unprognostic (5.07e-3)"			"unprognostic (6.85e-2)"					
CPS1	GATD6	ENSG00000021826	"Carbamoyl-phosphate synthase 1"	P31327	2	210477682-210679107	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Urea cycle"	"Allosteric enzyme, Ligase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 1031.6"	"Cell type enriched"	"Detected in many"	17	"Hepatocytes: 1760.9"	"Cell type enhanced"	"Detected in many"		"oligodendrocyte: 45.8"	"Group enriched"	"Detected in many"	16	"Liver Hepatocellular Carcinoma (TCGA): 133.0;Lung Adenocarcinoma (TCGA): 39.0;Stomach Adenocarcinoma (TCGA): 34.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"cervical cancer: 121.4"	"Testis - Early spermatids, Testis - Late spermatids"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB003781, HPA021400"	Enhanced		Supported	"Nucleoli,Nucleoli rim,Mid piece,Principal piece"			NA	NA		8200000		"Cluster 83: Liver - Metabolism"	"Cluster 30: White matter - Myelination"	"Cluster 7: Liver cancer - Metabolism"	"Cluster 43: Hepatocytes - Metabolism"	4	"Nucleoli, Nucleoli rim"	"Mid piece, Principal piece"	"CAB003781: , HPA021400: AB_1847197"		"unprognostic (3.14e-1)"	"unprognostic (9.84e-2)"	"unprognostic (7.99e-2)"	"unprognostic (5.27e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.14e-1)"		"unprognostic (1.81e-1)"	"unprognostic (6.22e-2)"	"unprognostic (8.44e-3)"	"potential prognostic unfavorable (6.37e-5)"	"validated prognostic favorable (1.61e-4)"	"validated prognostic favorable (5.38e-5)"	"unprognostic (4.62e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.00e-1)"		"unprognostic (6.87e-3)"	"unprognostic (3.20e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.70e-3)"	"unprognostic (1.44e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.39e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.16e-1)"		"unprognostic (1.28e-2)"
CPT1A	"CPT1, CPT1-L, L-CPT1"	ENSG00000110090	"Carnitine palmitoyltransferase 1A"	P50416	11	68754620-68844410	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Transport"	"Acyltransferase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 119.3"	"Cell type enhanced"	"Detected in many"		"endothelial cell: 107.2;fibroblast: 115.9;pericyte: 122.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Adrenal cortex cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008835	Supported		Supported	Mitochondria			NA	NA		17000	"Cluster 41: Basophils - Unknown function"	"Cluster 37: Liver & Intestine - Lipid metabolism"	"Cluster 42: Choroid plexus - Mitochondria"	"Cluster 7: Liver cancer - Metabolism"	"Cluster 16: Intestinal goblet cells - Mucin production"	10	Mitochondria		"HPA008835: AB_1078563"	"unprognostic (2.08e-2)"	"potential prognostic unfavorable (7.37e-5)"	"unprognostic (2.26e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.56e-1)"	"validated prognostic favorable (6.86e-8)"	"validated prognostic favorable (3.74e-4)"	"unprognostic (6.29e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.40e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.11e-1)"	"unprognostic (7.09e-2)"	"unprognostic (3.83e-1)"	"unprognostic (1.33e-3)"	"unprognostic (9.86e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.74e-2)"	"unprognostic (9.03e-2)"	"unprognostic (4.41e-1)"	"unprognostic (3.67e-1)"	"unprognostic (3.02e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.89e-1)"
CPT2	"CPT1, CPTASE"	ENSG00000157184	"Carnitine palmitoyltransferase 2"	P23786	1	53196792-53214197	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Transport"	"Acyltransferase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 88.3"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 83.9;Hepatocytes: 86.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Adrenal gland - Adrenal cortex cells, Heart muscle - Cardiomyocytes, Liver - Hepatocytes, Spleen - Macrophages"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028201, HPA028202, HPA028214"	Enhanced		Approved	Nucleoplasm,Nucleoli,Mitochondria			Yes	No			"Cluster 25: Non-specific - Unknown function"	"Cluster 37: Liver & Intestine - Lipid metabolism"	"Cluster 8: Immune cells - Immune response"	"Cluster 37: Non-specific - mRNA processing"	"Cluster 24: Cytotrophoblasts - Mitochondria"	10	"Nucleoplasm, Mitochondria"	Nucleoli	"HPA028201: AB_10599177, HPA028202: AB_10599942, HPA028214: AB_10601958"	"unprognostic (2.00e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.34e-1)"	"potential prognostic favorable (9.04e-6)"	"unprognostic (1.58e-1)"	"unprognostic (4.97e-1)"	"unprognostic (7.57e-2)"	"unprognostic (2.20e-1)"	"potential prognostic unfavorable (1.28e-4)"	"potential prognostic favorable (8.96e-12)"	"unprognostic (2.09e-3)"	"unprognostic (1.66e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.19e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.23e-1)"	"unprognostic (9.06e-2)"	"unprognostic (7.54e-2)"	"unprognostic (1.71e-3)"	"unprognostic (3.32e-1)"	"unprognostic (8.32e-2)"	"unprognostic (4.42e-2)"	"unprognostic (8.84e-2)"	"unprognostic (5.01e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.41e-2)"
CRBN	"MRT2, MRT2A"	ENSG00000113851	Cereblon	Q96SW2	3	3144628-3179727	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Transporters"	"Ubl conjugation pathway"		"Disease variant, FDA approved drug targets, Intellectual disability"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oocytes: 339.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 309.4"	"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Adrenal cortex cells, Spleen - Endothelial cells, Testis - Early spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045910	Approved						NA	NA			"Cluster 42: Non-specific - Vesicular transport"	"Cluster 4: Testis - Basic cellular processes"	"Cluster 28: Oligodendrocytes - Mixed function"	"Cluster 8: Non-specific - Basic cellular processes"	"Cluster 70: Spermatocytes & Spermatids - Spermatid development"	55			"HPA045910: AB_10960409"	"unprognostic (1.75e-2)"	"unprognostic (5.90e-2)"	"unprognostic (2.59e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.75e-2)"	"unprognostic (7.53e-2)"	"unprognostic (2.46e-1)"	"unprognostic (8.96e-3)"	"validated prognostic favorable (1.75e-7)"	"validated prognostic favorable (1.06e-4)"	"unprognostic (1.57e-2)"	"unprognostic (1.53e-1)"	"unprognostic (9.76e-3)"	"unprognostic (1.05e-3)"	"unprognostic (9.74e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.16e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.41e-1)"	"potential prognostic favorable (1.04e-5)"	"unprognostic (2.82e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.06e-1)"
CRHR1	"CRF-R, CRF1, CRHR"	ENSG00000120088	"Corticotropin releasing hormone receptor 1"	P34998	17	45784277-45835828	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"brain: 19.5;pituitary gland: 19.8"	"Cell type enriched"	"Detected in single"	10	"Bipolar cells: 1.6"	"Cell type enhanced"	"Detected in many"		"upper rhombic lip: 60.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Pituitary gland - Corticotropes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB025251	Enhanced						NA	NA				"Cluster 65: Cerebellum - Nervous system development"	"Cluster 15: Non-specific - Transcription"	"Cluster 1: Neuronal - Visual perception"	"Cluster 25: Bipolar cells - Visual perception"	6			"CAB025251: "			"unprognostic (7.33e-2)"					"unprognostic (2.49e-1)"							"unprognostic (3.10e-2)"																
CSF1R	"C-FMS, CD115, CSFR, FMS"	ENSG00000182578	"Colony stimulating factor 1 receptor"	P07333	5	150053291-150113372	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Neurodegeneration, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 110.4;placenta: 99.9"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 115.8;Hofbauer cells: 327.3;Kupffer cells: 256.3;Langerhans cells: 98.3;Macrophages: 218.3;Microglial cells: 128.8;monocytes: 218.3"	"Cell type enriched"	"Detected in many"	17	"central nervous system macrophage: 840.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 444.5;non-classical monocyte: 650.1"	"Lineage enriched"	"Detected in many"	5	"monocytes: 650.1"	"Cancer enhanced"	"Detected in many"		"Leukemia: 13.3"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Colon - Macrophages, Kidney - Macrophages, Liver - Kupffer cells, Lung - Macrophages, Minor Salivary Gland - Macrophages, Pancreas - Macrophages, Prostate - Macrophages, Skeletal muscle - Macrophages, Skin - Langerhans cells, Spleen - Macrophages, Stomach - Macrophages, Testis - Macrophages, Thyroid gland - Macrophages"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008970, HPA012323"	Approved		Supported	"Vesicles,Plasma membrane"	"Intracellular and membrane"	Receptor	NA	NA		960000000	"Cluster 40: Monocytes - Innate immune response"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 58: Macrophages - Innate immune response"	19	"Vesicles, Plasma membrane"		"CAB008970: , HPA012323: AB_1848977"	"unprognostic (1.28e-1)"	"unprognostic (6.19e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.78e-2)"	"unprognostic (1.01e-1)"	"unprognostic (8.10e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.41e-2)"	"unprognostic (9.98e-2)"	"unprognostic (6.89e-2)"	"unprognostic (5.10e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.73e-3)"	"unprognostic (1.93e-2)"	"unprognostic (3.91e-2)"	"unprognostic (7.55e-2)"	"unprognostic (2.76e-2)"	"unprognostic (9.96e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.01e-2)"	"unprognostic (9.85e-2)"	"unprognostic (3.02e-2)"	"potential prognostic unfavorable (5.12e-4)"	"unprognostic (3.95e-3)"	"unprognostic (2.40e-1)"
CSF2RA	"alphaGMR, CD116, CSF2R"	ENSG00000198223	"Colony stimulating factor 2 receptor subunit alpha"	P15509	X	1268800-1310381	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins"		Receptor	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 61.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 243.7;Extravillous trophoblasts: 130.8;Langerhans cells: 703.6;Macrophages: 108.0;Schwann cells: 140.4;Syncytiotrophoblasts: 345.1"	"Cell type enriched"	"Detected in single"	8	"central nervous system macrophage: 4.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 319.8"	"Group enriched"	"Detected in all"	29	"dendritic cells: 170.1;granulocytes: 319.8;monocytes: 160.9"	"Cancer enriched"	"Detected in many"	7	"Adrenocortical cancer: 111.7"	"Adipose subcutaneous - Adipocytes (Subcutaneous), Adrenal gland - Macrophages, Minor Salivary Gland - Macrophages, Pancreas - Macrophages, Skeletal muscle - Macrophages, Spleen - Neutrophils, Thyroid gland - T-cells"	"Low region specificity"	"Detected in single"							CAB016148	Uncertain				"Secreted to blood"	Receptor	NA	NA		6300000	"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 58: Placenta - Pregnancy"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 34: Testis cancer - Unknown function"	"Cluster 28: Dendritic cells - Antigen presentation"	2			"CAB016148: AB_626868"	"unprognostic (2.91e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.85e-2)"	"potential prognostic favorable (1.75e-4)"	"unprognostic (4.20e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.82e-1)"		"potential prognostic favorable (8.00e-4)"	"unprognostic (8.58e-2)"	"unprognostic (4.83e-3)"	"unprognostic (3.35e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.77e-2)"		"unprognostic (7.06e-2)"	"unprognostic (9.07e-3)"	"unprognostic (3.80e-2)"	"unprognostic (5.23e-2)"	"unprognostic (7.11e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.31e-3)"	"unprognostic (6.19e-2)"	"unprognostic (1.07e-3)"	"potential prognostic favorable (3.57e-4)"	"unprognostic (9.22e-2)"	"unprognostic (5.63e-3)"	"unprognostic (1.03e-3)"	"unprognostic (9.14e-2)"	"unprognostic (3.42e-1)"
CSF2RB	"betaGMR, CD131, IL3RB, IL5RB"	ENSG00000100368	"Colony stimulating factor 2 receptor subunit beta"	P32927	22	36913628-36940439	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 53.9;lymphoid tissue: 63.7"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 115.7;Extravillous trophoblasts: 43.3;granulocytes: 68.5;Kupffer cells: 36.9;Langerhans cells: 74.0;Late spermatids: 40.9;Macrophages: 36.3;monocytes: 36.6;Plasma cells: 43.1"	"Group enriched"	"Detected in some"	6	"central nervous system macrophage: 15.3;leukocyte: 5.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"basophil: 239.1;neutrophil: 76.3"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 239.1"	"Group enriched"	"Detected in some"	47	"Leukemia: 43.7;lymphoma: 16.5;Myeloma: 15.2"	"Adrenal gland - Macrophages, Spleen - Neutrophils, Testis - Late spermatids"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA078677			Approved	"Golgi apparatus"			NA	NA			"Cluster 41: Basophils - Unknown function"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 12: Non-specific - Vasculature"	"Cluster 49: HMC-1 - Innate immune response"	"Cluster 74: Neutrophils - Degranulation"	17	"Golgi apparatus"		"HPA078677: AB_2732389"	"unprognostic (3.93e-2)"	"unprognostic (1.56e-2)"	"unprognostic (5.87e-2)"	"unprognostic (2.98e-2)"	"unprognostic (6.20e-2)"	"unprognostic (6.34e-2)"	"unprognostic (6.50e-2)"	"unprognostic (9.21e-2)"	"potential prognostic favorable (4.95e-4)"	"unprognostic (3.53e-2)"	"unprognostic (2.35e-2)"	"unprognostic (4.95e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.32e-1)"	"potential prognostic favorable (5.00e-4)"	"unprognostic (2.38e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.58e-2)"	"unprognostic (4.46e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.71e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.25e-1)"	"unprognostic (9.41e-2)"	"unprognostic (4.39e-1)"	"unprognostic (3.74e-2)"	"unprognostic (9.69e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.35e-1)"
CSF3R	"CD114, GCSFR"	ENSG00000119535	"Colony stimulating factor 3 receptor"	Q99062	1	36466043-36483278	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	Receptor	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 192.3;lung: 132.6;lymphoid tissue: 366.7"	"Group enriched"	"Detected in many"	6	"Cytotrophoblasts: 395.7;Syncytiotrophoblasts: 1355.6"	"Cell type enriched"	"Detected in some"	13	"central nervous system macrophage: 410.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	7	"neutrophil: 1924.2"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 1924.2"	"Cancer enriched"	"Detected in some"	25	"Leukemia: 32.2"	"Adipose subcutaneous - Macrophages, Adipose visceral - Neutrophils, Colon - Neutrophils, Heart muscle - Neutrophils, Liver - Neutrophils, Lung - Neutrophil_2, Skeletal muscle - Neutrophils, Spleen - Neutrophils, Thyroid gland - Neutrophils"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB017116, HPA048086"	Enhanced				"Intracellular and membrane"	Receptor	NA	NA		4100000	"Cluster 21: Neutrophils - Unknown function"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 12: Non-specific - Vasculature"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 74: Neutrophils - Degranulation"	7			"CAB017116: , HPA048086: AB_2680257"	"unprognostic (1.05e-1)"	"unprognostic (2.86e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.94e-1)"	"unprognostic (5.81e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.95e-2)"	"unprognostic (3.25e-1)"	"unprognostic (4.07e-2)"	"unprognostic (5.05e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.58e-2)"	"unprognostic (8.72e-2)"	"unprognostic (8.56e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.83e-2)"	"unprognostic (3.81e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.44e-2)"	"unprognostic (7.89e-2)"	"potential prognostic unfavorable (2.26e-4)"	"unprognostic (1.90e-1)"	"unprognostic (2.79e-1)"
CSNK1E	"CKIE, CKIepsilon, HCKIE"	ENSG00000213923	"Casein kinase 1 epsilon"	P49674	22	38290691-38318084	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 14.1"	"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Skeletal muscle - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009626, HPA026288"	Approved		Approved	Nucleoplasm,Cytosol			NA	NA			"Cluster 8: Plasmacytoid DCs - Unknown function"	"Cluster 66: Non-specific - Transcription"	"Cluster 34: Non-specific - Mixed function"	"Cluster 66: Non-specific - Mitochondria"	"Cluster 35: Respiratory epithelial cells - Unknown function"	107	"Nucleoplasm, Cytosol"		"CAB009626: AB_2084517, HPA026288: AB_1847276"	"unprognostic (7.95e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.51e-3)"	"unprognostic (4.05e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.90e-3)"	"unprognostic (3.64e-2)"	"unprognostic (2.07e-1)"	"unprognostic (9.27e-3)"	"unprognostic (1.96e-2)"	"unprognostic (4.95e-2)"	"potential prognostic unfavorable (1.42e-7)"	"unprognostic (7.18e-2)"	"unprognostic (2.26e-3)"	"unprognostic (4.66e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.56e-3)"	"unprognostic (8.45e-2)"	"unprognostic (2.56e-1)"	"unprognostic (7.61e-2)"	"unprognostic (3.01e-3)"	"unprognostic (3.20e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.22e-1)"	"unprognostic (4.82e-2)"	"unprognostic (2.38e-2)"	"unprognostic (5.18e-2)"
CTLA4	"CD, CD152, CELIAC3, CTLA-4, GSE, IDDM12"	ENSG00000163599	"Cytotoxic T-lymphocyte associated protein 4"	P16410	2	203853888-203873965	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"		"Diabetes mellitus, Disease variant, FDA approved drug targets, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lymphoid tissue: 36.7"	"Group enriched"	"Detected in some"	7	"Schwann cells: 28.0;T-cells: 57.4"	"Cell type enhanced"	"Detected in some"		"central nervous system macrophage: 3.8;ependymal cell: 1.5;leukocyte: 3.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in some"	7	"T-reg: 42.6"	"Lineage enriched"	"Detected in single"	427	"T-cells: 42.6"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 8.2;skin cancer: 5.6"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Kidney - T-cells, Minor Salivary Gland - T-cells, Prostate - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"										NA	NA			"Cluster 9: T-regs - Cell cycle regulation"	"Cluster 36: Lymphoid tissue - Cytokine signaling"	"Cluster 39: Astrocytes - Mixed function"	"Cluster 9: Skin cancer - Melanin biosynthesis"	"Cluster 78: NK-cells & T-cells - Immune system & Transcription"	13				"unprognostic (2.09e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.29e-2)"	"unprognostic (4.53e-2)"	"unprognostic (7.26e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.92e-2)"		"potential prognostic favorable (1.13e-4)"		"potential prognostic unfavorable (2.59e-4)"	"unprognostic (3.43e-1)"			"unprognostic (4.87e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.10e-2)"			"unprognostic (3.80e-1)"	"unprognostic (9.07e-3)"		"unprognostic (1.64e-1)"	"unprognostic (1.31e-2)"	"potential prognostic favorable (8.73e-4)"	"unprognostic (1.12e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.70e-1)"
CXCR4	"CD184, D2S201E, fusin, HM89, HSY3RR, LESTR, NPY3R, NPYR, NPYY3R"	ENSG00000121966	"C-X-C motif chemokine receptor 4"	P61073	2	136114349-136119177	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"G-protein coupled receptor, Host cell receptor for virus entry, Receptor, Transducer"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 1229.2;lymphoid tissue: 543.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 1653.4;dendritic cells: 2147.0;monocytes: 2202.0;NK-cells: 1186.4;Schwann cells: 984.9;T-cells: 1749.3"	"Cell type enriched"	"Detected in some"	6	"leukocyte: 200.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Leukemia: 190.2;lymphoma: 270.2;Myeloma: 151.1"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Kidney - T-cells, Skin - T-cells, Testis - Macrophages, Thyroid gland - T-cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"										NA	NA			"Cluster 20: Non-specific - DNA binding"	"Cluster 77: Bone marrow - Cell proliferation"	"Cluster 12: Non-specific - Vasculature"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 78: NK-cells & T-cells - Immune system & Transcription"	15				"unprognostic (1.64e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.80e-1)"	"unprognostic (8.28e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.77e-1)"	"unprognostic (9.34e-3)"	"unprognostic (2.36e-3)"	"unprognostic (7.14e-3)"	"unprognostic (6.67e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.64e-2)"	"unprognostic (3.84e-2)"	"unprognostic (2.90e-2)"	"unprognostic (3.59e-1)"	"unprognostic (5.95e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.69e-3)"	"unprognostic (2.99e-1)"	"unprognostic (2.23e-1)"	"unprognostic (8.50e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.37e-2)"	"unprognostic (5.13e-3)"	"unprognostic (3.81e-1)"	"unprognostic (1.11e-3)"	"unprognostic (8.57e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.72e-1)"
CYP11A1	"CYP11A, P450SCC"	ENSG00000140459	"Cytochrome P450 family 11 subfamily A member 1"	P05108	15	74337759-74367646	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Steroidogenesis, Sterol metabolism"	"Monooxygenase, Oxidoreductase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	26	"adrenal gland: 978.1"	"Cell type enriched"	"Detected in some"	4	"Syncytiotrophoblasts: 1655.2"	"Cell type enhanced"	"Detected in some"		"choroid plexus epithelial cell: 13.8;ependymal cell: 26.0;fibroblast: 18.9"	"Cancer enhanced"	"Detected in many"		"Kidney Chromophobe (TCGA): 11.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	48	"basophil: 10.3"	"Lineage enriched"	"Detected in single"	48	"granulocytes: 10.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 7.6"	"Adrenal gland - Adrenal cortex cells, Testis - Leydig cells"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basal ganglia: 2.4;hippocampal formation: 1.5;hypothalamus: 1.7;midbrain: 5.9;pons: 1.5"	HPA016436	Enhanced						NA	NA			"Cluster 46: Basophils - Proteolysis"	"Cluster 26: Adrenal gland - Steroid metabolism"	"Cluster 44: Non-specific - Mixed function"	"Cluster 34: Testis cancer - Unknown function"	"Cluster 27: Syncytiotrophoblasts - Pregnancy"	1			"HPA016436: AB_1847423"	"unprognostic (1.53e-1)"		"unprognostic (2.39e-2)"							"unprognostic (2.77e-1)"	"potential prognostic unfavorable (3.14e-5)"	"unprognostic (5.01e-2)"	"unprognostic (4.22e-1)"	"unprognostic (8.64e-3)"	"unprognostic (6.94e-3)"			"unprognostic (9.52e-2)"		"unprognostic (9.13e-3)"	"unprognostic (2.10e-1)"		"unprognostic (9.57e-2)"						"unprognostic (2.28e-1)"		"unprognostic (9.45e-2)"
CYP11B1	"CPN1, CYP11B, FHI, P450C11"	ENSG00000160882	"Cytochrome P450 family 11 subfamily B member 1"	P15538	8	142872356-142879846	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroidogenesis"	"Monooxygenase, Oxidoreductase"	"Congenital adrenal hyperplasia, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	834	"adrenal gland: 3571.8"	"Group enriched"	"Detected in some"	222	"Early spermatids: 60.8;Late spermatids: 82.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Adrenal gland - Adrenal cortex cells, Testis - Late spermatids"									"HPA049171, HPA049565, HPA056348, HPA057752"	Supported		Approved	Mitochondria			NA	NA				"Cluster 26: Adrenal gland - Steroid metabolism"	"Cluster 17: Choroid plexus - Cilium"		"Cluster 36: Late spermatids - Unknown function"		Mitochondria		"HPA049171: AB_2680661, HPA049565: , HPA056348: AB_2683104, HPA057752: AB_2683516"																															
CYP11B2	"ALDOS, CPN2, CYP11B, CYP11BL, P-450C18, P450aldo"	ENSG00000179142	"Cytochrome P450 family 11 subfamily B member 2"	P19099	8	142910559-142917843	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism, Steroidogenesis"	"Monooxygenase, Oxidoreductase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	941	"adrenal gland: 173.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"												"HPA049171, HPA049565, HPA056348, HPA057752"	Supported		Approved	Mitochondria			NA	NA				"Cluster 26: Adrenal gland - Steroid metabolism"					Mitochondria		"HPA049171: AB_2680661, HPA049565: , HPA056348: AB_2683104, HPA057752: AB_2683516"																															
CYP17A1	"CPT7, CYP17, P450C17, S17AH"	ENSG00000148795	"Cytochrome P450 family 17 subfamily A member 1"	P05093	10	102830531-102837472	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroidogenesis"	"Lyase, Monooxygenase, Oxidoreductase"	"Congenital adrenal hyperplasia, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	83	"adrenal gland: 7970.9"	"Group enriched"	"Detected in some"	7	"Early spermatids: 28.9;Late spermatids: 21.8;Proximal tubular cells: 83.4"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Liver Hepatocellular Carcinoma (TCGA): 49.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"				"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA048533	Enhanced		Approved	Vesicles	"Intracellular and membrane"	Enzyme	NA	NA				"Cluster 26: Adrenal gland - Steroid metabolism"		"Cluster 70: DU4475 - Unknown function"	"Cluster 56: Proximal tubular cells - Amino acid metabolism"		Vesicles		"HPA048533: AB_2680432"										"unprognostic (1.87e-1)"	"potential prognostic favorable (5.84e-5)"	"unprognostic (1.21e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.14e-3)"	"unprognostic (3.68e-3)"					"unprognostic (2.96e-2)"	"unprognostic (2.92e-1)"							"unprognostic (3.81e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.04e-3)"	"unprognostic (3.24e-1)"
CYP19A1	"ARO, ARO1, aromatase, CPV1, CYAR, CYP19, P-450AROM"	ENSG00000137869	"Cytochrome P450 family 19 subfamily A member 1"	P11511	15	51208057-51338601	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism"	"Monooxygenase, Oxidoreductase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	15	"placenta: 120.5"	"Cell type enriched"	"Detected in some"	61	"Syncytiotrophoblasts: 2667.7"	"Cell type enhanced"	"Detected in some"		"medium spiny neuron: 4.6;thalamic excitatory: 10.8"	"Cancer enhanced"	"Detected in some"		"Glioblastoma Multiforme (TCGA): 2.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"lymphoma: 5.3;testis cancer: 15.0"	"Testis - Early spermatids"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB000355, HPA051194"	Enhanced		Uncertain	Mitochondria			NA	NA				"Cluster 58: Placenta - Pregnancy"	"Cluster 38: Sub-cortical - Mixed function"	"Cluster 50: Lymphoma - Unknown function"	"Cluster 27: Syncytiotrophoblasts - Pregnancy"	17	Mitochondria		"CAB000355: , HPA051194: AB_2681381"	"unprognostic (2.17e-2)"		"unprognostic (1.79e-2)"			"unprognostic (2.29e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.23e-1)"		"unprognostic (3.29e-1)"				"potential prognostic unfavorable (2.91e-6)"					"unprognostic (2.22e-2)"				"unprognostic (3.30e-1)"			"unprognostic (5.17e-2)"	"unprognostic (2.42e-1)"				
CYP3A4	CYP3A3	ENSG00000160868	"Cytochrome P450 family 3 subfamily A member 4"	P08684	7	99756960-99784248	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"liver: 3492.7"	"Group enriched"	"Detected in some"	59	"Hepatocytes: 2573.4;Proximal enterocytes: 1348.0"	"Cell type enhanced"	"Detected in some"		"bergmann glia: 3.2"	"Cancer enriched"	"Detected in some"	59	"Liver Hepatocellular Carcinoma (TCGA): 470.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Kidney - Proximal tubular cells, Liver - Hepatocytes"									"CAB033671, HPA072245, HPA075539"	Enhanced		Approved	Vesicles,Cytosol			NA	NA		78000		"Cluster 83: Liver - Metabolism"	"Cluster 53: Neurons - Mixed function"	"Cluster 34: Testis cancer - Unknown function"	"Cluster 43: Hepatocytes - Metabolism"	6	Cytosol	Vesicles	"CAB033671: AB_782375, HPA072245: , HPA075539: "						"unprognostic (1.81e-1)"				"unprognostic (1.91e-1)"				"validated prognostic favorable (9.13e-4)"	"validated prognostic favorable (4.53e-6)"							"unprognostic (5.97e-2)"	"unprognostic (6.70e-2)"					"unprognostic (3.13e-1)"			
CYP51A1	"CP51, CYP51, CYPL1, LDM, P450-14DM, P450L1"	ENSG00000001630	"Cytochrome P450 family 51 subfamily A member 1"	Q16850	7	92084987-92134803	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	"Monooxygenase, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 196.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 52.6;Kupffer cells: 56.0;Oligodendrocytes: 49.4;Squamous epithelial cells: 50.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Colon - Macrophages, Liver - Hepatocytes, Lung - Alveolar cells type 2, Testis - Early spermatids, Testis - Late spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041325, HPA043508"	Approved		Approved	"Endoplasmic reticulum"			NA	NA			"Cluster 13: Non-specific - Mitochondria"	"Cluster 69: Liver - Oxidoreductase activity"	"Cluster 49: Hindbrain - Mixed function"	"Cluster 57: Stomach & Colon cancer - Digestion"	"Cluster 62: Hepatocytes - Metabolism"	12	"Endoplasmic reticulum"		"HPA041325: AB_2677411, HPA043508: AB_2678520"	"unprognostic (4.11e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.94e-2)"	"potential prognostic unfavorable (3.28e-5)"	"unprognostic (2.94e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.01e-3)"	"potential prognostic unfavorable (7.26e-4)"	"potential prognostic favorable (5.89e-9)"	"unprognostic (8.45e-2)"	"unprognostic (3.05e-1)"	"unprognostic (7.08e-2)"	"unprognostic (2.72e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.95e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.28e-1)"	"unprognostic (4.86e-2)"	"unprognostic (7.71e-2)"
CYSLTR1	"CysLT(1), CysLT1, CYSLT1R"	ENSG00000173198	"Cysteinyl leukotriene receptor 1"	Q9Y271	X	78271468-78327691	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 11.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 27.2;B-cells: 61.7;dendritic cells: 68.2;granulocytes: 42.7;Hofbauer cells: 35.9;Kupffer cells: 28.7;Macrophages: 32.0;monocytes: 35.3;Plasma cells: 41.3"	"Cell type enhanced"	"Detected in some"		"central nervous system macrophage: 107.0;endothelial cell: 47.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 85.9"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"Leukemia: 7.9;lymphoma: 3.5;Myeloma: 7.0"		"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA010546	Approved						NA	NA			"Cluster 29: Non-specific - Unknown function"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 43: Hindbrain - Mixed function"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 73: B-cells - B-cell function"	3			"HPA010546: AB_1078268"	"unprognostic (1.95e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.07e-1)"	"potential prognostic favorable (2.20e-4)"		"unprognostic (2.73e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.67e-1)"			"potential prognostic favorable (4.83e-6)"	"unprognostic (1.81e-2)"			"unprognostic (4.92e-2)"	"unprognostic (1.78e-3)"	"unprognostic (8.24e-2)"	"unprognostic (2.69e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.75e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.06e-1)"		"unprognostic (7.04e-2)"		"unprognostic (4.11e-2)"	"unprognostic (2.69e-2)"	"unprognostic (5.53e-2)"	
CYSLTR2	"CysLT(2), CYSLT2R"	ENSG00000152207	"Cysteinyl leukotriene receptor 2"	Q9NS75	13	48653711-48711226	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 22.2;seminal vesicle: 15.3"	"Cell type enriched"	"Detected in some"	4	"monocytes: 103.0"	"Cell type enriched"	"Detected in some"	17	"pericyte: 426.1"	"Cancer enhanced"	"Detected in many"		"Kidney Renal Papillary Cell Carcinoma (TCGA): 20.2;Thyroid Carcinoma (TCGA): 15.9"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	12	"eosinophil: 89.7"	"Lineage enriched"	"Detected in many"	14	"granulocytes: 89.7"	"Cancer enhanced"	"Detected in some"		"Leukemia: 3.6;lymphoma: 3.1;Neuroblastoma: 2.9"	"Adrenal gland - Adrenal cortex cells"									HPA046528	Approved						NA	NA			"Cluster 19: Eosinophils - Unknown function"	"Cluster 7: Adipose tissue - Mixed function"	"Cluster 32: Cerebral cortex - Mixed function"	"Cluster 50: Lymphoma - Unknown function"	"Cluster 29: Monocytes - Innate immune response"	6			"HPA046528: AB_2679687"			"unprognostic (1.55e-1)"			"unprognostic (8.69e-2)"	"unprognostic (3.77e-2)"	"unprognostic (7.07e-2)"		"unprognostic (4.21e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.04e-2)"				"unprognostic (1.41e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.08e-1)"				"unprognostic (3.30e-1)"			"unprognostic (1.12e-1)"	"unprognostic (1.48e-1)"		"unprognostic (5.22e-2)"	"unprognostic (8.68e-2)"	
DBH	DBM	ENSG00000123454	"Dopamine beta-hydroxylase"	P09172	9	133636363-133659329	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Catecholamine biosynthesis"	"Monooxygenase, Oxidoreductase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"adrenal gland: 264.4"	"Cell type enriched"	"Detected in single"	63	"Oocytes: 58.8"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Liver Hepatocellular Carcinoma (TCGA): 2.5"	"Region enriched"	"Detected in many"	22	"pons: 513.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	24	"Neuroblastoma: 209.4"	"Adrenal gland - Adrenal medulla cells, Pituitary gland - Corticotropes"	"Region enriched"	"Detected in some"	6	"pons and medulla: 22.1"	"Region enriched"	"Detected in single"	26	"pons: 22.1"	"HPA002130, HPA005960, HPA070789"	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"	"Intracellular and membrane"	Enzyme	NA	NA		1000000000		"Cluster 26: Adrenal gland - Steroid metabolism"	"Cluster 41: Monoamines - Neurotransmitter signalling"	"Cluster 17: Neuroblastoma - Neuronal signaling"	"Cluster 44: Oocytes - Unknown function"	18	Vesicles	"Endoplasmic reticulum"	"HPA002130: AB_2666554, HPA005960: AB_1078628, HPA070789: AB_2686312"			"unprognostic (1.28e-2)"											"unprognostic (7.34e-3)"	"potential prognostic favorable (1.86e-5)"																"unprognostic (1.57e-1)"
DCK		ENSG00000156136	"Deoxycytidine kinase"	P27707	4	70992538-71030914	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"bone marrow: 43.4;lymphoid tissue: 103.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 99.2;dendritic cells: 223.2;Erythroid cells: 172.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"lymphoma: 102.1"		"Low region specificity"	"Detected in all"							"HPA059609, HPA062773"	Enhanced		Supported	Nucleoplasm			NA	NA			"Cluster 12: Non-specific - Mitochondrial translation"	"Cluster 71: Thymus - Adaptive immune response"	"Cluster 28: Oligodendrocytes - Mixed function"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 28: Dendritic cells - Antigen presentation"	15	Nucleoplasm		"HPA059609: AB_2684082, HPA062773: AB_2684865"	"unprognostic (1.04e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.45e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.29e-2)"	"unprognostic (5.88e-2)"	"potential prognostic unfavorable (5.35e-5)"	"potential prognostic favorable (2.42e-8)"	"unprognostic (1.95e-1)"	"unprognostic (1.19e-1)"	"potential prognostic unfavorable (1.29e-6)"	"unprognostic (1.52e-2)"	"potential prognostic unfavorable (9.80e-4)"	"unprognostic (3.78e-2)"	"unprognostic (2.32e-2)"	"unprognostic (7.68e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.14e-3)"	"unprognostic (1.77e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.97e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.97e-1)"
DDC	AADC	ENSG00000132437	"Dopa decarboxylase"	P20711	7	50458436-50565405	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Catecholamine biosynthesis"	"Decarboxylase, Lyase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 161.2;kidney: 303.6;retina: 170.3"	"Group enriched"	"Detected in some"	4	"Enteroendocrine cells: 368.3;Proximal enterocytes: 394.0;Proximal tubular cells: 315.4;Rod photoreceptor cells: 478.2"	"Cell type enhanced"	"Detected in single"		"splatter: 1.3"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	9	"midbrain: 179.5;pons: 59.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Neuroblastoma: 108.9"	"Adrenal gland - Adrenal medulla cells, Colon - Colon enterocytes, Kidney - Proximal tubular cells, Liver - Hepatocytes, Skin - Sebaceous gland cells, Testis - Early spermatids, Thyroid gland - Parafollicular cells"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"midbrain: 97.7;pons: 40.1"	HPA017742	Enhanced		Approved	"Actin filaments,Primary cilium"			NA	NA		100000		"Cluster 55: Kidney & Intestine - Metabolism"	"Cluster 41: Monoamines - Neurotransmitter signalling"	"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 22: Proximal enterocytes - Digestion"	1	"Actin filaments"	"Primary cilium"	"HPA017742: AB_1847832"			"unprognostic (2.47e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.38e-2)"	"unprognostic (1.47e-2)"					"potential prognostic favorable (2.83e-8)"	"unprognostic (1.73e-3)"	"unprognostic (5.61e-2)"	"unprognostic (2.73e-1)"	"potential prognostic unfavorable (1.71e-5)"	"unprognostic (9.25e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.93e-3)"	"unprognostic (2.96e-2)"	"unprognostic (4.48e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.85e-2)"	"unprognostic (1.67e-2)"		"unprognostic (1.02e-3)"	"unprognostic (3.45e-1)"		"unprognostic (6.25e-2)"	"unprognostic (3.79e-1)"		"potential prognostic unfavorable (2.27e-4)"
DDR2	"NTRKR3, TKT, TYRO10"	ENSG00000162733	"Discoidin domain receptor tyrosine kinase 2"	Q16832	1	162631373-162787405	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	Osteogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 84.7;Fibroblasts: 128.6;Leydig cells: 62.8;Mesothelial cells: 69.7;Peritubular cells: 85.6;Smooth muscle cells: 77.5"	"Cell type enhanced"	"Detected in all"		"choroid plexus epithelial cell: 472.9;fibroblast: 253.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Neuroblastoma: 44.3"	"Adrenal gland - Adrenal cortex cells, Lung - Fibroblast_1, Spleen - Fibroblast_1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070112			Approved	"Plasma membrane,Actin filaments"			Yes	No		530000		"Cluster 41: Smooth muscle tissue - ECM organization"	"Cluster 39: Astrocytes - Mixed function"	"Cluster 44: Connective tissue cells - ECM organization"	"Cluster 32: Smooth muscle cells - Muscle contraction"	37	"Plasma membrane, Actin filaments"		"HPA070112: AB_2686229"	"unprognostic (4.93e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.10e-2)"	"unprognostic (6.72e-3)"	"unprognostic (5.10e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.48e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.29e-3)"	"unprognostic (5.27e-2)"	"potential prognostic unfavorable (5.22e-7)"	"unprognostic (2.74e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.89e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.31e-3)"	"potential prognostic unfavorable (9.83e-6)"	"unprognostic (1.68e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.48e-2)"	"unprognostic (6.21e-2)"	"unprognostic (3.94e-3)"	"unprognostic (6.62e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.49e-1)"
DGAT2		ENSG00000062282	"Diacylglycerol O-acyltransferase 2"	Q96PD7	11	75759512-75801535	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins"	"Glycerol metabolism, Lipid biosynthesis, Lipid metabolism"	"Acyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"adipose tissue: 459.3;breast: 129.3;liver: 321.2;skin 1: 146.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 277.3;Hepatocytes: 103.0;Late spermatids: 95.1;Spermatocytes: 56.1;Spermatogonia: 46.5"	"Cell type enhanced"	"Detected in many"		"medium spiny neuron: 16.7"	"Cancer enhanced"	"Detected in all"		"Liver Hepatocellular Carcinoma (TCGA): 96.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"eosinophil: 138.1;neutrophil: 350.5"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 350.5"	"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Liver - Hepatocytes, Lung - Neutrophil_2, Minor Salivary Gland - Adipocytes (Minor salivary gland), Skin - Keratinocyte (granular), Spleen - Neutrophils, Testis - Early spermatids, Testis - Late spermatids"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 30.0"	HPA013351			Approved	Vesicles,Cytosol			NA	NA			"Cluster 21: Neutrophils - Unknown function"	"Cluster 11: Liver - Plasma proteins"	"Cluster 33: Neurons - Mixed function"	"Cluster 57: Stomach & Colon cancer - Digestion"	"Cluster 74: Neutrophils - Degranulation"		"Vesicles, Cytosol"		"HPA013351: AB_1847630"	"unprognostic (1.85e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.44e-2)"	"unprognostic (6.67e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.47e-1)"	"unprognostic (6.98e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.38e-2)"	"unprognostic (6.16e-2)"	"potential prognostic unfavorable (9.18e-4)"	"unprognostic (7.96e-3)"	"unprognostic (3.48e-3)"	"unprognostic (2.47e-1)"	"unprognostic (2.87e-2)"	"unprognostic (5.92e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.15e-1)"	"potential prognostic favorable (3.80e-4)"	"unprognostic (2.98e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.64e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.55e-1)"
DHFR		ENSG00000228716	"Dihydrofolate reductase"	P00374	5	80626226-80654983	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Methotrexate resistance, One-carbon metabolism"	"Oxidoreductase, RNA-binding"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 146.0;Spermatocytes: 100.4;Undifferentiated cells: 69.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Liver - Hepatocytes, Spleen - Mitotic cells (Spleen), Testis - Early spermatids, Testis - Spermatocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037129, HPA051465"	Uncertain		Approved	Mitochondria			NA	Yes			"Cluster 9: T-regs - Cell cycle regulation"	"Cluster 67: Lymphoid tissue & Bone marrow - Cell proliferation"	"Cluster 13: Oligodendrocytes - Mixed function"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 52: Non-specific - Cell proliferation"	48	Mitochondria		"CAB037129: AB_439683, HPA051465: AB_2681494"	"unprognostic (3.41e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.84e-2)"	"unprognostic (2.53e-1)"	"unprognostic (8.47e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.17e-1)"	"potential prognostic unfavorable (1.46e-4)"	"unprognostic (2.78e-3)"	"unprognostic (7.67e-2)"	"unprognostic (8.30e-3)"	"unprognostic (3.35e-3)"	"unprognostic (2.07e-3)"	"potential prognostic unfavorable (8.50e-4)"	"unprognostic (8.24e-3)"	"unprognostic (1.85e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.73e-1)"	"unprognostic (4.92e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.81e-1)"
DHODH		ENSG00000102967	"Dihydroorotate dehydrogenase (quinone)"	Q02127	16	72008588-72027664	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Pyrimidine biosynthesis"	Oxidoreductase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"liver: 103.2"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 132.4;Lymphatic endothelial cells: 38.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010123, HPA011942"	Approved		Enhanced	Nucleoplasm,Mitochondria,Cytosol			NA	NA			"Cluster 30: Non-specific - DNA binding"	"Cluster 83: Liver - Metabolism"	"Cluster 11: White matter - Signal transduction"	"Cluster 68: Non-specific - Cell cycle regulation"	"Cluster 62: Hepatocytes - Metabolism"	4	Mitochondria	"Nucleoplasm, Cytosol"	"HPA010123: AB_1847648, HPA011942: AB_1847649"	"unprognostic (5.38e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.92e-1)"	"potential prognostic unfavorable (1.51e-4)"	"unprognostic (4.05e-1)"	"unprognostic (3.05e-1)"	"unprognostic (8.77e-2)"	"unprognostic (5.58e-3)"	"unprognostic (2.66e-2)"	"unprognostic (9.93e-2)"	"potential prognostic favorable (4.72e-5)"	"unprognostic (2.65e-3)"	"unprognostic (2.05e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.94e-3)"	"unprognostic (2.00e-1)"	"unprognostic (7.93e-3)"	"unprognostic (3.08e-1)"	"unprognostic (2.43e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.56e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.36e-1)"	"potential prognostic unfavorable (3.01e-4)"	"unprognostic (1.84e-2)"
DIO3	TXDI3	ENSG00000197406	"Iodothyronine deiodinase 3"	P55073	14	101560139-101563452	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Thyroid hormones biosynthesis"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 24.2;placenta: 18.8"	"Cell type enriched"	"Detected in some"	4	"Syncytiotrophoblasts: 70.6"	"Cell type enriched"	"Detected in single"	4	"pericyte: 3.1"	"Cancer enhanced"	"Detected in many"		"Testicular Germ Cell Tumor (TCGA): 8.4"	"Region enhanced"	"Detected in some"		"thalamus: 7.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Gastric cancer: 8.1"	"Prostate - Macrophages, Spleen - Fibroblast_2, Thyroid gland - Macrophages"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"amygdala: 6.1;hippocampal formation: 7.7"	HPA073684			Supported	Vesicles			NA	NA				"Cluster 62: Connective tissue - ECM organization"	"Cluster 23: Choroid plexus - Mixed function"	"Cluster 57: Stomach & Colon cancer - Digestion"	"Cluster 50: Connective tissue cells - ECM organization"	12	Vesicles		"HPA073684: "	"unprognostic (5.51e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.15e-2)"	"unprognostic (6.95e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.53e-1)"																"unprognostic (1.98e-1)"	"unprognostic (9.77e-2)"		"potential prognostic favorable (8.86e-4)"	"unprognostic (1.16e-1)"		"unprognostic (1.99e-2)"	"unprognostic (8.93e-2)"		
DMD	"BMD, DXS142, DXS164, DXS206, DXS230, DXS239, DXS268, DXS269, DXS270, DXS272, MRX85"	ENSG00000198947	Dystrophin	P11532	X	31097677-33339609	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transporters"		Actin-binding	"Cancer-related genes, Cardiomyopathy, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Cardiomyocytes: 624.9;Excitatory neurons: 1232.8;Inhibitory neurons: 687.8;Oligodendrocyte precursor cells: 1090.0;Oligodendrocytes: 568.1;Rod photoreceptor cells: 394.5;Skeletal myocytes: 712.3"	"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Testicular Germ Cell Tumor (TCGA): 55.9;Thyroid Carcinoma (TCGA): 21.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Breast - Breast myoepithelial cells, Kidney - Fibroblasts, Liver - Hepatocytes, Prostate - Smooth muscle cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000119, HPA002725, HPA023885"	Enhanced						NA	NA			"Cluster 32: Basophils - Transcription"	"Cluster 3: Non-specific - Unknown function"	"Cluster 51: Neurons - Mixed function"	"Cluster 1: Neuronal - Visual perception"	"Cluster 34: Neurons - Neuronal signaling"	29			"CAB000119: , HPA002725: AB_1078714, HPA023885: AB_1847931"	"unprognostic (1.05e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.21e-2)"	"unprognostic (5.06e-2)"	"unprognostic (4.59e-2)"	"unprognostic (6.60e-2)"	"unprognostic (5.17e-2)"	"potential prognostic favorable (1.01e-5)"	"unprognostic (1.22e-3)"	"unprognostic (5.02e-3)"	"unprognostic (6.05e-2)"	"unprognostic (2.92e-3)"	"potential prognostic favorable (3.00e-4)"	"unprognostic (1.62e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.82e-2)"	"unprognostic (9.56e-2)"	"unprognostic (4.15e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.69e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.20e-2)"	"unprognostic (4.53e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.09e-1)"
DNMT1	"CXXC9, DNMT, MCMT"	ENSG00000130816	"DNA methyltransferase 1"	P26358	19	10133342-10231286	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Deafness, Disease variant, FDA approved drug targets, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 411.1;Spermatocytes: 246.0;Syncytiotrophoblasts: 303.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Testis - Spermatocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002694, CAB005876"	Enhanced		Supported	Nucleoplasm			NA	Yes			"Cluster 30: Non-specific - DNA binding"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 6: Non-specific - Immune response"	"Cluster 23: Non-specific - Transcription"	"Cluster 24: Cytotrophoblasts - Mitochondria"	85	Nucleoplasm		"CAB005876: AB_731983, HPA002694: AB_1847810"	"unprognostic (3.94e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.87e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.79e-2)"	"unprognostic (4.99e-3)"	"unprognostic (1.53e-1)"	"potential prognostic favorable (9.36e-4)"	"unprognostic (1.05e-1)"	"unprognostic (8.29e-2)"	"potential prognostic unfavorable (5.33e-4)"	"unprognostic (4.58e-3)"	"unprognostic (5.90e-3)"	"unprognostic (1.78e-3)"	"unprognostic (8.93e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.76e-3)"	"unprognostic (9.00e-3)"	"unprognostic (6.39e-3)"	"unprognostic (2.54e-2)"	"unprognostic (2.99e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.32e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.24e-1)"
DPEP1		ENSG00000015413	"Dipeptidase 1"	P16444	16	89613308-89638456	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism"	"Dipeptidase, Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"intestine: 376.5;kidney: 253.3;pancreas: 490.7"	"Group enriched"	"Detected in many"	6	"Peritubular cells: 1200.8;Proximal enterocytes: 4594.6"	"Cell type enhanced"	"Detected in some"		"ependymal cell: 3.9"	"Group enriched"	"Detected in many"	5	"Colon Adenocarcinoma (TCGA): 177.2;Rectum Adenocarcinoma (TCGA): 210.7"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	5	"colorectal cancer: 134.1"	"Kidney - Proximal tubular cells, Kidney - Proximal tubular cells, Minor Salivary Gland - Plasma cells, Spleen - Plasma cells, Stomach - Gastric enteroendocrine cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA009426, HPA012783"	Enhanced		Approved	"Nucleoplasm,Cell Junctions"	"Intracellular and membrane"	Enzyme	NA	NA		240000		"Cluster 48: Stomach - Proteolysis"	"Cluster 46: Brainstem - Mixed function"	"Cluster 57: Stomach & Colon cancer - Digestion"	"Cluster 22: Proximal enterocytes - Digestion"	21	"Nucleoplasm, Cell Junctions"		"HPA009426: AB_1847842, HPA012783: AB_1847843"	"unprognostic (7.53e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.17e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.43e-1)"			"potential prognostic favorable (7.23e-5)"	"unprognostic (5.49e-3)"	"unprognostic (3.41e-2)"	"unprognostic (9.61e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.16e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.52e-2)"	"unprognostic (8.28e-3)"	"unprognostic (3.01e-1)"		"unprognostic (6.14e-2)"	"unprognostic (3.09e-2)"	"unprognostic (8.77e-3)"	"unprognostic (6.57e-2)"	"unprognostic (3.45e-1)"		"unprognostic (1.23e-2)"	"unprognostic (2.91e-1)"		"unprognostic (1.39e-1)"
DPP4	"ADCP2, CD26, DPPIV"	ENSG00000197635	"Dipeptidyl peptidase 4"	P27487	2	161992245-162074394	"CD markers, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Cell adhesion, Host-virus interaction"	"Aminopeptidase, Hydrolase, Protease, Receptor, Serine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 134.2;parathyroid gland: 151.0;placenta: 129.7;prostate: 103.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 135.0;Prostatic glandular cells: 195.7;Proximal enterocytes: 277.2;Serous glandular cells: 142.3;Syncytiotrophoblasts: 167.3"	"Cell type enhanced"	"Detected in many"		"deep-layer corticothalamic and 6b: 38.5;leukocyte: 104.6"	"Cancer enhanced"	"Detected in all"		"Prostate Adenocarcinoma (TCGA): 108.1"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 52.4"	"Lineage enriched"	"Detected in many"	10	"T-cells: 52.4"	"Cancer enhanced"	"Detected in many"		"Kidney cancer: 54.4"	"Adipose visceral - Mesothelial cells, Kidney - Proximal tubular cells, Liver - Hepatocytes, Minor Salivary Gland - Minor salivary glandular cells, Prostate - Prostate glandular cells, Skin - Fibroblast_2, Testis - Early spermatids"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB045970, HPA068778, HPA071236"	Enhanced				"Secreted to blood"	Receptor	NA	NA	643000000	160000000	"Cluster 1: T-cells - Unknown function"	"Cluster 55: Kidney & Intestine - Metabolism"	"Cluster 53: Neurons - Mixed function"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 22: Proximal enterocytes - Digestion"	142			"CAB045970: AB_11140529, HPA068778: , HPA071236: "	"unprognostic (1.45e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.26e-1)"	"unprognostic (8.68e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.95e-1)"	"validated prognostic favorable (2.36e-9)"	"validated prognostic favorable (2.32e-5)"	"unprognostic (2.15e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.32e-2)"	"unprognostic (8.15e-3)"	"unprognostic (1.45e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.80e-3)"	"potential prognostic unfavorable (9.06e-4)"	"unprognostic (2.10e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.98e-2)"	"unprognostic (3.70e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.58e-1)"
DPYD	"DHPDHase, DPD"	ENSG00000188641	"Dihydropyrimidine dehydrogenase"	Q12882	1	97077743-97995000	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 66.4"	"Cell type enriched"	"Detected in many"	6	"Oligodendrocytes: 1593.7"	"Cell type enhanced"	"Detected in all"		"oligodendrocyte: 2324.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Adrenal gland - Adrenal cortex cells, Kidney - Fibroblasts, Liver - Hepatocytes, Liver - Hepatocytes, Prostate - Fibroblasts, Skin - Endothelial cells, Thyroid gland - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033241, HPA045210"	Uncertain						NA	NA		1400000	"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 11: Liver - Plasma proteins"	"Cluster 11: White matter - Signal transduction"	"Cluster 71: Lymphoma - Inflammatory response"	"Cluster 51: Oligodendrocytes - Unknown function"	4			"CAB033241: AB_2094323, HPA045210: AB_2679256"	"unprognostic (6.22e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.51e-2)"	"unprognostic (8.94e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.35e-3)"	"unprognostic (2.47e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.23e-1)"	"unprognostic (5.42e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.26e-3)"	"unprognostic (9.10e-3)"	"potential prognostic unfavorable (1.27e-4)"	"unprognostic (7.89e-2)"	"unprognostic (1.62e-1)"	"potential prognostic unfavorable (5.61e-4)"	"unprognostic (3.58e-2)"	"unprognostic (1.21e-1)"	"unprognostic (8.01e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.47e-2)"	"unprognostic (8.87e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.93e-1)"
DRD1		ENSG00000184845	"Dopamine receptor D1"	P21728	5	175440036-175444182	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"brain: 25.9;retina: 8.2"	"Group enriched"	"Detected in some"	15	"Bipolar cells: 31.3;Horizontal cells: 42.2"	"Group enriched"	"Detected in many"	4	"eccentric medium spiny neuron: 118.5;medium spiny neuron: 74.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"basal ganglia: 46.6;cerebral cortex: 12.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Bladder cancer: 1.1;Bone cancer: 1.6"		"Region enriched"	"Detected in many"	9	"basal ganglia: 164.5"	"Region enriched"	"Detected in many"	13	"basal ganglia: 119.1"	"HPA013393, HPA017304"		Supported	Approved	"Plasma membrane,Cytosol"			NA	NA				"Cluster 17: Neuronal - Synaptic function"	"Cluster 33: Neurons - Mixed function"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 71: Horizontal & Bipolar cells - Neuronal signaling"	11	"Plasma membrane"	Cytosol	"HPA013393: AB_1847833, HPA017304: "			"unprognostic (4.46e-1)"					"unprognostic (1.71e-1)"							"unprognostic (6.72e-3)"								"unprognostic (2.58e-1)"								
DRD2		ENSG00000149295	"Dopamine receptor D2"	P14416	11	113409605-113475691	"FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 65.2;pituitary gland: 58.0"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 7.3;Horizontal cells: 15.7"	"Cell type enriched"	"Detected in many"	9	"medium spiny neuron: 148.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 163.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Neuroblastoma: 7.6"	"Adrenal gland - Adrenal medulla cells, Pituitary gland - Lactotropes, Testis - Early spermatids, Testis - Late spermatids"	"Region enriched"	"Detected in many"	10	"basal ganglia: 205.4"	"Region enriched"	"Detected in many"	4	"basal ganglia: 192.0"	"HPA015139, HPA015691"	Supported	Supported					NA	NA				"Cluster 49: Pituitary gland - Hormone signaling"	"Cluster 33: Neurons - Mixed function"	"Cluster 24: Non-specific - Unknown function"	"Cluster 71: Horizontal & Bipolar cells - Neuronal signaling"	17			"HPA015139: , HPA015691: AB_1847834"			"unprognostic (3.30e-1)"		"unprognostic (2.17e-1)"	"unprognostic (7.41e-2)"	"unprognostic (6.47e-2)"	"unprognostic (1.62e-2)"		"unprognostic (4.03e-2)"								"unprognostic (9.51e-2)"		"unprognostic (9.94e-2)"	"unprognostic (3.06e-1)"	"unprognostic (3.16e-3)"			"unprognostic (1.36e-1)"	"unprognostic (1.02e-1)"					
DRD3		ENSG00000151577	"Dopamine receptor D3"	P35462	3	114127580-114199407	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets, Schizophrenia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	5	"brain: 3.2"	"Cell type enriched"	"Detected in some"	6	"Late spermatids: 24.0"	"Group enriched"	"Detected in many"	4	"mammillary body: 106.0;medium spiny neuron: 57.9"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"basal ganglia: 9.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Testis - Late spermatids"	"Region enriched"	"Detected in some"	5	"basal ganglia: 7.4"	"Region enriched"	"Detected in all"	9	"basal ganglia: 26.2"								NA	NA				"Cluster 5: Brain & Testis - Signal transduction"	"Cluster 33: Neurons - Mixed function"	"Cluster 72: Neuronal - Signal transduction"	"Cluster 63: Late spermatids - Spermatogenesis"	5																																		
DRD4		ENSG00000069696	"Dopamine receptor D4"	P21917	11	637269-640706	"FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"	"Biological rhythms"	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Bipolar cells: 150.1;Cone photoreceptor cells: 171.6;dendritic cells: 41.2;Rod photoreceptor cells: 169.0"	"Cell type enhanced"	"Detected in many"		"choroid plexus epithelial cell: 14.4"	"Cancer enhanced"	"Detected in single"		"Ovary Serous Cystadenocarcinoma (TCGA): 1.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"				"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA062682			Uncertain	"Plasma membrane,Centrosome"			NA	NA			"Cluster 44: Plasmacytoid DCs - Plasma membrane proteins"	"Cluster 66: Non-specific - Transcription"	"Cluster 37: Neurons - Mixed function"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 25: Bipolar cells - Visual perception"	10	"Plasma membrane"	Centrosome	"HPA062682: "			"unprognostic (1.24e-1)"												"unprognostic (1.25e-1)"					"unprognostic (3.92e-3)"	"unprognostic (2.59e-2)"										
DRD5	"DRD1B, DRD1L2"	ENSG00000169676	"Dopamine receptor D5"	P21918	4	9781634-9784009	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Dystonia, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 2.6;lymphoid tissue: 1.3;stomach 1: 4.3"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 1.1;Horizontal cells: 1.3"	"Cell type enhanced"	"Detected in some"		"deep-layer intratelencephalic: 6.9;LAMP5-LHX6 and Chandelier: 8.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Pituitary gland - Undifferentiated cells (Pituitary gland)"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"thalamus: 9.1"	HPA048930	Supported						NA	NA				"Cluster 33: Brain - Neuronal signaling"	"Cluster 24: Neurons - Mixed function"	"Cluster 7: Liver cancer - Metabolism"	"Cluster 65: Neurons - Synaptic function"	2			"HPA048930: AB_2680562"																															
ECHS1	SCEH	ENSG00000127884	"Enoyl-CoA hydratase, short chain 1"	P30084	10	133362485-133373354	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Isomerase, Lyase"	"Disease variant, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 1093.7"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 1624.1;Proximal tubular cells: 2032.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Adrenal gland - Adrenal cortex cells, Breast - Adipocytes (Breast), Heart muscle - Cardiomyocytes, Kidney - Proximal tubular cells, Liver - Hepatocytes, Skeletal muscle - Skeletal myocytes, Testis - Sertoli cells, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003783, HPA021995, HPA022476"	Enhanced		Enhanced	Mitochondria			NA	NA		660000	"Cluster 10: Non-specific - Membrane trafficking"	"Cluster 1: Liver & Kidney - Metabolism"	"Cluster 21: Non-specific - Metabolism"	"Cluster 52: Non-specific - Mitochondria"	"Cluster 56: Proximal tubular cells - Amino acid metabolism"	24	Mitochondria		"CAB003783: , HPA021995: AB_1847974, HPA022476: AB_1847975"	"unprognostic (1.02e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.49e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.79e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.89e-1)"	"potential prognostic favorable (2.89e-5)"	"unprognostic (1.98e-1)"	"unprognostic (1.61e-2)"	"unprognostic (6.28e-3)"	"unprognostic (2.24e-3)"	"unprognostic (2.84e-1)"	"unprognostic (9.70e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.09e-2)"	"unprognostic (5.45e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.50e-2)"	"unprognostic (7.90e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.34e-2)"	"unprognostic (4.40e-3)"	"unprognostic (2.36e-2)"	"unprognostic (9.27e-2)"	"unprognostic (2.59e-2)"	"unprognostic (3.50e-2)"
EDNRA	"ET-A, ETA-R, hET-AR"	ENSG00000151617	"Endothelin receptor type A"	P25101	4	147480917-147544954	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, FDA approved drug targets, Hypotrichosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 110.0"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 116.1;Leydig cells: 43.2;Ovarian stromal cells: 51.5;Peritubular cells: 66.9;Smooth muscle cells: 97.2"	"Group enriched"	"Detected in many"	24	"pericyte: 307.5;vascular associated smooth muscle cell: 339.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Adipose subcutaneous - Smooth muscle cells, Breast - Smooth muscle cells, Liver - Hepatic stellate cells, Minor Salivary Gland - Fibroblasts, Spleen - Fibroblast_1, Thyroid gland - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013774, CAB018957"	Uncertain		Approved	"Plasma membrane,Cytosol"			NA	NA				"Cluster 62: Connective tissue - ECM organization"	"Cluster 47: Endothelial cells - Vasculature"	"Cluster 33: Sarcoma - Muscle contraction"	"Cluster 48: Smooth muscle cells - Signal transduction"	27	"Plasma membrane, Cytosol"		"CAB018957: AB_2039838, HPA013774: AB_1847994"	"unprognostic (1.06e-1)"	"unprognostic (8.17e-2)"	"unprognostic (3.08e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.26e-2)"	"unprognostic (9.72e-2)"	"potential prognostic favorable (1.72e-4)"	"unprognostic (4.08e-1)"	"unprognostic (7.02e-2)"	"unprognostic (4.67e-3)"	"potential prognostic favorable (9.23e-4)"	"potential prognostic unfavorable (4.71e-5)"	"unprognostic (5.16e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.34e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.98e-3)"	"potential prognostic unfavorable (1.36e-5)"	"unprognostic (8.61e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.86e-2)"	"unprognostic (4.74e-3)"	"unprognostic (2.35e-3)"	"unprognostic (1.32e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.97e-2)"
EDNRB	"ETB, HSCR, HSCR2"	ENSG00000136160	"Endothelin receptor type B"	P24530	13	77895481-77975529	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Albinism, Deafness, Disease variant, FDA approved drug targets, Hirschsprung disease, Waardenburg syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 123.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 108.5;Astrocytes: 119.8;Endothelial cells: 74.1;Leydig cells: 82.0;Lymphatic endothelial cells: 93.3;Melanocytes: 173.5;Muller glia cells: 102.3;Sertoli cells: 103.3;Smooth muscle cells: 78.6"	"Group enriched"	"Detected in many"	4	"astrocyte: 449.1;bergmann glia: 203.3"	"Cancer enhanced"	"Detected in all"		"Skin Cuteneous Melanoma (TCGA): 284.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	12	"Myeloma: 84.2;skin cancer: 130.7"	"Liver - Hepatic stellate cells, Testis - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017842, HPA027546"	Approved		Supported	"Plasma membrane,Cytosol"			NA	NA				"Cluster 34: Non-specific - Mixed function"	"Cluster 19: Astrocytes - Mixed function"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 54: Lymphatic endothelial cells - Lymph vessel development"	1	"Plasma membrane"	Cytosol	"CAB017842: , HPA027546: AB_2672327"	"unprognostic (2.40e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.97e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.66e-1)"	"validated prognostic favorable (7.14e-12)"	"validated prognostic favorable (1.07e-4)"	"unprognostic (1.35e-3)"	"unprognostic (3.71e-3)"	"unprognostic (3.39e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.57e-2)"	"potential prognostic unfavorable (7.94e-4)"	"unprognostic (1.01e-1)"	"unprognostic (6.55e-2)"	"unprognostic (7.17e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.97e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.70e-1)"	"unprognostic (9.80e-2)"	"unprognostic (7.73e-2)"	"unprognostic (3.67e-3)"	"unprognostic (8.02e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.84e-1)"
EEF2	"EEF-2, EF2"	ENSG00000167658	"Eukaryotic translation elongation factor 2"	P13639	19	3976056-3985463	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Elongation factor, Hydrolase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Spleen - B-cells (Spleen)"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007795, HPA040534, HPA057351"	Enhanced		Approved	"Plasma membrane,Cytosol"			NA	NA		19000000	"Cluster 18: Non-specific - Translation"	"Cluster 18: Non-specific - Ribosome"	"Cluster 47: Endothelial cells - Vasculature"	"Cluster 25: Non-specific - Ribosome"	"Cluster 64: Non-specific - Ribosome"	61	"Plasma membrane, Cytosol"		"CAB007795: AB_598149, HPA040534: AB_2677024, HPA057351: AB_2683417"	"unprognostic (8.33e-2)"	"unprognostic (1.60e-2)"	"unprognostic (5.34e-2)"	"unprognostic (5.62e-3)"	"unprognostic (2.09e-1)"	"unprognostic (2.01e-1)"	"unprognostic (9.38e-2)"	"unprognostic (7.69e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.71e-1)"	"potential prognostic favorable (2.48e-4)"	"unprognostic (6.19e-3)"	"unprognostic (2.53e-1)"	"unprognostic (2.47e-3)"	"unprognostic (4.40e-3)"	"unprognostic (3.01e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.63e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.39e-2)"	"potential prognostic favorable (3.75e-4)"
EGF		ENSG00000138798	"Epidermal growth factor"	P01133	4	109912883-110013766	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins"		"Growth factor"	"Cancer-related genes, Disease variant, FDA approved drug targets, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 106.4;pancreas: 86.7;skeletal muscle: 28.6"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 13.7;Inhibitory neurons: 10.7;Muller glia cells: 22.9;Serous glandular cells: 19.1;Skeletal myocytes: 50.7"	"Cell type enhanced"	"Detected in many"		"hippocampal CA4: 46.4;lower rhombic lip: 44.0"	"Cancer enriched"	"Detected in many"	9	"Kidney Chromophobe (TCGA): 27.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Lung - Alveolar cells type 2, Minor Salivary Gland - Minor salivary glandular cells, Pancreas - Exocrine glandular cells, Prostate - Prostate glandular cells, Skin - Eccrine sweat gland cells, Spleen - Platelets, Testis - Early spermatids, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"										NA	NA		7900000		"Cluster 68: Non-specific - Protein processing"	"Cluster 39: Astrocytes - Mixed function"	"Cluster 7: Liver cancer - Metabolism"	"Cluster 17: Breast glandular cells - Lactation"	6					"unprognostic (5.33e-3)"	"unprognostic (8.70e-2)"			"unprognostic (2.56e-2)"	"unprognostic (6.29e-2)"	"unprognostic (4.94e-2)"		"unprognostic (1.01e-2)"	"unprognostic (1.52e-2)"	"unprognostic (5.41e-3)"	"unprognostic (4.37e-3)"			"unprognostic (1.19e-1)"	"unprognostic (2.50e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.81e-1)"				"potential prognostic unfavorable (8.39e-4)"	"unprognostic (1.89e-1)"		"unprognostic (9.49e-2)"					
EGFR	"ERBB, ERBB1, ERRP"	ENSG00000146648	"Epidermal growth factor receptor"	P00533	7	55019017-55211628	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins, Transporters"	"Host-virus interaction"	"Developmental protein, Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 63.5"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 278.2;Salivary duct cells: 235.0;Syncytiotrophoblasts: 428.1"	"Cell type enhanced"	"Detected in many"		"astrocyte: 363.8;bergmann glia: 419.5"	"Cancer enriched"	"Detected in all"	4	"Glioblastoma Multiforme (TCGA): 324.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Heart muscle - Fibroblasts, Prostate - Prostate basal glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000035, HPA001200, HPA018530, CAB068186, CAB073534, CAB080313, CAB080314, CAB080473, CAB080474, CAB080475, CAB080506, CAB080507, CAB080508, CAB080509, CAB080510, CAB080511, CAB080513"	Enhanced		Supported	"Nucleoli,Golgi apparatus,Plasma membrane,Cell Junctions,Primary cilium,Basal body,Cytosol,Mid piece,Principal piece,End piece"	"Secreted to blood"	Receptor	NA	NA	4740000	60000000		"Cluster 58: Placenta - Pregnancy"	"Cluster 19: Astrocytes - Mixed function"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 53: Fibroblasts - ECM organization"	904	"Golgi apparatus, Plasma membrane"	"Nucleoli, Cell Junctions, Primary cilium, Basal body, Cytosol, Mid piece, Principal piece, End piece"	"CAB000035: , CAB068186: AB_2665679, CAB073534: , CAB080313: , CAB080314: , CAB080473: , CAB080474: , CAB080475: , CAB080506: , CAB080507: , CAB080508: , CAB080509: , CAB080510: , CAB080511: , CAB080513: , HPA001200: AB_1078723, HPA018530: AB_1848044"	"unprognostic (7.14e-2)"	"unprognostic (2.28e-2)"	"unprognostic (9.66e-2)"	"unprognostic (2.14e-3)"	"unprognostic (9.48e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.73e-2)"	"unprognostic (2.68e-3)"	"potential prognostic favorable (8.23e-5)"	"unprognostic (1.24e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.01e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.90e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.35e-3)"	"unprognostic (2.91e-1)"	"unprognostic (5.73e-3)"	"potential prognostic unfavorable (4.42e-5)"	"unprognostic (1.11e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.92e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.14e-2)"	"unprognostic (9.81e-2)"
EGLN1	"C1orf12, HIFPH2, PHD2, SM-20, ZMYND6"	ENSG00000135766	"Egl-9 family hypoxia inducible factor 1"	Q9GZT9	1	231363751-231422287	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Congenital erythrocytosis, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 183.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 42.4;Inhibitory neurons: 50.4;Microglial cells: 42.0;Oligodendrocyte precursor cells: 43.4;Oligodendrocytes: 44.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	7	"neutrophil: 29.2"	"Lineage enriched"	"Detected in many"	15	"granulocytes: 29.2"	"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022129	Approved		Supported	Vesicles,Cytosol			NA	NA			"Cluster 35: Neutrophils - Protein binding"	"Cluster 19: Non-specific - Basic cellular processes"	"Cluster 7: Non-specific - Ribosome"	"Cluster 45: Non-specific - Nuclear processes"	"Cluster 49: Non-specific - Transcription"	30	Cytosol	Vesicles	"HPA022129: AB_1848046"	"unprognostic (2.79e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.35e-3)"	"unprognostic (4.38e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.97e-1)"	"potential prognostic favorable (8.41e-8)"	"unprognostic (1.39e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.51e-2)"	"unprognostic (1.96e-1)"	"potential prognostic unfavorable (5.96e-5)"	"unprognostic (5.67e-2)"	"unprognostic (3.92e-1)"	"unprognostic (5.72e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.03e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.51e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.93e-1)"
EGLN2	"HIFPH1, PHD1"	ENSG00000269858	"Egl-9 family hypoxia inducible factor 2"	Q96KS0	19	40798996-40808434	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 225.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 28.0;Ductal cells: 23.9;Enteroendocrine cells: 26.0;Late spermatids: 24.8;Paneth cells: 25.3"	"Low cell type specificity"	"Detected in some"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Skin - Endothelial cells, Testis - Early spermatids, Testis - Late spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056649			Supported	Nucleoplasm			NA	NA			"Cluster 21: Neutrophils - Unknown function"	"Cluster 44: Testis - Spermatogenesis"	"Cluster 32: Cerebral cortex - Mixed function"	"Cluster 4: Non-specific - Transcription"	"Cluster 49: Non-specific - Transcription"	8	Nucleoplasm		"HPA056649: AB_2683203"	"unprognostic (3.36e-2)"	"unprognostic (4.74e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.15e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.06e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.84e-1)"	"unprognostic (4.89e-2)"	"unprognostic (5.19e-3)"	"unprognostic (6.82e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.36e-1)"	"unprognostic (7.28e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.54e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.53e-3)"	"unprognostic (2.52e-1)"	"unprognostic (4.27e-1)"	"unprognostic (4.34e-1)"	"unprognostic (5.21e-3)"	"unprognostic (3.87e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.53e-1)"
EGLN3	"HIFPH3, PHD3"	ENSG00000129521	"Egl-9 family hypoxia inducible factor 3"	Q9H6Z9	14	33924227-34462774	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Apoptosis, DNA damage"	"Dioxygenase, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 106.7;skin 1: 114.4"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 121.1;dendritic cells: 332.0;Extravillous trophoblasts: 132.0;Suprabasal keratinocytes: 127.0"	"Cell type enhanced"	"Detected in all"		"astrocyte: 202.0"	"Cancer enriched"	"Detected in all"	5	"Kidney Renal Clear Cell Carcinoma (TCGA): 379.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	10	"plasmacytoid DC: 25.5"	"Lineage enriched"	"Detected in many"	14	"dendritic cells: 25.5"	"Cancer enhanced"	"Detected in all"		"Kidney cancer: 97.0"	"Liver - Vascular Endothelial cells, Skin - Keratinocyte (other)"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064895			Supported	Cytosol			NA	NA			"Cluster 29: Non-specific - Unknown function"	"Cluster 21: Testis - Unknown function"	"Cluster 19: Astrocytes - Mixed function"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 28: Dendritic cells - Antigen presentation"	56	Cytosol		"HPA064895: AB_2685384"	"unprognostic (2.03e-1)"	"unprognostic (4.41e-2)"	"unprognostic (4.70e-1)"	"unprognostic (5.28e-3)"	"unprognostic (2.99e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.91e-2)"	"unprognostic (8.97e-3)"	"unprognostic (1.58e-2)"	"potential prognostic unfavorable (1.45e-5)"	"potential prognostic favorable (1.01e-4)"	"unprognostic (1.83e-3)"	"unprognostic (1.15e-2)"	"validated prognostic unfavorable (1.32e-5)"	"validated prognostic unfavorable (3.69e-4)"	"potential prognostic unfavorable (1.62e-4)"	"unprognostic (1.90e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.83e-1)"	"unprognostic (3.63e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.26e-1)"	"potential prognostic unfavorable (3.66e-4)"	"unprognostic (6.39e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.67e-1)"
ELANE	"ELA2, HLE, HNE, NE, PMN-E"	ENSG00000197561	"Elastase, neutrophil expressed"	P08246	19	851014-856247	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	92	"bone marrow: 3840.6"	"Cell type enhanced"	"Detected in some"		"Fibroblasts: 12.5;Kupffer cells: 9.1;Langerhans cells: 5.5;Leydig cells: 6.8;Oocytes: 19.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"Pancreatic Adenocarcinoma (TCGA): 5.4;Stomach Adenocarcinoma (TCGA): 7.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"classical monocyte: 4.0;neutrophil: 12.2"	"Group enriched"	"Detected in many"	9	"granulocytes: 12.2;monocytes: 4.0"	"Cancer enriched"	"Detected in some"	227	"Leukemia: 236.6"	"Lung - Neutrophil_1, Pituitary gland - Neutrophils, Skin - Fibroblast_2, Spleen - Hematopoietic stem cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB015409, HPA066836, HPA073774"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Secreted to blood"	Enzyme	NA	NA	157000000	460000	"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 6: Bone marrow - Innate immune response"		"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 74: Neutrophils - Degranulation"	3	Vesicles	"Golgi apparatus"	"CAB015409: AB_831596, HPA066836: AB_2685733, HPA073774: "			"unprognostic (1.95e-1)"																			"unprognostic (2.50e-1)"						"unprognostic (1.86e-2)"			
ELOVL4	"CT118, SCA34, STGD2, STGD3"	ENSG00000118402	"ELOVL fatty acid elongase 4"	Q9GZR5	6	79914814-79947553	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase	"Disease variant, FDA approved drug targets, Ichthyosis, Intellectual disability, Neurodegeneration, Spinocerebellar ataxia, Stargardt disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 102.8;retina: 171.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 88.2;Cone photoreceptor cells: 270.2;Rod photoreceptor cells: 307.1;Suprabasal keratinocytes: 88.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"MAIT T-cell: 23.8"	"Lineage enriched"	"Detected in single"	238	"T-cells: 23.8"	"Cancer enhanced"	"Detected in many"		"Rhabdoid: 18.8"	"Heart muscle - Fibroblasts, Kidney - Podocytes, Spleen - Fibroblast_1, Testis - Spermatocytes, Testis - Spermatogonia"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"										NA	NA			"Cluster 1: T-cells - Unknown function"	"Cluster 76: Retina - Visual perception"	"Cluster 52: Neurons & Synapses - Synaptic function"	"Cluster 3: Rhabdoid - Membrane components"	"Cluster 66: Photoreceptor cells - Visual perception"	79				"unprognostic (2.29e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.32e-2)"			"unprognostic (5.06e-2)"	"unprognostic (1.86e-1)"	"unprognostic (7.39e-2)"	"potential prognostic unfavorable (3.00e-5)"						"unprognostic (3.83e-1)"	"unprognostic (4.25e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.85e-1)"		"unprognostic (6.68e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.62e-1)"			"unprognostic (5.44e-2)"		"unprognostic (4.53e-2)"	"unprognostic (1.31e-1)"	"potential prognostic unfavorable (1.30e-5)"
EPAS1	"bHLHe73, HIF2A, HLF, MOP2, PASD2"	ENSG00000116016	"Endothelial PAS domain protein 1"	Q99814	2	46293667-46386697	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Angiogenesis, Differentiation, Host-virus interaction, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Congenital erythrocytosis, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 399.3;placenta: 430.9"	"Cell type enhanced"	"Detected in all"		"Adipocytes: 795.3;Endothelial cells: 626.4;Extravillous trophoblasts: 336.1;Syncytiotrophoblasts: 365.0"	"Group enriched"	"Detected in all"	4	"endothelial cell: 1673.4;pericyte: 727.1;vascular associated smooth muscle cell: 610.1"	"Cancer enhanced"	"Detected in all"		"Kidney Renal Clear Cell Carcinoma (TCGA): 231.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	18	"basophil: 20.7;eosinophil: 8.4"	"Lineage enriched"	"Detected in single"	26	"granulocytes: 20.7"	"Low cancer specificity"	"Detected in all"			"Adipose visceral - Endothelial cells, Breast - Endothelial cells, Colon - Endothelial cells, Pituitary gland - Endothelial cells, Prostate - Endothelial cells, Skeletal muscle - Endothelial cells, Skin - Endothelial cells, Stomach - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031200, HPA069697"			Supported	"Nucleoplasm,Actin filaments,Cytokinetic bridge,Cytosol"			Yes	NA			"Cluster 46: Basophils - Proteolysis"	"Cluster 7: Adipose tissue - Mixed function"	"Cluster 42: Choroid plexus - Mitochondria"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	41	Nucleoplasm	"Actin filaments, Cytokinetic bridge, Cytosol"	"HPA031200: AB_2673785, HPA069697: AB_2732139"	"unprognostic (1.14e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.07e-2)"	"unprognostic (9.03e-2)"	"potential prognostic unfavorable (3.95e-4)"	"unprognostic (9.01e-2)"	"unprognostic (1.67e-1)"	"validated prognostic favorable (5.01e-10)"	"validated prognostic favorable (1.32e-4)"	"unprognostic (7.43e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.50e-2)"	"unprognostic (5.04e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.21e-2)"	"unprognostic (9.83e-2)"	"unprognostic (8.80e-2)"	"unprognostic (6.22e-2)"	"unprognostic (8.41e-2)"	"unprognostic (2.10e-1)"	"unprognostic (5.28e-2)"	"unprognostic (1.40e-1)"	"unprognostic (6.29e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.42e-1)"
EPCAM	"17-1A, 323/A3, Ber-Ep4, BerEp4, CD326, CO-17A, EGP-2, EGP34, EGP40, Ep-CAM, ESA, GA733-2, HEA125, KS1/4, KSA, Ly74, M4S1, MH99, MIC18, MK-1, MOC-31, MOC31, TACST-1, TACSTD1, TROP1"	ENSG00000119888	"Epithelial cell adhesion molecule"	P16422	2	47345158-47387601	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Tumor antigen"	"Cancer-related genes, Disease variant, FDA approved drug targets, Hereditary nonpolyposis colorectal cancer"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 780.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 2590.4;Intestinal goblet cells: 1370.3;Paneth cells: 2221.3;Proximal enterocytes: 2597.5;Undifferentiated cells: 1520.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"colorectal cancer: 762.9"	"Colon - Colon enterocytes, Liver - Cholangiocyte, Lung - Alveolar cells type 2, Skin - Eccrine sweat gland cells, Stomach - Gastric mucous cells, Testis - Spermatogonia, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB003809, HPA026761, CAB030012, CAB055098, HPA067463"	Enhanced		Supported	"Plasma membrane"			NA	NA		10000		"Cluster 55: Kidney & Intestine - Metabolism"	"Cluster 56: Hypothalamus - Neuropeptide signaling"	"Cluster 57: Stomach & Colon cancer - Digestion"	"Cluster 5: Enterocytes - Absorption"	7	"Plasma membrane"		"CAB003809: AB_562285, CAB030012: AB_756075, CAB055098: AB_2335685, HPA026761: AB_1848198, HPA067463: AB_2685846"	"unprognostic (3.41e-2)"	"unprognostic (1.52e-2)"	"unprognostic (8.29e-3)"	"unprognostic (2.22e-1)"	"unprognostic (4.13e-1)"	"unprognostic (8.83e-3)"		"unprognostic (9.22e-3)"	"unprognostic (4.51e-2)"	"unprognostic (2.73e-1)"	"potential prognostic favorable (3.91e-4)"	"unprognostic (4.55e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.00e-2)"	"unprognostic (9.92e-2)"	"unprognostic (2.74e-2)"	"unprognostic (5.14e-2)"	"unprognostic (4.88e-3)"	"unprognostic (2.48e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.42e-2)"		"unprognostic (6.94e-3)"	"unprognostic (7.93e-2)"	"unprognostic (3.56e-2)"	"unprognostic (6.07e-2)"
EPHA2	ECK	ENSG00000142627	"EPH receptor A2"	P29317	1	16124337-16156069	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, RAS pathway related proteins"	"Angiogenesis, Apoptosis, Cell adhesion, Differentiation, Host-virus interaction"	"Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Cataract, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 143.7"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 160.7;Club cells: 114.2;Glandular and luminal cells: 167.1;Ionocytes: 159.4;Squamous epithelial cells: 159.9;Suprabasal keratinocytes: 193.8"	"Group enriched"	"Detected in some"	4	"endothelial cell: 18.5;pericyte: 45.1;vascular associated smooth muscle cell: 30.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	94	"plasmacytoid DC: 9.4"	"Lineage enriched"	"Detected in single"	94	"dendritic cells: 9.4"	"Low cancer specificity"	"Detected in many"			"Colon - Endothelial cells, Minor Salivary Gland - Minor salivary gland basal cells, Prostate - Urothelial cells, Spleen - Fibroblast_1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			CAB010464			Supported	"Nuclear speckles,Golgi apparatus,Plasma membrane,Cell Junctions"			NA	Yes		31000	"Cluster 44: Plasmacytoid DCs - Plasma membrane proteins"	"Cluster 27: Squamous epithelium - Keratinization"	"Cluster 42: Choroid plexus - Mitochondria"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 12: Squamous epithelial cells - Keratinization"	125	"Plasma membrane, Cell Junctions"	"Nuclear speckles, Golgi apparatus"	"CAB010464: AB_631436"	"unprognostic (1.53e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.56e-1)"	"unprognostic (5.74e-2)"	"unprognostic (4.10e-1)"	"unprognostic (1.92e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.30e-3)"	"unprognostic (7.53e-2)"	"unprognostic (1.91e-1)"	"validated prognostic favorable (3.23e-5)"	"validated prognostic favorable (6.42e-5)"	"unprognostic (5.34e-2)"	"unprognostic (4.66e-2)"	"unprognostic (3.51e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.79e-3)"	"unprognostic (1.76e-1)"	"potential prognostic unfavorable (1.75e-4)"	"unprognostic (6.78e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.46e-2)"	"unprognostic (9.96e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.45e-1)"
EPOR		ENSG00000187266	"Erythropoietin receptor"	P19235	19	11377207-11384342	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins"		Receptor	"Cancer-related genes, Congenital erythrocytosis, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 84.7;Hofbauer cells: 37.0"	"Cell type enhanced"	"Detected in all"		"astrocyte: 24.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Colon - Endothelial cells, Skin - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077654			Supported	"Nuclear speckles,Plasma membrane"	"Intracellular and membrane"	Receptor	NA	Yes			"Cluster 35: Neutrophils - Protein binding"	"Cluster 51: Thyroid gland - Unknown function"	"Cluster 16: Non-specific - Transcription"	"Cluster 47: Leukemia - Hemostasis"	"Cluster 1: Erythroid cells - Oxygen transport"	20	"Plasma membrane"	"Nuclear speckles"	"HPA077654: "	"unprognostic (6.99e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.64e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.42e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.17e-1)"	"potential prognostic unfavorable (1.87e-4)"	"unprognostic (1.99e-1)"	"unprognostic (4.77e-1)"	"unprognostic (6.64e-2)"	"unprognostic (5.72e-2)"	"unprognostic (7.62e-2)"	"unprognostic (5.87e-2)"	"unprognostic (4.53e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.58e-2)"	"unprognostic (5.95e-3)"	"potential prognostic unfavorable (5.13e-4)"	"unprognostic (1.26e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.21e-2)"
ERBB2	"c-ERB-2, c-ERB2, CD340, HER-2, HER2, MLN-19, NEU, NGL, p185(erbB2)"	ENSG00000141736	"Erb-b2 receptor tyrosine kinase 2"	P04626	17	39687914-39730426	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Transcription, Transcription regulation"	"Activator, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 120.6"	"Group enriched"	"Detected in many"	4	"astrocyte: 27.0;bergmann glia: 16.9;choroid plexus epithelial cell: 15.4;ependymal cell: 55.2;fibroblast: 34.0;pericyte: 14.2;vascular associated smooth muscle cell: 20.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 5.0"	"Group enriched"	"Detected in many"	5	"granulocytes: 1.2;T-cells: 5.0"	"Group enriched"	"Detected in all"	5	"breast cancer: 705.7;Esophageal cancer: 445.4;Gastric cancer: 199.3"	"Adrenal gland - Fibroblasts, Lung - Alveolar cells type 1, Spleen - Fibroblast_1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000043, HPA001060, HPA001338, HPA001383, HPA007983, CAB020416, CAB062555"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"			NA	NA		640000	"Cluster 24: Non-specific - Transcription"	"Cluster 24: Parathyroid gland - Vesicular transport"	"Cluster 39: Astrocytes - Mixed function"	"Cluster 27: Breast cancer - Unknown function"	"Cluster 35: Respiratory epithelial cells - Unknown function"	194	"Plasma membrane"	"Nucleoplasm, Cytosol"	"CAB000043: AB_2335701, CAB020416: AB_442047, CAB062555: AB_2665610, HPA001060: AB_2666185, HPA001338: AB_2666279, HPA001383: AB_1078500, HPA007983: "	"unprognostic (6.10e-2)"	"unprognostic (5.53e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.11e-3)"	"unprognostic (2.48e-1)"	"unprognostic (7.78e-2)"	"potential prognostic unfavorable (7.20e-5)"	"unprognostic (2.40e-2)"	"unprognostic (1.18e-1)"	"potential prognostic favorable (1.76e-8)"	"unprognostic (1.16e-3)"	"unprognostic (5.15e-3)"	"unprognostic (8.44e-2)"	"unprognostic (5.43e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.94e-1)"	"potential prognostic unfavorable (6.98e-4)"	"unprognostic (5.27e-1)"	"potential prognostic unfavorable (6.95e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.07e-2)"	"unprognostic (8.31e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.76e-1)"
ERBB4	"ALS19, HER4"	ENSG00000178568	"Erb-b2 receptor tyrosine kinase 4"	Q15303	2	211375717-212538841	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Lactation, Transcription, Transcription regulation"	"Activator, Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Amyotrophic lateral sclerosis, Cancer-related genes, Disease variant, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 7.9;fallopian tube: 10.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 1916.0;Inhibitory neurons: 5860.5;Oligodendrocyte precursor cells: 2222.9;Oligodendrocytes: 977.4"	"Cell type enhanced"	"Detected in all"		"CGE interneuron: 8806.8;eccentric medium spiny neuron: 8570.1;LAMP5-LHX6 and Chandelier: 11575.6;MGE interneuron: 8483.6"	"Cancer enhanced"	"Detected in some"		"Breast Invasive Carcinoma (TCGA): 7.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Rhabdoid: 4.0"	"Adipose visceral - Mesothelial cells, Breast - Breast glandular cells, Minor Salivary Gland - Minor salivary glandular cells, Pituitary gland - Undifferentiated cells (Pituitary gland), Skin - Eccrine sweat gland cells, Testis - Sertoli cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000276, HPA012016, CAB025522"	Enhanced						NA	NA		180000		"Cluster 61: Brain - Neuronal signaling"	"Cluster 56: Hypothalamus - Neuropeptide signaling"	"Cluster 5: Rhabdoid - Unknown function"	"Cluster 69: Neurons - Neuronal signaling"	57			"CAB000276: , CAB025522: , HPA012016: AB_1846541"		"unprognostic (1.71e-1)"	"unprognostic (8.96e-2)"				"unprognostic (2.79e-1)"	"unprognostic (2.37e-1)"		"unprognostic (2.88e-2)"							"unprognostic (1.34e-1)"			"unprognostic (2.80e-2)"	"unprognostic (1.63e-1)"								"unprognostic (1.99e-1)"		"unprognostic (6.81e-3)"
ESR1	"ER-alpha, Era, ESR, NR3A1"	ENSG00000091831	"Estrogen receptor 1"	P03372	6	151656691-152129619	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"Cancer-related genes, Disease variant, FDA approved drug targets, Osteoporosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 80.8;endometrium 1: 107.4;fallopian tube: 62.8"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 73.4;Early spermatids: 35.5;Endometrial stromal cells: 72.4;Glandular and luminal cells: 95.3;Hepatocytes: 47.7;Secretory cells: 73.5"	"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"Breast Invasive Carcinoma (TCGA): 132.3;Uterine Corpus Endometrial Carcinoma (TCGA): 57.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"breast cancer: 20.8"	"Liver - Hepatocytes, Pituitary gland - Gonadotropes, Testis - Early spermatids, Testis - Late spermatids, Thyroid gland - Fibroblasts"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000037, HPA000449, HPA000450, CAB055099, CAB072858"	Enhanced		Approved	Nucleoplasm,Vesicles			NA	NA				"Cluster 62: Connective tissue - ECM organization"	"Cluster 56: Hypothalamus - Neuropeptide signaling"	"Cluster 27: Breast cancer - Unknown function"	"Cluster 37: Glandular & Luminal cells - Unknown function"	562	Vesicles	Nucleoplasm	"CAB000037: AB_563706, CAB055099: AB_2101946, CAB072858: AB_2665701, HPA000449: AB_1078753, HPA000450: AB_1078754"	"unprognostic (1.02e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.67e-1)"	"unprognostic (8.50e-2)"		"unprognostic (6.55e-2)"			"potential prognostic favorable (1.23e-4)"		"unprognostic (3.05e-2)"	"potential prognostic favorable (3.01e-4)"	"unprognostic (6.60e-2)"	"validated prognostic favorable (3.29e-5)"	"validated prognostic favorable (1.09e-9)"	"unprognostic (1.04e-1)"	"unprognostic (1.71e-1)"		"unprognostic (1.69e-2)"	"unprognostic (1.14e-2)"	"unprognostic (8.06e-2)"		"unprognostic (3.43e-1)"	"unprognostic (1.22e-1)"		"unprognostic (9.78e-2)"				"unprognostic (7.71e-2)"	"unprognostic (2.47e-2)"
ESR2	"ER-beta, Erb, NR3A2"	ENSG00000140009	"Estrogen receptor 2"	Q92731	14	64084232-64338112	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 5.9;testis: 5.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 53.9;Late spermatids: 80.5;Rod photoreceptor cells: 45.2;Spermatocytes: 19.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cancer enhanced"	"Detected in many"		"lymphoma: 5.6"	"Adipose subcutaneous - Adipocytes (Subcutaneous), Testis - Early spermatids"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 10.0"	"HPA068406, CAB079300"	Enhanced		Supported	Nucleoplasm,Vesicles			NA	NA			"Cluster 30: Non-specific - DNA binding"	"Cluster 78: Testis - Transcription"	"Cluster 48: Non-specific - Mixed function"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 11: Late spermatids - Unknown function"	67	Nucleoplasm	Vesicles	"CAB079300: , HPA068406: "			"unprognostic (1.12e-3)"			"unprognostic (3.19e-1)"		"unprognostic (5.24e-2)"											"unprognostic (1.53e-2)"							"unprognostic (4.20e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.72e-1)"		"unprognostic (2.58e-2)"
ESRRG	"ERR-gamma, ERRg, NR3B3"	ENSG00000196482	"Estrogen related receptor gamma"	P62508	1	216503246-217137755	"FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 28.0;parathyroid gland: 44.8;retina: 35.0;stomach 1: 34.2"	"Group enriched"	"Detected in many"	4	"Astrocytes: 313.7;Excitatory neurons: 401.0;Inhibitory neurons: 477.2;Oligodendrocyte precursor cells: 367.4;Oligodendrocytes: 203.5;Syncytiotrophoblasts: 201.4"	"Cell type enhanced"	"Detected in all"		"bergmann glia: 2637.2"	"Cancer enriched"	"Detected in many"	5	"Kidney Chromophobe (TCGA): 18.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Neuroblastoma: 14.7"	"Lung - Respiratory ciliated cells, Pituitary gland - Undifferentiated cells (Pituitary gland), Skeletal muscle - Skeletal myocytes, Skeletal muscle - Skeletal myocytes, Skin - Eccrine sweat gland cells, Stomach - Parietal cells, Testis - Early spermatids, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044678	Uncertain		Approved	Nucleoplasm			No	NA				"Cluster 24: Parathyroid gland - Vesicular transport"	"Cluster 49: Hindbrain - Mixed function"	"Cluster 70: DU4475 - Unknown function"	"Cluster 8: Neurons - Neuronal signaling"	23	Nucleoplasm		"HPA044678: AB_10963215"	"unprognostic (4.12e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.54e-2)"			"unprognostic (4.38e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.05e-1)"		"unprognostic (8.80e-2)"	"potential prognostic favorable (7.11e-8)"	"unprognostic (1.51e-2)"	"unprognostic (5.77e-2)"				"unprognostic (2.72e-2)"		"unprognostic (6.85e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.35e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.99e-2)"		"unprognostic (5.18e-2)"		"unprognostic (3.61e-2)"	"unprognostic (2.55e-1)"	"potential prognostic unfavorable (5.35e-4)"	"unprognostic (3.25e-1)"
ETFDH	ETFQO	ENSG00000171503	"Electron transfer flavoprotein dehydrogenase"	Q16134	4	158671968-158710742	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Transport"	Oxidoreductase	"Disease variant, FDA approved drug targets, Glutaricaciduria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 154.4;tongue: 167.6"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 177.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Adrenal gland - Adrenal cortex cells, Heart muscle - Cardiomyocytes, Liver - Hepatocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041978, HPA058140"	Enhanced		Supported	Nucleoplasm,Mitochondria,Cytosol			NA	NA			"Cluster 25: Non-specific - Unknown function"	"Cluster 35: Non-specific - Mitochondria"	"Cluster 42: Choroid plexus - Mitochondria"	"Cluster 22: Non-specific - mRNA splicing & Cell cycle"	"Cluster 68: Cardiomyocytes - Muscle contraction"	5	Mitochondria	"Nucleoplasm, Cytosol"	"HPA041978: AB_10795605, HPA058140: "	"unprognostic (2.87e-1)"	"unprognostic (5.95e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.98e-3)"	"unprognostic (2.61e-1)"	"unprognostic (4.62e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.18e-2)"	"validated prognostic favorable (2.13e-10)"	"validated prognostic favorable (5.12e-5)"	"unprognostic (1.33e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.70e-1)"	"unprognostic (9.76e-2)"	"unprognostic (3.78e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.71e-1)"	"potential prognostic unfavorable (6.28e-4)"	"unprognostic (4.02e-2)"
EZH2	"ENX-1, EZH1, KMT6, KMT6A"	ENSG00000106462	"Enhancer of zeste 2 polycomb repressive complex 2 subunit"	Q15910	7	148807257-148884321	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 25.0;lymphoid tissue: 35.7;testis: 25.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 124.4;Spermatocytes: 134.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 7.7"	"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Colon - Mitotic cells (Colon), Spleen - Mitotic cells (Spleen), Testis - Early spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009589, HPA029131"	Enhanced		Supported	Nucleoplasm			NA	NA			"Cluster 9: T-regs - Cell cycle regulation"	"Cluster 67: Lymphoid tissue & Bone marrow - Cell proliferation"		"Cluster 39: Non-specific - Transcription"	"Cluster 52: Non-specific - Cell proliferation"	271	Nucleoplasm		"CAB009589: , HPA029131: AB_2672920"	"unprognostic (2.39e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.10e-2)"	"unprognostic (3.75e-3)"	"unprognostic (2.57e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.43e-2)"	"unprognostic (2.72e-3)"	"potential prognostic unfavorable (1.07e-4)"	"unprognostic (1.21e-3)"	"unprognostic (1.42e-2)"	"potential prognostic unfavorable (5.10e-5)"	"validated prognostic unfavorable (1.91e-7)"	"validated prognostic unfavorable (2.43e-5)"	"unprognostic (4.25e-3)"	"unprognostic (2.68e-3)"	"unprognostic (1.50e-2)"	"unprognostic (8.93e-2)"	"unprognostic (2.52e-3)"	"unprognostic (8.84e-3)"	"potential prognostic unfavorable (3.12e-4)"	"unprognostic (4.68e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.65e-1)"	"unprognostic (3.64e-1)"	"unprognostic (9.03e-3)"	"unprognostic (1.06e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.27e-2)"
F10		ENSG00000126218	"Coagulation factor X"	P00742	13	113122799-113149529	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 156.1"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 109.1;Hepatocytes: 170.7;Leydig cells: 217.7;Peritubular cells: 232.6;Smooth muscle cells: 57.6"	"Cell type enhanced"	"Detected in many"		"fibroblast: 49.8;pericyte: 28.0"	"Cancer enriched"	"Detected in many"	9	"Liver Hepatocellular Carcinoma (TCGA): 183.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Adrenocortical cancer: 6.9;liver cancer: 16.8"	"Breast - Fibroblasts, Colon - Fibroblasts, Liver - Hepatocytes, Minor Salivary Gland - Fibroblasts, Pancreas - Alpha cells, Pituitary gland - Fibroblasts, Prostate - Fibroblasts, Skeletal muscle - Fibroblasts, Skin - Fibroblast_1, Skin - Fibroblast_2, Spleen - Fibroblast_2, Thyroid gland - Fibroblasts"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"	"Blood coagulation"	NA	NA		7900000000		"Cluster 83: Liver - Metabolism"	"Cluster 49: Hindbrain - Mixed function"	"Cluster 18: Liver cancer - Metabolism"	"Cluster 53: Fibroblasts - ECM organization"	11				"unprognostic (1.38e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.71e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.54e-1)"			"unprognostic (4.04e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.78e-3)"	"unprognostic (6.28e-2)"	"unprognostic (5.64e-3)"	"unprognostic (2.49e-3)"	"unprognostic (5.69e-2)"	"potential prognostic unfavorable (4.00e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.99e-2)"	"potential prognostic favorable (4.34e-5)"	"unprognostic (4.45e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.78e-2)"	"unprognostic (5.29e-2)"	"unprognostic (6.38e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.01e-2)"
F11	FXI	ENSG00000088926	"Coagulation factor XI"	P03951	4	186266189-186289681	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Heparin-binding, Hydrolase, Protease, Serine protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"liver: 235.6"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 69.2"	"Cell type enriched"	"Detected in some"	9	"midbrain-derived inhibitory: 33.8"	"Cancer enriched"	"Detected in some"	12	"Liver Hepatocellular Carcinoma (TCGA): 46.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"liver cancer: 1.8"	"Kidney - Ascending Loop of Henle cells, Liver - Hepatocytes, Lung - Alveolar cells type 2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA039808			Approved	Vesicles	"Secreted to blood"	"Blood coagulation"	NA	NA		2800000000		"Cluster 83: Liver - Metabolism"	"Cluster 38: Sub-cortical - Mixed function"	"Cluster 18: Liver cancer - Metabolism"	"Cluster 62: Hepatocytes - Metabolism"		Vesicles		"HPA039808: AB_2676693"										"unprognostic (1.91e-2)"	"potential prognostic favorable (4.99e-4)"	"unprognostic (2.90e-3)"		"validated prognostic favorable (1.19e-4)"	"validated prognostic favorable (5.80e-6)"	"unprognostic (3.74e-2)"	"unprognostic (6.64e-2)"					"unprognostic (6.81e-2)"	"unprognostic (4.06e-2)"								
F12		ENSG00000131187	"Coagulation factor XII"	P00748	5	177402133-177416583	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	311	"liver: 589.9"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 375.4"	"Cell type enhanced"	"Detected in many"		"hippocampal CA4: 19.9"	"Cancer enriched"	"Detected in many"	96	"Liver Hepatocellular Carcinoma (TCGA): 275.5"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 1.7"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.7"	"Low cancer specificity"	"Detected in many"			"Kidney - Proximal tubular cells, Liver - Hepatocytes, Stomach - Mitotic cells (Stomach)"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA003825	Approved				"Secreted to blood"	"Blood coagulation"	NA	NA	1040000	7400000000	"Cluster 19: Eosinophils - Unknown function"	"Cluster 31: Liver - Plasma proteins"		"Cluster 71: Lymphoma - Inflammatory response"	"Cluster 62: Hepatocytes - Metabolism"	43			"HPA003825: AB_1078790"		"unprognostic (5.73e-2)"	"unprognostic (4.24e-1)"	"unprognostic (1.13e-3)"	"unprognostic (8.13e-2)"	"unprognostic (8.98e-3)"	"unprognostic (8.33e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.39e-1)"		"unprognostic (1.81e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.12e-1)"	"validated prognostic favorable (8.62e-5)"	"validated prognostic favorable (1.55e-4)"			"unprognostic (3.36e-2)"			"unprognostic (2.85e-1)"	"unprognostic (2.65e-1)"	"unprognostic (4.61e-1)"		"unprognostic (3.83e-1)"	"unprognostic (1.37e-1)"		"unprognostic (7.12e-2)"			
F13A1	F13A	ENSG00000124491	"Coagulation factor XIII A chain"	P00488	6	6144084-6321013	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Acyltransferase, Transferase"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 224.8;placenta: 473.0"	"Group enriched"	"Detected in many"	4	"Hofbauer cells: 791.5;Langerhans cells: 206.4;Macrophages: 321.2"	"Cell type enhanced"	"Detected in many"		"central nervous system macrophage: 99.1;fibroblast: 174.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 141.3;myeloid DC: 179.8"	"Group enriched"	"Detected in many"	184	"dendritic cells: 179.8;granulocytes: 50.0;monocytes: 141.3"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 13.1;Leukemia: 20.7"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Colon - Macrophages, Heart muscle - Macrophages, Minor Salivary Gland - Macrophages, Pituitary gland - Macrophages, Prostate - Macrophages, Skeletal muscle - Macrophages, Spleen - Platelets, Stomach - Macrophages, Testis - Macrophages, Thyroid gland - Macrophages"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA001804, CAB002155"	Enhanced				"Secreted to blood"	"Blood coagulation"	NA	NA		2200000000	"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 58: Placenta - Pregnancy"	"Cluster 8: Immune cells - Immune response"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 58: Macrophages - Innate immune response"	15			"CAB002155: AB_564077, HPA001804: AB_1078792"	"unprognostic (1.58e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.99e-3)"	"unprognostic (6.41e-3)"	"unprognostic (3.38e-3)"	"unprognostic (4.55e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.27e-2)"	"unprognostic (3.94e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.05e-2)"	"unprognostic (8.60e-3)"	"potential prognostic unfavorable (3.86e-4)"	"unprognostic (1.59e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.81e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.90e-2)"	"unprognostic (5.49e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.30e-1)"
F13B	FXIIIB	ENSG00000143278	"Coagulation factor XIII B chain"	P05160	1	197038741-197067260	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"		"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	210	"liver: 194.1"	"Cell type enriched"	"Detected in some"	16	"Hepatocytes: 59.1"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	580	"Liver Hepatocellular Carcinoma (TCGA): 57.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Liver - Hepatocytes"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA003827, HPA052139"	Supported				"Secreted to blood"	"Blood coagulation"	NA	NA		4900000000		"Cluster 31: Liver - Plasma proteins"		"Cluster 18: Liver cancer - Metabolism"	"Cluster 43: Hepatocytes - Metabolism"	1			"HPA003827: AB_1078794, HPA052139: AB_2681744"														"potential prognostic favorable (6.42e-5)"	"unprognostic (4.78e-2)"																
F2		ENSG00000180210	"Coagulation factor II, thrombin"	P00734	11	46719196-46739506	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase, Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease variant, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	1310	"liver: 1180.6"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 841.1"	"Low cell type specificity"	"Detected in single"			"Cancer enriched"	"Detected in some"	76	"Liver Hepatocellular Carcinoma (TCGA): 827.3"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	10	"liver cancer: 64.3"	"Liver - Hepatocytes"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB016780, HPA051476, HPA054698"	Enhanced				"Secreted to blood"	"Blood coagulation"	NA	NA	108000000000	54000000000		"Cluster 31: Liver - Plasma proteins"	"Cluster 15: Non-specific - Transcription"	"Cluster 18: Liver cancer - Metabolism"	"Cluster 62: Hepatocytes - Metabolism"	8			"CAB016780: , HPA051476: AB_2681498, HPA054698: AB_2682578"											"validated prognostic unfavorable (1.23e-6)"	"validated prognostic unfavorable (4.97e-4)"		"unprognostic (1.43e-1)"	"unprognostic (1.69e-3)"	"potential prognostic unfavorable (1.80e-4)"												"unprognostic (9.50e-3)"	"unprognostic (4.13e-1)"		
F2R	"CF2R, PAR-1, PAR1, TR"	ENSG00000181104	"Coagulation factor II thrombin receptor"	P25116	5	76716126-76735770	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Blood coagulation, Hemostasis"	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 67.7"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 46.3;Endothelial cells: 52.1;Fibroblasts: 62.0;Lymphatic endothelial cells: 46.9;Mucus glandular cells: 41.6;NK-cells: 90.1;Smooth muscle cells: 41.3"	"Cell type enhanced"	"Detected in many"		"fibroblast: 35.2;leukocyte: 56.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 25.5"	"Group enriched"	"Detected in many"	14	"NK-cells: 7.0;T-cells: 25.5"	"Low cancer specificity"	"Detected in all"			"Adrenal gland - Fibroblasts, Heart muscle - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008973, CAB012962"	Approved						NA	NA			"Cluster 24: Non-specific - Transcription"	"Cluster 47: Spleen - Immune response"	"Cluster 46: Brainstem - Mixed function"	"Cluster 69: Skin cancer - ECM organization"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	6			"CAB008973: , CAB012962: AB_2533198"	"unprognostic (2.77e-1)"	"unprognostic (3.04e-1)"	"unprognostic (4.25e-2)"	"unprognostic (3.49e-2)"	"unprognostic (9.10e-2)"	"unprognostic (7.49e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.89e-3)"	"unprognostic (1.49e-2)"	"potential prognostic unfavorable (1.32e-5)"	"unprognostic (8.59e-2)"	"unprognostic (7.32e-2)"	"unprognostic (6.94e-3)"	"unprognostic (4.29e-3)"	"unprognostic (3.47e-2)"	"unprognostic (7.55e-2)"	"unprognostic (3.85e-2)"	"unprognostic (5.22e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.93e-1)"	"unprognostic (4.85e-1)"	"unprognostic (3.99e-1)"	"unprognostic (5.85e-3)"	"unprognostic (5.24e-2)"	"unprognostic (9.34e-3)"	"unprognostic (3.87e-1)"	"unprognostic (4.13e-2)"	"unprognostic (2.19e-1)"
F3	"CD142, TF"	ENSG00000117525	"Coagulation factor III, tissue factor"	P13726	1	94529173-94541759	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Blood coagulation, Hemostasis"		"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 673.7;Basal respiratory cells: 344.3;Club cells: 387.7;Exocrine glandular cells: 355.4;Ionocytes: 309.6;Peritubular cells: 505.4"	"Cell type enhanced"	"Detected in many"		"astrocyte: 248.5;fibroblast: 443.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"head and neck cancer: 655.6"	"Kidney - Podocytes, Liver - Cholangiocyte, Lung - Alveolar cells type 2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009438, HPA049292, HPA069132"	Uncertain		Approved	Vesicles	"Secreted to blood"	"Blood coagulation"	NA	NA	603000			"Cluster 64: Neuronal - Transcription"	"Cluster 40: Astrocytes - Astrocyte-neuron interactions"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 45: Non-specific - Mixed function"	12	Vesicles		"CAB009438: AB_668005, HPA049292: AB_2680701, HPA069132: AB_2686092"	"unprognostic (1.24e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.73e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.11e-2)"	"potential prognostic unfavorable (7.75e-5)"	"unprognostic (4.84e-3)"	"unprognostic (1.44e-3)"	"potential prognostic unfavorable (2.57e-4)"	"unprognostic (3.19e-2)"	"unprognostic (1.61e-2)"	"unprognostic (5.22e-2)"	"unprognostic (4.06e-2)"	"unprognostic (7.62e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.43e-1)"	"potential prognostic unfavorable (1.26e-5)"	"unprognostic (2.62e-2)"	"unprognostic (2.11e-1)"	"unprognostic (6.14e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.77e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.55e-1)"	"unprognostic (8.97e-2)"
F5		ENSG00000198734	"Coagulation factor V"	P12259	1	169511951-169586588	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"		"Disease variant, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"choroid plexus: 79.3;liver: 171.0;placenta: 45.4"	"Group enriched"	"Detected in many"	7	"Cholangiocytes: 95.4;Cytotrophoblasts: 83.4;Hepatocytes: 220.7;Syncytiotrophoblasts: 60.4"	"Cell type enriched"	"Detected in many"	7	"choroid plexus epithelial cell: 358.5"	"Cancer enriched"	"Detected in many"	6	"Liver Hepatocellular Carcinoma (TCGA): 78.0"	"Region enriched"	"Detected in all"	22	"choroid plexus: 306.3"	"Group enriched"	"Detected in some"	4	"classical monocyte: 4.1;eosinophil: 8.1;neutrophil: 7.0;T-reg: 6.2"	"Group enriched"	"Detected in many"	13	"granulocytes: 8.1;monocytes: 4.1;T-cells: 6.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 17.9"	"Adrenal gland - Neutrophils, Kidney - Podocytes, Liver - Hepatocytes, Lung - Neutrophil_2, Minor Salivary Gland - Minor salivary glandular cells, Prostate - Urothelial cells, Skin - Eccrine sweat gland cells, Spleen - Neutrophils"	"Group enriched"	"Detected in many"	5	"basal ganglia: 2.7;hippocampal formation: 6.6;pons and medulla: 4.4;thalamus: 5.5"	"Group enriched"	"Detected in all"	7	"amygdala: 53.1;basal ganglia: 46.2;cerebral cortex: 89.3;hippocampal formation: 80.9;olfactory bulb: 37.0"	HPA002036			Approved	"Golgi apparatus"	"Secreted to blood"	"Blood coagulation"	NA	NA	7670000000	9400000000	"Cluster 7: Non-specific - Innate immune response"	"Cluster 11: Liver - Plasma proteins"	"Cluster 36: Choroid plexus - Mixed function"	"Cluster 2: Mucus-secreting cells - Unknown function"	"Cluster 62: Hepatocytes - Metabolism"	4	"Golgi apparatus"		"HPA002036: AB_1078787"	"unprognostic (1.18e-1)"		"unprognostic (1.31e-1)"		"unprognostic (2.79e-1)"	"unprognostic (5.12e-2)"		"unprognostic (1.69e-1)"		"unprognostic (1.84e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.72e-1)"	"potential prognostic unfavorable (7.66e-5)"	"potential prognostic favorable (9.55e-4)"	"unprognostic (3.33e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.38e-1)"			"unprognostic (2.70e-2)"	"unprognostic (3.66e-2)"	"unprognostic (7.12e-2)"	"unprognostic (3.54e-2)"	"unprognostic (9.36e-2)"	"unprognostic (3.92e-1)"	"unprognostic (1.42e-3)"	"unprognostic (5.88e-2)"	"unprognostic (3.13e-1)"	"unprognostic (6.90e-2)"
F7		ENSG00000057593	"Coagulation factor VII"	P08709	13	113105788-113120685	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	102	"liver: 156.3"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 119.3"	"Cell type enhanced"	"Detected in some"		"mammillary body: 1.2"	"Cancer enriched"	"Detected in some"	15	"Liver Hepatocellular Carcinoma (TCGA): 63.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"breast cancer: 3.0;liver cancer: 8.7"	"Liver - Hepatocytes"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	"Blood coagulation"	NA	NA	351000000	720000000		"Cluster 31: Liver - Plasma proteins"	"Cluster 1: Neurons - Mixed function"	"Cluster 18: Liver cancer - Metabolism"	"Cluster 62: Hepatocytes - Metabolism"	3					"unprognostic (5.69e-2)"	"unprognostic (7.46e-2)"			"unprognostic (1.38e-1)"				"potential prognostic favorable (3.40e-5)"				"unprognostic (2.90e-3)"	"unprognostic (1.50e-1)"										"unprognostic (3.37e-1)"	"unprognostic (1.16e-1)"			"unprognostic (1.60e-1)"		
F8	"DXS1253E, F8C, FVIII, HEMA"	ENSG00000185010	"Coagulation factor VIII"	P00451	X	154835788-155026940	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase, Blood coagulation, Hemostasis"		"Disease variant, FDA approved drug targets, Hemophilia, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 51.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 107.1;Endothelial cells: 203.3;Lymphatic endothelial cells: 132.0"	"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"Kidney Renal Clear Cell Carcinoma (TCGA): 33.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Colon - Endothelial cells, Kidney - Endothelial cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB018777	Enhanced				"Secreted to blood"	"Blood coagulation"	NA	NA		27000000	"Cluster 33: Non-specific - ATP binding"	"Cluster 30: Heart muscle - Heart development"	"Cluster 23: Choroid plexus - Mixed function"	"Cluster 36: Non-specific - mRNA processing"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	2			"CAB018777: AB_640320"	"unprognostic (1.45e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.81e-2)"	"unprognostic (5.87e-3)"	"unprognostic (1.52e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.91e-1)"	"potential prognostic favorable (7.94e-10)"	"unprognostic (2.34e-3)"	"unprognostic (7.71e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.51e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.08e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.91e-1)"	"unprognostic (6.20e-3)"	"unprognostic (4.84e-2)"	"unprognostic (1.68e-2)"	"unprognostic (8.40e-2)"
F9	FIX	ENSG00000101981	"Coagulation factor IX"	P00740	X	139530739-139563459	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Disease variant, FDA approved drug targets, Hemophilia, Thrombophilia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	2448	"liver: 683.7"	"Group enriched"	"Detected in some"	12	"Hepatocytes: 519.8;Kupffer cells: 161.1"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	823	"Liver Hepatocellular Carcinoma (TCGA): 82.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Liver - Hepatocytes"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	"Blood coagulation"	NA	NA		5400000000		"Cluster 31: Liver - Plasma proteins"		"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 62: Hepatocytes - Metabolism"																		"unprognostic (1.65e-3)"	"potential prognostic favorable (3.31e-5)"																
FABP7	"B-FABP, BLBP"	ENSG00000164434	"Fatty acid binding protein 7"	O15540	6	122779716-122784074	"FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	Transport		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 175.8;retina: 169.9;tongue: 191.6"	"Cell type enriched"	"Detected in some"	4	"Muller glia cells: 1279.5"	"Cell type enhanced"	"Detected in many"		"bergmann glia: 58.7;deep-layer near-projecting: 62.7"	"Group enriched"	"Detected in many"	10	"Glioblastoma Multiforme (TCGA): 894.0;Kidney Renal Clear Cell Carcinoma (TCGA): 510.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"breast cancer: 41.3;Kidney cancer: 40.7;skin cancer: 60.5"	"Pituitary gland - Undifferentiated cells (Pituitary gland)"	"Region enriched"	"Detected in all"	5	"olfactory bulb: 1195.5"	"Low region specificity"	"Detected in all"			"CAB025488, HPA028825, CAB058697"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"			NA	NA			"Cluster 46: Basophils - Proteolysis"	"Cluster 28: Neuronal - Transcription"	"Cluster 10: Cerebellum - Nucleic acid binding"	"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 10: Muller glia cells - Visual perception"	5	Nucleoplasm	"Golgi apparatus, Cytosol"	"CAB025488: , CAB058697: AB_2665600, HPA028825: AB_10602130"	"unprognostic (1.73e-2)"	"potential prognostic favorable (1.58e-4)"	"unprognostic (3.92e-1)"			"unprognostic (1.52e-1)"	"unprognostic (7.27e-2)"	"potential prognostic unfavorable (1.91e-4)"			"unprognostic (1.94e-2)"	"unprognostic (7.43e-3)"	"unprognostic (9.44e-2)"	"potential prognostic unfavorable (7.16e-4)"		"unprognostic (8.74e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.71e-1)"							"unprognostic (4.34e-3)"	"unprognostic (1.27e-1)"		"unprognostic (2.55e-2)"		"unprognostic (6.28e-2)"
FADS1	"D5D, FADS6, FADSD5, LLCDL1, TU12"	ENSG00000149485	"Fatty acid desaturase 1"	O60427	11	61799627-61829318	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Transport"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 214.2;dendritic cells: 196.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Adrenal cortex cells, Skin - Sebaceous gland cells, Testis - Leydig cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042705	Approved						NA	NA			"Cluster 10: Non-specific - Membrane trafficking"	"Cluster 60: Choroid plexus - Transmembrane transport"	"Cluster 46: Brainstem - Mixed function"	"Cluster 44: Connective tissue cells - ECM organization"	"Cluster 28: Dendritic cells - Antigen presentation"	2			"HPA042705: AB_10795709"	"unprognostic (2.96e-2)"	"unprognostic (7.25e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.15e-3)"	"unprognostic (3.40e-1)"	"unprognostic (6.95e-3)"	"unprognostic (9.65e-3)"	"unprognostic (3.86e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.76e-3)"	"potential prognostic unfavorable (8.71e-4)"	"unprognostic (5.54e-3)"	"unprognostic (1.13e-1)"	"unprognostic (5.83e-2)"	"unprognostic (3.76e-1)"	"unprognostic (6.90e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.62e-1)"	"potential prognostic unfavorable (3.79e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.92e-2)"	"unprognostic (3.68e-2)"	"unprognostic (7.19e-3)"	"unprognostic (3.87e-2)"	"potential prognostic unfavorable (3.95e-6)"	"unprognostic (1.77e-1)"
FADS2	"D6D, DES6, FADSD6, LLCDL2, SLL0262, TU13"	ENSG00000134824	"Fatty acid desaturase 2"	O95864	11	61792980-61867354	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Transport"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 348.0"	"Cell type enriched"	"Detected in many"	6	"Basal prostatic cells: 445.0"	"Cell type enhanced"	"Detected in all"		"astrocyte: 188.6"	"Cancer enhanced"	"Detected in all"		"Glioblastoma Multiforme (TCGA): 280.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Minor Salivary Gland - Minor salivary glandular cells, Skin - Sebaceous gland cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006741, HPA079284"	Approved		Approved	"Nuclear membrane,Endoplasmic reticulum,Plasma membrane"			NA	NA			"Cluster 29: Non-specific - Unknown function"	"Cluster 33: Brain - Neuronal signaling"	"Cluster 46: Brainstem - Mixed function"	"Cluster 44: Connective tissue cells - ECM organization"	"Cluster 3: Basal prostatic cells - Lipid metabolism"	2	"Endoplasmic reticulum"	"Nuclear membrane, Plasma membrane"	"HPA006741: AB_1078796, HPA079284: "	"unprognostic (2.02e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.66e-3)"	"unprognostic (4.23e-2)"	"unprognostic (9.39e-3)"	"unprognostic (1.28e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.93e-2)"	"unprognostic (4.54e-2)"	"unprognostic (5.86e-3)"	"unprognostic (5.10e-2)"	"unprognostic (4.53e-2)"	"unprognostic (8.81e-3)"	"unprognostic (2.72e-1)"	"unprognostic (4.30e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.99e-3)"	"unprognostic (2.44e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.61e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.21e-3)"	"unprognostic (6.84e-2)"	"unprognostic (9.02e-2)"	"unprognostic (9.43e-3)"	"unprognostic (1.03e-1)"
FCER1A	"FCE1A, FcepsilonRIalpha, FCERIA"	ENSG00000179639	"Fc epsilon receptor Ia"	P12319	1	159289714-159308224	"FDA approved drug targets, Predicted membrane proteins"		"IgE-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 36.2"	"Cell type enriched"	"Detected in some"	11	"Langerhans cells: 2592.1"	"Group enriched"	"Detected in some"	4	"central nervous system macrophage: 1.5;leukocyte: 3.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	8	"basophil: 21795.4"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 21795.4"	"Group enriched"	"Detected in some"	116	"Leukemia: 39.1;lymphoma: 10.8"	"Skin - Langerhans cells"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	8	"spinal cord: 1.0"	"CAB022102, HPA036051, CAB055526"	Approved						NA	NA			"Cluster 46: Basophils - Proteolysis"	"Cluster 13: Skin - Cornification"		"Cluster 47: Leukemia - Hemostasis"	"Cluster 28: Dendritic cells - Antigen presentation"	8			"CAB022102: , CAB055526: , HPA036051: AB_2674919"	"unprognostic (1.06e-1)"	"unprognostic (8.32e-3)"	"unprognostic (8.26e-3)"	"unprognostic (5.73e-2)"		"unprognostic (2.25e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.26e-3)"		"validated prognostic favorable (4.30e-9)"	"validated prognostic favorable (5.63e-6)"	"unprognostic (6.82e-2)"	"unprognostic (7.44e-2)"	"unprognostic (3.35e-2)"	"unprognostic (6.85e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.42e-1)"	"unprognostic (3.55e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.65e-1)"		"unprognostic (1.48e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.33e-2)"	"unprognostic (9.56e-2)"	"unprognostic (4.20e-1)"	"unprognostic (3.98e-1)"
FCER1G	FcepsilonRIgamma	ENSG00000158869	"Fc epsilon receptor Ig"	P30273	1	161215234-161220699	"FDA approved drug targets, Predicted membrane proteins"	"Immunity, Innate immunity"	"IgE-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 436.7;lymphoid tissue: 458.8"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 923.3;granulocytes: 1001.3;Hofbauer cells: 2835.1;Kupffer cells: 1729.0;Langerhans cells: 1885.6;Macrophages: 1764.5;monocytes: 3873.6"	"Group enriched"	"Detected in some"	29	"central nervous system macrophage: 94.5;leukocyte: 60.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"non-classical monocyte: 7025.3"	"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in some"		"Leukemia: 55.5;lymphoma: 18.0"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Colon - Macrophages, Heart muscle - Macrophages, Kidney - Macrophages, Minor Salivary Gland - Macrophages, Pancreas - Macrophages, Pituitary gland - Macrophages, Prostate - Macrophages, Skeletal muscle - Macrophages, Stomach - Macrophages, Thyroid gland - Macrophages"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022108, HPA026872"	Supported						NA	NA		59000	"Cluster 10: Non-specific - Membrane trafficking"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 71: Lymphoma - Inflammatory response"	"Cluster 29: Monocytes - Innate immune response"	5			"CAB022108: , HPA026872: AB_1848473"	"unprognostic (2.13e-1)"	"unprognostic (1.10e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.52e-2)"	"unprognostic (8.27e-2)"	"unprognostic (1.94e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.65e-1)"	"potential prognostic unfavorable (7.40e-4)"	"unprognostic (2.68e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.25e-3)"	"unprognostic (5.09e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.13e-1)"	"unprognostic (6.46e-2)"	"unprognostic (9.97e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.79e-3)"	"unprognostic (3.07e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.00e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.90e-1)"
FCGR1A	"CD64, CD64A, FCG1, FcgammaRI, FcgammaRIa, FCGR1"	ENSG00000150337	"Fc gamma receptor Ia"	P12314	1	149782671-149791675	"CD markers, FDA approved drug targets, Predicted membrane proteins"	"Immunity, Innate immunity"	"IgG-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 98.2"	"Group enriched"	"Detected in some"	5	"Hofbauer cells: 236.8;Kupffer cells: 103.7;Late spermatids: 60.3;Macrophages: 79.6"	"Cell type enriched"	"Detected in single"	27	"central nervous system macrophage: 24.2"	"Cancer enhanced"	"Detected in all"		"Glioblastoma Multiforme (TCGA): 65.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 137.1;intermediate monocyte: 57.3;myeloid DC: 37.3;neutrophil: 98.7"	"Group enriched"	"Detected in many"	55	"dendritic cells: 37.3;granulocytes: 98.7;monocytes: 137.1"	"Cancer enriched"	"Detected in single"	27	"Leukemia: 25.7"	"Adipose visceral - Macrophages, Adrenal gland - Macrophages, Heart muscle - Macrophages, Kidney - Macrophages, Lung - Macrophages, Pituitary gland - Macrophages, Prostate - Macrophages, Stomach - Macrophages, Testis - Late spermatids, Thyroid gland - Macrophages"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026910			Uncertain	"Golgi apparatus,Vesicles,Plasma membrane"			NA	NA			"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 50: Epididymis - Male reproductive secretion"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 58: Macrophages - Innate immune response"	21	Vesicles	"Golgi apparatus, Plasma membrane"	"HPA026910: "	"unprognostic (5.28e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.68e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.24e-2)"	"unprognostic (8.62e-2)"	"unprognostic (3.13e-1)"	"unprognostic (5.95e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.51e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.07e-2)"	"unprognostic (2.05e-1)"	"unprognostic (9.91e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.21e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.69e-2)"	"unprognostic (6.35e-2)"	"unprognostic (3.73e-2)"	"unprognostic (7.51e-3)"	"unprognostic (5.60e-2)"	"unprognostic (1.35e-1)"
FCGR2A	"CD32, CD32A, CDw32, Fc-gamma-RIIa, FCG2, FcgammaRIIa, FCGR2, FCGR2A1, IGFR2"	ENSG00000143226	"Fc gamma receptor IIa"	P12318	1	161505430-161524013	"CD markers, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Immunity	"IgG-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 116.9;placenta: 130.3"	"Group enriched"	"Detected in many"	5	"Hofbauer cells: 201.0;Kupffer cells: 179.0;Langerhans cells: 422.4;Macrophages: 294.0;monocytes: 183.9"	"Group enriched"	"Detected in some"	31	"central nervous system macrophage: 82.9;leukocyte: 22.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"neutrophil: 2531.1"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 2531.1"	"Cancer enriched"	"Detected in some"	5	"Leukemia: 40.8"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Heart muscle - Macrophages, Kidney - Macrophages, Liver - Neutrophils, Lung - Neutrophil_2, Minor Salivary Gland - Macrophages, Pancreas - Macrophages, Pituitary gland - Macrophages, Prostate - Macrophages, Skeletal muscle - Macrophages, Skin - Macrophages, Spleen - Neutrophils, Testis - Macrophages, Thyroid gland - Macrophages"									"HPA010718, HPA010776, HPA014730"	Supported		Supported	"Golgi apparatus,Plasma membrane"			NA	NA		40000000	"Cluster 21: Neutrophils - Unknown function"	"Cluster 57: Lung - Lung function"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 47: Leukemia - Hemostasis"	"Cluster 58: Macrophages - Innate immune response"	4	"Plasma membrane"	"Golgi apparatus"	"HPA010718: AB_1078463, HPA010776: , HPA014730: AB_2669074"	"unprognostic (2.04e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.57e-2)"	"unprognostic (6.11e-2)"	"unprognostic (5.06e-3)"	"unprognostic (3.20e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.65e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.18e-3)"	"unprognostic (3.85e-3)"	"unprognostic (9.64e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.90e-2)"	"unprognostic (3.68e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.83e-3)"	"unprognostic (9.63e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.91e-1)"	"unprognostic (4.06e-1)"
FCGR2B	"CD32, CD32B, FCG2, FcgammaRIIb, FCGR2, FcGRIIB"	ENSG00000072694	"Fc gamma receptor IIb"	P31994	1	161663143-161678654	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins"	"Host-virus interaction"	"IgG-binding protein, Receptor"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	9	"placenta: 389.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 63.1;Endothelial cells: 81.2;Fibroblasts: 53.7;Kupffer cells: 52.9;Langerhans cells: 332.8;Macrophages: 125.2;Plasma cells: 61.7"	"Cell type enhanced"	"Detected in some"		"central nervous system macrophage: 8.4;leukocyte: 3.7;vascular associated smooth muscle cell: 1.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 328.6;memory B-cell: 203.6"	"Low lineage specificity"	"Detected in many"			"Cancer enhanced"	"Detected in some"		"Leukemia: 10.4;lymphoma: 25.1"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Liver - Sinusoid Endothelial cells, Minor Salivary Gland - Macrophages, Skeletal muscle - Macrophages, Spleen - B-cells (Spleen), Testis - Macrophages, Thyroid gland - Macrophages"									"CAB007796, HPA014730"	Enhanced						NA	NA			"Cluster 32: Basophils - Transcription"	"Cluster 58: Placenta - Pregnancy"	"Cluster 8: Immune cells - Immune response"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	8			"CAB007796: AB_562288, HPA014730: AB_2669074"	"unprognostic (4.29e-1)"	"unprognostic (8.73e-2)"	"unprognostic (2.89e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.19e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.43e-3)"	"unprognostic (9.25e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.71e-2)"	"unprognostic (2.52e-2)"	"unprognostic (9.35e-3)"	"unprognostic (1.47e-1)"	"unprognostic (6.11e-2)"	"unprognostic (7.35e-3)"	"unprognostic (9.11e-3)"	"unprognostic (1.22e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.96e-3)"	"unprognostic (2.74e-1)"	"unprognostic (6.03e-2)"	"unprognostic (2.48e-2)"	"unprognostic (4.38e-1)"	"unprognostic (3.28e-2)"	"unprognostic (9.93e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.77e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.55e-1)"
FCGR3A	"CD16, CD16a, FCG3, FcgammaRIIIa, FCGR3, FcGRIIIA"	ENSG00000203747	"Fc gamma receptor IIIa"	P08637	1	161541759-161550968	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	Immunity	"IgG-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 202.0;lymphoid tissue: 294.7"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 240.5;Kupffer cells: 656.2;Macrophages: 303.8;monocytes: 1050.2;NK-cells: 597.4"	"Group enriched"	"Detected in some"	73	"central nervous system macrophage: 8.0;leukocyte: 6.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"intermediate monocyte: 1806.3;non-classical monocyte: 4107.1"	"Lineage enriched"	"Detected in all"	6	"monocytes: 4107.1"	"Not detected"	"Not detected"			"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Colon - Macrophages, Heart muscle - Macrophages, Kidney - Macrophages, Liver - Kupffer cells, Lung - Macrophages, Pancreas - Macrophages, Pituitary gland - Macrophages, Prostate - Macrophages, Skeletal muscle - Macrophages, Skin - Macrophages, Spleen - Macrophages, Stomach - Macrophages, Thyroid gland - Macrophages"									"CAB032435, HPA055431"	Supported				"Secreted to blood"	Receptor	NA	NA			"Cluster 37: Monocytes & Neutrophils - Innate immune response"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 29: Monocytes - Innate immune response"	4			"CAB032435: AB_626925, HPA055431: AB_2682815"	"unprognostic (1.54e-1)"	"unprognostic (6.90e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.27e-2)"	"unprognostic (8.73e-2)"	"unprognostic (6.79e-2)"	"unprognostic (2.89e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.46e-1)"	"unprognostic (4.24e-3)"	"unprognostic (3.67e-2)"	"unprognostic (3.44e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.13e-3)"	"unprognostic (3.31e-2)"	"unprognostic (2.98e-1)"	"unprognostic (3.55e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.53e-1)"	"unprognostic (9.66e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.44e-2)"	"unprognostic (4.57e-2)"
FCGR3B	"CD16, CD16b, FCG3, FcgammaRIIIb, FCGR3, FcRIIIb"	ENSG00000162747	"Fc gamma receptor IIIb"	O75015	1	161623196-161631963	"CD markers, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"IgG-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.5;lymphoid tissue: 79.0"	"Cell type enriched"	"Detected in some"	7	"Serous glandular cells: 28.8"	"Group enriched"	"Detected in some"	23	"central nervous system macrophage: 2.1;leukocyte: 2.6"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"cerebral cortex: 11.0;pons: 4.2"	"Immune cell enriched"	"Detected in many"	356	"neutrophil: 6077.6"	"Lineage enriched"	"Detected in many"	356	"granulocytes: 6077.6"	"Not detected"	"Not detected"			"Adipose visceral - Neutrophils, Colon - Neutrophils, Heart muscle - Neutrophils, Minor Salivary Gland - Neutrophils, Pituitary gland - Neutrophils, Skeletal muscle - Neutrophils, Spleen - Neutrophils, Stomach - Neutrophils, Thyroid gland - Neutrophils"														"Secreted to blood"	Receptor	NA	NA			"Cluster 4: Neutrophils - Degranulation"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 12: Non-specific - Vasculature"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 74: Neutrophils - Degranulation"	16				"unprognostic (9.39e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.08e-1)"	"unprognostic (8.14e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.06e-3)"	"unprognostic (7.70e-2)"		"unprognostic (5.61e-2)"	"unprognostic (9.38e-3)"	"unprognostic (8.82e-2)"	"unprognostic (3.26e-2)"	"potential prognostic favorable (1.48e-4)"	"unprognostic (1.44e-1)"	"unprognostic (2.08e-1)"	"unprognostic (8.95e-2)"	"unprognostic (7.10e-2)"		"unprognostic (1.20e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.78e-2)"		"unprognostic (1.21e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.97e-2)"			"unprognostic (7.81e-2)"
FCGRT	"FcgammaRn, FcRn"	ENSG00000104870	"Fc gamma receptor and transporter"	P55899	19	49506816-49526428	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"IgG-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 1392.0;Paneth cells: 775.0;Proximal enterocytes: 1822.1"	"Cell type enhanced"	"Detected in many"		"central nervous system macrophage: 118.2;fibroblast: 65.1;pericyte: 58.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 2360.0"	"Group enriched"	"Detected in all"	17	"dendritic cells: 924.4;granulocytes: 2360.0;monocytes: 1367.7"	"Cancer enhanced"	"Detected in all"		"Bone cancer: 261.3"	"Adipose subcutaneous - Macrophages, Adrenal gland - Macrophages, Liver - Hepatocytes, Minor Salivary Gland - Macrophages, Skeletal muscle - Fibroblasts, Thyroid gland - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012122, HPA015130"	Uncertain						NA	NA		12000000	"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 11: Liver - Plasma proteins"	"Cluster 8: Immune cells - Immune response"	"Cluster 12: Bone cancer - Neuronal signaling"	"Cluster 58: Macrophages - Innate immune response"	34			"HPA012122: AB_1848474, HPA015130: AB_1848475"	"potential prognostic favorable (8.13e-4)"	"unprognostic (5.52e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.80e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.43e-2)"	"potential prognostic unfavorable (5.47e-4)"	"unprognostic (2.31e-1)"	"unprognostic (3.03e-1)"	"potential prognostic favorable (1.19e-8)"	"unprognostic (9.39e-3)"	"potential prognostic favorable (1.88e-4)"	"unprognostic (6.20e-2)"	"unprognostic (2.67e-2)"	"potential prognostic favorable (9.33e-6)"	"unprognostic (1.33e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.91e-1)"	"potential prognostic favorable (3.67e-4)"	"unprognostic (9.36e-2)"	"unprognostic (8.29e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.36e-1)"
FDPS		ENSG00000160752	"Farnesyl diphosphate synthase"	P14324	1	155308748-155320666	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Host-virus interaction, Isoprene biosynthesis, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Transferase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 344.6"	"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 958.5;Distal enterocytes: 509.2;Ionocytes: 764.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Adrenal cortex cells, Colon - Macrophages, Skin - Sebaceous gland cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028200	Approved		Approved	Nucleoplasm,Cytosol			NA	NA		2500000	"Cluster 25: Non-specific - Unknown function"	"Cluster 37: Liver & Intestine - Lipid metabolism"	"Cluster 49: Hindbrain - Mixed function"	"Cluster 45: Non-specific - Nuclear processes"	"Cluster 35: Respiratory epithelial cells - Unknown function"	21	Cytosol	Nucleoplasm	"HPA028200: AB_10612109"	"unprognostic (3.56e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.76e-2)"	"unprognostic (8.31e-3)"	"unprognostic (2.24e-2)"	"unprognostic (6.62e-2)"	"potential prognostic favorable (2.24e-6)"	"unprognostic (3.22e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.47e-3)"	"unprognostic (1.35e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.81e-2)"	"unprognostic (2.16e-1)"	"unprognostic (6.36e-2)"	"unprognostic (3.88e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.45e-2)"	"unprognostic (4.03e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.39e-1)"	"unprognostic (2.96e-2)"
FFAR1	"FFA1R, GPR40"	ENSG00000126266	"Free fatty acid receptor 1"	O14842	19	35347902-35353864	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"bone marrow: 3.0;brain: 2.3;ovary: 2.4;pancreas: 2.4"	"Group enriched"	"Detected in some"	4	"Enteroendocrine cells: 5.9;Granulosa cells: 4.6;Pancreatic endocrine cells: 6.8"	"Group enriched"	"Detected in some"	11	"committed oligodendrocyte precursor: 2.8;oligodendrocyte: 6.0"	"Cancer enriched"	"Detected in single"	9	"Pancreatic Adenocarcinoma (TCGA): 3.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.0"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.0"	"Cancer enhanced"	"Detected in single"		"lymphoma: 1.3"	"Pancreas - Alpha cells, Pancreas - Beta cells"	"Not detected"	"Not detected"							HPA048933			Supported	"Plasma membrane"			NA	NA				"Cluster 5: Brain & Testis - Signal transduction"	"Cluster 11: White matter - Signal transduction"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 20: Enteroendocrine cells - Hormone signaling"		"Plasma membrane"		"HPA048933: "																						"unprognostic (4.73e-2)"									
FFAR4	"GPR120, GPR129, O3FAR1, PGR4"	ENSG00000186188	"Free fatty acid receptor 4"	Q5NUL3	10	93566665-93604480	"FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters"	"Differentiation, Inflammatory response"	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"adipose tissue: 3.9;intestine: 11.0;lung: 3.4;pituitary gland: 10.7"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 30.4;Intestinal goblet cells: 81.8;Late spermatids: 19.1;Pancreatic endocrine cells: 22.1;Paneth cells: 12.9"	"Cell type enhanced"	"Detected in many"		"central nervous system macrophage: 36.7"	"Cancer enhanced"	"Detected in many"		"Colon Adenocarcinoma (TCGA): 7.3;Rectum Adenocarcinoma (TCGA): 5.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"colorectal cancer: 4.3"	"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Adrenal gland - Macrophages, Breast - Adipocytes (Breast), Colon - Colon enterocytes, Pituitary gland - Corticotropes, Testis - Late spermatids, Thyroid gland - Macrophages"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042563			Supported	"Vesicles,Plasma membrane,Basal body"			NA	NA			"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 45: Intestine - Digestion"	"Cluster 56: Hypothalamus - Neuropeptide signaling"	"Cluster 57: Stomach & Colon cancer - Digestion"	"Cluster 16: Intestinal goblet cells - Mucin production"		"Plasma membrane"	"Vesicles, Basal body"	"HPA042563: AB_10794762"					"unprognostic (8.43e-2)"	"unprognostic (2.07e-3)"	"unprognostic (1.68e-1)"	"unprognostic (4.03e-1)"				"unprognostic (2.93e-1)"	"unprognostic (7.64e-2)"			"unprognostic (5.70e-3)"	"unprognostic (1.56e-1)"					"unprognostic (3.24e-1)"	"unprognostic (1.88e-1)"		"unprognostic (1.29e-1)"	"unprognostic (7.93e-2)"		"unprognostic (8.04e-2)"			
FGA		ENSG00000171560	"Fibrinogen alpha chain"	P02671	4	154583126-154590742	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Adaptive immunity, Blood coagulation, Hemostasis, Immunity, Innate immunity"		"Amyloidosis, Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	386	"liver: 17848.7"	"Cell type enriched"	"Detected in many"	30	"Hepatocytes: 13631.3"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	21	"Liver Hepatocellular Carcinoma (TCGA): 5313.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	6	"liver cancer: 180.5"	"Liver - Hepatocytes, Stomach - Parietal cells, Testis - Early spermatids, Testis - Late spermatids"									"CAB016776, HPA051370, HPA064755"	Supported		Enhanced	"Endoplasmic reticulum"	"Secreted to blood"	"Blood coagulation"	NA	NA	407000000	160000000000		"Cluster 31: Liver - Plasma proteins"		"Cluster 18: Liver cancer - Metabolism"	"Cluster 62: Hepatocytes - Metabolism"	14	"Endoplasmic reticulum"		"CAB016776: , HPA051370: AB_2681458, HPA064755: AB_2685345"		"unprognostic (1.36e-1)"		"unprognostic (4.10e-2)"							"unprognostic (5.40e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.41e-3)"	"unprognostic (1.26e-3)"	"unprognostic (2.52e-2)"	"unprognostic (2.72e-1)"	"potential prognostic unfavorable (3.10e-5)"	"unprognostic (2.81e-1)"			"unprognostic (1.59e-1)"	"potential prognostic unfavorable (7.62e-6)"		"unprognostic (7.32e-2)"		"unprognostic (3.70e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.16e-1)"		"unprognostic (4.56e-1)"
FGB		ENSG00000171564	"Fibrinogen beta chain"	P02675	4	154563011-154572807	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Blood coagulation, Hemostasis, Immunity, Innate immunity"		"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	372	"liver: 17393.5"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 15989.7"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	21	"Liver Hepatocellular Carcinoma (TCGA): 4509.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	8	"liver cancer: 219.4"	"Liver - Hepatocytes"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA001900, HPA001901, CAB008624"	Enhanced		Enhanced	"Endoplasmic reticulum"	"Secreted to blood"	"Blood coagulation"	NA	NA		130000000000		"Cluster 31: Liver - Plasma proteins"		"Cluster 18: Liver cancer - Metabolism"	"Cluster 62: Hepatocytes - Metabolism"	23	"Endoplasmic reticulum"		"CAB008624: AB_1615610, HPA001900: AB_1078865, HPA001901: AB_1078864"	"unprognostic (1.05e-3)"	"unprognostic (8.75e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.84e-2)"		"unprognostic (3.73e-3)"					"unprognostic (1.02e-1)"	"unprognostic (4.31e-2)"	"unprognostic (4.17e-2)"	"unprognostic (7.12e-3)"	"potential prognostic favorable (7.15e-4)"	"unprognostic (7.37e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.83e-1)"				"unprognostic (8.27e-2)"	"potential prognostic unfavorable (3.44e-9)"		"unprognostic (1.46e-1)"		"unprognostic (3.78e-1)"	"unprognostic (2.40e-2)"	"unprognostic (9.50e-2)"		"unprognostic (1.01e-1)"
FGF1	"AFGF, ECGF, ECGF-beta, ECGFA, ECGFB, FGF-alpha, FGFA, GLIO703, HBGF1"	ENSG00000113578	"Fibroblast growth factor 1"	P05230	5	142592178-142698070	"Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 290.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 71.2;Breast myoepithelial cells: 29.1;Cardiomyocytes: 70.6;Muller glia cells: 66.4;Oligodendrocytes: 111.5"	"Cell type enhanced"	"Detected in all"		"fibroblast: 259.4;pericyte: 375.4;vascular associated smooth muscle cell: 234.3"	"Cancer enriched"	"Detected in many"	11	"Glioblastoma Multiforme (TCGA): 76.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Adipose visceral - Mesothelial cells, Kidney - Podocytes, Liver - Hepatic stellate cells, Skin - Outer root sheath cells, Thyroid gland - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003265, CAB017519"	Enhanced		Supported	Nucleoplasm	"Secreted in other tissues"	"Growth factor"	NA	NA				"Cluster 9: Oligodendrocytes - Myelination"	"Cluster 13: Oligodendrocytes - Mixed function"	"Cluster 70: DU4475 - Unknown function"	"Cluster 10: Muller glia cells - Visual perception"	28	Nucleoplasm		"CAB017519: AB_629473, HPA003265: AB_1848522"	"unprognostic (8.14e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.82e-1)"	"unprognostic (1.52e-2)"		"unprognostic (2.01e-1)"	"unprognostic (6.06e-2)"	"potential prognostic unfavorable (4.46e-4)"	"unprognostic (1.67e-1)"	"unprognostic (1.87e-1)"	"validated prognostic favorable (2.26e-6)"	"validated prognostic favorable (5.12e-4)"	"unprognostic (8.56e-2)"			"unprognostic (1.46e-2)"	"unprognostic (3.31e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.15e-3)"	"unprognostic (2.63e-2)"	"potential prognostic unfavorable (1.17e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.01e-1)"		"unprognostic (4.07e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.17e-3)"		"potential prognostic favorable (6.46e-5)"	"unprognostic (4.32e-2)"
FGF2	FGFB	ENSG00000138685	"Fibroblast growth factor 2"	P09038	4	122826682-122898236	"Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins, Transporters"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 33.5;Astrocytes: 105.3;Endometrial stromal cells: 38.6;Oligodendrocyte precursor cells: 39.6;Schwann cells: 56.0;Secretory cells: 37.4"	"Cell type enhanced"	"Detected in all"		"astrocyte: 189.6;bergmann glia: 186.9;choroid plexus epithelial cell: 151.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Endothelial cells, Heart muscle - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000125, HPA065502"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"	"Secreted in other tissues"	"Growth factor"	NA	NA				"Cluster 64: Neuronal - Transcription"	"Cluster 46: Brainstem - Mixed function"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	21	"Nucleoplasm, Nuclear bodies"		"CAB000125: , HPA065502: "	"unprognostic (8.59e-3)"	"unprognostic (4.34e-3)"	"unprognostic (4.75e-2)"	"unprognostic (2.44e-1)"	"unprognostic (7.71e-2)"	"unprognostic (2.77e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.96e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.18e-2)"	"unprognostic (7.38e-2)"		"unprognostic (4.88e-2)"	"unprognostic (3.85e-3)"	"unprognostic (1.66e-1)"			"potential prognostic unfavorable (5.26e-4)"	"unprognostic (1.14e-1)"	"unprognostic (2.06e-1)"		"unprognostic (1.49e-2)"	"unprognostic (2.74e-1)"	"unprognostic (4.48e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.29e-1)"
FGFR1	"BFGFR, CD331, CEK, FLG, FLT2, H2, H3, H4, H5, KAL2, N-SAM"	ENSG00000077782	"Fibroblast growth factor receptor 1"	P11362	8	38400215-38468834	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters"	"Transcription, Transcription regulation"	"Heparin-binding, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Craniosynostosis, Disease variant, Dwarfism, FDA approved drug targets, Holoprosencephaly, Hypogonadotropic hypogonadism, Intellectual disability, Kallmann syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 188.4;Leydig cells: 193.1;Oligodendrocyte precursor cells: 156.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cancer enhanced"	"Detected in all"		"Rhabdoid: 200.8"	"Breast - Fibroblasts, Kidney - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009029, CAB033614, HPA056402"	Approved		Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle,Primary cilium,Centriolar satellite,Basal body,Cytosol"			Yes	NA		46000000	"Cluster 43: Non-specific - Transcription & Translation"	"Cluster 41: Smooth muscle tissue - ECM organization"	"Cluster 44: Non-specific - Mixed function"	"Cluster 5: Rhabdoid - Unknown function"	"Cluster 53: Fibroblasts - ECM organization"	92	"Microtubules, Cytokinetic bridge, Mitotic spindle"	"Primary cilium, Centriolar satellite, Basal body, Cytosol"	"CAB033614: AB_783377, HPA009029: , HPA056402: AB_2683118"	"unprognostic (1.44e-1)"	"unprognostic (7.85e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.70e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.00e-2)"	"unprognostic (4.48e-3)"	"unprognostic (5.05e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.19e-2)"	"unprognostic (5.23e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.08e-2)"	"unprognostic (3.39e-2)"	"unprognostic (5.52e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.24e-3)"	"unprognostic (8.84e-2)"	"unprognostic (9.56e-3)"	"unprognostic (8.24e-2)"
FGFR2	"BEK, CD332, CEK3, CFD1, ECT1, JWS, K-SAM, KGFR, TK14, TK25"	ENSG00000066468	"Fibroblast growth factor receptor 2"	P21802	10	121478332-121598458	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Apoptosis	"Heparin-binding, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Craniosynostosis, Disease variant, Ectodermal dysplasia, FDA approved drug targets, Intellectual disability, Lacrimo-auriculo-dento-digital syndrome, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 594.1"	"Group enriched"	"Detected in many"	5	"Astrocytes: 216.4;Cholangiocytes: 190.8;Oligodendrocytes: 523.6"	"Group enriched"	"Detected in many"	4	"bergmann glia: 1277.6;choroid plexus epithelial cell: 1305.0;oligodendrocyte: 929.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"basophil: 3.0;eosinophil: 2.0"	"Lineage enriched"	"Detected in single"	28	"granulocytes: 3.0"	"Cancer enhanced"	"Detected in many"		"Gastric cancer: 171.5"	"Lung - Alveolar cells type 2, Minor Salivary Gland - Minor salivary gland ductal cells, Pituitary gland - Undifferentiated cells (Pituitary gland), Skin - Keratinocyte (other), Testis - Spermatogonia, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010886, HPA035305"	Uncertain		Approved	"Nucleoplasm,Vesicles,Cell Junctions"	"Secreted - unknown location"	Receptor	NA	NA		860000	"Cluster 46: Basophils - Proteolysis"	"Cluster 9: Oligodendrocytes - Myelination"	"Cluster 30: White matter - Myelination"	"Cluster 40: Non-specific - Unknown function"	"Cluster 51: Oligodendrocytes - Unknown function"	34	"Cell Junctions"	"Nucleoplasm, Vesicles"	"CAB010886: AB_259379, HPA035305: AB_10672862"	"unprognostic (1.73e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.18e-2)"	"unprognostic (6.89e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.04e-3)"	"unprognostic (2.90e-1)"	"unprognostic (1.11e-3)"	"potential prognostic favorable (3.24e-6)"	"unprognostic (6.37e-2)"	"unprognostic (8.26e-2)"	"unprognostic (6.57e-3)"	"unprognostic (7.91e-3)"	"unprognostic (3.60e-2)"	"unprognostic (1.82e-3)"	"potential prognostic favorable (2.43e-5)"	"unprognostic (3.77e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.53e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.99e-1)"
FGFR3	"ACH, CD333, CEK2, JTK4"	ENSG00000068078	"Fibroblast growth factor receptor 3"	P22607	4	1793293-1808872	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Apoptosis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Craniosynostosis, Deafness, Disease variant, Dwarfism, Ectodermal dysplasia, FDA approved drug targets, Lacrimo-auriculo-dento-digital syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 155.8;esophagus: 135.7;skin 1: 264.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 389.2;Basal keratinocytes: 98.3;Cholangiocytes: 70.6;Suprabasal keratinocytes: 96.2"	"Group enriched"	"Detected in many"	6	"astrocyte: 516.1;bergmann glia: 251.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Myeloma: 150.3"	"Minor Salivary Gland - Minor salivary gland basal cells, Pituitary gland - Corticotropes, Testis - Spermatogonia"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004231, HPA067204"	Enhanced		Supported	"Endoplasmic reticulum"	"Secreted - unknown location"	Receptor	NA	NA		1500000		"Cluster 80: Non-specific - Endocytosis"	"Cluster 19: Astrocytes - Mixed function"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 47: Astrocytes - Unknown function"	217	"Endoplasmic reticulum"		"CAB004231: AB_627596, HPA067204: AB_2685804"	"unprognostic (7.73e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.81e-2)"	"unprognostic (8.61e-2)"	"potential prognostic favorable (6.13e-6)"	"unprognostic (1.48e-1)"	"unprognostic (2.38e-3)"	"unprognostic (2.46e-2)"		"potential prognostic favorable (2.62e-4)"	"unprognostic (1.54e-3)"	"unprognostic (1.17e-1)"	"unprognostic (9.96e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.95e-3)"	"unprognostic (5.08e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.59e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.92e-1)"	"unprognostic (9.33e-3)"	"unprognostic (3.15e-2)"	"unprognostic (8.71e-2)"	"unprognostic (5.51e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.47e-2)"	"unprognostic (5.02e-2)"
FGFR4	"CD334, JTK2"	ENSG00000160867	"Fibroblast growth factor receptor 4"	P22455	5	177086905-177098144	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 80.5;lung: 63.4"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 61.1;Enteroendocrine cells: 17.0;Hepatocytes: 23.4;Proximal tubular cells: 17.0;Undifferentiated cells: 32.0"	"Cell type enriched"	"Detected in some"	7	"fibroblast: 21.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in all"		"liver cancer: 117.0"	"Liver - Hepatocytes, Lung - Fibroblast_1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB005196, HPA027273, HPA027369, HPA028251"	Approved				"Intracellular and membrane"	Receptor	NA	NA		4600000		"Cluster 47: Spleen - Immune response"	"Cluster 15: Non-specific - Transcription"	"Cluster 18: Liver cancer - Metabolism"	"Cluster 2: Skeletal myocytes - Muscle contraction"	28			"CAB005196: AB_631512, HPA027273: AB_10600212, HPA027369: AB_10599427, HPA028251: AB_10601221"	"unprognostic (8.24e-3)"	"unprognostic (6.16e-2)"	"unprognostic (3.94e-2)"	"unprognostic (2.00e-3)"	"unprognostic (9.33e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.22e-1)"		"unprognostic (3.24e-3)"	"unprognostic (8.63e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.60e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.42e-1)"	"unprognostic (4.41e-2)"	"unprognostic (4.76e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.12e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.54e-1)"		"unprognostic (4.13e-1)"
FGG		ENSG00000171557	"Fibrinogen gamma chain"	P02679	4	154604134-154612967	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"		"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	330	"liver: 16058.1"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 9849.5"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	9	"Liver Hepatocellular Carcinoma (TCGA): 4055.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	6	"liver cancer: 229.6"	"Liver - Hepatocytes"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA011159, HPA027529, CAB033120, HPA074638"	Supported		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to blood"	"Blood coagulation"	NA	NA	267000000000	81000000000		"Cluster 31: Liver - Plasma proteins"		"Cluster 71: Lymphoma - Inflammatory response"	"Cluster 62: Hepatocytes - Metabolism"	6	"Endoplasmic reticulum"	Vesicles	"CAB033120: AB_2103818, HPA011159: , HPA027529: AB_10601322, HPA074638: "	"unprognostic (2.72e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.97e-1)"	"unprognostic (6.99e-2)"							"unprognostic (6.67e-2)"	"unprognostic (4.64e-3)"	"unprognostic (9.60e-2)"	"unprognostic (5.43e-3)"	"unprognostic (2.77e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.67e-1)"	"potential prognostic unfavorable (1.24e-4)"	"unprognostic (2.58e-1)"			"unprognostic (8.80e-3)"	"potential prognostic unfavorable (3.59e-5)"					"unprognostic (3.39e-3)"	"unprognostic (3.28e-1)"		
FKBP1A	"FKBP-12, FKBP1, FKBP12, FKBP12C, PKC12, PPIASE"	ENSG00000088832	"FKBP prolyl isomerase 1A"	P62942	20	1368977-1393164	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Isomerase, Rotamase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Paneth cells: 1139.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"dendritic cells: 675.8;granulocytes: 976.4;monocytes: 1017.4"	"Low cancer specificity"	"Detected in all"			"Adrenal gland - Adrenal cortex cells, Breast - Endothelial cells, Colon - Endothelial cells, Kidney - Endothelial cells, Lung - Endothelial cells"	"Low region specificity"	"Detected in all"							"CAB004639, HPA051330, HPA051798"	Uncertain		Approved	"Golgi apparatus,Primary cilium,Basal body,Cytosol"			NA	NA		15000000	"Cluster 29: Non-specific - Unknown function"	"Cluster 61: Brain - Neuronal signaling"	"Cluster 33: Neurons - Mixed function"	"Cluster 48: Adipocytes & Endothelial cells - Angiogenesis"	"Cluster 57: Platelets - Hemostasis"	23	"Golgi apparatus"	"Primary cilium, Basal body, Cytosol"	"CAB004639: AB_425434, HPA051330: , HPA051798: AB_2681615"	"unprognostic (1.31e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.92e-1)"	"unprognostic (8.04e-2)"	"unprognostic (2.29e-2)"	"unprognostic (4.89e-1)"	"unprognostic (3.60e-3)"	"unprognostic (1.93e-3)"	"unprognostic (5.14e-2)"	"potential prognostic favorable (2.11e-6)"	"unprognostic (3.29e-2)"	"unprognostic (7.51e-2)"	"validated prognostic unfavorable (2.53e-7)"	"validated prognostic unfavorable (7.09e-5)"	"unprognostic (3.28e-2)"	"unprognostic (5.05e-3)"	"potential prognostic unfavorable (1.91e-4)"	"unprognostic (7.72e-3)"	"unprognostic (1.51e-1)"	"unprognostic (3.94e-1)"	"unprognostic (5.54e-3)"	"unprognostic (1.46e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.38e-1)"	"unprognostic (9.61e-3)"	"unprognostic (2.42e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.47e-1)"
FLT1	"FLT, VEGFR1"	ENSG00000102755	"Fms related receptor tyrosine kinase 1"	P17948	13	28300346-28495145	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Chemotaxis, Differentiation"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"placenta: 405.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 383.1;Endothelial cells: 364.4;Extravillous trophoblasts: 980.8;Microglial cells: 414.2;Syncytiotrophoblasts: 1127.1"	"Cell type enriched"	"Detected in many"	12	"endothelial cell: 3142.1"	"Cancer enhanced"	"Detected in all"		"Kidney Renal Clear Cell Carcinoma (TCGA): 123.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"skin cancer: 15.1;testis cancer: 39.8"	"Adipose visceral - Endothelial cells, Breast - Endothelial cells, Colon - Endothelial cells, Heart muscle - Endothelial cells, Liver - Vascular Endothelial cells, Minor Salivary Gland - Endothelial cells, Pituitary gland - Endothelial cells, Prostate - Endothelial cells, Skin - Endothelial cells, Stomach - Endothelial cells, Testis - Early spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011740, HPA014290, CAB068189, CAB068190"	Enhanced		Supported	"Plasma membrane,Actin filaments,Cytosol"	"Secreted to blood"	Receptor	NA	NA	876000	120000		"Cluster 58: Placenta - Pregnancy"	"Cluster 47: Endothelial cells - Vasculature"	"Cluster 49: HMC-1 - Innate immune response"	"Cluster 4: Extravillous trophoblasts - Unknown function"	21	"Plasma membrane"	"Actin filaments, Cytosol"	"CAB068189: AB_2665636, CAB068190: AB_2665637, HPA011740: AB_1858737, HPA014290: AB_1858738"	"unprognostic (1.82e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.42e-3)"	"unprognostic (4.86e-3)"	"unprognostic (3.34e-2)"	"unprognostic (2.12e-1)"	"unprognostic (5.01e-3)"	"unprognostic (6.22e-2)"	"unprognostic (1.45e-1)"	"validated prognostic favorable (2.61e-8)"	"validated prognostic favorable (3.90e-4)"	"unprognostic (1.78e-3)"	"unprognostic (7.66e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.42e-3)"	"unprognostic (9.15e-3)"	"unprognostic (2.65e-3)"	"unprognostic (2.15e-1)"	"unprognostic (3.53e-1)"	"potential prognostic unfavorable (8.13e-4)"	"unprognostic (3.90e-1)"	"unprognostic (2.96e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.41e-2)"	"unprognostic (9.98e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.28e-2)"	"unprognostic (6.21e-2)"	"unprognostic (7.24e-2)"	"unprognostic (6.25e-3)"
FLT3	"CD135, FLK2, STK1"	ENSG00000122025	"Fms related receptor tyrosine kinase 3"	P36888	13	28003274-28100592	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, RAS pathway related proteins"	"Host-virus interaction"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 5.2;brain: 9.1;lymphoid tissue: 6.3"	"Group enriched"	"Detected in some"	5	"dendritic cells: 60.0;Inhibitory neurons: 57.5;Kupffer cells: 30.9;Langerhans cells: 21.1;Macrophages: 19.1;Schwann cells: 51.1"	"Cell type enhanced"	"Detected in many"		"lower rhombic lip: 79.5;MGE interneuron: 94.6;upper rhombic lip: 84.5"	"Cancer enhanced"	"Detected in single"		"Breast Invasive Carcinoma (TCGA): 2.5"	"Region enhanced"	"Detected in many"		"cerebellum: 10.7"	"Group enriched"	"Detected in many"	13	"myeloid DC: 68.7;plasmacytoid DC: 26.3"	"Lineage enriched"	"Detected in many"	19	"dendritic cells: 68.7"	"Cancer enriched"	"Detected in single"	67	"Leukemia: 28.4"	"Prostate - Macrophages, Spleen - Neutrophils, Stomach - Macrophages, Testis - Late spermatids"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA047539			Approved	"Endoplasmic reticulum"			NA	NA		200000	"Cluster 2: Dendritic cells - Unknown function"	"Cluster 16: Non-specific - Transcription"	"Cluster 25: Non-specific - Transcription"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 28: Dendritic cells - Antigen presentation"	12	"Endoplasmic reticulum"		"HPA047539: AB_2680080"		"unprognostic (6.35e-3)"	"unprognostic (1.19e-2)"					"unprognostic (6.61e-2)"																							
FLT4	"PCL, VEGFR-3, VEGFR3"	ENSG00000037280	"Fms related receptor tyrosine kinase 4"	P35916	5	180601506-180649624	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins, Transporters"	Angiogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	4	"Lymphatic endothelial cells: 193.6"	"Cell type enriched"	"Detected in some"	8	"endothelial cell: 32.6"	"Cancer enhanced"	"Detected in all"		"Kidney Renal Clear Cell Carcinoma (TCGA): 20.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"MAIT T-cell: 3.8"	"Lineage enriched"	"Detected in single"	14	"T-cells: 3.8"	"Low cancer specificity"	"Detected in many"			"Kidney - Endothelial cells, Liver - Vascular Endothelial cells, Minor Salivary Gland - Endothelial cells, Pancreas - Endothelial cells, Prostate - Endothelial cells, Skeletal muscle - Endothelial cells"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA067906, HPA074389"	Approved		Approved	"Microtubules,Cytokinetic bridge,Primary cilium,Calyx,Connecting piece,Mid piece,Principal piece"	"Secreted to blood"	Receptor	Yes	NA	20000000	170000000	"Cluster 1: T-cells - Unknown function"	"Cluster 47: Spleen - Immune response"	"Cluster 47: Endothelial cells - Vasculature"	"Cluster 54: Non-specific - Transcription"	"Cluster 54: Lymphatic endothelial cells - Lymph vessel development"	24	"Microtubules, Primary cilium"	"Cytokinetic bridge, Calyx, Connecting piece, Mid piece, Principal piece"	"HPA067906: AB_2732775, HPA074389: "	"unprognostic (4.13e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.15e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.14e-2)"	"unprognostic (7.99e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.09e-2)"	"validated prognostic favorable (5.61e-6)"	"validated prognostic favorable (8.45e-5)"	"unprognostic (8.98e-2)"	"unprognostic (4.80e-2)"	"potential prognostic favorable (2.55e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.98e-2)"	"potential prognostic unfavorable (9.96e-4)"	"unprognostic (6.93e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.34e-1)"	"unprognostic (9.09e-3)"	"unprognostic (4.82e-2)"	"unprognostic (9.24e-2)"	"unprognostic (7.37e-2)"	"unprognostic (6.89e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.47e-2)"
FN1	"CIG, FINC, GFND2, LETS, MSF"	ENSG00000115414	"Fibronectin 1"	P02751	2	215360440-215436073	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase, Angiogenesis, Cell adhesion, Cell shape"	Heparin-binding	"Cancer-related genes, Disease variant, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 1674.5;placenta: 2828.8"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 3161.0;Fibroblasts: 697.7;Hepatocytes: 800.2;Pancreatic endocrine cells: 517.9;Smooth muscle cells: 482.6"	"Cell type enhanced"	"Detected in all"		"endothelial cell: 716.1;pericyte: 1227.5"	"Cancer enhanced"	"Detected in all"		"Thyroid Carcinoma (TCGA): 3346.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in all"		"testis cancer: 4284.8;thyroid cancer: 4456.7"	"Adipose subcutaneous - Adipose progenitor cells, Breast - Fibroblasts, Colon - Smooth muscle cells, Prostate - Smooth muscle cells, Skeletal muscle - Fibroblasts, Skin - Fibroblast_2, Spleen - Smooth muscle cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000126, HPA027066"	Enhanced				"Secreted to blood"	"Acute phase"	NA	NA	227000000000	80000000000		"Cluster 11: Liver - Plasma proteins"	"Cluster 12: Non-specific - Vasculature"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 32: Smooth muscle cells - Muscle contraction"	59			"CAB000126: , HPA027066: AB_10602500"	"unprognostic (2.38e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.37e-1)"	"potential prognostic unfavorable (8.26e-4)"	"unprognostic (2.89e-2)"	"unprognostic (2.20e-1)"	"unprognostic (9.78e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.21e-2)"	"potential prognostic unfavorable (4.98e-7)"	"unprognostic (9.55e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.32e-3)"	"unprognostic (7.42e-3)"	"unprognostic (9.45e-3)"	"potential prognostic unfavorable (3.40e-4)"	"unprognostic (7.71e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.05e-1)"	"unprognostic (3.47e-1)"	"unprognostic (9.78e-3)"	"unprognostic (1.01e-1)"	"potential prognostic unfavorable (3.60e-4)"	"unprognostic (8.07e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.75e-2)"
FNTA	"FPTA, PGGT1A, PTAR2"	ENSG00000168522	"Farnesyltransferase, CAAX box, alpha"	P49354	8	43034194-43085788	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		"Prenyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 229.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010149, HPA018830"	Approved		Approved	Cytosol			NA	NA		190000	"Cluster 25: Non-specific - Unknown function"	"Cluster 54: Non-specific - Basic cellular processes"	"Cluster 28: Oligodendrocytes - Mixed function"	"Cluster 40: Non-specific - Unknown function"	"Cluster 24: Cytotrophoblasts - Mitochondria"	13	Cytosol		"CAB010149: AB_2106299, HPA018830: AB_1848992"	"unprognostic (1.09e-1)"	"unprognostic (5.68e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.71e-3)"	"unprognostic (9.94e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.93e-3)"	"unprognostic (6.71e-3)"	"potential prognostic unfavorable (1.07e-5)"	"unprognostic (3.41e-3)"	"unprognostic (1.92e-2)"	"potential prognostic unfavorable (2.27e-5)"	"unprognostic (4.52e-2)"	"unprognostic (6.93e-2)"	"unprognostic (7.90e-3)"	"unprognostic (6.67e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.42e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.64e-1)"	"unprognostic (2.56e-1)"	"unprognostic (6.75e-2)"	"unprognostic (3.65e-1)"	"unprognostic (6.14e-2)"	"unprognostic (6.45e-3)"
FNTB	FPTB	ENSG00000257365	"Farnesyltransferase, CAAX box, beta"	P49356	14	64986895-65062652	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism"	"Prenyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"brain: 84.8"	"Cell type enhanced"	"Detected in many"		"Sertoli cells: 43.5"	"Cell type enhanced"	"Detected in all"		"oligodendrocyte: 210.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Skin - Keratinocyte (other), Spleen - Fibroblast_1, Testis - Sertoli cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062743	Uncertain		Approved	Centrosome			NA	NA			"Cluster 42: Non-specific - Vesicular transport"	"Cluster 9: Oligodendrocytes - Myelination"	"Cluster 30: White matter - Myelination"	"Cluster 69: Skin cancer - ECM organization"	"Cluster 57: Platelets - Hemostasis"	32	Centrosome		"HPA062743: AB_2684861"	"unprognostic (1.06e-2)"	"unprognostic (7.93e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.93e-1)"	"unprognostic (7.04e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.02e-1)"	"potential prognostic favorable (3.25e-5)"	"unprognostic (1.46e-2)"	"unprognostic (7.13e-2)"	"potential prognostic unfavorable (2.92e-5)"	"unprognostic (7.40e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.44e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.20e-1)"	"unprognostic (9.05e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.00e-2)"	"unprognostic (6.98e-2)"	"unprognostic (4.80e-1)"	"unprognostic (1.28e-1)"	"unprognostic (9.97e-2)"
FOLH1	"FOLH, GCP2, GCPII, NAALAD1, NAALAdase, PSM, PSMA"	ENSG00000086205	"Folate hydrolase 1"	Q04609	11	49145092-49208638	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Carboxypeptidase, Dipeptidase, Hydrolase, Metalloprotease, Multifunctional enzyme, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 259.0;prostate: 73.4"	"Group enriched"	"Detected in many"	13	"Oligodendrocytes: 342.1;Prostatic glandular cells: 547.4"	"Cell type enriched"	"Detected in many"	5	"oligodendrocyte: 694.1"	"Cancer enriched"	"Detected in all"	17	"Prostate Adenocarcinoma (TCGA): 277.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	25	"prostate cancer: 262.4;Rhabdoid: 177.2"	"Kidney - Proximal tubular cells, Kidney - Proximal tubular cells, Liver - Hepatocytes, Lung - Fibroblast_1, Minor Salivary Gland - Minor salivary glandular cells, Pancreas - Fibroblasts, Prostate - Prostate glandular cells, Stomach - Fibroblasts, Thyroid gland - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001451, HPA010593"	Enhanced				"Intracellular and membrane"	Enzyme	NA	NA				"Cluster 25: Small intestine - Absorption"	"Cluster 11: White matter - Signal transduction"	"Cluster 3: Rhabdoid - Membrane components"	"Cluster 40: Prostatic glandular cells - Transcription"				"CAB001451: AB_563979, HPA010593: AB_1079685"	"unprognostic (5.40e-3)"	"unprognostic (4.91e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.46e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.78e-1)"	"unprognostic (9.93e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.20e-1)"	"potential prognostic favorable (3.69e-6)"	"unprognostic (1.86e-2)"	"potential prognostic unfavorable (3.87e-5)"	"unprognostic (1.76e-3)"	"unprognostic (9.30e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.69e-2)"	"potential prognostic favorable (2.33e-4)"	"unprognostic (5.53e-3)"	"unprognostic (1.14e-2)"	"unprognostic (4.44e-3)"	"unprognostic (7.67e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.39e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.34e-1)"	"unprognostic (9.35e-2)"	"unprognostic (1.47e-1)"
FOLR1	"FOLR, FRalpha"	ENSG00000110195	"Folate receptor alpha"	P15328	11	72189558-72196323	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	Transport	Receptor	"FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	14	"choroid plexus: 2944.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 387.7;Alveolar cells type 2: 264.2;Breast glandular cells: 223.4;Ciliated cells: 209.6;Collecting duct cells: 254.8;Cytotrophoblasts: 468.5;Proximal tubular cells: 245.3;Secretory cells: 415.8;Syncytiotrophoblasts: 323.9"	"Group enriched"	"Detected in many"	4	"choroid plexus epithelial cell: 156.2;ependymal cell: 44.1"	"Cancer enhanced"	"Detected in many"		"Ovary Serous Cystadenocarcinoma (TCGA): 633.3"	"Region enriched"	"Detected in all"	38	"choroid plexus: 993.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"ovarian cancer: 85.2"	"Kidney - Proximal tubular cells, Lung - Alveolar cells type 1, Minor Salivary Gland - Minor salivary glandular cells, Pituitary gland - Undifferentiated cells (Pituitary gland), Skin - Eccrine sweat gland cells, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted to blood"	Receptor	NA	NA	448000	58000		"Cluster 60: Choroid plexus - Transmembrane transport"	"Cluster 36: Choroid plexus - Mixed function"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 17: Breast glandular cells - Lactation"	4				"unprognostic (1.62e-2)"	"unprognostic (3.07e-1)"	"unprognostic (7.33e-2)"	"unprognostic (3.44e-1)"	"unprognostic (8.91e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.36e-3)"	"unprognostic (1.16e-3)"	"unprognostic (1.05e-2)"	"unprognostic (2.85e-1)"	"potential prognostic favorable (3.68e-4)"	"unprognostic (2.11e-1)"	"unprognostic (6.32e-2)"	"potential prognostic unfavorable (3.17e-4)"	"unprognostic (4.26e-2)"	"unprognostic (4.55e-3)"	"unprognostic (6.90e-2)"	"unprognostic (5.50e-2)"	"unprognostic (8.25e-2)"	"unprognostic (5.34e-2)"	"unprognostic (7.13e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.35e-1)"	"unprognostic (9.84e-3)"	"unprognostic (2.70e-1)"	"unprognostic (3.06e-2)"		"unprognostic (1.71e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.19e-2)"
FPGS		ENSG00000136877	"Folylpolyglutamate synthase"	Q05932	9	127794597-127814327	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"One-carbon metabolism"	Ligase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Mesothelial cells: 79.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Adipocytes (Subcutaneous), Adrenal gland - Neutrophils"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050488	Approved				"Intracellular and membrane"	Enzyme	NA	NA			"Cluster 8: Plasmacytoid DCs - Unknown function"	"Cluster 68: Non-specific - Protein processing"	"Cluster 44: Non-specific - Mixed function"	"Cluster 6: Leukemia - Signal transduction"	"Cluster 45: Non-specific - Mixed function"				"HPA050488: AB_2681143"	"unprognostic (7.32e-2)"	"unprognostic (6.75e-2)"	"unprognostic (6.84e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.54e-3)"	"unprognostic (2.41e-2)"	"unprognostic (3.85e-1)"	"unprognostic (9.84e-3)"	"unprognostic (1.66e-1)"	"unprognostic (5.11e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.05e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.22e-2)"	"potential prognostic unfavorable (3.57e-4)"	"unprognostic (2.51e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.69e-2)"	"unprognostic (4.17e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.61e-2)"
FRK	"GTK, PTK5, RAK"	ENSG00000111816	"Fyn related Src family tyrosine kinase"	P42685	6	115931149-116060891	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"FDA approved drug targets, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 100.5;Oligodendrocytes: 91.0;Proximal enterocytes: 47.1"	"Group enriched"	"Detected in all"	4	"choroid plexus epithelial cell: 405.1;oligodendrocyte: 103.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Adipose subcutaneous - Smooth muscle cells, Minor Salivary Gland - Minor salivary glandular cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB025217, HPA030479, HPA072590"	Approved		Supported	Nucleoplasm,Cytosol			NA	NA				"Cluster 55: Kidney & Intestine - Metabolism"	"Cluster 9: Non-specific - Receptor signaling"	"Cluster 57: Stomach & Colon cancer - Digestion"	"Cluster 51: Oligodendrocytes - Unknown function"	13	Nucleoplasm	Cytosol	"CAB025217: , HPA030479: AB_2732457, HPA072590: "	"unprognostic (4.65e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.96e-1)"		"unprognostic (2.40e-1)"	"unprognostic (8.41e-2)"	"potential prognostic unfavorable (6.97e-4)"	"potential prognostic favorable (4.58e-7)"	"unprognostic (1.21e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.22e-2)"	"unprognostic (3.11e-1)"	"unprognostic (8.42e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.67e-1)"	"unprognostic (4.76e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.13e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.83e-1)"	"unprognostic (7.48e-2)"	"potential prognostic favorable (8.81e-4)"	"unprognostic (6.21e-2)"		"unprognostic (7.16e-2)"	"unprognostic (1.81e-1)"		"unprognostic (1.91e-1)"
FSHR	"FSHRO, LGR1, ODG1"	ENSG00000170820	"Follicle stimulating hormone receptor"	P23945	2	48962157-49154527	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"ovary: 2.7;testis: 2.2"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 1.8;Excitatory neurons: 9.7;Granulosa cells: 5.2;Late spermatids: 8.1;Oligodendrocyte precursor cells: 2.8;Sertoli cells: 2.7"	"Group enriched"	"Detected in many"	4	"bergmann glia: 147.8;deep-layer near-projecting: 94.2;mammillary body: 193.1;thalamic excitatory: 48.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Testis - Sertoli cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Intracellular and membrane"	Receptor	NA	NA				"Cluster 74: Spermatids - Flagellum assembly"	"Cluster 44: Non-specific - Mixed function"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 34: Neurons - Neuronal signaling"	4																																		
FTH1	"FHC, FTH, FTHL6, PIG15, PLIF"	ENSG00000167996	"Ferritin heavy chain 1"	P02794	11	61959718-61967634	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Iron storage"	Oxidoreductase	"Cancer-related genes, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 53887.5;monocytes: 46189.2;Proximal enterocytes: 29978.1"	"Cell type enhanced"	"Detected in all"		"oligodendrocyte: 1714.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"							CAB008623	Approved						NA	NA		4000000	"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 9: Oligodendrocytes - Myelination"	"Cluster 7: Non-specific - Ribosome"	"Cluster 7: Liver cancer - Metabolism"	"Cluster 14: Langerhans cells - Innate immune response"	43			"CAB008623: "	"unprognostic (1.98e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.58e-2)"	"unprognostic (3.19e-2)"	"unprognostic (5.05e-3)"	"potential prognostic unfavorable (7.62e-4)"	"unprognostic (4.20e-3)"	"potential prognostic unfavorable (1.19e-4)"	"unprognostic (6.80e-3)"	"unprognostic (2.87e-2)"	"validated prognostic unfavorable (3.05e-4)"	"validated prognostic unfavorable (1.12e-4)"	"unprognostic (1.91e-2)"	"unprognostic (3.41e-2)"	"unprognostic (9.69e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.47e-2)"	"unprognostic (9.86e-3)"	"unprognostic (8.00e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.98e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.31e-1)"	"unprognostic (6.70e-2)"
FTL	"MGC71996, NBIA3"	ENSG00000087086	"Ferritin light chain"	P02792	19	48965309-48966879	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Iron storage"		"Cancer-related genes, Cataract, Disease variant, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 14070.0"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 29778.7;Hofbauer cells: 77810.9;Kupffer cells: 52544.7;Macrophages: 30310.5;monocytes: 24547.4;Proximal tubular cells: 53178.3"	"Cell type enhanced"	"Detected in all"		"central nervous system macrophage: 1112.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"granulocytes: 125828.8;monocytes: 102246.5"	"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Kidney - Proximal tubular cells, Kidney - Proximal tubular cells, Lung - Macrophages, Minor Salivary Gland - Macrophages, Spleen - Macrophages"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020769, HPA041602"	Enhanced		Approved	Cytosol			NA	NA		100000000	"Cluster 29: Non-specific - Unknown function"	"Cluster 11: Liver - Plasma proteins"	"Cluster 27: Non-specific - Mixed function"	"Cluster 7: Liver cancer - Metabolism"	"Cluster 58: Macrophages - Innate immune response"	123	Cytosol		"CAB020769: , HPA041602: AB_2677575"	"unprognostic (3.14e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.68e-2)"	"unprognostic (3.77e-3)"	"unprognostic (1.71e-1)"	"unprognostic (4.44e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.01e-1)"	"potential prognostic unfavorable (4.85e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.56e-1)"	"unprognostic (9.84e-2)"	"unprognostic (6.87e-3)"	"unprognostic (9.80e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.15e-2)"	"unprognostic (9.63e-3)"	"unprognostic (2.01e-2)"
FXYD2	"ATP1G1, HOMG2, MGC12372"	ENSG00000137731	"FXYD domain containing ion transport regulator 2"	P54710	11	117800844-117828698	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"		"Disease variant, FDA approved drug targets, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"kidney: 3540.9"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 1055.0;Distal tubular cells: 4293.6;Ductal cells: 1077.7;Proximal tubular cells: 4148.6"	"Cell type enhanced"	"Detected in single"		"committed oligodendrocyte precursor: 1.1"	"Group enriched"	"Detected in many"	10	"Kidney Chromophobe (TCGA): 5066.0;Kidney Renal Clear Cell Carcinoma (TCGA): 1982.2;Kidney Renal Papillary Cell Carcinoma (TCGA): 2051.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"memory CD8 T-cell: 14.8;naive CD4 T-cell: 5.1;naive CD8 T-cell: 4.4;NK-cell: 9.6;plasmacytoid DC: 3.8"	"Group enriched"	"Detected in many"	7	"dendritic cells: 3.8;NK-cells: 9.6;T-cells: 14.8"	"Cancer enhanced"	"Detected in many"		"Kidney cancer: 220.9;Uterine cancer: 89.5"	"Liver - Cholangiocyte, Minor Salivary Gland - Minor salivary gland ductal cells, Stomach - Fibroblasts"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in some"	5	"spinal cord: 30.5"	"HPA064218, HPA068838"	Supported		Approved	Mitochondria			NA	NA			"Cluster 24: Non-specific - Transcription"	"Cluster 52: Kidney - Transmembrane transport"	"Cluster 53: Neurons - Mixed function"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 38: Proximal tubular cells - Transmembrane transport"	1	Mitochondria		"HPA064218: AB_2685214, HPA068838: AB_2686047"	"unprognostic (2.74e-1)"	"unprognostic (7.26e-3)"	"unprognostic (1.03e-2)"	"potential prognostic favorable (9.17e-4)"	"unprognostic (5.31e-2)"	"unprognostic (6.59e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.67e-3)"	"unprognostic (5.18e-2)"	"unprognostic (1.45e-2)"	"potential prognostic favorable (1.05e-6)"	"unprognostic (1.30e-3)"	"potential prognostic favorable (8.22e-6)"	"unprognostic (1.06e-3)"	"unprognostic (3.04e-2)"	"unprognostic (4.99e-3)"	"unprognostic (9.11e-2)"	"unprognostic (1.17e-1)"	"unprognostic (9.82e-2)"	"unprognostic (9.50e-2)"		"unprognostic (1.25e-2)"	"unprognostic (5.90e-3)"		"unprognostic (2.01e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.07e-1)"	"unprognostic (5.20e-2)"
GAA		ENSG00000171298	"Alpha glucosidase"	P10253	17	80101556-80119881	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"	"Disease variant, FDA approved drug targets, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 151.0;Extravillous trophoblasts: 163.0;Syncytiotrophoblasts: 158.2"	"Cell type enhanced"	"Detected in all"		"central nervous system macrophage: 99.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 66.6;eosinophil: 22.9;intermediate monocyte: 50.3;myeloid DC: 39.8;neutrophil: 27.1;non-classical monocyte: 69.0"	"Group enriched"	"Detected in all"	10	"dendritic cells: 39.8;granulocytes: 27.1;monocytes: 69.0"	"Low cancer specificity"	"Detected in all"			"Lung - Macrophages, Spleen - Macrophages, Testis - Early spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026970, HPA029126"	Enhanced		Approved	Vesicles			NA	NA		6400000	"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 44: Testis - Spermatogenesis"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 27: Breast cancer - Unknown function"	"Cluster 58: Macrophages - Innate immune response"	38	Vesicles		"HPA026970: AB_2672065, HPA029126: AB_2672918"	"unprognostic (7.79e-2)"	"unprognostic (3.90e-2)"	"unprognostic (5.84e-2)"	"unprognostic (2.48e-2)"	"unprognostic (9.18e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.35e-1)"	"unprognostic (9.13e-2)"	"unprognostic (7.29e-3)"	"unprognostic (3.29e-3)"	"unprognostic (6.43e-2)"	"unprognostic (1.50e-2)"	"unprognostic (6.82e-2)"	"unprognostic (5.99e-3)"	"unprognostic (8.95e-2)"	"unprognostic (8.61e-2)"	"unprognostic (3.71e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.65e-1)"	"unprognostic (4.74e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.29e-2)"	"unprognostic (7.76e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.92e-1)"	"unprognostic (7.70e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.36e-3)"	"unprognostic (3.25e-1)"
GABBR1	"GPRC3A, hGB1a"	ENSG00000204681	"Gamma-aminobutyric acid type B receptor subunit 1"	Q9UBS5	6	29555629-29633976	"FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, FDA approved drug targets, Intellectual disability"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 228.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 142.7;Excitatory neurons: 56.7;Horizontal cells: 56.0;Inhibitory neurons: 65.2;Oligodendrocyte precursor cells: 67.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050483	Uncertain		Uncertain	"Basal body,Cytosol"	"Intracellular and membrane"	Receptor	NA	NA				"Cluster 64: Neuronal - Transcription"	"Cluster 38: Sub-cortical - Mixed function"	"Cluster 47: Leukemia - Hemostasis"	"Cluster 47: Astrocytes - Unknown function"	13	"Basal body, Cytosol"		"HPA050483: AB_2681140"	"unprognostic (1.47e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.41e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.33e-1)"	"potential prognostic favorable (5.87e-5)"	"unprognostic (3.27e-2)"		"potential prognostic unfavorable (7.31e-7)"	"unprognostic (2.47e-2)"	"unprognostic (2.53e-1)"		"potential prognostic favorable (5.06e-5)"	"unprognostic (1.22e-2)"		"unprognostic (1.02e-1)"	"unprognostic (1.54e-2)"	"unprognostic (9.51e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.97e-3)"	"unprognostic (1.35e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.89e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.84e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.47e-1)"
GABBR2	"GABABR2, GPR51, GPRC3B, HG20"	ENSG00000136928	"Gamma-aminobutyric acid type B receptor subunit 2"	O75899	9	98288109-98708935	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, Epilepsy, FDA approved drug targets, Intellectual disability"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"brain: 62.9"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 373.5;Inhibitory neurons: 377.6"	"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"Bladder Urothelial Carcinoma (TCGA): 6.9;Glioblastoma Multiforme (TCGA): 12.3;Thyroid Carcinoma (TCGA): 17.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"thyroid cancer: 8.9"	"Adrenal gland - Adrenal cortex cells, Pituitary gland - Undifferentiated cells (Pituitary gland), Testis - Late spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013820, HPA031684, CAB079065"	Enhanced	Approved					NA	NA				"Cluster 22: Brain - Synaptic signal transduction"	"Cluster 40: Astrocytes - Astrocyte-neuron interactions"	"Cluster 48: Adipocytes & Endothelial cells - Angiogenesis"	"Cluster 65: Neurons - Synaptic function"	8			"CAB079065: , HPA013820: AB_1849364, HPA031684: AB_2673993"	"unprognostic (6.06e-2)"						"unprognostic (3.72e-1)"	"unprognostic (8.43e-3)"								"unprognostic (9.94e-2)"	"unprognostic (5.70e-1)"			"unprognostic (1.76e-2)"									"unprognostic (2.63e-1)"	"unprognostic (4.26e-2)"	
GABRA1	EJM5	ENSG00000022355	"Gamma-aminobutyric acid type A receptor subunit alpha1"	P14867	5	161847063-161899981	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	30	"brain: 54.1;retina: 17.3"	"Group enriched"	"Detected in some"	6	"Bipolar cells: 169.6;Excitatory neurons: 213.3;Inhibitory neurons: 206.2"	"Cell type enhanced"	"Detected in all"		"cerebellar inhibitory: 583.1"	"Cancer enhanced"	"Detected in single"		"Glioblastoma Multiforme (TCGA): 1.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	7	"breast cancer: 3.7"	"Adrenal gland - Adrenal medulla cells, Stomach - Gastric enteroendocrine cells, Testis - Early spermatids, Testis - Late spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022502, HPA029363, HPA055746"	Enhanced	Supported	Supported	"Nucleoplasm,Plasma membrane"			NA	NA				"Cluster 22: Brain - Synaptic signal transduction"	"Cluster 53: Neurons - Mixed function"	"Cluster 70: DU4475 - Unknown function"	"Cluster 25: Bipolar cells - Visual perception"	13	"Plasma membrane"	Nucleoplasm	"CAB022502: , HPA029363: , HPA055746: AB_2682904"							"unprognostic (1.08e-1)"	"unprognostic (1.27e-1)"																							
GABRA2		ENSG00000151834	"Gamma-aminobutyric acid type A receptor subunit alpha2"	P47869	4	46243548-46475230	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 38.6"	"Group enriched"	"Detected in many"	4	"Astrocytes: 403.5;Excitatory neurons: 151.0;Inhibitory neurons: 106.6"	"Cell type enhanced"	"Detected in all"		"bergmann glia: 1113.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Rhabdoid: 7.6"	"Breast - Endothelial cells, Pituitary gland - Somatotropes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029363, CAB079061"		Supported	Approved	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	Receptor	NA	NA				"Cluster 61: Brain - Neuronal signaling"	"Cluster 51: Neurons - Mixed function"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 34: Neurons - Neuronal signaling"	3	"Plasma membrane"	Nucleoplasm	"CAB079061: , HPA029363: "					"unprognostic (6.84e-2)"	"unprognostic (6.00e-3)"	"unprognostic (1.92e-2)"	"unprognostic (3.72e-2)"															"unprognostic (1.82e-1)"		"unprognostic (1.36e-1)"	"unprognostic (1.27e-3)"		"unprognostic (1.22e-1)"			
GABRA3		ENSG00000011677	"Gamma-aminobutyric acid type A receptor subunit alpha3"	P34903	X	152166234-152451315	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 16.9;choroid plexus: 33.0;retina: 8.7"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 67.9;Hofbauer cells: 13.8;Inhibitory neurons: 21.3;Oligodendrocyte precursor cells: 54.7"	"Low cell type specificity"	"Detected in all"			"Cancer enriched"	"Detected in many"	6	"Testicular Germ Cell Tumor (TCGA): 26.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Colon - Colon enteroendocrine cells, Testis - Spermatogonia"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000839, HPA029363"	Approved	Supported	Approved	"Nucleoplasm,Plasma membrane"			NA	NA				"Cluster 60: Choroid plexus - Transmembrane transport"	"Cluster 23: Choroid plexus - Mixed function"	"Cluster 32: Non-specific - Cell proliferation"	"Cluster 34: Neurons - Neuronal signaling"		"Plasma membrane"	Nucleoplasm	"HPA000839: AB_1078929, HPA029363: "	"unprognostic (1.26e-3)"			"unprognostic (2.28e-1)"			"unprognostic (7.92e-2)"	"potential prognostic favorable (9.98e-5)"	"unprognostic (1.63e-1)"							"unprognostic (2.42e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.86e-2)"							"unprognostic (2.21e-1)"	"unprognostic (1.60e-3)"	"unprognostic (5.85e-2)"		
GABRA4		ENSG00000109158	"Gamma-aminobutyric acid type A receptor subunit alpha4"	P48169	4	46918900-46993581	"FDA approved drug targets, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"brain: 9.7;heart muscle: 2.4"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 120.8;Inhibitory neurons: 153.2"	"Low cell type specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Adipose subcutaneous - Smooth muscle cells, Colon - Colon enteroendocrine cells, Pituitary gland - Lactotropes, Skin - Sebaceous gland cells, Testis - Early spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"										NA	NA				"Cluster 61: Brain - Neuronal signaling"	"Cluster 53: Neurons - Mixed function"	"Cluster 6: Leukemia - Signal transduction"	"Cluster 65: Neurons - Synaptic function"												"unprognostic (2.25e-1)"																							
GABRA5		ENSG00000186297	"Gamma-aminobutyric acid type A receptor subunit alpha5"	P31644	15	26866911-26949208	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"brain: 113.2"	"Group enriched"	"Detected in some"	10	"Excitatory neurons: 26.6;Inhibitory neurons: 13.5"	"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"Glioblastoma Multiforme (TCGA): 2.4;Lung Squamous Cell Carcinoma (TCGA): 1.4;Skin Cuteneous Melanoma (TCGA): 1.6;Testicular Germ Cell Tumor (TCGA): 2.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	6	"Rhabdoid: 22.0"		"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA029363, HPA077031, CAB079022"		Supported	Supported	"Nucleoplasm,Plasma membrane,Actin filaments,Cytosol"			NA	NA				"Cluster 33: Brain - Neuronal signaling"	"Cluster 51: Neurons - Mixed function"	"Cluster 1: Neuronal - Visual perception"	"Cluster 34: Neurons - Neuronal signaling"		"Plasma membrane"	"Nucleoplasm, Actin filaments, Cytosol"	"CAB079022: , HPA029363: , HPA077031: AB_2686825"							"unprognostic (1.45e-1)"	"unprognostic (5.29e-2)"										"unprognostic (9.13e-2)"									"unprognostic (1.46e-1)"		"unprognostic (4.71e-2)"		
GABRA6		ENSG00000145863	"Gamma-aminobutyric acid type A receptor subunit alpha6"	Q16445	5	161547063-161702593	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	281	"brain: 203.5"	"Cell type enhanced"	"Detected in single"		"Cone photoreceptor cells: 1.7"	"Cell type enhanced"	"Detected in many"		"upper rhombic lip: 194.6"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	14	"cerebellum: 150.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Testis - Sertoli cells"	"Region enriched"	"Detected in some"	40	"cerebellum: 1073.9"	"Region enriched"	"Detected in some"	39	"cerebellum: 263.8"	CAB022462	Approved						NA	NA				"Cluster 65: Cerebellum - Nervous system development"	"Cluster 35: Non-specific - DNA binding"	"Cluster 1: Neuronal - Visual perception"	"Cluster 65: Neurons - Synaptic function"				"CAB022462: "																															
GABRB1		ENSG00000163288	"Gamma-aminobutyric acid type A receptor subunit beta1"	P18505	4	46993723-47426447	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 13.3;heart muscle: 3.5"	"Group enriched"	"Detected in some"	15	"Astrocytes: 878.4;Excitatory neurons: 425.6;Inhibitory neurons: 485.1;Oligodendrocyte precursor cells: 250.5"	"Cell type enhanced"	"Detected in all"		"bergmann glia: 2822.9"	"Cancer enriched"	"Detected in single"	6	"Glioblastoma Multiforme (TCGA): 1.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Minor Salivary Gland - Minor salivary glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"										NA	NA				"Cluster 61: Brain - Neuronal signaling"	"Cluster 51: Neurons - Mixed function"	"Cluster 72: Neuronal - Signal transduction"	"Cluster 47: Astrocytes - Unknown function"	1										"unprognostic (3.02e-2)"	"unprognostic (3.05e-1)"																							
GABRB2		ENSG00000145864	"Gamma-aminobutyric acid type A receptor subunit beta2"	P47870	5	161288429-161549044	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 44.0"	"Group enriched"	"Detected in many"	20	"Excitatory neurons: 551.3;Inhibitory neurons: 748.3"	"Low cell type specificity"	"Detected in all"			"Cancer enriched"	"Detected in some"	18	"Thyroid Carcinoma (TCGA): 20.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Myeloma: 1.8"	"Adipose subcutaneous - Macrophages, Minor Salivary Gland - Minor salivary gland ductal cells, Testis - Spermatogonia"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001964, HPA067632"	Enhanced						NA	NA				"Cluster 22: Brain - Synaptic signal transduction"	"Cluster 53: Neurons - Mixed function"	"Cluster 17: Neuroblastoma - Neuronal signaling"	"Cluster 65: Neurons - Synaptic function"	3			"CAB001964: , HPA067632: AB_2685874"			"unprognostic (7.57e-3)"			"unprognostic (1.61e-3)"	"unprognostic (3.28e-2)"	"unprognostic (1.53e-1)"																		"unprognostic (2.09e-2)"				"unprognostic (8.55e-3)"	
GABRB3		ENSG00000166206	"Gamma-aminobutyric acid type A receptor subunit beta3"	P28472	15	26543552-26939539	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 45.7;retina: 29.3"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 129.9;Excitatory neurons: 502.0;Inhibitory neurons: 247.4;Oligodendrocyte precursor cells: 131.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Neuroblastoma: 47.4"	"Colon - Colon enteroendocrine cells, Testis - Spermatocytes, Testis - Spermatogonia"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"										NA	NA				"Cluster 17: Neuronal - Synaptic function"	"Cluster 51: Neurons - Mixed function"	"Cluster 17: Neuroblastoma - Neuronal signaling"	"Cluster 34: Neurons - Neuronal signaling"	2				"unprognostic (1.47e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.50e-1)"			"unprognostic (2.78e-1)"	"unprognostic (4.24e-2)"	"potential prognostic favorable (2.55e-4)"			"validated prognostic favorable (7.47e-9)"	"validated prognostic favorable (8.18e-4)"	"unprognostic (8.44e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.51e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.24e-1)"			"unprognostic (3.25e-2)"	"unprognostic (4.82e-2)"	"unprognostic (2.93e-1)"		"unprognostic (1.17e-1)"	"unprognostic (2.72e-1)"	"unprognostic (8.64e-3)"	"unprognostic (1.25e-1)"	"unprognostic (8.12e-2)"	
GABRD		ENSG00000187730	"Gamma-aminobutyric acid type A receptor subunit delta"	O14764	1	2019329-2030758	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	74	"brain: 259.8"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 14.4;Excitatory neurons: 29.0;Horizontal cells: 23.9;Inhibitory neurons: 36.0;Microglial cells: 8.1;Spermatogonia: 14.8"	"Cell type enhanced"	"Detected in many"		"LAMP5-LHX6 and Chandelier: 138.2;upper rhombic lip: 165.5"	"Cancer enhanced"	"Detected in many"		"Kidney Renal Clear Cell Carcinoma (TCGA): 12.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Rhabdoid: 2.1"		"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044371	Enhanced		Uncertain	"Golgi apparatus,Vesicles"			NA	NA				"Cluster 65: Cerebellum - Nervous system development"	"Cluster 37: Neurons - Mixed function"	"Cluster 27: Breast cancer - Unknown function"	"Cluster 65: Neurons - Synaptic function"	13	"Golgi apparatus, Vesicles"		"HPA044371: AB_2678916"	"potential prognostic unfavorable (7.19e-6)"	"unprognostic (3.31e-3)"	"unprognostic (1.59e-1)"	"unprognostic (7.05e-2)"			"unprognostic (1.50e-3)"	"unprognostic (1.96e-2)"		"unprognostic (3.25e-1)"	"validated prognostic favorable (1.20e-4)"	"validated prognostic favorable (2.26e-4)"		"unprognostic (4.20e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.07e-1)"		"unprognostic (1.04e-1)"				"unprognostic (4.25e-2)"	"unprognostic (2.00e-2)"		"unprognostic (1.62e-1)"		"potential prognostic unfavorable (5.28e-6)"	"unprognostic (1.72e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.91e-1)"	
GABRE		ENSG00000102287	"Gamma-aminobutyric acid type A receptor subunit epsilon"	P78334	X	151953124-151974680	"FDA approved drug targets, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 9.3;brain: 13.8;heart muscle: 9.1"	"Cell type enhanced"	"Detected in many"		"Mucus glandular cells: 63.5;Syncytiotrophoblasts: 76.6"	"Cell type enhanced"	"Detected in many"		"fibroblast: 26.5;pericyte: 48.6;vascular associated smooth muscle cell: 25.6"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"cerebral cortex: 33.2;hypothalamus: 103.9;midbrain: 81.8;pons: 74.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Pituitary gland - Endothelial cells, Spleen - Fibroblast_1"	"Region enriched"	"Detected in many"	4	"hypothalamus: 18.5"	"Region enhanced"	"Detected in many"		"hypothalamus: 45.2"	HPA045918	Uncertain						NA	NA				"Cluster 30: Heart muscle - Heart development"	"Cluster 56: Hypothalamus - Neuropeptide signaling"	"Cluster 7: Liver cancer - Metabolism"	"Cluster 35: Respiratory epithelial cells - Unknown function"	6			"HPA045918: AB_10961281"			"potential prognostic favorable (2.81e-4)"	"unprognostic (1.18e-2)"		"unprognostic (5.81e-2)"	"unprognostic (2.95e-1)"	"unprognostic (9.26e-2)"				"unprognostic (1.02e-1)"			"unprognostic (2.11e-2)"			"unprognostic (1.50e-1)"	"unprognostic (4.31e-2)"		"unprognostic (7.07e-2)"		"potential prognostic unfavorable (1.12e-4)"			"unprognostic (3.74e-2)"					
GABRG1		ENSG00000163285	"Gamma-aminobutyric acid type A receptor subunit gamma1"	Q8N1C3	4	46035769-46124054	"FDA approved drug targets, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 21.5"	"Cell type enriched"	"Detected in some"	4	"Astrocytes: 128.5"	"Cell type enhanced"	"Detected in many"		"bergmann glia: 350.0;ependymal cell: 484.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"Adrenocortical cancer: 1.4;Myeloma: 2.3"		"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035622, HPA058102"	Approved		Supported	"Plasma membrane"			NA	NA				"Cluster 33: Brain - Neuronal signaling"	"Cluster 56: Hypothalamus - Neuropeptide signaling"	"Cluster 11: Neuronal - Sensory perception"	"Cluster 47: Astrocytes - Unknown function"	1	"Plasma membrane"		"HPA035622: AB_10603669, HPA058102: "								"unprognostic (1.42e-2)"																							
GABRG2		ENSG00000113327	"Gamma-aminobutyric acid type A receptor subunit gamma2"	P18507	5	162000057-162162977	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 42.1;retina: 10.8"	"Group enriched"	"Detected in some"	9	"Bipolar cells: 110.3;Excitatory neurons: 232.1;Horizontal cells: 68.0;Inhibitory neurons: 160.7"	"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"Testicular Germ Cell Tumor (TCGA): 15.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 4.6"	"Group enriched"	"Detected in many"	5	"B-cells: 1.6;granulocytes: 4.6;T-cells: 1.5"	"Cancer enhanced"	"Detected in all"		"Gallbladder cancer: 36.0"	"Adrenal gland - Adrenal medulla cells, Colon - Colon enteroendocrine cells, Pituitary gland - Lactotropes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB079060		Supported					NA	NA			"Cluster 32: Basophils - Transcription"	"Cluster 22: Brain - Synaptic signal transduction"	"Cluster 53: Neurons - Mixed function"	"Cluster 56: Non-specific - Sensory perception"	"Cluster 34: Neurons - Neuronal signaling"	3			"CAB079060: "	"unprognostic (1.67e-2)"	"unprognostic (7.78e-3)"		"unprognostic (6.36e-3)"	"unprognostic (4.92e-3)"	"unprognostic (1.24e-1)"	"unprognostic (8.49e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.25e-3)"		"unprognostic (2.71e-2)"		"unprognostic (1.07e-1)"	"potential prognostic unfavorable (6.93e-5)"		"potential prognostic unfavorable (7.18e-4)"	"unprognostic (8.59e-2)"	"unprognostic (1.37e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.56e-1)"		"unprognostic (3.35e-1)"		"unprognostic (2.94e-2)"	"unprognostic (2.87e-2)"	"unprognostic (7.02e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.94e-1)"		"unprognostic (3.77e-3)"
GABRG3		ENSG00000182256	"Gamma-aminobutyric acid type A receptor subunit gamma3"	Q99928	15	26971181-27541984	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"retina: 26.3;testis: 9.0"	"Group enriched"	"Detected in some"	6	"Excitatory neurons: 428.9;Inhibitory neurons: 590.3;Late spermatids: 340.7;Muller glia cells: 158.8"	"Cell type enhanced"	"Detected in all"		"eccentric medium spiny neuron: 1425.8"	"Cancer enhanced"	"Detected in some"		"Prostate Adenocarcinoma (TCGA): 9.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"thyroid cancer: 3.1"	"Adrenal gland - Adrenal medulla cells, Minor Salivary Gland - Minor salivary glandular cells, Prostate - Prostate glandular cells, Skin - Eccrine sweat gland cells, Testis - Late spermatids"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA054010	Approved		Approved	"Nucleoli,Plasma membrane,Microtubules"			NA	NA				"Cluster 39: Retina & Testis - Cilium"	"Cluster 56: Hypothalamus - Neuropeptide signaling"	"Cluster 12: Bone cancer - Neuronal signaling"	"Cluster 69: Neurons - Neuronal signaling"		"Plasma membrane, Microtubules"	Nucleoli	"HPA054010: AB_2682342"								"unprognostic (1.76e-1)"										"unprognostic (9.49e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.74e-1)"				"unprognostic (1.06e-1)"						"unprognostic (2.18e-2)"	"unprognostic (1.51e-1)"
GABRP		ENSG00000094755	"Gamma-aminobutyric acid type A receptor subunit pi"	O00591	5	170763350-170814047	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 147.3;esophagus: 166.1"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 158.2;Breast myoepithelial cells: 68.3;Club cells: 74.0;Fibroblasts: 73.7;Glandular and luminal cells: 480.2;Ionocytes: 128.1"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 11.8"	"Group enriched"	"Detected in many"	8	"granulocytes: 11.8;monocytes: 5.8"	"Low cancer specificity"	"Detected in all"			"Lung - Respiratory ciliated cells, Prostate - Urothelial cells, Skin - Eccrine sweat gland cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			CAB014883	Uncertain						NA	NA			"Cluster 42: Non-specific - Vesicular transport"	"Cluster 29: Squamous epithelium - Innate immune response"	"Cluster 4: Non-specific - mRNA splicing & Cell cycle"	"Cluster 3: Rhabdoid - Membrane components"	"Cluster 37: Glandular & Luminal cells - Unknown function"				"CAB014883: "	"unprognostic (1.13e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.09e-3)"	"unprognostic (1.61e-3)"	"unprognostic (1.58e-3)"	"unprognostic (1.98e-3)"		"unprognostic (2.70e-1)"	"unprognostic (1.41e-1)"	"potential prognostic unfavorable (3.22e-4)"	"unprognostic (1.43e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.36e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.77e-2)"	"unprognostic (8.17e-2)"	"potential prognostic unfavorable (1.75e-4)"	"unprognostic (2.87e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.68e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.76e-1)"	"unprognostic (7.97e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.75e-3)"	"unprognostic (1.04e-2)"
GABRQ		ENSG00000268089	"Gamma-aminobutyric acid type A receptor subunit theta"	Q9UN88	X	152637895-152657542	"FDA approved drug targets, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 21.7;cervix: 7.4"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 4.5;Basal squamous epithelial cells: 4.4;Glandular and luminal cells: 3.5;Horizontal cells: 5.0;Squamous epithelial cells: 2.5;Suprabasal keratinocytes: 1.5"	"Cell type enhanced"	"Detected in many"		"eccentric medium spiny neuron: 79.3;hippocampal dentate gyrus: 31.2"	"Cancer enhanced"	"Detected in many"		"Testicular Germ Cell Tumor (TCGA): 9.3"	"Region enhanced"	"Detected in many"		"hypothalamus: 154.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Bone cancer: 7.1;Brain cancer: 7.3"	"Adrenal gland - Adrenal medulla cells, Colon - Colon enteroendocrine cells"	"Region enriched"	"Detected in many"	5	"hypothalamus: 52.6"	"Group enriched"	"Detected in many"	4	"hypothalamus: 12.4;midbrain: 33.1;pons: 10.2"								NA	NA				"Cluster 33: Brain - Neuronal signaling"	"Cluster 56: Hypothalamus - Neuropeptide signaling"	"Cluster 72: Neuronal - Signal transduction"	"Cluster 37: Glandular & Luminal cells - Unknown function"	3				"unprognostic (3.21e-3)"	"potential prognostic unfavorable (9.58e-5)"		"unprognostic (1.78e-1)"			"unprognostic (2.73e-1)"		"unprognostic (1.41e-1)"			"unprognostic (1.23e-3)"						"unprognostic (1.63e-1)"	"potential prognostic favorable (7.96e-4)"										"unprognostic (4.50e-1)"		
GAMT	"PIG2, TP53I2"	ENSG00000130005	"Guanidinoacetate N-methyltransferase"	Q14353	19	1397026-1401570	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 600.1;skeletal muscle: 1191.9;tongue: 447.8"	"Group enriched"	"Detected in many"	5	"Hepatocytes: 796.3;Proximal tubular cells: 384.0;Skeletal myocytes: 946.5"	"Cell type enhanced"	"Detected in all"		"oligodendrocyte: 63.8"	"Cancer enhanced"	"Detected in all"		"Liver Hepatocellular Carcinoma (TCGA): 355.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Heart muscle - Cardiomyocytes, Kidney - Proximal tubular cells, Kidney - Proximal tubular cells, Liver - Hepatocytes, Skin - Keratinocyte (other), Testis - Sertoli cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051806	Approved						NA	NA		250000	"Cluster 12: Non-specific - Mitochondrial translation"	"Cluster 19: Non-specific - Basic cellular processes"	"Cluster 11: White matter - Signal transduction"	"Cluster 35: RS4;11 - Unknown function"	"Cluster 43: Hepatocytes - Metabolism"	8			"HPA051806: AB_2681619"	"unprognostic (2.65e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.50e-2)"	"unprognostic (4.24e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.38e-2)"	"potential prognostic unfavorable (4.89e-4)"	"unprognostic (1.47e-1)"	"unprognostic (1.96e-2)"	"potential prognostic favorable (3.69e-5)"	"unprognostic (3.71e-2)"	"unprognostic (2.83e-3)"	"unprognostic (1.71e-2)"	"unprognostic (5.04e-3)"	"unprognostic (1.16e-1)"	"unprognostic (3.80e-3)"	"unprognostic (6.87e-3)"	"unprognostic (5.23e-2)"	"unprognostic (4.44e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.11e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.39e-1)"	"unprognostic (9.69e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.56e-2)"	"unprognostic (7.20e-2)"
GANAB	"G2AN, GIIA, GluII, KIAA0088"	ENSG00000089597	"Glucosidase II alpha subunit"	Q14697	11	62624826-62646726	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Colon - Macrophages, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026874, HPA061426"	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	Enzyme	NA	NA		24000000	"Cluster 13: Non-specific - Mitochondria"	"Cluster 53: Non-specific - Glycosylation"	"Cluster 21: Non-specific - Metabolism"	"Cluster 63: Non-specific - Protein processing"	"Cluster 4: Extravillous trophoblasts - Unknown function"	25	"Endoplasmic reticulum"		"HPA026874: AB_1849745, HPA061426: AB_2684516"	"unprognostic (3.40e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.62e-3)"	"unprognostic (7.31e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.20e-1)"	"unprognostic (3.39e-3)"	"unprognostic (1.68e-1)"	"potential prognostic unfavorable (3.55e-4)"	"potential prognostic favorable (1.24e-5)"	"unprognostic (5.06e-3)"	"unprognostic (1.43e-1)"	"unprognostic (5.48e-3)"	"unprognostic (9.03e-3)"	"unprognostic (1.60e-3)"	"potential prognostic unfavorable (4.73e-4)"	"unprognostic (2.15e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.97e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.93e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.56e-2)"	"unprognostic (8.66e-2)"
GANC		ENSG00000214013	"Glucosidase alpha, neutral C"	Q8TET4	15	42273201-42353666	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 80.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Lung - Alveolar cells type 2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016949, HPA051522"	Approved		Approved	Cytosol			NA	NA			"Cluster 23: B-cells - Immunoglobulins"	"Cluster 53: Non-specific - Glycosylation"	"Cluster 11: White matter - Signal transduction"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 72: Alveolar cells - Lung function"		Cytosol		"HPA016949: AB_1849465, HPA051522: "	"unprognostic (1.92e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.63e-2)"	"unprognostic (9.79e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.23e-3)"	"unprognostic (1.23e-3)"	"potential prognostic favorable (6.85e-4)"	"potential prognostic favorable (1.00e-4)"	"unprognostic (5.51e-2)"	"unprognostic (6.65e-3)"	"unprognostic (3.89e-3)"	"unprognostic (1.42e-1)"	"unprognostic (4.28e-2)"	"unprognostic (2.13e-1)"	"unprognostic (8.25e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.69e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.25e-1)"	"unprognostic (5.77e-2)"	"unprognostic (6.24e-2)"	"unprognostic (4.12e-3)"	"unprognostic (1.03e-1)"
GAPDH	GAPD	ENSG00000111640	"Glyceraldehyde-3-phosphate dehydrogenase"	P04406	12	6534512-6538374	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Glycolysis, Immunity, Innate immunity, Translation regulation"	"Oxidoreductase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"skeletal muscle: 26611.3;tongue: 18150.7"	"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 11520.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Skeletal muscle - Skeletal myocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005197, CAB016392, HPA040067, HPA061280, CAB079968"	Supported		Enhanced	"Nuclear membrane,Vesicles,Plasma membrane,Cytosol"			No	No		1100000000	"Cluster 26: Monocytes - Plasma membrane proteins"	"Cluster 14: Skeletal muscle - Muscle contraction"	"Cluster 27: Non-specific - Mixed function"	"Cluster 38: Non-specific - Transcription"	"Cluster 45: Non-specific - Mixed function"	134	"Plasma membrane, Cytosol"	"Nuclear membrane, Vesicles"	"CAB005197: AB_641107, CAB016392: AB_627678, CAB079968: , HPA040067: AB_10965903, HPA061280: AB_2684463"	"unprognostic (2.72e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.26e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.00e-3)"	"unprognostic (2.31e-3)"	"potential prognostic unfavorable (3.31e-5)"	"unprognostic (2.74e-3)"	"unprognostic (2.57e-2)"	"validated prognostic unfavorable (3.95e-6)"	"validated prognostic unfavorable (8.80e-10)"	"validated prognostic unfavorable (1.61e-7)"	"validated prognostic unfavorable (1.15e-5)"	"unprognostic (8.44e-2)"	"unprognostic (2.50e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.63e-3)"	"unprognostic (4.52e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.78e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.95e-3)"
GART	"GARS-AIRS-GART, PGFT, PRGS"	ENSG00000159131	"Phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase"	P22102	21	33503931-33543491	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Purine biosynthesis"	"Ligase, Multifunctional enzyme, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Testis - Spermatocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002119, HPA005779"	Approved		Approved	Mitochondria,Cytosol			NA	NA		280000	"Cluster 5: Non-specific - Cell proliferation"	"Cluster 4: Testis - Basic cellular processes"	"Cluster 28: Oligodendrocytes - Mixed function"	"Cluster 47: Leukemia - Hemostasis"	"Cluster 39: Non-specific - Basic cellular processes"	13	Cytosol	Mitochondria	"HPA002119: AB_1849482, HPA005779: AB_1849484"	"unprognostic (2.44e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.25e-2)"	"potential prognostic unfavorable (2.99e-4)"	"unprognostic (6.12e-2)"	"unprognostic (3.20e-1)"	"unprognostic (7.58e-2)"	"unprognostic (5.20e-2)"	"unprognostic (5.69e-2)"	"unprognostic (4.46e-2)"	"potential prognostic favorable (3.72e-4)"	"unprognostic (3.54e-1)"	"unprognostic (5.05e-3)"	"unprognostic (1.24e-2)"	"potential prognostic unfavorable (4.32e-4)"	"unprognostic (2.03e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.83e-1)"	"potential prognostic unfavorable (5.85e-4)"	"unprognostic (2.45e-1)"	"unprognostic (4.06e-3)"	"unprognostic (1.85e-3)"	"unprognostic (7.51e-2)"	"unprognostic (6.82e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.73e-1)"	"unprognostic (8.05e-2)"	"unprognostic (2.29e-1)"
GAST	GAS	ENSG00000184502	Gastrin	P01350	17	41712331-41715969	"Cancer-related genes, FDA approved drug targets, Predicted secreted proteins"		Hormone	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	167	"stomach 1: 9294.1"	"Group enriched"	"Detected in some"	4	"Glandular and luminal cells: 105.4;Plasma cells: 56.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Pancreatic Adenocarcinoma (TCGA): 99.5;Stomach Adenocarcinoma (TCGA): 40.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"cervical cancer: 2.8;colorectal cancer: 2.5;Esophageal cancer: 4.6;Gastric cancer: 9.0;head and neck cancer: 5.9"		"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			CAB000038	Enhanced				"Secreted to digestive system"	Hormone	NA	NA		81000		"Cluster 48: Stomach - Proteolysis"	"Cluster 56: Hypothalamus - Neuropeptide signaling"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 23: Plasma cells - Humoral immune response"	24			"CAB000038: "				"unprognostic (8.80e-2)"					"unprognostic (8.49e-3)"					"unprognostic (5.63e-3)"	"unprognostic (2.04e-1)"			"unprognostic (1.81e-1)"	"unprognostic (3.50e-3)"			"unprognostic (2.28e-1)"						"unprognostic (3.31e-1)"			
GCGR	GGR	ENSG00000215644	"Glucagon receptor"	P47871	17	81804132-81814008	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Diabetes mellitus, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	18	"kidney: 48.6;liver: 165.5"	"Cell type enriched"	"Detected in some"	6	"Hepatocytes: 56.2"	"Cell type enhanced"	"Detected in some"		"fibroblast: 1.5;mammillary body: 1.5"	"Group enriched"	"Detected in some"	13	"Kidney Chromophobe (TCGA): 28.3;Liver Hepatocellular Carcinoma (TCGA): 9.9"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Adrenal gland - Adrenal medulla cells, Pancreas - Beta cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA071228			Uncertain	"Golgi apparatus"			NA	NA				"Cluster 1: Liver & Kidney - Metabolism"	"Cluster 19: Astrocytes - Mixed function"	"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 62: Hepatocytes - Metabolism"		"Golgi apparatus"		"HPA071228: AB_2686368"										"unprognostic (3.92e-3)"			"unprognostic (2.24e-1)"	"unprognostic (3.85e-2)"	"potential prognostic favorable (1.25e-4)"						"unprognostic (1.39e-1)"								"unprognostic (5.53e-2)"		"unprognostic (4.87e-3)"
GGCX	VKCFD1	ENSG00000115486	"Gamma-glutamyl carboxylase"	P38435	2	85544720-85561532	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Lyase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 104.6"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 142.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Liver - Hepatocytes, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018284	Enhanced						NA	NA			"Cluster 10: Non-specific - Membrane trafficking"	"Cluster 83: Liver - Metabolism"	"Cluster 50: Non-specific - Nucleic acid binding"	"Cluster 45: Non-specific - Nuclear processes"	"Cluster 62: Hepatocytes - Metabolism"	23			"HPA018284: AB_1849641"	"unprognostic (1.61e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.98e-1)"	"unprognostic (6.44e-3)"	"unprognostic (2.86e-1)"	"unprognostic (2.81e-3)"	"unprognostic (1.46e-1)"	"unprognostic (6.22e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.16e-1)"	"potential prognostic favorable (7.75e-4)"	"unprognostic (1.72e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.86e-2)"	"unprognostic (3.96e-2)"	"unprognostic (3.95e-2)"	"unprognostic (6.27e-2)"	"unprognostic (4.59e-2)"	"unprognostic (6.63e-2)"	"potential prognostic unfavorable (6.41e-5)"	"unprognostic (2.32e-2)"	"potential prognostic unfavorable (1.75e-4)"	"unprognostic (4.03e-2)"	"unprognostic (2.78e-1)"	"unprognostic (9.31e-3)"	"unprognostic (7.98e-2)"	"unprognostic (5.33e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.29e-2)"
GGPS1	GGPPS1	ENSG00000152904	"Geranylgeranyl diphosphate synthase 1"	O95749	1	235327350-235344532	"Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Isoprene biosynthesis, Lipid metabolism"	Transferase	"Congenital muscular dystrophy, Deafness, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 188.4;Late spermatids: 258.2"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Testis - Early spermatids, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029472, HPA050727"	Enhanced		Supported	Nucleoplasm,Cytosol			NA	NA			"Cluster 36: Eosinophils - Protein ubiquitination"	"Cluster 39: Retina & Testis - Cilium"	"Cluster 28: Oligodendrocytes - Mixed function"	"Cluster 45: Non-specific - Nuclear processes"	"Cluster 36: Late spermatids - Unknown function"	10	Cytosol	Nucleoplasm	"HPA029472: AB_10696206, HPA050727: "	"unprognostic (1.66e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.26e-1)"	"unprognostic (9.98e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.50e-2)"	"unprognostic (5.91e-3)"	"potential prognostic favorable (1.08e-4)"	"unprognostic (1.83e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.22e-1)"	"unprognostic (9.58e-3)"	"unprognostic (5.97e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.39e-2)"	"unprognostic (9.75e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.88e-3)"	"unprognostic (3.02e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.85e-1)"
GHR	GHBP	ENSG00000112964	"Growth hormone receptor"	P10912	5	42423439-42721878	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins"	Endocytosis	Receptor	"Disease variant, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 81.8;liver: 206.8"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 51.2;Hepatocytes: 119.8;Inhibitory neurons: 111.4;Oligodendrocyte precursor cells: 169.8;Syncytiotrophoblasts: 46.6"	"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"Prostate Adenocarcinoma (TCGA): 17.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"skin cancer: 6.9"	"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Liver - Hepatocytes, Lung - Fibroblast_1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045339, HPA057705"	Enhanced		Supported	"Plasma membrane,Cytosol,Cytoplasmic bodies"	"Secreted to blood"	Receptor	NA	NA	2200000	14000000		"Cluster 83: Liver - Metabolism"	"Cluster 56: Hypothalamus - Neuropeptide signaling"	"Cluster 3: Rhabdoid - Membrane components"	"Cluster 8: Neurons - Neuronal signaling"	31	"Plasma membrane, Cytosol, Cytoplasmic bodies"		"HPA045339: AB_2679294, HPA057705: AB_2683507"	"unprognostic (6.47e-2)"	"unprognostic (1.26e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.23e-1)"	"unprognostic (4.88e-2)"	"unprognostic (2.95e-1)"	"potential prognostic favorable (4.80e-5)"	"unprognostic (3.73e-2)"	"unprognostic (6.78e-2)"	"validated prognostic favorable (2.53e-10)"	"validated prognostic favorable (1.24e-4)"	"unprognostic (2.09e-1)"	"validated prognostic favorable (3.06e-6)"	"validated prognostic favorable (1.71e-4)"		"unprognostic (2.92e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.98e-2)"	"unprognostic (5.90e-2)"		"unprognostic (2.97e-3)"	"unprognostic (3.57e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.27e-1)"		"unprognostic (5.69e-3)"	"unprognostic (1.43e-1)"	"potential prognostic unfavorable (6.29e-4)"	
GHRHR		ENSG00000106128	"Growth hormone releasing hormone receptor"	Q02643	7	30938669-30993254	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	351	"pituitary gland: 206.1"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 1.9;Spermatocytes: 1.6;Spermatogonia: 2.6"	"Low cell type specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	10	"prostate cancer: 2.1"	"Adrenal gland - Adrenal medulla cells, Kidney - Proximal tubular cells, Pituitary gland - Somatotropes"	"Not detected"	"Not detected"			"Not detected"	"Not detected"										NA	NA				"Cluster 49: Pituitary gland - Hormone signaling"		"Cluster 60: Prostate cancer - Unknown function"	"Cluster 67: Spermatogonia - Spermatogenesis"												"unprognostic (1.86e-1)"							"unprognostic (1.02e-1)"																
GIP		ENSG00000159224	"Gastric inhibitory polypeptide"	P09681	17	48958554-48968596	"FDA approved drug targets, Plasma proteins, Predicted secreted proteins"		Hormone	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	208	"intestine: 251.8"	"Cell type enriched"	"Detected in single"	35	"Enteroendocrine cells: 19.5"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	53	"Testicular Germ Cell Tumor (TCGA): 116.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"liver cancer: 2.8"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA021612, HPA064596"	Enhanced				"Secreted to blood"	Hormone	NA	NA	33900	380000		"Cluster 25: Small intestine - Absorption"		"Cluster 1: Neuronal - Visual perception"	"Cluster 20: Enteroendocrine cells - Hormone signaling"	15			"HPA021612: AB_1849506, HPA064596: "																						"unprognostic (5.62e-3)"							"unprognostic (2.42e-1)"		
GLP1R	GLP-1R	ENSG00000112164	"Glucagon like peptide 1 receptor"	P43220	6	39048781-39091303	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 2.6;pancreas: 6.8;salivary gland: 2.1"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 1.0;Cardiomyocytes: 5.2;Exocrine glandular cells: 1.7;Inhibitory neurons: 1.2;Melanocytes: 1.7;Pancreatic endocrine cells: 1.7"	"Cell type enhanced"	"Detected in some"		"splatter: 5.3;vascular associated smooth muscle cell: 3.0"	"Cancer enhanced"	"Detected in some"		"Pancreatic Adenocarcinoma (TCGA): 1.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	5	"Leukemia: 1.9"	"Heart muscle - Cardiomyocytes, Skin - Eccrine sweat gland cells"	"Region enriched"	"Detected in many"	4	"basal ganglia: 20.7"	"Low region specificity"	"Detected in some"										NA	NA				"Cluster 15: Pancreas - Proteolysis"	"Cluster 56: Hypothalamus - Neuropeptide signaling"	"Cluster 59: Leukemia - T-cell receptor"	"Cluster 68: Cardiomyocytes - Muscle contraction"	52																									"unprognostic (7.38e-2)"	"unprognostic (3.11e-1)"							"unprognostic (2.28e-2)"	
GLP2R		ENSG00000065325	"Glucagon like peptide 2 receptor"	O95838	17	9822206-9892099	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 11.8;intestine: 13.0;urinary bladder: 11.4"	"Cell type enriched"	"Detected in some"	4	"Rod photoreceptor cells: 26.6"	"Cell type enhanced"	"Detected in some"		"amygdala excitatory: 12.2;upper-layer intratelencephalic: 33.8"	"Cancer enhanced"	"Detected in single"		"Pancreatic Adenocarcinoma (TCGA): 2.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"cervical cancer: 17.9;liver cancer: 9.1;Rhabdoid: 8.6"	"Adipose subcutaneous - Adipocytes (Subcutaneous), Breast - Adipocytes (Breast), Liver - Hepatic stellate cells, Lung - Fibroblast_2, Pancreas - Fibroblasts"	"Group enriched"	"Detected in some"	5	"cerebral cortex: 2.1;hippocampal formation: 2.4"	"Low region specificity"	"Detected in all"			"CAB022690, HPA049244"	Approved		Supported	"Plasma membrane"			NA	NA				"Cluster 45: Intestine - Digestion"	"Cluster 51: Neurons - Mixed function"	"Cluster 3: Rhabdoid - Membrane components"	"Cluster 66: Photoreceptor cells - Visual perception"		"Plasma membrane"		"CAB022690: , HPA049244: AB_2680690"						"unprognostic (9.87e-2)"																"unprognostic (2.87e-1)"	"unprognostic (3.49e-3)"			"unprognostic (6.02e-2)"					
GLRA1	STHE	ENSG00000145888	"Glycine receptor alpha 1"	P23415	5	151822513-151924851	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	7	"retina: 2.4"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 7.0;Excitatory neurons: 1.7;Inhibitory neurons: 4.8;Oligodendrocyte precursor cells: 1.4;Oligodendrocytes: 1.2"	"Cell type enhanced"	"Detected in many"		"lower rhombic lip: 33.0;splatter: 41.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Adrenal gland - Adrenal medulla cells, Pancreas - Beta cells"	"Group enriched"	"Detected in many"	5	"hypothalamus: 9.4;midbrain: 15.1;pons and medulla: 26.3"	"Low region specificity"	"Detected in all"			"HPA078885, CAB079042"		Supported	Approved	"Vesicles,Plasma membrane"			NA	NA				"Cluster 76: Retina - Visual perception"	"Cluster 43: Hindbrain - Mixed function"	"Cluster 1: Neuronal - Visual perception"	"Cluster 69: Neurons - Neuronal signaling"	2	"Vesicles, Plasma membrane"		"CAB079042: , HPA078885: "																							"unprognostic (4.02e-2)"								
GLRA2	GLR	ENSG00000101958	"Glycine receptor alpha 2"	P23416	X	14529298-14731812	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, FDA approved drug targets, Intellectual disability"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 9.4;retina: 3.1"	"Cell type enriched"	"Detected in some"	5	"Inhibitory neurons: 71.3"	"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in some"		"Rectum Adenocarcinoma (TCGA): 1.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Pituitary gland - Gonadotropes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB070422, HPA078885"	Approved		Approved	"Vesicles,Plasma membrane"			NA	NA				"Cluster 28: Neuronal - Transcription"	"Cluster 56: Hypothalamus - Neuropeptide signaling"	"Cluster 40: Non-specific - Unknown function"	"Cluster 69: Neurons - Neuronal signaling"		"Vesicles, Plasma membrane"		"CAB070422: AB_11153055, HPA078885: "					"unprognostic (1.18e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.20e-1)"																	"unprognostic (2.49e-1)"	"unprognostic (9.84e-2)"					
GLRA3		ENSG00000145451	"Glycine receptor alpha 3"	O75311	4	174636920-174829247	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 5.4;breast: 1.9"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 14.2;Early spermatids: 19.7;Excitatory neurons: 50.8;Horizontal cells: 13.2;Inhibitory neurons: 10.7;Late spermatids: 26.2"	"Cell type enhanced"	"Detected in many"		"amygdala excitatory: 161.0;upper-layer intratelencephalic: 145.1"	"Cancer enriched"	"Detected in single"	4	"Breast Invasive Carcinoma (TCGA): 2.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"lymphoma: 1.4"	"Adrenal gland - Adrenal medulla cells, Breast - Breast glandular cells, Colon - Colon enteroendocrine cells, Pancreas - Beta cells, Pituitary gland - Thyrotropes, Testis - Early spermatids, Testis - Late spermatids"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA078885			Approved	"Vesicles,Plasma membrane"			NA	NA				"Cluster 33: Brain - Neuronal signaling"	"Cluster 56: Hypothalamus - Neuropeptide signaling"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 34: Neurons - Neuronal signaling"	1	"Vesicles, Plasma membrane"		"HPA078885: "		"unprognostic (1.57e-2)"	"unprognostic (2.44e-1)"					"unprognostic (4.32e-3)"									"unprognostic (1.36e-1)"														
GNRHR	"GRHR, LHRHR"	ENSG00000109163	"Gonadotropin releasing hormone receptor"	P30968	4	67737118-67754388	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, FDA approved drug targets, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	7	"pituitary gland: 5.3"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 1.1;Granulosa cells: 6.3;Inhibitory neurons: 1.2;Suprabasal keratinocytes: 2.4"	"Low cell type specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Pituitary gland - Gonadotropes"	"Not detected"	"Not detected"							HPA013424	Enhanced						NA	NA				"Cluster 49: Pituitary gland - Hormone signaling"	"Cluster 24: Neurons - Mixed function"	"Cluster 11: Neuronal - Sensory perception"	"Cluster 59: Suprabasal keratinocytes - Cornification"				"HPA013424: AB_2668840"																															
GRIA1	"GluA1, GLUR1, GLURA"	ENSG00000155511	"Glutamate ionotropic receptor AMPA type subunit 1"	P42261	5	153489615-153813869	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, FDA approved drug targets, Intellectual disability"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 54.9;retina: 30.8"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 311.1;Inhibitory neurons: 582.5"	"Cell type enhanced"	"Detected in all"		"bergmann glia: 3812.0;hippocampal CA4: 4632.2"	"Cancer enriched"	"Detected in some"	16	"Glioblastoma Multiforme (TCGA): 23.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Kidney cancer: 6.7"	"Lung - Fibroblast_1, Testis - Early spermatids, Thyroid gland - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035202	Enhanced						NA	NA				"Cluster 17: Neuronal - Synaptic function"	"Cluster 29: Forebrain - Mixed function"	"Cluster 5: Rhabdoid - Unknown function"	"Cluster 65: Neurons - Synaptic function"	14			"HPA035202: AB_2674516"		"unprognostic (2.81e-1)"	"unprognostic (5.78e-2)"				"unprognostic (1.87e-1)"	"unprognostic (9.65e-2)"									"unprognostic (9.28e-2)"														
GRIK1	"GluK1, GLUR5"	ENSG00000171189	"Glutamate ionotropic receptor kainate type subunit 1"	P39086	21	29536933-29940033	"FDA approved drug targets, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"adrenal gland: 12.1;brain: 10.8;retina: 38.0"	"Group enriched"	"Detected in some"	12	"Inhibitory neurons: 2151.1;Oligodendrocyte precursor cells: 809.4"	"Cell type enhanced"	"Detected in all"		"lower rhombic lip: 3228.1;MGE interneuron: 3708.2;midbrain-derived inhibitory: 8188.5"	"Cancer enriched"	"Detected in some"	5	"Glioblastoma Multiforme (TCGA): 9.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Adrenal gland - Adrenal medulla cells, Breast - Breast glandular cells, Testis - Early spermatids, Testis - Late spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014623, HPA073879"	Uncertain		Supported	"Vesicles,Plasma membrane"			NA	NA				"Cluster 17: Neuronal - Synaptic function"	"Cluster 49: Hindbrain - Mixed function"	"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 65: Neurons - Synaptic function"	3	"Plasma membrane"	Vesicles	"HPA014623: AB_1850305, HPA073879: "			"unprognostic (2.10e-1)"				"unprognostic (1.08e-3)"	"unprognostic (3.99e-3)"																"unprognostic (4.72e-3)"							
GRIK2	"GluK2, GLUR6, MRT6"	ENSG00000164418	"Glutamate ionotropic receptor kainate type subunit 2"	Q13002	6	100962701-102081622	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, Epilepsy, FDA approved drug targets, Intellectual disability"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"brain: 61.2"	"Group enriched"	"Detected in some"	26	"Excitatory neurons: 699.9;Inhibitory neurons: 2270.7;Oligodendrocyte precursor cells: 1157.9"	"Low cell type specificity"	"Detected in all"			"Cancer enriched"	"Detected in many"	4	"Glioblastoma Multiforme (TCGA): 9.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Neuroblastoma: 6.2;skin cancer: 8.4"	"Colon - Enteric glia cells, Kidney - Podocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014395, HPA014623, CAB022463"	Approved				"Intracellular and membrane"	Receptor	NA	NA				"Cluster 65: Cerebellum - Nervous system development"	"Cluster 10: Cerebellum - Nucleic acid binding"	"Cluster 69: Skin cancer - ECM organization"	"Cluster 69: Neurons - Neuronal signaling"	5			"CAB022463: , HPA014395: AB_1850303, HPA014623: AB_1850305"			"unprognostic (1.06e-1)"			"unprognostic (6.01e-3)"	"unprognostic (9.41e-2)"	"unprognostic (1.57e-3)"								"unprognostic (2.40e-3)"	"unprognostic (7.87e-2)"	"unprognostic (7.95e-2)"	"unprognostic (1.02e-1)"				"unprognostic (2.71e-2)"			"unprognostic (2.25e-1)"	"unprognostic (6.00e-2)"		"unprognostic (2.09e-1)"	"unprognostic (3.05e-3)"	"unprognostic (3.37e-2)"
GRIK3	"GluK3, GLUR7"	ENSG00000163873	"Glutamate ionotropic receptor kainate type subunit 3"	Q13003	1	36795527-37034515	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.0;intestine: 7.6;pituitary gland: 9.0"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 37.6;Inhibitory neurons: 103.8;Oligodendrocyte precursor cells: 68.4;Schwann cells: 31.5"	"Cell type enhanced"	"Detected in many"		"MGE interneuron: 365.1"	"Cancer enriched"	"Detected in some"	4	"Glioblastoma Multiforme (TCGA): 23.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Bone cancer: 11.1;lung cancer: 9.2;Neuroblastoma: 7.0"	"Adipose visceral - Smooth muscle cells, Colon - Enteric glia cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"										NA	NA				"Cluster 80: Non-specific - Endocytosis"	"Cluster 52: Neurons & Synapses - Synaptic function"	"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 8: Neurons - Neuronal signaling"						"unprognostic (1.77e-1)"	"unprognostic (1.18e-2)"				"unprognostic (3.22e-1)"	"unprognostic (5.68e-2)"			"validated prognostic favorable (2.93e-5)"	"validated prognostic favorable (4.06e-4)"								"unprognostic (1.33e-1)"	"unprognostic (1.36e-2)"						"unprognostic (3.08e-1)"		"unprognostic (2.84e-1)"		
GRIK4	"GluK4, GRIK, KA1"	ENSG00000149403	"Glutamate ionotropic receptor kainate type subunit 4"	Q16099	11	120511746-120988906	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.6"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 78.6;Excitatory neurons: 111.7;Inhibitory neurons: 41.7;Oligodendrocyte precursor cells: 183.9;Oligodendrocytes: 100.8;Oocytes: 77.9"	"Low cell type specificity"	"Detected in all"			"Cancer enriched"	"Detected in some"	6	"Glioblastoma Multiforme (TCGA): 6.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	5	"Myeloma: 4.2"	"Lung - Fibroblast_1, Pituitary gland - Undifferentiated cells (Pituitary gland), Stomach - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074453	Enhanced						NA	NA				"Cluster 33: Brain - Neuronal signaling"	"Cluster 51: Neurons - Mixed function"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 76: Oligodendrocyte precursor - Unknown function"				"HPA074453: AB_2732255"			"unprognostic (1.06e-1)"				"unprognostic (1.91e-1)"	"unprognostic (8.55e-3)"																						"unprognostic (6.96e-3)"	
GRIK5	"GluK5, GRIK2, KA2"	ENSG00000105737	"Glutamate ionotropic receptor kainate type subunit 5"	Q16478	19	41998321-42070206	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.7;testis: 32.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 17.0;Bipolar cells: 20.1;Excitatory neurons: 31.3;Horizontal cells: 17.6;Inhibitory neurons: 29.8;Oligodendrocyte precursor cells: 29.7;Rod photoreceptor cells: 17.1"	"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Glioblastoma Multiforme (TCGA): 35.3;Kidney Chromophobe (TCGA): 10.6;Ovary Serous Cystadenocarcinoma (TCGA): 11.9;Thyroid Carcinoma (TCGA): 11.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Leukemia: 9.9;Neuroblastoma: 19.3"	"Adipose subcutaneous - Smooth muscle cells, Spleen - Fibroblast_1, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074001			Supported	"Nucleoplasm,Plasma membrane"			NA	NA				"Cluster 22: Brain - Synaptic signal transduction"	"Cluster 29: Forebrain - Mixed function"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 25: Bipolar cells - Visual perception"	2	"Plasma membrane"	Nucleoplasm	"HPA074001: AB_2732248"			"unprognostic (9.31e-2)"				"unprognostic (1.41e-1)"	"unprognostic (1.94e-2)"		"unprognostic (1.59e-1)"			"unprognostic (5.06e-3)"			"unprognostic (1.66e-1)"		"unprognostic (8.59e-2)"		"unprognostic (1.32e-3)"	"unprognostic (8.04e-3)"	"potential prognostic favorable (4.37e-4)"		"unprognostic (1.06e-1)"		"unprognostic (6.18e-2)"		"unprognostic (1.44e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.46e-1)"
GRIN1	"GluN1, NMDAR1"	ENSG00000176884	"Glutamate ionotropic receptor NMDA type subunit 1"	Q05586	9	137138346-137168756	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, Epilepsy, FDA approved drug targets, Intellectual disability"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	66	"brain: 220.0"	"Group enriched"	"Detected in some"	10	"Excitatory neurons: 128.2;Horizontal cells: 125.3;Inhibitory neurons: 128.6"	"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"Glioblastoma Multiforme (TCGA): 4.6;Prostate Adenocarcinoma (TCGA): 1.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Neuroblastoma: 4.9;prostate cancer: 2.5"	"Colon - Colon enteroendocrine cells, Minor Salivary Gland - Minor salivary glandular cells, Prostate - Prostate glandular cells, Skin - Eccrine sweat gland cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067773	Enhanced						NA	NA				"Cluster 22: Brain - Synaptic signal transduction"	"Cluster 52: Neurons & Synapses - Synaptic function"	"Cluster 17: Neuroblastoma - Neuronal signaling"	"Cluster 69: Neurons - Neuronal signaling"	11			"HPA067773: "			"unprognostic (2.45e-1)"			"unprognostic (1.98e-1)"	"unprognostic (5.17e-2)"	"unprognostic (2.05e-2)"																"unprognostic (1.73e-1)"		"unprognostic (9.92e-3)"					
GRIN2A	"GluN2A, NMDAR2A"	ENSG00000183454	"Glutamate ionotropic receptor NMDA type subunit 2A"	Q12879	16	9753404-10182928	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Cancer-related genes, Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 15.7"	"Group enriched"	"Detected in many"	13	"Excitatory neurons: 811.1;Inhibitory neurons: 864.4"	"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in some"		"Kidney Renal Clear Cell Carcinoma (TCGA): 2.0;Ovary Serous Cystadenocarcinoma (TCGA): 2.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Adipose subcutaneous - Smooth muscle cells, Heart muscle - Cardiomyocytes, Thyroid gland - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022725, HPA050216"	Enhanced		Uncertain	"Endoplasmic reticulum,Vesicles"			NA	NA				"Cluster 22: Brain - Synaptic signal transduction"	"Cluster 53: Neurons - Mixed function"	"Cluster 11: Neuronal - Sensory perception"	"Cluster 65: Neurons - Synaptic function"	15	"Endoplasmic reticulum"	Vesicles	"CAB022725: , HPA050216: "			"unprognostic (1.65e-1)"				"unprognostic (1.02e-1)"	"unprognostic (6.45e-2)"			"unprognostic (2.26e-1)"	"unprognostic (1.98e-2)"								"unprognostic (1.78e-1)"			"unprognostic (1.47e-1)"			"unprognostic (4.28e-2)"					
GRIN2B	"GluN2B, NMDAR2B"	ENSG00000273079	"Glutamate ionotropic receptor NMDA type subunit 2B"	Q13224	12	13437942-13982002	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, Epilepsy, FDA approved drug targets, Intellectual disability"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	17	"brain: 7.1"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 604.2;Inhibitory neurons: 845.7"	"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in some"		"Colon Adenocarcinoma (TCGA): 1.1;Rectum Adenocarcinoma (TCGA): 1.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"colorectal cancer: 1.5"	"Liver - Hepatocytes, Pituitary gland - Undifferentiated cells (Pituitary gland), Testis - Early spermatids, Testis - Late spermatids"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA069762	Approved						NA	NA				"Cluster 33: Brain - Neuronal signaling"	"Cluster 51: Neurons - Mixed function"	"Cluster 57: Stomach & Colon cancer - Digestion"	"Cluster 65: Neurons - Synaptic function"	26			"HPA069762: AB_2686192"					"unprognostic (1.63e-1)"	"unprognostic (5.01e-2)"		"unprognostic (9.12e-2)"																	"unprognostic (5.18e-2)"	"unprognostic (1.15e-1)"					
GRIN2C	"GluN2C, NMDAR2C"	ENSG00000161509	"Glutamate ionotropic receptor NMDA type subunit 2C"	Q14957	17	74842023-74861504	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 115.9"	"Cell type enriched"	"Detected in some"	4	"Astrocytes: 131.6"	"Cell type enhanced"	"Detected in many"		"astrocyte: 133.3;bergmann glia: 60.7;upper rhombic lip: 99.1"	"Cancer enhanced"	"Detected in some"		"Thyroid Carcinoma (TCGA): 6.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"				"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	14	"cerebellum: 53.4"								NA	NA				"Cluster 65: Cerebellum - Nervous system development"	"Cluster 37: Neurons - Mixed function"	"Cluster 2: Mucus-secreting cells - Unknown function"	"Cluster 47: Astrocytes - Unknown function"	62					"unprognostic (1.19e-1)"	"unprognostic (8.40e-2)"	"unprognostic (1.30e-2)"			"unprognostic (1.49e-1)"	"unprognostic (1.85e-2)"																						"unprognostic (1.48e-2)"	
GRIN2D	"EB11, GluN2D, NMDAR2D, NR2D"	ENSG00000105464	"Glutamate ionotropic receptor NMDA type subunit 2D"	O15399	19	48393668-48444931	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.5"	"Group enriched"	"Detected in some"	4	"Inhibitory neurons: 35.0;Oligodendrocyte precursor cells: 14.6"	"Cell type enhanced"	"Detected in many"		"CGE interneuron: 74.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Adipose subcutaneous - Adipose progenitor cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009006	Approved						NA	NA				"Cluster 5: Brain & Testis - Signal transduction"	"Cluster 38: Sub-cortical - Mixed function"	"Cluster 57: Stomach & Colon cancer - Digestion"	"Cluster 69: Neurons - Neuronal signaling"				"CAB009006: AB_2279191"	"potential prognostic unfavorable (3.80e-4)"	"unprognostic (8.20e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.50e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.89e-1)"	"unprognostic (3.39e-1)"							"potential prognostic unfavorable (7.71e-4)"		"unprognostic (1.49e-1)"	"unprognostic (2.21e-1)"	"potential prognostic unfavorable (8.74e-5)"		"unprognostic (9.08e-2)"	"unprognostic (1.06e-1)"		"unprognostic (9.50e-2)"	"unprognostic (6.27e-3)"	"unprognostic (2.95e-1)"	"unprognostic (2.33e-2)"	"unprognostic (8.32e-2)"		"unprognostic (2.44e-1)"
GRIN3A	GluN3A	ENSG00000198785	"Glutamate ionotropic receptor NMDA type subunit 3A"	Q8TCU5	9	101569352-101738647	"FDA approved drug targets, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 7.4"	"Cell type enriched"	"Detected in some"	5	"Inhibitory neurons: 210.8"	"Cell type enhanced"	"Detected in all"		"LAMP5-LHX6 and Chandelier: 410.7;MGE interneuron: 314.1"	"Cancer enriched"	"Detected in single"	7	"Prostate Adenocarcinoma (TCGA): 4.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Gastric cancer: 3.1;prostate cancer: 3.6"		"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"										NA	NA			"Cluster 37: Monocytes & Neutrophils - Innate immune response"	"Cluster 61: Brain - Neuronal signaling"	"Cluster 1: Neurons - Mixed function"	"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 65: Neurons - Synaptic function"	3						"unprognostic (2.08e-1)"					"unprognostic (2.36e-2)"																"unprognostic (1.98e-1)"							
GRIN3B	GluN3B	ENSG00000116032	"Glutamate ionotropic receptor NMDA type subunit 3B"	O60391	19	1000419-1009732	"FDA approved drug targets, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 4.0"	"Group enriched"	"Detected in some"	6	"Ciliated cells: 39.7;Spermatogonia: 11.2"	"Cell type enriched"	"Detected in single"	19	"ependymal cell: 14.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Lung - Respiratory ciliated cells"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.6"	"Region enriched"	"Detected in single"	8	"spinal cord: 5.6"								NA	NA				"Cluster 59: Fallopian tube - Tissue development"	"Cluster 43: Hindbrain - Mixed function"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 42: Ciliated cells - Cilium assembly"	8						"unprognostic (1.72e-2)"									"unprognostic (6.03e-2)"	"unprognostic (2.63e-1)"		"unprognostic (5.93e-2)"																"unprognostic (9.78e-2)"
GRM5	"GPRC1E, mGlu5, MGLUR5, PPP1R86"	ENSG00000168959	"Glutamate metabotropic receptor 5"	P41594	11	88504576-89065982	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 14.4"	"Group enriched"	"Detected in some"	26	"Excitatory neurons: 872.0;Inhibitory neurons: 927.5;Oligodendrocyte precursor cells: 976.3"	"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in some"		"Kidney Renal Papillary Cell Carcinoma (TCGA): 2.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	7	"Gallbladder cancer: 2.6"	"Lung - Respiratory ciliated cells, Pituitary gland - Lactotropes, Testis - Early spermatids, Testis - Late spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	Receptor	NA	NA				"Cluster 61: Brain - Neuronal signaling"	"Cluster 53: Neurons - Mixed function"	"Cluster 50: Lymphoma - Unknown function"	"Cluster 65: Neurons - Synaptic function"	3										"unprognostic (7.68e-2)"	"unprognostic (4.36e-2)"					"unprognostic (3.01e-3)"																		
GSR		ENSG00000104687	"Glutathione-disulfide reductase"	P00390	8	30678066-30727846	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes, Disease variant, FDA approved drug targets, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 32.3"	"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adipose visceral - Macrophages, Adrenal gland - Adrenal cortex cells, Spleen - Macrophages, Stomach - Gastric mucous cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001538, CAB008632, HPA064806"	Approved		Supported	Cytosol			NA	NA		64000000	"Cluster 42: Non-specific - Vesicular transport"	"Cluster 55: Kidney & Intestine - Metabolism"	"Cluster 23: Choroid plexus - Mixed function"	"Cluster 7: Liver cancer - Metabolism"	"Cluster 5: Enterocytes - Absorption"		Cytosol		"CAB008632: AB_1616690, HPA001538: AB_1078986, HPA064806: "	"potential prognostic favorable (7.98e-4)"	"unprognostic (7.89e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.39e-3)"	"potential prognostic favorable (2.04e-4)"	"unprognostic (1.15e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.95e-3)"	"potential prognostic favorable (1.31e-5)"	"unprognostic (7.44e-2)"	"unprognostic (7.17e-3)"	"potential prognostic unfavorable (3.93e-6)"	"unprognostic (8.37e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.60e-1)"	"unprognostic (7.21e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.53e-2)"	"unprognostic (2.93e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.71e-2)"	"unprognostic (7.69e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.48e-2)"	"unprognostic (5.35e-2)"
GSS		ENSG00000100983	"Glutathione synthetase"	P48637	20	34928432-34956027	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Glutathione biosynthesis"	Ligase	"Disease variant, FDA approved drug targets, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 183.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Testis - Sertoli cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054508, HPA059315"	Enhanced		Supported	Nucleoplasm			NA	NA		31000000	"Cluster 33: Non-specific - ATP binding"	"Cluster 53: Non-specific - Glycosylation"	"Cluster 14: Neurons - Synaptic function"	"Cluster 62: Non-specific - Plasma proteins"	"Cluster 56: Proximal tubular cells - Amino acid metabolism"	1	Nucleoplasm		"HPA054508: AB_2682509, HPA059315: AB_2683976"	"unprognostic (5.50e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.71e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.83e-3)"	"potential prognostic favorable (1.04e-7)"	"potential prognostic unfavorable (8.01e-5)"	"unprognostic (1.17e-3)"	"unprognostic (1.55e-3)"	"unprognostic (4.86e-2)"	"unprognostic (8.46e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.85e-1)"	"unprognostic (8.52e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.28e-2)"
GUCY1A1	"GC-SA3, GUC1A3, GUCY1A3"	ENSG00000164116	"Guanylate cyclase 1 soluble subunit alpha 1"	Q02108	4	155666726-155737059	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"cGMP biosynthesis"	Lyase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 125.4;Cardiomyocytes: 101.7;Inhibitory neurons: 68.3;Prostatic glandular cells: 170.2;Sertoli cells: 76.2;Smooth muscle cells: 146.2"	"Cell type enhanced"	"Detected in all"		"midbrain-derived inhibitory: 584.0"	"Cancer enhanced"	"Detected in all"		"Prostate Adenocarcinoma (TCGA): 48.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 8.3;non-classical monocyte: 10.1;plasmacytoid DC: 11.5"	"Group enriched"	"Detected in many"	35	"dendritic cells: 11.5;monocytes: 10.1;NK-cells: 8.3"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 29.1"	"Adipose subcutaneous - Smooth muscle cells, Adipose visceral - Endothelial cells, Adrenal gland - Fibroblasts, Kidney - Fibroblasts, Liver - Hepatic stellate cells, Pituitary gland - Fibroblasts, Spleen - Fibroblast_1, Thyroid gland - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010887, HPA056004, HPA058617"	Uncertain		Supported	Nucleoplasm			NA	NA		14000	"Cluster 10: Non-specific - Membrane trafficking"	"Cluster 7: Adipose tissue - Mixed function"	"Cluster 33: Neurons - Mixed function"	"Cluster 60: Prostate cancer - Unknown function"	"Cluster 48: Smooth muscle cells - Signal transduction"	2	Nucleoplasm		"CAB010887: AB_259901, HPA056004: AB_2683007, HPA058617: AB_2732624"	"unprognostic (3.45e-2)"	"unprognostic (8.61e-2)"		"unprognostic (9.27e-3)"	"unprognostic (6.29e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.83e-3)"	"unprognostic (7.31e-3)"	"unprognostic (3.93e-3)"	"validated prognostic favorable (1.33e-6)"	"validated prognostic favorable (4.13e-6)"	"unprognostic (8.26e-2)"	"unprognostic (2.64e-1)"		"potential prognostic favorable (5.94e-4)"	"unprognostic (2.65e-1)"	"unprognostic (8.38e-2)"	"unprognostic (7.93e-3)"	"unprognostic (6.44e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.00e-1)"	"unprognostic (9.77e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.24e-1)"	"potential prognostic favorable (4.77e-4)"	"unprognostic (1.41e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.74e-3)"	"unprognostic (9.73e-2)"	"unprognostic (2.56e-1)"
GUCY1A2	"GC-SA2, GUC1A2"	ENSG00000152402	"Guanylate cyclase 1 soluble subunit alpha 2"	P33402	11	106674019-107018476	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"cGMP biosynthesis"	Lyase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 17.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 341.5;Granulosa cells: 91.0;Inhibitory neurons: 136.1;Oligodendrocyte precursor cells: 195.7;Smooth muscle cells: 83.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Adrenal gland - Fibroblasts, Breast - Endothelial cells, Kidney - Fibroblasts, Liver - Hepatic stellate cells, Spleen - Fibroblast_1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009534	Uncertain						NA	NA				"Cluster 62: Connective tissue - ECM organization"	"Cluster 52: Neurons & Synapses - Synaptic function"	"Cluster 3: Rhabdoid - Membrane components"	"Cluster 34: Neurons - Neuronal signaling"	4			"CAB009534: AB_2279509"		"unprognostic (7.71e-2)"	"unprognostic (5.77e-2)"			"unprognostic (6.48e-2)"	"unprognostic (7.75e-2)"	"unprognostic (3.14e-2)"			"potential prognostic favorable (6.74e-4)"	"unprognostic (1.53e-3)"				"unprognostic (6.45e-2)"	"unprognostic (1.33e-1)"		"unprognostic (1.15e-1)"	"unprognostic (3.59e-2)"		"unprognostic (1.99e-1)"	"unprognostic (1.29e-1)"			"unprognostic (2.55e-1)"					
GUCY1B1	"GC-S-beta-1, GC-SB3, GUC1B3, GUCY1B3"	ENSG00000061918	"Guanylate cyclase 1 soluble subunit beta 1"	Q02153	4	155758992-155807811	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"cGMP biosynthesis"	Lyase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 49.2;Excitatory neurons: 67.5;Inhibitory neurons: 56.5;Sertoli cells: 70.7;Smooth muscle cells: 84.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"intermediate monocyte: 7.2;non-classical monocyte: 24.0"	"Lineage enriched"	"Detected in many"	13	"monocytes: 24.0"	"Low cancer specificity"	"Detected in many"			"Liver - Hepatic stellate cells, Thyroid gland - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010890, HPA020870, HPA077706"	Approved		Approved	Cytosol			NA	NA			"Cluster 37: Monocytes & Neutrophils - Innate immune response"	"Cluster 61: Brain - Neuronal signaling"	"Cluster 14: Neurons - Synaptic function"	"Cluster 55: Lymphoma - Immune response"	"Cluster 48: Smooth muscle cells - Signal transduction"	6	Cytosol		"CAB010890: AB_259911, HPA020870: AB_1850444, HPA077706: "	"unprognostic (2.17e-2)"	"unprognostic (1.71e-1)"		"unprognostic (3.00e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.13e-1)"	"unprognostic (7.26e-3)"	"unprognostic (1.32e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.37e-1)"	"validated prognostic favorable (4.35e-4)"	"validated prognostic favorable (9.04e-5)"	"potential prognostic unfavorable (7.61e-4)"	"unprognostic (1.02e-1)"		"unprognostic (3.71e-3)"	"unprognostic (7.76e-3)"	"unprognostic (2.65e-1)"	"unprognostic (7.32e-3)"	"unprognostic (8.45e-2)"	"unprognostic (6.21e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.71e-1)"	"unprognostic (5.46e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.80e-2)"	"potential prognostic unfavorable (8.98e-6)"	"unprognostic (5.30e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.69e-2)"
GUCY2C	"GUC2C, STAR"	ENSG00000070019	"Guanylate cyclase 2C"	P25092	12	14612632-14696599	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"cGMP biosynthesis"	"Lyase, Receptor"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"intestine: 66.3"	"Group enriched"	"Detected in some"	10	"Distal enterocytes: 35.4;Enteroendocrine cells: 127.7;Intestinal goblet cells: 59.7;Paneth cells: 99.7;Proximal enterocytes: 70.4;Undifferentiated cells: 41.1"	"Cell type enriched"	"Detected in many"	7	"choroid plexus epithelial cell: 50.8"	"Group enriched"	"Detected in many"	6	"Colon Adenocarcinoma (TCGA): 34.1;Rectum Adenocarcinoma (TCGA): 37.9;Stomach Adenocarcinoma (TCGA): 13.3"	"Region enriched"	"Detected in many"	4	"choroid plexus: 6.8"	"Immune cell enhanced"	"Detected in some"		"memory B-cell: 1.5"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"Bile duct cancer: 10.5;colorectal cancer: 17.5;Gastric cancer: 7.2"	"Colon - Colon enterocytes, Minor Salivary Gland - Minor salivary gland basal cells"	"Region enhanced"	"Detected in some"		"midbrain: 1.8"	"Low region specificity"	"Detected in many"			"HPA037655, HPA073759"	Uncertain		Uncertain	Vesicles			NA	NA			"Cluster 2: Dendritic cells - Unknown function"	"Cluster 45: Intestine - Digestion"	"Cluster 8: Immune cells - Immune response"	"Cluster 57: Stomach & Colon cancer - Digestion"	"Cluster 20: Enteroendocrine cells - Hormone signaling"	1	Vesicles		"HPA037655: AB_10672388, HPA073759: "					"unprognostic (6.14e-2)"	"unprognostic (1.25e-2)"				"unprognostic (4.01e-3)"				"validated prognostic unfavorable (1.31e-5)"	"validated prognostic unfavorable (9.46e-6)"	"unprognostic (3.77e-2)"	"unprognostic (5.29e-2)"		"unprognostic (8.45e-2)"			"unprognostic (8.33e-2)"	"unprognostic (1.99e-1)"		"unprognostic (2.03e-3)"	"unprognostic (1.83e-2)"		"unprognostic (1.10e-1)"	"unprognostic (3.57e-1)"		
HADH	"HADH1, HADHSC, SCHAD"	ENSG00000138796	"Hydroxyacyl-CoA dehydrogenase"	Q16836	4	107989714-108035241	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Oxidoreductase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 288.6;Hepatocytes: 310.8;Proximal enterocytes: 386.9;Proximal tubular cells: 250.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Adrenal gland - Adrenal cortex cells, Heart muscle - Cardiomyocytes, Kidney - Proximal tubular cells, Liver - Hepatocytes, Minor Salivary Gland - Minor salivary glandular cells, Skeletal muscle - Skeletal myocytes, Skin - Sebaceous gland cells, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039588, HPA043888"	Enhanced		Supported	Mitochondria			No	Yes		830000	"Cluster 13: Non-specific - Mitochondria"	"Cluster 35: Non-specific - Mitochondria"	"Cluster 21: Non-specific - Metabolism"	"Cluster 22: Non-specific - mRNA splicing & Cell cycle"	"Cluster 22: Proximal enterocytes - Digestion"	6	Mitochondria		"HPA039588: AB_10673425, HPA043888: AB_2678716"	"unprognostic (4.57e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.54e-1)"	"unprognostic (8.13e-3)"	"unprognostic (6.59e-2)"	"potential prognostic unfavorable (2.02e-4)"	"potential prognostic favorable (6.62e-13)"	"unprognostic (2.15e-3)"	"unprognostic (7.66e-3)"	"unprognostic (4.79e-3)"	"potential prognostic favorable (2.47e-4)"	"unprognostic (1.31e-1)"	"unprognostic (2.56e-2)"	"unprognostic (5.67e-2)"	"unprognostic (4.29e-3)"	"unprognostic (8.42e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.92e-1)"	"unprognostic (6.61e-2)"	"unprognostic (3.52e-3)"	"unprognostic (2.63e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.25e-3)"
HAO1	"GOX, GOX1"	ENSG00000101323	"Hydroxyacid oxidase 1"	Q9UJM8	20	7882985-7940458	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"Amino-acid biosynthesis"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	587	"liver: 589.2"	"Cell type enriched"	"Detected in some"	17	"Hepatocytes: 304.4"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	179	"Liver Hepatocellular Carcinoma (TCGA): 120.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Kidney - Proximal tubular cells, Liver - Hepatocytes"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA049552, HPA072442"	Enhanced		Supported	Vesicles			NA	NA		180000		"Cluster 31: Liver - Plasma proteins"		"Cluster 7: Liver cancer - Metabolism"	"Cluster 43: Hepatocytes - Metabolism"		Vesicles		"HPA049552: AB_2680814, HPA072442: "														"unprognostic (1.58e-3)"	"unprognostic (3.05e-3)"																
HBA1	HBA-T3	ENSG00000206172	"Hemoglobin subunit alpha 1"	P69905	16	176680-177522	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Oxygen transport, Transport"		"Disease variant, FDA approved drug targets, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"bone marrow: 23966.1"	"Cell type enriched"	"Detected in many"	105	"Erythroid cells: 56964.9"	"Cell type enhanced"	"Detected in many"		"endothelial cell: 18.7"	"Cancer enhanced"	"Detected in all"		"Glioblastoma Multiforme (TCGA): 370.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 143.5;plasmacytoid DC: 101.4"	"Group enriched"	"Detected in all"	5	"dendritic cells: 101.4;granulocytes: 143.5"	"Cancer enriched"	"Detected in many"	55	"Leukemia: 983.6"	"Liver - Erythroid cells, Spleen - Erythrocytes"									"CAB032534, HPA043780"	Enhanced						NA	NA		18000000000	"Cluster 21: Neutrophils - Unknown function"	"Cluster 77: Bone marrow - Cell proliferation"	"Cluster 42: Choroid plexus - Mitochondria"	"Cluster 47: Leukemia - Hemostasis"	"Cluster 1: Erythroid cells - Oxygen transport"	33			"CAB032534: AB_2294993, HPA043780: AB_2678667"	"unprognostic (3.66e-2)"	"unprognostic (6.01e-2)"	"unprognostic (8.96e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.77e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.41e-1)"	"potential prognostic favorable (2.23e-5)"	"unprognostic (2.89e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.99e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.45e-2)"	"unprognostic (4.26e-1)"	"unprognostic (2.27e-2)"	"unprognostic (6.20e-3)"	"unprognostic (3.84e-2)"	"unprognostic (5.60e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.84e-1)"
HBA2	HBA-T2	ENSG00000188536	"Hemoglobin subunit alpha 2"	P69905	16	172876-173710	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Oxygen transport, Transport"		"Disease variant, FDA approved drug targets, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"bone marrow: 37617.4"	"Cell type enriched"	"Detected in many"	96	"Erythroid cells: 55683.9"	"Cell type enhanced"	"Detected in many"		"endothelial cell: 40.0;vascular associated smooth muscle cell: 14.1"	"Cancer enhanced"	"Detected in all"		"Glioblastoma Multiforme (TCGA): 937.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"eosinophil: 316.7;neutrophil: 961.9;plasmacytoid DC: 488.2"	"Group enriched"	"Detected in all"	7	"dendritic cells: 488.2;granulocytes: 961.9"	"Cancer enriched"	"Detected in many"	34	"Leukemia: 1053.9"	"Liver - Erythroid cells, Spleen - Erythrocytes"									"CAB038417, HPA043780"	Enhanced						NA	NA		18000000000	"Cluster 22: Eosinophils - Transcription"	"Cluster 77: Bone marrow - Cell proliferation"	"Cluster 42: Choroid plexus - Mitochondria"	"Cluster 47: Leukemia - Hemostasis"	"Cluster 1: Erythroid cells - Oxygen transport"	32			"CAB038417: , HPA043780: AB_2678667"	"unprognostic (3.83e-3)"	"unprognostic (2.28e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.33e-3)"	"unprognostic (2.66e-1)"	"unprognostic (9.57e-2)"	"potential prognostic favorable (1.29e-4)"	"unprognostic (9.46e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.11e-1)"	"unprognostic (9.46e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.73e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.26e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.40e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.08e-1)"	"unprognostic (7.99e-2)"	"unprognostic (3.31e-1)"
HBB	"beta-globin, CD113t-C"	ENSG00000244734	"Hemoglobin subunit beta"	P68871	11	5225464-5229395	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Oxygen transport, Transport"	"Hypotensive agent, Vasoactive"	"Congenital dyserythropoietic anemia, Disease variant, FDA approved drug targets, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	11	"bone marrow: 131241.6"	"Cell type enriched"	"Detected in many"	216	"Erythroid cells: 265225.8"	"Cell type enhanced"	"Detected in many"		"endothelial cell: 66.8;pericyte: 24.6;vascular associated smooth muscle cell: 41.3"	"Cancer enhanced"	"Detected in all"		"Glioblastoma Multiforme (TCGA): 1324.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"neutrophil: 662.1;plasmacytoid DC: 380.8"	"Group enriched"	"Detected in all"	11	"dendritic cells: 380.8;granulocytes: 662.1"	"Cancer enriched"	"Detected in many"	5	"Leukemia: 132.1"	"Liver - Erythroid cells, Spleen - Erythrocytes"									"CAB009526, HPA043234"	Enhanced						NA	NA		14000000000	"Cluster 35: Neutrophils - Protein binding"	"Cluster 77: Bone marrow - Cell proliferation"	"Cluster 42: Choroid plexus - Mitochondria"	"Cluster 47: Leukemia - Hemostasis"	"Cluster 1: Erythroid cells - Oxygen transport"	38			"CAB009526: AB_2143058, HPA043234: AB_2678378"	"unprognostic (2.19e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.45e-1)"	"unprognostic (5.89e-2)"	"unprognostic (9.95e-2)"	"unprognostic (4.90e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.29e-3)"	"unprognostic (4.10e-1)"	"unprognostic (2.98e-1)"	"potential prognostic favorable (4.13e-7)"	"unprognostic (1.09e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.02e-2)"	"unprognostic (4.04e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.63e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.58e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.54e-3)"	"unprognostic (5.07e-1)"	"unprognostic (7.81e-2)"	"unprognostic (2.71e-2)"	"unprognostic (4.90e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.31e-1)"
HCAR2	"GPR109A, HCA2, HM74A, NIACR1, Puma-g, PUMAG"	ENSG00000182782	"Hydroxycarboxylic acid receptor 2"	Q8TDS4	12	122701293-122703357	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"	Apoptosis	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 39.7;skin 1: 29.3"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 55.7;Basal prostatic cells: 154.4;Basal respiratory cells: 46.7;Basal squamous epithelial cells: 98.6;Langerhans cells: 141.4;Suprabasal keratinocytes: 65.7"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Head and Neck Squamous Cell Carcinoma (TCGA): 37.6"	"Region enriched"	"Detected in some"	5	"cerebral cortex: 12.1"	"Immune cell enriched"	"Detected in many"	5	"neutrophil: 177.3"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 177.3"	"Cancer enhanced"	"Detected in some"		"Bladder cancer: 21.1;Esophageal cancer: 21.1;head and neck cancer: 40.0"	"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Lung - NK-cells (Lung), Skin - Keratinocyte (other), Testis - Late spermatids"									HPA028660	Approved		Supported	"Cell Junctions"			NA	NA			"Cluster 28: Neutrophils - Unknown function"	"Cluster 27: Squamous epithelium - Keratinization"	"Cluster 12: Non-specific - Vasculature"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 74: Neutrophils - Degranulation"		"Cell Junctions"		"HPA028660: AB_10602139"	"unprognostic (1.47e-2)"	"unprognostic (3.36e-2)"		"unprognostic (6.83e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.55e-3)"		"unprognostic (6.03e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.91e-3)"	"unprognostic (6.78e-2)"			"unprognostic (2.23e-1)"	"unprognostic (1.61e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.80e-1)"	"unprognostic (7.52e-2)"			"unprognostic (4.97e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.52e-1)"	"unprognostic (7.29e-2)"	"unprognostic (2.25e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.19e-1)"	
HCAR3	"GPR109B, HCA3, HM74"	ENSG00000255398	"Hydroxycarboxylic acid receptor 3"	P49019	12	122714756-122716811	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 27.1;esophagus: 16.3;lymphoid tissue: 19.2;skin 1: 16.8"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 78.8;Basal prostatic cells: 190.1;Basal respiratory cells: 53.3;Basal squamous epithelial cells: 138.3;Langerhans cells: 71.4;monocytes: 57.9;Squamous epithelial cells: 45.4;Suprabasal keratinocytes: 87.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"Bladder Urothelial Carcinoma (TCGA): 12.9;Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA): 13.4;Head and Neck Squamous Cell Carcinoma (TCGA): 16.0;Kidney Chromophobe (TCGA): 4.7;Lung Squamous Cell Carcinoma (TCGA): 10.0"	"Region enriched"	"Detected in some"	5	"cerebral cortex: 10.1"	"Group enriched"	"Detected in many"	6	"basophil: 58.8;neutrophil: 177.8;non-classical monocyte: 84.6"	"Group enriched"	"Detected in many"	50	"granulocytes: 177.8;monocytes: 84.6"	"Cancer enhanced"	"Detected in some"		"Bladder cancer: 7.3;Gallbladder cancer: 6.8;head and neck cancer: 10.4"	"Adipose visceral - Adipocytes (Visceral), Lung - NK-cells (Lung), Prostate - Urothelial cells, Skin - Keratinocyte (other)"									HPA028660	Approved		Approved	"Cell Junctions"			NA	NA			"Cluster 28: Neutrophils - Unknown function"	"Cluster 77: Bone marrow - Cell proliferation"	"Cluster 12: Non-specific - Vasculature"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 12: Squamous epithelial cells - Keratinization"		"Cell Junctions"		"HPA028660: AB_10602139"	"unprognostic (3.12e-2)"	"unprognostic (1.91e-1)"		"unprognostic (3.74e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.19e-2)"		"unprognostic (1.55e-1)"	"unprognostic (8.99e-2)"	"unprognostic (7.01e-2)"					"unprognostic (1.11e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.28e-1)"			"unprognostic (1.67e-2)"	"unprognostic (3.26e-2)"		"unprognostic (7.27e-2)"	"unprognostic (4.07e-2)"		"unprognostic (1.12e-1)"	"unprognostic (3.47e-1)"		
HCRTR1	"ORXR1, OX1R, OXR1"	ENSG00000121764	"Hypocretin receptor 1"	O43613	1	31617686-31632518	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"adrenal gland: 1.1"	"Cell type enriched"	"Detected in single"	4	"Late spermatids: 4.4"	"Cell type enhanced"	"Detected in some"		"CGE interneuron: 4.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Adrenal gland - Adrenal medulla cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA014018	Approved						NA	NA				"Cluster 54: Non-specific - Basic cellular processes"	"Cluster 41: Monoamines - Neurotransmitter signalling"	"Cluster 54: Non-specific - Transcription"	"Cluster 63: Late spermatids - Spermatogenesis"	2			"HPA014018: AB_1854810"																															
HCRTR2	"ORXR2, OX2R, OXR2"	ENSG00000137252	"Hypocretin receptor 2"	O43614	6	55106460-55282617	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 11.3;Inhibitory neurons: 17.6;Peritubular cells: 4.4"	"Cell type enhanced"	"Detected in many"		"cerebellar inhibitory: 120.7;deep-layer corticothalamic and 6b: 132.2;LAMP5-LHX6 and Chandelier: 186.6;lower rhombic lip: 211.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"cervical cancer: 1.0"	"Pituitary gland - Gonadotropes"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA054516, HPA070481"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"			NA	NA					"Cluster 49: Hindbrain - Mixed function"	"Cluster 5: Rhabdoid - Unknown function"	"Cluster 65: Neurons - Synaptic function"	1	"Plasma membrane"	Nucleoplasm	"HPA054516: AB_2682513, HPA070481: "																															
HDAC1	"GON-10, HD1, KDAC1, RPD3L1"	ENSG00000116478	"Histone deacetylase 1"	Q13547	1	32292083-32333635	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005017, HPA029693, CAB068191"	Enhanced		Enhanced	Nucleoplasm			NA	NA		5300	"Cluster 36: Eosinophils - Protein ubiquitination"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 39: Astrocytes - Mixed function"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 45: Non-specific - Mixed function"	645	Nucleoplasm		"CAB005017: AB_2248344, CAB068191: AB_2665664, HPA029693: AB_10601659"	"unprognostic (4.14e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.27e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.74e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.48e-2)"	"unprognostic (4.26e-1)"	"potential prognostic unfavorable (2.99e-10)"	"unprognostic (1.07e-3)"	"unprognostic (4.08e-2)"	"unprognostic (5.83e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.46e-3)"	"unprognostic (5.09e-2)"	"unprognostic (8.31e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.70e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.27e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.19e-1)"
HDAC10	DKFZP761B039	ENSG00000100429	"Histone deacetylase 10"	Q969S8	22	50245183-50251405	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Autophagy, DNA damage, DNA recombination, DNA repair"	Hydrolase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019662, CAB045977"	Supported		Supported	Nucleoplasm,Cytosol			NA	NA			"Cluster 25: Non-specific - Unknown function"	"Cluster 47: Spleen - Immune response"	"Cluster 23: Choroid plexus - Mixed function"	"Cluster 54: Non-specific - Transcription"	"Cluster 80: Non-specific - Transcription"	10	"Nucleoplasm, Cytosol"		"CAB045977: AB_11124034, HPA019662: "	"unprognostic (2.06e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.55e-2)"	"unprognostic (7.22e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.31e-3)"	"unprognostic (7.75e-2)"	"unprognostic (1.10e-1)"	"unprognostic (9.20e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.06e-3)"	"unprognostic (2.11e-1)"	"potential prognostic unfavorable (1.37e-4)"	"unprognostic (2.92e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.51e-2)"	"potential prognostic unfavorable (2.28e-4)"	"unprognostic (1.47e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.57e-3)"	"unprognostic (2.78e-3)"	"unprognostic (9.73e-2)"
HDAC11		ENSG00000163517	"Histone deacetylase 11"	Q96DB2	3	13479724-13506424	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 96.8;testis: 81.8"	"Group enriched"	"Detected in many"	11	"Early spermatids: 279.4;Late spermatids: 727.2"	"Cell type enhanced"	"Detected in all"		"oligodendrocyte: 67.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Heart muscle - Cardiomyocytes, Skeletal muscle - Skeletal myocytes, Testis - Late spermatids, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"										NA	NA		230000	"Cluster 33: Non-specific - ATP binding"	"Cluster 44: Testis - Spermatogenesis"	"Cluster 11: White matter - Signal transduction"	"Cluster 2: Mucus-secreting cells - Unknown function"	"Cluster 36: Late spermatids - Unknown function"	14				"unprognostic (9.44e-2)"	"unprognostic (7.28e-2)"	"unprognostic (7.65e-3)"	"unprognostic (1.82e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.91e-1)"	"validated prognostic favorable (6.96e-8)"	"validated prognostic favorable (1.50e-4)"	"potential prognostic favorable (3.30e-7)"	"validated prognostic unfavorable (2.45e-6)"	"validated prognostic unfavorable (4.39e-4)"	"unprognostic (1.10e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.75e-2)"	"unprognostic (5.89e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.23e-2)"	"unprognostic (8.40e-2)"
HDAC2	"KDAC2, RPD3, YAF1"	ENSG00000196591	"Histone deacetylase 2"	Q92769	6	113933028-114011308	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Testis - Spermatocytes, Testis - Spermatogonia"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005054, HPA011727"	Supported		Supported	Nucleoplasm			NA	NA		11000	"Cluster 33: Non-specific - ATP binding"	"Cluster 16: Non-specific - Transcription"	"Cluster 28: Oligodendrocytes - Mixed function"	"Cluster 28: Non-specific - Nuclear processes"	"Cluster 39: Non-specific - Basic cellular processes"	411	Nucleoplasm		"CAB005054: AB_562295, HPA011727: AB_1850540"	"unprognostic (5.85e-2)"	"potential prognostic unfavorable (2.58e-4)"	"unprognostic (4.20e-3)"	"unprognostic (7.19e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.43e-2)"	"unprognostic (9.74e-3)"	"unprognostic (2.90e-2)"	"potential prognostic unfavorable (2.40e-5)"	"potential prognostic favorable (9.82e-6)"	"unprognostic (3.25e-2)"	"unprognostic (1.49e-2)"	"validated prognostic unfavorable (1.81e-11)"	"validated prognostic unfavorable (7.88e-5)"	"unprognostic (9.66e-3)"	"unprognostic (1.37e-3)"	"unprognostic (9.83e-2)"	"unprognostic (7.22e-2)"	"unprognostic (8.21e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.95e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.04e-1)"	"unprognostic (4.25e-3)"
HDAC3	"HD3, KDAC3, RPD3, RPD3-2"	ENSG00000171720	"Histone deacetylase 3"	O15379	5	141620876-141636849	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"Biological rhythms, Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adipose visceral - Adipose progenitor cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005583, HPA052052, CAB072336"	Supported		Supported	"Nucleoplasm,Golgi apparatus"			NA	NA			"Cluster 12: Non-specific - Mitochondrial translation"	"Cluster 35: Non-specific - Mitochondria"	"Cluster 14: Neurons - Synaptic function"	"Cluster 22: Non-specific - mRNA splicing & Cell cycle"	"Cluster 14: Langerhans cells - Innate immune response"	141	Nucleoplasm	"Golgi apparatus"	"CAB005583: AB_562296, CAB072336: , HPA052052: AB_2681708"	"unprognostic (6.66e-2)"	"unprognostic (1.78e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.72e-1)"	"potential prognostic favorable (7.04e-4)"	"unprognostic (3.86e-1)"	"unprognostic (1.68e-1)"	"unprognostic (5.21e-2)"	"unprognostic (5.09e-2)"	"unprognostic (8.59e-3)"	"potential prognostic favorable (7.82e-6)"	"unprognostic (9.07e-2)"	"unprognostic (2.17e-1)"	"potential prognostic unfavorable (3.70e-4)"	"unprognostic (5.64e-2)"	"unprognostic (3.92e-1)"	"unprognostic (4.14e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.90e-3)"	"unprognostic (4.50e-2)"	"unprognostic (3.32e-3)"	"unprognostic (3.59e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.37e-3)"	"unprognostic (1.46e-1)"
HDAC4	"BDMR, HA6116, HD4, HDAC-4, HDAC-A, HDACA, KIAA0288"	ENSG00000068024	"Histone deacetylase 4"	P56524	2	239048168-239401654	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"Disease variant, Epilepsy, FDA approved drug targets, Intellectual disability"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 56.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 58.8;Excitatory neurons: 114.0;Inhibitory neurons: 81.4;Late spermatids: 71.8;Oligodendrocyte precursor cells: 80.2;Oligodendrocytes: 115.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 32.0;neutrophil: 47.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 47.0"	"Low cancer specificity"	"Detected in all"			"Breast - Fibroblasts, Minor Salivary Gland - Endothelial cells, Prostate - Smooth muscle cells, Testis - Late spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048723, HPA071448"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"			NA	NA			"Cluster 35: Neutrophils - Protein binding"	"Cluster 2: Skeletal muscle - Striated muscle contraction"	"Cluster 32: Cerebral cortex - Mixed function"	"Cluster 59: Leukemia - T-cell receptor"	"Cluster 34: Neurons - Neuronal signaling"	89	"Nuclear speckles"	"Nucleoplasm, Cytosol"	"HPA048723: AB_2680501, HPA071448: "	"unprognostic (5.13e-2)"	"unprognostic (2.60e-1)"	"potential prognostic favorable (5.12e-4)"	"unprognostic (6.39e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.26e-2)"	"unprognostic (8.97e-2)"	"potential prognostic favorable (2.43e-4)"	"unprognostic (1.29e-2)"	"unprognostic (5.11e-2)"	"unprognostic (6.51e-3)"	"unprognostic (1.90e-2)"	"unprognostic (2.41e-1)"	"potential prognostic unfavorable (3.36e-4)"	"unprognostic (1.23e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.83e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.88e-3)"	"potential prognostic unfavorable (1.54e-4)"	"unprognostic (4.11e-1)"	"unprognostic (1.95e-3)"	"unprognostic (6.59e-2)"	"unprognostic (3.31e-2)"	"unprognostic (8.41e-3)"	"unprognostic (1.30e-2)"	"unprognostic (9.53e-2)"	"unprognostic (4.29e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.87e-2)"	"unprognostic (6.70e-2)"
HDAC5	"FLJ90614, KIAA0600, NY-CO-9"	ENSG00000108840	"Histone deacetylase 5"	Q9UQL6	17	44076746-44123702	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 247.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Lung - Fibroblast_1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019400, HPA030991, HPA076420"	Approved		Supported	"Nuclear speckles,Golgi apparatus,Cytosol"			NA	NA			"Cluster 2: Dendritic cells - Unknown function"	"Cluster 21: Testis - Unknown function"	"Cluster 16: Non-specific - Transcription"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 27: Syncytiotrophoblasts - Pregnancy"	65	"Nuclear speckles"	"Golgi apparatus, Cytosol"	"CAB019400: AB_2116626, HPA030991: AB_10795286, HPA076420: "	"unprognostic (3.24e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.10e-1)"	"potential prognostic favorable (5.15e-4)"	"unprognostic (1.47e-1)"	"unprognostic (3.37e-1)"	"validated prognostic favorable (9.67e-6)"	"validated prognostic favorable (1.21e-4)"	"unprognostic (2.29e-1)"	"potential prognostic unfavorable (4.86e-4)"	"unprognostic (6.60e-3)"	"unprognostic (4.29e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.15e-1)"	"unprognostic (9.56e-2)"	"unprognostic (6.01e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.42e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.66e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.56e-2)"
HDAC6	"FLJ16239, HD6, JM21, KIAA0901, PPP1R90"	ENSG00000094631	"Histone deacetylase 6"	Q9UBN7	X	48801377-48824982	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins"	"Autophagy, Transcription, Transcription regulation"	"Actin-binding, Chromatin regulator, Hydrolase, Repressor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 90.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Liver - Hepatocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003714, CAB004236, HPA026321"	Supported		Supported	"Nucleoplasm,Centrosome,Basal body,Cytosol"			NA	NA			"Cluster 25: Non-specific - Unknown function"	"Cluster 78: Testis - Transcription"	"Cluster 41: Monoamines - Neurotransmitter signalling"	"Cluster 36: Non-specific - mRNA processing"	"Cluster 79: Spermatocytes & Spermatogonia - Spermatogenesis"	199	"Centrosome, Basal body, Cytosol"	Nucleoplasm	"CAB004236: AB_627708, HPA003714: AB_1850544, HPA026321: AB_1850546"	"potential prognostic favorable (9.11e-4)"	"unprognostic (1.12e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.94e-3)"	"unprognostic (3.35e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.35e-2)"	"unprognostic (3.60e-3)"	"unprognostic (2.08e-2)"	"unprognostic (9.15e-3)"	"potential prognostic favorable (1.55e-5)"	"unprognostic (2.56e-2)"	"potential prognostic favorable (8.12e-5)"	"unprognostic (6.06e-2)"	"unprognostic (1.21e-2)"	"unprognostic (5.30e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.23e-3)"	"unprognostic (9.08e-2)"	"unprognostic (1.20e-2)"	"unprognostic (6.54e-2)"	"potential prognostic unfavorable (7.50e-4)"	"unprognostic (1.69e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.52e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.07e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.96e-2)"
HDAC7	"DKFZP586J0917, HDAC7A"	ENSG00000061273	"Histone deacetylase 7"	Q8WUI4	12	47782722-47833132	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"endothelial cell: 137.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"neutrophil: 6.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 6.5"	"Low cancer specificity"	"Detected in all"			"Adipose visceral - Adipose progenitor cells, Kidney - Endothelial cells, Liver - Vascular Endothelial cells, Minor Salivary Gland - Minor salivary glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004775			Approved	Cytosol			NA	NA			"Cluster 21: Neutrophils - Unknown function"	"Cluster 41: Smooth muscle tissue - ECM organization"	"Cluster 42: Choroid plexus - Mitochondria"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	39	Cytosol		"HPA004775: AB_1850548"	"unprognostic (2.18e-3)"	"unprognostic (1.27e-1)"	"unprognostic (8.90e-2)"	"unprognostic (1.09e-3)"	"unprognostic (9.24e-2)"	"unprognostic (9.69e-2)"	"unprognostic (1.86e-2)"	"unprognostic (5.19e-3)"	"unprognostic (3.18e-2)"	"unprognostic (7.12e-2)"	"potential prognostic favorable (8.09e-4)"	"unprognostic (2.53e-2)"	"unprognostic (4.67e-1)"	"unprognostic (9.36e-3)"	"unprognostic (1.33e-3)"	"unprognostic (3.34e-1)"	"potential prognostic unfavorable (9.03e-4)"	"unprognostic (1.80e-2)"	"unprognostic (9.15e-2)"	"unprognostic (4.11e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.49e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.97e-2)"	"unprognostic (2.82e-1)"
HDAC8	"HDACL1, KDAC8, MRXS6, RPD3, WTS"	ENSG00000147099	"Histone deacetylase 8"	Q9BY41	X	72329516-72573101	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"Disease variant, FDA approved drug targets, Intellectual disability, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 114.6;Excitatory neurons: 180.5;Inhibitory neurons: 183.4;Microglial cells: 128.8;Oligodendrocyte precursor cells: 137.7;Oligodendrocytes: 131.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adipose visceral - Adipose progenitor cells, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048560	Supported						NA	NA			"Cluster 42: Non-specific - Vesicular transport"	"Cluster 50: Epididymis - Male reproductive secretion"	"Cluster 9: Non-specific - Receptor signaling"	"Cluster 36: Non-specific - mRNA processing"	"Cluster 8: Neurons - Neuronal signaling"	1			"HPA048560: AB_2680442"	"unprognostic (1.10e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.48e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.09e-3)"	"unprognostic (1.08e-1)"	"potential prognostic unfavorable (3.62e-6)"	"unprognostic (1.65e-1)"	"unprognostic (2.90e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.56e-2)"	"unprognostic (9.06e-2)"	"unprognostic (8.29e-2)"	"unprognostic (6.83e-3)"	"unprognostic (3.71e-2)"	"unprognostic (8.79e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.97e-2)"	"unprognostic (2.84e-2)"	"unprognostic (8.02e-3)"	"unprognostic (3.27e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.27e-2)"	"unprognostic (7.77e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.12e-2)"	"unprognostic (6.88e-3)"
HDAC9	"HD7, HDAC, HDAC7B, KIAA0744, MITR"	ENSG00000048052	"Histone deacetylase 9"	Q9UKV0	7	18086949-19002416	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 207.4;Excitatory neurons: 363.4;Inhibitory neurons: 422.1;Microglial cells: 319.4;Oligodendrocyte precursor cells: 302.8;Oligodendrocytes: 217.0;Oocytes: 166.9"	"Cell type enhanced"	"Detected in all"		"choroid plexus epithelial cell: 3812.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 73.7"	"Group enriched"	"Detected in all"	9	"B-cells: 53.2;dendritic cells: 73.7;monocytes: 24.3"	"Low cancer specificity"	"Detected in all"			"Breast - Endothelial cells, Prostate - Smooth muscle cells, Testis - Early spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028926	Uncertain		Approved	Nucleoplasm			NA	NA			"Cluster 2: Dendritic cells - Unknown function"	"Cluster 16: Non-specific - Transcription"	"Cluster 23: Choroid plexus - Mixed function"	"Cluster 5: Rhabdoid - Unknown function"	"Cluster 69: Neurons - Neuronal signaling"	19	Nucleoplasm		"HPA028926: AB_10602327"	"unprognostic (1.84e-1)"	"unprognostic (3.36e-3)"	"unprognostic (5.14e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.48e-1)"	"unprognostic (4.22e-1)"	"unprognostic (9.82e-3)"	"unprognostic (5.46e-2)"	"unprognostic (8.49e-2)"	"potential prognostic favorable (1.07e-4)"	"unprognostic (2.04e-2)"	"unprognostic (2.05e-1)"		"unprognostic (4.47e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.93e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.77e-1)"	"unprognostic (9.34e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.30e-1)"	"unprognostic (7.78e-2)"	"unprognostic (5.11e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.01e-2)"
HMGCR		ENSG00000113161	"3-hydroxy-3-methylglutaryl-CoA reductase"	P04035	5	75336329-75364001	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Disease variant, FDA approved drug targets, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 102.6"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 233.0;Suprabasal keratinocytes: 130.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Adrenal cortex cells, Lung - Alveolar cells type 2, Minor Salivary Gland - Minor salivary gland basal cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008338, CAB016797, CAB078688"	Supported						NA	NA			"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 37: Liver & Intestine - Lipid metabolism"	"Cluster 24: Neurons - Mixed function"	"Cluster 66: Non-specific - Mitochondria"	"Cluster 37: Glandular & Luminal cells - Unknown function"	8			"CAB016797: , CAB078688: AB_2665607, HPA008338: AB_10960401"	"unprognostic (6.96e-2)"	"unprognostic (1.20e-2)"	"unprognostic (3.41e-2)"	"potential prognostic unfavorable (3.95e-6)"	"unprognostic (4.24e-3)"	"unprognostic (6.25e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.88e-3)"	"potential prognostic favorable (1.41e-4)"	"unprognostic (9.61e-3)"	"unprognostic (6.95e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.43e-2)"	"unprognostic (8.44e-2)"	"unprognostic (2.29e-2)"	"unprognostic (6.90e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.70e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.43e-2)"	"unprognostic (7.41e-2)"	"unprognostic (8.04e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.02e-1)"
HMMR	"CD168, RHAMM"	ENSG00000072571	"Hyaluronan mediated motility receptor"	O75330	5	163460203-163491941	"CD markers, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 20.3;lymphoid tissue: 26.5;testis: 26.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 103.7;Erythroid cells: 123.5;Extravillous trophoblasts: 59.3;Late spermatids: 62.4;Spermatocytes: 94.5"	"Low cell type specificity"	"Detected in some"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.5"	"Low lineage specificity"	"Detected in single"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Mitotic cells (Adrenal gland), Colon - Mitotic cells (Colon), Lung - Mitotic cells (Lung), Minor Salivary Gland - Mitotic cells (Minor salivary gland), Skin - Mitotic cells (Skin), Spleen - Mitotic cells (Spleen), Stomach - Mitotic cells (Stomach), Testis - Early spermatids, Thyroid gland - Mitotic cells (Thyroid)"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB002433, HPA040025, HPA043926, HPA061524"	Enhanced		Enhanced	Microtubules,Centrosome,Cytosol			Yes	Yes			"Cluster 13: Non-specific - Mitochondria"	"Cluster 67: Lymphoid tissue & Bone marrow - Cell proliferation"	"Cluster 30: White matter - Myelination"	"Cluster 22: Non-specific - mRNA splicing & Cell cycle"	"Cluster 52: Non-specific - Cell proliferation"	25	Microtubules	"Centrosome, Cytosol"	"CAB002433: AB_564080, HPA040025: AB_2676805, HPA043926: , HPA061524: AB_2684551"	"unprognostic (3.14e-2)"	"unprognostic (3.10e-2)"	"unprognostic (6.94e-3)"	"unprognostic (6.23e-2)"	"unprognostic (1.54e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.62e-2)"	"unprognostic (2.21e-2)"	"potential prognostic unfavorable (1.83e-4)"	"validated prognostic unfavorable (6.62e-6)"	"validated prognostic unfavorable (1.22e-7)"	"potential prognostic unfavorable (3.18e-7)"	"validated prognostic unfavorable (4.04e-8)"	"validated prognostic unfavorable (2.90e-10)"	"validated prognostic unfavorable (8.47e-7)"	"validated prognostic unfavorable (3.79e-4)"	"unprognostic (6.08e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.10e-1)"	"validated prognostic unfavorable (6.82e-4)"	"validated prognostic unfavorable (9.43e-4)"	"unprognostic (3.38e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.52e-1)"		"unprognostic (4.72e-2)"
HPD	"4-HPPD, 4HPPD, GLOD3, PPD"	ENSG00000158104	"4-hydroxyphenylpyruvate dioxygenase"	P32754	12	121839527-121863596	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	"Dioxygenase, Oxidoreductase"	"Disease variant, FDA approved drug targets, Intellectual disability"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 2452.6"	"Group enriched"	"Detected in some"	12	"Hepatocytes: 1582.3;Proximal tubular cells: 1484.3"	"Cell type enriched"	"Detected in many"	10	"choroid plexus epithelial cell: 130.4"	"Cancer enriched"	"Detected in many"	52	"Liver Hepatocellular Carcinoma (TCGA): 1099.3"	"Region enriched"	"Detected in many"	16	"choroid plexus: 242.9"	"Immune cell enhanced"	"Detected in some"		"eosinophil: 7.9"	"Group enriched"	"Detected in many"	4	"dendritic cells: 3.8;granulocytes: 7.9"	"Group enriched"	"Detected in many"	5	"liver cancer: 40.7;lung cancer: 14.8;Rhabdoid: 39.7"	"Breast - Fibroblasts, Kidney - Proximal tubular cells, Liver - Hepatocytes, Prostate - Smooth muscle cells, Spleen - Fibroblast_2, Testis - Late spermatids"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA038321, HPA038322"	Enhanced		Uncertain	"Nuclear speckles"			NA	NA		19000000	"Cluster 2: Dendritic cells - Unknown function"	"Cluster 1: Liver & Kidney - Metabolism"	"Cluster 36: Choroid plexus - Mixed function"	"Cluster 7: Liver cancer - Metabolism"	"Cluster 56: Proximal tubular cells - Amino acid metabolism"	3	"Nuclear speckles"		"HPA038321: AB_2675957, HPA038322: AB_10670778"	"unprognostic (8.08e-2)"	"unprognostic (8.33e-3)"		"unprognostic (9.12e-2)"			"unprognostic (2.49e-2)"	"potential prognostic unfavorable (5.43e-8)"		"unprognostic (2.13e-1)"	"unprognostic (7.02e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.06e-1)"		"unprognostic (1.21e-2)"		"unprognostic (1.21e-3)"		"unprognostic (1.44e-2)"							"unprognostic (4.29e-1)"		"potential prognostic unfavorable (4.25e-4)"
HPRT1	"HGPRT, HPRT"	ENSG00000165704	"Hypoxanthine phosphoribosyltransferase 1"	P00492	X	134460165-134520513	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Purine salvage"	"Glycosyltransferase, Transferase"	"Disease variant, FDA approved drug targets, Gout"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 181.3;Spermatocytes: 222.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Testis - Sertoli cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006360, CAB012200"	Enhanced		Supported	"Cytosol,Mid piece,Principal piece,End piece,Annulus"			NA	NA		8700000	"Cluster 12: Non-specific - Mitochondrial translation"	"Cluster 17: Neuronal - Synaptic function"	"Cluster 1: Neurons - Mixed function"	"Cluster 30: Non-specific - Gene expression regulation"	"Cluster 79: Spermatocytes & Spermatogonia - Spermatogenesis"	18	Cytosol	"Mid piece, Principal piece, End piece, Annulus"	"CAB012200: AB_297217, HPA006360: AB_1079082"	"unprognostic (3.25e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.59e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.87e-2)"	"unprognostic (4.76e-2)"	"potential prognostic unfavorable (1.36e-6)"	"unprognostic (6.72e-2)"	"unprognostic (1.73e-2)"	"unprognostic (6.14e-3)"	"potential prognostic unfavorable (7.00e-7)"	"unprognostic (1.31e-2)"	"potential prognostic unfavorable (1.40e-5)"	"unprognostic (3.69e-3)"	"unprognostic (2.27e-3)"	"unprognostic (8.45e-3)"	"unprognostic (5.99e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.12e-2)"	"potential prognostic unfavorable (5.84e-4)"	"unprognostic (5.68e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.21e-2)"
HRH1		ENSG00000196639	"Histamine receptor H1"	P35367	3	11137093-11263557	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 31.6;Excitatory neurons: 33.5;Glandular and luminal cells: 39.2;Granulosa cells: 43.7;Secretory cells: 62.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Liver - Kupffer cells, Spleen - Macrophages, Thyroid gland - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029740	Uncertain		Supported	"Plasma membrane,Cytosol"			NA	NA				"Cluster 41: Smooth muscle tissue - ECM organization"	"Cluster 51: Neurons - Mixed function"	"Cluster 72: Neuronal - Signal transduction"	"Cluster 37: Glandular & Luminal cells - Unknown function"	1	"Plasma membrane"	Cytosol	"HPA029740: AB_10601578"	"unprognostic (1.64e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.47e-2)"	"unprognostic (4.87e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.74e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.02e-1)"		"unprognostic (2.39e-1)"	"unprognostic (1.43e-3)"	"potential prognostic unfavorable (1.54e-5)"	"unprognostic (6.03e-2)"	"unprognostic (8.71e-2)"	"unprognostic (7.41e-3)"	"unprognostic (1.81e-2)"	"potential prognostic unfavorable (1.21e-4)"	"unprognostic (7.38e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.02e-3)"	"unprognostic (5.31e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.64e-2)"		"unprognostic (1.66e-1)"	"unprognostic (7.02e-2)"
HRH2		ENSG00000113749	"Histamine receptor H2"	P25021	5	175658030-175710756	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 26.9;heart muscle: 25.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 42.9;Excitatory neurons: 60.1;Hofbauer cells: 28.8;Kupffer cells: 38.0;Macrophages: 43.7;Oocytes: 23.5;Smooth muscle cells: 34.0"	"Cell type enhanced"	"Detected in many"		"medium spiny neuron: 176.5"	"Cancer enhanced"	"Detected in many"		"Kidney Renal Clear Cell Carcinoma (TCGA): 22.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 106.4;neutrophil: 141.7"	"Group enriched"	"Detected in many"	5	"granulocytes: 141.7;monocytes: 40.9"	"Cancer enhanced"	"Detected in some"		"Leukemia: 7.1;Myeloma: 3.5;skin cancer: 3.7"	"Liver - Neutrophils, Lung - Neutrophil_2, Pituitary gland - Macrophages, Spleen - Neutrophils, Stomach - Parietal cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA013770	Approved						NA	NA			"Cluster 21: Neutrophils - Unknown function"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 53: Neurons - Mixed function"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 48: Smooth muscle cells - Signal transduction"				"HPA013770: AB_1851086"	"unprognostic (2.74e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.04e-1)"		"unprognostic (4.47e-2)"	"unprognostic (3.30e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.41e-3)"	"potential prognostic favorable (3.05e-5)"	"unprognostic (4.16e-2)"	"unprognostic (7.43e-2)"			"unprognostic (3.57e-2)"	"unprognostic (1.93e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.92e-3)"		"unprognostic (2.57e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.35e-2)"		"unprognostic (1.56e-1)"	"unprognostic (9.43e-2)"	"unprognostic (3.20e-2)"	"unprognostic (4.75e-2)"		"unprognostic (1.24e-1)"
HRH3	GPCR97	ENSG00000101180	"Histamine receptor H3"	Q9Y5N1	20	62214960-62220278	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	27	"brain: 54.1"	"Group enriched"	"Detected in some"	4	"Horizontal cells: 15.7;Inhibitory neurons: 22.7"	"Cell type enhanced"	"Detected in many"		"cerebellar inhibitory: 122.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"lung cancer: 5.0;Neuroblastoma: 9.3"		"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"										NA	NA				"Cluster 22: Brain - Synaptic signal transduction"	"Cluster 38: Sub-cortical - Mixed function"	"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 69: Neurons - Neuronal signaling"	1																																		
HRH4	"AXOR35, GPCR105, GPRv53, H4R, HH4R"	ENSG00000134489	"Histamine receptor H4"	Q9H3N8	18	24460637-24479961	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"granulocytes: 5.1;Langerhans cells: 1.1;Melanocytes: 1.7;Spermatocytes: 1.1"	"Low cell type specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	123	"basophil: 212.9;eosinophil: 61.3"	"Lineage enriched"	"Detected in many"	191	"granulocytes: 212.9"	"Not detected"	"Not detected"			"Skin - Mast cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA035009	Uncertain						NA	NA			"Cluster 46: Basophils - Proteolysis"		"Cluster 48: Non-specific - Mixed function"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 30: Granulocytes - Unknown function"				"HPA035009: AB_10671507"																										"unprognostic (1.80e-2)"					
HSD11B1	"HSD11, HSD11B, SDR26C1"	ENSG00000117594	"Hydroxysteroid 11-beta dehydrogenase 1"	P28845	1	209686178-209734949	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Oxidoreductase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"liver: 938.4"	"Cell type enriched"	"Detected in many"	12	"Hepatocytes: 629.9"	"Cell type enhanced"	"Detected in all"		"fibroblast: 151.2"	"Cancer enriched"	"Detected in many"	22	"Liver Hepatocellular Carcinoma (TCGA): 301.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory CD4 T-cell: 5.7"	"Lineage enriched"	"Detected in single"	17	"T-cells: 5.7"	"Cancer enhanced"	"Detected in many"		"Esophageal cancer: 20.1;thyroid cancer: 12.2"	"Colon - Fibroblasts, Kidney - Fibroblasts, Spleen - Fibroblast_1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047729	Enhanced						NA	NA		140000	"Cluster 43: Non-specific - Transcription & Translation"	"Cluster 83: Liver - Metabolism"	"Cluster 26: Oligodendrocytes - Mixed function"	"Cluster 44: Connective tissue cells - ECM organization"	"Cluster 43: Hepatocytes - Metabolism"	2			"HPA047729: AB_2680135"	"unprognostic (4.56e-1)"	"unprognostic (1.18e-2)"	"unprognostic (8.73e-2)"	"unprognostic (7.37e-2)"	"unprognostic (7.37e-2)"	"unprognostic (3.80e-2)"	"unprognostic (6.43e-3)"	"unprognostic (3.04e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.81e-1)"	"potential prognostic unfavorable (2.18e-4)"	"unprognostic (5.77e-2)"	"potential prognostic unfavorable (1.03e-5)"	"unprognostic (5.27e-2)"	"potential prognostic favorable (9.53e-6)"	"unprognostic (1.49e-2)"	"unprognostic (4.64e-3)"	"unprognostic (5.76e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.46e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.58e-2)"	"unprognostic (3.83e-1)"	"unprognostic (3.48e-1)"		"unprognostic (1.27e-2)"	"unprognostic (8.33e-3)"	"unprognostic (6.62e-2)"	"unprognostic (1.57e-1)"
HSD17B10	"17b-HSD10, ABAD, CAMR, ERAB, HADH2, MHBD, MRPP2, MRXS10, SDR5C1"	ENSG00000072506	"Hydroxysteroid 17-beta dehydrogenase 10"	Q99714	X	53431258-53434370	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Steroid metabolism, tRNA processing"	Oxidoreductase	"Disease variant, FDA approved drug targets, Intellectual disability, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 525.7;Proximal tubular cells: 383.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adipose visceral - Adipocytes (Visceral), Liver - Hepatocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001432	Approved						NA	NA		320000	"Cluster 13: Non-specific - Mitochondria"	"Cluster 37: Liver & Intestine - Lipid metabolism"	"Cluster 45: Non-specific - Mixed function"	"Cluster 36: Non-specific - mRNA processing"	"Cluster 56: Proximal tubular cells - Amino acid metabolism"	56			"HPA001432: AB_1078740"	"unprognostic (2.72e-1)"	"unprognostic (1.08e-2)"	"unprognostic (4.86e-3)"	"unprognostic (7.95e-3)"	"unprognostic (2.23e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.49e-1)"	"unprognostic (9.44e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.48e-1)"	"unprognostic (4.35e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.22e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.15e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.31e-1)"
HSD3B1	"HSD3B, HSDB3, SDR11E1"	ENSG00000203857	"Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1"	P14060	1	119507198-119515054	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Steroid metabolism, Steroidogenesis"	"Isomerase, Multifunctional enzyme, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"placenta: 75.2"	"Cell type enriched"	"Detected in some"	4	"Syncytiotrophoblasts: 697.5"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Bladder Urothelial Carcinoma (TCGA): 4.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Bladder cancer: 15.5;Gastric cancer: 12.8;testis cancer: 24.4"	"Skin - Sebaceous gland cells"									"HPA043261, HPA043264, HPA044028"	Supported		Approved	"Nucleoli,Endoplasmic reticulum,Microtubules,Cytokinetic bridge,Primary cilium,Primary cilium transition zone"			Yes	NA				"Cluster 58: Placenta - Pregnancy"	"Cluster 53: Neurons - Mixed function"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 27: Syncytiotrophoblasts - Pregnancy"	8	"Nucleoli, Endoplasmic reticulum, Primary cilium"	"Microtubules, Cytokinetic bridge, Primary cilium transition zone"	"HPA043261: AB_2630368, HPA043264: AB_2678398, HPA044028: AB_2678781"	"unprognostic (5.46e-3)"																	"unprognostic (1.41e-2)"													
HSD3B2	SDR11E2	ENSG00000203859	"Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2"	P26439	1	119414931-119423035	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Steroidogenesis"	"Isomerase, Multifunctional enzyme, Oxidoreductase"	"Congenital adrenal hyperplasia, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	56	"adrenal gland: 2106.0"	"Cell type enriched"	"Detected in some"	16	"Proximal enterocytes: 51.7"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"Testicular Germ Cell Tumor (TCGA): 1.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	18	"skin cancer: 9.2"	"Adrenal gland - Adrenal cortex cells"									"HPA043261, HPA043264, HPA044028"	Supported		Approved	"Nucleoli,Endoplasmic reticulum,Microtubules,Cytokinetic bridge,Primary cilium,Primary cilium transition zone"			Yes	NA				"Cluster 26: Adrenal gland - Steroid metabolism"	"Cluster 53: Neurons - Mixed function"	"Cluster 9: Skin cancer - Melanin biosynthesis"	"Cluster 22: Proximal enterocytes - Digestion"	2	"Endoplasmic reticulum, Primary cilium"	"Nucleoli, Microtubules, Cytokinetic bridge, Primary cilium transition zone"	"HPA043261: AB_2630368, HPA043264: AB_2678398, HPA044028: AB_2678781"						"unprognostic (7.33e-2)"																							"unprognostic (2.75e-1)"		
HTR1A	"5-HT1A, ADRB2RL1, ADRBRL1"	ENSG00000178394	"5-hydroxytryptamine receptor 1A"	P08908	5	63957874-63962507	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Behavior	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"brain: 2.0;ovary: 1.4"	"Group enriched"	"Detected in some"	6	"Leydig cells: 6.4;Ovarian stromal cells: 2.3"	"Cell type enhanced"	"Detected in single"		"hippocampal CA1-3: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	17	"Rhabdoid: 8.0"		"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA018073	Uncertain						NA	NA				"Cluster 33: Brain - Neuronal signaling"	"Cluster 14: Neurons - Synaptic function"	"Cluster 1: Neuronal - Visual perception"	"Cluster 6: Ovarian stromal cells - Transcription"	6			"HPA018073: AB_1856704"																															
HTR1B	"5-HT1B, 5-HT1DB, HTR1D2, S12"	ENSG00000135312	"5-hydroxytryptamine receptor 1B"	P28222	6	77460924-77463491	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	Behavior	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.9;placenta: 6.4;stomach 1: 4.9"	"Cell type enhanced"	"Detected in some"		"Horizontal cells: 1.9;Smooth muscle cells: 1.2"	"Cell type enhanced"	"Detected in some"		"endothelial cell: 4.7;medium spiny neuron: 4.3"	"Cancer enhanced"	"Detected in single"		"Testicular Germ Cell Tumor (TCGA): 1.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	4	"Adrenocortical cancer: 8.0"	"Adipose subcutaneous - Smooth muscle cells, Adipose visceral - Smooth muscle cells, Lung - Smooth muscle cells, Skeletal muscle - Smooth muscle cells, Testis - Late spermatids"	"Region enriched"	"Detected in all"	4	"basal ganglia: 38.6"	"Region enhanced"	"Detected in many"		"basal ganglia: 12.0"	HPA028808	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane"			NA	NA				"Cluster 34: Non-specific - Mixed function"	"Cluster 56: Hypothalamus - Neuropeptide signaling"	"Cluster 48: Adipocytes & Endothelial cells - Angiogenesis"	"Cluster 32: Smooth muscle cells - Muscle contraction"	43	"Plasma membrane"	"Endoplasmic reticulum"	"HPA028808: AB_2672782"			"unprognostic (1.82e-2)"																				"unprognostic (1.86e-1)"						"unprognostic (5.19e-2)"		
HTR1D	"5-HT1D, HT1DA, HTRL, RDC4"	ENSG00000179546	"5-hydroxytryptamine receptor 1D"	P28221	1	23191895-23217502	"FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 7.0;intestine: 8.3"	"Group enriched"	"Detected in some"	5	"Cholangiocytes: 5.7;Proximal enterocytes: 7.4"	"Cell type enhanced"	"Detected in some"		"eccentric medium spiny neuron: 8.1;medium spiny neuron: 6.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"midbrain: 25.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Adrenocortical cancer: 10.6"	"Colon - Colon enteroendocrine cells, Pancreas - Ductal cells, Testis - Late spermatids"																NA	NA				"Cluster 25: Small intestine - Absorption"	"Cluster 1: Neurons - Mixed function"	"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 22: Proximal enterocytes - Digestion"					"unprognostic (7.51e-3)"		"unprognostic (5.79e-3)"	"unprognostic (3.70e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.36e-3)"		"unprognostic (2.03e-2)"						"unprognostic (1.23e-3)"	"potential prognostic unfavorable (3.72e-9)"	"potential prognostic unfavorable (1.04e-4)"	"unprognostic (2.23e-3)"					"potential prognostic unfavorable (2.09e-4)"	"unprognostic (1.40e-1)"		"unprognostic (7.36e-3)"	"unprognostic (2.67e-1)"		"unprognostic (8.56e-2)"	"unprognostic (2.15e-1)"		
HTR1E	5-HT1E	ENSG00000168830	"5-hydroxytryptamine receptor 1E"	P28566	6	86937528-87016679	"FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.3;ovary: 4.1"	"Group enriched"	"Detected in some"	18	"Excitatory neurons: 121.1;Inhibitory neurons: 99.3"	"Cell type enhanced"	"Detected in many"		"mammillary body: 325.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	7	"Neuroblastoma: 2.3"	"Colon - Colon enteroendocrine cells, Stomach - Chief cells"					"Low region specificity"	"Detected in many"			HPA004931	Approved						NA	NA				"Cluster 64: Neuronal - Transcription"	"Cluster 53: Neurons - Mixed function"	"Cluster 17: Neuroblastoma - Neuronal signaling"	"Cluster 69: Neurons - Neuronal signaling"	3			"HPA004931: AB_1856706"			"unprognostic (1.23e-3)"																												
HTR1F	"5-HT1F, HTR1EL"	ENSG00000179097	"5-hydroxytryptamine receptor 1F"	P30939	3	87792706-87993839	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"placenta: 1.7;retina: 3.5"	"Group enriched"	"Detected in some"	6	"Excitatory neurons: 224.7;Inhibitory neurons: 75.4"	"Cell type enhanced"	"Detected in many"		"pericyte: 44.6;vascular associated smooth muscle cell: 21.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Bone cancer: 1.4;Leukemia: 1.3;thyroid cancer: 1.8"	"Pituitary gland - Lactotropes"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA005555	Uncertain						NA	NA			"Cluster 46: Basophils - Proteolysis"	"Cluster 76: Retina - Visual perception"	"Cluster 53: Neurons - Mixed function"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 34: Neurons - Neuronal signaling"				"HPA005555: AB_1856708"			"unprognostic (1.19e-1)"					"unprognostic (3.95e-1)"																							
HTR2A	"5-HT2A, HTR2"	ENSG00000102468	"5-hydroxytryptamine receptor 2A"	P28223	13	46831546-46897076	"FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters"	"Behavior, Host-virus interaction"	"G-protein coupled receptor, Host cell receptor for virus entry, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 18.8"	"Cell type enriched"	"Detected in some"	8	"Excitatory neurons: 79.0"	"Cell type enhanced"	"Detected in many"		"mammillary body: 206.5"	"Cancer enhanced"	"Detected in single"		"Glioblastoma Multiforme (TCGA): 1.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"Bile duct cancer: 2.6"	"Prostate - Fibroblasts, Thyroid gland - Smooth muscle cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014011	Enhanced						NA	NA				"Cluster 61: Brain - Neuronal signaling"	"Cluster 53: Neurons - Mixed function"	"Cluster 2: Mucus-secreting cells - Unknown function"	"Cluster 34: Neurons - Neuronal signaling"	5			"HPA014011: AB_1856709"						"unprognostic (6.03e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.34e-2)"																		"unprognostic (1.87e-2)"					
HTR2B	"5-HT(2B), 5-HT2B"	ENSG00000135914	"5-hydroxytryptamine receptor 2B"	P41595	2	231108230-231125042	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	Behavior	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 16.8;cervix: 20.7;endometrium 1: 18.2;smooth muscle: 16.2"	"Cell type enhanced"	"Detected in some"		"Endometrial stromal cells: 16.5;Microglial cells: 4.5;Peritubular cells: 4.8"	"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"Skin Cuteneous Melanoma (TCGA): 6.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	15	"basophil: 1.9;T-reg: 1.0"	"Group enriched"	"Detected in many"	15	"granulocytes: 1.9;T-cells: 1.0"	"Group enriched"	"Detected in some"	7	"Rhabdoid: 18.6;skin cancer: 13.6"	"Adrenal gland - Adrenal cortex cells, Kidney - Fibroblasts"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA012867, HPA063658"	Enhanced		Supported	Nucleoplasm			NA	NA				"Cluster 62: Connective tissue - ECM organization"	"Cluster 10: Cerebellum - Nucleic acid binding"	"Cluster 5: Rhabdoid - Unknown function"	"Cluster 9: Endometrial stromal cells - Transcription"	3	Nucleoplasm		"HPA012867: AB_1856710, HPA063658: AB_2685079"		"unprognostic (6.89e-2)"	"unprognostic (6.66e-2)"	"unprognostic (5.64e-2)"		"unprognostic (1.45e-1)"		"unprognostic (1.51e-3)"			"unprognostic (5.74e-3)"	"unprognostic (5.21e-2)"	"unprognostic (1.46e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.67e-3)"	"unprognostic (2.10e-2)"	"unprognostic (2.40e-1)"		"unprognostic (9.58e-2)"	"potential prognostic unfavorable (7.27e-4)"		"unprognostic (1.51e-1)"	"potential prognostic favorable (4.91e-4)"			"potential prognostic favorable (3.86e-4)"	"unprognostic (2.97e-2)"	"potential prognostic unfavorable (5.04e-5)"			"unprognostic (4.35e-2)"
HTR2C	"5-HT2C, 5HTR2C, HTR1C"	ENSG00000147246	"5-hydroxytryptamine receptor 2C"	P28335	X	114584078-114910061	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"	Behavior	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	146	"brain: 28.1;choroid plexus: 107.4"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 22.9;Inhibitory neurons: 52.3;Oligodendrocyte precursor cells: 9.4"	"Cell type enriched"	"Detected in all"	6	"choroid plexus epithelial cell: 14796.7"	"Cancer enhanced"	"Detected in single"		"Testicular Germ Cell Tumor (TCGA): 1.6"	"Region enriched"	"Detected in all"	12	"choroid plexus: 620.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Gallbladder cancer: 3.5;Myeloma: 2.6"		"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"										NA	NA				"Cluster 60: Choroid plexus - Transmembrane transport"	"Cluster 36: Choroid plexus - Mixed function"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 69: Neurons - Neuronal signaling"	22																																"unprognostic (1.04e-1)"		
HTR3A	"5-HT3A, 5-HT3R, HTR3"	ENSG00000166736	"5-hydroxytryptamine receptor 3A"	P46098	11	113975075-113990313	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 2.5;intestine: 2.0;lymphoid tissue: 7.8;pancreas: 2.5;salivary gland: 4.8"	"Group enriched"	"Detected in some"	5	"Ductal cells: 25.0;Exocrine glandular cells: 71.5;Pancreatic endocrine cells: 23.8"	"Cell type enriched"	"Detected in some"	4	"CGE interneuron: 12.4"	"Cancer enhanced"	"Detected in many"		"Ovary Serous Cystadenocarcinoma (TCGA): 25.6"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	15	"memory B-cell: 3.9;naive B-cell: 13.9;plasmacytoid DC: 11.6"	"Group enriched"	"Detected in many"	128	"B-cells: 13.9;dendritic cells: 11.6"	"Group enriched"	"Detected in some"	9	"lymphoma: 15.4;Neuroblastoma: 12.9"	"Colon - Colon enteroendocrine cells, Spleen - B-cells (Spleen)"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	12	"amygdala: 2.7;cerebral cortex: 4.1;hippocampal formation: 3.9"	HPA069442	Supported						NA	NA			"Cluster 23: B-cells - Immunoglobulins"	"Cluster 36: Lymphoid tissue - Cytokine signaling"	"Cluster 51: Neurons - Mixed function"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 45: Non-specific - Mixed function"	3			"HPA069442: AB_2732132"				"unprognostic (6.38e-3)"					"unprognostic (3.64e-3)"				"unprognostic (1.87e-2)"			"potential prognostic unfavorable (8.16e-4)"	"unprognostic (3.60e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.80e-1)"	"unprognostic (6.92e-2)"	"unprognostic (9.05e-3)"	"unprognostic (1.13e-2)"	"unprognostic (8.34e-2)"								"unprognostic (4.88e-2)"
HTR3B	5-HT3B	ENSG00000149305	"5-hydroxytryptamine receptor 3B"	O95264	11	113904796-113949079	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 2.1"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 4.3;Melanocytes: 1.7;Rod photoreceptor cells: 1.6;Sertoli cells: 2.7"	"Cell type enhanced"	"Detected in some"		"deep-layer intratelencephalic: 6.5;upper-layer intratelencephalic: 20.8"	"Cancer enhanced"	"Detected in single"		"Kidney Chromophobe (TCGA): 1.6"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cancer enriched"	"Detected in single"	8	"Neuroblastoma: 2.9"	"Colon - Colon enteroendocrine cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA039559	Approved						NA	NA			"Cluster 20: Non-specific - DNA binding"	"Cluster 61: Brain - Neuronal signaling"	"Cluster 53: Neurons - Mixed function"	"Cluster 17: Neuroblastoma - Neuronal signaling"	"Cluster 34: Neurons - Neuronal signaling"	1			"HPA039559: AB_10672779"						"unprognostic (6.23e-2)"				"unprognostic (3.64e-2)"																"unprognostic (2.59e-2)"					
HTR3C		ENSG00000178084	"5-hydroxytryptamine receptor 3C"	Q8WXA8	3	184053047-184060673	"FDA approved drug targets, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"lung: 2.4"	"Cell type enhanced"	"Detected in some"		"Lymphatic endothelial cells: 3.6;Oocytes: 2.9"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"Uterine Corpus Endometrial Carcinoma (TCGA): 0.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Not detected"	"Not detected"										NA	NA				"Cluster 57: Lung - Lung function"		"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 54: Lymphatic endothelial cells - Lymph vessel development"	1																																		
HTR3D		ENSG00000186090	"5-hydroxytryptamine receptor 3D"	Q70Z44	3	184031544-184039369	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Not detected"	"Not detected"										NA	NA						"Cluster 31: Non-specific - Antiviral immune response"		1																																		
HTR3E		ENSG00000186038	"5-hydroxytryptamine receptor 3E"	A5X5Y0	3	184097064-184106995	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Inhibitory neurons: 1.0;Oligodendrocyte precursor cells: 2.4"	"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in single"		"Uterine Corpus Endometrial Carcinoma (TCGA): 0.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"												HPA049764	Enhanced						NA	NA					"Cluster 9: Non-specific - Receptor signaling"	"Cluster 24: Non-specific - Unknown function"	"Cluster 16: Intestinal goblet cells - Mucin production"				"HPA049764: AB_2680869"																															"unprognostic (4.56e-1)"
HTR4	5-HT4	ENSG00000164270	"5-hydroxytryptamine receptor 4"	Q13639	5	148446042-148677235	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 2.9;heart muscle: 4.4;intestine: 8.8"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 40.6;Inhibitory neurons: 42.9"	"Cell type enhanced"	"Detected in many"		"hippocampal dentate gyrus: 298.5;mammillary body: 292.7;medium spiny neuron: 469.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	4	"Rhabdoid: 2.1"	"Adrenal gland - Adrenal cortex cells, Pituitary gland - Lactotropes"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040591	Enhanced						NA	NA				"Cluster 45: Intestine - Digestion"	"Cluster 51: Neurons - Mixed function"	"Cluster 5: Rhabdoid - Unknown function"	"Cluster 8: Neurons - Neuronal signaling"	6			"HPA040591: AB_2677028"						"unprognostic (8.76e-2)"																				"unprognostic (3.37e-2)"					
HTR6	"5-HT6, 5-HT6R"	ENSG00000158748	"5-hydroxytryptamine receptor 6"	P50406	1	19664875-19680966	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"brain: 3.4"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 1.6;Spermatogonia: 1.1"	"Cell type enhanced"	"Detected in many"		"medium spiny neuron: 15.5"	"Cancer enhanced"	"Detected in single"		"Kidney Renal Clear Cell Carcinoma (TCGA): 2.3"	"Region enhanced"	"Detected in many"		"basal ganglia: 22.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Bone cancer: 2.0;Rhabdoid: 3.2"		"Low region specificity"	"Detected in many"							HPA068165	Uncertain						NA	NA			"Cluster 11: T-cells - Unknown function"	"Cluster 33: Brain - Neuronal signaling"	"Cluster 33: Neurons - Mixed function"	"Cluster 5: Rhabdoid - Unknown function"	"Cluster 34: Neurons - Neuronal signaling"	12			"HPA068165: "											"unprognostic (7.33e-2)"	"unprognostic (1.62e-1)"																			
HTR7	5-HT7	ENSG00000148680	"5-hydroxytryptamine receptor 7"	P34969	10	90740823-90858039	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, RAS pathway related proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"parathyroid gland: 12.7;testis: 8.5"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 9.2;Excitatory neurons: 5.7;Inhibitory neurons: 23.4;Macrophages: 3.6;Spermatocytes: 10.9"	"Cell type enhanced"	"Detected in many"		"LAMP5-LHX6 and Chandelier: 134.7;mammillary body: 335.5"	"Group enriched"	"Detected in some"	4	"Bladder Urothelial Carcinoma (TCGA): 3.1;Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA): 2.5;Head and Neck Squamous Cell Carcinoma (TCGA): 5.0;Lung Squamous Cell Carcinoma (TCGA): 2.5;Testicular Germ Cell Tumor (TCGA): 1.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	12	"myeloid DC: 1.4"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 1.4"	"Low cancer specificity"	"Detected in many"			"Testis - Early spermatids"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB022708, HPA065367, HPA073617"	Approved	Supported	Approved	"Nucleoplasm,Nuclear speckles,Plasma membrane,Primary cilium,Cytosol"			NA	NA			"Cluster 26: Monocytes - Plasma membrane proteins"	"Cluster 24: Parathyroid gland - Vesicular transport"	"Cluster 38: Sub-cortical - Mixed function"	"Cluster 72: Neuronal - Signal transduction"	"Cluster 8: Neurons - Neuronal signaling"	1	"Plasma membrane"	"Nucleoplasm, Nuclear speckles, Primary cilium, Cytosol"	"CAB022708: , HPA065367: , HPA073617: AB_2732228"	"unprognostic (1.43e-1)"		"unprognostic (3.78e-2)"	"unprognostic (1.54e-3)"				"unprognostic (8.63e-2)"	"unprognostic (1.48e-2)"			"unprognostic (9.57e-2)"						"unprognostic (1.76e-1)"	"unprognostic (1.58e-2)"				"unprognostic (3.13e-2)"						"unprognostic (1.50e-1)"		
ICAM1	"BB2, CD54"	ENSG00000090339	"Intercellular adhesion molecule 1"	P05362	19	10271093-10286615	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 212.5;urinary bladder: 207.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 518.0;Alveolar cells type 2: 276.8;Endothelial cells: 318.0;Langerhans cells: 216.7;Macrophages: 230.4;monocytes: 345.6"	"Cell type enriched"	"Detected in some"	8	"endothelial cell: 105.4"	"Cancer enhanced"	"Detected in all"		"Lung Adenocarcinoma (TCGA): 244.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002126, CAB002142, HPA004877"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"			NA	NA		1200000000	"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 12: Non-specific - Vasculature"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	35	"Plasma membrane"	"Vesicles, Cytosol"	"CAB002142: AB_563596, HPA002126: AB_1078470, HPA004877: AB_1846317"	"unprognostic (8.42e-2)"	"unprognostic (4.57e-3)"	"unprognostic (7.39e-2)"	"unprognostic (2.30e-2)"	"unprognostic (3.86e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.61e-3)"	"unprognostic (4.21e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.67e-2)"	"potential prognostic unfavorable (2.83e-4)"	"unprognostic (2.22e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.95e-3)"	"unprognostic (3.28e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.50e-2)"	"unprognostic (4.08e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.04e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.65e-1)"	"potential prognostic favorable (2.21e-4)"	"unprognostic (9.78e-2)"	"unprognostic (1.21e-1)"	"unprognostic (8.87e-3)"	"unprognostic (1.17e-1)"	"unprognostic (6.59e-2)"
IDE		ENSG00000119912	"Insulin degrading enzyme"	P14735	10	92451684-92574096	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Host-virus interaction"	"Allosteric enzyme, Host cell receptor for virus entry, Hydrolase, Metalloprotease, Protease, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Adrenal cortex cells, Skin - Keratinocyte (granular), Testis - Early spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063478	Approved				"Secreted in other tissues"	Receptor	NA	NA		230000	"Cluster 33: Non-specific - ATP binding"	"Cluster 21: Testis - Unknown function"	"Cluster 21: Non-specific - Metabolism"	"Cluster 52: Non-specific - Mitochondria"	"Cluster 70: Spermatocytes & Spermatids - Spermatid development"	24			"HPA063478: AB_2685020"	"unprognostic (1.35e-1)"	"unprognostic (2.25e-3)"	"unprognostic (2.34e-1)"	"unprognostic (4.72e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.48e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.15e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.14e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.37e-1)"	"unprognostic (5.49e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.19e-3)"	"unprognostic (3.22e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.69e-2)"	"unprognostic (8.05e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.91e-1)"	"unprognostic (8.85e-2)"	"unprognostic (2.56e-2)"
IDH1		ENSG00000138413	"Isocitrate dehydrogenase (NADP(+)) 1"	O75874	2	208236229-208266074	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Glyoxylate bypass, Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 520.1"	"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 319.0;Hepatocytes: 304.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Adrenal gland - Adrenal cortex cells, Liver - Hepatocytes, Lung - Macrophages, Prostate - Prostate glandular cells, Skin - Sebaceous gland cells, Spleen - Macrophages"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033218, HPA035248, HPA057936, CAB062556"	Enhanced		Approved	"Nuclear bodies,Cytosol"			NA	NA		17000000	"Cluster 10: Non-specific - Membrane trafficking"	"Cluster 83: Liver - Metabolism"	"Cluster 21: Non-specific - Metabolism"	"Cluster 7: Liver cancer - Metabolism"	"Cluster 24: Cytotrophoblasts - Mitochondria"	18	"Nuclear bodies, Cytosol"		"CAB033218: AB_2123166, CAB062556: AB_2665593, HPA035248: AB_10600714, HPA057936: AB_2683559"	"potential prognostic favorable (3.03e-4)"	"unprognostic (4.85e-2)"	"unprognostic (3.55e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.15e-3)"	"unprognostic (2.31e-2)"	"unprognostic (7.38e-2)"	"unprognostic (8.56e-3)"	"potential prognostic unfavorable (5.77e-6)"	"unprognostic (7.13e-3)"	"unprognostic (7.78e-3)"	"unprognostic (5.31e-2)"	"unprognostic (1.54e-3)"	"unprognostic (4.10e-2)"	"unprognostic (5.47e-2)"	"unprognostic (4.10e-1)"	"unprognostic (2.20e-1)"	"unprognostic (5.93e-2)"	"unprognostic (2.81e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.42e-2)"	"unprognostic (8.63e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.09e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.50e-2)"	"unprognostic (6.75e-3)"
IDH2	IDH-2	ENSG00000182054	"Isocitrate dehydrogenase (NADP(+)) 2"	P48735	15	90083045-90102477	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Glyoxylate bypass, Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"heart muscle: 476.6;skeletal muscle: 1256.7;tongue: 1548.2"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 567.2;Cytotrophoblasts: 742.0;Distal tubular cells: 934.3;Extravillous trophoblasts: 653.5;Syncytiotrophoblasts: 607.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Breast - Breast glandular cells, Colon - Smooth muscle cells, Heart muscle - Cardiomyocytes, Lung - Mitotic cells (Lung), Skeletal muscle - Skeletal myocytes, Spleen - Mitotic cells (Spleen), Stomach - Parietal cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007831	Enhanced		Supported	Mitochondria			NA	NA		6000000	"Cluster 10: Non-specific - Membrane trafficking"	"Cluster 35: Non-specific - Mitochondria"	"Cluster 39: Astrocytes - Mixed function"	"Cluster 27: Breast cancer - Unknown function"	"Cluster 24: Cytotrophoblasts - Mitochondria"	23	Mitochondria		"HPA007831: AB_1851397"	"unprognostic (1.46e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.31e-1)"	"potential prognostic favorable (3.83e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.84e-2)"	"potential prognostic favorable (2.20e-5)"	"unprognostic (3.67e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.76e-3)"	"unprognostic (9.43e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.75e-2)"	"unprognostic (2.40e-1)"	"unprognostic (5.74e-2)"	"unprognostic (5.02e-3)"	"unprognostic (1.15e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.01e-1)"
IDH3A		ENSG00000166411	"Isocitrate dehydrogenase (NAD(+)) 3 catalytic subunit alpha"	P50213	15	78131498-78171945	"Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Oxidoreductase	"Disease variant, FDA approved drug targets, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 95.4"	"Low cell type specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 144.0"	"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Adrenal cortex cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041465, HPA062971"	Supported		Enhanced	Mitochondria			No	No		25000	"Cluster 44: Plasmacytoid DCs - Plasma membrane proteins"	"Cluster 35: Non-specific - Mitochondria"	"Cluster 23: Choroid plexus - Mixed function"	"Cluster 58: Non-specific - Nuclear processes"	"Cluster 8: Neurons - Neuronal signaling"	9	Mitochondria		"HPA041465: AB_10794377, HPA062971: AB_2684913"	"unprognostic (8.71e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.52e-1)"	"potential prognostic unfavorable (6.15e-4)"	"validated prognostic favorable (9.24e-5)"	"validated prognostic favorable (4.52e-4)"	"unprognostic (1.03e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.56e-2)"	"unprognostic (8.43e-2)"	"unprognostic (3.59e-1)"	"unprognostic (3.83e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.46e-3)"	"unprognostic (1.22e-1)"	"unprognostic (4.29e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.97e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.14e-1)"
IFNAR1	"IFNAR, IFRC"	ENSG00000142166	"Interferon alpha and beta receptor subunit 1"	P17181	21	33324387-33359864	"Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Receptor	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029226	Approved						NA	NA		150000	"Cluster 2: Dendritic cells - Unknown function"	"Cluster 40: Non-specific - Transcription"	"Cluster 27: Non-specific - Mixed function"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 77: Plasma cells - Protein processing"	19			"HPA029226: AB_2672954"	"unprognostic (1.73e-1)"	"unprognostic (1.82e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.08e-2)"	"unprognostic (7.54e-2)"	"unprognostic (1.77e-1)"	"potential prognostic favorable (1.49e-5)"	"unprognostic (4.36e-3)"	"unprognostic (4.55e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.13e-2)"	"unprognostic (8.42e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.09e-1)"	"unprognostic (4.18e-2)"	"potential prognostic unfavorable (2.94e-4)"	"unprognostic (3.83e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.30e-1)"	"unprognostic (8.54e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.50e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.98e-1)"
IFNAR2	IFNABR	ENSG00000159110	"Interferon alpha and beta receptor subunit 2"	P48551	21	33205282-33265675	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 86.2;Plasma cells: 86.7"	"Cell type enhanced"	"Detected in all"		"endothelial cell: 336.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"Myeloma: 108.5"	"Colon - Endothelial cells, Heart muscle - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	Receptor	NA	NA		1200000	"Cluster 10: Non-specific - Membrane trafficking"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 47: Endothelial cells - Vasculature"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 77: Plasma cells - Protein processing"	21				"unprognostic (5.14e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.23e-2)"	"potential prognostic unfavorable (3.54e-4)"	"unprognostic (4.46e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.37e-1)"	"unprognostic (3.10e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.40e-3)"	"unprognostic (6.89e-2)"	"unprognostic (2.81e-2)"	"potential prognostic unfavorable (8.05e-4)"	"unprognostic (6.00e-2)"	"unprognostic (7.16e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.66e-2)"	"unprognostic (3.94e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.06e-1)"	"potential prognostic favorable (9.75e-4)"	"unprognostic (9.23e-2)"	"unprognostic (8.08e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.22e-1)"
IFNG		ENSG00000111537	"Interferon gamma"	P01579	12	68154768-68159740	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Antiviral defense, Growth regulation"	Cytokine	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 11.4;lymphoid tissue: 7.3"	"Group enriched"	"Detected in many"	15	"NK-cells: 81.0;T-cells: 211.4"	"Cell type enriched"	"Detected in single"	86	"leukocyte: 37.1"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"gdT-cell: 5.5;memory CD4 T-cell: 2.4;memory CD8 T-cell: 6.6;naive CD8 T-cell: 3.7"	"Lineage enriched"	"Detected in single"	7	"T-cells: 6.6"	"Not detected"	"Not detected"			"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Thyroid gland - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB010344	Approved				"Secreted to blood"	Interferon	NA	NA			"Cluster 24: Non-specific - Transcription"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"		"Cluster 59: Leukemia - T-cell receptor"	"Cluster 19: NK-cells - Adaptive immune response"	11			"CAB010344: AB_2123447"			"unprognostic (5.88e-2)"	"unprognostic (2.75e-3)"							"unprognostic (2.63e-3)"	"unprognostic (2.89e-1)"			"unprognostic (2.68e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.76e-1)"		"unprognostic (4.17e-2)"									"unprognostic (8.39e-2)"	"unprognostic (2.70e-1)"		
IFNGR1	"CD119, IFNGR"	ENSG00000027697	"Interferon gamma receptor 1"	P15260	6	137197483-137219449	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 840.3;Ionocytes: 628.8;monocytes: 682.3"	"Cell type enhanced"	"Detected in all"		"central nervous system macrophage: 750.0;endothelial cell: 370.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Spleen - Macrophages"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025889, HPA029213, HPA063871, CAB080493, CAB080494, CAB080495"	Supported		Supported	"Plasma membrane"			NA	NA			"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 30: White matter - Myelination"	"Cluster 71: Lymphoma - Inflammatory response"	"Cluster 35: Respiratory epithelial cells - Unknown function"	24	"Plasma membrane"		"CAB025889: , CAB080493: , CAB080494: , CAB080495: , HPA029213: AB_10601023, HPA063871: AB_2685138"	"unprognostic (1.31e-1)"	"unprognostic (2.66e-1)"	"unprognostic (9.31e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.36e-2)"	"unprognostic (8.76e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.26e-1)"	"unprognostic (5.61e-2)"	"unprognostic (8.62e-3)"	"potential prognostic favorable (4.69e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.12e-2)"	"unprognostic (4.87e-3)"	"unprognostic (4.63e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.15e-1)"	"unprognostic (6.69e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.42e-1)"
IFNGR2	"AF-1, IFNGT1"	ENSG00000159128	"Interferon gamma receptor 2"	P38484	21	33403413-33479348	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins"		Receptor	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"monocytes: 267.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 671.0"	"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Spleen - Neutrophils"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001535	Approved		Approved	"Nucleoplasm,Golgi apparatus"			NA	NA			"Cluster 37: Monocytes & Neutrophils - Innate immune response"	"Cluster 7: Adipose tissue - Mixed function"	"Cluster 12: Non-specific - Vasculature"	"Cluster 69: Skin cancer - ECM organization"	"Cluster 29: Monocytes - Innate immune response"	28	"Nucleoplasm, Golgi apparatus"		"HPA001535: AB_1078432"	"unprognostic (5.83e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.58e-1)"	"potential prognostic unfavorable (1.58e-4)"	"unprognostic (3.51e-1)"	"potential prognostic unfavorable (7.45e-4)"	"unprognostic (1.92e-1)"	"unprognostic (4.89e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.60e-1)"	"potential prognostic favorable (9.15e-4)"	"unprognostic (1.17e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.86e-3)"	"unprognostic (5.83e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.54e-1)"	"unprognostic (4.98e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.35e-3)"	"unprognostic (1.58e-1)"	"unprognostic (5.68e-2)"	"unprognostic (7.13e-2)"	"unprognostic (4.23e-1)"	"unprognostic (7.42e-2)"	"unprognostic (3.51e-2)"	"unprognostic (3.09e-2)"	"unprognostic (9.13e-2)"
IGF1R	"CD221, IGFIR, IGFR, JTK13, MGC18216"	ENSG00000140443	"Insulin like growth factor 1 receptor"	P08069	15	98648539-98964530	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Host-virus interaction"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 231.4;Inhibitory neurons: 186.7;Microglial cells: 234.4;Oligodendrocyte precursor cells: 223.1;Oligodendrocytes: 242.8"	"Cell type enhanced"	"Detected in all"		"endothelial cell: 1591.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.3"	"Group enriched"	"Detected in many"	6	"granulocytes: 4.3;T-cells: 1.4"	"Low cancer specificity"	"Detected in all"			"Liver - Vascular Endothelial cells, Minor Salivary Gland - Minor salivary glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004822, CAB010268, HPA045563"	Approved		Approved	"Nucleoli,Nucleoli rim,Plasma membrane,Primary cilium"			NA	NA		21000	"Cluster 35: Neutrophils - Protein binding"	"Cluster 64: Neuronal - Transcription"	"Cluster 42: Choroid plexus - Mitochondria"	"Cluster 58: Non-specific - Nuclear processes"	"Cluster 37: Glandular & Luminal cells - Unknown function"	126	"Nucleoli rim, Plasma membrane"	"Nucleoli, Primary cilium"	"CAB010268: AB_671792, HPA004822: , HPA045563: AB_2679368"	"unprognostic (1.45e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.15e-1)"	"potential prognostic unfavorable (7.78e-4)"	"unprognostic (2.57e-2)"	"potential prognostic unfavorable (4.03e-5)"	"unprognostic (1.43e-1)"	"unprognostic (9.27e-3)"	"unprognostic (4.46e-2)"	"unprognostic (3.08e-1)"	"validated prognostic favorable (3.89e-9)"	"validated prognostic favorable (2.90e-4)"	"unprognostic (1.95e-1)"		"unprognostic (4.72e-2)"	"unprognostic (5.61e-2)"	"potential prognostic unfavorable (3.73e-4)"	"unprognostic (1.75e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.66e-2)"	"unprognostic (3.49e-1)"	"unprognostic (8.00e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.20e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.04e-1)"	"unprognostic (6.77e-2)"	"unprognostic (4.48e-3)"
IGHG1		ENSG00000211896	"Immunoglobulin heavy constant gamma 1 (G1m marker)"	P01857	14	105736343-105743071	"Disease related genes, FDA approved drug targets, Immunoglobulin genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"lymphoid tissue: 5665.1;urinary bladder: 3867.4"	"Cell type enriched"	"Detected in many"	5	"Plasma cells: 12047.8"	"Cell type enriched"	"Detected in some"	10	"leukocyte: 12.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	6	"memory B-cell: 768.6"	"Lineage enriched"	"Detected in many"	122	"B-cells: 768.6"	"Cancer enriched"	"Detected in some"	8	"Myeloma: 1184.5"	"Adipose subcutaneous - Plasma cells, Adipose visceral - Plasma cells, Adrenal gland - Plasma cells, Breast - Plasma cells, Colon - Plasma cells, Heart muscle - Plasma cells, Kidney - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Pancreas - Plasma cells, Pituitary gland - Plasma cells, Prostate - Plasma cells, Skeletal muscle - Plasma cells, Skin - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"									"HPA001245, CAB008642"	Supported				"Immunoglobulin genes"	Immunity	NA	NA		220000000000	"Cluster 17: B-cells - Immunoglobulins"		"Cluster 8: Immune cells - Immune response"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 77: Plasma cells - Protein processing"	36			"CAB008642: AB_1617595, HPA001245: AB_1079121"	"unprognostic (3.44e-3)"	"unprognostic (4.44e-3)"		"unprognostic (2.33e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.60e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.87e-1)"	"potential prognostic favorable (2.46e-4)"	"unprognostic (1.14e-1)"	"potential prognostic unfavorable (3.50e-4)"	"unprognostic (9.46e-2)"	"unprognostic (3.38e-3)"	"unprognostic (3.58e-2)"		"unprognostic (5.34e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.26e-2)"	"unprognostic (2.14e-2)"	"unprognostic (7.20e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.07e-2)"	"unprognostic (2.70e-3)"	"unprognostic (4.48e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.65e-2)"
IGHG2		ENSG00000211893	"Immunoglobulin heavy constant gamma 2 (G2m marker)"	P01859	14	105639559-105644790	"FDA approved drug targets, Immunoglobulin genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 189.5;urinary bladder: 108.3"	"Cell type enriched"	"Detected in some"	11	"Plasma cells: 4935.4"	"Cell type enriched"	"Detected in single"	11	"leukocyte: 4.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	460	"memory B-cell: 344.6;naive B-cell: 128.5"	"Lineage enriched"	"Detected in single"	670	"B-cells: 344.6"	"Group enriched"	"Detected in some"	9	"lymphoma: 19.2;Myeloma: 54.1"	"Adipose subcutaneous - Plasma cells, Adipose visceral - Plasma cells, Adrenal gland - Plasma cells, Breast - Plasma cells, Colon - Plasma cells, Heart muscle - Plasma cells, Kidney - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Pancreas - Plasma cells, Pituitary gland - Plasma cells, Prostate - Plasma cells, Skeletal muscle - Plasma cells, Skin - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"									HPA001245	Approved				"Immunoglobulin genes"	Immunity	NA	NA		260000000000	"Cluster 17: B-cells - Immunoglobulins"		"Cluster 8: Immune cells - Immune response"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 77: Plasma cells - Protein processing"	28			"HPA001245: AB_1079121"	"unprognostic (9.17e-3)"	"unprognostic (1.01e-1)"		"potential prognostic favorable (3.62e-5)"	"unprognostic (3.20e-1)"	"unprognostic (8.89e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.78e-3)"	"potential prognostic favorable (8.19e-5)"	"unprognostic (2.87e-2)"	"potential prognostic unfavorable (3.60e-4)"	"unprognostic (6.22e-3)"	"unprognostic (1.44e-2)"	"unprognostic (4.10e-2)"		"unprognostic (3.87e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.76e-2)"	"unprognostic (2.21e-2)"	"unprognostic (6.18e-2)"	"unprognostic (3.02e-1)"	"unprognostic (4.52e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.27e-2)"	"unprognostic (8.39e-2)"	"unprognostic (3.90e-3)"	"unprognostic (8.31e-2)"	"unprognostic (2.96e-1)"	"unprognostic (3.81e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.65e-2)"
IGHG4		ENSG00000211892	"Immunoglobulin heavy constant gamma 4 (G4m marker)"	P01861	14	105620506-105626066	"FDA approved drug targets, Immunoglobulin genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 2402.4"	"Group enriched"	"Detected in some"	4	"B-cells: 423.0;Plasma cells: 595.5"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	457	"memory B-cell: 123.0;naive B-cell: 74.3"	"Lineage enriched"	"Detected in single"	569	"B-cells: 123.0"	"Group enriched"	"Detected in some"	43	"lymphoma: 133.6;Myeloma: 34.1"	"Adipose subcutaneous - Plasma cells, Adipose visceral - Mesothelial cells, Adrenal gland - Plasma cells, Breast - Plasma cells, Colon - Plasma cells, Heart muscle - Plasma cells, Kidney - Plasma cells, Lung - Plasma cells, Pituitary gland - Plasma cells, Prostate - Plasma cells, Skeletal muscle - Plasma cells, Skin - Plasma cells, Spleen - Plasma cells"									HPA001245	Approved				"Immunoglobulin genes"	Immunity	NA	NA		170000000000	"Cluster 17: B-cells - Immunoglobulins"		"Cluster 43: Hindbrain - Mixed function"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 77: Plasma cells - Protein processing"	20			"HPA001245: AB_1079121"	"unprognostic (3.88e-2)"	"unprognostic (4.37e-3)"		"unprognostic (5.42e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.47e-1)"	"unprognostic (3.18e-3)"	"unprognostic (5.65e-2)"	"potential prognostic favorable (6.88e-4)"	"unprognostic (2.10e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.31e-2)"	"potential prognostic unfavorable (6.78e-5)"	"unprognostic (3.95e-1)"		"unprognostic (6.49e-3)"	"unprognostic (9.67e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.57e-1)"	"unprognostic (4.76e-2)"	"unprognostic (7.83e-3)"	"unprognostic (1.12e-1)"	"unprognostic (5.38e-2)"	"potential prognostic favorable (4.51e-6)"	"unprognostic (2.15e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.43e-2)"	"unprognostic (3.77e-1)"
IKBKB	"IKK-beta, IKK2, IKKB, NFKBIKB"	ENSG00000104365	"Inhibitor of nuclear factor kappa B kinase subunit beta"	O14920	8	42271302-42332460	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Host-virus interaction"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, FDA approved drug targets, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"endothelial cell: 229.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001249, CAB004447"	Enhanced		Supported	Cytosol			NA	NA			"Cluster 29: Non-specific - Unknown function"	"Cluster 19: Non-specific - Basic cellular processes"	"Cluster 42: Choroid plexus - Mitochondria"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 55: Non-specific - Transcription"	128	Cytosol		"CAB004447: AB_627785, HPA001249: AB_1079126"	"unprognostic (2.84e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.06e-2)"	"unprognostic (2.40e-1)"	"potential prognostic favorable (1.60e-5)"	"unprognostic (7.36e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.51e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.01e-3)"	"unprognostic (2.99e-1)"	"unprognostic (2.79e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.64e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.38e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.90e-1)"	"unprognostic (7.52e-2)"
IL11RA		ENSG00000137070	"Interleukin 11 receptor subunit alpha"	Q14626	9	34652162-34661902	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins"		Receptor	"Craniosynostosis, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 49.2;Late spermatids: 98.4;Sertoli cells: 40.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cancer enhanced"	"Detected in many"		"Neuroblastoma: 14.6"	"Adipose subcutaneous - Adipose progenitor cells, Heart muscle - Cardiomyocytes, Liver - Hepatocytes, Thyroid gland - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013162, CAB032830, HPA036652, HPA036653"	Supported		Approved	"Vesicles,Plasma membrane"	"Secreted to blood"	Receptor	NA	NA			"Cluster 5: Non-specific - Cell proliferation"	"Cluster 66: Non-specific - Transcription"	"Cluster 13: Oligodendrocytes - Mixed function"	"Cluster 1: Neuronal - Visual perception"	"Cluster 53: Fibroblasts - ECM organization"	1	"Vesicles, Plasma membrane"		"CAB032830: AB_2123745, HPA013162: AB_2668790, HPA036652: AB_2675229, HPA036653: "	"unprognostic (1.71e-1)"	"unprognostic (1.91e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.49e-2)"	"unprognostic (9.19e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.77e-2)"	"potential prognostic unfavorable (5.81e-5)"	"unprognostic (3.87e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.57e-2)"	"unprognostic (8.82e-2)"	"unprognostic (5.17e-3)"	"unprognostic (1.38e-3)"	"unprognostic (6.81e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.69e-2)"	"potential prognostic favorable (9.36e-4)"	"unprognostic (2.85e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.95e-2)"	"unprognostic (5.60e-2)"
IL12B	"CLMF, CLMF2, IL-12B, NKSF, NKSF2"	ENSG00000113302	"Interleukin 12B"	P29460	5	159314780-159330863	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Cytokine	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"lymphoid tissue: 1.3"	"Cell type enriched"	"Detected in single"	4	"Langerhans cells: 2.0"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	5	"Testicular Germ Cell Tumor (TCGA): 5.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	13	"lymphoma: 4.0"	"Minor Salivary Gland - Minor salivary gland ductal cells, Pituitary gland - Somatotropes"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA040970	Supported				"Secreted to blood"	Interleukin	NA	NA	140000			"Cluster 36: Lymphoid tissue - Cytokine signaling"	"Cluster 48: Non-specific - Mixed function"	"Cluster 55: Lymphoma - Immune response"	"Cluster 14: Langerhans cells - Innate immune response"	4			"HPA040970: AB_10796234"			"unprognostic (6.32e-2)"							"unprognostic (9.15e-2)"																			"unprognostic (6.01e-2)"		
IL13	"ALRH, BHR1, IL-13, MGC116786, MGC116788, MGC116789, P600"	ENSG00000169194	"Interleukin 13"	P35225	5	132656263-132661110	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	44	"testis: 23.6"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 103.1;granulocytes: 122.5;Late spermatids: 199.5;Spermatocytes: 35.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	45	"lymphoma: 4.8"	"Testis - Early spermatids, Testis - Late spermatids"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	Interleukin	NA	NA	40000			"Cluster 32: Endocrine & Neural - Unknown function"		"Cluster 59: Leukemia - T-cell receptor"	"Cluster 36: Late spermatids - Unknown function"	10																																		
IL17A	"CTLA8, IL-17, IL-17A, IL17"	ENSG00000112115	"Interleukin 17A"	Q16552	6	52186375-52190638	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity, Inflammatory response, Innate immunity"	Cytokine	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"lymphoid tissue: 1.4"	"Cell type enriched"	"Detected in some"	10	"T-cells: 23.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"				"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052258	Uncertain				"Secreted to blood"	Interleukin	NA	NA	9920			"Cluster 36: Lymphoid tissue - Cytokine signaling"		"Cluster 20: Myeloma - Immune response"	"Cluster 78: NK-cells & T-cells - Immune system & Transcription"	5			"HPA052258: "																															
IL17F	"IL-17F, ML-1, ML1"	ENSG00000112116	"Interleukin 17F"	Q96PD4	6	52236681-52245689	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted secreted proteins"	"Adaptive immunity, Immunity, Inflammatory response, Innate immunity"	Cytokine	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"lymphoid tissue: 2.1"	"Cell type enriched"	"Detected in single"	6	"T-cells: 4.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	85	"lymphoma: 18.6"	"Testis - Early spermatids, Testis - Late spermatids"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	Interleukin	NA	NA	30000			"Cluster 36: Lymphoid tissue - Cytokine signaling"		"Cluster 71: Lymphoma - Inflammatory response"	"Cluster 78: NK-cells & T-cells - Immune system & Transcription"	5																																		
IL1B	"IL-1B, IL1-BETA, IL1F2"	ENSG00000125538	"Interleukin 1 beta"	P01584	2	112829751-112836816	"Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Inflammatory response"	"Cytokine, Mitogen, Pyrogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 198.6;urinary bladder: 121.6"	"Cell type enriched"	"Detected in many"	5	"monocytes: 11738.5"	"Group enriched"	"Detected in some"	39	"central nervous system macrophage: 27.1;leukocyte: 6.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"neutrophil: 94.5"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 94.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 177.9;Sarcoma: 319.5"		"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"	Interleukin	NA	NA	2330		"Cluster 28: Neutrophils - Unknown function"	"Cluster 77: Bone marrow - Cell proliferation"	"Cluster 44: Non-specific - Mixed function"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 29: Monocytes - Innate immune response"	7				"unprognostic (2.08e-1)"	"unprognostic (2.39e-2)"	"unprognostic (9.31e-2)"	"potential prognostic unfavorable (5.36e-5)"	"unprognostic (5.84e-3)"	"unprognostic (6.84e-2)"	"unprognostic (4.71e-2)"	"unprognostic (6.12e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.01e-1)"	"unprognostic (3.34e-1)"	"unprognostic (9.36e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.93e-3)"	"unprognostic (1.16e-3)"	"unprognostic (3.19e-2)"	"unprognostic (2.24e-2)"	"unprognostic (2.24e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.52e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.33e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.09e-1)"
IL1R1	"CD121A, D2S1473, IL1R, IL1RA"	ENSG00000115594	"Interleukin 1 receptor type 1"	P14778	2	102064544-102179874	"Cancer-related genes, CD markers, Enzymes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Inflammatory response"	"Hydrolase, Receptor"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 303.4;Glandular and luminal cells: 312.5;Langerhans cells: 221.8;Mesothelial cells: 245.0;Prostatic glandular cells: 291.9"	"Cell type enhanced"	"Detected in many"		"endothelial cell: 312.2;fibroblast: 120.4;pericyte: 102.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Low cancer specificity"	"Detected in many"			"Kidney - Endothelial cells, Pituitary gland - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001237, HPA005823, CAB007779, HPA029560"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"	"Secreted to blood"	Receptor	NA	NA		870000	"Cluster 35: Neutrophils - Protein binding"	"Cluster 62: Connective tissue - ECM organization"	"Cluster 12: Non-specific - Vasculature"	"Cluster 44: Connective tissue cells - ECM organization"	"Cluster 37: Glandular & Luminal cells - Unknown function"	13	"Nucleoplasm, Vesicles"	"Plasma membrane, Cytosol"	"CAB007779: AB_562073, HPA001237: , HPA005823: AB_2667445, HPA029560: AB_2673094"	"unprognostic (2.65e-2)"	"unprognostic (4.67e-3)"	"unprognostic (2.16e-2)"	"unprognostic (6.26e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.24e-2)"	"potential prognostic unfavorable (8.74e-4)"	"unprognostic (2.42e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.41e-2)"	"unprognostic (8.22e-3)"	"unprognostic (1.69e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.34e-3)"	"unprognostic (2.02e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.86e-2)"	"unprognostic (5.11e-2)"	"unprognostic (9.99e-2)"	"unprognostic (3.78e-2)"	"unprognostic (9.79e-3)"	"unprognostic (7.90e-2)"	"unprognostic (6.69e-2)"	"unprognostic (2.78e-1)"
IL1RL2	"IL-36R, IL1R-rp2, IL1RRP2"	ENSG00000115598	"Interleukin 1 receptor like 2"	Q9HB29	2	102187006-102240002	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 12.0"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 6.1;Excitatory neurons: 9.4;Glandular and luminal cells: 6.6;Langerhans cells: 7.8;monocytes: 5.9;Suprabasal keratinocytes: 6.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"cervical cancer: 4.0"	"Skin - Keratinocyte (other)"	"Low region specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"hippocampal formation: 1.5"								NA	NA				"Cluster 13: Skin - Cornification"	"Cluster 24: Neurons - Mixed function"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 29: Monocytes - Innate immune response"	1				"unprognostic (1.34e-1)"	"unprognostic (4.13e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.83e-3)"			"unprognostic (1.05e-1)"	"unprognostic (5.48e-2)"	"potential prognostic favorable (1.43e-4)"	"unprognostic (2.55e-2)"	"unprognostic (6.34e-2)"	"unprognostic (4.63e-3)"	"unprognostic (1.65e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.13e-3)"	"potential prognostic favorable (6.53e-4)"	"unprognostic (6.30e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.40e-1)"		"unprognostic (3.52e-3)"		"unprognostic (1.28e-1)"	"unprognostic (1.93e-2)"		"unprognostic (1.28e-2)"		"unprognostic (4.33e-2)"	"unprognostic (1.45e-2)"
IL23A	"IL-23, IL-23A, IL23P19, P19, SGRF"	ENSG00000110944	"Interleukin 23 subunit alpha"	Q9NPF7	12	56334174-56340410	"FDA approved drug targets, Predicted secreted proteins"	"Antiviral defense, Immunity, Inflammatory response, Innate immunity, Tissue remodeling"	Cytokine	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"urinary bladder: 42.8"	"Cell type enriched"	"Detected in many"	4	"Langerhans cells: 205.4"	"Low cell type specificity"	"Detected in some"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"MAIT T-cell: 14.2;memory B-cell: 19.0;memory CD4 T-cell: 25.8;memory CD8 T-cell: 12.5;naive B-cell: 21.6;naive CD4 T-cell: 28.2;naive CD8 T-cell: 17.7;T-reg: 15.6"	"Group enriched"	"Detected in many"	12	"B-cells: 21.6;T-cells: 28.2"	"Low cancer specificity"	"Detected in many"			"Testis - Early spermatids"	"Region enhanced"	"Detected in some"		"white matter: 3.9"	"Not detected"	"Not detected"			HPA001554	Approved		Approved	Cytosol	"Secreted to blood"	Interleukin	NA	NA	11000		"Cluster 43: Non-specific - Transcription & Translation"	"Cluster 29: Squamous epithelium - Innate immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 45: Non-specific - Mixed function"	5	Cytosol		"HPA001554: AB_1079135"	"unprognostic (8.92e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.56e-2)"		"unprognostic (1.11e-1)"	"unprognostic (7.39e-3)"		"potential prognostic unfavorable (7.16e-10)"	"unprognostic (5.04e-3)"	"unprognostic (1.15e-2)"		"unprognostic (1.27e-1)"	"potential prognostic unfavorable (1.30e-4)"	"unprognostic (4.19e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.70e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.80e-1)"	"unprognostic (3.62e-1)"		"unprognostic (8.08e-2)"	"unprognostic (4.35e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.50e-1)"
IL2RA	"CD25, IDDM10, IL2R"	ENSG00000134460	"Interleukin 2 receptor subunit alpha"	P01589	10	6010689-6062370	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins"	Immunity	Receptor	"Cancer-related genes, Diabetes mellitus, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 18.1;lymphoid tissue: 17.5;urinary bladder: 10.5"	"Cell type enhanced"	"Detected in some"		"B-cells: 12.1;granulocytes: 21.6;Kupffer cells: 7.5;Macrophages: 11.7;NK-cells: 12.2;T-cells: 25.2"	"Cell type enriched"	"Detected in some"	5	"leukocyte: 13.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	8	"basophil: 192.6;T-reg: 271.0"	"Group enriched"	"Detected in many"	15	"granulocytes: 192.6;T-cells: 271.0"	"Cancer enriched"	"Detected in some"	31	"lymphoma: 158.1"	"Heart muscle - Macrophages, Minor Salivary Gland - Macrophages, Pituitary gland - Macrophages, Stomach - Macrophages, Thyroid gland - Macrophages"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB002419, HPA054622"	Enhanced						NA	NA		270000	"Cluster 5: Non-specific - Cell proliferation"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 8: Immune cells - Immune response"	"Cluster 71: Lymphoma - Inflammatory response"	"Cluster 14: Langerhans cells - Innate immune response"	1			"CAB002419: AB_563538, HPA054622: AB_2682546"	"unprognostic (1.10e-1)"	"unprognostic (1.68e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.96e-2)"	"unprognostic (7.10e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.10e-2)"	"potential prognostic unfavorable (7.60e-4)"	"unprognostic (1.11e-2)"		"potential prognostic unfavorable (8.13e-5)"	"unprognostic (4.84e-2)"	"unprognostic (7.93e-3)"		"unprognostic (4.14e-1)"	"unprognostic (1.94e-1)"	"potential prognostic unfavorable (2.71e-4)"	"unprognostic (9.68e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.15e-2)"	"unprognostic (3.65e-1)"	"unprognostic (5.21e-2)"	"potential prognostic unfavorable (8.26e-4)"		"unprognostic (1.17e-1)"	"unprognostic (1.36e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.33e-2)"	"unprognostic (7.39e-2)"	"unprognostic (4.95e-3)"
IL2RB	"CD122, IL15RB"	ENSG00000100385	"Interleukin 2 receptor subunit beta"	P14784	22	37118666-37175118	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Host-virus interaction"	Receptor	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 34.4;lymphoid tissue: 48.0"	"Group enriched"	"Detected in many"	7	"Extravillous trophoblasts: 97.1;NK-cells: 299.6;T-cells: 95.9"	"Cell type enriched"	"Detected in single"	131	"leukocyte: 108.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"gdT-cell: 49.8;NK-cell: 184.0"	"Group enriched"	"Detected in many"	30	"NK-cells: 184.0;T-cells: 49.8"	"Cancer enriched"	"Detected in some"	8	"lymphoma: 69.8"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Adrenal gland - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Liver - NK-cells (Liver), Minor Salivary Gland - T-cells, Pancreas - T-cells, Pituitary gland - T-cells, Prostate - T-cells, Thyroid gland - T-cells"	"Region enriched"	"Detected in single"	7	"basal ganglia: 1.8"	"Low region specificity"	"Detected in many"			HPA062657	Enhanced						NA	NA			"Cluster 15: NK-cells - Unknown function"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 38: Sub-cortical - Mixed function"	"Cluster 59: Leukemia - T-cell receptor"	"Cluster 19: NK-cells - Adaptive immune response"	9			"HPA062657: AB_2684822"	"unprognostic (3.48e-2)"	"unprognostic (4.47e-3)"	"unprognostic (1.98e-3)"	"unprognostic (3.00e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.58e-3)"	"unprognostic (1.16e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.52e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.67e-2)"	"potential prognostic unfavorable (5.33e-4)"	"unprognostic (3.82e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.84e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.43e-1)"	"unprognostic (9.56e-2)"	"unprognostic (9.04e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.91e-2)"	"potential prognostic favorable (6.40e-4)"	"unprognostic (9.05e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.12e-2)"	"unprognostic (3.12e-1)"
IL2RG	"CD132, CIDX, IMD4, SCIDX1"	ENSG00000147168	"Interleukin 2 receptor subunit gamma"	P31785	X	71107404-71112108	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	Receptor	"Cancer-related genes, Disease variant, FDA approved drug targets, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 112.7;lymphoid tissue: 332.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 111.4;dendritic cells: 92.3;Distal enterocytes: 97.2;Langerhans cells: 150.0;NK-cells: 280.1;Plasma cells: 127.0;Proximal enterocytes: 79.5;T-cells: 192.5"	"Cell type enriched"	"Detected in single"	116	"leukocyte: 11.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"Leukemia: 207.1;lymphoma: 145.1;Myeloma: 354.9"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Adrenal gland - T-cells, Colon - T-cells, Kidney - T-cells, Liver - T-cells, Minor Salivary Gland - Plasma cells, Pancreas - T-cells, Pituitary gland - T-cells, Prostate - T-cells, Spleen - T-cells, Thyroid gland - T-cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA046641, CAB080341"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"			NA	NA		49000	"Cluster 1: T-cells - Unknown function"	"Cluster 36: Lymphoid tissue - Cytokine signaling"	"Cluster 42: Choroid plexus - Mitochondria"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 19: NK-cells - Adaptive immune response"	9	"Plasma membrane"	Nucleoplasm	"CAB080341: , HPA046641: AB_2679733"	"unprognostic (1.11e-2)"	"unprognostic (4.75e-3)"	"unprognostic (4.55e-3)"	"unprognostic (6.80e-2)"	"unprognostic (2.87e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.13e-3)"	"unprognostic (3.08e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.33e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.15e-1)"	"unprognostic (9.48e-2)"	"unprognostic (3.91e-1)"	"unprognostic (9.50e-2)"	"unprognostic (5.57e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.56e-2)"	"potential prognostic favorable (2.33e-4)"	"unprognostic (1.70e-1)"	"unprognostic (4.79e-2)"	"unprognostic (6.17e-2)"	"unprognostic (2.32e-2)"
IL3RA	CD123	ENSG00000185291	"Interleukin 3 receptor subunit alpha"	P26951	X	1336616-1382689	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 79.5;dendritic cells: 466.3;Endothelial cells: 81.2;Langerhans cells: 57.8;Oocytes: 139.0"	"Low cell type specificity"	"Detected in some"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"basophil: 2669.0"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 2669.0"	"Cancer enhanced"	"Detected in many"		"Leukemia: 20.7"	"Adipose subcutaneous - Endothelial cells, Adipose visceral - Endothelial cells, Adrenal gland - Endothelial cells, Breast - Endothelial cells, Colon - Endothelial cells, Heart muscle - Endothelial cells, Kidney - Endothelial cells, Liver - Vascular Endothelial cells, Minor Salivary Gland - Endothelial cells, Prostate - Endothelial cells, Skeletal muscle - Endothelial cells, Skin - Endothelial cells, Testis - Endothelial cells, Thyroid gland - Endothelial cells"									"HPA003539, CAB018374"	Uncertain						NA	NA			"Cluster 41: Basophils - Unknown function"	"Cluster 7: Adipose tissue - Mixed function"	"Cluster 6: Non-specific - Immune response"	"Cluster 21: Lymphoma - Adaptive immune response"	"Cluster 28: Dendritic cells - Antigen presentation"	18			"CAB018374: AB_2233620, HPA003539: AB_1078438"	"unprognostic (2.78e-2)"	"unprognostic (1.01e-3)"	"unprognostic (5.83e-2)"	"unprognostic (1.97e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.55e-1)"		"unprognostic (5.44e-3)"	"unprognostic (1.43e-1)"	"validated prognostic favorable (2.65e-4)"	"validated prognostic favorable (2.52e-4)"	"unprognostic (2.17e-3)"	"unprognostic (2.45e-1)"		"unprognostic (9.21e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.16e-3)"	"unprognostic (2.90e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.50e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.19e-2)"	"unprognostic (5.59e-2)"	"unprognostic (4.27e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.90e-3)"	"unprognostic (1.42e-1)"	"unprognostic (5.39e-2)"
IL4	"BCGF-1, BCGF1, BSF1, IL-4, MGC79402"	ENSG00000113520	"Interleukin 4"	P05112	5	132673986-132682678	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"B-cell activation"	"Cytokine, Growth factor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"T-cells: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in single"	862	"basophil: 476.8"	"Lineage enriched"	"Detected in single"	862	"granulocytes: 476.8"	"Cancer enhanced"	"Detected in single"		"lymphoma: 1.8"		"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA072995, CAB078477"	Approved				"Secreted to blood"	Interleukin	NA	NA	13600		"Cluster 46: Basophils - Proteolysis"		"Cluster 10: Cerebellum - Nucleic acid binding"	"Cluster 50: Lymphoma - Unknown function"	"Cluster 78: NK-cells & T-cells - Immune system & Transcription"	3			"CAB078477: AB_417057, HPA072995: AB_2732215"																															
IL4R	CD124	ENSG00000077238	"Interleukin 4 receptor"	P24394	16	27313668-27364778	"Cancer-related genes, CD markers, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	Immunity	Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 71.7;granulocytes: 115.8"	"Cell type enhanced"	"Detected in many"		"central nervous system macrophage: 90.5;endothelial cell: 197.2;vascular associated smooth muscle cell: 79.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"naive B-cell: 77.1"	"Group enriched"	"Detected in all"	5	"B-cells: 77.1;granulocytes: 31.1"	"Cancer enhanced"	"Detected in all"		"Gallbladder cancer: 139.2"	"Adrenal gland - Neutrophils, Kidney - Endothelial cells, Skeletal muscle - Endothelial cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB004451, HPA050124, HPA070380"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Centriolar satellite"	"Secreted to blood"	Receptor	NA	NA	38500	59000	"Cluster 34: B-cells - Unknown function"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 74: Neutrophils - Degranulation"	12	"Plasma membrane"	"Nucleoplasm, Centriolar satellite"	"CAB004451: AB_626889, HPA050124: AB_2681026, HPA070380: "	"unprognostic (1.22e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.80e-3)"	"unprognostic (2.44e-3)"	"unprognostic (2.15e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.53e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.76e-1)"	"unprognostic (7.42e-2)"	"potential prognostic favorable (2.13e-4)"	"unprognostic (7.35e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.99e-3)"	"potential prognostic unfavorable (3.26e-4)"	"unprognostic (4.67e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.50e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.20e-2)"
IL5	"EDF, IL-5, TRF"	ENSG00000113525	"Interleukin 5"	P05113	5	132541445-132556838	"Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Cytokine, Growth factor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"testis: 4.9"	"Group enriched"	"Detected in some"	9	"granulocytes: 6.7;Spermatocytes: 17.3"	"Low cell type specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"memory B-cell: 1.4"	"Lineage enriched"	"Detected in single"	8	"B-cells: 1.4"	"Cancer enriched"	"Detected in single"	4	"lymphoma: 1.5"		"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB010304	Approved				"Secreted to blood"	Interleukin	NA	NA	4130			"Cluster 46: Testis - Spermatogenesis"	"Cluster 4: Non-specific - mRNA splicing & Cell cycle"	"Cluster 59: Leukemia - T-cell receptor"	"Cluster 31: Spermatocytes - Spermatogenesis"	4			"CAB010304: AB_2296159"																															
IL5RA	"CD125, CDw125, IL5R"	ENSG00000091181	"Interleukin 5 receptor subunit alpha"	Q01344	3	3066324-3126613	"CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 6.0;fallopian tube: 10.4"	"Group enriched"	"Detected in some"	5	"Ciliated cells: 31.3;granulocytes: 34.5;Plasma cells: 16.6"	"Cell type enriched"	"Detected in many"	4	"ependymal cell: 101.1"	"Cancer enhanced"	"Detected in some"		"Prostate Adenocarcinoma (TCGA): 3.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	190	"basophil: 179.4;eosinophil: 356.1"	"Lineage enriched"	"Detected in many"	253	"granulocytes: 356.1"	"Cancer enhanced"	"Detected in some"		"lymphoma: 2.7;Myeloma: 8.5"	"Adipose subcutaneous - Mast cells, Colon - Mast cells, Lung - Respiratory ciliated cells, Minor Salivary Gland - Plasma cells, Prostate - Prostate glandular cells, Skin - Mast cells, Spleen - Plasma cells, Testis - Early spermatids, Testis - Late spermatids"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Intracellular and membrane"	Receptor	NA	NA		7700000	"Cluster 22: Eosinophils - Transcription"	"Cluster 8: Ciliated cells - Cilium organization"	"Cluster 3: Choroid plexus - Cilium"	"Cluster 50: Lymphoma - Unknown function"	"Cluster 42: Ciliated cells - Cilium assembly"	9						"unprognostic (7.54e-2)"			"unprognostic (1.46e-1)"											"unprognostic (1.72e-3)"		"unprognostic (1.09e-1)"					"unprognostic (3.08e-2)"		"unprognostic (4.14e-2)"					"unprognostic (1.74e-2)"
IL6	"BSF2, HGF, HSF, IFNB2, IL-6"	ENSG00000136244	"Interleukin 6"	P05231	7	22725884-22732002	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Acute phase"	"Cytokine, Growth factor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 210.6;urinary bladder: 265.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 182.3;Endothelial cells: 239.2;Fibroblasts: 109.1;Glandular and luminal cells: 328.1;monocytes: 160.7;Smooth muscle cells: 310.9"	"Group enriched"	"Detected in some"	12	"central nervous system macrophage: 3.4;choroid plexus epithelial cell: 2.1;endothelial cell: 3.1;vascular associated smooth muscle cell: 5.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"choroid plexus: 15.1"	"Group enriched"	"Detected in some"	47	"memory B-cell: 4.1;naive B-cell: 5.2"	"Lineage enriched"	"Detected in single"	52	"B-cells: 5.2"	"Cancer enhanced"	"Detected in many"		"Kidney cancer: 219.1"	"Colon - Neutrophils"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB023406, CAB072821"	Supported		Approved	Vesicles	"Secreted to blood"	"Acute phase"	NA	NA	5700	91000	"Cluster 14: Non-specific - Unknown function"	"Cluster 7: Adipose tissue - Mixed function"	"Cluster 36: Choroid plexus - Mixed function"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 48: Smooth muscle cells - Signal transduction"	7	Vesicles		"CAB023406: AB_617317, CAB072821: "	"unprognostic (3.09e-1)"	"unprognostic (2.74e-2)"	"unprognostic (5.92e-3)"	"unprognostic (2.89e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.00e-1)"	"unprognostic (3.88e-3)"	"unprognostic (7.66e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.11e-1)"	"potential prognostic unfavorable (2.42e-6)"	"unprognostic (3.56e-2)"	"unprognostic (3.64e-2)"		"unprognostic (1.64e-2)"	"unprognostic (6.65e-2)"	"unprognostic (2.31e-2)"	"unprognostic (6.49e-3)"	"unprognostic (4.43e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.43e-2)"	"unprognostic (4.08e-2)"	"unprognostic (2.84e-1)"	"unprognostic (5.49e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.28e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.51e-2)"
IL6R	"CD126, gp80, IL-1Ra, IL-6R, IL6RA"	ENSG00000160712	"Interleukin 6 receptor"	P08887	1	154405193-154469450	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 56.9;skeletal muscle: 90.8"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 86.2;Langerhans cells: 91.5"	"Cell type enhanced"	"Detected in many"		"central nervous system macrophage: 194.2;endothelial cell: 88.4;fibroblast: 101.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 89.4"	"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"Myeloma: 83.8"	"Pituitary gland - Corticotropes, Spleen - Neutrophils"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted to blood"	Receptor	NA	NA	24800000	19000000	"Cluster 7: Non-specific - Innate immune response"	"Cluster 19: Non-specific - Basic cellular processes"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 29: Monocytes - Innate immune response"	7				"unprognostic (1.11e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.77e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.95e-2)"	"unprognostic (2.54e-1)"	"unprognostic (8.01e-2)"	"unprognostic (7.43e-3)"	"unprognostic (4.60e-2)"	"unprognostic (5.42e-2)"	"potential prognostic favorable (6.13e-6)"	"unprognostic (7.34e-3)"	"unprognostic (1.54e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.09e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.01e-2)"	"unprognostic (8.25e-2)"	"potential prognostic favorable (3.20e-4)"	"unprognostic (2.03e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.87e-1)"	"unprognostic (7.90e-2)"
IMPDH1	"LCA11, RP10, sWSS2608"	ENSG00000106348	"Inosine monophosphate dehydrogenase 1"	P20839	7	128392277-128410252	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"GMP biosynthesis, Purine biosynthesis"	"DNA-binding, Oxidoreductase, RNA-binding"	"Disease variant, FDA approved drug targets, Leber congenital amaurosis, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 102.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 166.2;Cone photoreceptor cells: 175.0;Rod photoreceptor cells: 186.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 89.2;eosinophil: 89.3;intermediate monocyte: 104.6;myeloid DC: 60.0;neutrophil: 198.3;non-classical monocyte: 136.7"	"Group enriched"	"Detected in all"	5	"dendritic cells: 60.0;granulocytes: 198.3;monocytes: 136.7"	"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Pituitary gland - Gonadotropes, Spleen - Neutrophils"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001400	Approved		Supported	"Cytosol,Rods & Rings"			NA	NA			"Cluster 7: Non-specific - Innate immune response"	"Cluster 76: Retina - Visual perception"	"Cluster 32: Cerebral cortex - Mixed function"	"Cluster 39: Non-specific - Transcription"	"Cluster 66: Photoreceptor cells - Visual perception"	4	Cytosol	"Rods & Rings"	"HPA001400: AB_1079139"	"unprognostic (1.05e-3)"	"unprognostic (1.83e-2)"	"unprognostic (3.79e-1)"	"unprognostic (2.27e-3)"	"unprognostic (1.00e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.14e-3)"	"unprognostic (2.16e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.04e-2)"	"validated prognostic unfavorable (2.02e-5)"	"validated prognostic unfavorable (1.09e-4)"	"unprognostic (3.12e-3)"	"potential prognostic unfavorable (2.75e-8)"	"unprognostic (3.46e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.30e-3)"	"unprognostic (5.22e-2)"	"unprognostic (9.50e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.10e-2)"	"unprognostic (6.14e-2)"	"unprognostic (4.74e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.89e-1)"	"unprognostic (4.40e-1)"	"unprognostic (8.84e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.76e-1)"
IMPDH2		ENSG00000178035	"Inosine monophosphate dehydrogenase 2"	P12268	3	49024325-49029447	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"GMP biosynthesis, Purine biosynthesis"	"DNA-binding, Oxidoreductase, RNA-binding"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adipose visceral - Adipose progenitor cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001400, CAB020717"	Approved		Supported	"Cytosol,Rods & Rings"			NA	NA		190000	"Cluster 18: Non-specific - Translation"	"Cluster 18: Non-specific - Ribosome"	"Cluster 27: Non-specific - Mixed function"	"Cluster 25: Non-specific - Ribosome"	"Cluster 64: Non-specific - Ribosome"	35	Cytosol	"Rods & Rings"	"CAB020717: , HPA001400: AB_1079139"	"unprognostic (1.39e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.67e-2)"	"unprognostic (4.55e-3)"	"unprognostic (3.85e-1)"	"unprognostic (1.73e-3)"	"unprognostic (2.04e-3)"	"unprognostic (1.03e-2)"	"potential prognostic unfavorable (1.23e-4)"	"potential prognostic favorable (4.86e-5)"	"unprognostic (1.44e-2)"	"unprognostic (4.19e-1)"	"validated prognostic unfavorable (7.42e-5)"	"validated prognostic unfavorable (4.15e-4)"	"unprognostic (2.00e-1)"	"potential prognostic unfavorable (2.78e-4)"	"unprognostic (1.33e-1)"	"unprognostic (6.53e-2)"	"unprognostic (3.40e-2)"	"unprognostic (8.28e-3)"	"unprognostic (4.72e-3)"	"unprognostic (5.49e-3)"	"unprognostic (1.34e-2)"	"unprognostic (3.14e-3)"	"unprognostic (8.54e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.28e-2)"	"unprognostic (3.46e-2)"
INSR	CD220	ENSG00000171105	"Insulin receptor"	P06213	19	7112255-7294414	"CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Carbohydrate metabolism"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Diabetes mellitus, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"monocytes: 261.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"dendritic cells: 9.8;granulocytes: 5.9;monocytes: 12.6"	"Cancer enhanced"	"Detected in all"		"Myeloma: 24.6"	"Pituitary gland - Corticotropes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036302, HPA036303"	Uncertain		Approved	"Vesicles,Plasma membrane,Primary cilium transition zone,Centriolar satellite,Basal body"			NA	Yes		140000	"Cluster 10: Non-specific - Membrane trafficking"	"Cluster 68: Non-specific - Protein processing"	"Cluster 26: Oligodendrocytes - Mixed function"	"Cluster 6: Leukemia - Signal transduction"	"Cluster 55: Non-specific - Transcription"	103	"Vesicles, Plasma membrane"	"Primary cilium transition zone, Centriolar satellite, Basal body"	"HPA036302: AB_2675048, HPA036303: "	"unprognostic (1.21e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.41e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.46e-1)"	"unprognostic (4.55e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.14e-1)"	"validated prognostic favorable (5.63e-8)"	"validated prognostic favorable (5.67e-5)"	"unprognostic (2.44e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.91e-2)"	"unprognostic (9.70e-2)"	"potential prognostic favorable (2.02e-4)"	"unprognostic (2.30e-1)"	"unprognostic (3.88e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.40e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.29e-1)"
ITGA2B	"CD41, CD41B, GP2B, PPP1R93"	ENSG00000005961	"Integrin subunit alpha 2b"	P08514	17	44372180-44389649	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 16.4;epididymis: 10.4;lymphoid tissue: 10.9"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 38.7;Late spermatids: 26.7;Lymphatic endothelial cells: 8.9;Oligodendrocyte precursor cells: 9.0"	"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in some"		"Testicular Germ Cell Tumor (TCGA): 6.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	14	"basophil: 65.1"	"Lineage enriched"	"Detected in single"	75	"granulocytes: 65.1"	"Cancer enriched"	"Detected in some"	59	"Leukemia: 83.1"	"Spleen - Platelets, Testis - Late spermatids"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB018611, HPA031168, HPA031169, HPA031170, HPA031171"	Enhanced		Approved	"Plasma membrane"			NA	NA		120000000	"Cluster 41: Basophils - Unknown function"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 48: Non-specific - Mixed function"	"Cluster 47: Leukemia - Hemostasis"	"Cluster 57: Platelets - Hemostasis"	8	"Plasma membrane"		"CAB018611: AB_2265153, HPA031168: AB_10664706, HPA031169: AB_10669671, HPA031170: AB_10696214, HPA031171: AB_10669773"	"unprognostic (2.44e-2)"		"unprognostic (2.67e-1)"	"unprognostic (1.27e-2)"				"unprognostic (9.29e-3)"												"unprognostic (5.64e-2)"	"unprognostic (3.09e-1)"								"unprognostic (1.49e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.52e-1)"
ITGA4	CD49D	ENSG00000115232	"Integrin subunit alpha 4"	P13612	2	181457202-181538940	"Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 46.0;lymphoid tissue: 72.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 97.4;Erythroid cells: 158.8;Kupffer cells: 101.2;Macrophages: 101.4;monocytes: 212.7;NK-cells: 269.6;Oocytes: 172.8;Plasma cells: 117.2;T-cells: 156.6"	"Cell type enriched"	"Detected in many"	4	"leukocyte: 647.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"Leukemia: 112.7;Myeloma: 80.8"	"Adipose visceral - T-cells, Adrenal gland - Macrophages, Breast - T-cells, Thyroid gland - T-cells"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	7	"cerebellum: 18.6"	HPA074961			Approved	"Plasma membrane"	"Intracellular and membrane"	Receptor	NA	NA		140000	"Cluster 25: Non-specific - Unknown function"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 35: Non-specific - DNA binding"	"Cluster 47: Leukemia - Hemostasis"	"Cluster 78: NK-cells & T-cells - Immune system & Transcription"	9	"Plasma membrane"		"HPA074961: AB_2732273"	"unprognostic (2.03e-2)"	"unprognostic (2.69e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.59e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.37e-3)"	"unprognostic (9.56e-2)"	"potential prognostic favorable (7.59e-4)"	"unprognostic (5.42e-2)"	"unprognostic (3.01e-3)"	"unprognostic (3.03e-1)"	"unprognostic (4.21e-2)"	"potential prognostic favorable (9.06e-4)"	"unprognostic (5.85e-3)"	"unprognostic (2.06e-2)"	"unprognostic (7.26e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.30e-2)"	"unprognostic (3.18e-1)"	"unprognostic (7.23e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.77e-2)"	"unprognostic (3.33e-3)"	"unprognostic (4.44e-2)"	"unprognostic (3.18e-1)"
ITGAL	"CD11A, LFA-1, LFA1A"	ENSG00000005844	"Integrin subunit alpha L"	P20701	16	30472658-30523567	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Host-virus interaction, Phagocytosis"	"Integrin, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 36.5;lymphoid tissue: 63.4"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 43.0;monocytes: 180.8;NK-cells: 191.9;T-cells: 88.6"	"Cell type enriched"	"Detected in many"	5	"leukocyte: 391.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"non-classical monocyte: 122.4"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	95	"Leukemia: 76.8;lymphoma: 43.9;Myeloma: 52.9"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Adrenal gland - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Liver - T-cells, Minor Salivary Gland - T-cells, Pancreas - T-cells, Pituitary gland - T-cells, Prostate - T-cells, Spleen - T-cells, Thyroid gland - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB025011	Enhanced						NA	NA		4600000	"Cluster 37: Monocytes & Neutrophils - Innate immune response"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 49: HMC-1 - Innate immune response"	"Cluster 19: NK-cells - Adaptive immune response"	7			"CAB025011: "	"unprognostic (1.70e-1)"	"unprognostic (1.30e-2)"	"potential prognostic favorable (4.34e-4)"	"unprognostic (2.50e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.82e-1)"	"unprognostic (6.44e-2)"	"unprognostic (4.83e-2)"	"potential prognostic favorable (8.09e-4)"	"unprognostic (4.51e-1)"	"unprognostic (8.80e-3)"	"unprognostic (2.59e-1)"	"unprognostic (6.15e-2)"	"unprognostic (2.47e-1)"	"unprognostic (7.68e-3)"	"unprognostic (1.87e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.85e-1)"	"unprognostic (6.30e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.82e-2)"	"unprognostic (5.35e-2)"	"unprognostic (3.56e-1)"	"unprognostic (4.25e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.64e-1)"
ITGAV	"CD51, MSK8, VNRA, VTNR"	ENSG00000138448	"Integrin subunit alpha V"	P06756	2	186590010-186680901	"Cancer-related genes, CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 181.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cancer enhanced"	"Detected in all"		"testis cancer: 265.2"	"Adrenal gland - Adrenal cortex cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002499, HPA004856"	Supported		Approved	"Focal adhesion sites,Cytosol"			NA	NA		1400000	"Cluster 37: Monocytes & Neutrophils - Innate immune response"	"Cluster 7: Adipose tissue - Mixed function"	"Cluster 27: Non-specific - Mixed function"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 45: Non-specific - Mixed function"	21	"Focal adhesion sites, Cytosol"		"CAB002499: AB_563594, HPA004856: AB_1846316"	"unprognostic (6.72e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.21e-1)"	"potential prognostic unfavorable (9.83e-4)"	"unprognostic (4.26e-1)"	"unprognostic (4.39e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.07e-1)"	"unprognostic (9.40e-2)"	"potential prognostic favorable (4.05e-8)"	"unprognostic (1.08e-2)"	"unprognostic (2.13e-3)"	"potential prognostic unfavorable (3.68e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.44e-3)"	"potential prognostic unfavorable (7.00e-5)"	"unprognostic (1.90e-1)"	"unprognostic (6.01e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.94e-2)"	"unprognostic (3.17e-1)"	"unprognostic (3.36e-2)"	"unprognostic (6.85e-2)"	"potential prognostic unfavorable (6.45e-5)"	"unprognostic (1.29e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.20e-1)"
ITGAX	CD11C	ENSG00000140678	"Integrin subunit alpha X"	P20702	16	31355134-31382999	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 47.5;lung: 56.3;lymphoid tissue: 65.9"	"Cell type enhanced"	"Detected in some"		"granulocytes: 76.6;Hofbauer cells: 70.9;Langerhans cells: 141.8;Macrophages: 125.7;monocytes: 419.8;NK-cells: 63.4"	"Cell type enriched"	"Detected in some"	5	"central nervous system macrophage: 457.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 86.3"	"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in some"		"Leukemia: 7.5;lymphoma: 7.8"	"Adipose visceral - Neutrophils, Heart muscle - Neutrophils, Kidney - T-cells, Liver - Neutrophils, Skeletal muscle - Neutrophils, Spleen - Neutrophils, Thyroid gland - T-cells"	"Not detected"	"Not detected"							"CAB004458, HPA004723, CAB072871, CAB080214"	Enhanced		Supported	"Vesicles,Plasma membrane"			NA	NA		45000	"Cluster 37: Monocytes & Neutrophils - Innate immune response"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 12: Non-specific - Vasculature"	"Cluster 49: HMC-1 - Innate immune response"	"Cluster 29: Monocytes - Innate immune response"	2	"Vesicles, Plasma membrane"		"CAB004458: AB_626859, CAB072871: AB_2665723, CAB080214: , HPA004723: AB_1846231"	"unprognostic (1.92e-1)"	"unprognostic (5.48e-3)"	"unprognostic (1.24e-2)"	"unprognostic (3.52e-1)"	"unprognostic (8.23e-2)"	"unprognostic (5.35e-2)"	"unprognostic (9.77e-2)"	"unprognostic (9.55e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.02e-2)"	"unprognostic (3.16e-1)"	"unprognostic (3.37e-1)"	"unprognostic (4.36e-2)"	"unprognostic (8.16e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.74e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.64e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.77e-3)"	"unprognostic (2.49e-2)"	"unprognostic (3.41e-2)"	"unprognostic (5.05e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.62e-1)"
ITGB1	"CD29, FNRB, GPIIA, MDF2, MSK12"	ENSG00000150093	"Integrin subunit beta 1"	P05556	10	32887273-33005792	"Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Host-virus interaction, Myogenesis"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Ductal cells: 1089.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Colon - Smooth muscle cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003434, HPA059297, HPA069003"	Enhanced		Supported	"Endoplasmic reticulum,Plasma membrane,Focal adhesion sites"			NA	NA		180000000	"Cluster 16: Non-specific - Cell proliferation"	"Cluster 62: Connective tissue - ECM organization"	"Cluster 47: Endothelial cells - Vasculature"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 45: Non-specific - Mixed function"	92	"Plasma membrane, Focal adhesion sites"	"Endoplasmic reticulum"	"CAB003434: AB_303570, HPA059297: AB_2732634, HPA069003: AB_2732125"	"unprognostic (4.54e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.88e-1)"	"unprognostic (5.64e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.28e-2)"	"unprognostic (7.99e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.98e-3)"	"potential prognostic favorable (4.33e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.23e-3)"	"unprognostic (8.77e-2)"	"validated prognostic unfavorable (1.05e-5)"	"validated prognostic unfavorable (7.17e-4)"	"potential prognostic unfavorable (2.85e-4)"	"unprognostic (2.00e-2)"	"unprognostic (1.71e-2)"	"potential prognostic unfavorable (7.34e-4)"	"unprognostic (1.55e-3)"	"unprognostic (1.99e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.51e-1)"	"unprognostic (5.64e-2)"	"unprognostic (2.77e-1)"	"unprognostic (4.34e-3)"	"unprognostic (3.02e-1)"	"unprognostic (9.42e-2)"	"unprognostic (1.39e-1)"
ITGB3	"CD61, GP3A, GPIIIa"	ENSG00000259207	"Integrin subunit beta 3"	P05106	17	47253827-47313743	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 54.6"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 9.7;Pancreatic endocrine cells: 10.2;Proximal tubular cells: 19.4;Salivary duct cells: 14.8;Sertoli cells: 13.6"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in all"		"Skin Cuteneous Melanoma (TCGA): 42.7;Thyroid Carcinoma (TCGA): 54.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	17	"basophil: 5.6;neutrophil: 3.0"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 5.6"	"Cancer enhanced"	"Detected in many"		"Kidney cancer: 99.0;skin cancer: 125.1"	"Liver - Vascular Endothelial cells, Prostate - Smooth muscle cells, Spleen - Platelets, Testis - Spermatogonia"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA027852	Approved		Supported	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	Receptor	NA	NA		54000000	"Cluster 35: Neutrophils - Protein binding"	"Cluster 51: Thyroid gland - Unknown function"	"Cluster 12: Non-specific - Vasculature"	"Cluster 69: Skin cancer - ECM organization"	"Cluster 57: Platelets - Hemostasis"	26	"Plasma membrane"	Nucleoplasm	"HPA027852: AB_10601760"	"unprognostic (3.07e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.97e-1)"	"potential prognostic unfavorable (1.29e-5)"	"unprognostic (2.03e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.19e-2)"	"unprognostic (6.47e-3)"	"potential prognostic unfavorable (6.40e-4)"	"unprognostic (1.20e-3)"	"unprognostic (2.55e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.08e-1)"	"unprognostic (8.90e-2)"	"unprognostic (1.38e-1)"	"potential prognostic unfavorable (1.51e-4)"	"unprognostic (6.12e-2)"	"potential prognostic unfavorable (8.56e-4)"	"unprognostic (3.74e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.33e-2)"	"unprognostic (8.62e-2)"	"unprognostic (8.26e-2)"	"unprognostic (5.73e-2)"	"unprognostic (6.30e-3)"	"unprognostic (3.24e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.83e-2)"
ITGB7		ENSG00000139626	"Integrin subunit beta 7"	P26010	12	53191323-53207282	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 29.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 37.7;NK-cells: 95.2;Plasma cells: 104.8;Schwann cells: 32.8;T-cells: 54.8"	"Cell type enriched"	"Detected in some"	5	"leukocyte: 38.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cancer enriched"	"Detected in many"	18	"Myeloma: 982.6"	"Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Lung - T-cells, Prostate - T-cells, Thyroid gland - T-cells"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA042277			Approved	"Plasma membrane,Cytosol"			NA	NA		220000	"Cluster 36: Eosinophils - Protein ubiquitination"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 19: NK-cells - Adaptive immune response"	3	"Plasma membrane, Cytosol"		"HPA042277: AB_10793877"	"unprognostic (8.50e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.38e-2)"	"unprognostic (9.63e-3)"	"unprognostic (7.07e-2)"	"unprognostic (1.69e-1)"	"potential prognostic unfavorable (9.37e-4)"	"unprognostic (1.30e-1)"	"potential prognostic favorable (1.09e-4)"	"unprognostic (1.40e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.53e-2)"	"unprognostic (3.70e-3)"	"potential prognostic favorable (9.95e-4)"	"unprognostic (1.40e-1)"	"unprognostic (1.98e-3)"	"unprognostic (8.08e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.33e-1)"	"unprognostic (7.97e-3)"	"potential prognostic unfavorable (6.63e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.75e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.33e-2)"	"unprognostic (5.55e-1)"	"unprognostic (8.27e-2)"	"unprognostic (2.11e-2)"	"unprognostic (7.71e-2)"
JAK1	"JAK1A, JAK1B, JTK3"	ENSG00000162434	"Janus kinase 1"	P23458	1	64833223-65067754	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"NK-cells: 619.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Adrenal cortex cells, Testis - Spermatogonia"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB013088	Approved						NA	NA			"Cluster 5: Non-specific - Cell proliferation"	"Cluster 19: Non-specific - Basic cellular processes"	"Cluster 42: Choroid plexus - Mitochondria"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 19: NK-cells - Adaptive immune response"	63			"CAB013088: "	"unprognostic (1.02e-2)"	"unprognostic (4.40e-3)"	"unprognostic (5.56e-3)"	"unprognostic (3.28e-1)"	"unprognostic (4.31e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.41e-3)"	"validated prognostic favorable (9.34e-9)"	"validated prognostic favorable (2.87e-4)"	"unprognostic (2.85e-1)"	"unprognostic (6.04e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.12e-2)"	"unprognostic (6.32e-2)"	"unprognostic (3.42e-2)"	"unprognostic (8.80e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.50e-2)"	"unprognostic (6.79e-2)"	"unprognostic (6.49e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.94e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.17e-3)"
JAK2	JTK10	ENSG00000096968	"Janus kinase 2"	O60674	9	4984390-5129948	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Innate immunity"	"Chromatin regulator, Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 90.3;Inhibitory neurons: 117.1;Microglial cells: 102.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 133.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 133.0"	"Low cancer specificity"	"Detected in all"			"Testis - Spermatocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013089, HPA040820, HPA043870"	Approved		Supported	"Nucleoplasm,Plasma membrane,Focal adhesion sites"			No	No			"Cluster 46: Basophils - Proteolysis"	"Cluster 7: Adipose tissue - Mixed function"	"Cluster 53: Neurons - Mixed function"	"Cluster 47: Leukemia - Hemostasis"	"Cluster 29: Monocytes - Innate immune response"	44	Nucleoplasm	"Plasma membrane, Focal adhesion sites"	"CAB013089: AB_2533647, HPA040820: AB_2677151, HPA043870: AB_2678708"	"unprognostic (2.70e-2)"	"unprognostic (5.40e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.05e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.00e-1)"	"unprognostic (6.81e-3)"	"unprognostic (2.82e-2)"	"potential prognostic favorable (1.07e-4)"	"unprognostic (1.09e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.89e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.21e-2)"	"unprognostic (9.70e-2)"	"unprognostic (9.49e-2)"	"unprognostic (2.15e-1)"	"unprognostic (6.38e-3)"	"unprognostic (7.43e-2)"	"unprognostic (1.49e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.80e-2)"	"unprognostic (8.10e-3)"	"unprognostic (4.82e-2)"	"unprognostic (5.27e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.77e-1)"	"unprognostic (5.43e-2)"	"unprognostic (9.78e-3)"
JAK3	"JAK-3, JAK3_HUMAN, JAKL, L-JAK, LJAK"	ENSG00000105639	"Janus kinase 3"	P52333	19	17824780-17848071	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Innate immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 53.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 25.0;Hofbauer cells: 17.3;monocytes: 28.6;NK-cells: 21.9;Plasma cells: 18.4;T-cells: 43.2"	"Group enriched"	"Detected in many"	4	"central nervous system macrophage: 20.5;leukocyte: 70.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"Leukemia: 6.1;lymphoma: 11.9;Myeloma: 9.4"	"Breast - T-cells, Prostate - T-cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA070314	Enhanced		Approved	"Plasma membrane,Cytosol"			NA	NA			"Cluster 33: Non-specific - ATP binding"	"Cluster 47: Spleen - Immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 71: Lymphoma - Inflammatory response"	"Cluster 7: T-cells - T-cell receptor"	21	"Plasma membrane, Cytosol"		"HPA070314: AB_2686251"	"unprognostic (2.33e-1)"	"unprognostic (2.97e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.59e-1)"	"unprognostic (6.24e-3)"	"unprognostic (1.86e-1)"	"potential prognostic favorable (1.89e-4)"	"unprognostic (6.31e-2)"	"potential prognostic unfavorable (1.36e-8)"	"unprognostic (3.30e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.85e-2)"	"unprognostic (9.87e-2)"	"unprognostic (6.26e-2)"	"unprognostic (6.45e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.49e-2)"	"potential prognostic unfavorable (2.50e-4)"	"unprognostic (2.48e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.70e-2)"	"unprognostic (6.28e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.31e-1)"
JUN	"AP-1, c-Jun"	ENSG00000177606	"Jun proto-oncogene, AP-1 transcription factor subunit"	P05412	1	58776845-58784048	"Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Ovarian stromal cells: 5164.4"	"Cell type enhanced"	"Detected in all"		"astrocyte: 239.9;endothelial cell: 299.8;vascular associated smooth muscle cell: 260.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Thyroid gland - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003801, CAB007780, HPA059474, HPA066898, CAB080216, CAB080219, CAB080220"	Enhanced		Enhanced	Nucleoplasm			Yes	No			"Cluster 14: Non-specific - Unknown function"	"Cluster 18: Non-specific - Ribosome"	"Cluster 31: Non-specific - Transcription"	"Cluster 72: Neuronal - Signal transduction"	"Cluster 80: Non-specific - Transcription"	199	Nucleoplasm		"CAB003801: AB_365485, CAB007780: AB_562268, CAB080216: , CAB080219: , CAB080220: , HPA059474: AB_2684030, HPA066898: "	"unprognostic (1.36e-2)"	"unprognostic (9.79e-2)"	"unprognostic (8.33e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.27e-1)"	"potential prognostic favorable (3.22e-4)"	"unprognostic (2.36e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.81e-3)"	"unprognostic (2.71e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.81e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.48e-2)"	"unprognostic (4.66e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.39e-1)"
KCNA1	"AEMK, HUK1, Kv1.1, MBK1, RBK1"	ENSG00000111262	"Potassium voltage-gated channel subfamily A member 1"	Q09470	12	4909905-4918256	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	40	"brain: 52.8"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 8.8;Excitatory neurons: 38.3;Horizontal cells: 21.4;Inhibitory neurons: 17.9;Oligodendrocyte precursor cells: 15.1"	"Cell type enhanced"	"Detected in some"		"upper rhombic lip: 2.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	5	"lung cancer: 2.5"	"Pituitary gland - Thyrotropes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074471	Approved						NA	NA				"Cluster 65: Cerebellum - Nervous system development"	"Cluster 52: Neurons & Synapses - Synaptic function"	"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 34: Neurons - Neuronal signaling"	18			"HPA074471: "								"unprognostic (2.28e-2)"																							
KCNA10	Kv1.8	ENSG00000143105	"Potassium voltage-gated channel subfamily A member 10"	Q16322	1	110517217-110519175	"FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Testis - Late spermatids"	"Not detected"	"Not detected"			"Not detected"	"Not detected"										NA	NA						"Cluster 11: Neuronal - Sensory perception"		6																																		
KCNA2	"HK4, Kv1.2"	ENSG00000177301	"Potassium voltage-gated channel subfamily A member 2"	P16389	1	110519837-110631474	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 32.1;retina: 9.4"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 47.4;Early spermatids: 16.9;Excitatory neurons: 35.5;Horizontal cells: 33.4;Inhibitory neurons: 35.6;Muller glia cells: 15.6;Oligodendrocyte precursor cells: 34.0"	"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"Glioblastoma Multiforme (TCGA): 3.9;Skin Cuteneous Melanoma (TCGA): 1.1;Testicular Germ Cell Tumor (TCGA): 3.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.3"	"Lineage enriched"	"Detected in single"	8	"T-cells: 1.3"	"Group enriched"	"Detected in some"	5	"Bone cancer: 8.0;Myeloma: 3.0"	"Colon - Enteric glia cells, Testis - Spermatogonia"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB001976	Enhanced						NA	NA				"Cluster 22: Brain - Synaptic signal transduction"	"Cluster 52: Neurons & Synapses - Synaptic function"	"Cluster 12: Bone cancer - Neuronal signaling"	"Cluster 8: Neurons - Neuronal signaling"	13			"CAB001976: "							"unprognostic (1.35e-1)"	"unprognostic (8.14e-2)"											"unprognostic (4.55e-1)"								"unprognostic (3.11e-2)"		"unprognostic (3.44e-1)"		
KCNA3	"HLK3, HPCN3, Kv1.3, MK3"	ENSG00000177272	"Potassium voltage-gated channel subfamily A member 3"	P22001	1	110653560-110674940	"FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 1.9;lung: 2.1;lymphoid tissue: 2.5"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 12.7;Inhibitory neurons: 57.6;Plasma cells: 49.8;T-cells: 24.0"	"Cell type enhanced"	"Detected in some"		"leukocyte: 6.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"gdT-cell: 5.6;MAIT T-cell: 5.3;memory CD4 T-cell: 8.5;memory CD8 T-cell: 9.6;naive B-cell: 2.6;naive CD4 T-cell: 5.0;naive CD8 T-cell: 4.6;T-reg: 8.5"	"Group enriched"	"Detected in many"	6	"B-cells: 2.6;T-cells: 9.6"	"Cancer enriched"	"Detected in some"	5	"Myeloma: 5.6"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Colon - T-cells, Minor Salivary Gland - Plasma cells, Skin - T-cells, Testis - Spermatocytes, Thyroid gland - T-cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016625	Approved						NA	NA			"Cluster 11: T-cells - Unknown function"	"Cluster 47: Spleen - Immune response"	"Cluster 1: Neurons - Mixed function"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 7: T-cells - T-cell receptor"	102			"HPA016625: AB_2669407"			"unprognostic (7.90e-2)"			"unprognostic (1.03e-1)"		"unprognostic (4.85e-2)"				"unprognostic (2.23e-2)"				"unprognostic (8.41e-3)"	"unprognostic (1.07e-3)"		"unprognostic (4.17e-1)"				"unprognostic (1.42e-1)"			"unprognostic (7.88e-2)"		"unprognostic (4.08e-2)"	"unprognostic (2.81e-2)"		
KCNA4	"HK1, HPCN2, KCNA4L, Kv1.4, PCN2"	ENSG00000182255	"Potassium voltage-gated channel subfamily A member 4"	P22459	11	30009730-30017030	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Cataract, Disease variant, Dystonia, FDA approved drug targets, Intellectual disability"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 5.9;brain: 7.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 12.7;Cardiomyocytes: 3.5;Excitatory neurons: 7.9;Horizontal cells: 6.9;Mesothelial cells: 6.8;Muller glia cells: 3.9"	"Cell type enhanced"	"Detected in many"		"mammillary body: 57.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Adipose visceral - Mesothelial cells, Adrenal gland - Adrenal cortex cells, Colon - Colon enteroendocrine cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB001977, HPA016422"	Approved						NA	NA				"Cluster 17: Neuronal - Synaptic function"	"Cluster 33: Neurons - Mixed function"	"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 71: Horizontal & Bipolar cells - Neuronal signaling"	13			"CAB001977: , HPA016422: AB_1855574"								"unprognostic (1.86e-3)"																							
KCNA5	"HK2, HPCN1, Kv1.5"	ENSG00000130037	"Potassium voltage-gated channel subfamily A member 5"	P22460	12	5043879-5046788	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Atrial fibrillation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"choroid plexus: 59.0;heart muscle: 38.5"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 128.0;Cardiomyocytes: 21.5;dendritic cells: 18.9;Horizontal cells: 34.0;Smooth muscle cells: 29.1"	"Cell type enhanced"	"Detected in many"		"choroid plexus epithelial cell: 14.0;ependymal cell: 14.6;vascular associated smooth muscle cell: 38.9"	"Cancer enhanced"	"Detected in some"		"Pancreatic Adenocarcinoma (TCGA): 3.1"	"Region enriched"	"Detected in all"	7	"choroid plexus: 113.8"	"Immune cell enriched"	"Detected in single"	122	"plasmacytoid DC: 12.2"	"Lineage enriched"	"Detected in single"	122	"dendritic cells: 12.2"	"Cancer enriched"	"Detected in single"	6	"Leukemia: 1.8"	"Adipose subcutaneous - Smooth muscle cells, Adipose visceral - Smooth muscle cells, Pancreas - Alpha cells, Pancreas - Beta cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021516, CAB022562"	Approved						NA	NA			"Cluster 44: Plasmacytoid DCs - Plasma membrane proteins"	"Cluster 60: Choroid plexus - Transmembrane transport"	"Cluster 36: Choroid plexus - Mixed function"	"Cluster 6: Leukemia - Signal transduction"	"Cluster 25: Bipolar cells - Visual perception"	14			"CAB022562: , HPA021516: AB_2670732"			"unprognostic (2.26e-1)"					"unprognostic (1.91e-1)"			"unprognostic (1.99e-1)"	"unprognostic (3.36e-3)"	"unprognostic (2.29e-2)"									"unprognostic (2.23e-2)"							"unprognostic (2.03e-1)"		
KCNA6	"HBK2, Kv1.6, PPP1R96"	ENSG00000151079	"Potassium voltage-gated channel subfamily A member 6"	P17658	12	4809334-4813318	"FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 9.4"	"Group enriched"	"Detected in some"	8	"Astrocytes: 13.3;Excitatory neurons: 26.9;Inhibitory neurons: 51.1;Oligodendrocyte precursor cells: 20.8"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Glioblastoma Multiforme (TCGA): 4.6;Testicular Germ Cell Tumor (TCGA): 3.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"Leukemia: 2.3;testis cancer: 7.8"		"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA076475			Approved	"Vesicles,Plasma membrane,Cytosol"			NA	NA				"Cluster 61: Brain - Neuronal signaling"	"Cluster 56: Hypothalamus - Neuropeptide signaling"	"Cluster 59: Leukemia - T-cell receptor"	"Cluster 8: Neurons - Neuronal signaling"	8	"Plasma membrane, Cytosol"	Vesicles	"HPA076475: "			"unprognostic (2.00e-1)"				"unprognostic (2.27e-1)"	"unprognostic (4.51e-2)"																					"unprognostic (1.67e-1)"		
KCNA7	"HAK6, Kv1.7"	ENSG00000104848	"Potassium voltage-gated channel subfamily A member 7"	Q96RP8	19	49067397-49072699	"FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	53	"skeletal muscle: 76.8;tongue: 19.8"	"Cell type enriched"	"Detected in some"	33	"Skeletal myocytes: 57.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Pituitary gland - Gonadotropes"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA075990			Approved	"Vesicles,Plasma membrane"			NA	NA				"Cluster 2: Skeletal muscle - Striated muscle contraction"	"Cluster 6: Non-specific - Immune response"	"Cluster 72: Neuronal - Signal transduction"	"Cluster 2: Skeletal myocytes - Muscle contraction"		"Vesicles, Plasma membrane"		"HPA075990: "																							"unprognostic (1.53e-2)"			"potential prognostic favorable (3.83e-4)"					
KCNB1	Kv2.1	ENSG00000158445	"Potassium voltage-gated channel subfamily B member 1"	Q14721	20	49293394-49484297	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Exocytosis, Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"retina: 111.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 134.9;Cone photoreceptor cells: 309.2;Excitatory neurons: 145.6;Inhibitory neurons: 85.9;Rod photoreceptor cells: 352.3"	"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in some"		"Glioblastoma Multiforme (TCGA): 2.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Neuroblastoma: 3.5;Rhabdoid: 4.0"	"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Pituitary gland - Thyrotropes, Prostate - Smooth muscle cells, Spleen - Fibroblast_2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001979, HPA042434"	Enhanced						NA	NA				"Cluster 76: Retina - Visual perception"	"Cluster 53: Neurons - Mixed function"	"Cluster 5: Rhabdoid - Unknown function"	"Cluster 66: Photoreceptor cells - Visual perception"	8			"CAB001979: , HPA042434: AB_2677996"			"unprognostic (1.80e-1)"				"unprognostic (2.86e-1)"	"potential prognostic favorable (7.76e-7)"				"unprognostic (4.95e-2)"		"unprognostic (7.89e-2)"												"unprognostic (2.76e-2)"		"unprognostic (1.39e-3)"			
KCNB2	Kv2.2	ENSG00000182674	"Potassium voltage-gated channel subfamily B member 2"	Q92953	8	72537225-72938349	"FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.2;lymphoid tissue: 2.2;retina: 4.4"	"Group enriched"	"Detected in some"	11	"Cone photoreceptor cells: 178.4;Excitatory neurons: 269.5;Inhibitory neurons: 230.5"	"Cell type enhanced"	"Detected in all"		"miscellaneous: 1482.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"lung cancer: 2.8"	"Colon - Colon enteroendocrine cells, Pancreas - Alpha cells, Pancreas - Beta cells, Testis - Late spermatids"					"Low region specificity"	"Detected in many"			HPA065970			Approved	"Nucleoli,Plasma membrane,Midbody"			Yes	NA				"Cluster 17: Neuronal - Synaptic function"	"Cluster 14: Neurons - Synaptic function"	"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 69: Neurons - Neuronal signaling"	2	"Plasma membrane"	"Nucleoli, Midbody"	"HPA065970: AB_2685591"								"unprognostic (3.13e-2)"																							
KCNC1	Kv3.1	ENSG00000129159	"Potassium voltage-gated channel subfamily C member 1"	P48547	11	17734774-17856804	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"brain: 102.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 55.7;Excitatory neurons: 46.6;Horizontal cells: 272.6;Inhibitory neurons: 115.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 3.3;neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 3.3"	"Cancer enhanced"	"Detected in some"		"Neuroblastoma: 7.7"	"Adrenal gland - Adrenal medulla cells, Colon - Colon enteroendocrine cells, Pancreas - Alpha cells, Pituitary gland - Corticotropes, Testis - Early spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047634, HPA048249"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Vesicles,Cytosol"			NA	NA			"Cluster 20: Non-specific - DNA binding"	"Cluster 65: Cerebellum - Nervous system development"	"Cluster 37: Neurons - Mixed function"	"Cluster 17: Neuroblastoma - Neuronal signaling"	"Cluster 71: Horizontal & Bipolar cells - Neuronal signaling"	2	"Nucleoplasm, Nuclear membrane"	"Vesicles, Cytosol"	"HPA047634: AB_2680109, HPA048249: "		"unprognostic (3.33e-2)"	"unprognostic (3.85e-1)"			"unprognostic (2.73e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.62e-2)"																		"unprognostic (5.10e-2)"			"unprognostic (1.18e-1)"		
KCNC2	Kv3.2	ENSG00000166006	"Potassium voltage-gated channel subfamily C member 2"	Q96PR1	12	75040077-75209839	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets, Intellectual disability"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 38.8"	"Group enriched"	"Detected in some"	10	"Excitatory neurons: 377.2;Inhibitory neurons: 1368.9"	"Cell type enhanced"	"Detected in all"		"LAMP5-LHX6 and Chandelier: 2159.6;MGE interneuron: 1938.6"	"Group enriched"	"Detected in some"	8	"Breast Invasive Carcinoma (TCGA): 5.6;Prostate Adenocarcinoma (TCGA): 14.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"breast cancer: 1.2;Sarcoma: 1.0"	"Colon - Colon enteroendocrine cells, Pituitary gland - Lactotropes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019664, CAB022571"	Uncertain						NA	NA				"Cluster 17: Neuronal - Synaptic function"	"Cluster 52: Neurons & Synapses - Synaptic function"	"Cluster 27: Breast cancer - Unknown function"	"Cluster 65: Neurons - Synaptic function"				"CAB022571: , HPA019664: AB_1855578"		"unprognostic (3.60e-1)"	"unprognostic (1.80e-1)"				"unprognostic (1.21e-1)"	"unprognostic (1.75e-2)"							"unprognostic (1.60e-1)"									"unprognostic (1.30e-1)"							
KCNC3	"Kv3.3, SCA13"	ENSG00000131398	"Potassium voltage-gated channel subfamily C member 3"	Q14003	19	50311937-50333515	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 65.2;thyroid gland: 50.6"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 19.4;Excitatory neurons: 15.1;Glandular and luminal cells: 14.9;Inhibitory neurons: 17.6;monocytes: 16.5;Secretory cells: 19.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Lung - Alveolar cells type 2, Spleen - Macrophages, Stomach - Gastric enteroendocrine cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018041	Approved						NA	NA				"Cluster 65: Cerebellum - Nervous system development"	"Cluster 52: Neurons & Synapses - Synaptic function"	"Cluster 55: Lymphoma - Immune response"	"Cluster 37: Glandular & Luminal cells - Unknown function"	11			"HPA018041: AB_1855579"	"unprognostic (3.29e-3)"	"unprognostic (1.12e-1)"	"potential prognostic favorable (1.67e-4)"	"unprognostic (2.05e-1)"		"unprognostic (3.70e-1)"	"unprognostic (6.61e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.27e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.73e-2)"	"unprognostic (8.21e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.79e-2)"	"unprognostic (6.38e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.15e-3)"	"unprognostic (3.10e-2)"	"potential prognostic unfavorable (3.45e-4)"		"unprognostic (8.15e-2)"	"unprognostic (1.45e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.87e-2)"	"unprognostic (7.63e-2)"
KCND1	Kv4.1	ENSG00000102057	"Potassium voltage-gated channel subfamily D member 1"	Q9NSA2	X	48961378-48971844	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 12.1"	"Cell type enhanced"	"Detected in some"		"Fibroblasts: 2.4;Peritubular cells: 4.0;Rod photoreceptor cells: 4.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000524, HPA001066"	Supported		Uncertain	Nucleoplasm			Yes	No				"Cluster 28: Neuronal - Transcription"	"Cluster 25: Non-specific - Transcription"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 53: Fibroblasts - ECM organization"		Nucleoplasm		"HPA000524: AB_2666013, HPA001066: AB_1079662"	"unprognostic (2.38e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.50e-1)"	"unprognostic (1.10e-1)"		"unprognostic (2.20e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.53e-1)"			"potential prognostic unfavorable (1.19e-5)"	"unprognostic (1.64e-2)"	"unprognostic (9.18e-3)"			"unprognostic (6.29e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.15e-1)"	"potential prognostic unfavorable (2.88e-4)"	"unprognostic (1.48e-1)"	"potential prognostic favorable (3.21e-5)"	"unprognostic (8.48e-3)"			"unprognostic (1.23e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.37e-2)"	"unprognostic (6.83e-2)"	"unprognostic (3.44e-2)"
KCND2	"KIAA1044, Kv4.2, RK5"	ENSG00000184408	"Potassium voltage-gated channel subfamily D member 2"	Q9NZV8	7	120273175-120750337	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Autism, Autism spectrum disorder, Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 36.3"	"Group enriched"	"Detected in some"	11	"Excitatory neurons: 667.4;Inhibitory neurons: 1026.1;Oligodendrocyte precursor cells: 1832.4"	"Cell type enhanced"	"Detected in all"		"midbrain-derived inhibitory: 5323.0;upper rhombic lip: 5357.6"	"Cancer enhanced"	"Detected in many"		"Glioblastoma Multiforme (TCGA): 12.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"lung cancer: 2.9"	"Pituitary gland - Lactotropes, Thyroid gland - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029068	Enhanced						NA	NA				"Cluster 65: Cerebellum - Nervous system development"	"Cluster 37: Neurons - Mixed function"	"Cluster 11: Neuronal - Sensory perception"	"Cluster 8: Neurons - Neuronal signaling"	11			"HPA029068: AB_10601436"	"unprognostic (3.12e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.48e-2)"				"unprognostic (3.55e-1)"	"potential prognostic favorable (2.04e-5)"								"unprognostic (1.35e-3)"	"unprognostic (1.39e-1)"	"unprognostic (7.16e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.41e-2)"	"unprognostic (5.03e-2)"								
KCND3	"KSHIVB, Kv4.3, SCA19, SCA22"	ENSG00000171385	"Potassium voltage-gated channel subfamily D member 3"	Q9UK17	1	111770662-111989668	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Brugada syndrome, Disease variant, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 34.6;Cardiomyocytes: 36.9;Excitatory neurons: 102.1;Hepatocytes: 32.7;Horizontal cells: 40.9;Inhibitory neurons: 84.6;Late spermatids: 34.4;Oligodendrocyte precursor cells: 42.9"	"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"Prostate Adenocarcinoma (TCGA): 12.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"lung cancer: 1.6"	"Liver - Hepatocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029452	Approved						NA	NA				"Cluster 28: Neuronal - Transcription"	"Cluster 38: Sub-cortical - Mixed function"	"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 34: Neurons - Neuronal signaling"	4			"HPA029452: AB_10602239"	"unprognostic (2.39e-3)"	"unprognostic (9.43e-3)"	"unprognostic (1.18e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.34e-3)"	"unprognostic (2.94e-1)"		"unprognostic (1.68e-1)"	"unprognostic (5.41e-3)"	"unprognostic (2.58e-3)"	"unprognostic (1.82e-1)"		"unprognostic (4.59e-3)"	"unprognostic (9.59e-3)"	"unprognostic (9.40e-3)"	"unprognostic (4.55e-2)"	"unprognostic (9.48e-2)"		"unprognostic (4.74e-2)"	"unprognostic (2.23e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.50e-1)"		"unprognostic (3.62e-1)"			
KCNH2	"erg1, HERG, Kv11.1, LQT2"	ENSG00000055118	"Potassium voltage-gated channel subfamily H member 2"	Q12809	7	150944961-150978321	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Deafness, Disease variant, FDA approved drug targets, Long QT syndrome, Short QT syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 40.8;pituitary gland: 42.1"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 209.8;Cardiomyocytes: 80.3;Erythroid cells: 116.1;granulocytes: 43.3;Horizontal cells: 57.3;Sertoli cells: 65.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Leukemia: 23.5;Neuroblastoma: 41.8"	"Adipose subcutaneous - Smooth muscle cells, Adipose visceral - Smooth muscle cells, Lung - Fibroblast_1, Pancreas - Alpha cells, Pancreas - Beta cells, Prostate - Smooth muscle cells, Skin - Smooth muscle cells, Testis - Sertoli cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"										NA	NA				"Cluster 28: Neuronal - Transcription"	"Cluster 49: Hindbrain - Mixed function"	"Cluster 47: Leukemia - Hemostasis"	"Cluster 1: Erythroid cells - Oxygen transport"	11				"unprognostic (1.37e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.54e-3)"	"unprognostic (5.49e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.84e-1)"		"unprognostic (9.34e-2)"		"unprognostic (2.44e-1)"	"unprognostic (2.61e-3)"		"unprognostic (3.93e-2)"	"potential prognostic favorable (3.21e-4)"	"unprognostic (1.26e-1)"	"unprognostic (4.68e-2)"		"unprognostic (5.02e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.45e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.08e-2)"		"unprognostic (9.69e-2)"	"unprognostic (6.13e-2)"		"unprognostic (5.49e-2)"
KCNH6	"erg2, HERG2, Kv11.2"	ENSG00000173826	"Potassium voltage-gated channel subfamily H member 6"	Q9H252	17	63523334-63548977	"FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 4.7;kidney: 6.8;pituitary gland: 5.2;prostate: 3.8;retina: 4.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 42.1;Cone photoreceptor cells: 11.9;Enteroendocrine cells: 27.3;Horizontal cells: 11.3;Prostatic glandular cells: 24.5;Proximal enterocytes: 40.9"	"Cell type enhanced"	"Detected in many"		"mammillary body: 6.3;splatter: 5.7"	"Cancer enhanced"	"Detected in some"		"Prostate Adenocarcinoma (TCGA): 8.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Gastric cancer: 6.2;lung cancer: 9.7;prostate cancer: 5.3"	"Kidney - Proximal tubular cells, Kidney - Proximal tubular cells, Pancreas - Alpha cells, Pituitary gland - Corticotropes, Prostate - Prostate glandular cells, Stomach - Gastric enteroendocrine cells, Testis - Late spermatids"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"medulla oblongata: 1.4;olfactory bulb: 3.2;spinal cord: 3.2"	HPA061704	Approved						NA	NA				"Cluster 39: Retina & Testis - Cilium"	"Cluster 49: Hindbrain - Mixed function"	"Cluster 11: Neuronal - Sensory perception"	"Cluster 22: Proximal enterocytes - Digestion"				"HPA061704: "	"unprognostic (1.22e-2)"										"unprognostic (3.70e-3)"	"unprognostic (1.25e-1)"	"unprognostic (7.56e-2)"				"unprognostic (1.92e-2)"					"potential prognostic favorable (4.51e-4)"		"unprognostic (3.49e-1)"					"unprognostic (3.10e-1)"		
KCNH7	"erg3, HERG3, Kv11.3"	ENSG00000184611	"Potassium voltage-gated channel subfamily H member 7"	Q9NS40	2	162371407-162838767	"FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.4;retina: 1.5"	"Group enriched"	"Detected in some"	6	"Excitatory neurons: 663.4;Inhibitory neurons: 337.4"	"Low cell type specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"lung cancer: 2.0"	"Lung - Neutrophil_2, Pituitary gland - Corticotropes, Spleen - Neutrophils, Testis - Early spermatids, Testis - Late spermatids"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"amygdala: 21.6;cerebral cortex: 85.1;hippocampal formation: 55.9;olfactory bulb: 53.9"	HPA018039	Uncertain						NA	NA				"Cluster 17: Neuronal - Synaptic function"	"Cluster 53: Neurons - Mixed function"	"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 34: Neurons - Neuronal signaling"				"HPA018039: AB_1852125"								"unprognostic (4.19e-3)"																							
KCNJ1	"Kir1.1, ROMK1"	ENSG00000151704	"Potassium inwardly rectifying channel subfamily J member 1"	P48048	11	128836315-128867373	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Bartter syndrome, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	43	"kidney: 191.1"	"Group enriched"	"Detected in some"	96	"Collecting duct cells: 23.3;Distal tubular cells: 79.9"	"Cell type enhanced"	"Detected in many"		"amygdala excitatory: 6.9;medium spiny neuron: 9.6"	"Group enriched"	"Detected in some"	7	"Kidney Chromophobe (TCGA): 34.1;Kidney Renal Papillary Cell Carcinoma (TCGA): 14.0"	"Region enhanced"	"Detected in some"		"basal ganglia: 3.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Kidney - Ascending Loop of Henle cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA026962	Enhanced						NA	NA				"Cluster 52: Kidney - Transmembrane transport"	"Cluster 33: Neurons - Mixed function"	"Cluster 50: Lymphoma - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	3			"HPA026962: AB_10601934"										"unprognostic (2.21e-1)"	"unprognostic (4.88e-2)"	"unprognostic (3.75e-2)"	"unprognostic (3.99e-1)"				"unprognostic (4.10e-1)"													"unprognostic (1.42e-1)"	
KCNJ10	"Kir1.2, Kir4.1"	ENSG00000177807	"Potassium inwardly rectifying channel subfamily J member 10"	P78508	1	159998651-160070160	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Deafness, Disease variant, Epilepsy, FDA approved drug targets, Intellectual disability"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 113.7;kidney: 27.0;retina: 35.6"	"Group enriched"	"Detected in some"	7	"Astrocytes: 88.2;Muller glia cells: 66.1;Oligodendrocyte precursor cells: 33.5;Oligodendrocytes: 87.3"	"Group enriched"	"Detected in many"	16	"astrocyte: 115.7;bergmann glia: 102.9;committed oligodendrocyte precursor: 69.0;ependymal cell: 35.9;oligodendrocyte: 141.2;oligodendrocyte precursor cell: 67.7"	"Cancer enriched"	"Detected in some"	6	"Glioblastoma Multiforme (TCGA): 42.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"skin cancer: 2.0"	"Kidney - Ascending Loop of Henle cells, Liver - Kupffer cells, Spleen - Macrophages, Stomach - Parietal cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078302	Enhanced						NA	NA				"Cluster 9: Oligodendrocytes - Myelination"	"Cluster 19: Astrocytes - Mixed function"	"Cluster 32: Non-specific - Cell proliferation"	"Cluster 10: Muller glia cells - Visual perception"	10			"HPA078302: AB_2732378"			"unprognostic (1.18e-1)"			"unprognostic (2.22e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.34e-1)"		"unprognostic (8.30e-2)"							"unprognostic (2.23e-1)"		"unprognostic (5.43e-2)"							"unprognostic (5.48e-2)"	"unprognostic (1.49e-1)"		"unprognostic (2.96e-1)"		
KCNJ11	"BIR, Kir6.2"	ENSG00000187486	"Potassium inwardly rectifying channel subfamily J member 11"	Q14654	11	17365172-17389331	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Diabetes mellitus, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 129.9;tongue: 41.5"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 7.8;Cardiomyocytes: 19.5;Enteroendocrine cells: 6.3;Inhibitory neurons: 5.7;Skeletal myocytes: 13.7"	"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in many"		"Kidney Chromophobe (TCGA): 25.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Heart muscle - Cardiomyocytes, Testis - Spermatogonia"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048891	Approved						NA	NA				"Cluster 79: Non-specific - Transcription"	"Cluster 37: Neurons - Mixed function"	"Cluster 16: Thyroid cancer - Neuronal signaling"	"Cluster 68: Cardiomyocytes - Muscle contraction"	3			"HPA048891: AB_2680547"	"unprognostic (2.43e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.31e-1)"	"unprognostic (4.16e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.69e-1)"	"potential prognostic unfavorable (8.17e-5)"	"unprognostic (4.04e-2)"	"unprognostic (1.07e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.89e-2)"	"unprognostic (7.25e-3)"	"unprognostic (9.06e-2)"	"unprognostic (4.62e-3)"	"unprognostic (6.18e-2)"	"unprognostic (4.41e-3)"	"unprognostic (2.17e-2)"	"unprognostic (3.33e-2)"		"unprognostic (2.69e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.00e-1)"
KCNJ12	"hIRK1, IRK2, KCNJN1, Kir2.2, Kir2.2v"	ENSG00000184185	"Potassium inwardly rectifying channel subfamily J member 12"	Q14500	17	21376357-21419870	"FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 41.5;skeletal muscle: 66.7;tongue: 24.8"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 14.2;Horizontal cells: 30.2;Muller glia cells: 9.1;Skeletal myocytes: 19.5"	"Cell type enhanced"	"Detected in many"		"upper rhombic lip: 44.5"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"cerebellum: 58.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Breast - Fibroblasts, Skeletal muscle - Skeletal myocytes"									HPA027021	Approved		Uncertain	"Nucleoplasm,Golgi apparatus,Cytosol"			NA	NA				"Cluster 79: Non-specific - Transcription"	"Cluster 15: Non-specific - Transcription"	"Cluster 27: Breast cancer - Unknown function"	"Cluster 71: Horizontal & Bipolar cells - Neuronal signaling"	13	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA027021: AB_10602912"			"unprognostic (1.01e-3)"	"unprognostic (2.04e-1)"					"unprognostic (3.70e-2)"				"unprognostic (5.14e-3)"							"unprognostic (4.92e-2)"	"unprognostic (1.56e-1)"						"unprognostic (2.78e-3)"		"unprognostic (1.35e-1)"	"unprognostic (4.27e-2)"	"unprognostic (9.21e-2)"
KCNJ14	"IRK4, Kir2.4"	ENSG00000182324	"Potassium inwardly rectifying channel subfamily J member 14"	Q9UNX9	19	48455574-48466980	"FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"retina: 56.9"	"Cell type enriched"	"Detected in many"	6	"Rod photoreceptor cells: 308.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Low cancer specificity"	"Detected in many"				"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"										NA	NA				"Cluster 76: Retina - Visual perception"	"Cluster 19: Astrocytes - Mixed function"	"Cluster 56: Non-specific - Sensory perception"	"Cluster 66: Photoreceptor cells - Visual perception"					"unprognostic (1.06e-2)"	"unprognostic (4.77e-2)"	"unprognostic (9.62e-2)"	"unprognostic (3.84e-3)"	"potential prognostic unfavorable (1.04e-4)"	"unprognostic (2.74e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.37e-3)"		"unprognostic (1.65e-2)"			"unprognostic (1.39e-2)"					"unprognostic (7.81e-3)"		"unprognostic (5.88e-2)"		"unprognostic (6.69e-3)"	"unprognostic (1.75e-2)"	"unprognostic (3.70e-3)"	"unprognostic (3.25e-1)"	"unprognostic (7.12e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.18e-2)"		"unprognostic (7.93e-2)"
KCNJ15	"IRKK, Kir1.3, Kir4.2"	ENSG00000157551	"Potassium inwardly rectifying channel subfamily J member 15"	Q99712	21	38155549-38307357	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 232.9;thyroid gland: 125.7"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 2: 86.7;Cholangiocytes: 87.8;Early spermatids: 141.5;Late spermatids: 77.7;Proximal tubular cells: 198.6"	"Cell type enhanced"	"Detected in some"		"deep-layer near-projecting: 1.5;fibroblast: 1.2;hippocampal CA1-3: 1.1"	"Cancer enhanced"	"Detected in many"		"Kidney Renal Papillary Cell Carcinoma (TCGA): 102.3;Thyroid Carcinoma (TCGA): 124.4"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	21	"neutrophil: 398.0"	"Lineage enriched"	"Detected in many"	21	"granulocytes: 398.0"	"Cancer enhanced"	"Detected in many"		"Bladder cancer: 22.2;head and neck cancer: 20.7"	"Adrenal gland - Neutrophils, Colon - Neutrophils, Heart muscle - Neutrophils, Kidney - Proximal tubular cells, Lung - Alveolar cells type 2, Prostate - Urothelial cells, Spleen - Neutrophils"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA016702	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"			NA	NA			"Cluster 4: Neutrophils - Degranulation"	"Cluster 52: Kidney - Transmembrane transport"	"Cluster 12: Non-specific - Vasculature"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 38: Proximal tubular cells - Transmembrane transport"	3	"Plasma membrane"	"Vesicles, Cytosol"	"HPA016702: AB_1855560"	"unprognostic (2.35e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.19e-1)"	"unprognostic (9.52e-2)"	"unprognostic (8.13e-2)"	"unprognostic (2.25e-1)"			"unprognostic (1.56e-3)"	"unprognostic (8.50e-2)"	"validated prognostic favorable (1.05e-11)"	"validated prognostic favorable (2.35e-4)"	"potential prognostic favorable (1.28e-4)"		"unprognostic (1.65e-1)"	"unprognostic (4.44e-3)"	"unprognostic (9.52e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.23e-2)"	"potential prognostic unfavorable (5.68e-4)"		"unprognostic (5.55e-2)"	"unprognostic (2.00e-2)"	"unprognostic (8.87e-3)"	"unprognostic (2.39e-2)"	"unprognostic (1.53e-2)"	"unprognostic (8.79e-2)"	"unprognostic (4.27e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.54e-3)"
KCNJ2	"IRK1, Kir2.1, LQT7"	ENSG00000123700	"Potassium inwardly rectifying channel subfamily J member 2"	P63252	17	70168673-70180044	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Atrial fibrillation, Disease variant, FDA approved drug targets, Long QT syndrome, Short QT syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 34.8"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 36.3;Horizontal cells: 61.1;monocytes: 61.8;Oligodendrocytes: 153.3;Skeletal myocytes: 36.1"	"Cell type enhanced"	"Detected in many"		"oligodendrocyte: 237.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"neutrophil: 30.7"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 30.7"	"Cancer enhanced"	"Detected in many"		"Rhabdoid: 11.3"	"Liver - Kupffer cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029109	Approved						NA	NA			"Cluster 28: Neutrophils - Unknown function"	"Cluster 24: Parathyroid gland - Vesicular transport"	"Cluster 28: Oligodendrocytes - Mixed function"	"Cluster 5: Rhabdoid - Unknown function"	"Cluster 51: Oligodendrocytes - Unknown function"	10			"HPA029109: AB_10602913"	"unprognostic (3.15e-1)"	"unprognostic (4.61e-1)"	"unprognostic (2.15e-2)"	"unprognostic (6.16e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.69e-1)"	"unprognostic (8.74e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.64e-2)"	"unprognostic (2.65e-3)"	"unprognostic (3.45e-2)"		"unprognostic (1.37e-1)"	"unprognostic (1.34e-1)"	"unprognostic (6.78e-2)"	"unprognostic (1.98e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.72e-1)"		"unprognostic (1.93e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.20e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.89e-2)"	"unprognostic (5.65e-2)"	"unprognostic (7.91e-2)"	"unprognostic (2.12e-2)"
KCNJ3	"GIRK1, KGA, Kir3.1"	ENSG00000162989	"Potassium inwardly rectifying channel subfamily J member 3"	P48549	2	154697855-154858354	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 39.5"	"Group enriched"	"Detected in many"	5	"Excitatory neurons: 299.2;Inhibitory neurons: 413.7"	"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"Breast Invasive Carcinoma (TCGA): 21.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"prostate cancer: 2.9"	"Adipose subcutaneous - Smooth muscle cells, Kidney - Ascending Loop of Henle cells, Liver - Hepatocytes, Spleen - B-cells (Spleen)"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024231, HPA064138"	Uncertain		Approved	"Plasma membrane,Mitochondria"			NA	NA				"Cluster 65: Cerebellum - Nervous system development"	"Cluster 35: Non-specific - DNA binding"	"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 8: Neurons - Neuronal signaling"	2	Mitochondria	"Plasma membrane"	"HPA024231: AB_1855558, HPA064138: "		"unprognostic (1.63e-1)"	"unprognostic (2.04e-1)"		"unprognostic (7.17e-2)"	"unprognostic (1.54e-2)"	"unprognostic (8.51e-2)"	"unprognostic (3.52e-2)"		"unprognostic (2.23e-1)"	"potential prognostic favorable (8.20e-9)"	"unprognostic (9.44e-3)"	"unprognostic (5.39e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.42e-1)"					"unprognostic (9.15e-2)"		"unprognostic (1.02e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.83e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.27e-3)"		"unprognostic (2.30e-1)"			"unprognostic (1.04e-1)"
KCNJ4	"HIR, hIRK2, HRK1, IRK3, Kir2.3"	ENSG00000168135	"Potassium inwardly rectifying channel subfamily J member 4"	P48050	22	38426327-38455199	"FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	28	"brain: 84.9;heart muscle: 32.3"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 13.8;Horizontal cells: 7.6;Inhibitory neurons: 10.6;Microglial cells: 3.6;Muller glia cells: 7.3;Sertoli cells: 2.7"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Glioblastoma Multiforme (TCGA): 3.6;Kidney Renal Papillary Cell Carcinoma (TCGA): 2.4;Liver Hepatocellular Carcinoma (TCGA): 2.5;Uterine Corpus Endometrial Carcinoma (TCGA): 1.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Rhabdoid: 3.3"	"Adipose visceral - Mesothelial cells, Heart muscle - Cardiomyocytes"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	15	"amygdala: 29.3;basal ganglia: 68.9;cerebral cortex: 74.2;hippocampal formation: 61.3;olfactory bulb: 76.3"								NA	NA				"Cluster 61: Brain - Neuronal signaling"	"Cluster 53: Neurons - Mixed function"	"Cluster 1: Neuronal - Visual perception"	"Cluster 8: Neurons - Neuronal signaling"	9										"unprognostic (7.27e-2)"	"unprognostic (4.18e-1)"				"unprognostic (2.14e-2)"	"unprognostic (9.62e-3)"	"unprognostic (7.65e-2)"	"unprognostic (1.01e-3)"																"unprognostic (1.76e-2)"
KCNJ8	Kir6.1	ENSG00000121361	"Potassium inwardly rectifying channel subfamily J member 8"	Q15842	12	21764955-21775600	"Disease related genes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 69.0"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 20.2;Cardiomyocytes: 24.1;Granulosa cells: 19.5;Hepatocytes: 22.8;Muller glia cells: 20.3;Sertoli cells: 73.4;Smooth muscle cells: 45.7"	"Cell type enriched"	"Detected in many"	5	"pericyte: 92.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	15	"eosinophil: 1.5"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 1.5"	"Cancer enhanced"	"Detected in many"		"Kidney cancer: 6.8;liver cancer: 7.0;Neuroblastoma: 11.5"	"Breast - Endothelial cells, Kidney - Fibroblasts, Minor Salivary Gland - Endothelial cells, Skin - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031066	Uncertain						NA	NA				"Cluster 43: Non-specific - Mitochondrial translation"	"Cluster 42: Choroid plexus - Mitochondria"	"Cluster 34: Testis cancer - Unknown function"	"Cluster 48: Smooth muscle cells - Signal transduction"	3			"HPA031066: AB_10602240"	"unprognostic (1.58e-2)"	"unprognostic (2.87e-2)"	"unprognostic (4.04e-1)"		"unprognostic (9.85e-3)"	"unprognostic (4.37e-2)"	"unprognostic (8.03e-2)"	"unprognostic (4.98e-1)"	"unprognostic (2.93e-1)"	"unprognostic (9.15e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.05e-2)"	"unprognostic (5.11e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.29e-1)"	"unprognostic (6.86e-2)"	"unprognostic (4.99e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.14e-2)"	"unprognostic (3.44e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.00e-1)"	"unprognostic (9.93e-2)"	"unprognostic (8.35e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.83e-2)"	"unprognostic (7.02e-3)"	"unprognostic (1.05e-1)"	"potential prognostic unfavorable (7.44e-4)"	"unprognostic (1.22e-1)"
KCNK2	"K2p2.1, TREK-1"	ENSG00000082482	"Potassium two pore domain channel subfamily K member 2"	O95069	1	215005775-215237090	"FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"adrenal gland: 51.4"	"Group enriched"	"Detected in some"	10	"Excitatory neurons: 19.0;Inhibitory neurons: 51.6;Microglial cells: 28.6;Oligodendrocyte precursor cells: 42.9"	"Cell type enriched"	"Detected in many"	4	"fibroblast: 583.5"	"Cancer enhanced"	"Detected in many"		"Breast Invasive Carcinoma (TCGA): 5.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"breast cancer: 13.3"	"Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"										NA	NA				"Cluster 26: Adrenal gland - Steroid metabolism"	"Cluster 33: Neurons - Mixed function"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 69: Neurons - Neuronal signaling"						"unprognostic (3.26e-2)"	"unprognostic (4.77e-2)"				"unprognostic (8.84e-2)"	"unprognostic (6.62e-3)"			"unprognostic (9.11e-2)"	"unprognostic (2.91e-1)"						"unprognostic (1.85e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.72e-2)"	"unprognostic (3.14e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.87e-2)"				"unprognostic (1.70e-3)"			"unprognostic (1.20e-2)"	"unprognostic (3.75e-3)"
KCNK3	"K2p3.1, TASK, TASK-1, TASK1"	ENSG00000171303	"Potassium two pore domain channel subfamily K member 3"	O14649	2	26692722-26733420	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"adrenal gland: 170.2"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 67.1;Collecting duct cells: 103.1;Enteroendocrine cells: 28.1;Exocrine glandular cells: 78.8;Smooth muscle cells: 30.4"	"Cell type enhanced"	"Detected in many"		"midbrain-derived inhibitory: 48.5;pericyte: 66.0"	"Cancer enhanced"	"Detected in many"		"Kidney Renal Clear Cell Carcinoma (TCGA): 21.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Kidney cancer: 11.5;thyroid cancer: 10.3"	"Adrenal gland - Adrenal cortex cells, Pituitary gland - Gonadotropes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"										NA	NA				"Cluster 26: Adrenal gland - Steroid metabolism"	"Cluster 49: Hindbrain - Mixed function"	"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 48: Smooth muscle cells - Signal transduction"	5				"unprognostic (1.86e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.57e-2)"	"unprognostic (1.69e-2)"			"unprognostic (2.60e-1)"	"potential prognostic favorable (1.28e-5)"			"unprognostic (5.89e-3)"	"potential prognostic favorable (8.89e-4)"	"potential prognostic unfavorable (3.10e-4)"			"unprognostic (1.71e-3)"	"unprognostic (4.28e-2)"	"unprognostic (3.53e-3)"	"unprognostic (5.04e-2)"	"unprognostic (1.22e-1)"		"unprognostic (3.62e-2)"	"unprognostic (1.57e-1)"	"unprognostic (9.26e-3)"		"unprognostic (3.17e-1)"		"unprognostic (2.99e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.43e-2)"	"unprognostic (4.57e-2)"
KCNK9	"K2p9.1, TASK-3, TASK3"	ENSG00000169427	"Potassium two pore domain channel subfamily K member 9"	Q9NPC2	8	139600838-139704109	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"Disease variant, FDA approved drug targets, Intellectual disability"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 9.2"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 15.4;Horizontal cells: 10.7;Inhibitory neurons: 7.6;Late spermatids: 9.2;Oocytes: 51.5"	"Cell type enhanced"	"Detected in many"		"mammillary body: 53.4;upper rhombic lip: 107.4"	"Cancer enriched"	"Detected in single"	5	"Kidney Renal Clear Cell Carcinoma (TCGA): 2.8"	"Region enhanced"	"Detected in many"		"cerebellum: 19.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Neuroblastoma: 1.1;thyroid cancer: 1.6"	"Pituitary gland - Corticotropes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA075842			Approved	"Plasma membrane"			NA	NA				"Cluster 65: Cerebellum - Nervous system development"	"Cluster 35: Non-specific - DNA binding"	"Cluster 16: Thyroid cancer - Neuronal signaling"	"Cluster 44: Oocytes - Unknown function"		"Plasma membrane"		"HPA075842: "								"unprognostic (2.64e-2)"			"unprognostic (5.11e-3)"	"unprognostic (1.34e-1)"									"unprognostic (2.85e-1)"		"unprognostic (1.91e-1)"								
KCNMA1	"KCa1.1, mSLO1, SLO"	ENSG00000156113	"Potassium calcium-activated channel subfamily M alpha 1"	Q12791	10	76869601-77638369	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 134.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 446.8;Bipolar cells: 485.5;Excitatory neurons: 989.5;Inhibitory neurons: 610.3;Oligodendrocyte precursor cells: 664.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 2.5;non-classical monocyte: 1.7"	"Lineage enhanced"	"Detected in single"		"monocytes: 2.5"	"Low cancer specificity"	"Detected in many"			"Adipose subcutaneous - Smooth muscle cells, Adipose visceral - Smooth muscle cells, Heart muscle - Smooth muscle cells, Prostate - Smooth muscle cells, Spleen - Macrophages, Testis - Early spermatids, Testis - Late spermatids, Thyroid gland - Smooth muscle cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054648	Approved						NA	NA			"Cluster 40: Monocytes - Innate immune response"	"Cluster 41: Smooth muscle tissue - ECM organization"	"Cluster 40: Astrocytes - Astrocyte-neuron interactions"	"Cluster 72: Neuronal - Signal transduction"	"Cluster 34: Neurons - Neuronal signaling"	2			"HPA054648: AB_2682556"	"unprognostic (3.41e-2)"	"unprognostic (8.13e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.35e-1)"	"unprognostic (4.26e-1)"	"potential prognostic favorable (7.57e-5)"	"unprognostic (2.38e-2)"	"unprognostic (8.94e-2)"	"unprognostic (5.27e-1)"	"unprognostic (5.40e-3)"	"potential prognostic favorable (7.51e-4)"	"unprognostic (2.54e-1)"	"unprognostic (2.08e-1)"	"unprognostic (7.68e-2)"	"unprognostic (9.29e-2)"	"potential prognostic unfavorable (6.61e-4)"	"unprognostic (2.06e-3)"	"unprognostic (1.26e-2)"	"unprognostic (4.84e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.41e-1)"	"unprognostic (6.05e-2)"
KCNMB1	hslo-beta	ENSG00000145936	"Potassium calcium-activated channel subfamily M regulatory beta subunit 1"	Q16558	5	170374671-170389634	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 57.2;intestine: 72.5;smooth muscle: 51.1"	"Cell type enriched"	"Detected in many"	5	"Peritubular cells: 354.8"	"Group enriched"	"Detected in many"	10	"central nervous system macrophage: 172.4;fibroblast: 70.5;lower rhombic lip: 50.2;vascular associated smooth muscle cell: 78.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 5.7;monocytes: 5.9"	"Cancer enhanced"	"Detected in some"		"Leukemia: 3.2"	"Adipose subcutaneous - Smooth muscle cells, Adipose visceral - Smooth muscle cells, Adrenal gland - Smooth muscle cells, Colon - Smooth muscle cells, Heart muscle - Smooth muscle cells, Lung - Smooth muscle cells, Minor Salivary Gland - Smooth muscle cells, Pituitary gland - Smooth muscle cells, Prostate - Smooth muscle cells, Skeletal muscle - Smooth muscle cells, Spleen - Smooth muscle cells, Thyroid gland - Smooth muscle cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"										NA	NA			"Cluster 10: Non-specific - Membrane trafficking"	"Cluster 41: Smooth muscle tissue - ECM organization"	"Cluster 49: Hindbrain - Mixed function"	"Cluster 6: Leukemia - Signal transduction"	"Cluster 32: Smooth muscle cells - Muscle contraction"					"unprognostic (7.51e-2)"	"unprognostic (2.06e-2)"	"unprognostic (4.05e-1)"	"unprognostic (1.33e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.18e-3)"	"unprognostic (6.82e-2)"		"unprognostic (1.72e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.15e-1)"		"unprognostic (1.21e-1)"	"unprognostic (9.98e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.50e-1)"	"unprognostic (6.67e-2)"	"unprognostic (6.44e-3)"	"unprognostic (6.66e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.85e-2)"	"unprognostic (6.51e-3)"
KCNMB2		ENSG00000197584	"Potassium calcium-activated channel subfamily M regulatory beta subunit 2"	Q9Y691	3	178272932-178844429	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 34.5;fallopian tube: 13.4"	"Group enriched"	"Detected in some"	4	"Inhibitory neurons: 758.1;Oligodendrocyte precursor cells: 1860.2"	"Cell type enhanced"	"Detected in all"		"oligodendrocyte precursor cell: 3205.3"	"Cancer enhanced"	"Detected in many"		"Pancreatic Adenocarcinoma (TCGA): 5.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"lung cancer: 3.9;lymphoma: 7.5"	"Colon - Enteric glia cells, Lung - Respiratory ciliated cells, Pancreas - Alpha cells, Pituitary gland - Somatotropes"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB022649	Uncertain						NA	NA				"Cluster 50: Epididymis - Male reproductive secretion"	"Cluster 51: Neurons - Mixed function"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 76: Oligodendrocyte precursor - Unknown function"	7			"CAB022649: "			"unprognostic (1.63e-2)"				"unprognostic (2.97e-2)"	"unprognostic (1.42e-2)"		"unprognostic (1.71e-1)"	"unprognostic (7.71e-2)"		"unprognostic (8.03e-3)"				"unprognostic (1.59e-3)"			"unprognostic (3.05e-2)"	"unprognostic (2.60e-2)"	"unprognostic (9.31e-3)"	"unprognostic (7.27e-2)"	"unprognostic (2.04e-2)"							
KCNMB3	"KCNMB2, KCNMBL"	ENSG00000171121	"Potassium calcium-activated channel subfamily M regulatory beta subunit 3"	Q9NPA1	3	179236691-179267002	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 9.5;Late spermatids: 11.0;Oligodendrocytes: 5.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"				"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA015665, HPA019185"	Approved		Approved	Nucleoplasm,Mitochondria			NA	NA				"Cluster 43: Non-specific - Mitochondrial translation"	"Cluster 48: Non-specific - Mixed function"	"Cluster 6: Leukemia - Signal transduction"	"Cluster 63: Late spermatids - Spermatogenesis"		Nucleoplasm	Mitochondria	"HPA015665: AB_1852142, HPA019185: AB_1852144"	"unprognostic (6.17e-2)"	"unprognostic (7.46e-2)"	"unprognostic (2.87e-1)"	"unprognostic (5.40e-2)"	"potential prognostic unfavorable (1.50e-4)"	"unprognostic (6.58e-2)"	"unprognostic (5.17e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.61e-2)"	"validated prognostic unfavorable (3.01e-9)"	"validated prognostic unfavorable (9.35e-4)"	"unprognostic (8.50e-2)"	"unprognostic (2.28e-3)"	"unprognostic (9.39e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.28e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.89e-3)"	"unprognostic (4.21e-3)"	"unprognostic (3.52e-3)"	"unprognostic (2.07e-3)"	"unprognostic (4.71e-2)"	"unprognostic (4.58e-1)"		"unprognostic (5.98e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.40e-3)"
KCNMB4		ENSG00000135643	"Potassium calcium-activated channel subfamily M regulatory beta subunit 4"	Q86W47	12	70366290-70434292	"FDA approved drug targets, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 39.6"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 92.2;Inhibitory neurons: 43.2;Oligodendrocytes: 80.8;Schwann cells: 135.6"	"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"Glioblastoma Multiforme (TCGA): 16.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Rhabdoid: 14.0"	"Colon - Enteric glia cells, Heart muscle - Fibroblasts, Liver - Vascular Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072287	Enhanced	Approved	Approved	Cytosol			NA	NA				"Cluster 9: Oligodendrocytes - Myelination"	"Cluster 11: White matter - Signal transduction"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 34: Neurons - Neuronal signaling"	2	Cytosol		"HPA072287: AB_2686507"	"unprognostic (3.20e-1)"	"unprognostic (3.72e-1)"	"unprognostic (8.17e-2)"	"unprognostic (5.30e-3)"	"unprognostic (9.16e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.73e-3)"		"unprognostic (3.54e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.38e-2)"		"unprognostic (1.39e-1)"	"unprognostic (3.83e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.45e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.38e-1)"	"unprognostic (3.67e-3)"	"unprognostic (9.38e-3)"	"unprognostic (2.32e-3)"	"unprognostic (5.83e-2)"	"unprognostic (4.06e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.84e-2)"	"unprognostic (2.16e-1)"
KCNN1	"hSK1, KCa2.1"	ENSG00000105642	"Potassium calcium-activated channel subfamily N member 1"	Q92952	19	17951293-18000085	"FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	49	"brain: 106.5"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 12.4;Langerhans cells: 18.1"	"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in many"		"Testicular Germ Cell Tumor (TCGA): 7.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Bone cancer: 16.2"	"Pituitary gland - Undifferentiated cells (Pituitary gland), Testis - Spermatogonia"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065938			Approved	"Actin filaments,Cytosol"			Yes	No				"Cluster 33: Brain - Neuronal signaling"	"Cluster 51: Neurons - Mixed function"	"Cluster 12: Bone cancer - Neuronal signaling"	"Cluster 28: Dendritic cells - Antigen presentation"		"Actin filaments, Cytosol"		"HPA065938: AB_2685582"			"unprognostic (7.84e-2)"				"unprognostic (2.36e-1)"	"unprognostic (4.00e-1)"		"unprognostic (1.00e-2)"	"unprognostic (6.57e-3)"	"unprognostic (7.98e-2)"	"unprognostic (2.80e-1)"							"unprognostic (2.47e-1)"									"unprognostic (1.62e-1)"		"unprognostic (2.95e-1)"
KCNN2	"hSK2, KCa2.2"	ENSG00000080709	"Potassium calcium-activated channel subfamily N member 2"	Q9H2S1	5	114055926-114496500	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"Disease variant, Dystonia, FDA approved drug targets, Intellectual disability"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 20.1;liver: 31.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 34.4;Excitatory neurons: 145.1;Inhibitory neurons: 93.0;Oligodendrocyte precursor cells: 59.4;Prostatic glandular cells: 30.0"	"Cell type enhanced"	"Detected in all"		"hippocampal CA1-3: 649.6"	"Group enriched"	"Detected in many"	7	"Glioblastoma Multiforme (TCGA): 10.7;Prostate Adenocarcinoma (TCGA): 37.2;Skin Cuteneous Melanoma (TCGA): 10.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"prostate cancer: 28.6;skin cancer: 8.3"	"Adrenal gland - Adrenal cortex cells, Heart muscle - Cardiomyocytes, Liver - Hepatocytes, Testis - Spermatogonia"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038221	Uncertain		Uncertain	"Nucleoplasm,Plasma membrane"			NA	NA				"Cluster 69: Liver - Oxidoreductase activity"	"Cluster 29: Forebrain - Mixed function"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 65: Neurons - Synaptic function"	1	"Nucleoplasm, Plasma membrane"		"HPA038221: AB_10673044"	"unprognostic (1.94e-1)"	"unprognostic (1.98e-3)"	"unprognostic (1.37e-1)"			"unprognostic (9.59e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.82e-1)"			"potential prognostic favorable (1.11e-4)"	"unprognostic (2.01e-2)"		"unprognostic (9.68e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.46e-3)"	"unprognostic (1.66e-1)"	"unprognostic (8.47e-2)"			"unprognostic (8.82e-2)"	"unprognostic (1.38e-2)"	"unprognostic (5.36e-2)"		"unprognostic (6.18e-2)"	"unprognostic (3.25e-2)"		"unprognostic (1.76e-1)"		"unprognostic (1.50e-1)"
KCNN3	"hSK3, KCa2.3, SKCA3"	ENSG00000143603	"Potassium calcium-activated channel subfamily N member 3"	Q9UGI6	1	154697455-154870281	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 160.1;Ciliated cells: 28.9;Lymphatic endothelial cells: 51.8;Plasma cells: 40.5;Skeletal myocytes: 84.9"	"Cell type enhanced"	"Detected in all"		"astrocyte: 617.3;ependymal cell: 350.8"	"Cancer enhanced"	"Detected in many"		"Glioblastoma Multiforme (TCGA): 10.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 4.7;memory B-cell: 2.6"	"Group enriched"	"Detected in many"	12	"B-cells: 2.6;granulocytes: 4.7;monocytes: 1.4"	"Group enriched"	"Detected in some"	5	"lymphoma: 18.8;Myeloma: 37.2"	"Adipose subcutaneous - Smooth muscle cells, Colon - Enteric glia cells, Heart muscle - Fibroblasts"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA017990, HPA057127"	Enhanced		Approved	"Plasma membrane,Cytosol"			NA	NA			"Cluster 23: B-cells - Immunoglobulins"	"Cluster 33: Brain - Neuronal signaling"	"Cluster 19: Astrocytes - Mixed function"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 54: Lymphatic endothelial cells - Lymph vessel development"		"Plasma membrane, Cytosol"		"HPA017990: AB_2669730, HPA057127: AB_2683345"	"unprognostic (1.57e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.40e-1)"		"unprognostic (2.06e-1)"	"unprognostic (1.29e-1)"	"potential prognostic favorable (4.11e-4)"	"unprognostic (3.52e-2)"	"unprognostic (2.34e-1)"	"validated prognostic favorable (1.10e-8)"	"validated prognostic favorable (7.85e-6)"				"unprognostic (9.14e-2)"	"unprognostic (9.51e-2)"	"unprognostic (3.92e-2)"	"unprognostic (5.45e-2)"	"unprognostic (4.40e-3)"		"unprognostic (2.64e-3)"	"unprognostic (1.49e-2)"			"unprognostic (3.86e-2)"		"unprognostic (6.89e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.47e-2)"
KCNN4	"hIKCa1, hKCa4, hSK4, IK, KCa3.1"	ENSG00000104783	"Potassium calcium-activated channel subfamily N member 4"	O15554	19	43766533-43780976	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Immunity, Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"Disease variant, FDA approved drug targets, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 122.7"	"Group enriched"	"Detected in many"	5	"Cytotrophoblasts: 223.3;Syncytiotrophoblasts: 783.0"	"Cell type enhanced"	"Detected in many"		"central nervous system macrophage: 11.0;leukocyte: 9.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Breast - Breast glandular cells (progenitors), Minor Salivary Gland - Minor salivary glandular cells, Skin - Eccrine sweat gland cells, Spleen - B-cells (Spleen), Stomach - Gastric mucous cells"	"Region enhanced"	"Detected in single"		"olfactory bulb: 1.9"	"Not detected"	"Not detected"			"HPA013367, HPA053841, HPA059622"	Approved		Approved	"Plasma membrane,Cytosol"			NA	NA			"Cluster 14: Non-specific - Unknown function"	"Cluster 48: Stomach - Proteolysis"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 69: Skin cancer - ECM organization"	"Cluster 27: Syncytiotrophoblasts - Pregnancy"	40	"Plasma membrane, Cytosol"		"HPA013367: , HPA053841: AB_2682278, HPA059622: AB_2684085"	"unprognostic (4.27e-3)"	"unprognostic (4.76e-3)"	"unprognostic (5.18e-2)"	"unprognostic (1.70e-3)"	"unprognostic (7.19e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.79e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.30e-2)"	"unprognostic (9.87e-2)"	"validated prognostic unfavorable (1.54e-5)"	"validated prognostic unfavorable (1.44e-4)"	"unprognostic (1.87e-3)"	"unprognostic (2.28e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.97e-3)"	"unprognostic (4.10e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.02e-2)"	"unprognostic (9.67e-2)"	"unprognostic (3.70e-1)"	"potential prognostic unfavorable (9.06e-5)"	"unprognostic (4.22e-1)"	"unprognostic (8.41e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.20e-1)"	"unprognostic (4.69e-3)"	"unprognostic (3.00e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.47e-3)"
KCNQ1	"JLNS1, KCNA8, KCNA9, Kv7.1, KVLQT1, LQT, LQT1"	ENSG00000053918	"Potassium voltage-gated channel subfamily Q member 1"	P51787	11	2444684-2849105	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel"	"Atrial fibrillation, Deafness, Diabetes mellitus, Disease variant, FDA approved drug targets, Long QT syndrome, Short QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 191.0;stomach 1: 96.2"	"Cell type enhanced"	"Detected in many"		"Microglial cells: 68.0"	"Cell type enhanced"	"Detected in all"		"central nervous system macrophage: 392.3"	"Cancer enhanced"	"Detected in all"		"Kidney Chromophobe (TCGA): 119.6"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cancer enhanced"	"Detected in many"		"colorectal cancer: 32.2;Gastric cancer: 20.3"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Skeletal muscle - Macrophages, Spleen - Macrophages, Stomach - Parietal cells, Thyroid gland - Thyroid glandular cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA011306, HPA048553, HPA071107"	Enhanced		Enhanced	"Endoplasmic reticulum,Plasma membrane,Cytosol"			NA	NA			"Cluster 2: Dendritic cells - Unknown function"	"Cluster 24: Parathyroid gland - Vesicular transport"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 57: Stomach & Colon cancer - Digestion"	"Cluster 16: Intestinal goblet cells - Mucin production"	9	"Endoplasmic reticulum"	"Plasma membrane, Cytosol"	"HPA011306: , HPA048553: AB_2680438, HPA071107: "	"unprognostic (1.69e-3)"	"unprognostic (3.84e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.76e-2)"	"potential prognostic favorable (9.37e-5)"	"unprognostic (1.16e-3)"	"unprognostic (9.03e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.50e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.05e-3)"	"unprognostic (4.64e-1)"	"unprognostic (6.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.88e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.87e-3)"	"unprognostic (8.78e-3)"	"unprognostic (4.42e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.41e-2)"
KDR	"CD309, FLK1, VEGFR, VEGFR2"	ENSG00000128052	"Kinase insert domain receptor"	P35968	4	55078481-55125595	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation, Host-virus interaction"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Adipocytes: 138.5;Endothelial cells: 159.5;Lymphatic endothelial cells: 111.0;Mesothelial cells: 193.9;Muller glia cells: 172.6"	"Group enriched"	"Detected in many"	4	"endothelial cell: 114.8;fibroblast: 55.5"	"Cancer enhanced"	"Detected in many"		"Kidney Renal Clear Cell Carcinoma (TCGA): 27.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	6	"Rhabdoid: 54.8"	"Adipose subcutaneous - Endothelial cells, Adrenal gland - Endothelial cells, Breast - Endothelial cells, Colon - Endothelial cells, Heart muscle - Endothelial cells, Kidney - Endothelial cells, Liver - Sinusoid Endothelial cells, Minor Salivary Gland - Endothelial cells, Skeletal muscle - Endothelial cells, Stomach - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004028, HPA069304, HPA073577"	Enhanced		Approved	"Nuclear membrane,Vesicles,Cytosol,Connecting piece,Mid piece,Principal piece"	"Intracellular and membrane"	Receptor	NA	NA		10000000		"Cluster 7: Adipose tissue - Mixed function"	"Cluster 42: Choroid plexus - Mitochondria"	"Cluster 5: Rhabdoid - Unknown function"	"Cluster 54: Lymphatic endothelial cells - Lymph vessel development"	44	Vesicles	"Nuclear membrane, Cytosol, Connecting piece, Mid piece, Principal piece"	"CAB004028: AB_2212507, HPA069304: , HPA073577: "	"unprognostic (2.09e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.24e-1)"		"unprognostic (3.63e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.04e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.09e-1)"	"validated prognostic favorable (5.31e-10)"	"validated prognostic favorable (1.73e-5)"	"unprognostic (3.65e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.62e-3)"	"unprognostic (8.98e-2)"	"unprognostic (2.02e-3)"	"unprognostic (5.90e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.01e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.09e-3)"
KEAP1	"INrf2, KIAA0132, KLHL19, MGC10630, MGC1114, MGC20887, MGC4407, MGC9454"	ENSG00000079999	"Kelch like ECH associated protein 1"	Q14145	19	10486125-10503558	"Cancer-related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"		"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 171.9"	"Low cell type specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005558, CAB025337"	Approved		Supported	"Nucleoplasm,Centriolar satellite,Cytosol"			NA	NA			"Cluster 13: Non-specific - Mitochondria"	"Cluster 14: Skeletal muscle - Muscle contraction"	"Cluster 28: Oligodendrocytes - Mixed function"	"Cluster 23: Non-specific - Transcription"	"Cluster 39: Non-specific - Basic cellular processes"	149	"Nucleoplasm, Centriolar satellite"	Cytosol	"CAB025337: , HPA005558: AB_1079175"	"unprognostic (1.54e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.85e-2)"	"unprognostic (5.35e-3)"	"unprognostic (2.62e-1)"	"unprognostic (8.63e-2)"	"unprognostic (2.78e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.86e-2)"	"unprognostic (5.96e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.46e-2)"	"unprognostic (4.45e-2)"	"unprognostic (6.61e-3)"	"unprognostic (5.93e-3)"	"unprognostic (8.08e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.36e-2)"	"unprognostic (4.04e-3)"	"unprognostic (4.29e-3)"	"unprognostic (2.90e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.20e-2)"
KIT	"C-Kit, CD117, PBT, SCFR"	ENSG00000157404	"KIT proto-oncogene, receptor tyrosine kinase"	P10721	4	54657267-54740783	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 82.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 984.7;Melanocytes: 386.5"	"Cell type enhanced"	"Detected in many"		"cerebellar inhibitory: 699.5;CGE interneuron: 325.6;midbrain-derived inhibitory: 571.8"	"Cancer enhanced"	"Detected in many"		"Kidney Chromophobe (TCGA): 143.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 16.1;eosinophil: 9.6;NK-cell: 11.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 16.1;NK-cells: 11.1"	"Cancer enhanced"	"Detected in many"		"Leukemia: 28.3"	"Adipose subcutaneous - Mast cells, Lung - Mast cells, Minor Salivary Gland - Minor salivary glandular cells, Testis - Spermatogonia, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003288, HPA004471, CAB068253, CAB072867, HPA073252"	Enhanced	Supported	Supported	"Plasma membrane"			NA	NA		46000000	"Cluster 32: Basophils - Transcription"	"Cluster 73: Breast - Lactation"	"Cluster 35: Non-specific - DNA binding"	"Cluster 49: HMC-1 - Innate immune response"	"Cluster 30: Granulocytes - Unknown function"	42	"Plasma membrane"		"CAB003288: AB_2335702, CAB068253: AB_2665717, CAB072867: AB_2665718, HPA004471: AB_1078431, HPA073252: AB_2686589"	"unprognostic (7.25e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.57e-1)"	"unprognostic (2.82e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.60e-1)"	"validated prognostic favorable (7.36e-5)"	"validated prognostic favorable (6.08e-5)"	"unprognostic (2.94e-1)"		"unprognostic (7.19e-3)"	"unprognostic (2.19e-3)"	"unprognostic (1.04e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.38e-1)"			"unprognostic (2.74e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.24e-2)"	"potential prognostic favorable (3.33e-4)"	"unprognostic (1.39e-2)"	"unprognostic (8.07e-2)"	"unprognostic (2.38e-3)"	"unprognostic (7.41e-2)"	"unprognostic (1.10e-2)"	"unprognostic (3.71e-1)"
KLK3	"APS, PSA"	ENSG00000142515	"Kallikrein related peptidase 3"	P07288	19	50854915-50860764	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	320	"prostate: 7740.7"	"Cell type enriched"	"Detected in some"	900	"Prostatic glandular cells: 23789.4"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	1441	"Prostate Adenocarcinoma (TCGA): 19654.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	1800	"prostate cancer: 2405.5"	"Minor Salivary Gland - Minor salivary gland ductal cells, Prostate - Prostate glandular cells, Testis - Late spermatids"									"CAB000070, HPA000764"	Enhanced				"Secreted in male reproductive system"	Enzyme	NA	NA		9000000		"Cluster 64: Neuronal - Transcription"		"Cluster 60: Prostate cancer - Unknown function"	"Cluster 40: Prostatic glandular cells - Transcription"	22			"CAB000070: , HPA000764: AB_1079700"	"unprognostic (3.82e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.69e-2)"	"unprognostic (1.18e-1)"						"unprognostic (3.01e-1)"			"unprognostic (5.88e-1)"									"unprognostic (8.51e-2)"		"unprognostic (8.70e-2)"	"unprognostic (1.53e-1)"	"potential prognostic unfavorable (4.00e-4)"			"unprognostic (2.44e-1)"	"unprognostic (2.76e-1)"	"unprognostic (5.53e-2)"
KLKB1	KLK3	ENSG00000164344	"Kallikrein B1"	P03952	4	186226438-186258471	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis, Inflammatory response"	"Hydrolase, Protease, Serine protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	28	"liver: 318.1"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 223.6"	"Cell type enhanced"	"Detected in all"		"astrocyte: 107.4"	"Cancer enriched"	"Detected in some"	14	"Liver Hepatocellular Carcinoma (TCGA): 45.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Liver - Hepatocytes"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"	"Blood coagulation"	NA	NA	28900000000	7400000000		"Cluster 31: Liver - Plasma proteins"	"Cluster 23: Choroid plexus - Mixed function"	"Cluster 12: Bone cancer - Neuronal signaling"	"Cluster 62: Hepatocytes - Metabolism"	9						"unprognostic (2.68e-2)"					"unprognostic (3.20e-1)"			"unprognostic (9.13e-2)"	"unprognostic (7.11e-3)"	"unprognostic (3.86e-2)"	"unprognostic (8.81e-3)"	"potential prognostic favorable (8.52e-5)"							"unprognostic (4.06e-3)"									
KRAS	"K-Ras4B, KRAS1, KRAS2"	ENSG00000133703	"KRAS proto-oncogene, GTPase"	P01116	12	25205246-25250936	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, RAS pathway related proteins"		Hydrolase	"Cancer-related genes, Cardiomyopathy, Deafness, Disease variant, Ectodermal dysplasia, FDA approved drug targets, Intellectual disability, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"Bile duct cancer: 225.6"		"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049830, HPA072761"	Approved		Approved	Cytosol			NA	NA			"Cluster 7: Non-specific - Innate immune response"	"Cluster 67: Lymphoid tissue & Bone marrow - Cell proliferation"	"Cluster 14: Neurons - Synaptic function"	"Cluster 57: Stomach & Colon cancer - Digestion"	"Cluster 29: Monocytes - Innate immune response"	424	Cytosol		"HPA049830: AB_2680903, HPA072761: "	"unprognostic (3.53e-2)"	"unprognostic (7.54e-3)"	"unprognostic (2.14e-1)"	"potential prognostic unfavorable (4.34e-4)"	"unprognostic (9.27e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.55e-1)"	"unprognostic (9.60e-2)"	"potential prognostic favorable (1.57e-6)"	"unprognostic (2.69e-2)"	"unprognostic (7.19e-3)"	"unprognostic (2.56e-2)"	"unprognostic (2.37e-1)"	"potential prognostic unfavorable (3.46e-4)"	"unprognostic (8.79e-2)"	"unprognostic (4.19e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.44e-2)"	"unprognostic (2.38e-3)"	"unprognostic (5.24e-3)"	"unprognostic (6.67e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.47e-2)"	"unprognostic (3.46e-1)"
KRT12	K12	ENSG00000187242	"Keratin 12"	Q99456	17	40861303-40867223	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Corneal dystrophy, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 5.4;Intestinal goblet cells: 1.5;Late spermatids: 1.8;Paneth cells: 8.5;Proximal enterocytes: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"Bone cancer: 1.0"	"Skin - Keratinocyte (other)"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA055217, HPA055835"	Enhanced						NA	NA		73000000				"Cluster 12: Bone cancer - Neuronal signaling"	"Cluster 5: Enterocytes - Absorption"				"HPA055217: AB_2682742, HPA055835: AB_2682935"															"unprognostic (1.65e-1)"																
KRT2	"KRT2A, KRTE"	ENSG00000172867	"Keratin 2"	P35908	12	52644558-52652211	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, FDA approved drug targets, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	57	"skin 1: 4511.5"	"Cell type enriched"	"Detected in some"	30	"Suprabasal keratinocytes: 130.9"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	7	"Skin Cuteneous Melanoma (TCGA): 47.0"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"naive CD4 T-cell: 1.4"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.4"	"Not detected"	"Not detected"			"Skin - Keratinocyte (other)"	"Group enriched"	"Detected in some"	6	"amygdala: 1.7;hippocampal formation: 2.7"	"Not detected"	"Not detected"			"HPA006299, CAB037321"	Enhanced		Approved	"Intermediate filaments,Cytosol"			NA	NA		6900000000	"Cluster 43: Non-specific - Transcription & Translation"	"Cluster 82: Skin - Keratinization"		"Cluster 24: Non-specific - Unknown function"	"Cluster 12: Squamous epithelial cells - Keratinization"	32	"Intermediate filaments, Cytosol"		"CAB037321: , HPA006299: AB_1079180"									"unprognostic (6.19e-2)"										"unprognostic (3.35e-1)"								"unprognostic (3.55e-1)"				
LAG3	CD223	ENSG00000089692	"Lymphocyte activating 3"	P18627	12	6772512-6778455	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 13.3;lymphoid tissue: 23.0;ovary: 18.0"	"Cell type enhanced"	"Detected in many"		"Leydig cells: 38.5;Ovarian stromal cells: 28.1;Peritubular cells: 64.9;T-cells: 53.2"	"Cell type enriched"	"Detected in single"	39	"leukocyte: 37.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	8	"choroid plexus: 8.5"	"Immune cell enhanced"	"Detected in many"		"gdT-cell: 12.6;MAIT T-cell: 10.0;memory CD8 T-cell: 11.0"	"Lineage enriched"	"Detected in single"	49	"T-cells: 12.6"	"Cancer enhanced"	"Detected in some"		"lymphoma: 8.0"	"Breast - T-cells, Minor Salivary Gland - T-cells, Pituitary gland - T-cells, Thyroid gland - T-cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002301, HPA013967"	Enhanced				"Intracellular and membrane"	Immunity	NA	NA		12000	"Cluster 1: T-cells - Unknown function"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 36: Choroid plexus - Mixed function"	"Cluster 21: Lymphoma - Adaptive immune response"	"Cluster 78: NK-cells & T-cells - Immune system & Transcription"	1			"CAB002301: AB_564101, HPA013967: AB_1846277"	"unprognostic (9.77e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.50e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.28e-3)"			"unprognostic (5.36e-3)"		"unprognostic (2.80e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.16e-3)"	"unprognostic (3.19e-1)"	"unprognostic (3.96e-3)"	"unprognostic (6.29e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.90e-3)"	"unprognostic (3.94e-1)"	"unprognostic (4.63e-2)"	"potential prognostic favorable (3.09e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.68e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.43e-1)"	"unprognostic (5.45e-3)"	"unprognostic (3.94e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.39e-1)"
LCK		ENSG00000182866	"LCK proto-oncogene, Src family tyrosine kinase"	P06239	1	32251244-32286165	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins"	"Host-virus interaction"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"lymphoid tissue: 340.6"	"Group enriched"	"Detected in many"	9	"NK-cells: 187.9;T-cells: 247.1"	"Cell type enriched"	"Detected in some"	56	"leukocyte: 205.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in all"	12	"gdT-cell: 1075.1;MAIT T-cell: 1006.3;memory CD4 T-cell: 1091.0;memory CD8 T-cell: 1162.8;naive CD4 T-cell: 1226.0;naive CD8 T-cell: 1132.2;NK-cell: 627.6;T-reg: 1617.2"	"Group enriched"	"Detected in all"	12	"NK-cells: 627.6;T-cells: 1617.2"	"Cancer enhanced"	"Detected in many"		"Leukemia: 92.1;lymphoma: 66.3"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Adrenal gland - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Liver - T-cells, Lung - T-cells, Minor Salivary Gland - T-cells, Pancreas - T-cells, Pituitary gland - T-cells, Prostate - T-cells, Skin - T-cells, Spleen - T-cells, Thyroid gland - T-cells"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"HPA003494, CAB003816"	Enhanced		Approved	"Golgi apparatus"			NA	NA			"Cluster 11: T-cells - Unknown function"	"Cluster 71: Thymus - Adaptive immune response"	"Cluster 8: Immune cells - Immune response"	"Cluster 59: Leukemia - T-cell receptor"	"Cluster 19: NK-cells - Adaptive immune response"	85	"Golgi apparatus"		"CAB003816: AB_562158, HPA003494: AB_1852751"	"potential prognostic favorable (4.17e-5)"	"unprognostic (2.56e-3)"	"unprognostic (2.13e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.87e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.49e-3)"	"unprognostic (1.15e-1)"	"potential prognostic favorable (4.77e-4)"	"unprognostic (2.74e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.52e-2)"	"unprognostic (7.50e-3)"	"unprognostic (1.19e-2)"	"unprognostic (6.58e-3)"	"unprognostic (7.97e-3)"	"unprognostic (2.33e-1)"	"unprognostic (4.02e-1)"	"unprognostic (1.46e-1)"	"unprognostic (7.94e-3)"	"unprognostic (5.23e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.28e-2)"	"potential prognostic favorable (4.21e-5)"	"unprognostic (1.46e-1)"	"unprognostic (2.15e-2)"	"unprognostic (9.15e-2)"	"unprognostic (5.02e-2)"
LDHA		ENSG00000134333	"Lactate dehydrogenase A"	P00338	11	18394560-18408425	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes, Disease variant, FDA approved drug targets, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 1895.3;Extravillous trophoblasts: 2258.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Heart muscle - Macrophages"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015336, CAB069404"	Uncertain		Supported	Cytosol			NA	NA		150000000	"Cluster 33: Non-specific - ATP binding"	"Cluster 19: Non-specific - Basic cellular processes"	"Cluster 14: Neurons - Synaptic function"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 45: Non-specific - Mixed function"	34	Cytosol		"CAB015336: AB_2134947, CAB069404: "	"unprognostic (2.96e-3)"	"unprognostic (2.59e-1)"	"unprognostic (2.42e-1)"	"potential prognostic unfavorable (9.33e-4)"	"unprognostic (2.29e-1)"	"unprognostic (2.09e-1)"	"potential prognostic unfavorable (1.84e-4)"	"unprognostic (1.04e-2)"	"unprognostic (2.21e-2)"	"potential prognostic unfavorable (8.71e-7)"	"potential prognostic favorable (1.22e-6)"	"unprognostic (2.02e-1)"	"unprognostic (1.26e-3)"	"validated prognostic unfavorable (6.75e-9)"	"validated prognostic unfavorable (4.81e-6)"	"validated prognostic unfavorable (2.07e-7)"	"validated prognostic unfavorable (7.09e-5)"	"unprognostic (6.23e-2)"	"unprognostic (2.83e-1)"	"unprognostic (7.11e-2)"	"unprognostic (4.23e-2)"	"validated prognostic unfavorable (4.52e-6)"	"validated prognostic unfavorable (7.22e-4)"	"unprognostic (1.90e-3)"	"unprognostic (4.76e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.23e-1)"
LDHB		ENSG00000111716	"Lactate dehydrogenase B"	P07195	12	21635342-21757857	"Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 1880.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 2410.3;Cytotrophoblasts: 1740.7;Distal tubular cells: 2511.0;Proximal tubular cells: 2857.5;Syncytiotrophoblasts: 1575.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Heart muscle - Cardiomyocytes, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"							"CAB004641, HPA019007"	Enhanced		Supported	Cytosol			No	No		430000000	"Cluster 39: T-cells - T-cell receptor"	"Cluster 23: Non-specific - Cellular respiration"	"Cluster 19: Astrocytes - Mixed function"	"Cluster 38: Non-specific - Transcription"	"Cluster 39: Non-specific - Basic cellular processes"	38	Cytosol		"CAB004641: AB_425525, HPA019007: AB_2670008"	"unprognostic (7.47e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.43e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.46e-3)"	"unprognostic (1.52e-3)"	"unprognostic (3.39e-3)"	"unprognostic (4.03e-2)"	"potential prognostic favorable (7.02e-5)"	"unprognostic (1.27e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.71e-2)"	"unprognostic (2.79e-1)"	"potential prognostic unfavorable (8.99e-5)"	"unprognostic (9.36e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.55e-3)"	"unprognostic (2.22e-1)"	"unprognostic (7.04e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.89e-1)"	"unprognostic (9.25e-2)"
LEPR	"CD295, OBR"	ENSG00000116678	"Leptin receptor"	P48357	1	65420652-65641559	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins"		Receptor	"Cancer-related genes, FDA approved drug targets, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 126.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 97.7;Endothelial cells: 85.6;Fibroblasts: 91.9;Hepatocytes: 137.3;Microglial cells: 123.5"	"Group enriched"	"Detected in all"	4	"choroid plexus epithelial cell: 132.0;endothelial cell: 493.1;fibroblast: 492.0"	"Cancer enriched"	"Detected in many"	5	"Liver Hepatocellular Carcinoma (TCGA): 39.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 5.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 5.0"	"Low cancer specificity"	"Detected in all"			"Prostate - Endothelial cells, Thyroid gland - Fibroblasts"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA030899	Approved	Supported	Approved	"Vesicles,Plasma membrane,Primary cilium,Basal body,Cytosol"	"Intracellular and membrane"	Receptor	NA	NA		7700000	"Cluster 33: Non-specific - ATP binding"	"Cluster 83: Liver - Metabolism"	"Cluster 36: Choroid plexus - Mixed function"	"Cluster 47: Leukemia - Hemostasis"	"Cluster 53: Fibroblasts - ECM organization"	7	Vesicles	"Plasma membrane, Primary cilium, Basal body, Cytosol"	"HPA030899: AB_10610003"	"unprognostic (4.19e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.50e-3)"	"unprognostic (1.17e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.06e-2)"	"potential prognostic favorable (5.17e-7)"	"unprognostic (3.92e-3)"	"unprognostic (1.75e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.85e-2)"	"unprognostic (4.63e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.66e-1)"		"unprognostic (7.42e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.10e-2)"	"unprognostic (4.15e-2)"
LHCGR	"HHG, LCGR, LGR2, LHR, ULG5"	ENSG00000138039	"Luteinizing hormone/choriogonadotropin receptor"	P22888	2	48686774-48755730	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"ovary: 2.1;testis: 2.1"	"Cell type enhanced"	"Detected in some"		"Leydig cells: 1.0;Microglial cells: 6.3;Oligodendrocyte precursor cells: 1.9;Proximal tubular cells: 1.1"	"Cell type enriched"	"Detected in single"	19	"fibroblast: 2.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Breast - Adipocytes (Breast)"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB009814, HPA073668"	Uncertain		Supported	"Plasma membrane,Centriolar satellite"			NA	NA				"Cluster 74: Spermatids - Flagellum assembly"	"Cluster 44: Non-specific - Mixed function"	"Cluster 72: Neuronal - Signal transduction"	"Cluster 6: Ovarian stromal cells - Transcription"	1	"Plasma membrane"	"Centriolar satellite"	"CAB009814: AB_2135467, HPA073668: "																							"unprognostic (1.45e-2)"								
LIPF	"HGL, HLAL"	ENSG00000182333	"Lipase F, gastric type"	P07098	10	88664441-88678814	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	142	"stomach 1: 36201.8"	"Cell type enriched"	"Detected in some"	316	"Gastric mucus-secreting cells: 1628.3"	"Cell type enriched"	"Detected in single"	28	"ependymal cell: 6.1"	"Cancer enriched"	"Detected in some"	59	"Stomach Adenocarcinoma (TCGA): 595.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Stomach - Chief cells"	"Region enriched"	"Detected in single"	77	"olfactory bulb: 7.6"					HPA045930	Enhanced				"Secreted to digestive system"	Enzyme	NA	NA				"Cluster 48: Stomach - Proteolysis"		"Cluster 27: Breast cancer - Unknown function"	"Cluster 46: Gastric mucus-secreting cells - Digestion"	1			"HPA045930: AB_10959518"																												"unprognostic (2.52e-1)"			
LPL	LIPD	ENSG00000175445	"Lipoprotein lipase"	P06858	8	19901717-19967259	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	"Heparin-binding, Hydrolase"	"Disease variant, FDA approved drug targets, Hyperlipidemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 904.9;heart muscle: 394.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 404.3;Breast glandular cells: 110.6;Cardiomyocytes: 655.2;Schwann cells: 154.4"	"Group enriched"	"Detected in many"	9	"cerebellar inhibitory: 150.9;medium spiny neuron: 166.6;pericyte: 236.7"	"Cancer enhanced"	"Detected in many"		"Glioblastoma Multiforme (TCGA): 62.0"	"Region enhanced"	"Detected in all"		"basal ganglia: 106.9"	"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 4.2"	"Lineage enriched"	"Detected in single"	6	"monocytes: 4.2"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 15.6"	"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Minor Salivary Gland - Adipocytes (Minor salivary gland), Skin - Adipocytes (Skin), Testis - Endothelial cells"	"Region enhanced"	"Detected in many"		"basal ganglia: 45.3"	"Group enriched"	"Detected in all"	4	"basal ganglia: 101.9;spinal cord: 74.2"	HPA048749			Approved	Vesicles	"Secreted to blood"	Enzyme	NA	NA		45000000	"Cluster 40: Monocytes - Innate immune response"	"Cluster 7: Adipose tissue - Mixed function"	"Cluster 10: Cerebellum - Nucleic acid binding"	"Cluster 12: Bone cancer - Neuronal signaling"	"Cluster 17: Breast glandular cells - Lactation"	12	Vesicles		"HPA048749: AB_2680511"	"unprognostic (1.40e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.05e-3)"	"unprognostic (9.02e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.71e-1)"	"unprognostic (9.05e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.88e-2)"	"validated prognostic favorable (2.81e-6)"	"validated prognostic favorable (5.95e-5)"	"unprognostic (2.19e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.23e-3)"	"unprognostic (7.53e-2)"	"unprognostic (6.01e-3)"	"unprognostic (1.90e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.78e-2)"	"unprognostic (8.05e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.97e-1)"	"unprognostic (4.34e-1)"	"unprognostic (4.89e-2)"	"potential prognostic unfavorable (1.21e-4)"	"unprognostic (3.55e-3)"	"unprognostic (2.43e-1)"	
LTA	"LT, TNFB, TNFSF1"	ENSG00000226979	"Lymphotoxin alpha"	P01374	6	31572054-31574324	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted secreted proteins"		Cytokine	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 1.9;lymphoid tissue: 5.5;testis: 4.1"	"Cell type enhanced"	"Detected in some"		"B-cells: 11.3;dendritic cells: 3.4;NK-cells: 3.2;T-cells: 14.5"	"Cell type enriched"	"Detected in single"	12	"leukocyte: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	9	"lymphoma: 17.1"	"Adipose visceral - T-cells, Breast - T-cells, Thyroid gland - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA007729	Uncertain				"Secreted to blood"	Cytokine	NA	NA	8150			"Cluster 70: Lymphoid tissue - Immune response"		"Cluster 50: Lymphoma - Unknown function"	"Cluster 7: T-cells - T-cell receptor"	19			"HPA007729: AB_1852906"			"unprognostic (5.13e-3)"																												
M6PR	"CD-M6PR, CD-MPR"	ENSG00000003056	"Mannose-6-phosphate receptor, cation dependent"	P20645	12	8940361-8949761	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 237.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Adrenal cortex cells, Spleen - Macrophages"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034464, HPA040445"	Approved						NA	NA		52000	"Cluster 42: Non-specific - Vesicular transport"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 21: Non-specific - Metabolism"	"Cluster 38: Non-specific - Transcription"	"Cluster 58: Macrophages - Innate immune response"	14			"CAB034464: AB_2139108, HPA040445: AB_2676989"	"unprognostic (2.47e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.16e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.52e-3)"	"unprognostic (1.00e-2)"	"unprognostic (6.31e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.17e-2)"	"potential prognostic unfavorable (3.42e-4)"	"unprognostic (1.68e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.97e-2)"	"unprognostic (2.98e-3)"	"unprognostic (3.63e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.76e-2)"	"unprognostic (7.40e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.50e-2)"
MAOA		ENSG00000189221	"Monoamine oxidase A"	P21397	X	43654907-43746817	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Catecholamine metabolism, Neurotransmitter degradation"	Oxidoreductase	"Disease variant, FDA approved drug targets, Intellectual disability"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 213.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 309.6;Proximal enterocytes: 817.1;Proximal tubular cells: 517.8"	"Cell type enhanced"	"Detected in many"		"endothelial cell: 246.7;pericyte: 107.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Neuroblastoma: 47.6;prostate cancer: 69.7"	"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Adrenal gland - Adrenal cortex cells, Breast - Adipocytes (Breast), Spleen - Fibroblast_2, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009437, HPA054807, HPA059299"	Enhanced		Supported	Mitochondria,Cytosol			No	No				"Cluster 55: Kidney & Intestine - Metabolism"	"Cluster 41: Monoamines - Neurotransmitter signalling"	"Cluster 50: Lymphoma - Unknown function"	"Cluster 22: Proximal enterocytes - Digestion"	3	Mitochondria	Cytosol	"CAB009437: AB_2137260, HPA054807: AB_2682607, HPA059299: AB_2683970"	"unprognostic (7.11e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.44e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.78e-2)"	"unprognostic (5.28e-2)"	"unprognostic (4.23e-2)"	"unprognostic (3.11e-1)"	"unprognostic (4.52e-2)"	"potential prognostic favorable (5.86e-4)"	"unprognostic (6.34e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.34e-1)"	"unprognostic (5.16e-2)"	"unprognostic (3.29e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.83e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.90e-1)"	"unprognostic (3.04e-3)"	"unprognostic (4.16e-1)"	"unprognostic (1.70e-2)"	"unprognostic (6.12e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.75e-1)"
MAOB		ENSG00000069535	"Monoamine oxidase B"	P27338	X	43766610-43882450	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 308.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 130.1;granulocytes: 213.3;Hepatocytes: 210.6;Ovarian stromal cells: 154.7;Proximal enterocytes: 179.7;Proximal tubular cells: 142.5"	"Cell type enhanced"	"Detected in all"		"ependymal cell: 315.8"	"Cancer enhanced"	"Detected in all"		"Glioblastoma Multiforme (TCGA): 147.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"liver cancer: 36.5"	"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Adrenal gland - Adrenal cortex cells, Heart muscle - Cardiomyocytes, Liver - Hepatocytes, Lung - Fibroblast_1, Prostate - Smooth muscle cells, Spleen - Smooth muscle cells, Thyroid gland - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002328, CAB037200"	Enhanced						NA	NA		51000		"Cluster 69: Liver - Oxidoreductase activity"	"Cluster 46: Brainstem - Mixed function"	"Cluster 18: Liver cancer - Metabolism"	"Cluster 6: Ovarian stromal cells - Transcription"	30			"CAB037200: AB_1841012, HPA002328: AB_1854062"	"unprognostic (8.68e-3)"	"unprognostic (1.12e-2)"	"unprognostic (2.66e-1)"	"unprognostic (9.16e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.90e-2)"	"potential prognostic unfavorable (6.66e-5)"	"unprognostic (7.49e-2)"	"unprognostic (2.04e-1)"	"potential prognostic favorable (2.86e-7)"	"unprognostic (2.61e-2)"	"potential prognostic favorable (7.79e-5)"	"unprognostic (1.53e-1)"	"unprognostic (6.40e-3)"	"unprognostic (1.41e-3)"	"unprognostic (3.06e-3)"	"unprognostic (3.57e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.70e-3)"	"potential prognostic unfavorable (3.20e-4)"	"unprognostic (3.89e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.13e-3)"	"unprognostic (3.91e-2)"	"unprognostic (2.81e-1)"	"potential prognostic favorable (4.37e-4)"
MAP1A	MAP1L	ENSG00000166963	"Microtubule associated protein 1A"	P78559	15	43510958-43531620	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 156.2"	"Cell type enhanced"	"Detected in many"		"Ciliated cells: 66.1;dendritic cells: 201.5;Horizontal cells: 182.5;Peritubular cells: 75.7"	"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"Glioblastoma Multiforme (TCGA): 29.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	61	"plasmacytoid DC: 10.5"	"Lineage enriched"	"Detected in single"	61	"dendritic cells: 10.5"	"Low cancer specificity"	"Detected in many"			"Adipose subcutaneous - Adipose progenitor cells, Breast - Fibroblasts, Lung - Fibroblast_2, Prostate - Smooth muscle cells, Skin - Fibroblast_2, Spleen - Fibroblast_1, Testis - Spermatogonia"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039063, HPA039064, HPA066488"	Enhanced		Approved	"Cytosol,Mid piece,Principal piece"			No	No		20000	"Cluster 8: Plasmacytoid DCs - Unknown function"	"Cluster 33: Brain - Neuronal signaling"	"Cluster 52: Neurons & Synapses - Synaptic function"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 53: Fibroblasts - ECM organization"	9	Cytosol	"Mid piece, Principal piece"	"HPA039063: AB_2676327, HPA039064: AB_10673302, HPA066488: AB_2685676"	"unprognostic (2.36e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.07e-2)"	"unprognostic (2.44e-2)"	"potential prognostic unfavorable (8.23e-4)"	"unprognostic (2.44e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.93e-3)"			"unprognostic (4.38e-2)"	"unprognostic (9.01e-2)"	"unprognostic (7.19e-2)"	"unprognostic (2.17e-2)"	"potential prognostic unfavorable (3.46e-4)"	"unprognostic (1.46e-1)"	"unprognostic (9.63e-3)"	"unprognostic (6.82e-2)"	"unprognostic (5.89e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.09e-2)"	"unprognostic (7.01e-2)"	"unprognostic (4.59e-2)"	"potential prognostic unfavorable (1.72e-5)"	"unprognostic (2.33e-1)"
MAP2	"MAP2A, MAP2B, MAP2C"	ENSG00000078018	"Microtubule associated protein 2"	P11137	2	209424047-209734147	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"brain: 269.8;retina: 397.0"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 863.2;Excitatory neurons: 853.5;Inhibitory neurons: 789.0;Oligodendrocyte precursor cells: 646.2;Rod photoreceptor cells: 515.2"	"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"Glioblastoma Multiforme (TCGA): 101.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Neuroblastoma: 63.9"	"Pituitary gland - Undifferentiated cells (Pituitary gland)"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001984, HPA008273, HPA012828"	Enhanced	Supported	Enhanced	"Plasma membrane,Primary cilium,Cytosol"			NA	NA			"Cluster 23: B-cells - Immunoglobulins"	"Cluster 17: Neuronal - Synaptic function"	"Cluster 14: Neurons - Synaptic function"	"Cluster 7: Liver cancer - Metabolism"	"Cluster 69: Neurons - Neuronal signaling"	10	"Plasma membrane, Cytosol"	"Primary cilium"	"CAB001984: , HPA008273: AB_1853945, HPA012828: AB_1853946"	"unprognostic (1.22e-1)"	"unprognostic (3.02e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.58e-2)"		"unprognostic (9.87e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.51e-2)"	"validated prognostic favorable (2.05e-5)"	"validated prognostic favorable (3.23e-4)"	"potential prognostic unfavorable (8.85e-4)"	"unprognostic (2.08e-2)"	"unprognostic (9.43e-2)"	"unprognostic (2.41e-2)"	"unprognostic (8.47e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.13e-1)"		"unprognostic (6.29e-2)"	"unprognostic (2.80e-2)"	"potential prognostic unfavorable (7.53e-4)"	"unprognostic (1.91e-1)"	"unprognostic (5.14e-2)"	"unprognostic (3.66e-2)"
MAP2K1	"MAPKK1, MEK1, PRKMK1"	ENSG00000169032	"Mitogen-activated protein kinase kinase 1"	Q02750	15	66386837-66491656	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Cardiomyopathy, Disease variant, Ectodermal dysplasia, FDA approved drug targets, Intellectual disability"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 182.8;Langerhans cells: 316.8;monocytes: 356.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Testis - Spermatogonia"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003834, HPA026430, CAB080093"	Approved		Supported	"Plasma membrane,Basal body,Cytosol"			NA	NA		84000	"Cluster 44: Plasmacytoid DCs - Plasma membrane proteins"	"Cluster 61: Brain - Neuronal signaling"	"Cluster 51: Neurons - Mixed function"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 29: Monocytes - Innate immune response"	69	"Plasma membrane, Cytosol"	"Basal body"	"CAB003834: AB_562310, CAB080093: , HPA026430: AB_1853742"	"unprognostic (1.16e-2)"	"unprognostic (4.36e-3)"	"unprognostic (9.52e-2)"	"unprognostic (5.73e-3)"	"unprognostic (6.40e-2)"	"unprognostic (3.65e-1)"	"unprognostic (6.05e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.96e-3)"	"unprognostic (4.30e-2)"	"potential prognostic favorable (8.43e-4)"	"unprognostic (1.38e-3)"	"unprognostic (2.21e-1)"	"unprognostic (4.82e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.10e-2)"	"potential prognostic unfavorable (1.17e-4)"	"unprognostic (2.52e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.73e-2)"	"unprognostic (5.36e-3)"	"unprognostic (3.28e-1)"	"unprognostic (3.53e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.14e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.74e-1)"
MAP2K2	"MEK2, PRKMK2"	ENSG00000126934	"Mitogen-activated protein kinase kinase 2"	P36507	19	4090321-4124122	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Cardiomyopathy, Disease variant, Ectodermal dysplasia, FDA approved drug targets, Intellectual disability"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 271.0"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 725.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Testis - Early spermatids, Testis - Late spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003835, HPA051993"	Supported		Supported	"Cytosol,Mid piece,Principal piece,End piece"			NA	NA		110000	"Cluster 45: Eosinophils - Unknown function"	"Cluster 35: Non-specific - Mitochondria"	"Cluster 52: Neurons & Synapses - Synaptic function"	"Cluster 23: Non-specific - Transcription"	"Cluster 36: Late spermatids - Unknown function"	122	Cytosol	"Mid piece, Principal piece, End piece"	"CAB003835: AB_562312, HPA051993: AB_2681685"	"unprognostic (1.46e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.70e-2)"	"potential prognostic favorable (1.87e-4)"	"unprognostic (4.76e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.85e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.64e-1)"	"unprognostic (7.34e-2)"	"potential prognostic unfavorable (5.03e-5)"	"unprognostic (2.20e-2)"	"unprognostic (5.07e-3)"	"potential prognostic unfavorable (1.42e-6)"	"unprognostic (2.50e-2)"	"unprognostic (2.98e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.18e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.17e-3)"	"unprognostic (1.01e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.15e-2)"
MAP3K1	"MAPKKK1, MEKK, MEKK1"	ENSG00000095015	"Mitogen-activated protein kinase kinase kinase 1"	Q13233	5	56815549-56896152	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 197.2"	"Cell type enhanced"	"Detected in all"		"oligodendrocyte precursor cell: 299.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Skin - Keratinocyte (other)"	"Region enriched"	"Detected in all"	6	"olfactory bulb: 18.2"	"Low region specificity"	"Detected in all"			"CAB004500, HPA046509"	Approved		Approved	Cytosol			NA	NA			"Cluster 40: Monocytes - Innate immune response"	"Cluster 40: Non-specific - Transcription"	"Cluster 42: Choroid plexus - Mitochondria"	"Cluster 6: Leukemia - Signal transduction"	"Cluster 73: B-cells - B-cell function"	45	Cytosol		"CAB004500: AB_627926, HPA046509: AB_2679678"	"unprognostic (4.13e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.94e-1)"	"unprognostic (6.21e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.73e-3)"	"unprognostic (9.47e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.11e-3)"	"unprognostic (6.12e-2)"	"validated prognostic favorable (2.68e-8)"	"validated prognostic favorable (6.14e-5)"	"unprognostic (2.05e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.47e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.93e-2)"	"unprognostic (9.05e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.05e-1)"	"unprognostic (3.91e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.58e-1)"
MAP4		ENSG00000047849	"Microtubule associated protein 4"	P27816	3	47850690-48089272	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 872.8;skeletal muscle: 717.7"	"Group enriched"	"Detected in all"	4	"Bipolar cells: 347.9;Cardiomyocytes: 1225.2;Cone photoreceptor cells: 486.0;Skeletal myocytes: 561.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Breast - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038149, HPA038150"	Enhanced		Approved	"Plasma membrane,Microtubules,Primary cilium,Basal body,Cytosol,Acrosome,Equatorial segment"			NA	NA		470000	"Cluster 44: Plasmacytoid DCs - Plasma membrane proteins"	"Cluster 54: Non-specific - Basic cellular processes"	"Cluster 19: Astrocytes - Mixed function"	"Cluster 8: Non-specific - Basic cellular processes"	"Cluster 68: Cardiomyocytes - Muscle contraction"	73	"Plasma membrane, Microtubules, Primary cilium, Cytosol"	"Basal body, Acrosome, Equatorial segment"	"HPA038149: AB_10672471, HPA038150: AB_10672505"	"unprognostic (3.70e-2)"	"unprognostic (1.77e-1)"	"unprognostic (9.34e-2)"	"unprognostic (6.10e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.42e-2)"	"unprognostic (2.75e-1)"	"unprognostic (5.11e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.76e-3)"	"unprognostic (3.31e-3)"	"unprognostic (3.68e-2)"	"potential prognostic favorable (6.40e-4)"	"potential prognostic unfavorable (1.67e-4)"	"unprognostic (1.26e-2)"	"unprognostic (8.11e-2)"	"potential prognostic unfavorable (2.11e-4)"	"unprognostic (3.61e-2)"	"unprognostic (7.13e-2)"	"unprognostic (3.87e-2)"	"unprognostic (9.64e-2)"	"unprognostic (6.07e-2)"	"unprognostic (7.45e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.26e-3)"	"unprognostic (3.22e-1)"	"unprognostic (9.14e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.90e-2)"
MAPK1	"ERK, ERK2, MAPK2, p41mapk, PRKM1, PRKM2"	ENSG00000100030	"Mitogen-activated protein kinase 1"	P28482	22	21759657-21867680	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"DNA-binding, Kinase, Repressor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"NK-cells: 204.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Adrenal cortex cells, Skin - Keratinocyte (other), Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003995, CAB004229, HPA005700, HPA030069, CAB079932, CAB079933"	Enhanced		Supported	"Nucleoplasm,Microtubules,Primary cilium,Primary cilium tip,Basal body"			NA	NA		170000	"Cluster 37: Monocytes & Neutrophils - Innate immune response"	"Cluster 61: Brain - Neuronal signaling"	"Cluster 33: Neurons - Mixed function"	"Cluster 66: Non-specific - Mitochondria"	"Cluster 19: NK-cells - Adaptive immune response"	192	Nucleoplasm	"Microtubules, Primary cilium, Primary cilium tip, Basal body"	"CAB004229: AB_627547, CAB079932: , CAB079933: , HPA003995: AB_1078751, HPA005700: AB_1078750, HPA030069: AB_10602035"	"unprognostic (6.01e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.27e-1)"	"potential prognostic favorable (1.27e-6)"	"unprognostic (4.91e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.24e-3)"	"potential prognostic unfavorable (5.21e-4)"	"unprognostic (1.52e-1)"	"unprognostic (9.62e-2)"	"unprognostic (9.27e-2)"	"unprognostic (8.98e-3)"	"unprognostic (1.70e-1)"	"unprognostic (9.52e-3)"	"unprognostic (9.83e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.40e-2)"	"unprognostic (9.44e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.33e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.30e-1)"
MAPK11	"p38-2, p38Beta, PRKM11, SAPK2"	ENSG00000185386	"Mitogen-activated protein kinase 11"	Q15759	22	50263713-50270767	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 63.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 28.2;Astrocytes: 15.8;Endothelial cells: 23.6;Excitatory neurons: 15.3;Microglial cells: 12.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Colon - Endothelial cells, Liver - Vascular Endothelial cells, Minor Salivary Gland - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012961, HPA045069, HPA073133"	Approved		Approved	Cytosol			NA	NA				"Cluster 22: Brain - Synaptic signal transduction"	"Cluster 51: Neurons - Mixed function"	"Cluster 71: Lymphoma - Inflammatory response"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	29	Cytosol		"CAB012961: AB_2533144, HPA045069: AB_2679207, HPA073133: "	"unprognostic (1.09e-2)"	"unprognostic (4.89e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.71e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.53e-2)"	"unprognostic (4.00e-3)"	"unprognostic (2.68e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.14e-2)"	"unprognostic (9.00e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.63e-1)"	"unprognostic (6.64e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.43e-3)"	"potential prognostic unfavorable (3.06e-4)"	"unprognostic (1.14e-1)"	"unprognostic (4.39e-2)"	"unprognostic (2.14e-2)"	"unprognostic (3.22e-1)"	"unprognostic (3.24e-1)"	"unprognostic (5.09e-2)"	"unprognostic (2.63e-1)"	"unprognostic (9.50e-2)"
MAPK3	"ERK1, p44erk1, p44mapk, PRKM3"	ENSG00000102882	"Mitogen-activated protein kinase 3"	P27361	16	30114105-30123506	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Cell cycle, Host-virus interaction"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 313.7;Late spermatids: 263.1;Proximal enterocytes: 227.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"eosinophil: 49.2;neutrophil: 21.6"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 49.2"	"Low cancer specificity"	"Detected in all"			"Testis - Spermatogonia"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002683, HPA003995, HPA005700, HPA030069"	Approved		Approved	"Nucleoplasm,Microtubules,Primary cilium,Primary cilium tip,Basal body"			NA	NA		26000	"Cluster 36: Eosinophils - Protein ubiquitination"	"Cluster 33: Brain - Neuronal signaling"	"Cluster 51: Neurons - Mixed function"	"Cluster 54: Non-specific - Transcription"	"Cluster 5: Enterocytes - Absorption"	109	"Nucleoplasm, Microtubules"	"Primary cilium, Primary cilium tip, Basal body"	"CAB002683: , HPA003995: AB_1078751, HPA005700: AB_1078750, HPA030069: AB_10602035"	"unprognostic (1.23e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.90e-1)"	"unprognostic (9.14e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.41e-1)"	"unprognostic (7.32e-2)"	"potential prognostic favorable (4.11e-7)"	"unprognostic (3.91e-3)"	"unprognostic (2.61e-2)"	"validated prognostic unfavorable (7.45e-5)"	"validated prognostic unfavorable (3.39e-4)"	"unprognostic (4.37e-2)"	"unprognostic (4.88e-2)"	"unprognostic (4.41e-3)"	"unprognostic (4.10e-2)"	"unprognostic (9.34e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.06e-2)"	"unprognostic (5.11e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.78e-1)"	"unprognostic (9.64e-2)"	"unprognostic (9.83e-2)"
MAPT	"DDPAC, FLJ31424, FTDP-17, MAPTL, MGC138549, MSTD, MTBT1, MTBT2, PPND, PPP1R103, tau, tau-40"	ENSG00000186868	"Microtubule associated protein tau"	P10636	17	45894527-46028334	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Alzheimer disease, Disease variant, FDA approved drug targets, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 135.5;skeletal muscle: 76.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 135.0;Bipolar cells: 278.2;Early spermatids: 130.2;Excitatory neurons: 182.9;Horizontal cells: 226.6;Inhibitory neurons: 147.3;Late spermatids: 428.0;Muller glia cells: 123.3;Oligodendrocyte precursor cells: 121.7;Oligodendrocytes: 152.5"	"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"Breast Invasive Carcinoma (TCGA): 30.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.7"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	4	"Bone cancer: 46.4;Neuroblastoma: 13.7"	"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Heart muscle - Cardiomyocytes, Kidney - Proximal tubular cells, Thyroid gland - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000151, HPA048895, HPA069524, HPA069570, CAB072344"	Enhanced		Supported	"Nuclear speckles,Plasma membrane,End piece"	"Secreted to blood"	"No annotated function"	NA	NA		53000		"Cluster 22: Brain - Synaptic signal transduction"	"Cluster 14: Neurons - Synaptic function"	"Cluster 12: Bone cancer - Neuronal signaling"	"Cluster 25: Bipolar cells - Visual perception"	218	"Plasma membrane, End piece"	"Nuclear speckles"	"CAB000151: , CAB072344: , HPA048895: AB_2680550, HPA069524: AB_2686145, HPA069570: AB_2686155"	"unprognostic (1.23e-1)"	"unprognostic (8.49e-3)"	"unprognostic (1.19e-1)"				"unprognostic (2.85e-1)"	"potential prognostic favorable (6.46e-4)"		"unprognostic (1.10e-1)"	"potential prognostic favorable (6.36e-9)"	"unprognostic (1.27e-3)"	"unprognostic (7.13e-2)"	"potential prognostic unfavorable (6.92e-5)"	"unprognostic (5.22e-2)"							"unprognostic (2.30e-2)"		"unprognostic (3.42e-2)"			"unprognostic (9.86e-2)"		"unprognostic (7.28e-2)"		
MB	PVALB	ENSG00000198125	Myoglobin	P02144	22	35606764-35637951	"Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters"	"Oxygen transport, Transport"	"Muscle protein, Oxidoreductase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	37	"heart muscle: 12732.9;skeletal muscle: 39294.3;tongue: 27932.7"	"Group enriched"	"Detected in many"	38	"Cardiomyocytes: 3199.2;Skeletal myocytes: 5324.9"	"Cell type enhanced"	"Detected in single"		"mammillary body: 1.2"	"Group enriched"	"Detected in many"	5	"Breast Invasive Carcinoma (TCGA): 53.1;Head and Neck Squamous Cell Carcinoma (TCGA): 104.6;Prostate Adenocarcinoma (TCGA): 99.0"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	6	"NK-cell: 1.3"	"Lineage enriched"	"Detected in single"	6	"NK-cells: 1.3"	"Cancer enhanced"	"Detected in many"		"breast cancer: 78.8;prostate cancer: 80.1"	"Heart muscle - Cardiomyocytes, Pituitary gland - Corticotropes, Skeletal muscle - Skeletal myocytes, Skin - Eccrine sweat gland cells"	"Low region specificity"	"Detected in many"							"CAB000060, HPA003123"	Enhanced						NA	NA		87000000	"Cluster 14: Non-specific - Unknown function"	"Cluster 14: Skeletal muscle - Muscle contraction"	"Cluster 19: Astrocytes - Mixed function"	"Cluster 27: Breast cancer - Unknown function"	"Cluster 68: Cardiomyocytes - Muscle contraction"	1			"CAB000060: , HPA003123: AB_1079442"	"unprognostic (1.60e-1)"	"unprognostic (4.64e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.31e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.06e-1)"		"unprognostic (5.21e-3)"	"potential prognostic unfavorable (5.94e-5)"			"unprognostic (1.61e-1)"	"unprognostic (2.52e-3)"	"unprognostic (8.05e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.08e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.57e-1)"	"unprognostic (3.23e-3)"	"potential prognostic unfavorable (5.43e-4)"	"unprognostic (3.64e-2)"	"unprognostic (2.33e-1)"	"unprognostic (9.98e-3)"	"unprognostic (1.06e-1)"		"unprognostic (1.77e-1)"	"potential prognostic unfavorable (5.60e-4)"	"unprognostic (1.30e-1)"
MC1R	MSH-R	ENSG00000258839	"Melanocortin 1 receptor"	Q01726	16	89912119-89920973	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 27.1;testis: 28.2"	"Cell type enhanced"	"Detected in many"		"Horizontal cells: 8.8;Melanocytes: 20.6;Spermatocytes: 10.3"	"Low cell type specificity"	"Detected in many"			"Cancer enriched"	"Detected in all"	8	"Skin Cuteneous Melanoma (TCGA): 81.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in all"		"skin cancer: 49.6"		"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"										NA	NA				"Cluster 78: Testis - Transcription"	"Cluster 10: Cerebellum - Nucleic acid binding"	"Cluster 9: Skin cancer - Melanin biosynthesis"	"Cluster 31: Spermatocytes - Spermatogenesis"	2				"unprognostic (2.83e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.26e-2)"	"unprognostic (4.66e-3)"	"unprognostic (8.15e-2)"	"unprognostic (5.34e-2)"	"unprognostic (2.90e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.13e-1)"	"validated prognostic unfavorable (3.06e-12)"	"validated prognostic unfavorable (4.39e-4)"	"unprognostic (2.34e-3)"	"unprognostic (1.87e-1)"	"unprognostic (5.16e-3)"	"potential prognostic unfavorable (1.47e-4)"	"unprognostic (9.81e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.48e-2)"	"unprognostic (7.17e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.37e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.50e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.84e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.66e-2)"	"unprognostic (8.42e-2)"
MC2R	ACTHR	ENSG00000185231	"Melanocortin 2 receptor"	Q01718	18	13882044-13915707	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	32	"adrenal gland: 56.1"	"Cell type enhanced"	"Detected in single"		"Late spermatids: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Adrenal gland - Adrenal cortex cells, Pituitary gland - Gonadotropes"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA079148	Enhanced						NA	NA				"Cluster 26: Adrenal gland - Steroid metabolism"	"Cluster 4: Non-specific - mRNA splicing & Cell cycle"	"Cluster 56: Non-specific - Sensory perception"	"Cluster 63: Late spermatids - Spermatogenesis"	4			"HPA079148: "																															
MC4R		ENSG00000166603	"Melanocortin 4 receptor"	P32245	18	60371062-60372775	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, FDA approved drug targets, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 3.4;fallopian tube: 2.9;retina: 3.8"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 7.0;Cone photoreceptor cells: 5.1"	"Cell type enhanced"	"Detected in many"		"deep-layer corticothalamic and 6b: 7.7;deep-layer near-projecting: 15.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Breast - Plasma cells, Minor Salivary Gland - Plasma cells"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 13.5"	HPA016719	Uncertain						NA	NA				"Cluster 17: Neuronal - Synaptic function"	"Cluster 56: Hypothalamus - Neuropeptide signaling"	"Cluster 2: Mucus-secreting cells - Unknown function"	"Cluster 25: Bipolar cells - Visual perception"	2			"HPA016719: AB_1853617"																															
MDH2		ENSG00000146701	"Malate dehydrogenase 2"	P40926	7	76048051-76067508	"Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Oxidoreductase	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 672.4;tongue: 578.8"	"Low cell type specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Adrenal cortex cells, Heart muscle - Cardiomyocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019714, HPA019716, HPA019848, HPA026720"	Enhanced		Enhanced	Mitochondria			No	No		10000000	"Cluster 13: Non-specific - Mitochondria"	"Cluster 12: Heart muscle - Cardiac muscle contraction"	"Cluster 14: Neurons - Synaptic function"	"Cluster 39: Non-specific - Transcription"	"Cluster 39: Non-specific - Basic cellular processes"	41	Mitochondria		"HPA019714: AB_1853678, HPA019716: AB_1853680, HPA019848: AB_1853683, HPA026720: AB_1853685"	"unprognostic (1.85e-1)"	"unprognostic (5.60e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.56e-3)"	"unprognostic (7.76e-2)"	"unprognostic (4.29e-3)"	"unprognostic (7.59e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.16e-3)"	"potential prognostic favorable (2.76e-4)"	"unprognostic (2.45e-3)"	"unprognostic (1.87e-3)"	"unprognostic (6.77e-2)"	"unprognostic (4.38e-3)"	"unprognostic (2.46e-3)"	"unprognostic (6.50e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.89e-1)"	"unprognostic (6.69e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.93e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.82e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.38e-2)"
MET	"DFNB97, HGFR, RCCP2"	ENSG00000105976	"MET proto-oncogene, receptor tyrosine kinase"	P08581	7	116672196-116798377	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins, Transporters"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Deafness, Disease variant, FDA approved drug targets, Non-syndromic deafness, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 41.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 95.5;Cytotrophoblasts: 75.8;Glandular and luminal cells: 138.4;Mesothelial cells: 72.0;Salivary duct cells: 113.4"	"Cell type enhanced"	"Detected in many"		"choroid plexus epithelial cell: 64.5;hippocampal CA1-3: 48.0;oligodendrocyte: 44.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Gastric cancer: 289.3"	"Adipose visceral - Mesothelial cells, Lung - Alveolar cells type 2, Testis - Endothelial cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB005282, HPA055607"	Approved		Approved	"Plasma membrane,Cytosol"	"Secreted to blood"	Receptor	NA	NA	179000000	72000000		"Cluster 11: Liver - Plasma proteins"	"Cluster 53: Neurons - Mixed function"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 37: Glandular & Luminal cells - Unknown function"	76	"Plasma membrane"	Cytosol	"CAB005282: AB_631940, HPA055607: AB_2682860"	"unprognostic (1.50e-1)"	"unprognostic (3.09e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.67e-2)"	"unprognostic (5.15e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.21e-3)"	"unprognostic (8.75e-2)"	"potential prognostic unfavorable (2.97e-4)"	"unprognostic (2.45e-2)"	"unprognostic (7.22e-3)"	"unprognostic (1.55e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.01e-2)"	"unprognostic (3.73e-2)"	"unprognostic (7.01e-3)"	"unprognostic (2.15e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.05e-2)"	"potential prognostic unfavorable (6.80e-6)"	"unprognostic (3.17e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.96e-2)"	"unprognostic (5.90e-3)"	"unprognostic (9.20e-2)"	"unprognostic (8.35e-2)"	"unprognostic (5.32e-2)"	"unprognostic (3.05e-2)"	"unprognostic (9.39e-2)"
MGAM	MGA	ENSG00000257335	Maltase-glucoamylase	O43451	7	141907813-142106747	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase, Multifunctional enzyme"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 24.9;intestine: 85.2"	"Group enriched"	"Detected in some"	7	"Late spermatids: 157.6;Proximal enterocytes: 502.3"	"Cell type enhanced"	"Detected in many"		"astrocyte: 29.6"	"Cancer enriched"	"Detected in some"	4	"Kidney Renal Clear Cell Carcinoma (TCGA): 7.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	7	"neutrophil: 13.5"	"Lineage enriched"	"Detected in single"	102	"granulocytes: 13.5"	"Cancer enhanced"	"Detected in some"		"breast cancer: 1.9;skin cancer: 4.3"	"Adipose visceral - Neutrophils, Heart muscle - Neutrophils, Kidney - Proximal tubular cells, Kidney - Proximal tubular cells, Liver - Neutrophils, Lung - Neutrophil_2, Skeletal muscle - Neutrophils, Spleen - Neutrophils, Thyroid gland - Neutrophils"	"Region enriched"	"Detected in single"	12	"olfactory bulb: 2.0"	"Low region specificity"	"Detected in all"			HPA002270	Enhanced						NA	NA		1500000	"Cluster 4: Neutrophils - Degranulation"	"Cluster 25: Small intestine - Absorption"	"Cluster 12: Non-specific - Vasculature"	"Cluster 69: Skin cancer - ECM organization"	"Cluster 22: Proximal enterocytes - Digestion"	5			"HPA002270: AB_1079366"			"unprognostic (1.79e-1)"			"unprognostic (2.40e-2)"		"unprognostic (3.63e-1)"		"unprognostic (3.30e-1)"	"potential prognostic favorable (2.74e-12)"	"unprognostic (1.19e-3)"	"unprognostic (8.39e-2)"										"unprognostic (1.31e-2)"			"unprognostic (1.42e-1)"					
MME	"CALLA, CD10, NEP"	ENSG00000196549	"Membrane metalloendopeptidase"	P08473	3	155024124-155183704	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Charcot-Marie-Tooth disease, Disease variant, FDA approved drug targets, Neurodegeneration, Neuropathy, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 324.3;kidney: 292.0"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 76.6;Cytotrophoblasts: 78.8;Endometrial stromal cells: 269.5;Prostatic glandular cells: 119.5;Proximal enterocytes: 322.6;Syncytiotrophoblasts: 127.2"	"Group enriched"	"Detected in many"	7	"lower rhombic lip: 200.6;medium spiny neuron: 247.5"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"basal ganglia: 37.9"	"Immune cell enriched"	"Detected in some"	123	"neutrophil: 139.9"	"Lineage enriched"	"Detected in many"	123	"granulocytes: 139.9"	"Low cancer specificity"	"Detected in many"			"Adipose visceral - Adipocytes (Visceral), Heart muscle - Fibroblasts, Kidney - Podocytes, Liver - Hepatocytes, Prostate - Prostate glandular cells"	"Region enhanced"	"Detected in many"		"basal ganglia: 28.1"	"Region enhanced"	"Detected in all"		"basal ganglia: 43.8"	"CAB000013, HPA052583, HPA056072"	Enhanced		Approved	"Plasma membrane,Centrosome,Basal body,Cytosol"			NA	NA		380000	"Cluster 35: Neutrophils - Protein binding"	"Cluster 55: Kidney & Intestine - Metabolism"	"Cluster 49: Hindbrain - Mixed function"	"Cluster 44: Connective tissue cells - ECM organization"	"Cluster 74: Neutrophils - Degranulation"	8	"Plasma membrane, Centrosome, Basal body"	Cytosol	"CAB000013: AB_563478, HPA052583: AB_2681872, HPA056072: AB_2683027"	"unprognostic (2.30e-1)"	"unprognostic (2.49e-1)"	"unprognostic (5.64e-2)"	"unprognostic (5.09e-3)"	"unprognostic (8.46e-2)"	"unprognostic (2.60e-2)"		"unprognostic (3.20e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.31e-2)"	"potential prognostic favorable (3.40e-4)"	"unprognostic (2.64e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.31e-1)"	"potential prognostic unfavorable (2.61e-4)"	"unprognostic (1.59e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.93e-2)"	"unprognostic (6.95e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.37e-3)"	"unprognostic (3.65e-2)"
MMUT	"MCM, MUT"	ENSG00000146085	"Methylmalonyl-CoA mutase"	P22033	6	49430360-49463253	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Isomerase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 193.0"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 86.1;Hepatocytes: 105.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Adipocytes (Subcutaneous), Adrenal gland - Adrenal cortex cells, Liver - Hepatocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035971, HPA035972"	Enhanced		Approved	Mitochondria,Cytosol			NA	NA		88000	"Cluster 33: Non-specific - ATP binding"	"Cluster 1: Liver & Kidney - Metabolism"	"Cluster 50: Non-specific - Nucleic acid binding"	"Cluster 28: Non-specific - Nuclear processes"	"Cluster 62: Hepatocytes - Metabolism"	9	Cytosol	Mitochondria	"HPA035971: AB_10696648, HPA035972: AB_2674895"	"unprognostic (3.13e-1)"	"unprognostic (7.55e-3)"		"unprognostic (7.74e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.94e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.43e-2)"	"unprognostic (9.34e-2)"	"validated prognostic favorable (1.90e-10)"	"validated prognostic favorable (1.39e-4)"	"potential prognostic favorable (8.48e-4)"	"unprognostic (3.08e-2)"		"unprognostic (2.49e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.22e-1)"	"unprognostic (6.01e-2)"	"potential prognostic unfavorable (4.70e-4)"	"unprognostic (6.27e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.85e-3)"	"unprognostic (9.49e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.40e-1)"
MOCS2	"MOCO1, MOCS2A, MOCS2B"	ENSG00000164172	"Molybdenum cofactor synthesis 2"	"O96007, O96033"	5	53095679-53110063	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Molybdenum cofactor biosynthesis"	Transferase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 217.0;Distal tubular cells: 507.1;Proximal tubular cells: 269.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Heart muscle - Cardiomyocytes, Liver - Hepatocytes, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037679, HPA037680"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"			NA	NA			"Cluster 11: T-cells - Unknown function"	"Cluster 23: Non-specific - Cellular respiration"	"Cluster 14: Neurons - Synaptic function"	"Cluster 22: Non-specific - mRNA splicing & Cell cycle"	"Cluster 39: Non-specific - Basic cellular processes"	2	Cytosol	"Nucleoplasm, Nuclear speckles"	"HPA037679: AB_2675604, HPA037680: AB_10673635"	"potential prognostic favorable (3.82e-4)"	"unprognostic (1.80e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.36e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.39e-2)"	"potential prognostic favorable (8.16e-14)"	"unprognostic (1.68e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.45e-2)"	"unprognostic (6.71e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.81e-1)"	"unprognostic (6.11e-2)"	"unprognostic (9.16e-2)"	"unprognostic (5.05e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.55e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.04e-1)"
MPL	"CD110, THPOR, TPOR"	ENSG00000117400	"MPL proto-oncogene, thrombopoietin receptor"	P40238	1	43337818-43354466	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"Erythroid cells: 2.2;Ovarian stromal cells: 3.1;Rod photoreceptor cells: 2.0"	"Cell type enhanced"	"Detected in some"		"ependymal cell: 3.1;upper-layer intratelencephalic: 4.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.4"	"Cancer enriched"	"Detected in single"	9	"Leukemia: 5.9"	"Testis - Early spermatids"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.5"	"Low region specificity"	"Detected in many"			HPA007619			Supported	"Nuclear membrane,Plasma membrane"			NA	NA			"Cluster 35: Neutrophils - Protein binding"	"Cluster 40: Non-specific - Transcription"	"Cluster 11: White matter - Signal transduction"	"Cluster 47: Leukemia - Hemostasis"	"Cluster 57: Platelets - Hemostasis"	3	"Plasma membrane"	"Nuclear membrane"	"HPA007619: AB_1854080"			"unprognostic (1.08e-2)"			"unprognostic (6.27e-2)"							"potential prognostic favorable (1.69e-4)"													"unprognostic (1.46e-1)"					"unprognostic (9.80e-3)"
MR1	HLALS	ENSG00000153029	"Major histocompatibility complex, class I-related"	Q95460	1	181033374-181061938	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"monocytes: 40.8"	"Cell type enhanced"	"Detected in many"		"central nervous system macrophage: 50.4;leukocyte: 48.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adipose visceral - Adipose progenitor cells, Adrenal gland - Adrenal cortex cells, Lung - Macrophages, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048304			Supported	"Plasma membrane"	"Intracellular and membrane"	Immunity	NA	NA			"Cluster 42: Non-specific - Vesicular transport"	"Cluster 16: Non-specific - Transcription"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 58: Macrophages - Innate immune response"	1	"Plasma membrane"		"HPA048304: AB_2680347"	"unprognostic (2.35e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.26e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.35e-2)"	"unprognostic (4.72e-3)"	"unprognostic (1.84e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.26e-1)"	"unprognostic (6.11e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.22e-2)"	"unprognostic (3.76e-1)"	"unprognostic (2.68e-1)"	"unprognostic (3.29e-3)"	"unprognostic (3.15e-1)"	"unprognostic (1.62e-3)"	"unprognostic (5.02e-2)"	"unprognostic (7.80e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.38e-1)"	"unprognostic (6.73e-3)"	"unprognostic (4.59e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.35e-1)"
MRC1	"bA541I19.1, CD206, CLEC13D, CLEC13DL, MRC1L1"	ENSG00000260314	"Mannose receptor C-type 1"	P22897	10	17809348-17911164	"CD markers, FDA approved drug targets, Plasma proteins, Predicted membrane proteins"	"Endocytosis, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 118.5"	"Group enriched"	"Detected in many"	4	"Breast glandular cells: 124.7;Hofbauer cells: 157.9;Kupffer cells: 348.2;Langerhans cells: 206.5;Lymphatic endothelial cells: 244.1;Macrophages: 414.9"	"Cell type enriched"	"Detected in many"	17	"central nervous system macrophage: 199.8"	"Cancer enhanced"	"Detected in many"		"Lung Adenocarcinoma (TCGA): 24.3"	"Region enhanced"	"Detected in all"		"choroid plexus: 20.4"	"Immune cell enriched"	"Detected in single"	16	"myeloid DC: 4.8"	"Lineage enriched"	"Detected in single"	16	"dendritic cells: 4.8"	"Cancer enriched"	"Detected in some"	7	"Rhabdoid: 8.4"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Colon - Macrophages, Heart muscle - Macrophages, Kidney - Macrophages, Lung - Macrophages, Minor Salivary Gland - Macrophages, Pancreas - Macrophages, Pituitary gland - Macrophages, Prostate - Macrophages, Skeletal muscle - Macrophages, Skin - Macrophages, Stomach - Macrophages, Thyroid gland - Macrophages"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004114, HPA045134, CAB068203"	Enhanced						NA	NA		140000000	"Cluster 2: Dendritic cells - Unknown function"	"Cluster 57: Lung - Lung function"	"Cluster 23: Choroid plexus - Mixed function"	"Cluster 5: Rhabdoid - Unknown function"	"Cluster 58: Macrophages - Innate immune response"	1			"CAB068203: AB_2665652, HPA004114: AB_1846270, HPA045134: AB_2679228"	"unprognostic (8.75e-2)"	"unprognostic (8.57e-2)"	"unprognostic (5.99e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.96e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.65e-2)"		"unprognostic (3.16e-1)"	"unprognostic (7.44e-2)"	"potential prognostic favorable (3.42e-4)"	"unprognostic (1.24e-1)"	"unprognostic (8.90e-2)"	"unprognostic (2.10e-2)"	"unprognostic (8.99e-2)"	"potential prognostic favorable (4.36e-4)"	"unprognostic (4.42e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.90e-1)"	"unprognostic (7.74e-3)"		"unprognostic (8.51e-2)"		"unprognostic (3.03e-1)"	"unprognostic (9.27e-3)"	"unprognostic (1.01e-1)"	"unprognostic (5.62e-3)"	"unprognostic (2.72e-2)"	"unprognostic (3.94e-2)"	"unprognostic (3.98e-2)"	
MS4A1	"B1, Bp35, CD20, FMC7"	ENSG00000156738	"Membrane spanning 4-domains A1"	P11836	11	60455846-60470752	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"B-cell activation"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 655.0"	"Cell type enriched"	"Detected in some"	55	"B-cells: 969.4"	"Cell type enriched"	"Detected in single"	99	"leukocyte: 50.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	96	"memory B-cell: 627.9;naive B-cell: 630.0"	"Lineage enriched"	"Detected in many"	96	"B-cells: 630.0"	"Cancer enriched"	"Detected in some"	6	"lymphoma: 397.8"	"Breast - T-cells, Lung - B-cells (Lung), Spleen - B-cells (Spleen), Thyroid gland - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000015, HPA014341, HPA014391"	Enhanced		Supported	"Plasma membrane"			NA	NA			"Cluster 23: B-cells - Immunoglobulins"	"Cluster 36: Lymphoid tissue - Cytokine signaling"		"Cluster 55: Lymphoma - Immune response"	"Cluster 73: B-cells - B-cell function"	34	"Plasma membrane"		"CAB000015: AB_2282030, HPA014341: AB_1846265, HPA014391: AB_1846264"	"unprognostic (1.71e-1)"	"validated prognostic favorable (3.10e-4)"	"validated prognostic favorable (2.75e-5)"	"potential prognostic favorable (4.40e-5)"	"unprognostic (1.25e-1)"	"unprognostic (9.81e-2)"			"potential prognostic favorable (9.96e-7)"		"unprognostic (6.54e-3)"	"unprognostic (9.61e-2)"			"unprognostic (1.54e-2)"	"potential prognostic favorable (1.29e-4)"	"unprognostic (3.75e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.31e-1)"		"unprognostic (6.53e-2)"	"unprognostic (8.62e-2)"	"unprognostic (3.32e-1)"	"unprognostic (3.46e-2)"	"unprognostic (4.36e-2)"	"unprognostic (3.36e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.93e-1)"	"unprognostic (6.81e-2)"	"unprognostic (6.82e-2)"	
MS4A2	"APY, FCER1B, IGER"	ENSG00000149534	"Membrane spanning 4-domains A2"	Q01362	11	60088261-60098467	"FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"IgE-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 12.2"	"Cell type enriched"	"Detected in some"	29	"granulocytes: 1187.8"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	873	"basophil: 275.8"	"Lineage enriched"	"Detected in single"	1528	"granulocytes: 275.8"	"Cancer enriched"	"Detected in single"	14	"Leukemia: 1.9"	"Adipose subcutaneous - Mast cells, Adipose visceral - Mast cells, Colon - Mast cells, Kidney - T-cells, Lung - Mast cells, Minor Salivary Gland - Mast cells, Skin - Mast cells"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in all"		"spinal cord: 20.9"	HPA059967	Enhanced						NA	NA			"Cluster 46: Basophils - Proteolysis"	"Cluster 75: Epithelium - Extracellular exosomes"	"Cluster 6: Non-specific - Immune response"	"Cluster 47: Leukemia - Hemostasis"	"Cluster 30: Granulocytes - Unknown function"	1			"HPA059967: AB_2684183"		"unprognostic (5.94e-2)"	"unprognostic (1.82e-1)"			"unprognostic (7.98e-2)"					"validated prognostic favorable (7.36e-4)"	"validated prognostic favorable (7.02e-5)"	"unprognostic (6.06e-2)"			"unprognostic (2.24e-3)"	"unprognostic (2.03e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.84e-1)"			"unprognostic (1.41e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.44e-3)"		"unprognostic (1.48e-2)"		"unprognostic (2.91e-2)"			
MST1R	"CD136, CDw136, PTK8, RON, SEA"	ENSG00000164078	"Macrophage stimulating 1 receptor"	Q04912	3	49887002-49903873	"CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 18.8;skin 1: 31.1;stomach 1: 26.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 25.7;Distal enterocytes: 32.8;Gastric mucus-secreting cells: 92.0;Intestinal goblet cells: 25.9;Proximal enterocytes: 21.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Gallbladder cancer: 49.5"	"Adipose visceral - Mesothelial cells, Minor Salivary Gland - Minor salivary gland basal cells, Prostate - Urothelial cells, Skin - Keratinocyte (other), Stomach - Gastric mucous cells, Testis - Late spermatids"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA007657, HPA008180, CAB008972"	Enhanced		Approved	Cytosol			NA	NA				"Cluster 45: Intestine - Digestion"		"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 46: Gastric mucus-secreting cells - Digestion"	12	Cytosol		"CAB008972: , HPA007657: AB_1079292, HPA008180: AB_1079291"	"unprognostic (3.03e-1)"	"unprognostic (2.38e-2)"	"unprognostic (7.02e-3)"	"unprognostic (1.29e-2)"	"unprognostic (2.41e-1)"	"unprognostic (8.94e-3)"			"unprognostic (2.46e-1)"			"unprognostic (2.14e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.12e-3)"	"unprognostic (2.30e-2)"	"unprognostic (5.05e-3)"	"potential prognostic unfavorable (3.86e-5)"	"unprognostic (3.71e-2)"	"unprognostic (1.15e-3)"	"unprognostic (3.64e-1)"	"unprognostic (5.34e-1)"	"unprognostic (2.13e-3)"	"unprognostic (2.41e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.79e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.61e-1)"	"potential prognostic favorable (6.59e-4)"	"unprognostic (2.23e-2)"
MT-ND1	"MTND1, NAD1, ND1"	ENSG00000198888	"Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1"	P03886	MT	3307-4262	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"	Translocase	"Alzheimer disease, Amyloidosis, Diabetes mellitus, Disease variant, Epilepsy, FDA approved drug targets, Leber hereditary optic neuropathy, MELAS syndrome, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 124124.2"	"Cell type enhanced"	"Detected in all"		"Bipolar cells: 21652.6;Cardiomyocytes: 30374.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 9528.1"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 9528.1"	"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033779, HPA066847"	Approved						NA	NA			"Cluster 21: Neutrophils - Unknown function"	"Cluster 23: Non-specific - Cellular respiration"	"Cluster 42: Choroid plexus - Mitochondria"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 68: Cardiomyocytes - Muscle contraction"	16			"CAB033779: AB_2149736, HPA066847: "	"unprognostic (2.68e-2)"	"unprognostic (5.32e-3)"		"unprognostic (1.23e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.60e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.95e-1)"	"potential prognostic favorable (7.45e-6)"	"unprognostic (2.80e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.06e-2)"		"unprognostic (3.20e-1)"	"unprognostic (4.50e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.69e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.75e-3)"	"unprognostic (1.08e-3)"	"unprognostic (8.12e-2)"	"unprognostic (1.77e-3)"	"unprognostic (4.31e-2)"	"unprognostic (2.19e-1)"	"unprognostic (8.74e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.60e-2)"	"unprognostic (4.55e-3)"
MTNR1A	MEL-1A-R	ENSG00000168412	"Melatonin receptor 1A"	P48039	4	186526792-186555567	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"kidney: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"Bone cancer: 1.2"	"Kidney - Proximal tubular cells, Kidney - Proximal tubular cells, Testis - Early spermatids"	"Not detected"	"Not detected"			"Not detected"	"Not detected"										NA	NA				"Cluster 52: Kidney - Transmembrane transport"	"Cluster 10: Cerebellum - Nucleic acid binding"	"Cluster 12: Bone cancer - Neuronal signaling"	"Cluster 56: Proximal tubular cells - Amino acid metabolism"	26									"unprognostic (4.79e-2)"																				"unprognostic (4.87e-2)"					
MTNR1B		ENSG00000134640	"Melatonin receptor 1B"	P49286	11	92969651-92985066	"FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"placenta: 1.0"	"Cell type enhanced"	"Detected in single"		"Granulosa cells: 1.2"	"Cell type enhanced"	"Detected in some"		"ependymal cell: 3.5;medium spiny neuron: 2.1;midbrain-derived inhibitory: 5.3"	"Cancer enhanced"	"Detected in single"		"Liver Hepatocellular Carcinoma (TCGA): 1.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Rhabdoid: 3.8;testis cancer: 1.2"	"Testis - Early spermatids"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA074024	Supported						NA	NA				"Cluster 34: Non-specific - Mixed function"	"Cluster 33: Neurons - Mixed function"	"Cluster 5: Rhabdoid - Unknown function"	"Cluster 27: Syncytiotrophoblasts - Pregnancy"	7			"HPA074024: "														"unprognostic (2.68e-2)"	"unprognostic (1.48e-1)"																
MTOR	"FLJ44809, FRAP, FRAP1, FRAP2, RAFT1, RAPT1"	ENSG00000198793	"Mechanistic target of rapamycin kinase"	P42345	1	11106535-11262556	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Epilepsy, FDA approved drug targets, Intellectual disability"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Testis - Early spermatids, Testis - Spermatocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB069425, CAB080053, CAB080065, CAB080070, CAB080081, CAB080095, CAB080096, CAB080097"	Supported		Supported	"Golgi apparatus,Cytosol"			NA	NA			"Cluster 29: Non-specific - Unknown function"	"Cluster 4: Testis - Basic cellular processes"	"Cluster 38: Sub-cortical - Mixed function"	"Cluster 37: Non-specific - mRNA processing"	"Cluster 55: Non-specific - Transcription"	146	"Golgi apparatus, Cytosol"		"CAB069425: , CAB080053: , CAB080065: , CAB080070: , CAB080081: , CAB080095: , CAB080096: , CAB080097: "	"unprognostic (6.92e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.46e-2)"	"unprognostic (9.82e-3)"	"unprognostic (5.57e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.59e-2)"	"unprognostic (4.09e-2)"	"unprognostic (9.36e-3)"	"unprognostic (4.39e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.52e-2)"	"unprognostic (7.53e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.65e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.05e-1)"	"unprognostic (3.97e-1)"	"unprognostic (8.73e-2)"	"unprognostic (3.60e-1)"
MTR	cblG	ENSG00000116984	"5-methyltetrahydrofolate-homocysteine methyltransferase"	Q99707	1	236795260-236921278	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Amino-acid biosynthesis, Methionine biosynthesis"	"Methyltransferase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 139.4;Glandular and luminal cells: 124.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Spleen - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054915	Approved		Approved	"Microtubules,Cytokinetic bridge,Primary cilium,Basal body,Cytosol"			Yes	NA			"Cluster 3: Non-specific - Nuclear processes"	"Cluster 51: Thyroid gland - Unknown function"	"Cluster 30: White matter - Myelination"	"Cluster 45: Non-specific - Nuclear processes"	"Cluster 37: Glandular & Luminal cells - Unknown function"	13	"Microtubules, Primary cilium"	"Cytokinetic bridge, Basal body, Cytosol"	"HPA054915: AB_2732589"	"unprognostic (2.30e-2)"	"unprognostic (8.50e-2)"	"unprognostic (2.63e-2)"	"unprognostic (4.15e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.29e-1)"	"potential prognostic favorable (7.87e-6)"	"unprognostic (3.29e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.20e-1)"	"unprognostic (9.10e-2)"	"unprognostic (2.78e-2)"	"unprognostic (5.82e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.90e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.80e-3)"	"unprognostic (4.82e-1)"	"unprognostic (2.08e-3)"	"unprognostic (8.46e-2)"
MTTP	"ABL, MTP"	ENSG00000138823	"Microsomal triglyceride transfer protein"	P55157	4	99564081-99623997	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Lipid transport, Transport"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"intestine: 267.5;liver: 258.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 206.9;Muller glia cells: 127.4;Proximal enterocytes: 560.1"	"Group enriched"	"Detected in many"	5	"astrocyte: 14.8;bergmann glia: 9.2;ependymal cell: 30.4"	"Cancer enriched"	"Detected in many"	9	"Liver Hepatocellular Carcinoma (TCGA): 49.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"Gastric cancer: 5.1;liver cancer: 18.2"	"Heart muscle - Cardiomyocytes, Kidney - Proximal tubular cells, Kidney - Proximal tubular cells, Testis - Early spermatids"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA051170, HPA054862"	Uncertain		Approved	"Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"	Transport	NA	NA		540000		"Cluster 37: Liver & Intestine - Lipid metabolism"	"Cluster 39: Astrocytes - Mixed function"	"Cluster 18: Liver cancer - Metabolism"	"Cluster 22: Proximal enterocytes - Digestion"	3	"Endoplasmic reticulum, Cytosol"		"HPA051170: , HPA054862: AB_2682628"					"unprognostic (2.84e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.00e-3)"	"unprognostic (3.03e-2)"			"unprognostic (1.44e-1)"	"unprognostic (2.28e-1)"		"unprognostic (3.82e-1)"	"unprognostic (5.47e-2)"		"unprognostic (2.23e-1)"					"unprognostic (1.02e-2)"	"unprognostic (2.27e-1)"		"unprognostic (5.26e-1)"	"unprognostic (4.56e-2)"		"unprognostic (4.55e-3)"	"unprognostic (2.37e-1)"		
MYH7	"CMD1S, CMH1, MPD1"	ENSG00000092054	"Myosin heavy chain 7"	P12883	14	23412740-23435660	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin"	"Cardiomyopathy, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	71	"heart muscle: 7325.3;skeletal muscle: 14038.0;tongue: 5171.5"	"Cell type enriched"	"Detected in some"	31	"Cardiomyocytes: 13369.4"	"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in some"	8	"Head and Neck Squamous Cell Carcinoma (TCGA): 18.6;Prostate Adenocarcinoma (TCGA): 21.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Heart muscle - Cardiomyocytes, Pituitary gland - Corticotropes, Skeletal muscle - Skeletal myocytes"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA001239, HPA001349, CAB015384"	Enhanced		Uncertain	"Focal adhesion sites"			NA	NA		28000000		"Cluster 12: Heart muscle - Cardiac muscle contraction"	"Cluster 56: Hypothalamus - Neuropeptide signaling"	"Cluster 33: Sarcoma - Muscle contraction"	"Cluster 68: Cardiomyocytes - Muscle contraction"	14	"Focal adhesion sites"		"CAB015384: AB_2147279, HPA001239: AB_1079438, HPA001349: AB_1079437"							"unprognostic (2.50e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.12e-2)"															"unprognostic (2.19e-1)"							
NDUFV3	CI-10k	ENSG00000160194	"NADH:ubiquinone oxidoreductase subunit V3"	P56181	21	42879644-42913304	"FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 84.9"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 883.4;Late spermatids: 1632.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Heart muscle - Cardiomyocytes, Testis - Early spermatids, Testis - Late spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019791, HPA020463, HPA030427, CAB034142"	Enhanced		Enhanced	Mitochondria			NA	NA			"Cluster 10: Non-specific - Membrane trafficking"	"Cluster 79: Non-specific - Transcription"	"Cluster 6: Non-specific - Immune response"	"Cluster 47: Leukemia - Hemostasis"	"Cluster 63: Late spermatids - Spermatogenesis"	11	Mitochondria		"CAB034142: AB_2298212, HPA019791: AB_1854357, HPA020463: AB_1854358, HPA030427: AB_10603024"	"unprognostic (4.69e-3)"	"unprognostic (3.43e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.04e-3)"	"unprognostic (3.50e-1)"	"unprognostic (4.02e-1)"	"unprognostic (8.32e-2)"	"unprognostic (3.35e-2)"	"unprognostic (8.75e-2)"	"unprognostic (4.52e-3)"	"unprognostic (1.56e-2)"	"unprognostic (3.29e-1)"	"unprognostic (3.14e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.73e-3)"	"unprognostic (9.91e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.28e-3)"	"unprognostic (2.68e-1)"	"unprognostic (4.55e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.05e-1)"	"potential prognostic favorable (6.73e-4)"	"unprognostic (1.73e-1)"	"unprognostic (3.97e-2)"
NEU1	NEU	ENSG00000204386	"Neuraminidase 1"	Q99519	6	31857659-31862905	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Lipid degradation, Lipid metabolism"	"Glycosidase, Hydrolase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 240.5"	"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"Kidney Chromophobe (TCGA): 5.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 3.0"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.0"	"Low cancer specificity"	"Detected in some"			"Prostate - Prostate glandular cells, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015634, HPA021506"	Approved		Supported	"Vesicles,Cell Junctions"			NA	NA		160000	"Cluster 20: Non-specific - DNA binding"	"Cluster 66: Non-specific - Transcription"	"Cluster 15: Non-specific - Transcription"	"Cluster 20: Myeloma - Immune response"	"Cluster 80: Non-specific - Transcription"	28	Vesicles	"Cell Junctions"	"HPA015634: AB_1854386, HPA021506: AB_1854385"			"unprognostic (6.33e-2)"			"unprognostic (6.98e-2)"		"unprognostic (1.27e-1)"		"unprognostic (4.91e-3)"	"potential prognostic favorable (4.57e-5)"	"unprognostic (1.22e-3)"	"unprognostic (2.14e-1)"		"potential prognostic unfavorable (4.89e-5)"						"unprognostic (3.09e-2)"		"unprognostic (1.93e-1)"	"unprognostic (4.64e-2)"		"unprognostic (1.25e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.75e-2)"	"unprognostic (3.61e-1)"
NFKB1	"KBF1, NF-kappaB, NF-kB1, NFkappaB, NFKB-p50, p105, p50"	ENSG00000109320	"Nuclear factor kappa B subunit 1"	P19838	4	102501330-102617302	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"granulocytes: 374.3;Langerhans cells: 784.4;monocytes: 566.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Adrenal cortex cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004031, HPA027305"	Enhanced		Supported	Nucleoplasm,Cytosol			NA	NA			"Cluster 37: Monocytes & Neutrophils - Innate immune response"	"Cluster 29: Squamous epithelium - Innate immune response"	"Cluster 6: Non-specific - Immune response"	"Cluster 59: Leukemia - T-cell receptor"	"Cluster 29: Monocytes - Innate immune response"	123	Nucleoplasm	Cytosol	"CAB004031: AB_330564, HPA027305: AB_1854429"	"unprognostic (4.37e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.82e-3)"	"unprognostic (5.42e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.74e-1)"	"unprognostic (5.06e-2)"	"unprognostic (3.08e-3)"	"validated prognostic favorable (4.25e-8)"	"validated prognostic favorable (2.69e-5)"	"unprognostic (3.00e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.70e-1)"	"potential prognostic unfavorable (5.09e-4)"	"unprognostic (4.18e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.62e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.36e-1)"	"potential prognostic favorable (3.66e-4)"	"unprognostic (9.03e-2)"	"unprognostic (4.05e-1)"	"unprognostic (2.80e-1)"	"unprognostic (5.26e-3)"	"unprognostic (1.07e-2)"	"unprognostic (4.41e-1)"
NFKB2	"LYT-10, NF-kB2, p105, p49/p100, p52"	ENSG00000077150	"Nuclear factor kappa B subunit 2"	Q00653	10	102394110-102402524	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"granulocytes: 114.7;Langerhans cells: 143.6;monocytes: 213.8"	"Cell type enhanced"	"Detected in some"		"endothelial cell: 13.5;leukocyte: 9.8;vascular associated smooth muscle cell: 10.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 2.9"	"Low lineage specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"Adrenocortical cancer: 129.7"	"Pituitary gland - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008422, CAB022098, HPA023900"	Enhanced		Enhanced	Nucleoplasm,Cytosol			NA	NA			"Cluster 20: Non-specific - DNA binding"	"Cluster 47: Spleen - Immune response"	"Cluster 12: Non-specific - Vasculature"	"Cluster 55: Lymphoma - Immune response"	"Cluster 29: Monocytes - Innate immune response"	43	"Nucleoplasm, Cytosol"		"CAB022098: , HPA008422: AB_1854434, HPA023900: AB_1854435"	"unprognostic (9.83e-2)"	"unprognostic (9.75e-3)"	"unprognostic (2.18e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.66e-2)"	"unprognostic (8.13e-2)"	"unprognostic (3.23e-3)"	"unprognostic (6.83e-2)"	"unprognostic (1.38e-1)"	"unprognostic (9.92e-3)"	"potential prognostic unfavorable (5.50e-4)"	"unprognostic (2.31e-2)"	"unprognostic (3.48e-3)"	"unprognostic (1.02e-3)"	"unprognostic (1.59e-1)"	"unprognostic (9.04e-3)"	"unprognostic (2.77e-2)"	"unprognostic (3.19e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.07e-3)"	"unprognostic (4.38e-3)"	"unprognostic (9.50e-2)"	"potential prognostic favorable (3.88e-4)"	"potential prognostic favorable (1.19e-4)"	"unprognostic (3.84e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.09e-2)"
NISCH	"I-1, IRAS, KIAA0975"	ENSG00000010322	Nischarin	Q9Y2I1	3	52455118-52493068	"FDA approved drug targets, Predicted intracellular proteins"	Apoptosis	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 280.1"	"Cell type enhanced"	"Detected in all"		"Peritubular cells: 239.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Pituitary gland - Somatotropes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023189	Approved		Approved	"Nucleoplasm,Vesicles,Microtubules,Cytokinetic bridge,Cytosol"			Yes	NA			"Cluster 30: Non-specific - DNA binding"	"Cluster 65: Cerebellum - Nervous system development"	"Cluster 10: Cerebellum - Nucleic acid binding"	"Cluster 8: Non-specific - Basic cellular processes"	"Cluster 58: Macrophages - Innate immune response"	35	"Nucleoplasm, Cytosol"	"Vesicles, Microtubules, Cytokinetic bridge"	"HPA023189: AB_1854495"	"unprognostic (4.33e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.01e-3)"	"unprognostic (2.67e-2)"	"unprognostic (4.12e-2)"	"unprognostic (8.33e-2)"	"unprognostic (5.45e-3)"	"unprognostic (1.13e-3)"	"unprognostic (2.09e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.71e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.00e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.73e-3)"	"unprognostic (3.15e-1)"	"unprognostic (7.15e-2)"	"unprognostic (9.83e-3)"	"unprognostic (7.37e-3)"	"unprognostic (9.17e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.67e-1)"	"unprognostic (5.26e-2)"
NNMT		ENSG00000166741	"Nicotinamide N-methyltransferase"	P40261	11	114257787-114313536	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 379.3"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 566.3;Hepatocytes: 4159.2;Mesothelial cells: 851.9;Skeletal myocytes: 1444.2"	"Cell type enhanced"	"Detected in many"		"CGE interneuron: 27.7;endothelial cell: 37.1"	"Cancer enhanced"	"Detected in all"		"Kidney Renal Clear Cell Carcinoma (TCGA): 89.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Adrenocortical cancer: 59.6"	"Skin - Macrophages, Testis - Endothelial cells"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA059180	Approved		Approved	"Golgi apparatus,Cytosol"			NA	NA		180000		"Cluster 83: Liver - Metabolism"	"Cluster 12: Non-specific - Vasculature"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 43: Hepatocytes - Metabolism"	1	"Golgi apparatus"	Cytosol	"HPA059180: AB_2683940"	"unprognostic (1.78e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.43e-2)"	"unprognostic (7.34e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.01e-3)"	"unprognostic (9.17e-3)"	"unprognostic (3.38e-1)"	"unprognostic (2.59e-2)"	"unprognostic (5.59e-2)"	"unprognostic (4.14e-1)"	"unprognostic (5.68e-2)"	"unprognostic (2.32e-3)"	"unprognostic (6.90e-2)"	"unprognostic (3.43e-1)"	"unprognostic (7.25e-3)"	"unprognostic (3.52e-2)"	"unprognostic (2.26e-3)"	"unprognostic (6.41e-3)"	"unprognostic (3.09e-2)"	"unprognostic (4.26e-1)"	"unprognostic (5.29e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.52e-2)"	"unprognostic (4.96e-2)"	"potential prognostic unfavorable (4.23e-4)"	"unprognostic (3.74e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.73e-1)"
NNT		ENSG00000112992	"Nicotinamide nucleotide transhydrogenase"	Q13423	5	43602692-43707405	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Translocase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 230.4;tongue: 369.3"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 466.8;Hepatocytes: 361.0"	"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"Kidney Chromophobe (TCGA): 105.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Adrenal gland - Adrenal cortex cells, Breast - Adipocytes (Breast), Heart muscle - Cardiomyocytes, Liver - Hepatocytes, Skeletal muscle - Skeletal myocytes, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004829, CAB004975, HPA066564"	Enhanced		Approved	Mitochondria			NA	NA		110000	"Cluster 33: Non-specific - ATP binding"	"Cluster 35: Non-specific - Mitochondria"	"Cluster 23: Choroid plexus - Mixed function"	"Cluster 7: Liver cancer - Metabolism"	"Cluster 43: Hepatocytes - Metabolism"	11	Mitochondria		"CAB004975: AB_425908, HPA004829: AB_1079495, HPA066564: "	"unprognostic (1.03e-1)"	"unprognostic (2.96e-1)"	"unprognostic (4.73e-1)"	"unprognostic (2.25e-1)"	"unprognostic (7.90e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.72e-2)"	"unprognostic (5.32e-2)"	"unprognostic (6.25e-2)"	"potential prognostic unfavorable (1.57e-4)"	"potential prognostic favorable (2.05e-10)"	"unprognostic (2.31e-2)"	"unprognostic (3.06e-3)"	"unprognostic (2.82e-2)"	"unprognostic (1.04e-3)"	"unprognostic (1.82e-2)"	"unprognostic (7.17e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.01e-1)"	"unprognostic (8.60e-3)"	"unprognostic (1.97e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.29e-1)"
NOD2	"BLAU, CARD15, CD, CLR16.3, IBD1, NLRC2, PSORAS1"	ENSG00000167207	"Nucleotide binding oligomerization domain containing 2"	Q9HC29	16	50693588-50733077	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins"	"Adaptive immunity, Autophagy, Immunity, Innate immunity"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 10.5;esophagus: 11.4;skin 1: 14.0;vagina: 11.9"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 9.7;Kupffer cells: 10.8;Langerhans cells: 30.2;Macrophages: 15.0;monocytes: 26.2;Suprabasal keratinocytes: 15.0"	"Cell type enriched"	"Detected in some"	4	"leukocyte: 15.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"classical monocyte: 21.7;eosinophil: 5.6;intermediate monocyte: 12.2;myeloid DC: 20.4;neutrophil: 10.0;non-classical monocyte: 8.4"	"Group enriched"	"Detected in many"	9	"dendritic cells: 20.4;granulocytes: 10.0;monocytes: 21.7"	"Cancer enhanced"	"Detected in some"		"lymphoma: 5.7"	"Adipose visceral - Macrophages, Lung - NK-cells (Lung), Skin - Keratinocyte (other)"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA041985, HPA054494"	Enhanced		Supported	"Golgi apparatus,Cytosol"			No	NA			"Cluster 26: Monocytes - Plasma membrane proteins"	"Cluster 27: Squamous epithelium - Keratinization"	"Cluster 44: Non-specific - Mixed function"	"Cluster 71: Lymphoma - Inflammatory response"	"Cluster 29: Monocytes - Innate immune response"	45	"Golgi apparatus, Cytosol"		"HPA041985: AB_2677780, HPA054494: AB_2682505"	"unprognostic (5.48e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.42e-3)"	"unprognostic (3.49e-1)"	"unprognostic (6.89e-2)"		"potential prognostic unfavorable (7.23e-4)"	"unprognostic (1.09e-3)"			"unprognostic (7.31e-3)"	"unprognostic (8.10e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.86e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.01e-2)"	"unprognostic (7.01e-3)"	"unprognostic (3.35e-3)"		"unprognostic (5.06e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.81e-3)"	"unprognostic (1.09e-3)"		"unprognostic (2.55e-1)"
NOS1	"nNOS, NOS"	ENSG00000089250	"Nitric oxide synthase 1"	P29475	12	117208142-117452170	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"		"Calmodulin-binding, Oxidoreductase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"skeletal muscle: 35.5;tongue: 55.0"	"Cell type enhanced"	"Detected in some"		"Inhibitory neurons: 30.7;Oligodendrocyte precursor cells: 45.3;Salivary duct cells: 22.1;Skeletal myocytes: 8.8"	"Cell type enhanced"	"Detected in all"		"cerebellar inhibitory: 194.9;LAMP5-LHX6 and Chandelier: 205.1;splatter: 285.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Esophageal cancer: 4.5;Sarcoma: 4.2"	"Adipose visceral - Smooth muscle cells, Colon - Colon enteroendocrine cells, Pituitary gland - Corticotropes, Testis - Spermatogonia"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002167, HPA058312, HPA069509"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"			NA	NA				"Cluster 14: Skeletal muscle - Muscle contraction"	"Cluster 24: Neurons - Mixed function"	"Cluster 33: Sarcoma - Muscle contraction"	"Cluster 65: Neurons - Synaptic function"	8	"Plasma membrane"	Nucleoplasm	"CAB002167: AB_564073, HPA058312: AB_2683676, HPA069509: "								"unprognostic (8.60e-2)"	"unprognostic (2.45e-1)"				"unprognostic (2.71e-1)"				"unprognostic (6.84e-3)"	"unprognostic (5.58e-2)"													
NOS2	"HEP-NOS, iNOS, NOS, NOS2A"	ENSG00000007171	"Nitric oxide synthase 2"	P35228	17	27756766-27800529	"Cancer-related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Calmodulin-binding, Oxidoreductase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 20.2;lymphoid tissue: 14.2"	"Cell type enhanced"	"Detected in some"		"Extravillous trophoblasts: 31.1;Granulosa cells: 6.3;Proximal enterocytes: 12.5;Undifferentiated cells: 12.7"	"Cell type enhanced"	"Detected in many"		"upper-layer intratelencephalic: 4.5"	"Group enriched"	"Detected in many"	4	"Colon Adenocarcinoma (TCGA): 21.5;Glioblastoma Multiforme (TCGA): 13.7;Lung Squamous Cell Carcinoma (TCGA): 15.9;Rectum Adenocarcinoma (TCGA): 15.6;Stomach Adenocarcinoma (TCGA): 10.9"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"colorectal cancer: 2.7;Uterine cancer: 2.6"	"Kidney - Endothelial cells, Testis - Spermatogonia"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB002014	Enhanced						NA	NA				"Cluster 25: Small intestine - Absorption"	"Cluster 53: Neurons - Mixed function"	"Cluster 1: Neuronal - Visual perception"	"Cluster 4: Extravillous trophoblasts - Unknown function"	11			"CAB002014: "	"unprognostic (1.28e-2)"		"unprognostic (2.79e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.89e-3)"		"validated prognostic favorable (2.97e-6)"	"validated prognostic favorable (3.38e-4)"						"unprognostic (8.32e-3)"	"unprognostic (2.39e-3)"						"unprognostic (8.46e-2)"	"unprognostic (1.37e-2)"		"unprognostic (9.59e-2)"			
NOS3	"ECNOS, eNOS"	ENSG00000164867	"Nitric oxide synthase 3"	P29474	7	150991017-151014588	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Calmodulin-binding, Oxidoreductase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 60.9"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 18.8;Early spermatids: 94.6;Endothelial cells: 26.3;Late spermatids: 33.8"	"Cell type enriched"	"Detected in some"	8	"endothelial cell: 82.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Lineage enriched"	"Detected in single"	4	"T-cells: 2.3"	"Low cancer specificity"	"Detected in many"			"Adrenal gland - Endothelial cells, Breast - Endothelial cells, Colon - Endothelial cells, Heart muscle - Endothelial cells, Kidney - Endothelial cells, Liver - Vascular Endothelial cells, Minor Salivary Gland - Endothelial cells, Pituitary gland - Endothelial cells, Prostate - Endothelial cells, Testis - Late spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB002168	Enhanced						NA	NA			"Cluster 31: T-cells - T-cell receptor"	"Cluster 47: Spleen - Immune response"	"Cluster 47: Endothelial cells - Vasculature"	"Cluster 48: Adipocytes & Endothelial cells - Angiogenesis"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	58			"CAB002168: AB_564072"	"unprognostic (2.72e-1)"	"unprognostic (7.54e-2)"	"unprognostic (3.21e-3)"	"unprognostic (4.80e-2)"	"unprognostic (3.78e-2)"	"unprognostic (8.85e-2)"	"unprognostic (2.07e-1)"	"unprognostic (7.01e-2)"	"unprognostic (6.27e-2)"	"unprognostic (2.01e-2)"	"potential prognostic favorable (3.84e-6)"	"unprognostic (1.29e-3)"	"potential prognostic unfavorable (2.68e-5)"	"unprognostic (9.37e-2)"	"potential prognostic favorable (3.24e-4)"	"unprognostic (3.48e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.03e-3)"	"unprognostic (7.31e-3)"	"unprognostic (8.63e-2)"	"unprognostic (2.28e-2)"	"unprognostic (4.11e-1)"
NPC1L1	SLC65A2	ENSG00000015520	"NPC1 like intracellular cholesterol transporter 1"	Q9UHC9	7	44512535-44541330	"FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"intestine: 52.7;liver: 46.9"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 33.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"Liver Hepatocellular Carcinoma (TCGA): 10.5;Pancreatic Adenocarcinoma (TCGA): 11.4;Stomach Adenocarcinoma (TCGA): 7.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Gastric cancer: 9.2;liver cancer: 7.6"	"Kidney - Proximal tubular cells, Testis - Late spermatids"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB070127, CAB070128"	Enhanced						NA	NA				"Cluster 37: Liver & Intestine - Lipid metabolism"	"Cluster 37: Neurons - Mixed function"	"Cluster 57: Stomach & Colon cancer - Digestion"	"Cluster 62: Hepatocytes - Metabolism"				"CAB070127: AB_10002744, CAB070128: AB_10000815"			"unprognostic (6.94e-2)"		"unprognostic (4.22e-2)"	"unprognostic (8.97e-2)"						"unprognostic (2.32e-3)"	"potential prognostic unfavorable (7.13e-5)"	"unprognostic (7.74e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.31e-3)"					"unprognostic (7.01e-2)"	"unprognostic (2.43e-1)"		"unprognostic (2.91e-1)"	"unprognostic (2.54e-1)"		"unprognostic (1.46e-2)"	"unprognostic (2.66e-1)"		
NPR1	"ANPa, ANPRA, GUCY2A, NPRA"	ENSG00000169418	"Natriuretic peptide receptor 1"	P16066	1	153678688-153693992	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"cGMP biosynthesis"	"Lyase, Receptor, Vasoactive"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 64.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 91.2;Alveolar cells type 2: 25.0;Endothelial cells: 49.3;Fibroblasts: 35.2;Secretory cells: 87.8"	"Group enriched"	"Detected in some"	6	"endothelial cell: 14.8;vascular associated smooth muscle cell: 4.1"	"Group enriched"	"Detected in all"	4	"Kidney Renal Clear Cell Carcinoma (TCGA): 18.0;Kidney Renal Papillary Cell Carcinoma (TCGA): 21.3;Ovary Serous Cystadenocarcinoma (TCGA): 55.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Neuroblastoma: 6.9;ovarian cancer: 7.8;Rhabdoid: 6.5"	"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Adrenal gland - Endothelial cells, Breast - Adipocytes (Breast), Liver - Vascular Endothelial cells, Minor Salivary Gland - Endothelial cells, Prostate - Endothelial cells, Testis - Endothelial cells"	"Region enriched"	"Detected in all"	5	"olfactory bulb: 18.7"	"Low region specificity"	"Detected in many"			HPA031087			Approved	"Nucleoplasm,Nucleoli,Plasma membrane"			NA	NA				"Cluster 7: Adipose tissue - Mixed function"	"Cluster 47: Endothelial cells - Vasculature"	"Cluster 44: Connective tissue cells - ECM organization"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	1	Nucleoli	"Nucleoplasm, Plasma membrane"	"HPA031087: AB_10601975"	"unprognostic (4.79e-1)"	"unprognostic (2.46e-1)"	"potential prognostic favorable (4.42e-5)"	"unprognostic (8.76e-3)"	"unprognostic (2.09e-1)"	"unprognostic (4.54e-2)"	"unprognostic (9.28e-2)"	"unprognostic (3.65e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.20e-2)"	"potential prognostic favorable (2.72e-5)"	"unprognostic (9.59e-3)"	"potential prognostic favorable (5.21e-5)"	"unprognostic (1.42e-2)"	"potential prognostic favorable (9.01e-4)"	"unprognostic (1.41e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.57e-2)"	"potential prognostic favorable (8.44e-4)"	"unprognostic (1.27e-1)"	"unprognostic (6.03e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.14e-1)"	"potential prognostic unfavorable (7.17e-4)"	"unprognostic (1.70e-1)"	"unprognostic (9.30e-2)"	"potential prognostic unfavorable (6.09e-4)"
NPR2	"AMDM, ANPb, ANPRB, GC-B, GUCY2B, NPRB"	ENSG00000159899	"Natriuretic peptide receptor 2"	P20594	9	35791003-35809732	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"cGMP biosynthesis, Osteogenesis"	"Lyase, Receptor"	"Disease variant, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 33.8;Excitatory neurons: 66.8;Inhibitory neurons: 66.0;Microglial cells: 33.1;Oligodendrocyte precursor cells: 48.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Breast - Fibroblasts, Lung - Fibroblast_1, Prostate - Fibroblasts, Skin - Fibroblast_2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"										NA	NA			"Cluster 8: Plasmacytoid DCs - Unknown function"	"Cluster 66: Non-specific - Transcription"	"Cluster 24: Neurons - Mixed function"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 65: Neurons - Synaptic function"	3				"unprognostic (5.75e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.17e-1)"	"unprognostic (7.64e-3)"	"unprognostic (3.65e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.14e-1)"	"unprognostic (2.15e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.44e-3)"	"unprognostic (6.32e-2)"	"potential prognostic favorable (2.59e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.67e-1)"	"unprognostic (8.71e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.83e-1)"	"unprognostic (6.46e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.16e-1)"
NPY	PYY4	ENSG00000122585	"Neuropeptide Y"	P01303	7	24284188-24291862	"FDA approved drug targets, Plasma proteins, Predicted secreted proteins"		Neuropeptide	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"adrenal gland: 118.5;brain: 285.3;prostate: 321.4"	"Cell type enriched"	"Detected in some"	14	"Prostatic glandular cells: 1630.9"	"Cell type enriched"	"Detected in many"	8	"splatter: 1711.7"	"Cancer enriched"	"Detected in many"	174	"Prostate Adenocarcinoma (TCGA): 3813.8"	"Region enriched"	"Detected in many"	9	"hypothalamus: 885.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	15	"Neuroblastoma: 353.3;prostate cancer: 285.9"	"Adrenal gland - Adrenal medulla cells, Prostate - Prostate glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB016733, CAB034368, HPA036636, HPA044572, HPA056798"	Supported	Supported	Supported	"Golgi apparatus"	"Secreted to blood"	Neuropeptide	NA	NA	30700000	12000		"Cluster 33: Brain - Neuronal signaling"	"Cluster 56: Hypothalamus - Neuropeptide signaling"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 40: Prostatic glandular cells - Transcription"	2	"Golgi apparatus"		"CAB016733: , CAB034368: AB_2298657, HPA036636: , HPA044572: AB_2678996, HPA056798: AB_2630371"	"unprognostic (8.24e-3)"	"unprognostic (2.76e-2)"					"unprognostic (7.53e-2)"	"unprognostic (3.81e-1)"		"unprognostic (8.69e-1)"						"unprognostic (2.63e-1)"		"unprognostic (1.87e-1)"		"unprognostic (2.83e-2)"	"unprognostic (9.01e-3)"	"unprognostic (2.41e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.53e-2)"	"unprognostic (5.79e-2)"	"unprognostic (9.59e-2)"		"unprognostic (1.73e-3)"	"unprognostic (2.86e-1)"	"unprognostic (2.56e-1)"	"unprognostic (4.21e-2)"
NR1H4	"FXR, HRR-1, HRR1, RIP14"	ENSG00000012504	"Nuclear receptor subfamily 1 group H member 4"	Q96RI1	12	100473708-100564414	"Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors, Transporters"	"Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"	"Disease variant, FDA approved drug targets, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 38.1;liver: 116.9"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 89.7;Granulosa cells: 87.5;Hepatocytes: 109.1;Oocytes: 59.6;Proximal enterocytes: 336.8;Proximal tubular cells: 149.8"	"Group enriched"	"Detected in some"	5	"ependymal cell: 24.3;vascular associated smooth muscle cell: 13.6"	"Group enriched"	"Detected in many"	10	"Kidney Renal Clear Cell Carcinoma (TCGA): 37.4;Kidney Renal Papillary Cell Carcinoma (TCGA): 37.4;Liver Hepatocellular Carcinoma (TCGA): 40.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"Gastric cancer: 3.8;Kidney cancer: 14.8;liver cancer: 12.1"	"Adrenal gland - Adrenal cortex cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA047699			Supported	"Nucleoplasm,Nuclear speckles,Primary cilium tip,Cytosol"			NA	NA				"Cluster 83: Liver - Metabolism"	"Cluster 48: Non-specific - Mixed function"	"Cluster 18: Liver cancer - Metabolism"	"Cluster 22: Proximal enterocytes - Digestion"	13	"Nucleoplasm, Nuclear speckles"	"Primary cilium tip, Cytosol"	"HPA047699: AB_10965320"	"unprognostic (3.35e-1)"				"unprognostic (7.52e-2)"	"unprognostic (4.48e-2)"				"unprognostic (2.87e-1)"	"potential prognostic favorable (7.74e-4)"	"unprognostic (1.94e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.59e-1)"	"unprognostic (7.80e-2)"							"unprognostic (7.18e-2)"	"unprognostic (2.10e-2)"			"unprognostic (3.86e-3)"		"unprognostic (3.52e-1)"	"unprognostic (1.55e-1)"		
NR1I2	"BXR, ONR1, PAR2, PXR, SXR"	ENSG00000144852	"Nuclear receptor subfamily 1 group I member 2"	O75469	3	119780484-119818487	"FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors, Transporters"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"intestine: 30.4;liver: 46.0"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 20.7;Hepatocytes: 25.9;Intestinal goblet cells: 6.6;Paneth cells: 9.6;Proximal enterocytes: 43.0;Undifferentiated cells: 7.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	26	"Colon Adenocarcinoma (TCGA): 17.7;Liver Hepatocellular Carcinoma (TCGA): 10.5;Pancreatic Adenocarcinoma (TCGA): 5.1;Rectum Adenocarcinoma (TCGA): 19.0;Stomach Adenocarcinoma (TCGA): 5.4"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	15	"NK-cell: 2.9"	"Lineage enriched"	"Detected in single"	15	"NK-cells: 2.9"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 5.3;Gastric cancer: 3.9"	"Colon - Colon enterocytes, Liver - Hepatocytes"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA029309, HPA055121, HPA073926"			Supported	Nucleoplasm			NA	NA				"Cluster 37: Liver & Intestine - Lipid metabolism"		"Cluster 57: Stomach & Colon cancer - Digestion"	"Cluster 5: Enterocytes - Absorption"	21	Nucleoplasm		"HPA029309: AB_2672990, HPA055121: AB_2682703, HPA073926: AB_2686643"			"unprognostic (1.51e-1)"		"unprognostic (3.36e-2)"	"unprognostic (1.47e-2)"								"unprognostic (6.31e-3)"	"potential prognostic favorable (4.75e-6)"							"unprognostic (3.51e-2)"	"unprognostic (7.04e-2)"		"unprognostic (2.29e-3)"	"unprognostic (1.33e-1)"		"unprognostic (2.38e-1)"			
NR3C1	"GR, GRL"	ENSG00000113580	"Nuclear receptor subfamily 3 group C member 1"	P04150	5	143277931-143435512	"Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Cell cycle, Cell division, Chromosome partition, Mitosis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Receptor, RNA-binding"	"Disease variant, FDA approved drug targets, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"dendritic cells: 942.3;Excitatory neurons: 397.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Fibroblasts, Testis - Peritubular cells, Thyroid gland - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004248, CAB010435"	Supported		Supported	Nucleoplasm,Mitochondria,Cytosol			NA	NA			"Cluster 35: Neutrophils - Protein binding"	"Cluster 19: Non-specific - Basic cellular processes"	"Cluster 31: Non-specific - Transcription"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 28: Dendritic cells - Antigen presentation"	120	"Nucleoplasm, Cytosol"	Mitochondria	"CAB010435: AB_2155784, HPA004248: AB_1078976"	"unprognostic (9.89e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.21e-1)"	"unprognostic (9.03e-2)"	"unprognostic (3.09e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.37e-1)"	"potential prognostic unfavorable (1.01e-5)"	"potential prognostic favorable (9.64e-5)"	"unprognostic (2.33e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.06e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.84e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.57e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.86e-2)"	"unprognostic (4.19e-3)"	"unprognostic (2.20e-2)"
NR3C2	"MLR, MR"	ENSG00000151623	"Nuclear receptor subfamily 3 group C member 2"	P08235	4	148078762-148444698	"Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 252.0;Excitatory neurons: 266.6;Inhibitory neurons: 258.3;Microglial cells: 168.2;Oligodendrocyte precursor cells: 216.0"	"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"Kidney Chromophobe (TCGA): 27.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 1.8"	"Lineage enriched"	"Detected in single"	6	"T-cells: 1.8"	"Low cancer specificity"	"Detected in many"			"Liver - Hepatocytes, Minor Salivary Gland - Minor salivary gland ductal cells, Spleen - Endothelial cells, Testis - Early spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009155, HPA074979"	Enhanced		Supported	Nucleoplasm			NA	NA			"Cluster 43: Non-specific - Transcription & Translation"	"Cluster 55: Kidney & Intestine - Metabolism"	"Cluster 29: Forebrain - Mixed function"	"Cluster 57: Stomach & Colon cancer - Digestion"	"Cluster 34: Neurons - Neuronal signaling"	5	Nucleoplasm		"CAB009155: AB_2155949, HPA074979: AB_2686724"	"unprognostic (6.05e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.70e-3)"	"unprognostic (3.65e-2)"	"unprognostic (5.80e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.71e-2)"		"unprognostic (8.19e-2)"	"validated prognostic favorable (3.39e-10)"	"validated prognostic favorable (6.82e-5)"	"unprognostic (2.58e-3)"	"unprognostic (8.48e-3)"	"potential prognostic favorable (1.74e-5)"	"unprognostic (9.93e-3)"	"unprognostic (5.46e-2)"	"unprognostic (3.64e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.72e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.04e-2)"		"unprognostic (1.30e-1)"		"unprognostic (8.73e-2)"	"unprognostic (6.98e-2)"
NTRK1	"MTC, TRK, TRKA"	ENSG00000198400	"Neurotrophic receptor tyrosine kinase 1"	P04629	1	156815636-156881850	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 6.8"	"Group enriched"	"Detected in some"	6	"Bipolar cells: 25.1;granulocytes: 39.3;Horizontal cells: 18.3"	"Cell type enhanced"	"Detected in many"		"fibroblast: 21.3;lower rhombic lip: 25.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in all"	5	"cerebral cortex: 23.8;medulla oblongata: 30.7;pons: 47.8"	"Immune cell enriched"	"Detected in single"	116	"basophil: 94.9"	"Lineage enriched"	"Detected in single"	772	"granulocytes: 94.9"	"Group enriched"	"Detected in some"	8	"Leukemia: 9.0;Neuroblastoma: 17.4"	"Adrenal gland - Adrenal medulla cells, Heart muscle - Fibroblasts, Kidney - Intercalated cells, Lung - Mast cells, Stomach - Fibroblasts"	"Region enhanced"	"Detected in many"		"basal ganglia: 8.4"	"Region enriched"	"Detected in single"	6	"basal ganglia: 5.4"	"CAB004606, HPA035799, HPA076570, CAB080140"	Enhanced		Approved	Vesicles,Cytosol			NA	NA		38000	"Cluster 46: Basophils - Proteolysis"	"Cluster 74: Spermatids - Flagellum assembly"	"Cluster 49: Hindbrain - Mixed function"	"Cluster 49: HMC-1 - Innate immune response"	"Cluster 30: Granulocytes - Unknown function"	144	"Vesicles, Cytosol"		"CAB004606: AB_628397, CAB080140: , HPA035799: AB_2674788, HPA076570: "			"unprognostic (2.30e-2)"																							"unprognostic (3.70e-2)"					
NTRK2	TRKB	ENSG00000148053	"Neurotrophic receptor tyrosine kinase 2"	Q16620	9	84668375-85095751	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters"	"Differentiation, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, Epilepsy, FDA approved drug targets, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 241.7;thyroid gland: 122.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 1085.3;Excitatory neurons: 725.3;Inhibitory neurons: 841.1;Oligodendrocyte precursor cells: 523.5"	"Cell type enhanced"	"Detected in all"		"astrocyte: 2595.8"	"Cancer enhanced"	"Detected in many"		"Glioblastoma Multiforme (TCGA): 135.6;Thyroid Carcinoma (TCGA): 104.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"colorectal cancer: 8.8;Esophageal cancer: 9.1"	"Breast - Breast myoepithelial cells, Liver - Hepatic stellate cells, Minor Salivary Gland - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007637, CAB010346, HPA074873"	Enhanced		Supported	"Plasma membrane"			NA	NA		11000000		"Cluster 33: Brain - Neuronal signaling"	"Cluster 40: Astrocytes - Astrocyte-neuron interactions"	"Cluster 7: Liver cancer - Metabolism"	"Cluster 8: Neurons - Neuronal signaling"	24	"Plasma membrane"		"CAB010346: AB_2155274, HPA007637: AB_1080385, HPA074873: "	"unprognostic (1.74e-1)"	"unprognostic (1.65e-3)"	"unprognostic (4.55e-2)"	"unprognostic (9.27e-2)"	"unprognostic (4.97e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.15e-2)"	"unprognostic (3.51e-2)"		"unprognostic (1.48e-3)"	"potential prognostic favorable (1.81e-4)"	"unprognostic (9.59e-2)"			"unprognostic (2.95e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.15e-1)"		"unprognostic (5.05e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.71e-1)"	"unprognostic (5.08e-3)"	"unprognostic (8.42e-3)"	"unprognostic (1.99e-2)"	"unprognostic (2.25e-2)"	"unprognostic (8.57e-2)"	"unprognostic (3.68e-2)"
NTRK3	TRKC	ENSG00000140538	"Neurotrophic receptor tyrosine kinase 3"	Q16288	15	87859751-88256791	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 227.0;Early spermatids: 123.1;Excitatory neurons: 348.4;Inhibitory neurons: 266.4;Late spermatids: 152.3;Microglial cells: 169.1;Oligodendrocyte precursor cells: 468.8"	"Cell type enhanced"	"Detected in all"		"fibroblast: 2426.8"	"Group enriched"	"Detected in many"	5	"Glioblastoma Multiforme (TCGA): 22.8;Testicular Germ Cell Tumor (TCGA): 9.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Brain cancer: 7.1;Neuroblastoma: 7.8;thyroid cancer: 5.2"	"Adipose subcutaneous - Smooth muscle cells, Adipose visceral - Smooth muscle cells, Heart muscle - Smooth muscle cells, Skeletal muscle - Smooth muscle cells, Testis - Early spermatids, Testis - Late spermatids, Thyroid gland - Smooth muscle cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009233, HPA027484, HPA048065"	Approved		Supported	"Nuclear membrane,Nucleoli,Nucleoli rim"			NA	NA		8900000		"Cluster 64: Neuronal - Transcription"	"Cluster 51: Neurons - Mixed function"	"Cluster 72: Neuronal - Signal transduction"	"Cluster 34: Neurons - Neuronal signaling"	59	"Nucleoli, Nucleoli rim"	"Nuclear membrane"	"CAB009233: AB_632555, HPA027484: AB_2672297, HPA048065: AB_2680245"		"potential prognostic favorable (6.86e-4)"	"unprognostic (3.83e-1)"				"unprognostic (1.58e-1)"	"unprognostic (7.07e-3)"			"unprognostic (1.03e-1)"	"unprognostic (2.59e-2)"	"unprognostic (4.23e-2)"						"unprognostic (1.83e-1)"	"unprognostic (2.44e-1)"				"unprognostic (2.48e-1)"		"unprognostic (1.58e-1)"			"unprognostic (3.90e-3)"	"unprognostic (1.91e-2)"	
NTSR2	NTR2	ENSG00000169006	"Neurotensin receptor 2"	O95665	2	11658178-11670195	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	50	"brain: 111.2"	"Cell type enriched"	"Detected in some"	15	"Astrocytes: 31.0"	"Cell type enriched"	"Detected in some"	25	"astrocyte: 65.2"	"Cancer enriched"	"Detected in single"	18	"Glioblastoma Multiforme (TCGA): 10.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Adipose visceral - Adipocytes (Visceral)"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"										NA	NA				"Cluster 33: Brain - Neuronal signaling"	"Cluster 19: Astrocytes - Mixed function"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 47: Astrocytes - Unknown function"											"unprognostic (4.77e-2)"	"unprognostic (3.40e-1)"																							
ODC1	ODC	ENSG00000115758	"Ornithine decarboxylase 1"	P11926	2	10439968-10448327	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Polyamine biosynthesis"	"Decarboxylase, Lyase"	"Disease variant, FDA approved drug targets, Hypotrichosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 559.0;Late spermatids: 871.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Testis - Early spermatids, Testis - Late spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001536, CAB035996, HPA075384"	Approved		Approved	"Golgi apparatus,Cytosol"			NA	NA			"Cluster 12: Non-specific - Mitochondrial translation"	"Cluster 4: Testis - Basic cellular processes"	"Cluster 21: Non-specific - Metabolism"	"Cluster 6: Leukemia - Signal transduction"	"Cluster 57: Platelets - Hemostasis"	7	"Golgi apparatus"	Cytosol	"CAB035996: , HPA001536: AB_1079521, HPA075384: "	"unprognostic (1.73e-1)"	"unprognostic (4.14e-1)"	"unprognostic (6.59e-3)"	"unprognostic (2.74e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.95e-1)"	"potential prognostic unfavorable (7.62e-4)"	"potential prognostic favorable (9.59e-5)"	"unprognostic (8.23e-3)"	"unprognostic (6.99e-2)"	"potential prognostic unfavorable (8.50e-5)"	"unprognostic (1.19e-3)"	"unprognostic (2.52e-1)"	"unprognostic (2.23e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.14e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.81e-3)"	"unprognostic (4.25e-2)"	"unprognostic (9.21e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.38e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.07e-1)"
OGDH	"E1k, KGD1, OGDC-E1, OGDH2"	ENSG00000105953	"Oxoglutarate dehydrogenase"	Q02218	7	44606572-44709066	"Citric acid cycle related proteins, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Glycolysis	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 313.4;skeletal muscle: 350.8;tongue: 360.2"	"Low cell type specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adipose visceral - Adipocytes (Visceral), Adrenal gland - Adrenal cortex cells, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019514, HPA020347"	Supported		Enhanced	Mitochondria			No	No		89000	"Cluster 33: Non-specific - ATP binding"	"Cluster 23: Non-specific - Cellular respiration"	"Cluster 44: Non-specific - Mixed function"	"Cluster 67: Non-specific - Unknown function"	"Cluster 29: Monocytes - Innate immune response"	19	Mitochondria		"HPA019514: AB_1854772, HPA020347: AB_1854773"	"unprognostic (1.89e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.89e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.21e-2)"	"unprognostic (6.14e-3)"	"unprognostic (6.85e-2)"	"unprognostic (5.28e-2)"	"potential prognostic favorable (3.38e-11)"	"unprognostic (1.66e-2)"	"potential prognostic favorable (8.90e-4)"	"unprognostic (2.07e-1)"	"unprognostic (3.01e-3)"	"unprognostic (7.95e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.45e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.98e-1)"	"unprognostic (5.95e-2)"	"unprognostic (4.41e-2)"	"unprognostic (6.41e-2)"
OPRD1		ENSG00000116329	"Opioid receptor delta 1"	P41143	1	28812170-28871267	"FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 2.8"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 11.4;Inhibitory neurons: 15.2"	"Cell type enhanced"	"Detected in many"		"MGE interneuron: 72.6"	"Cancer enhanced"	"Detected in single"		"Skin Cuteneous Melanoma (TCGA): 2.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Neuroblastoma: 7.1;skin cancer: 4.4"	"Colon - Colon enteroendocrine cells, Kidney - Proximal tubular cells, Pancreas - Beta cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA070831	Approved						NA	NA				"Cluster 33: Brain - Neuronal signaling"	"Cluster 24: Neurons - Mixed function"	"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 8: Neurons - Neuronal signaling"	13			"HPA070831: AB_2732167"			"unprognostic (3.13e-1)"			"unprognostic (1.53e-1)"		"potential prognostic favorable (2.59e-4)"																		"unprognostic (2.22e-2)"	"unprognostic (5.15e-2)"				
OPRK1	"KOR, OPRK"	ENSG00000082556	"Opioid receptor kappa 1"	P41145	8	53225724-53251637	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	Behavior	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.1;prostate: 1.6;skeletal muscle: 1.1"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 6.4;Extravillous trophoblasts: 9.2;Glandular and luminal cells: 8.6;Inhibitory neurons: 9.7;Leydig cells: 5.1;Prostatic glandular cells: 18.3"	"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in some"		"Prostate Adenocarcinoma (TCGA): 3.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Leukemia: 2.1;prostate cancer: 3.8"	"Colon - Colon enteroendocrine cells, Minor Salivary Gland - Adipocytes (Minor salivary gland), Prostate - Prostate glandular cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA067549	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"			NA	NA				"Cluster 17: Neuronal - Synaptic function"	"Cluster 24: Neurons - Mixed function"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 37: Glandular & Luminal cells - Unknown function"	6	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA067549: AB_2732770"								"unprognostic (2.87e-1)"																"unprognostic (2.15e-2)"							"unprognostic (8.42e-2)"
OPRM1	"MOP, MOR1"	ENSG00000112038	"Opioid receptor mu 1"	P35372	6	154010496-154246867	"FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.1;testis: 2.8"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 36.1;Excitatory neurons: 39.8;Inhibitory neurons: 22.4;Late spermatids: 34.8;Microglial cells: 9.8"	"Cell type enhanced"	"Detected in all"		"eccentric medium spiny neuron: 374.0"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cancer enriched"	"Detected in single"	7	"Neuroblastoma: 4.3"	"Adrenal gland - Adrenal medulla cells, Testis - Early spermatids, Testis - Late spermatids"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA014509, HPA067435"	Enhanced	Supported					NA	NA				"Cluster 78: Testis - Transcription"	"Cluster 38: Sub-cortical - Mixed function"	"Cluster 17: Neuroblastoma - Neuronal signaling"	"Cluster 34: Neurons - Neuronal signaling"	39			"HPA014509: AB_1854801, HPA067435: "						"unprognostic (5.81e-2)"																				"unprognostic (3.24e-3)"					"unprognostic (1.35e-1)"
ORM1		ENSG00000229314	"Orosomucoid 1"	P02763	9	114323098-114326479	"Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Acute phase, Transport"		"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	177	"liver: 41892.9"	"Cell type enriched"	"Detected in some"	53	"Hepatocytes: 54806.5"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	13	"Liver Hepatocellular Carcinoma (TCGA): 7670.7"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in some"	47	"neutrophil: 201.8"	"Lineage enriched"	"Detected in many"	47	"granulocytes: 201.8"	"Cancer enriched"	"Detected in many"	4	"liver cancer: 243.4"	"Liver - Hepatocytes, Lung - Neutrophil_2"									"CAB006265, HPA046438, HPA047725, HPA057726"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	"Acute phase"	NA	NA	945000000000	45000000000	"Cluster 4: Neutrophils - Degranulation"	"Cluster 31: Liver - Plasma proteins"	"Cluster 54: Immune cells - T cell receptor"	"Cluster 18: Liver cancer - Metabolism"	"Cluster 43: Hepatocytes - Metabolism"	22	Vesicles	"Golgi apparatus"	"CAB006265: AB_425575, HPA046438: AB_2679666, HPA047725: AB_2680133, HPA057726: AB_2683512"	"unprognostic (3.25e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.16e-3)"	"unprognostic (9.91e-3)"	"unprognostic (1.59e-2)"					"unprognostic (1.86e-2)"			"unprognostic (2.66e-1)"	"potential prognostic favorable (1.16e-4)"	"unprognostic (6.02e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.59e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.24e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.20e-2)"	"unprognostic (9.18e-2)"
ORM2	"AGP-B, AGP-B', AGP2"	ENSG00000228278	"Orosomucoid 2"	P19652	9	114329869-114333251	"FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Acute phase, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	297	"liver: 8652.9"	"Cell type enriched"	"Detected in some"	44	"Hepatocytes: 9678.3"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	33	"Liver Hepatocellular Carcinoma (TCGA): 2268.7"	"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in single"	39	"neutrophil: 13.2"	"Lineage enriched"	"Detected in single"	39	"granulocytes: 13.2"	"Cancer enriched"	"Detected in some"	27	"liver cancer: 95.6"	"Liver - Hepatocytes, Testis - Late spermatids"									"HPA046438, HPA047725, HPA057726"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	"Acute phase"	NA	NA	422000000	29000000000	"Cluster 4: Neutrophils - Degranulation"	"Cluster 31: Liver - Plasma proteins"	"Cluster 33: Neurons - Mixed function"	"Cluster 18: Liver cancer - Metabolism"	"Cluster 43: Hepatocytes - Metabolism"	5	Vesicles	"Golgi apparatus"	"HPA046438: AB_2679666, HPA047725: AB_2680133, HPA057726: AB_2683512"		"unprognostic (2.88e-3)"	"unprognostic (3.41e-1)"								"potential prognostic unfavorable (5.27e-6)"			"unprognostic (6.53e-2)"	"unprognostic (8.21e-3)"	"unprognostic (9.83e-2)"	"unprognostic (4.84e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.81e-1)"		"unprognostic (6.38e-3)"	"unprognostic (5.16e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.09e-1)"		"unprognostic (6.66e-1)"	"unprognostic (3.28e-1)"			"unprognostic (5.20e-1)"
OXTR	OTR	ENSG00000180914	"Oxytocin receptor"	P30559	3	8750381-8769628	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"breast: 52.4"	"Cell type enriched"	"Detected in many"	6	"Breast myoepithelial cells: 158.7"	"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in many"		"Ovary Serous Cystadenocarcinoma (TCGA): 9.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Pancreas - Ductal cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"										NA	NA				"Cluster 73: Breast - Lactation"	"Cluster 41: Monoamines - Neurotransmitter signalling"	"Cluster 72: Neuronal - Signal transduction"	"Cluster 34: Neurons - Neuronal signaling"					"unprognostic (1.70e-3)"	"unprognostic (1.51e-1)"	"unprognostic (3.33e-2)"	"unprognostic (6.41e-2)"	"unprognostic (6.02e-2)"	"unprognostic (3.87e-3)"	"unprognostic (1.46e-1)"	"unprognostic (8.40e-3)"			"unprognostic (4.98e-2)"	"unprognostic (1.79e-1)"	"unprognostic (9.55e-2)"		"unprognostic (9.41e-2)"	"unprognostic (4.93e-3)"	"unprognostic (1.18e-3)"			"unprognostic (1.71e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.83e-1)"	"unprognostic (2.80e-2)"			"unprognostic (4.27e-2)"		"unprognostic (3.79e-2)"	"unprognostic (4.84e-2)"		"unprognostic (3.32e-2)"
P2RX4	P2X4	ENSG00000135124	"Purinergic receptor P2X 4"	Q99571	12	121210065-121234106	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 135.4;Hofbauer cells: 118.5;Intestinal goblet cells: 100.8;Proximal enterocytes: 94.8;Syncytiotrophoblasts: 157.5"	"Cell type enhanced"	"Detected in all"		"central nervous system macrophage: 108.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adipose visceral - Adipose progenitor cells, Lung - Macrophages"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039494	Enhanced						NA	NA			"Cluster 42: Non-specific - Vesicular transport"	"Cluster 45: Intestine - Digestion"	"Cluster 25: Non-specific - Transcription"	"Cluster 38: Non-specific - Transcription"	"Cluster 24: Cytotrophoblasts - Mitochondria"	13			"HPA039494: AB_10969132"	"unprognostic (3.44e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.16e-1)"	"unprognostic (4.26e-1)"	"unprognostic (3.34e-2)"	"unprognostic (6.58e-2)"	"unprognostic (3.20e-2)"	"unprognostic (7.98e-2)"	"unprognostic (2.59e-2)"	"unprognostic (5.34e-2)"	"potential prognostic favorable (6.10e-5)"	"unprognostic (2.70e-2)"	"unprognostic (1.63e-2)"	"potential prognostic unfavorable (3.43e-5)"	"unprognostic (8.97e-3)"	"unprognostic (2.26e-1)"	"unprognostic (2.68e-1)"	"unprognostic (4.76e-3)"	"unprognostic (7.02e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.25e-2)"	"unprognostic (9.56e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.76e-2)"	"unprognostic (3.52e-1)"	"unprognostic (1.96e-1)"
P2RY12	"HORK3, P2Y12, SP1999"	ENSG00000169313	"Purinergic receptor P2Y12"	Q9H244	3	151336843-151384753	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters"	"Blood coagulation, Hemostasis"	"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 43.4"	"Cell type enriched"	"Detected in some"	12	"Microglial cells: 402.6"	"Cell type enriched"	"Detected in all"	108	"central nervous system macrophage: 1814.1"	"Cancer enriched"	"Detected in some"	10	"Glioblastoma Multiforme (TCGA): 23.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 8.3"	"Group enriched"	"Detected in many"	11	"dendritic cells: 3.2;monocytes: 8.3"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 3.0"	"Adrenal gland - Macrophages, Minor Salivary Gland - Macrophages, Pancreas - Macrophages, Spleen - Macrophages"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013796, HPA014518"	Enhanced						NA	NA			"Cluster 40: Monocytes - Innate immune response"	"Cluster 33: Brain - Neuronal signaling"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 65: Non-specific - Unknown function"	"Cluster 58: Macrophages - Innate immune response"				"HPA013796: AB_1854884, HPA014518: AB_2669027"		"unprognostic (1.72e-2)"	"unprognostic (8.45e-2)"				"unprognostic (2.48e-2)"	"unprognostic (5.79e-2)"			"unprognostic (2.38e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.74e-2)"			"potential prognostic favorable (1.84e-4)"	"unprognostic (2.12e-1)"		"unprognostic (1.29e-2)"				"unprognostic (1.31e-1)"								
PAH	PH	ENSG00000171759	"Phenylalanine hydroxylase"	P00439	12	102836889-102958410	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Phenylalanine catabolism"	"Allosteric enzyme, Monooxygenase, Oxidoreductase"	"Disease variant, FDA approved drug targets, Phenylketonuria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"kidney: 478.9;liver: 1365.3"	"Group enriched"	"Detected in some"	5	"Cholangiocytes: 244.2;Hepatocytes: 742.1;Proximal tubular cells: 215.7"	"Cell type enhanced"	"Detected in many"		"midbrain-derived inhibitory: 35.4"	"Cancer enriched"	"Detected in many"	13	"Liver Hepatocellular Carcinoma (TCGA): 322.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	7	"liver cancer: 43.8"	"Kidney - Proximal tubular cells, Liver - Hepatocytes, Testis - Early spermatids, Testis - Late spermatids"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA028407, HPA031642"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"			No	NA		16000		"Cluster 1: Liver & Kidney - Metabolism"	"Cluster 40: Astrocytes - Astrocyte-neuron interactions"	"Cluster 18: Liver cancer - Metabolism"	"Cluster 43: Hepatocytes - Metabolism"	1	"Endoplasmic reticulum, Vesicles"		"HPA028407: AB_10601241, HPA031642: AB_2673974"		"unprognostic (1.51e-1)"	"unprognostic (1.54e-1)"		"unprognostic (5.18e-1)"	"unprognostic (8.74e-2)"		"unprognostic (1.21e-1)"		"unprognostic (5.93e-2)"	"potential prognostic favorable (4.17e-5)"	"unprognostic (2.19e-3)"	"unprognostic (2.89e-1)"	"potential prognostic favorable (2.34e-4)"	"unprognostic (1.50e-3)"	"unprognostic (1.63e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.06e-1)"				"potential prognostic favorable (6.57e-4)"	"unprognostic (9.79e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.87e-2)"		"unprognostic (3.35e-2)"	"unprognostic (1.89e-1)"		
PARP1	"ADPRT, ARTD1, PARP, PARS, Poly-PARP, PPOL"	ENSG00000143799	"Poly(ADP-ribose) polymerase 1"	P09874	1	226360210-226408154	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, DNA damage, DNA repair, Immunity, Innate immunity, Transcription, Transcription regulation"	"Allosteric enzyme, DNA-binding, Glycosyltransferase, Nucleotidyltransferase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 346.6;Cytotrophoblasts: 496.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Adrenal cortex cells, Testis - Spermatogonia"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000147, CAB003839, CAB003840, HPA045168, CAB075726, CAB075727, CAB080368"	Supported	Supported	Supported	Nucleoplasm,Nucleoli			NA	NA		64000	"Cluster 14: Non-specific - Unknown function"	"Cluster 36: Lymphoid tissue - Cytokine signaling"	"Cluster 28: Oligodendrocytes - Mixed function"	"Cluster 6: Leukemia - Signal transduction"	"Cluster 24: Cytotrophoblasts - Mitochondria"	536	Nucleoplasm	Nucleoli	"CAB000147: AB_430876, CAB003839: AB_365493, CAB003840: AB_562187, CAB075726: AB_2665732, CAB075727: AB_2665733, CAB080368: , HPA045168: AB_2679240"	"unprognostic (2.34e-1)"	"unprognostic (3.23e-1)"	"unprognostic (3.71e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.56e-3)"	"unprognostic (5.57e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.23e-3)"	"unprognostic (6.09e-2)"	"unprognostic (1.11e-3)"	"unprognostic (4.18e-2)"	"unprognostic (7.97e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.51e-2)"	"unprognostic (4.43e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.56e-2)"	"unprognostic (4.23e-1)"
PARP2	"ADPRTL2, ARTD2"	ENSG00000129484	"Poly(ADP-ribose) polymerase 2"	Q9UGN5	14	20343615-20357904	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Allosteric enzyme, DNA-binding, Glycosyltransferase, Nucleotidyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018137, HPA052003"	Approved		Supported	Nucleoplasm,Nucleoli			NA	Yes			"Cluster 33: Non-specific - ATP binding"	"Cluster 65: Cerebellum - Nervous system development"	"Cluster 34: Non-specific - Mixed function"	"Cluster 30: Non-specific - Gene expression regulation"	"Cluster 15: Non-specific - Mixed function"	20	Nucleoplasm	Nucleoli	"HPA018137: , HPA052003: AB_2681689"	"unprognostic (9.96e-3)"	"unprognostic (1.16e-1)"	"unprognostic (5.10e-2)"	"unprognostic (6.78e-3)"	"unprognostic (3.18e-1)"	"unprognostic (2.14e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.95e-2)"	"potential prognostic unfavorable (5.68e-4)"	"unprognostic (1.17e-2)"	"unprognostic (7.87e-2)"	"unprognostic (8.50e-2)"	"validated prognostic unfavorable (1.10e-4)"	"validated prognostic unfavorable (1.51e-4)"	"unprognostic (1.00e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.61e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.31e-1)"	"unprognostic (6.35e-2)"	"unprognostic (2.83e-3)"	"unprognostic (4.44e-2)"	"unprognostic (3.94e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.47e-1)"	"unprognostic (7.45e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.76e-1)"
PARP3	"ADPRT3, ADPRTL3, ARTD3, hPARP-3, IRT1, pADPRT-3"	ENSG00000041880	"Poly(ADP-ribose) polymerase family member 3"	Q9Y6F1	3	51942345-51948867	"FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Glycosyltransferase, Nucleotidyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 33.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020984, HPA067657"	Supported		Supported	"Nucleoplasm,Nuclear bodies"			Yes	No			"Cluster 12: Non-specific - Mitochondrial translation"	"Cluster 55: Kidney & Intestine - Metabolism"	"Cluster 19: Astrocytes - Mixed function"	"Cluster 8: Non-specific - Basic cellular processes"	"Cluster 22: Proximal enterocytes - Digestion"	5	"Nucleoplasm, Nuclear bodies"		"HPA020984: , HPA067657: AB_2685881"	"potential prognostic favorable (8.19e-4)"	"unprognostic (1.18e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.85e-1)"	"potential prognostic favorable (5.91e-8)"	"unprognostic (5.75e-2)"	"unprognostic (1.39e-3)"	"unprognostic (3.45e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.54e-1)"	"unprognostic (8.89e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.61e-3)"	"unprognostic (2.30e-1)"	"unprognostic (4.30e-1)"	"unprognostic (5.67e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.85e-1)"	"unprognostic (3.21e-2)"	"unprognostic (8.41e-3)"
PCSK9	"FH3, HCHOLA3, NARC-1"	ENSG00000169174	"Proprotein convertase subtilisin/kexin type 9"	Q8NBP7	1	55039447-55064852	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Hydrolase, Protease, Serine protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 47.6"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 31.1;Hepatocytes: 28.2;Kupffer cells: 13.4"	"Group enriched"	"Detected in some"	5	"lower rhombic lip: 10.3;upper rhombic lip: 8.0"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"cerebellum: 7.1;medulla oblongata: 1.8;pons: 4.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Lung - Alveolar cells type 2, Spleen - Neutrophils"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted to blood"	Enzyme	NA	NA	143000000	320000000		"Cluster 83: Liver - Metabolism"	"Cluster 37: Neurons - Mixed function"	"Cluster 57: Stomach & Colon cancer - Digestion"	"Cluster 62: Hepatocytes - Metabolism"	36				"unprognostic (8.78e-3)"		"unprognostic (7.09e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.39e-1)"	"unprognostic (1.00e-1)"			"unprognostic (9.55e-2)"					"potential prognostic unfavorable (1.70e-4)"	"unprognostic (2.23e-1)"	"unprognostic (7.23e-3)"	"unprognostic (3.63e-2)"	"unprognostic (2.03e-1)"	"unprognostic (7.04e-3)"			"unprognostic (3.53e-3)"	"unprognostic (4.80e-2)"		"unprognostic (2.25e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.20e-1)"		"unprognostic (3.15e-1)"
PDCD1	"CD279, hSLE1, PD-1, PD1, SLEB2"	ENSG00000188389	"Programmed cell death 1"	Q15116	2	241849884-241858894	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Adaptive immunity, Apoptosis, Immunity"		"FDA approved drug targets, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 6.5;lymphoid tissue: 15.7"	"Cell type enriched"	"Detected in some"	4	"T-cells: 34.1"	"Cell type enriched"	"Detected in single"	35	"leukocyte: 25.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"midbrain: 3.1"	"Group enriched"	"Detected in many"	5	"gdT-cell: 4.4;MAIT T-cell: 4.8;memory CD4 T-cell: 8.7;memory CD8 T-cell: 12.4;T-reg: 4.3"	"Lineage enriched"	"Detected in single"	55	"T-cells: 12.4"	"Cancer enhanced"	"Detected in some"		"breast cancer: 1.2;lymphoma: 1.6"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Adrenal gland - T-cells, Colon - T-cells, Liver - T-cells, Prostate - T-cells, Skin - T-cells, Thyroid gland - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035981, CAB038418, CAB076386"	Enhanced						NA	NA			"Cluster 9: T-regs - Cell cycle regulation"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 19: Astrocytes - Mixed function"	"Cluster 70: DU4475 - Unknown function"	"Cluster 78: NK-cells & T-cells - Immune system & Transcription"	10			"CAB038418: AB_1160824, CAB076386: AB_881954, HPA035981: AB_10669664"	"unprognostic (4.27e-2)"	"unprognostic (1.50e-2)"	"unprognostic (6.30e-3)"	"unprognostic (2.35e-3)"	"unprognostic (2.57e-2)"	"unprognostic (1.79e-1)"			"potential prognostic favorable (4.39e-4)"		"unprognostic (1.92e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.88e-3)"	"unprognostic (3.45e-1)"	"unprognostic (7.17e-3)"	"unprognostic (3.98e-1)"		"unprognostic (1.65e-1)"				"unprognostic (5.85e-2)"				"unprognostic (9.20e-2)"	"unprognostic (4.57e-3)"	"unprognostic (6.28e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.13e-2)"
PDE10A		ENSG00000112541	"Phosphodiesterase 10A"	Q9Y233	6	165327287-165988117	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		"Allosteric enzyme, Hydrolase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 22.2"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 197.9;Inhibitory neurons: 200.4;Microglial cells: 85.0;Muller glia cells: 114.8"	"Cell type enhanced"	"Detected in all"		"medium spiny neuron: 3075.4"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in all"	5	"basal ganglia: 147.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Adrenocortical cancer: 21.3"	"Liver - Vascular Endothelial cells, Minor Salivary Gland - Endothelial cells, Skin - Endothelial cells, Testis - Early spermatids"	"Region enriched"	"Detected in all"	11	"basal ganglia: 350.2"	"Region enriched"	"Detected in all"	4	"basal ganglia: 242.1"	"CAB045998, HPA047200"	Supported						NA	NA				"Cluster 64: Neuronal - Transcription"	"Cluster 33: Neurons - Mixed function"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 65: Neurons - Synaptic function"	1			"CAB045998: AB_2162589, HPA047200: AB_2679981"	"unprognostic (2.02e-1)"	"unprognostic (2.63e-3)"	"unprognostic (4.53e-1)"			"unprognostic (3.92e-2)"		"potential prognostic favorable (4.14e-4)"			"unprognostic (5.39e-2)"	"unprognostic (3.47e-2)"					"unprognostic (2.59e-1)"		"unprognostic (1.28e-1)"				"unprognostic (3.95e-1)"	"unprognostic (2.32e-2)"		"unprognostic (2.65e-2)"		"unprognostic (3.57e-3)"		"unprognostic (2.21e-2)"	
PDE1B	PDES1B	ENSG00000123360	"Phosphodiesterase 1B"	Q01064	12	54549601-54579239	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 56.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 18.0;Hofbauer cells: 7.9;Horizontal cells: 11.3;Inhibitory neurons: 9.8;Kupffer cells: 10.3;Macrophages: 9.1;Ovarian stromal cells: 11.2;Smooth muscle cells: 10.6"	"Cell type enhanced"	"Detected in many"		"medium spiny neuron: 260.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"basal ganglia: 192.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"Bone cancer: 8.0;Leukemia: 8.6;lymphoma: 5.7;Myeloma: 2.6"	"Breast - Adipocytes (Breast), Pancreas - Endothelial cells"	"Region enriched"	"Detected in all"	6	"basal ganglia: 999.7"	"Region enriched"	"Detected in all"	7	"basal ganglia: 291.5"	HPA018492	Enhanced						NA	NA				"Cluster 33: Brain - Neuronal signaling"	"Cluster 33: Neurons - Mixed function"	"Cluster 12: Bone cancer - Neuronal signaling"	"Cluster 48: Smooth muscle cells - Signal transduction"	1			"HPA018492: AB_1855119"	"unprognostic (1.75e-1)"	"unprognostic (3.46e-1)"	"unprognostic (2.67e-3)"				"unprognostic (6.02e-3)"	"unprognostic (2.99e-3)"			"potential prognostic favorable (5.40e-5)"	"unprognostic (1.65e-2)"	"unprognostic (3.20e-2)"		"unprognostic (3.85e-2)"		"unprognostic (5.44e-2)"		"unprognostic (1.09e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.61e-1)"	"potential prognostic favorable (6.18e-4)"	"unprognostic (4.13e-1)"					"unprognostic (3.30e-3)"	"unprognostic (3.36e-1)"	"unprognostic (3.12e-2)"	
PDE3A	CGI-PDE	ENSG00000172572	"Phosphodiesterase 3A"	Q14432	12	20368537-20688583	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"		Hydrolase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 41.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 93.2;Bipolar cells: 79.2;Cardiomyocytes: 209.8;Horizontal cells: 95.7;Inhibitory neurons: 75.1;Smooth muscle cells: 71.7"	"Cell type enriched"	"Detected in all"	4	"vascular associated smooth muscle cell: 2523.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"cervical cancer: 7.4"	"Adipose subcutaneous - Smooth muscle cells, Breast - Endothelial cells, Kidney - Fibroblasts, Prostate - Smooth muscle cells, Skin - Endothelial cells"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 18.4"	"HPA014492, HPA074258"	Approved		Approved	"Plasma membrane"			NA	NA		20000		"Cluster 30: Heart muscle - Heart development"	"Cluster 38: Sub-cortical - Mixed function"	"Cluster 3: Rhabdoid - Membrane components"	"Cluster 69: Neurons - Neuronal signaling"	7	"Plasma membrane"		"HPA014492: AB_1855120, HPA074258: "		"unprognostic (6.53e-2)"	"unprognostic (8.36e-2)"	"unprognostic (7.11e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.18e-1)"			"unprognostic (1.03e-3)"	"potential prognostic favorable (4.05e-4)"			"unprognostic (6.80e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.42e-2)"		"unprognostic (2.96e-1)"	"unprognostic (3.96e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.90e-2)"	"unprognostic (3.03e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.64e-1)"		"unprognostic (1.03e-1)"
PDE3B	HcGIP1	ENSG00000152270	"Phosphodiesterase 3B"	Q13370	11	14643804-14872044	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins"	Angiogenesis	Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 62.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 162.9;Excitatory neurons: 135.7;Inhibitory neurons: 151.5;Microglial cells: 183.4;Oligodendrocyte precursor cells: 111.3;T-cells: 72.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"granulocytes: 3.9;T-cells: 6.3"	"Low cancer specificity"	"Detected in many"			"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Minor Salivary Gland - Minor salivary glandular cells, Testis - Early spermatids, Testis - Spermatocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056111			Approved	"Endoplasmic reticulum"			NA	NA			"Cluster 43: Non-specific - Transcription & Translation"	"Cluster 11: Liver - Plasma proteins"	"Cluster 35: Non-specific - DNA binding"	"Cluster 59: Leukemia - T-cell receptor"	"Cluster 78: NK-cells & T-cells - Immune system & Transcription"	16	"Endoplasmic reticulum"		"HPA056111: AB_2683041"	"unprognostic (2.99e-1)"	"unprognostic (6.30e-2)"	"unprognostic (9.07e-3)"	"unprognostic (3.59e-2)"	"unprognostic (1.70e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.79e-3)"	"unprognostic (1.18e-3)"	"unprognostic (7.29e-3)"	"unprognostic (1.33e-2)"	"unprognostic (2.33e-1)"	"potential prognostic unfavorable (5.12e-4)"	"unprognostic (1.27e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.91e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.51e-1)"			"potential prognostic favorable (3.65e-4)"	"unprognostic (7.50e-3)"	"unprognostic (3.02e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.18e-1)"		"unprognostic (5.05e-2)"
PDE4A	DPDE2	ENSG00000065989	"Phosphodiesterase 4A"	P27815	19	10416773-10469630	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 232.9;Late spermatids: 193.9;monocytes: 204.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Skin - Fibroblast_2, Testis - Late spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017632, HPA043310, HPA076091"	Uncertain		Supported	"Nucleoplasm,Plasma membrane"			NA	NA			"Cluster 25: Non-specific - Unknown function"	"Cluster 79: Non-specific - Transcription"	"Cluster 52: Neurons & Synapses - Synaptic function"	"Cluster 47: Leukemia - Hemostasis"	"Cluster 29: Monocytes - Innate immune response"		"Plasma membrane"	Nucleoplasm	"CAB017632: AB_1127109, HPA043310: AB_2678419, HPA076091: AB_2686775"	"unprognostic (6.10e-3)"	"unprognostic (1.21e-3)"	"unprognostic (5.89e-2)"	"unprognostic (1.37e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.88e-2)"	"unprognostic (5.99e-2)"	"unprognostic (5.61e-2)"	"unprognostic (5.69e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.96e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.93e-2)"	"unprognostic (3.51e-2)"	"unprognostic (8.93e-2)"	"potential prognostic unfavorable (8.66e-4)"	"unprognostic (3.94e-2)"	"unprognostic (8.68e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.12e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.35e-2)"	"unprognostic (7.77e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.38e-1)"
PDE4B	DPDE4	ENSG00000184588	"Phosphodiesterase 4B"	Q07343	1	65792514-66374579	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 74.6"	"Group enriched"	"Detected in many"	5	"Oligodendrocyte precursor cells: 1616.4;Oligodendrocytes: 3759.6"	"Cell type enhanced"	"Detected in all"		"oligodendrocyte: 5976.5"	"Cancer enhanced"	"Detected in all"		"Glioblastoma Multiforme (TCGA): 64.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 89.5"	"Group enriched"	"Detected in all"	5	"B-cells: 37.6;granulocytes: 89.5;T-cells: 34.8"	"Cancer enhanced"	"Detected in many"		"Rhabdoid: 47.5"	"Colon - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003005	Uncertain		Supported	"Golgi apparatus,Primary cilium,Cytosol"			NA	NA			"Cluster 43: Non-specific - Transcription & Translation"	"Cluster 5: Brain & Testis - Signal transduction"	"Cluster 28: Oligodendrocytes - Mixed function"	"Cluster 65: Non-specific - Unknown function"	"Cluster 51: Oligodendrocytes - Unknown function"	8	"Golgi apparatus, Cytosol"	"Primary cilium"	"HPA003005: AB_1079587"	"unprognostic (2.02e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.87e-2)"	"unprognostic (7.90e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.85e-3)"	"unprognostic (5.31e-2)"	"unprognostic (5.20e-2)"	"unprognostic (6.07e-3)"	"unprognostic (3.94e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.94e-1)"	"potential prognostic favorable (5.48e-4)"	"unprognostic (5.17e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.70e-3)"	"unprognostic (5.40e-1)"	"unprognostic (6.51e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.98e-2)"	"unprognostic (5.31e-1)"	"unprognostic (8.69e-2)"	"unprognostic (1.81e-2)"	"unprognostic (7.48e-3)"	"unprognostic (2.47e-1)"	"unprognostic (6.15e-3)"	"unprognostic (3.10e-1)"
PDE4C	DPDE1	ENSG00000105650	"Phosphodiesterase 4C"	Q08493	19	18207965-18248200	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 23.7"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 1.9;Excitatory neurons: 8.0;Gastric mucus-secreting cells: 2.9;Inhibitory neurons: 2.0;Smooth muscle cells: 1.7"	"Group enriched"	"Detected in many"	5	"pericyte: 107.6;vascular associated smooth muscle cell: 88.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Rhabdoid: 2.4"		"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA048975, HPA054218"	Approved		Approved	"Midbody ring,Centrosome,Basal body,Cytosol"			Yes	NA				"Cluster 14: Skeletal muscle - Muscle contraction"	"Cluster 51: Neurons - Mixed function"	"Cluster 1: Neuronal - Visual perception"	"Cluster 34: Neurons - Neuronal signaling"		"Centrosome, Cytosol"	"Midbody ring, Basal body"	"HPA048975: AB_2680581, HPA054218: "			"unprognostic (7.28e-2)"	"unprognostic (7.85e-2)"				"unprognostic (2.52e-1)"			"unprognostic (6.93e-3)"	"unprognostic (5.55e-2)"			"unprognostic (1.21e-3)"		"unprognostic (5.57e-2)"				"unprognostic (2.42e-2)"		"unprognostic (7.16e-2)"			"unprognostic (1.57e-1)"			"unprognostic (1.36e-1)"		"unprognostic (4.83e-2)"
PDE4D	DPDE3	ENSG00000113448	"Phosphodiesterase 4D"	Q08499	5	58969038-60522120	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 74.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 587.4;Excitatory neurons: 2871.5;Inhibitory neurons: 1067.5;Oligodendrocyte precursor cells: 795.7;Oligodendrocytes: 412.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"eosinophil: 58.2"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 58.2"	"Low cancer specificity"	"Detected in all"			"Testis - Spermatogonia"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045895	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Plasma membrane,Primary cilium,Cytosol"			NA	NA			"Cluster 22: Eosinophils - Transcription"	"Cluster 56: Non-specific - Unknown function"	"Cluster 40: Astrocytes - Astrocyte-neuron interactions"	"Cluster 7: Liver cancer - Metabolism"	"Cluster 34: Neurons - Neuronal signaling"	18	"Plasma membrane, Cytosol"	"Nucleoplasm, Nuclear membrane, Primary cilium"	"HPA045895: AB_10960275"	"unprognostic (2.73e-2)"	"unprognostic (1.77e-1)"	"unprognostic (7.47e-2)"	"potential prognostic unfavorable (4.94e-4)"	"unprognostic (2.29e-2)"	"unprognostic (5.48e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.15e-2)"	"potential prognostic unfavorable (4.19e-4)"	"potential prognostic favorable (2.53e-8)"	"unprognostic (2.01e-2)"	"unprognostic (6.58e-2)"	"unprognostic (2.29e-3)"	"unprognostic (9.25e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.87e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.81e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.08e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.21e-2)"	"unprognostic (9.13e-2)"
PDE5A		ENSG00000138735	"Phosphodiesterase 5A"	O76074	4	119494397-119628804	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		"Allosteric enzyme, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 63.9;Inhibitory neurons: 55.8;Oligodendrocyte precursor cells: 53.3;Peritubular cells: 96.4;Smooth muscle cells: 81.6"	"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"Thyroid Carcinoma (TCGA): 61.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Heart muscle - Fibroblasts, Kidney - Fibroblasts, Liver - Hepatic stellate cells, Testis - Peritubular cells, Thyroid gland - Fibroblasts"	"Region enhanced"	"Detected in all"		"cerebellum: 18.2"	"Low region specificity"	"Detected in all"			"HPA004729, HPA012873"	Approved		Approved	"Basal body,Cytosol"			NA	NA		1100000		"Cluster 75: Epithelium - Extracellular exosomes"	"Cluster 10: Cerebellum - Nucleic acid binding"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 32: Smooth muscle cells - Muscle contraction"	5	Cytosol	"Basal body"	"HPA004729: AB_1079588, HPA012873: AB_1855124"	"unprognostic (5.31e-3)"	"unprognostic (1.33e-1)"	"potential prognostic unfavorable (3.93e-4)"	"unprognostic (3.39e-2)"	"unprognostic (7.13e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.75e-1)"	"unprognostic (7.17e-2)"	"potential prognostic unfavorable (1.76e-4)"	"unprognostic (2.55e-3)"	"potential prognostic favorable (6.20e-4)"	"unprognostic (2.93e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.64e-2)"	"unprognostic (9.68e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.73e-2)"	"unprognostic (4.47e-3)"	"unprognostic (3.42e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.12e-2)"	"unprognostic (9.70e-3)"
PDGFRA	"CD140a, GAS9, PDGFR2"	ENSG00000134853	"Platelet derived growth factor receptor alpha"	P16234	4	54229280-54298245	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Chemotaxis, Host-virus interaction"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 193.9"	"Group enriched"	"Detected in many"	9	"Endometrial stromal cells: 368.4;Fibroblasts: 258.5;Leydig cells: 422.2;Oligodendrocyte precursor cells: 468.8;Ovarian stromal cells: 204.8;Peritubular cells: 377.5"	"Group enriched"	"Detected in some"	13	"fibroblast: 133.8;oligodendrocyte precursor cell: 320.9"	"Cancer enhanced"	"Detected in all"		"Glioblastoma Multiforme (TCGA): 101.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Rhabdoid: 78.7;thyroid cancer: 38.5"	"Adrenal gland - Fibroblasts, Breast - Fibroblasts, Heart muscle - Fibroblasts, Kidney - Fibroblasts, Minor Salivary Gland - Macrophages, Pituitary gland - Fibroblasts, Prostate - Fibroblasts, Spleen - Fibroblast_2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004947, CAB018143"	Supported		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cell Junctions,Primary cilium"	"Intracellular and membrane"	Receptor	NA	NA		290000		"Cluster 62: Connective tissue - ECM organization"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 44: Connective tissue cells - ECM organization"	"Cluster 53: Fibroblasts - ECM organization"	36	"Nucleoplasm, Plasma membrane"	"Nuclear bodies, Cell Junctions, Primary cilium"	"CAB018143: AB_2162351, HPA004947: AB_2732399"	"unprognostic (1.39e-1)"	"unprognostic (2.75e-1)"	"unprognostic (4.29e-1)"	"unprognostic (3.15e-2)"	"unprognostic (5.76e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.95e-1)"	"unprognostic (8.34e-3)"	"potential prognostic favorable (6.22e-5)"	"unprognostic (2.31e-1)"	"unprognostic (3.55e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.09e-3)"	"unprognostic (7.37e-2)"	"unprognostic (4.97e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.17e-2)"	"unprognostic (3.70e-3)"	"unprognostic (9.86e-2)"	"unprognostic (6.95e-2)"	"unprognostic (8.35e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.53e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.22e-2)"
PDGFRB	"CD140b, JTK12, PDGFR, PDGFR1"	ENSG00000113721	"Platelet derived growth factor receptor beta"	P09619	5	150113839-150155872	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters"	Chemotaxis	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 138.3;Leydig cells: 158.6;Peritubular cells: 202.3;Sertoli cells: 514.0;Smooth muscle cells: 264.7"	"Cell type enhanced"	"Detected in many"		"pericyte: 1272.1;vascular associated smooth muscle cell: 573.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.6"	"Low lineage specificity"	"Detected in single"			"Cancer enhanced"	"Detected in many"		"Adrenocortical cancer: 36.3;testis cancer: 35.2"	"Adipose subcutaneous - Adipose progenitor cells, Adipose visceral - Adipose progenitor cells, Adrenal gland - Fibroblasts, Kidney - Fibroblasts, Pituitary gland - Fibroblasts, Prostate - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003842, CAB018144, HPA028499"	Enhanced		Supported	"Golgi apparatus,Vesicles"			NA	NA		24000000	"Cluster 33: Non-specific - ATP binding"	"Cluster 7: Adipose tissue - Mixed function"	"Cluster 23: Choroid plexus - Mixed function"	"Cluster 44: Connective tissue cells - ECM organization"	"Cluster 48: Smooth muscle cells - Signal transduction"	59	Vesicles	"Golgi apparatus"	"CAB003842: AB_562328, CAB018144: AB_2162497, HPA028499: AB_10602018"	"unprognostic (2.32e-2)"	"unprognostic (5.35e-2)"	"unprognostic (7.84e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.22e-2)"	"unprognostic (9.09e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.21e-3)"	"potential prognostic unfavorable (5.35e-5)"	"unprognostic (1.18e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.43e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.85e-3)"	"unprognostic (1.34e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.00e-2)"	"unprognostic (6.30e-3)"	"unprognostic (7.20e-3)"	"unprognostic (2.45e-2)"	"unprognostic (9.92e-2)"	"unprognostic (6.78e-2)"
PDK1		ENSG00000152256	"Pyruvate dehydrogenase kinase 1"	Q15118	2	172555373-172608669	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 147.2;Plasma cells: 143.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"B-cells: 8.6;granulocytes: 25.2;T-cells: 21.3"	"Cancer enhanced"	"Detected in all"		"Myeloma: 69.6"	"Adrenal gland - Adrenal cortex cells, Minor Salivary Gland - Plasma cells, Spleen - Plasma cells, Testis - Early spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017554, HPA027376, HPA059083"	Supported						NA	NA			"Cluster 22: Eosinophils - Transcription"	"Cluster 16: Non-specific - Transcription"	"Cluster 2: Neurons - Nucleosome"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 77: Plasma cells - Protein processing"	40			"CAB017554: AB_2161138, HPA027376: AB_1855139, HPA059083: AB_2683899"	"unprognostic (5.34e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.63e-2)"	"potential prognostic unfavorable (1.61e-6)"	"unprognostic (3.59e-1)"	"unprognostic (6.36e-3)"	"unprognostic (1.59e-2)"	"unprognostic (7.83e-2)"	"unprognostic (4.12e-1)"	"potential prognostic unfavorable (1.25e-4)"	"potential prognostic favorable (1.02e-6)"	"unprognostic (1.22e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.35e-2)"	"unprognostic (3.76e-2)"	"unprognostic (7.67e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.80e-2)"	"unprognostic (6.67e-3)"	"potential prognostic unfavorable (3.66e-4)"	"unprognostic (2.48e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.79e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.22e-2)"	"unprognostic (3.05e-1)"
PDXK	"C21orf124, C21orf97, FLJ21324, FLJ31940, MGC15873, PKH, PNK, PRED79"	ENSG00000160209	"Pyridoxal kinase"	O00764	21	43719094-43762307	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"Charcot-Marie-Tooth disease, Disease variant, FDA approved drug targets, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 74.7"	"Group enriched"	"Detected in all"	5	"Early spermatids: 1609.5;Late spermatids: 4352.9"	"Cell type enhanced"	"Detected in all"		"endothelial cell: 381.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Minor Salivary Gland - Minor salivary glandular cells, Testis - Early spermatids, Testis - Late spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030196, HPA030197, HPA030198, CAB033918"	Enhanced		Enhanced	Nucleoplasm			NA	NA		500000	"Cluster 37: Monocytes & Neutrophils - Innate immune response"	"Cluster 33: Brain - Neuronal signaling"	"Cluster 40: Astrocytes - Astrocyte-neuron interactions"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 63: Late spermatids - Spermatogenesis"	1	Nucleoplasm		"CAB033918: AB_2162502, HPA030196: AB_10599735, HPA030197: AB_10601792, HPA030198: AB_10603570"	"unprognostic (1.16e-1)"	"unprognostic (4.38e-3)"	"unprognostic (3.55e-2)"	"unprognostic (4.41e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.90e-3)"	"unprognostic (1.32e-1)"	"unprognostic (9.40e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.13e-2)"	"unprognostic (4.74e-3)"	"unprognostic (6.55e-3)"	"unprognostic (1.56e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.00e-2)"	"unprognostic (3.62e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.26e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.55e-3)"	"unprognostic (2.08e-1)"	"potential prognostic unfavorable (9.37e-4)"	"unprognostic (2.55e-1)"
PGA5		ENSG00000256713	"Pepsinogen A5"	P0DJD9	11	61241175-61251444	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins"	Digestion	"Aspartyl protease, Hydrolase, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	2028	"stomach 1: 38780.0"	"Cell type enriched"	"Detected in some"	22	"Exocrine glandular cells: 1696.1"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	33	"Stomach Adenocarcinoma (TCGA): 298.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	29	"classical monocyte: 1.8;intermediate monocyte: 4.3;non-classical monocyte: 2.4"	"Lineage enriched"	"Detected in single"	44	"monocytes: 4.3"	"Not detected"	"Not detected"			"Stomach - Chief cells"									HPA046875	Supported				"Secreted to digestive system"	Enzyme	NA	NA			"Cluster 40: Monocytes - Innate immune response"	"Cluster 48: Stomach - Proteolysis"	"Cluster 51: Neurons - Mixed function"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 45: Non-specific - Mixed function"				"HPA046875: AB_2679851"							"unprognostic (3.38e-2)"				"unprognostic (4.21e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.49e-2)"							"unprognostic (9.99e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.60e-2)"						"unprognostic (1.42e-2)"		"unprognostic (2.08e-2)"	
PGF	"D12S1900, PGFL, PIGF, PLGF, PlGF-2, SHGC-10760"	ENSG00000119630	"Placental growth factor"	P49763	14	74941834-74955626	"Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 50.6;thyroid gland: 51.0"	"Group enriched"	"Detected in many"	21	"Extravillous trophoblasts: 1887.4;Syncytiotrophoblasts: 2188.7"	"Group enriched"	"Detected in some"	5	"pericyte: 117.7;vascular associated smooth muscle cell: 79.9"	"Cancer enhanced"	"Detected in all"		"Kidney Renal Clear Cell Carcinoma (TCGA): 138.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Sarcoma: 41.1"		"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"spinal cord: 12.2"	HPA041624			Approved	Nucleoplasm,Mitochondria,Cytosol	"Secreted to blood"	"Growth factor"	No	No	20800			"Cluster 60: Choroid plexus - Transmembrane transport"	"Cluster 44: Non-specific - Mixed function"	"Cluster 34: Testis cancer - Unknown function"	"Cluster 4: Extravillous trophoblasts - Unknown function"	2	Nucleoplasm	"Mitochondria, Cytosol"	"HPA041624: AB_10794522"	"unprognostic (6.22e-2)"	"unprognostic (2.41e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.96e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.70e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.70e-2)"	"potential prognostic unfavorable (7.33e-4)"	"unprognostic (2.33e-2)"	"potential prognostic unfavorable (2.67e-5)"	"potential prognostic unfavorable (3.18e-4)"	"unprognostic (2.14e-1)"	"unprognostic (5.53e-2)"	"potential prognostic unfavorable (6.21e-5)"	"unprognostic (6.96e-3)"	"unprognostic (5.08e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.30e-3)"	"unprognostic (6.48e-3)"	"unprognostic (1.72e-2)"	"unprognostic (5.25e-3)"	"unprognostic (9.52e-3)"	"unprognostic (8.82e-3)"	"unprognostic (1.97e-1)"	"unprognostic (3.42e-3)"	"unprognostic (9.40e-2)"	"unprognostic (2.93e-2)"	"unprognostic (4.33e-2)"
PGR	"NR3C3, PR"	ENSG00000082175	"Progesterone receptor"	P06401	11	101029624-101129813	"Cancer-related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors, Transporters"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"cervix: 61.6;endometrium 1: 100.2;fallopian tube: 33.2;smooth muscle: 75.6"	"Cell type enhanced"	"Detected in many"		"Ciliated cells: 54.3;Early spermatids: 76.2;Endometrial stromal cells: 163.3;Glandular and luminal cells: 74.1;Late spermatids: 41.4;Secretory cells: 99.2"	"Group enriched"	"Detected in many"	6	"endothelial cell: 121.0;ependymal cell: 32.7;fibroblast: 83.6;pericyte: 55.4;vascular associated smooth muscle cell: 37.6"	"Group enriched"	"Detected in some"	7	"Breast Invasive Carcinoma (TCGA): 20.6;Uterine Corpus Endometrial Carcinoma (TCGA): 15.7"	"Region enriched"	"Detected in all"	5	"hypothalamus: 19.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	27	"breast cancer: 7.2"	"Liver - Hepatic stellate cells, Lung - Fibroblast_1, Pituitary gland - Gonadotropes, Spleen - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB000068, HPA004751, HPA008428, HPA017176, CAB055100"	Enhanced						NA	NA				"Cluster 62: Connective tissue - ECM organization"	"Cluster 56: Hypothalamus - Neuropeptide signaling"	"Cluster 27: Breast cancer - Unknown function"	"Cluster 9: Endometrial stromal cells - Transcription"	30			"CAB000068: AB_442124, CAB055100: AB_2532076, HPA004751: AB_1079681, HPA008428: AB_1079680, HPA017176: AB_1855728"		"unprognostic (8.34e-2)"	"unprognostic (2.63e-1)"	"unprognostic (6.88e-2)"						"unprognostic (2.46e-1)"							"unprognostic (1.03e-1)"			"unprognostic (2.26e-1)"	"unprognostic (3.72e-2)"		"unprognostic (9.08e-2)"	"unprognostic (3.23e-1)"		"unprognostic (7.95e-3)"					"unprognostic (5.12e-3)"
PIK3CA	PI3K	ENSG00000121879	"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha"	P42336	3	179148114-179240093	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Angiogenesis, Lipid metabolism, Phagocytosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 122.4;Inhibitory neurons: 117.0;Oligodendrocyte precursor cells: 122.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Adrenal cortex cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009985, CAB017804"	Approved		Approved	"Microtubules,Primary cilium,Mitochondria,Cytosol"			NA	NA			"Cluster 20: Non-specific - DNA binding"	"Cluster 16: Non-specific - Transcription"	"Cluster 37: Neurons - Mixed function"	"Cluster 63: Non-specific - Protein processing"	"Cluster 32: Smooth muscle cells - Muscle contraction"	44	"Primary cilium, Cytosol"	"Microtubules, Mitochondria"	"CAB017804: , HPA009985: AB_1079610"	"unprognostic (2.75e-1)"	"unprognostic (2.49e-2)"	"unprognostic (9.47e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.38e-2)"	"potential prognostic favorable (2.60e-6)"	"unprognostic (1.26e-3)"	"unprognostic (3.71e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.58e-3)"	"potential prognostic unfavorable (4.92e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.37e-2)"	"unprognostic (7.17e-2)"	"unprognostic (1.95e-3)"	"unprognostic (2.39e-3)"	"unprognostic (7.49e-2)"	"unprognostic (6.69e-2)"	"unprognostic (5.37e-2)"	"unprognostic (9.64e-2)"	"unprognostic (4.05e-2)"	"unprognostic (8.15e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.03e-1)"
PIK3CD	p110D	ENSG00000171608	"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta"	O00329	1	9629889-9729114	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Adaptive immunity, Chemotaxis, Differentiation, Immunity, Inflammatory response, Innate immunity, Lipid metabolism"	"Kinase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 46.2;intestine: 11.7;lymphoid tissue: 44.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 23.9;dendritic cells: 34.2;Kupffer cells: 26.0;Macrophages: 22.9;Microglial cells: 27.7;NK-cells: 28.4;T-cells: 35.2"	"Group enriched"	"Detected in all"	5	"central nervous system macrophage: 185.3;leukocyte: 245.1;pericyte: 237.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"Leukemia: 57.4;lymphoma: 54.3"	"Adrenal gland - Macrophages, Prostate - T-cells, Testis - Spermatogonia, Thyroid gland - T-cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015420, HPA044953"	Enhanced		Approved	"Vesicles,Microtubules,Cytokinetic bridge,Primary cilium,Primary cilium tip,Cytosol"			Yes	No			"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 18: Non-specific - Mixed function"	"Cluster 6: Leukemia - Signal transduction"	"Cluster 7: T-cells - T-cell receptor"	11	Vesicles	"Microtubules, Cytokinetic bridge, Primary cilium, Primary cilium tip, Cytosol"	"CAB015420: AB_831654, HPA044953: AB_2679153"	"unprognostic (2.54e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.12e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.70e-1)"	"unprognostic (8.43e-2)"	"unprognostic (6.33e-2)"	"unprognostic (7.70e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.30e-1)"	"potential prognostic favorable (5.14e-5)"	"unprognostic (2.86e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.63e-3)"	"unprognostic (1.99e-2)"	"unprognostic (8.44e-3)"	"unprognostic (1.97e-1)"	"unprognostic (7.88e-3)"	"unprognostic (1.18e-1)"	"unprognostic (5.07e-2)"	"potential prognostic unfavorable (2.14e-4)"	"unprognostic (4.25e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.74e-1)"
PIK3CG		ENSG00000105851	"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma"	P48736	7	106865278-106908980	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"Angiogenesis, Chemotaxis, Endocytosis, Immunity, Inflammatory response, Lipid metabolism"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 43.1;lymphoid tissue: 19.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 31.8;dendritic cells: 118.4;Macrophages: 37.3;monocytes: 85.0;NK-cells: 36.0;Plasma cells: 84.3"	"Group enriched"	"Detected in some"	20	"central nervous system macrophage: 97.0;leukocyte: 90.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	14	"Leukemia: 18.8;lymphoma: 26.1;Myeloma: 22.5"	"Adrenal gland - Macrophages, Testis - Early spermatids, Testis - Spermatocytes"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA069976	Enhanced		Supported	"Plasma membrane,Cytosol"			NA	NA			"Cluster 40: Monocytes - Innate immune response"	"Cluster 77: Bone marrow - Cell proliferation"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 77: Plasma cells - Protein processing"	9	"Plasma membrane"	Cytosol	"HPA069976: AB_2686224"	"unprognostic (2.79e-2)"	"unprognostic (7.74e-2)"	"unprognostic (8.79e-3)"	"unprognostic (3.05e-1)"	"unprognostic (4.81e-2)"	"unprognostic (3.92e-1)"	"unprognostic (8.55e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.51e-3)"		"unprognostic (1.61e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.01e-1)"			"potential prognostic favorable (9.44e-4)"	"unprognostic (4.14e-2)"	"unprognostic (7.30e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.06e-2)"		"unprognostic (4.51e-2)"	"unprognostic (1.75e-1)"			"unprognostic (8.38e-3)"		"unprognostic (5.03e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.05e-1)"	"unprognostic (3.40e-1)"
PKLR		ENSG00000143627	"Pyruvate kinase L/R"	P30613	1	155289293-155301438	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"	"Disease variant, FDA approved drug targets, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 19.3;kidney: 24.2;liver: 89.7"	"Group enriched"	"Detected in some"	9	"Erythroid cells: 61.0;Hepatocytes: 50.4;Late spermatids: 24.5;Proximal enterocytes: 34.2;Proximal tubular cells: 36.8"	"Low cell type specificity"	"Detected in some"			"Cancer enriched"	"Detected in many"	7	"Liver Hepatocellular Carcinoma (TCGA): 70.9"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Leukemia: 7.2;skin cancer: 2.9"	"Kidney - Proximal tubular cells, Liver - Hepatocytes, Skin - Sebaceous gland cells, Testis - Late spermatids"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.6"	"Low region specificity"	"Detected in all"			"HPA006653, CAB034376, CAB034378"	Enhanced		Approved	Cytosol			No	NA		7600000		"Cluster 1: Liver & Kidney - Metabolism"	"Cluster 10: Cerebellum - Nucleic acid binding"	"Cluster 47: Leukemia - Hemostasis"	"Cluster 1: Erythroid cells - Oxygen transport"	2	Cytosol		"CAB034376: AB_2163671, CAB034378: AB_2252321, HPA006653: AB_2667632"					"unprognostic (1.96e-1)"						"potential prognostic favorable (7.04e-7)"	"unprognostic (7.94e-3)"	"unprognostic (2.73e-3)"	"unprognostic (5.53e-2)"	"unprognostic (2.20e-2)"										"unprognostic (2.82e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.04e-1)"				"unprognostic (1.14e-1)"
PLA2G10	GXPLA2	ENSG00000069764	"Phospholipase A2 group X"	O15496	16	14672548-14694308	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted secreted proteins, RAS pathway related proteins"	"Lipid metabolism, Phospholipid metabolism"	Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 26.2;stomach 1: 40.8"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 230.7;Enteroendocrine cells: 55.2;Exocrine glandular cells: 52.6;Extravillous trophoblasts: 64.7;Gastric mucus-secreting cells: 73.7;Intestinal goblet cells: 144.6;Paneth cells: 68.2"	"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"Colon Adenocarcinoma (TCGA): 18.7;Lung Adenocarcinoma (TCGA): 46.2;Pancreatic Adenocarcinoma (TCGA): 42.7;Rectum Adenocarcinoma (TCGA): 20.1;Stomach Adenocarcinoma (TCGA): 33.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Gallbladder cancer: 6.0;Gastric cancer: 4.1;pancreatic cancer: 4.4"	"Colon - Colon enterocytes, Stomach - Gastric mucous cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA041893	Uncertain				"Secreted in other tissues"	Enzyme	NA	NA				"Cluster 45: Intestine - Digestion"		"Cluster 57: Stomach & Colon cancer - Digestion"	"Cluster 5: Enterocytes - Absorption"	42			"HPA041893: AB_10794495"	"unprognostic (3.98e-2)"	"unprognostic (1.45e-2)"	"unprognostic (4.29e-2)"	"unprognostic (9.33e-2)"	"unprognostic (3.73e-2)"	"unprognostic (2.28e-1)"										"unprognostic (5.96e-2)"	"unprognostic (4.65e-2)"	"unprognostic (2.24e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.81e-1)"		"unprognostic (7.78e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.67e-1)"	"unprognostic (2.51e-2)"	"unprognostic (3.12e-2)"		"unprognostic (6.39e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.97e-2)"	"unprognostic (2.51e-1)"
PLA2G1B	"PLA2, PLA2A, PPLA2"	ENSG00000170890	"Phospholipase A2 group IB"	P04054	12	120322115-120327779	"Candidate cardiovascular disease genes, Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Lipid metabolism, Phospholipid metabolism"	Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	2908	"pancreas: 113918.1"	"Cell type enriched"	"Detected in some"	39	"Exocrine glandular cells: 9563.7"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	82	"Pancreatic Adenocarcinoma (TCGA): 1402.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Lung - Alveolar cells type 2, Pancreas - Exocrine glandular cells, Testis - Late spermatids"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA047822, HPA060803"	Enhanced				"Secreted to digestive system"	Enzyme	NA	NA		2100000	"Cluster 43: Non-specific - Transcription & Translation"	"Cluster 15: Pancreas - Proteolysis"		"Cluster 7: Liver cancer - Metabolism"	"Cluster 60: Pancreatic exocrine cells - Proteolysis"	1			"HPA047822: AB_2680169, HPA060803: AB_2684369"			"unprognostic (1.47e-2)"								"unprognostic (1.75e-2)"	"unprognostic (1.72e-1)"		"unprognostic (1.47e-1)"	"unprognostic (5.57e-3)"	"unprognostic (1.23e-3)"	"unprognostic (2.66e-2)"	"unprognostic (2.87e-3)"	"unprognostic (2.25e-1)"	"unprognostic (7.91e-2)"		"unprognostic (1.27e-1)"	"unprognostic (5.36e-2)"					"unprognostic (2.11e-1)"			
PLA2G2A	"PLA2B, PLA2L"	ENSG00000188257	"Phospholipase A2 group IIA"	P14555	1	19975431-19980416	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Inflammatory response, Lipid metabolism, Phospholipid metabolism"	"Antimicrobial, Bacteriolytic enzyme, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adipose tissue: 904.0;intestine: 1462.3;placenta: 558.1;urinary bladder: 630.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 640.8;Exocrine glandular cells: 430.1;Fibroblasts: 1056.7;Mesothelial cells: 1444.4;Proximal enterocytes: 427.4;Undifferentiated cells: 2509.4"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in all"		"Prostate Adenocarcinoma (TCGA): 3345.8"	"Region enhanced"	"Detected in some"		"choroid plexus: 6.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"colorectal cancer: 84.8;Gastric cancer: 164.6"	"Colon - Macrophages, Lung - Fibroblast_2, Thyroid gland - Macrophages"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA015236	Enhanced				"Secreted to blood"	Enzyme	NA	NA	1000000	650000		"Cluster 45: Intestine - Digestion"	"Cluster 12: Non-specific - Vasculature"	"Cluster 57: Stomach & Colon cancer - Digestion"	"Cluster 16: Intestinal goblet cells - Mucin production"	1			"HPA015236: AB_10601047"	"unprognostic (2.93e-2)"	"unprognostic (1.56e-2)"	"potential prognostic favorable (2.23e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.44e-3)"	"unprognostic (9.16e-2)"	"potential prognostic unfavorable (3.59e-4)"	"unprognostic (4.42e-2)"	"unprognostic (3.83e-1)"	"potential prognostic unfavorable (7.49e-9)"		"potential prognostic unfavorable (1.56e-4)"	"unprognostic (1.46e-1)"	"unprognostic (8.48e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.89e-1)"	"unprognostic (8.86e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.67e-1)"	"unprognostic (5.08e-3)"	"unprognostic (5.90e-2)"	"potential prognostic unfavorable (6.51e-4)"	"unprognostic (3.16e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.78e-1)"
PLAT		ENSG00000104368	"Plasminogen activator, tissue type"	P00750	8	42174718-42207709	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Plasminogen activation"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 237.9;urinary bladder: 174.7"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 133.4;Breast glandular cells: 99.1;Endometrial stromal cells: 101.4;Endothelial cells: 108.9;Fibroblasts: 93.6;granulocytes: 135.2;Lymphatic endothelial cells: 87.5"	"Group enriched"	"Detected in all"	4	"central nervous system macrophage: 78.9;endothelial cell: 233.4;oligodendrocyte precursor cell: 69.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"skin cancer: 246.4"	"Kidney - Endothelial cells, Minor Salivary Gland - Endothelial cells, Pituitary gland - Fibroblasts, Prostate - Urothelial cells, Testis - Sertoli cells, Thyroid gland - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003412, CAB009335"	Supported		Approved	"Actin filaments"	"Secreted to blood"	Enzyme	NA	NA	9900000	620000		"Cluster 24: Parathyroid gland - Vesicular transport"	"Cluster 47: Endothelial cells - Vasculature"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	5	"Actin filaments"		"CAB009335: AB_2237146, HPA003412: AB_1858205"	"unprognostic (5.66e-2)"	"unprognostic (1.15e-3)"	"unprognostic (3.43e-2)"	"unprognostic (6.21e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.49e-3)"	"unprognostic (9.18e-2)"	"unprognostic (2.57e-1)"	"validated prognostic favorable (4.77e-4)"	"validated prognostic favorable (7.71e-4)"	"unprognostic (3.62e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.25e-1)"	"potential prognostic unfavorable (1.83e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.74e-2)"	"unprognostic (2.28e-2)"	"unprognostic (5.11e-3)"	"unprognostic (2.84e-1)"	"unprognostic (4.16e-1)"	"unprognostic (2.58e-1)"	"unprognostic (8.58e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.97e-3)"	"unprognostic (9.14e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.85e-1)"
PLAUR	"CD87, UPAR, URKR"	ENSG00000011422	"Plasminogen activator, urokinase receptor"	Q03405	19	43646095-43670547	"Cancer-related genes, CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"bone marrow: 680.7"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 806.7;Langerhans cells: 2298.1;Macrophages: 885.5;monocytes: 3085.0"	"Cell type enhanced"	"Detected in all"		"central nervous system macrophage: 39.5;leukocyte: 49.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1177.3"	"Group enriched"	"Detected in all"	4	"granulocytes: 1177.3;monocytes: 553.8"	"Low cancer specificity"	"Detected in all"			"Thyroid gland - Neutrophils"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA050843, CAB073533"	Uncertain		Supported	"Plasma membrane"	"Intracellular and membrane"	Receptor	NA	NA		13000000	"Cluster 7: Non-specific - Innate immune response"	"Cluster 77: Bone marrow - Cell proliferation"	"Cluster 12: Non-specific - Vasculature"	"Cluster 72: Neuronal - Signal transduction"	"Cluster 29: Monocytes - Innate immune response"	5	"Plasma membrane"		"CAB073533: , HPA050843: AB_2681255"	"unprognostic (1.01e-1)"	"unprognostic (8.30e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.73e-3)"	"unprognostic (1.43e-1)"	"unprognostic (9.42e-2)"	"unprognostic (1.67e-3)"	"unprognostic (7.01e-3)"	"unprognostic (9.80e-3)"	"unprognostic (1.78e-1)"	"potential prognostic unfavorable (1.24e-6)"	"unprognostic (2.64e-2)"	"unprognostic (2.51e-1)"	"potential prognostic unfavorable (4.24e-5)"	"unprognostic (1.64e-1)"	"potential prognostic unfavorable (4.67e-4)"	"unprognostic (3.24e-3)"	"unprognostic (2.28e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.28e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.37e-3)"	"unprognostic (9.71e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.75e-3)"	"unprognostic (1.52e-2)"	"unprognostic (8.71e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.52e-2)"	"unprognostic (6.37e-2)"
PLG		ENSG00000122194	Plasminogen	P00747	6	160702194-160754097	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis, Tissue remodeling"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease variant, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"liver: 2571.0"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 1618.7"	"Low cell type specificity"	"Detected in some"			"Cancer enriched"	"Detected in some"	41	"Liver Hepatocellular Carcinoma (TCGA): 397.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"liver cancer: 2.6"	"Kidney - Proximal tubular cells, Kidney - Proximal tubular cells, Liver - Hepatocytes, Lung - Respiratory ciliated cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB000668, CAB016678, HPA021602, HPA048823, HPA053770"	Supported		Approved	Vesicles	"Secreted to blood"	"Blood coagulation"	NA	NA	140000000000	54000000000		"Cluster 1: Liver & Kidney - Metabolism"	"Cluster 14: Neurons - Synaptic function"	"Cluster 18: Liver cancer - Metabolism"	"Cluster 62: Hepatocytes - Metabolism"	16	Vesicles		"CAB000668: , CAB016678: AB_1621208, HPA021602: AB_1855453, HPA048823: AB_2680532, HPA053770: AB_2682256"											"potential prognostic favorable (5.22e-8)"	"unprognostic (3.27e-3)"		"unprognostic (2.54e-3)"	"potential prognostic favorable (7.62e-4)"								"potential prognostic unfavorable (5.74e-4)"								
PLIN3	"M6PRBP1, PP17, TIP47"	ENSG00000105355	"Perilipin 3"	O60664	19	4838341-4867694	"FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Transport		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 280.6"	"Cell type enhanced"	"Detected in many"		"oligodendrocyte: 30.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adipose visceral - Macrophages, Adrenal gland - Adrenal cortex cells, Colon - Macrophages, Heart muscle - Macrophages"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006427, HPA066538"	Uncertain		Supported	"Lipid droplets"			NA	Yes		7700000	"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 19: Non-specific - Basic cellular processes"	"Cluster 30: White matter - Myelination"	"Cluster 72: Neuronal - Signal transduction"	"Cluster 5: Enterocytes - Absorption"	26	"Lipid droplets"		"HPA006427: AB_1079289, HPA066538: AB_2685687"	"unprognostic (1.82e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.81e-1)"	"unprognostic (6.64e-3)"	"unprognostic (3.68e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.02e-3)"	"unprognostic (4.67e-2)"	"unprognostic (2.24e-2)"	"validated prognostic unfavorable (6.78e-6)"	"validated prognostic unfavorable (2.69e-5)"	"unprognostic (2.61e-1)"	"validated prognostic unfavorable (7.88e-5)"	"validated prognostic unfavorable (6.49e-4)"	"validated prognostic unfavorable (1.57e-7)"	"validated prognostic unfavorable (1.23e-4)"	"unprognostic (7.40e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.35e-2)"	"unprognostic (3.59e-2)"	"unprognostic (9.31e-2)"	"unprognostic (5.98e-2)"	"unprognostic (6.59e-2)"	"unprognostic (4.67e-3)"	"unprognostic (2.52e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.71e-1)"	"unprognostic (1.17e-3)"
PMEL	"D12S53E, gp100, HMB-45, HMB45, ME20, Pmel17, SI, SIL, SILV"	ENSG00000185664	"Premelanosome protein"	P40967	12	55954105-55973317	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Melanin biosynthesis"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"cervix: 78.0;endometrium 1: 31.2;skin 1: 112.3"	"Cell type enriched"	"Detected in many"	61	"Melanocytes: 2210.9"	"Low cell type specificity"	"Detected in many"			"Cancer enriched"	"Detected in all"	552	"Skin Cuteneous Melanoma (TCGA): 7481.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	49	"skin cancer: 3389.1"	"Liver - Hepatocytes, Skin - Melanocytes"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA031649	Enhanced		Supported	"Endoplasmic reticulum,Golgi apparatus"	"Intracellular and membrane"	Other	NA	NA		7500000		"Cluster 13: Skin - Cornification"	"Cluster 15: Non-specific - Transcription"	"Cluster 9: Skin cancer - Melanin biosynthesis"	"Cluster 26: Schwann cells & Melanocytes - Mixed function"		"Endoplasmic reticulum"	"Golgi apparatus"	"HPA031649: AB_2673976"	"unprognostic (9.14e-2)"	"unprognostic (2.57e-1)"		"unprognostic (1.91e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.50e-2)"		"unprognostic (1.35e-1)"	"unprognostic (1.65e-1)"	"potential prognostic favorable (9.28e-4)"	"unprognostic (1.25e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.91e-1)"	"unprognostic (2.70e-2)"	"unprognostic (7.93e-3)"	"unprognostic (1.48e-1)"	"unprognostic (7.72e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.05e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.78e-2)"	"unprognostic (9.68e-2)"	"unprognostic (4.82e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.80e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.02e-1)"
PNLIP	PL	ENSG00000175535	"Pancreatic lipase"	P16233	10	116545931-116567855	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4811	"pancreas: 430750.5"	"Cell type enriched"	"Detected in some"	15	"Exocrine glandular cells: 2323.2"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	4399	"Pancreatic Adenocarcinoma (TCGA): 3428.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Pancreas - Exocrine glandular cells"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA062430, HPA062494"	Enhanced				"Secreted to digestive system"	Enzyme	NA	NA		8000000		"Cluster 15: Pancreas - Proteolysis"		"Cluster 66: Non-specific - Mitochondria"	"Cluster 60: Pancreatic exocrine cells - Proteolysis"				"HPA062430: AB_2684761, HPA062494: AB_2684782"																						"unprognostic (1.68e-2)"	"unprognostic (6.04e-2)"								
PNP	"NP, PUNP"	ENSG00000198805	"Purine nucleoside phosphorylase"	P00491	14	20461992-20477094	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Purine salvage"	"Glycosyltransferase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 313.1;epididymis: 570.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 360.2;Syncytiotrophoblasts: 572.9"	"Cell type enhanced"	"Detected in many"		"bergmann glia: 33.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Heart muscle - Endothelial cells, Skeletal muscle - Endothelial cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA001625	Enhanced		Supported	Cytosol			NA	NA		57000000	"Cluster 30: Non-specific - DNA binding"	"Cluster 53: Non-specific - Glycosylation"	"Cluster 44: Non-specific - Mixed function"	"Cluster 30: Non-specific - Gene expression regulation"	"Cluster 24: Cytotrophoblasts - Mitochondria"	10	Cytosol		"HPA001625: AB_1854577"	"unprognostic (3.47e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.69e-1)"	"unprognostic (9.51e-3)"	"unprognostic (2.11e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.55e-1)"	"validated prognostic favorable (4.97e-6)"	"validated prognostic favorable (6.02e-4)"	"unprognostic (2.29e-3)"	"potential prognostic unfavorable (9.25e-4)"	"unprognostic (1.47e-3)"	"potential prognostic unfavorable (4.23e-4)"	"unprognostic (4.52e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.59e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.65e-2)"	"unprognostic (9.17e-3)"	"unprognostic (4.56e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.69e-1)"
POLA1	"NSX, p180, POLA"	ENSG00000101868	"DNA polymerase alpha 1, catalytic subunit"	P09884	X	24693873-24996986	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"DNA replication, Host-virus interaction"	"DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"	"Disease variant, Dwarfism, FDA approved drug targets, Intellectual disability"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 40.8;Inhibitory neurons: 62.8;Microglial cells: 54.6;Oligodendrocyte precursor cells: 55.7;Oligodendrocytes: 90.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002947, CAB012274"	Supported		Supported	Nucleoplasm,Cytosol			NA	NA			"Cluster 14: Non-specific - Unknown function"	"Cluster 71: Thymus - Adaptive immune response"	"Cluster 13: Oligodendrocytes - Mixed function"	"Cluster 36: Non-specific - mRNA processing"	"Cluster 65: Neurons - Synaptic function"	24	Nucleoplasm	Cytosol	"CAB012274: , HPA002947: AB_1079652"	"unprognostic (6.67e-3)"	"unprognostic (5.24e-2)"	"unprognostic (5.59e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.20e-2)"	"potential prognostic favorable (1.89e-7)"	"unprognostic (9.13e-3)"	"unprognostic (1.69e-2)"	"unprognostic (8.41e-3)"	"potential prognostic unfavorable (8.21e-4)"	"unprognostic (3.40e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.77e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.31e-1)"	"unprognostic (7.86e-2)"	"unprognostic (1.97e-3)"	"unprognostic (1.26e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.21e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.26e-1)"
POLB		ENSG00000070501	"DNA polymerase beta"	P06746	8	42338454-42371808	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, DNA synthesis"	"DNA-binding, DNA-directed DNA polymerase, Lyase, Nucleotidyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 172.2"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 253.4;Early spermatids: 278.9;Late spermatids: 156.8"	"Cell type enhanced"	"Detected in all"		"upper rhombic lip: 189.9"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 134.1"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Heart muscle - Cardiomyocytes, Skeletal muscle - Skeletal myocytes, Testis - Early spermatids, Testis - Late spermatids, Thyroid gland - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011616, HPA049104, HPA069013, CAB080371"	Enhanced		Supported	Vesicles,Cytosol			NA	NA			"Cluster 10: Non-specific - Membrane trafficking"	"Cluster 65: Cerebellum - Nervous system development"	"Cluster 35: Non-specific - DNA binding"	"Cluster 29: Non-specific - Unknown function"	"Cluster 28: Dendritic cells - Antigen presentation"	32	"Vesicles, Cytosol"		"CAB011616: AB_731977, CAB080371: , HPA049104: AB_2680632, HPA069013: "	"unprognostic (6.63e-2)"	"unprognostic (1.67e-2)"	"unprognostic (9.63e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.21e-1)"	"potential prognostic favorable (5.11e-4)"	"unprognostic (4.14e-2)"	"unprognostic (1.20e-2)"	"unprognostic (5.68e-3)"	"unprognostic (3.82e-2)"	"potential prognostic unfavorable (3.99e-4)"	"unprognostic (1.26e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.80e-2)"	"unprognostic (1.38e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.24e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.61e-3)"	"unprognostic (1.79e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.51e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.17e-2)"	"unprognostic (6.44e-2)"	"unprognostic (8.52e-2)"	"unprognostic (3.97e-1)"	"unprognostic (4.82e-2)"	"unprognostic (4.01e-2)"
POLE	POLE1	ENSG00000177084	"DNA polymerase epsilon, catalytic subunit"	Q07864	12	132623753-132687376	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"DNA-binding, DNA-directed DNA polymerase, Hydrolase, Nucleotidyltransferase, Transferase"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 44.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Testis - Spermatocytes"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA058210, HPA067385"			Enhanced	"Nucleoplasm,Plasma membrane"			NA	NA				"Cluster 16: Non-specific - Transcription"	"Cluster 15: Non-specific - Transcription"	"Cluster 54: Non-specific - Transcription"	"Cluster 79: Spermatocytes & Spermatogonia - Spermatogenesis"	42	Nucleoplasm	"Plasma membrane"	"HPA058210: AB_2683639, HPA067385: AB_2685830"	"unprognostic (2.75e-2)"	"unprognostic (9.47e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.97e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.30e-1)"	"unprognostic (5.05e-2)"	"unprognostic (2.09e-2)"	"unprognostic (6.35e-3)"	"unprognostic (9.94e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.98e-2)"	"unprognostic (6.50e-2)"	"unprognostic (8.61e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.07e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.73e-3)"	"unprognostic (4.77e-2)"	"unprognostic (5.60e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.67e-3)"	"unprognostic (7.50e-3)"	"potential prognostic unfavorable (6.82e-4)"	"unprognostic (4.00e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.39e-2)"	"unprognostic (4.00e-3)"
POLE2	DPE2	ENSG00000100479	"DNA polymerase epsilon 2, accessory subunit"	P56282	14	49643555-49688422	"FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"DNA replication"	DNA-binding	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 18.1"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 23.6;Oocytes: 30.9;Spermatogonia: 23.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Low cancer specificity"	"Detected in all"			"Spleen - Mitotic cells (Spleen), Testis - Spermatocytes, Testis - Spermatogonia"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA027555	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"			No	No			"Cluster 16: Non-specific - Cell proliferation"	"Cluster 77: Bone marrow - Cell proliferation"	"Cluster 9: Non-specific - Receptor signaling"	"Cluster 30: Non-specific - Gene expression regulation"	"Cluster 52: Non-specific - Cell proliferation"	24	"Nucleoplasm, Nuclear bodies"	Vesicles	"HPA027555: AB_10610282"	"unprognostic (6.46e-2)"	"unprognostic (3.63e-1)"	"unprognostic (8.20e-3)"	"unprognostic (7.30e-3)"	"unprognostic (4.33e-2)"	"unprognostic (7.58e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.10e-3)"	"potential prognostic unfavorable (5.04e-4)"	"unprognostic (3.80e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.14e-1)"	"validated prognostic unfavorable (2.63e-4)"	"validated prognostic unfavorable (1.70e-4)"	"potential prognostic unfavorable (7.54e-5)"	"unprognostic (6.87e-3)"	"unprognostic (1.31e-2)"	"unprognostic (4.28e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.79e-3)"	"validated prognostic unfavorable (4.67e-4)"	"validated prognostic unfavorable (2.21e-4)"	"unprognostic (4.53e-3)"	"unprognostic (1.45e-3)"	"unprognostic (2.80e-1)"	"unprognostic (4.31e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.46e-2)"
POLE3	"CHARAC17, CHRAC17, CHRAC2, p17, Ybl1"	ENSG00000148229	"DNA polymerase epsilon 3, accessory subunit"	Q9NRF9	9	113407235-113410675	"FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		DNA-binding	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004477, HPA047945"	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol			NA	NA		7600	"Cluster 12: Non-specific - Mitochondrial translation"	"Cluster 4: Testis - Basic cellular processes"	"Cluster 37: Neurons - Mixed function"	"Cluster 43: Non-specific - Basic cellular processes"	"Cluster 52: Non-specific - Cell proliferation"	35	Nucleoplasm	"Nucleoli, Cytosol"	"HPA004477: , HPA047945: AB_2680218"	"unprognostic (1.66e-1)"	"unprognostic (1.60e-2)"	"unprognostic (5.29e-2)"	"unprognostic (4.67e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.92e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.59e-3)"	"unprognostic (2.28e-2)"	"unprognostic (2.34e-2)"	"potential prognostic favorable (3.59e-7)"	"unprognostic (3.35e-2)"	"unprognostic (9.42e-2)"	"validated prognostic unfavorable (9.31e-5)"	"validated prognostic unfavorable (2.81e-4)"	"unprognostic (7.02e-3)"	"unprognostic (1.87e-3)"	"unprognostic (1.23e-1)"	"unprognostic (7.82e-2)"	"unprognostic (3.32e-1)"	"unprognostic (3.47e-1)"	"unprognostic (9.74e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.19e-1)"	"unprognostic (5.44e-3)"
POLE4	p12	ENSG00000115350	"DNA polymerase epsilon 4, accessory subunit"	Q9NR33	2	74958643-74970128	"FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		DNA-binding	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054979, HPA071815, HPA076606"	Approved		Enhanced	Nucleoplasm,Cytosol			NA	NA			"Cluster 29: Non-specific - Unknown function"	"Cluster 54: Non-specific - Basic cellular processes"	"Cluster 33: Neurons - Mixed function"	"Cluster 26: Non-specific - Mitochondria & RNA binding"	"Cluster 39: Non-specific - Basic cellular processes"	20	Nucleoplasm	Cytosol	"HPA054979: AB_2682661, HPA071815: AB_2686453, HPA076606: "	"unprognostic (1.46e-3)"	"unprognostic (6.77e-2)"	"unprognostic (1.65e-1)"	"unprognostic (9.30e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.01e-1)"	"unprognostic (5.23e-2)"	"unprognostic (6.59e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.05e-2)"	"validated prognostic unfavorable (8.82e-4)"	"validated prognostic unfavorable (1.66e-6)"	"potential prognostic unfavorable (4.37e-4)"	"unprognostic (6.32e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.33e-2)"	"unprognostic (2.32e-1)"	"unprognostic (5.04e-2)"	"unprognostic (6.37e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.61e-3)"	"unprognostic (2.43e-3)"	"unprognostic (2.98e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.28e-2)"
PPARA	"hPPAR, NR1C1, PPAR"	ENSG00000186951	"Peroxisome proliferator activated receptor alpha"	Q07869	22	46150521-46243755	"FDA approved drug targets, Metabolic proteins, Nuclear receptors, Predicted intracellular proteins, Transcription factors, Transporters"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 40.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 105.9;Hepatocytes: 125.1;Proximal enterocytes: 87.3;Rod photoreceptor cells: 144.6"	"Cell type enhanced"	"Detected in all"		"choroid plexus epithelial cell: 180.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"eosinophil: 9.8;plasmacytoid DC: 2.9"	"Group enriched"	"Detected in many"	5	"dendritic cells: 2.9;granulocytes: 9.8"	"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Skin - Sebaceous gland cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066941, HPA067049, CAB075701"	Supported		Supported	"Nucleoplasm,Primary cilium,Centriolar satellite,Basal body"			NA	NA			"Cluster 22: Eosinophils - Transcription"	"Cluster 35: Non-specific - Mitochondria"	"Cluster 42: Choroid plexus - Mitochondria"	"Cluster 57: Stomach & Colon cancer - Digestion"	"Cluster 66: Photoreceptor cells - Visual perception"	38	Nucleoplasm	"Primary cilium, Centriolar satellite, Basal body"	"CAB075701: , HPA066941: , HPA067049: AB_2685770"	"unprognostic (1.79e-2)"	"unprognostic (4.00e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.67e-2)"	"unprognostic (5.82e-2)"	"unprognostic (5.52e-2)"	"unprognostic (4.53e-3)"	"unprognostic (4.96e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.48e-2)"	"validated prognostic favorable (7.88e-8)"	"validated prognostic favorable (1.63e-5)"	"unprognostic (8.96e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.16e-3)"	"unprognostic (7.48e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.52e-1)"	"unprognostic (6.33e-2)"	"unprognostic (3.15e-2)"	"unprognostic (7.51e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.90e-3)"	"unprognostic (3.39e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.32e-1)"
PPARD	"FAAR, NR1C2, NUC1, NUCII, PPARB"	ENSG00000112033	"Peroxisome proliferator activated receptor delta"	Q03181	6	35342558-35428191	"FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Microglial cells: 56.4;Syncytiotrophoblasts: 98.1"	"Cell type enhanced"	"Detected in all"		"central nervous system macrophage: 227.5;endothelial cell: 368.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB017635	Approved						NA	NA			"Cluster 36: Eosinophils - Protein ubiquitination"	"Cluster 80: Non-specific - Endocytosis"	"Cluster 47: Endothelial cells - Vasculature"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 45: Non-specific - Mixed function"	16			"CAB017635: AB_1128605"	"unprognostic (8.50e-2)"	"unprognostic (5.02e-3)"	"unprognostic (4.09e-2)"	"unprognostic (5.54e-2)"	"unprognostic (9.75e-2)"	"unprognostic (2.61e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.16e-3)"	"unprognostic (4.58e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.32e-2)"	"potential prognostic unfavorable (4.54e-4)"	"unprognostic (4.26e-1)"	"unprognostic (6.27e-3)"	"unprognostic (7.06e-3)"	"unprognostic (2.81e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.79e-2)"	"unprognostic (2.45e-2)"	"unprognostic (9.83e-3)"	"unprognostic (4.00e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.31e-1)"
PPARG	"NR1C3, PPARG1, PPARG2, PPARgamma"	ENSG00000132170	"Peroxisome proliferator activated receptor gamma"	P37231	3	12287368-12434356	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"Cancer-related genes, Diabetes mellitus, Disease variant, FDA approved drug targets, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 157.6"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 238.2;Cytotrophoblasts: 114.9;Distal enterocytes: 118.5;Extravillous trophoblasts: 250.4;Syncytiotrophoblasts: 107.6"	"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"Bladder Urothelial Carcinoma (TCGA): 111.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Minor Salivary Gland - Adipocytes (Minor salivary gland), Stomach - Gastric mucous cells, Testis - Spermatocytes, Testis - Spermatogonia"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"CAB004282, HPA051239, HPA063663"	Approved		Enhanced	Nucleoplasm,Vesicles			NA	NA				"Cluster 7: Adipose tissue - Mixed function"	"Cluster 37: Neurons - Mixed function"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 58: Macrophages - Innate immune response"	98	"Nucleoplasm, Vesicles"		"CAB004282: AB_628115, HPA051239: AB_2681400, HPA063663: AB_2685081"	"unprognostic (7.28e-3)"	"unprognostic (1.03e-2)"	"unprognostic (3.95e-3)"	"unprognostic (1.01e-2)"	"unprognostic (4.68e-2)"	"potential prognostic favorable (5.10e-4)"	"unprognostic (4.27e-3)"	"unprognostic (2.25e-1)"	"unprognostic (5.42e-3)"	"unprognostic (2.40e-2)"	"validated prognostic favorable (7.99e-8)"	"validated prognostic favorable (2.54e-5)"	"unprognostic (6.14e-2)"	"validated prognostic unfavorable (8.15e-7)"	"validated prognostic unfavorable (8.34e-6)"	"unprognostic (2.35e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.70e-2)"	"unprognostic (5.10e-1)"	"unprognostic (5.82e-2)"	"unprognostic (6.67e-3)"	"unprognostic (2.69e-3)"	"unprognostic (3.87e-2)"	"unprognostic (8.11e-2)"	"unprognostic (2.23e-2)"	"unprognostic (4.14e-3)"	"unprognostic (9.88e-2)"
PPIA	CYPA	ENSG00000196262	"Peptidylprolyl isomerase A"	P62937	7	44796680-44824564	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Host-virus interaction"	"Isomerase, Rotamase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"												"CAB004655, HPA058345"	Uncertain				"Secreted to blood"	Enzyme	NA	NA		210000000	"Cluster 13: Non-specific - Mitochondria"	"Cluster 33: Brain - Neuronal signaling"	"Cluster 14: Neurons - Synaptic function"	"Cluster 67: Non-specific - Unknown function"	"Cluster 49: Non-specific - Transcription"	52			"CAB004655: AB_425607, HPA058345: AB_2683685"	"unprognostic (9.63e-3)"	"unprognostic (6.63e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.11e-3)"	"unprognostic (8.90e-3)"	"unprognostic (7.13e-2)"	"potential prognostic unfavorable (4.53e-4)"	"unprognostic (4.48e-2)"	"validated prognostic unfavorable (1.91e-5)"	"validated prognostic unfavorable (4.99e-9)"	"potential prognostic unfavorable (8.07e-6)"	"unprognostic (1.46e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.80e-2)"	"unprognostic (7.52e-2)"	"potential prognostic unfavorable (6.29e-5)"	"unprognostic (8.07e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.13e-1)"	"unprognostic (2.18e-1)"	"unprognostic (6.18e-2)"	"unprognostic (5.99e-2)"
PPIF	"Cyp-D, CypD, hCyP3"	ENSG00000108179	"Peptidylprolyl isomerase F"	P30405	10	79347469-79355334	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Apoptosis, Necrosis"	"Isomerase, Rotamase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 411.2;Macrophages: 183.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 75.3"	"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"Adrenocortical cancer: 544.5"	"Heart muscle - Cardiomyocytes, Skin - Keratinocyte (granular), Stomach - Gastric mucous cells, Testis - Sertoli cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077416			Supported	Mitochondria			NA	NA		1500000	"Cluster 21: Neutrophils - Unknown function"	"Cluster 35: Non-specific - Mitochondria"	"Cluster 27: Non-specific - Mixed function"	"Cluster 52: Non-specific - Mitochondria"	"Cluster 29: Monocytes - Innate immune response"	26	Mitochondria		"HPA077416: AB_2686840"	"unprognostic (2.25e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.53e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.64e-2)"	"potential prognostic favorable (2.44e-4)"	"unprognostic (3.54e-3)"	"unprognostic (1.95e-2)"	"unprognostic (2.57e-3)"	"unprognostic (3.55e-3)"	"unprognostic (8.79e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.60e-2)"	"unprognostic (5.31e-3)"	"unprognostic (6.49e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.42e-2)"	"unprognostic (1.40e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.63e-2)"	"unprognostic (7.51e-2)"	"unprognostic (1.33e-1)"	"potential prognostic unfavorable (2.86e-4)"	"unprognostic (4.23e-2)"
PPP3R1	"CALNB1, CNB, CNB1"	ENSG00000221823	"Protein phosphatase 3 regulatory subunit B, alpha"	P63098	2	68178857-68256237	"FDA approved drug targets, Predicted intracellular proteins"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 163.2;retina: 184.1"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 146.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 2.7"	"Low lineage specificity"	"Detected in single"			"Low cancer specificity"	"Detected in all"			"Lung - Endothelial cells, Skin - Keratinocyte (other)"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005610, HPA047157"	Approved		Approved	"Plasma membrane,Primary cilium,Cytosol"			NA	NA		30000	"Cluster 35: Neutrophils - Protein binding"	"Cluster 17: Neuronal - Synaptic function"	"Cluster 51: Neurons - Mixed function"	"Cluster 26: Non-specific - Mitochondria & RNA binding"	"Cluster 58: Macrophages - Innate immune response"	22	"Plasma membrane"	"Primary cilium, Cytosol"	"CAB005610: AB_325975, HPA047157: AB_2679960"	"unprognostic (2.60e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.23e-3)"	"unprognostic (2.84e-1)"	"unprognostic (7.49e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.66e-3)"	"potential prognostic favorable (2.48e-5)"	"unprognostic (6.02e-2)"	"potential prognostic unfavorable (3.65e-4)"	"unprognostic (6.85e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.47e-2)"	"unprognostic (7.72e-2)"	"unprognostic (4.43e-2)"	"potential prognostic unfavorable (6.20e-4)"	"unprognostic (1.40e-2)"	"unprognostic (9.26e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.95e-1)"	"unprognostic (7.52e-3)"	"unprognostic (3.02e-1)"
PPP3R2	PPP3RL	ENSG00000188386	"Protein phosphatase 3 regulatory subunit B, beta"	Q96LZ3	9	101591604-101595021	"FDA approved drug targets, Predicted intracellular proteins"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	622	"testis: 78.6"	"Group enriched"	"Detected in some"	17	"Early spermatids: 453.5;Late spermatids: 208.6;Spermatocytes: 494.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Testis - Early spermatids"	"Not detected"	"Not detected"							HPA047157	Uncertain		Approved	"Plasma membrane,Primary cilium,Cytosol"			NA	NA				"Cluster 10: Testis - Spermatid development"	"Cluster 24: Neurons - Mixed function"	"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 70: Spermatocytes & Spermatids - Spermatid development"	7	"Plasma membrane"	"Primary cilium, Cytosol"	"HPA047157: AB_2679960"																															
PRDX5	"ACR1, AOEB166, B166, MGC117264, MGC142283, MGC142285, PLP, PMP20, PRDX6, PRXV, SBBI10"	ENSG00000126432	"Peroxiredoxin 5"	P30044	11	64318121-64321811	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Antioxidant, Oxidoreductase, Peroxidase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 1360.4"	"Cell type enhanced"	"Detected in all"		"Ciliated cells: 1873.2"	"Cell type enhanced"	"Detected in all"		"ependymal cell: 214.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Heart muscle - Cardiomyocytes, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008661, HPA037915, HPA037916"	Enhanced		Supported	Mitochondria			NA	NA		7500000	"Cluster 29: Non-specific - Unknown function"	"Cluster 23: Non-specific - Cellular respiration"	"Cluster 44: Non-specific - Mixed function"	"Cluster 24: Non-specific - Unknown function"	"Cluster 42: Ciliated cells - Cilium assembly"	17	Mitochondria		"CAB008661: AB_1620988, HPA037915: AB_2675735, HPA037916: AB_2675736"	"unprognostic (1.73e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.85e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.84e-3)"	"unprognostic (6.01e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.58e-3)"	"validated prognostic unfavorable (9.83e-5)"	"validated prognostic unfavorable (5.27e-5)"	"unprognostic (1.26e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.97e-2)"	"unprognostic (9.96e-2)"	"potential prognostic favorable (1.75e-5)"	"unprognostic (1.37e-1)"	"unprognostic (2.08e-3)"	"unprognostic (3.56e-1)"	"unprognostic (5.12e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.78e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.96e-1)"	"unprognostic (4.83e-2)"	"unprognostic (1.80e-1)"
PRG2	"BMPG, MBP, proMBP"	ENSG00000186652	"Proteoglycan 2, pro eosinophil major basic protein"	P13727	11	57386780-57390650	"FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	Immunity	"Antibiotic, Antimicrobial, Heparin-binding"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"placenta: 2526.3"	"Group enriched"	"Detected in some"	21	"Erythroid cells: 34.9;Extravillous trophoblasts: 106.5"	"Cell type enhanced"	"Detected in single"		"pericyte: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	36	"basophil: 7.3"	"Lineage enriched"	"Detected in single"	74	"granulocytes: 7.3"	"Cancer enriched"	"Detected in some"	47	"Leukemia: 370.8"	"Lung - Neutrophil_1, Spleen - Hematopoietic stem cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA038515	Supported				"Secreted in female reproductive system"	Immunity	NA	NA		74000000		"Cluster 58: Placenta - Pregnancy"		"Cluster 49: HMC-1 - Innate immune response"	"Cluster 4: Extravillous trophoblasts - Unknown function"	146			"HPA038515: AB_10675800"			"unprognostic (1.38e-1)"												"potential prognostic favorable (7.58e-5)"																
PRKAA1	AMPKa1	ENSG00000132356	"Protein kinase AMP-activated catalytic subunit alpha 1"	Q13131	5	40759389-40798374	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Autophagy, Biological rhythms, Cholesterol biosynthesis, Cholesterol metabolism, Fatty acid biosynthesis, Fatty acid metabolism, Host-virus interaction, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism, Transcription, Transcription regulation, Wnt signaling pathway"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 287.8;Late spermatids: 486.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Adrenal cortex cells, Testis - Early spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005050, HPA035409, HPA064946"	Supported		Supported	"Nuclear speckles,Primary cilium,Basal body,Cytosol"			NA	NA			"Cluster 35: Neutrophils - Protein binding"	"Cluster 78: Testis - Transcription"	"Cluster 45: Non-specific - Mixed function"	"Cluster 29: Non-specific - Unknown function"	"Cluster 63: Late spermatids - Spermatogenesis"	87	"Nuclear speckles"	"Primary cilium, Basal body, Cytosol"	"CAB005050: AB_562037, HPA035409: AB_2674613, HPA064946: AB_2685390"	"unprognostic (1.57e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.18e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.90e-3)"	"unprognostic (1.61e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.57e-3)"	"potential prognostic favorable (1.15e-6)"	"unprognostic (1.99e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.46e-2)"	"unprognostic (3.66e-2)"	"unprognostic (5.75e-2)"	"unprognostic (4.68e-2)"	"potential prognostic unfavorable (6.73e-5)"	"unprognostic (4.57e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.38e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.93e-2)"	"unprognostic (3.12e-2)"
PRKAA2	"AMPK, AMPKa2, PRKAA"	ENSG00000162409	"Protein kinase AMP-activated catalytic subunit alpha 2"	P54646	1	56645314-56715335	"Enzymes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Autophagy, Biological rhythms, Cholesterol biosynthesis, Cholesterol metabolism, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism, Transcription, Transcription regulation, Wnt signaling pathway"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 39.4;skeletal muscle: 37.2;tongue: 35.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 486.4;Excitatory neurons: 105.7;Inhibitory neurons: 114.1;Rod photoreceptor cells: 124.8;Skeletal myocytes: 222.5"	"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"Kidney Renal Clear Cell Carcinoma (TCGA): 9.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Adipose subcutaneous - Smooth muscle cells, Heart muscle - Cardiomyocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044540	Approved		Supported	"Nucleoplasm,Nuclear speckles,Golgi apparatus,Basal body,Cytosol"			NA	NA				"Cluster 12: Heart muscle - Cardiac muscle contraction"	"Cluster 23: Choroid plexus - Mixed function"	"Cluster 7: Liver cancer - Metabolism"	"Cluster 68: Cardiomyocytes - Muscle contraction"	118	"Nuclear speckles"	"Nucleoplasm, Golgi apparatus, Basal body, Cytosol"	"HPA044540: AB_2678977"		"unprognostic (2.74e-3)"	"unprognostic (1.34e-1)"	"unprognostic (6.14e-3)"		"unprognostic (1.48e-2)"	"unprognostic (2.40e-2)"	"unprognostic (2.50e-2)"		"unprognostic (2.15e-1)"	"potential prognostic favorable (4.38e-10)"	"unprognostic (1.83e-3)"	"unprognostic (4.97e-2)"	"potential prognostic unfavorable (2.80e-4)"	"unprognostic (2.72e-2)"	"unprognostic (1.59e-2)"	"unprognostic (6.89e-2)"	"unprognostic (5.35e-3)"	"unprognostic (4.52e-2)"	"unprognostic (5.14e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.11e-1)"		"unprognostic (2.69e-2)"		"unprognostic (8.31e-3)"		"unprognostic (3.68e-2)"	"unprognostic (6.88e-2)"
PRKAB1		ENSG00000111725	"Protein kinase AMP-activated non-catalytic subunit beta 1"	Q9Y478	12	119667864-119681624	"FDA approved drug targets, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 55.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Lung - Alveolar cells type 2, Spleen - Endothelial cells, Testis - Spermatocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004247, CAB005058"	Enhanced		Approved	"Nucleoplasm,Primary cilium transition zone,Cytosol"			NA	NA			"Cluster 42: Non-specific - Vesicular transport"	"Cluster 40: Non-specific - Transcription"	"Cluster 30: White matter - Myelination"	"Cluster 38: Non-specific - Transcription"	"Cluster 1: Erythroid cells - Oxygen transport"	30	Cytosol	"Nucleoplasm, Primary cilium transition zone"	"CAB005058: AB_562038, HPA004247: AB_1078149"	"unprognostic (1.13e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.25e-1)"	"unprognostic (9.11e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.49e-1)"	"validated prognostic favorable (3.45e-9)"	"validated prognostic favorable (1.01e-4)"	"unprognostic (6.14e-2)"	"unprognostic (3.53e-2)"	"unprognostic (4.53e-3)"	"unprognostic (6.04e-3)"	"unprognostic (5.06e-2)"	"unprognostic (6.40e-3)"	"unprognostic (1.94e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.80e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.30e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.25e-1)"
PRKAB2		ENSG00000131791	"Protein kinase AMP-activated non-catalytic subunit beta 2"	O43741	1	147155106-147172550	"FDA approved drug targets, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 93.8;tongue: 99.8"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 78.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Adrenal cortex cells, Liver - Hepatocytes, Lung - Fibroblast_1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044342	Enhanced		Approved	Nucleoplasm,Cytosol			NA	NA			"Cluster 41: Basophils - Unknown function"	"Cluster 19: Non-specific - Basic cellular processes"	"Cluster 37: Neurons - Mixed function"	"Cluster 45: Non-specific - Nuclear processes"	"Cluster 32: Smooth muscle cells - Muscle contraction"	219	Nucleoplasm	Cytosol	"HPA044342: AB_10966508"	"unprognostic (5.31e-2)"	"potential prognostic unfavorable (7.91e-4)"	"unprognostic (5.21e-2)"	"unprognostic (3.02e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.09e-2)"	"unprognostic (9.12e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.30e-3)"	"unprognostic (1.32e-2)"	"unprognostic (3.76e-3)"	"potential prognostic favorable (2.28e-4)"	"unprognostic (2.25e-2)"	"unprognostic (7.14e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.51e-2)"	"unprognostic (8.69e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.60e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.60e-1)"	"unprognostic (7.91e-2)"	"unprognostic (4.09e-1)"	"potential prognostic unfavorable (4.39e-4)"	"unprognostic (6.47e-2)"
PRKAG1		ENSG00000181929	"Protein kinase AMP-activated non-catalytic subunit gamma 1"	P54619	12	49002274-49018807	"FDA approved drug targets, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Adrenal cortex cells, Heart muscle - Cardiomyocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077805			Approved	"Nucleoplasm,Nuclear bodies,Basal body,Cytosol"			NA	NA			"Cluster 10: Non-specific - Membrane trafficking"	"Cluster 35: Non-specific - Mitochondria"	"Cluster 16: Non-specific - Transcription"	"Cluster 38: Non-specific - Transcription"	"Cluster 39: Non-specific - Basic cellular processes"	49	"Nuclear bodies, Cytosol"	"Nucleoplasm, Basal body"	"HPA077805: AB_2686855"	"unprognostic (1.36e-1)"	"unprognostic (6.19e-3)"	"unprognostic (1.38e-2)"	"unprognostic (9.58e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.67e-1)"	"unprognostic (6.75e-3)"	"unprognostic (2.08e-2)"	"potential prognostic favorable (2.47e-8)"	"unprognostic (1.91e-1)"	"unprognostic (6.83e-3)"	"validated prognostic unfavorable (5.93e-7)"	"validated prognostic unfavorable (5.40e-4)"	"unprognostic (1.50e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.60e-2)"	"unprognostic (2.72e-1)"	"unprognostic (9.15e-2)"	"unprognostic (5.53e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.87e-2)"	"unprognostic (5.71e-3)"	"unprognostic (9.87e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.84e-3)"
PRKAG2	"AAKG, AAKG2, CMH6, H91620p, WPWS"	ENSG00000106617	"Protein kinase AMP-activated non-catalytic subunit gamma 2"	Q9UGJ0	7	151556124-151877125	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"		"Cardiomyopathy, Disease variant, FDA approved drug targets, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 138.2"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 201.5"	"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"Kidney Chromophobe (TCGA): 69.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Prostate - Smooth muscle cells, Testis - Spermatogonia"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004246, CAB018641"	Uncertain		Approved	Nucleoplasm			NA	NA			"Cluster 35: Neutrophils - Protein binding"	"Cluster 30: Heart muscle - Heart development"	"Cluster 38: Sub-cortical - Mixed function"	"Cluster 72: Neuronal - Signal transduction"	"Cluster 34: Neurons - Neuronal signaling"	9	Nucleoplasm		"CAB018641: AB_2170355, HPA004246: AB_1078151"	"unprognostic (6.14e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.46e-2)"	"unprognostic (6.06e-3)"	"unprognostic (2.50e-1)"	"unprognostic (3.90e-1)"	"unprognostic (2.55e-2)"	"unprognostic (2.12e-3)"	"unprognostic (1.49e-1)"	"potential prognostic favorable (3.99e-5)"	"unprognostic (4.92e-2)"	"potential prognostic unfavorable (1.91e-4)"	"unprognostic (1.44e-1)"	"unprognostic (7.69e-3)"	"unprognostic (2.97e-1)"	"unprognostic (2.17e-1)"	"unprognostic (7.02e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.16e-2)"	"unprognostic (8.92e-2)"	"unprognostic (3.05e-1)"	"potential prognostic unfavorable (4.35e-4)"	"unprognostic (2.14e-1)"	"unprognostic (3.16e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.33e-1)"
PRKAG3		ENSG00000115592	"Protein kinase AMP-activated non-catalytic subunit gamma 3"	Q9UGI9	2	218822308-218832086	"FDA approved drug targets, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skeletal muscle: 80.3"	"Cell type enriched"	"Detected in some"	27	"Skeletal myocytes: 28.3"	"Cell type enriched"	"Detected in single"	6	"medium spiny neuron: 1.9"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"basal ganglia: 3.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"				"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"										NA	NA				"Cluster 2: Skeletal muscle - Striated muscle contraction"	"Cluster 33: Neurons - Mixed function"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 2: Skeletal myocytes - Muscle contraction"	30																																		
PRKCA	"PKCA, PKCalpha"	ENSG00000154229	"Protein kinase C alpha"	P17252	17	66302613-66810743	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Angiogenesis, Apoptosis, Cell adhesion"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 34.8"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 535.7;Bipolar cells: 204.7;Excitatory neurons: 239.5;Inhibitory neurons: 384.2;Microglial cells: 268.4;Oligodendrocyte precursor cells: 796.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Adipose visceral - Adipose progenitor cells, Adrenal gland - Adrenal cortex cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003844, HPA006563, HPA006564, CAB016290"	Enhanced	Approved	Enhanced	"Plasma membrane,Cytosol"			NA	NA		170000	"Cluster 11: T-cells - Unknown function"	"Cluster 17: Neuronal - Synaptic function"	"Cluster 29: Forebrain - Mixed function"	"Cluster 72: Neuronal - Signal transduction"	"Cluster 25: Bipolar cells - Visual perception"	119	"Plasma membrane, Cytosol"		"CAB003844: AB_562331, CAB016290: AB_628141, HPA006563: AB_1079626, HPA006564: AB_1079625"	"unprognostic (2.13e-2)"	"unprognostic (5.59e-1)"	"unprognostic (3.81e-2)"	"potential prognostic unfavorable (3.97e-4)"	"unprognostic (1.32e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.98e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.83e-2)"	"potential prognostic unfavorable (5.02e-4)"	"unprognostic (3.50e-3)"	"unprognostic (7.80e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.81e-2)"	"unprognostic (8.91e-2)"	"unprognostic (4.01e-1)"	"unprognostic (1.77e-1)"	"unprognostic (6.46e-3)"	"unprognostic (7.15e-2)"	"unprognostic (9.55e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.73e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.18e-1)"	"unprognostic (4.68e-3)"	"unprognostic (6.96e-3)"
PRKCB	"PKCB, PKCbeta, PRKCB1, PRKCB2"	ENSG00000166501	"Protein kinase C beta"	P05771	16	23835983-24220611	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins, Transporters"	"Adaptive immunity, Apoptosis, Immunity, Transcription, Transcription regulation"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 111.3;lymphoid tissue: 46.0"	"Cell type enhanced"	"Detected in many"		"B-cells: 196.9;dendritic cells: 294.4;Excitatory neurons: 848.7;Inhibitory neurons: 306.1;Kupffer cells: 175.5;monocytes: 262.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"Bone cancer: 46.8;Leukemia: 59.7;lymphoma: 24.6"	"Adrenal gland - Macrophages, Liver - Kupffer cells, Skin - Keratinocyte (other), Testis - Sertoli cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003843, HPA048321, HPA054203"	Approved		Supported	Nucleoplasm,Cytosol			NA	NA		440000	"Cluster 32: Basophils - Transcription"	"Cluster 5: Brain & Testis - Signal transduction"	"Cluster 53: Neurons - Mixed function"	"Cluster 47: Leukemia - Hemostasis"	"Cluster 34: Neurons - Neuronal signaling"	31	Nucleoplasm	Cytosol	"CAB003843: AB_562197, HPA048321: AB_2680357, HPA054203: AB_2682416"	"unprognostic (1.06e-1)"	"unprognostic (3.41e-3)"	"unprognostic (3.37e-3)"	"unprognostic (8.39e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.66e-2)"	"unprognostic (5.24e-3)"		"unprognostic (9.06e-3)"	"unprognostic (7.61e-2)"	"unprognostic (2.17e-1)"		"unprognostic (6.78e-3)"	"potential prognostic favorable (4.40e-5)"	"unprognostic (1.71e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.37e-1)"	"unprognostic (8.20e-2)"		"unprognostic (1.01e-1)"	"unprognostic (2.24e-2)"	"unprognostic (6.18e-2)"	"unprognostic (5.35e-2)"	"unprognostic (4.85e-2)"	"unprognostic (9.51e-3)"	"unprognostic (2.32e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.91e-1)"
PRKCD		ENSG00000163932	"Protein kinase C delta"	Q05655	3	53156009-53192717	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 73.8"	"Cell type enhanced"	"Detected in many"		"central nervous system macrophage: 122.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"dendritic cells: 55.3;granulocytes: 49.5;monocytes: 71.9"	"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Heart muscle - Macrophages, Skeletal muscle - Macrophages, Spleen - Neutrophils, Stomach - Gastric mucous cells"	"Group enriched"	"Detected in all"	5	"basal ganglia: 121.5;thalamus: 334.8"	"Low region specificity"	"Detected in all"			"HPA001863, HPA001890, CAB010469, CAB013225"	Enhanced		Enhanced	"Endoplasmic reticulum,Golgi apparatus,Cytosol"			NA	NA		110000	"Cluster 29: Non-specific - Unknown function"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 51: Neurons - Mixed function"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 73: B-cells - B-cell function"	45	Cytosol	"Endoplasmic reticulum, Golgi apparatus"	"CAB010469: AB_632229, CAB013225: , HPA001863: AB_1079627, HPA001890: AB_1079628"	"unprognostic (3.23e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.01e-2)"	"unprognostic (8.54e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.53e-2)"	"unprognostic (2.99e-1)"	"unprognostic (6.74e-2)"	"potential prognostic favorable (8.14e-6)"	"unprognostic (6.06e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.58e-3)"	"unprognostic (3.82e-3)"	"potential prognostic favorable (1.27e-4)"	"unprognostic (1.60e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.55e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.20e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.41e-1)"
PRKCE		ENSG00000171132	"Protein kinase C epsilon"	Q02156	2	45651345-46187990	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Cell adhesion, Cell cycle, Cell division, Immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 31.2"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 148.8;Excitatory neurons: 381.3;Inhibitory neurons: 509.5;Late spermatids: 472.0;Oligodendrocyte precursor cells: 138.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cancer specificity"	"Detected in all"			"Lung - Endothelial cells, Testis - Late spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001948, HPA008236, HPA044496"	Enhanced	Supported	Supported	"Vesicles,Plasma membrane,Intermediate filaments,Cytosol"			NA	NA			"Cluster 23: B-cells - Immunoglobulins"	"Cluster 22: Brain - Synaptic signal transduction"	"Cluster 51: Neurons - Mixed function"	"Cluster 6: Leukemia - Signal transduction"	"Cluster 65: Neurons - Synaptic function"	30	"Intermediate filaments, Cytosol"	"Vesicles, Plasma membrane"	"CAB001948: , HPA008236: , HPA044496: AB_2678959"	"unprognostic (4.97e-2)"	"unprognostic (8.67e-2)"	"unprognostic (7.77e-2)"	"unprognostic (8.60e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.74e-2)"	"unprognostic (2.76e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.91e-1)"	"potential prognostic favorable (1.41e-10)"	"unprognostic (5.19e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.65e-1)"	"unprognostic (7.12e-2)"	"unprognostic (1.49e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.44e-2)"	"unprognostic (2.90e-2)"	"unprognostic (9.64e-2)"	"potential prognostic unfavorable (8.47e-4)"	"unprognostic (1.20e-2)"	"unprognostic (2.28e-2)"	"unprognostic (9.93e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.09e-2)"	"unprognostic (8.86e-2)"
PRKCG	"MGC57564, PKCC, PKCG, PKCgamma, SCA14"	ENSG00000126583	"Protein kinase C gamma"	P05129	19	53879190-53907652	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, RAS pathway related proteins"	"Biological rhythms"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"brain: 87.6"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 21.9;Inhibitory neurons: 12.2;Oocytes: 19.9"	"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in many"		"Testicular Germ Cell Tumor (TCGA): 3.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Pancreas - Alpha cells, Stomach - Gastric enteroendocrine cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054560	Enhanced						NA	NA				"Cluster 61: Brain - Neuronal signaling"	"Cluster 51: Neurons - Mixed function"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 69: Neurons - Neuronal signaling"	9			"HPA054560: AB_2682523"					"unprognostic (9.96e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.43e-1)"												"unprognostic (7.02e-2)"		"unprognostic (9.83e-3)"	"unprognostic (3.69e-2)"		"unprognostic (3.68e-1)"	"unprognostic (1.72e-1)"		"unprognostic (3.88e-2)"	"unprognostic (1.01e-1)"		"unprognostic (4.42e-1)"
PRKCI	"DXS1179E, PKCI"	ENSG00000163558	"Protein kinase C iota"	P41743	3	170222424-170305977	"Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Alveolar cells type 2: 134.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026574, HPA038635"	Approved		Supported	"Microtubules,Cytokinetic bridge,Primary cilium,Cytosol"			Yes	No			"Cluster 3: Non-specific - Nuclear processes"	"Cluster 24: Parathyroid gland - Vesicular transport"	"Cluster 14: Neurons - Synaptic function"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 72: Alveolar cells - Lung function"	67	Cytosol	"Microtubules, Cytokinetic bridge, Primary cilium"	"HPA026574: AB_1855428, HPA038635: AB_2676124"	"unprognostic (1.48e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.36e-1)"	"unprognostic (7.05e-2)"	"unprognostic (9.27e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.84e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.91e-2)"	"potential prognostic favorable (3.65e-7)"	"unprognostic (3.78e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.15e-2)"	"unprognostic (2.64e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.06e-1)"	"potential prognostic unfavorable (7.92e-4)"	"potential prognostic unfavorable (2.05e-4)"	"unprognostic (1.65e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.50e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.46e-1)"
PRKCQ		ENSG00000065675	"Protein kinase C theta"	Q04759	10	6427143-6580301	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Immunity, Inflammatory response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"lymphoid tissue: 32.2;skeletal muscle: 118.7;tongue: 107.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 21.7;NK-cells: 33.6;Oligodendrocyte precursor cells: 23.1;Oligodendrocytes: 70.0;Skeletal myocytes: 34.2;T-cells: 37.6"	"Cell type enhanced"	"Detected in all"		"choroid plexus epithelial cell: 245.3;leukocyte: 413.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"gdT-cell: 23.1;MAIT T-cell: 17.9;memory CD4 T-cell: 24.5;memory CD8 T-cell: 24.4;naive CD4 T-cell: 19.1;naive CD8 T-cell: 17.9;NK-cell: 13.3;T-reg: 39.8"	"Group enriched"	"Detected in many"	11	"NK-cells: 13.3;T-cells: 39.8"	"Cancer enriched"	"Detected in many"	6	"Leukemia: 18.2"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Liver - T-cells, Lung - Alveolar cells type 2, Prostate - T-cells, Skeletal muscle - Skeletal myocytes, Skin - T-cells, Spleen - T-cells, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065279, HPA073098"			Enhanced	"Centriolar satellite"			NA	NA			"Cluster 5: Non-specific - Cell proliferation"	"Cluster 14: Skeletal muscle - Muscle contraction"	"Cluster 11: White matter - Signal transduction"	"Cluster 59: Leukemia - T-cell receptor"	"Cluster 78: NK-cells & T-cells - Immune system & Transcription"	21	"Centriolar satellite"		"HPA065279: AB_2685453, HPA073098: AB_2686571"	"unprognostic (4.19e-2)"	"unprognostic (6.06e-3)"	"potential prognostic favorable (8.48e-4)"	"unprognostic (7.96e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.41e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.45e-3)"	"unprognostic (8.22e-2)"	"unprognostic (6.05e-2)"			"unprognostic (2.61e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.21e-3)"	"unprognostic (3.33e-1)"	"unprognostic (1.35e-1)"	"unprognostic (9.12e-2)"	"unprognostic (1.14e-2)"		"unprognostic (8.72e-2)"	"unprognostic (1.12e-3)"		"unprognostic (7.92e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.73e-2)"
PRKCZ	PKC2	ENSG00000067606	"Protein kinase C zeta"	Q05513	1	2050411-2185395	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Inflammatory response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 149.3"	"Group enriched"	"Detected in many"	4	"Late spermatids: 712.5;Syncytiotrophoblasts: 1279.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"eosinophil: 16.3"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 16.3"	"Low cancer specificity"	"Detected in all"			"Adipose visceral - Mesothelial cells, Prostate - Prostate glandular cells, Skin - Keratinocyte (other), Testis - Late spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021851	Enhanced		Supported	"Plasma membrane,Basal body,Cytosol,Flagellar centriole,Mid piece,End piece"			NA	NA			"Cluster 22: Eosinophils - Transcription"	"Cluster 65: Cerebellum - Nervous system development"	"Cluster 37: Neurons - Mixed function"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 27: Syncytiotrophoblasts - Pregnancy"	105	Cytosol	"Plasma membrane, Basal body, Flagellar centriole, Mid piece, End piece"	"HPA021851: AB_1855433"	"unprognostic (9.52e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.91e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.79e-2)"	"unprognostic (9.42e-3)"	"unprognostic (2.00e-1)"	"potential prognostic favorable (3.35e-4)"	"unprognostic (3.07e-1)"	"unprognostic (8.30e-3)"	"potential prognostic favorable (2.71e-10)"	"unprognostic (6.89e-3)"	"unprognostic (1.19e-2)"	"unprognostic (2.72e-2)"	"potential prognostic unfavorable (6.15e-4)"	"unprognostic (7.94e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.49e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.04e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.70e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.25e-1)"	"unprognostic (8.46e-2)"
PRLR		ENSG00000113494	"Prolactin receptor"	P16471	5	35048756-35230487	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 124.2;parathyroid gland: 79.9"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 59.1;Breast glandular cells: 71.4;Endometrial stromal cells: 107.2;Proximal tubular cells: 46.7;Syncytiotrophoblasts: 65.0"	"Cell type enriched"	"Detected in many"	17	"choroid plexus epithelial cell: 2839.2"	"Group enriched"	"Detected in many"	6	"Breast Invasive Carcinoma (TCGA): 40.8;Kidney Chromophobe (TCGA): 16.4"	"Region enriched"	"Detected in all"	19	"choroid plexus: 1734.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	8	"breast cancer: 36.0"	"Adrenal gland - Adrenal cortex cells, Kidney - Proximal tubular cells, Kidney - Proximal tubular cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Intracellular and membrane"	Receptor	NA	NA			"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 60: Choroid plexus - Transmembrane transport"	"Cluster 36: Choroid plexus - Mixed function"	"Cluster 27: Breast cancer - Unknown function"	"Cluster 9: Endometrial stromal cells - Transcription"	8					"unprognostic (8.08e-3)"	"unprognostic (3.52e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.34e-1)"		"unprognostic (3.42e-2)"		"unprognostic (3.44e-3)"	"unprognostic (1.35e-3)"	"unprognostic (1.74e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.39e-2)"	"unprognostic (3.30e-3)"	"unprognostic (1.04e-3)"	"unprognostic (2.65e-1)"	"unprognostic (9.50e-2)"	"unprognostic (2.22e-1)"			"potential prognostic favorable (7.01e-4)"	"unprognostic (8.49e-2)"	"unprognostic (6.88e-3)"	"unprognostic (2.51e-2)"	"unprognostic (7.77e-2)"		"unprognostic (9.49e-2)"			"unprognostic (3.13e-1)"
PROC		ENSG00000115718	"Protein C, inactivator of coagulation factors Va and VIIIa"	P04070	2	127418427-127429242	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease variant, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	40	"liver: 584.1"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 339.4"	"Cell type enhanced"	"Detected in some"		"deep-layer near-projecting: 3.9;lower rhombic lip: 6.0"	"Cancer enriched"	"Detected in many"	7	"Liver Hepatocellular Carcinoma (TCGA): 301.0"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	9	"plasmacytoid DC: 59.8"	"Lineage enriched"	"Detected in many"	9	"dendritic cells: 59.8"	"Cancer enriched"	"Detected in many"	6	"liver cancer: 28.4"	"Kidney - Proximal tubular cells, Kidney - Proximal tubular cells, Liver - Hepatocytes, Skin - Outer root sheath cells"					"Not detected"	"Not detected"			"HPA005550, CAB016721, CAB016792"	Approved				"Secreted to blood"	"Blood coagulation"	NA	NA		3100000000	"Cluster 8: Plasmacytoid DCs - Unknown function"	"Cluster 31: Liver - Plasma proteins"	"Cluster 26: Oligodendrocytes - Mixed function"	"Cluster 18: Liver cancer - Metabolism"	"Cluster 43: Hepatocytes - Metabolism"	2			"CAB016721: , CAB016792: , HPA005550: AB_1079687"	"unprognostic (7.94e-3)"	"unprognostic (2.01e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.49e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.90e-2)"	"unprognostic (3.68e-1)"		"unprognostic (1.67e-2)"		"unprognostic (4.80e-3)"	"unprognostic (1.54e-2)"	"unprognostic (4.75e-3)"	"unprognostic (7.99e-3)"	"potential prognostic favorable (9.35e-4)"	"unprognostic (4.14e-1)"	"unprognostic (1.95e-2)"	"unprognostic (5.99e-2)"		"unprognostic (3.90e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.63e-2)"	"unprognostic (2.81e-2)"	"unprognostic (4.92e-2)"		"unprognostic (3.76e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.73e-2)"	"unprognostic (9.58e-3)"
PROCR	"CCD41, CD201, EPCR"	ENSG00000101000	"Protein C receptor"	Q9UNN8	20	35172072-35216240	"Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Blood coagulation, Hemostasis"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 122.7"	"Cell type enriched"	"Detected in many"	4	"Mesothelial cells: 659.6"	"Cell type enhanced"	"Detected in all"		"central nervous system macrophage: 51.7;endothelial cell: 66.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 14.8"	"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Minor Salivary Gland - Endothelial cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA039461	Enhanced						NA	NA		530000000	"Cluster 33: Non-specific - ATP binding"	"Cluster 7: Adipose tissue - Mixed function"	"Cluster 6: Non-specific - Immune response"	"Cluster 48: Adipocytes & Endothelial cells - Angiogenesis"	"Cluster 53: Fibroblasts - ECM organization"	1			"HPA039461: AB_10673359"	"unprognostic (2.04e-1)"	"unprognostic (3.22e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.30e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.87e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.68e-3)"	"unprognostic (8.57e-3)"	"unprognostic (1.14e-1)"	"unprognostic (7.52e-2)"	"unprognostic (2.54e-2)"	"unprognostic (8.08e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.43e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.74e-2)"	"unprognostic (3.85e-2)"	"unprognostic (8.42e-2)"	"unprognostic (4.53e-3)"	"unprognostic (7.66e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.73e-2)"
PROS1	PROS	ENSG00000184500	"Protein S"	P07225	3	93873051-93980003	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis"		"Disease variant, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 137.3;liver: 274.9"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 261.3;Mesothelial cells: 85.9"	"Group enriched"	"Detected in all"	4	"choroid plexus epithelial cell: 939.1;ependymal cell: 337.2"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	34	"choroid plexus: 214.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"skin cancer: 46.7"	"Adrenal gland - Fibroblasts, Breast - Fibroblasts, Liver - Hepatocytes, Minor Salivary Gland - Macrophages"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007724, HPA023974, CAB032610"	Approved				"Secreted to blood"	"Blood coagulation"	NA	NA	22500000000	8100000000		"Cluster 83: Liver - Metabolism"	"Cluster 36: Choroid plexus - Mixed function"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 53: Fibroblasts - ECM organization"	19			"CAB032610: AB_2237647, HPA007724: AB_1079688, HPA023974: AB_1855738"	"unprognostic (3.93e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.41e-1)"	"potential prognostic unfavorable (1.88e-4)"	"unprognostic (2.02e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.82e-3)"	"potential prognostic favorable (3.02e-7)"	"unprognostic (5.17e-3)"	"unprognostic (1.34e-1)"	"unprognostic (7.58e-2)"	"unprognostic (4.64e-1)"	"unprognostic (6.34e-2)"	"unprognostic (3.68e-1)"	"unprognostic (6.29e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.91e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.44e-2)"	"unprognostic (6.81e-2)"	"unprognostic (7.35e-2)"	"potential prognostic unfavorable (1.52e-4)"	"unprognostic (1.80e-1)"	"unprognostic (7.22e-2)"	"unprognostic (2.94e-1)"
PSMB1	"HC5, PMSB1"	ENSG00000008018	"Proteasome 20S subunit beta 1"	P20618	6	170535120-170553307	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"Deafness, FDA approved drug targets, Intellectual disability"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 1289.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029635, HPA029637, CAB033911"	Enhanced		Supported	Nucleoplasm			NA	NA		12000000	"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 35: Non-specific - Mitochondria"	"Cluster 21: Non-specific - Metabolism"	"Cluster 28: Non-specific - Nuclear processes"	"Cluster 15: Non-specific - Mixed function"	253	Nucleoplasm		"CAB033911: AB_2268890, HPA029635: AB_10599738, HPA029637: AB_10601793"	"potential prognostic unfavorable (2.99e-4)"	"potential prognostic unfavorable (2.34e-5)"	"unprognostic (2.91e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.33e-2)"	"unprognostic (3.44e-2)"	"unprognostic (5.54e-2)"	"unprognostic (5.60e-1)"	"unprognostic (1.23e-3)"	"unprognostic (5.21e-2)"	"unprognostic (2.15e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.80e-2)"	"unprognostic (9.48e-3)"	"potential prognostic unfavorable (1.02e-4)"	"potential prognostic unfavorable (5.40e-4)"	"unprognostic (1.84e-2)"	"unprognostic (2.94e-3)"	"unprognostic (1.35e-1)"	"unprognostic (4.61e-2)"	"unprognostic (4.30e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.69e-2)"	"unprognostic (4.06e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.72e-1)"	"unprognostic (2.28e-2)"	"unprognostic (9.09e-3)"	"unprognostic (2.26e-1)"
PSMB10	"beta2i, LMP10, MECL1, MGC1665"	ENSG00000205220	"Proteasome 20S subunit beta 10"	P40306	16	67934506-67936864	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 119.4"	"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 145.3"	"Cell type enhanced"	"Detected in some"		"leukocyte: 4.9;pericyte: 4.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Spleen - T-cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030224, HPA030225, CAB034384, CAB080377"	Enhanced		Approved	Vesicles,Cytosol			NA	NA		1300000	"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 22: Non-specific - Mixed function"	"Cluster 35: RS4;11 - Unknown function"	"Cluster 7: T-cells - T-cell receptor"	27	"Vesicles, Cytosol"		"CAB034384: AB_2171876, CAB080377: , HPA030224: AB_2673382, HPA030225: AB_10603231"	"unprognostic (3.33e-1)"	"unprognostic (8.71e-3)"	"unprognostic (3.72e-2)"	"unprognostic (6.77e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.51e-2)"	"unprognostic (6.10e-3)"	"unprognostic (1.43e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.64e-2)"	"unprognostic (8.08e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.84e-3)"	"unprognostic (1.66e-1)"
PSMB2	HC7-I	ENSG00000126067	"Proteasome 20S subunit beta 2"	P49721	1	35599541-35641526	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 465.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026322, HPA026324"	Approved		Enhanced	Nucleoplasm			NA	NA		7900000	"Cluster 10: Non-specific - Membrane trafficking"	"Cluster 43: Non-specific - Mitochondrial translation"	"Cluster 30: White matter - Myelination"	"Cluster 37: Non-specific - mRNA processing"	"Cluster 15: Non-specific - Mixed function"	153	Nucleoplasm		"HPA026322: AB_1855821, HPA026324: AB_1855822"	"unprognostic (1.44e-1)"	"unprognostic (5.69e-2)"	"unprognostic (5.06e-2)"	"unprognostic (7.29e-2)"	"potential prognostic favorable (6.59e-5)"	"unprognostic (1.51e-1)"	"unprognostic (1.94e-2)"	"unprognostic (4.89e-2)"	"unprognostic (8.32e-2)"	"unprognostic (1.37e-3)"	"unprognostic (6.17e-2)"	"unprognostic (3.68e-2)"	"unprognostic (3.13e-1)"	"potential prognostic unfavorable (2.02e-6)"	"unprognostic (1.03e-2)"	"potential prognostic unfavorable (7.24e-4)"	"unprognostic (2.87e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.57e-1)"	"unprognostic (4.36e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.86e-1)"	"unprognostic (7.02e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.93e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.81e-2)"
PSMB5	MB1	ENSG00000100804	"Proteasome 20S subunit beta 5"	P28074	14	23016543-23035230	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049518, HPA061796"	Approved		Supported	"Nucleoplasm,Centrosome,Mid piece,Principal piece"			NA	NA		6500000	"Cluster 13: Non-specific - Mitochondria"	"Cluster 14: Skeletal muscle - Muscle contraction"	"Cluster 27: Non-specific - Mixed function"	"Cluster 30: Non-specific - Gene expression regulation"	"Cluster 15: Non-specific - Mixed function"	120	Nucleoplasm	"Centrosome, Mid piece, Principal piece"	"HPA049518: AB_2680802, HPA061796: AB_2684612"	"potential prognostic unfavorable (4.44e-4)"	"unprognostic (1.30e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.32e-2)"	"potential prognostic favorable (9.63e-5)"	"unprognostic (3.01e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.36e-2)"	"potential prognostic unfavorable (2.60e-5)"	"unprognostic (2.64e-2)"	"unprognostic (3.99e-3)"	"unprognostic (2.02e-1)"	"unprognostic (3.99e-2)"	"validated prognostic unfavorable (7.07e-6)"	"validated prognostic unfavorable (2.93e-6)"	"unprognostic (2.72e-3)"	"potential prognostic unfavorable (2.12e-4)"	"unprognostic (3.42e-2)"	"unprognostic (2.16e-1)"	"potential prognostic favorable (1.02e-4)"	"unprognostic (2.91e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.98e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.09e-2)"	"unprognostic (4.30e-1)"	"unprognostic (6.98e-3)"
PSMB8	"beta5i, D6S216E, LMP7, PSMB5i, RING10"	ENSG00000204264	"Proteasome 20S subunit beta 8"	P28062	6	32840717-32844679	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Host-virus interaction, Immunity"	"Hydrolase, Protease, Threonine protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 335.0"	"Cell type enhanced"	"Detected in many"		"endothelial cell: 47.4;leukocyte: 52.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Breast - T-cells, Heart muscle - Endothelial cells, Skeletal muscle - Endothelial cells, Thyroid gland - T-cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046995, HPA050327"	Enhanced		Approved	"Vesicles,Cytokinetic bridge"			Yes	No		2300000	"Cluster 25: Non-specific - Unknown function"	"Cluster 47: Spleen - Immune response"	"Cluster 22: Non-specific - Mixed function"	"Cluster 31: Non-specific - Antiviral immune response"	"Cluster 14: Langerhans cells - Innate immune response"	40	Vesicles	"Cytokinetic bridge"	"HPA046995: AB_2679896, HPA050327: AB_2681088"	"unprognostic (3.53e-1)"	"unprognostic (2.98e-2)"	"unprognostic (3.40e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.61e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.03e-3)"	"unprognostic (1.07e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.81e-2)"	"unprognostic (3.36e-3)"	"unprognostic (1.47e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.76e-3)"	"unprognostic (3.53e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.62e-3)"	"unprognostic (3.57e-2)"
PSMB9	"beta1i, LMP2, PSMB6i, RING12"	ENSG00000240065	"Proteasome 20S subunit beta 9"	P28065	6	32844136-32859851	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Immunity"	"Hydrolase, Protease, Threonine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 157.0"	"Cell type enhanced"	"Detected in many"		"NK-cells: 326.2;Proximal enterocytes: 354.8"	"Cell type enhanced"	"Detected in many"		"endothelial cell: 63.9;leukocyte: 99.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Thyroid gland - T-cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015180, HPA042818, HPA053280"	Enhanced		Supported	Cytosol			NA	NA		480000	"Cluster 42: Non-specific - Vesicular transport"	"Cluster 47: Spleen - Immune response"	"Cluster 43: Hindbrain - Mixed function"	"Cluster 31: Non-specific - Antiviral immune response"	"Cluster 14: Langerhans cells - Innate immune response"	39	Cytosol		"CAB015180: AB_2172368, HPA042818: AB_2678186, HPA053280: AB_2682098"	"unprognostic (2.40e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.73e-1)"	"unprognostic (3.47e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.87e-2)"	"unprognostic (3.34e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.44e-1)"	"unprognostic (6.48e-2)"	"unprognostic (4.86e-3)"	"unprognostic (1.61e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.15e-2)"	"unprognostic (6.42e-2)"	"unprognostic (4.32e-1)"	"unprognostic (3.46e-1)"	"unprognostic (7.92e-3)"	"potential prognostic favorable (7.28e-4)"	"unprognostic (2.00e-3)"	"unprognostic (7.15e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.32e-2)"	"unprognostic (9.85e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.54e-1)"
PTAFR		ENSG00000169403	"Platelet activating factor receptor"	P25105	1	28147166-28193936	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 40.6;lymphoid tissue: 29.9"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 36.4;granulocytes: 74.7;Hofbauer cells: 76.0;Ionocytes: 32.0;Kupffer cells: 83.2;Langerhans cells: 86.2;Macrophages: 64.9"	"Cell type enriched"	"Detected in many"	10	"central nervous system macrophage: 142.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 256.9;eosinophil: 908.6;neutrophil: 749.9"	"Group enriched"	"Detected in many"	5	"granulocytes: 908.6;monocytes: 256.9"	"Cancer enhanced"	"Detected in many"		"Gallbladder cancer: 22.4"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Colon - Macrophages, Heart muscle - Macrophages, Liver - Kupffer cells, Lung - Macrophages, Minor Salivary Gland - Macrophages, Pituitary gland - Macrophages, Skeletal muscle - Macrophages, Stomach - Macrophages, Thyroid gland - Macrophages"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027542, HPA027543"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Primary cilium"			NA	NA			"Cluster 21: Neutrophils - Unknown function"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 49: HMC-1 - Innate immune response"	"Cluster 58: Macrophages - Innate immune response"	26	"Plasma membrane"	"Nucleoplasm, Vesicles, Primary cilium"	"HPA027542: , HPA027543: AB_10610287"	"unprognostic (1.18e-1)"	"unprognostic (1.95e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.33e-2)"	"unprognostic (6.16e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.80e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.87e-3)"	"unprognostic (4.20e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.16e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.59e-1)"
PTGDR	"DP, DP1, PTGDR1"	ENSG00000168229	"Prostaglandin D2 receptor"	Q13258	14	52267698-52276724	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"	"Mast cell degranulation"	"G-protein coupled receptor, Receptor, Transducer"	"Asthma, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 7.6;lymphoid tissue: 6.1"	"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 16.2;NK-cells: 116.8;T-cells: 29.2;Undifferentiated cells: 30.6"	"Group enriched"	"Detected in some"	4	"fibroblast: 129.4;leukocyte: 251.6"	"Cancer enhanced"	"Detected in some"		"Colon Adenocarcinoma (TCGA): 1.9"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"gdT-cell: 68.2;MAIT T-cell: 33.5;memory CD8 T-cell: 40.9;naive CD8 T-cell: 22.6;NK-cell: 90.5"	"Group enriched"	"Detected in many"	33	"NK-cells: 90.5;T-cells: 68.2"	"Cancer enhanced"	"Detected in single"		"Leukemia: 1.7"	"Adipose visceral - T-cells, Adrenal gland - T-cells, Kidney - T-cells, Liver - NK-cells (Liver), Lung - NK-cells (Lung), Stomach - Fibroblasts, Thyroid gland - T-cells"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA046586, HPA049668"	Enhanced		Approved	"Plasma membrane,Cytosol"			NA	NA			"Cluster 15: NK-cells - Unknown function"	"Cluster 47: Spleen - Immune response"	"Cluster 17: Choroid plexus - Cilium"	"Cluster 6: Leukemia - Signal transduction"	"Cluster 19: NK-cells - Adaptive immune response"	5	"Plasma membrane, Cytosol"		"HPA046586: , HPA049668: "			"unprognostic (2.30e-2)"		"unprognostic (2.76e-1)"	"unprognostic (1.20e-2)"						"unprognostic (1.83e-2)"					"unprognostic (1.22e-1)"		"unprognostic (2.73e-1)"						"unprognostic (4.13e-2)"	"unprognostic (5.36e-2)"					
PTGER1	EP1	ENSG00000160951	"Prostaglandin E receptor 1"	P34995	19	14472466-14475354	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"kidney: 30.1"	"Cell type enriched"	"Detected in some"	16	"Collecting duct cells: 83.6"	"Cell type enhanced"	"Detected in some"		"pericyte: 3.0;vascular associated smooth muscle cell: 5.2"	"Cancer enhanced"	"Detected in some"		"Ovary Serous Cystadenocarcinoma (TCGA): 5.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"Neuroblastoma: 1.6"	"Spleen - Fibroblast_1, Stomach - Fibroblasts"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"										NA	NA			"Cluster 15: NK-cells - Unknown function"	"Cluster 52: Kidney - Transmembrane transport"	"Cluster 6: Non-specific - Immune response"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 48: Smooth muscle cells - Signal transduction"							"unprognostic (6.87e-2)"													"unprognostic (5.95e-2)"				"unprognostic (1.18e-1)"	"unprognostic (1.48e-1)"					"unprognostic (3.34e-2)"		"unprognostic (6.64e-2)"	"unprognostic (2.42e-1)"		"unprognostic (1.48e-1)"
PTGER2	EP2	ENSG00000125384	"Prostaglandin E receptor 2"	P43116	14	52314305-52328598	"FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 37.9"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 30.2;Macrophages: 35.1;monocytes: 108.6;NK-cells: 110.6;T-cells: 64.5"	"Cell type enriched"	"Detected in some"	12	"leukocyte: 55.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"choroid plexus: 6.4"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"				"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"										NA	NA			"Cluster 3: Non-specific - Nuclear processes"	"Cluster 77: Bone marrow - Cell proliferation"	"Cluster 8: Immune cells - Immune response"	"Cluster 44: Connective tissue cells - ECM organization"	"Cluster 19: NK-cells - Adaptive immune response"					"unprognostic (1.18e-1)"	"unprognostic (2.84e-1)"	"unprognostic (4.29e-2)"	"unprognostic (3.53e-2)"	"unprognostic (7.24e-3)"	"unprognostic (1.03e-1)"		"unprognostic (8.48e-2)"		"unprognostic (6.07e-2)"	"potential prognostic unfavorable (7.49e-4)"	"unprognostic (1.35e-1)"	"unprognostic (9.36e-2)"		"unprognostic (7.23e-3)"	"unprognostic (1.33e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.95e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.56e-1)"	"unprognostic (7.32e-2)"	"unprognostic (2.64e-2)"		"unprognostic (2.78e-2)"	"unprognostic (1.12e-1)"		"unprognostic (1.33e-1)"
PTGER3	"EP3, lnc003875"	ENSG00000050628	"Prostaglandin E receptor 3"	P43115	1	70852353-71047816	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 52.2;endometrium 1: 90.7;kidney: 77.9;smooth muscle: 65.5"	"Group enriched"	"Detected in many"	5	"Distal tubular cells: 156.7;Langerhans cells: 93.2;Mesothelial cells: 50.2"	"Cell type enhanced"	"Detected in many"		"choroid plexus epithelial cell: 78.9;deep-layer near-projecting: 72.2;upper-layer intratelencephalic: 56.8"	"Cancer enriched"	"Detected in many"	7	"Kidney Chromophobe (TCGA): 204.3"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	62	"basophil: 40.2"	"Lineage enriched"	"Detected in single"	62	"granulocytes: 40.2"	"Cancer enriched"	"Detected in some"	6	"Bone cancer: 47.6"	"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Skin - Keratinocyte (granular)"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010689	Uncertain						NA	NA			"Cluster 46: Basophils - Proteolysis"	"Cluster 51: Thyroid gland - Unknown function"	"Cluster 23: Choroid plexus - Mixed function"	"Cluster 12: Bone cancer - Neuronal signaling"	"Cluster 28: Dendritic cells - Antigen presentation"	3			"HPA010689: AB_1855883"	"unprognostic (1.74e-1)"	"unprognostic (9.66e-3)"	"unprognostic (4.54e-1)"		"unprognostic (1.15e-1)"	"unprognostic (2.86e-2)"			"unprognostic (5.74e-3)"	"unprognostic (5.45e-2)"	"validated prognostic favorable (3.54e-5)"	"validated prognostic favorable (4.01e-4)"	"potential prognostic unfavorable (2.47e-5)"			"unprognostic (1.22e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.90e-1)"	"unprognostic (5.33e-3)"	"unprognostic (7.73e-3)"	"unprognostic (8.37e-2)"	"unprognostic (3.58e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.57e-2)"	"unprognostic (6.30e-3)"	"unprognostic (6.33e-2)"	"unprognostic (4.50e-3)"			"unprognostic (2.43e-2)"
PTGER4	EP4	ENSG00000171522	"Prostaglandin E receptor 4"	P35408	5	40679915-40693735	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 84.8;pancreas: 52.5"	"Cell type enhanced"	"Detected in many"		"Langerhans cells: 144.6;monocytes: 379.9;NK-cells: 165.9;T-cells: 243.4"	"Cell type enriched"	"Detected in many"	8	"leukocyte: 81.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Adrenal gland - Fibroblasts, Skeletal muscle - Fibroblasts, Testis - Early spermatids"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA011226, HPA012756"	Approved						NA	NA			"Cluster 37: Monocytes & Neutrophils - Innate immune response"	"Cluster 40: Non-specific - Transcription"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 59: Leukemia - T-cell receptor"	"Cluster 78: NK-cells & T-cells - Immune system & Transcription"	2			"HPA011226: AB_1855885, HPA012756: AB_1855884"	"unprognostic (1.24e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.82e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.85e-1)"	"unprognostic (8.56e-3)"	"potential prognostic favorable (1.11e-4)"	"unprognostic (7.15e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.58e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.61e-1)"	"unprognostic (9.98e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.04e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.41e-1)"
PTGFR	FP	ENSG00000122420	"Prostaglandin F receptor"	P43088	1	78303884-78540701	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 19.3"	"Cell type enhanced"	"Detected in some"		"Club cells: 21.9;Collecting duct cells: 11.7;Fibroblasts: 27.5;Inhibitory neurons: 9.9;Late spermatids: 10.9;Microglial cells: 17.0"	"Cell type enhanced"	"Detected in many"		"fibroblast: 212.7;hippocampal dentate gyrus: 53.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Brain cancer: 6.9;prostate cancer: 6.4"	"Adipose subcutaneous - Adipose progenitor cells, Adipose visceral - Adipose progenitor cells, Heart muscle - Fibroblasts, Minor Salivary Gland - Fibroblasts, Prostate - Fibroblasts"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"										NA	NA				"Cluster 62: Connective tissue - ECM organization"	"Cluster 29: Forebrain - Mixed function"	"Cluster 44: Connective tissue cells - ECM organization"	"Cluster 53: Fibroblasts - ECM organization"	1				"unprognostic (2.82e-2)"	"unprognostic (4.05e-2)"	"unprognostic (5.81e-2)"			"unprognostic (1.52e-1)"		"unprognostic (3.13e-2)"		"unprognostic (2.12e-1)"	"unprognostic (2.59e-2)"	"unprognostic (3.34e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.62e-1)"	"unprognostic (7.34e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.73e-1)"		"unprognostic (2.12e-2)"			"unprognostic (2.12e-1)"	"unprognostic (2.30e-1)"	"unprognostic (6.87e-2)"		"unprognostic (1.30e-1)"		"potential prognostic unfavorable (1.73e-4)"			
PTGIR	IP	ENSG00000160013	"Prostaglandin I2 receptor"	P43119	19	46620468-46625089	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 53.8"	"Cell type enriched"	"Detected in some"	6	"Langerhans cells: 239.5"	"Cell type enhanced"	"Detected in some"		"central nervous system macrophage: 5.1;leukocyte: 5.2;vascular associated smooth muscle cell: 7.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	10	"classical monocyte: 28.3;intermediate monocyte: 65.3;myeloid DC: 20.9;non-classical monocyte: 38.9"	"Group enriched"	"Detected in many"	11	"dendritic cells: 20.9;monocytes: 65.3"	"Cancer enhanced"	"Detected in some"		"Leukemia: 6.4;Neuroblastoma: 7.7"	"Spleen - Fibroblast_1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"										NA	NA			"Cluster 40: Monocytes - Innate immune response"	"Cluster 7: Adipose tissue - Mixed function"	"Cluster 51: Neurons - Mixed function"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 14: Langerhans cells - Innate immune response"	6				"unprognostic (1.57e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.03e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.48e-1)"		"unprognostic (4.84e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.19e-2)"	"unprognostic (5.97e-2)"	"potential prognostic unfavorable (2.01e-4)"	"unprognostic (2.89e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.18e-1)"		"unprognostic (1.53e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.17e-3)"	"unprognostic (1.14e-3)"	"unprognostic (3.21e-1)"	"unprognostic (1.18e-1)"
PTGIS	"CYP8A1, PGIS"	ENSG00000124212	"Prostaglandin I2 synthase"	Q16647	20	49503874-49568137	"Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Isomerase, Lyase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 78.1;urinary bladder: 79.0"	"Cell type enriched"	"Detected in many"	4	"Mesothelial cells: 441.0"	"Cell type enhanced"	"Detected in many"		"fibroblast: 95.5;vascular associated smooth muscle cell: 54.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Kidney cancer: 16.7"	"Heart muscle - Fibroblasts, Lung - Fibroblast_2, Pancreas - Fibroblasts, Spleen - Smooth muscle cells, Thyroid gland - Smooth muscle cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009517, HPA014193, HPA052244"	Enhanced		Approved	"Endoplasmic reticulum,Golgi apparatus,Cytosol"			NA	NA				"Cluster 41: Smooth muscle tissue - ECM organization"	"Cluster 23: Choroid plexus - Mixed function"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 53: Fibroblasts - ECM organization"	1	"Endoplasmic reticulum"	"Golgi apparatus, Cytosol"	"CAB009517: AB_2173209, HPA014193: AB_1855746, HPA052244: AB_2732574"	"unprognostic (4.67e-2)"	"unprognostic (5.16e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.25e-3)"	"unprognostic (6.13e-2)"	"unprognostic (1.05e-2)"	"potential prognostic unfavorable (7.64e-4)"	"unprognostic (1.25e-1)"		"unprognostic (6.25e-2)"	"unprognostic (3.21e-1)"	"potential prognostic unfavorable (1.10e-5)"	"unprognostic (6.37e-3)"	"unprognostic (6.55e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.78e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.38e-3)"	"unprognostic (2.27e-2)"	"unprognostic (6.81e-2)"	"unprognostic (8.30e-3)"	"unprognostic (5.44e-3)"	"unprognostic (6.03e-2)"	"unprognostic (5.76e-3)"	"unprognostic (5.01e-3)"	"unprognostic (1.99e-1)"	"unprognostic (4.23e-3)"	"unprognostic (1.08e-1)"
PTGS1	"COX1, PGHS-1, PTGHS"	ENSG00000095303	"Prostaglandin-endoperoxide synthase 1"	P23219	9	122370530-122395703	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Dioxygenase, Oxidoreductase, Peroxidase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 104.6;skin 1: 148.5;urinary bladder: 169.2"	"Group enriched"	"Detected in many"	4	"Glandular and luminal cells: 178.4;granulocytes: 193.1"	"Cell type enriched"	"Detected in some"	8	"central nervous system macrophage: 109.6"	"Cancer enhanced"	"Detected in all"		"Ovary Serous Cystadenocarcinoma (TCGA): 85.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 28.8"	"Group enriched"	"Detected in many"	6	"dendritic cells: 20.0;granulocytes: 28.8;monocytes: 13.1"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 32.5;ovarian cancer: 30.4"	"Adrenal gland - Macrophages, Heart muscle - Fibroblasts, Skeletal muscle - Fibroblasts, Skin - Keratinocyte (other), Spleen - Platelets"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA002834, CAB020315"	Enhanced		Uncertain	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	Enzyme	NA	NA		4300000	"Cluster 29: Non-specific - Unknown function"	"Cluster 13: Skin - Cornification"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 49: HMC-1 - Innate immune response"	"Cluster 37: Glandular & Luminal cells - Unknown function"	4	"Golgi apparatus, Vesicles"		"CAB020315: , HPA002834: AB_1079711"	"unprognostic (4.58e-3)"	"unprognostic (2.00e-1)"	"unprognostic (3.75e-1)"	"unprognostic (5.37e-2)"	"unprognostic (5.62e-2)"	"unprognostic (3.35e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.64e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.07e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.94e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.26e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.47e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.25e-1)"	"unprognostic (9.27e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.52e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.28e-2)"
PTGS2	COX2	ENSG00000073756	"Prostaglandin-endoperoxide synthase 2"	P35354	1	186671791-186680922	"Cancer-related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Dioxygenase, Oxidoreductase, Peroxidase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 115.6;seminal vesicle: 123.1;urinary bladder: 156.5"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 225.6;Basal prostatic cells: 712.9;granulocytes: 577.7;Langerhans cells: 383.2;Macrophages: 272.0;monocytes: 363.4"	"Cell type enriched"	"Detected in many"	7	"endothelial cell: 100.5"	"Cancer enhanced"	"Detected in many"		"Lung Adenocarcinoma (TCGA): 34.5"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	16	"neutrophil: 11.8"	"Lineage enriched"	"Detected in single"	16	"granulocytes: 11.8"	"Low cancer specificity"	"Detected in many"			"Heart muscle - Fibroblasts"	"Region enhanced"	"Detected in many"		"hippocampal formation: 15.1"	"Low region specificity"	"Detected in all"			"CAB000113, HPA001335, CAB080135"	Enhanced		Supported	Vesicles,Cytosol	"Intracellular and membrane"	Enzyme	NA	NA			"Cluster 4: Neutrophils - Degranulation"	"Cluster 77: Bone marrow - Cell proliferation"	"Cluster 53: Neurons - Mixed function"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 3: Basal prostatic cells - Lipid metabolism"	9	Vesicles	Cytosol	"CAB000113: , CAB080135: , HPA001335: AB_1079712"	"unprognostic (3.09e-2)"	"unprognostic (3.75e-3)"	"unprognostic (5.70e-2)"	"unprognostic (2.33e-2)"	"unprognostic (6.91e-3)"	"unprognostic (1.24e-1)"	"unprognostic (5.25e-2)"	"potential prognostic unfavorable (7.31e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.14e-2)"			"unprognostic (1.01e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.75e-1)"	"unprognostic (9.67e-3)"	"unprognostic (5.46e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.59e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.77e-2)"		"unprognostic (1.53e-1)"	"unprognostic (6.14e-2)"
PTH1R	"PTHR, PTHR1"	ENSG00000160801	"Parathyroid hormone 1 receptor"	Q03431	3	46877721-46903799	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"kidney: 570.9"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 33.1;Distal tubular cells: 49.2;Extravillous trophoblasts: 72.7;Late spermatids: 31.5;Proximal tubular cells: 214.6;Sertoli cells: 57.1"	"Cell type enriched"	"Detected in many"	6	"pericyte: 798.2"	"Cancer enriched"	"Detected in many"	6	"Kidney Renal Papillary Cell Carcinoma (TCGA): 141.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"testis cancer: 4.8"	"Spleen - Fibroblast_2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007491, HPA075879"	Enhanced		Supported	"Nucleoli,Plasma membrane,Cytosol"			NA	NA				"Cluster 52: Kidney - Transmembrane transport"	"Cluster 47: Endothelial cells - Vasculature"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 38: Proximal tubular cells - Transmembrane transport"	17	"Plasma membrane, Cytosol"	Nucleoli	"HPA007491: , HPA075879: "	"unprognostic (2.48e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.40e-2)"			"unprognostic (2.32e-1)"	"unprognostic (2.94e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.03e-1)"	"validated prognostic favorable (2.29e-5)"	"validated prognostic favorable (3.76e-4)"	"potential prognostic favorable (4.34e-4)"	"unprognostic (1.08e-2)"	"potential prognostic favorable (5.61e-4)"	"unprognostic (7.69e-2)"	"unprognostic (5.46e-2)"	"unprognostic (2.25e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.97e-2)"	"unprognostic (3.60e-2)"	"unprognostic (8.41e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.59e-2)"			"unprognostic (4.15e-2)"		"unprognostic (1.81e-1)"	"potential prognostic unfavorable (5.38e-5)"	"unprognostic (9.26e-2)"
PTH2R	PTHR2	ENSG00000144407	"Parathyroid hormone 2 receptor"	P49190	2	208359714-208854503	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"retina: 15.9"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 11.9;Excitatory neurons: 15.4;Proximal tubular cells: 14.6;Rod photoreceptor cells: 24.0"	"Cell type enhanced"	"Detected in many"		"hippocampal dentate gyrus: 95.4"	"Cancer enhanced"	"Detected in many"		"Ovary Serous Cystadenocarcinoma (TCGA): 7.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Minor Salivary Gland - Minor salivary glandular cells, Pituitary gland - Undifferentiated cells (Pituitary gland), Skin - Eccrine sweat gland cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA010655	Approved						NA	NA				"Cluster 76: Retina - Visual perception"	"Cluster 40: Astrocytes - Astrocyte-neuron interactions"	"Cluster 47: Leukemia - Hemostasis"	"Cluster 34: Neurons - Neuronal signaling"	2			"HPA010655: AB_2668333"	"unprognostic (3.18e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.55e-1)"					"unprognostic (1.27e-2)"	"unprognostic (2.14e-1)"			"unprognostic (8.27e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.74e-2)"			"unprognostic (1.43e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.74e-2)"		"unprognostic (3.28e-2)"								"unprognostic (1.52e-1)"
QPRT	QPRTase	ENSG00000103485	"Quinolinate phosphoribosyltransferase"	Q15274	16	29663279-29698699	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Glycosyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 115.0;liver: 179.0"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 422.5;Extravillous trophoblasts: 351.0;Hepatocytes: 372.3;Proximal tubular cells: 527.4;Syncytiotrophoblasts: 192.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"classical monocyte: 4.3;intermediate monocyte: 5.3;myeloid DC: 5.9;non-classical monocyte: 9.1;plasmacytoid DC: 3.1"	"Group enriched"	"Detected in many"	8	"dendritic cells: 5.9;monocytes: 9.1"	"Low cancer specificity"	"Detected in all"			"Adrenal gland - Adrenal cortex cells, Heart muscle - Cardiomyocytes, Kidney - Proximal tubular cells, Liver - Hepatocytes, Skin - Fibroblast_1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA011887, HPA076010"	Enhanced		Approved	Vesicles			NA	NA		480000	"Cluster 10: Non-specific - Membrane trafficking"	"Cluster 53: Non-specific - Glycosylation"	"Cluster 41: Monoamines - Neurotransmitter signalling"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 56: Proximal tubular cells - Amino acid metabolism"	15	Vesicles		"HPA011887: AB_2668555, HPA076010: "	"unprognostic (6.57e-3)"	"potential prognostic unfavorable (4.34e-5)"	"unprognostic (1.90e-2)"	"unprognostic (6.66e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.34e-3)"	"unprognostic (1.23e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.07e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.66e-3)"	"unprognostic (5.51e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.62e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.94e-3)"	"unprognostic (5.04e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.57e-2)"	"unprognostic (2.41e-3)"	"unprognostic (2.71e-1)"	"unprognostic (4.74e-2)"	"unprognostic (6.37e-2)"
RAF1	"c-Raf, CRAF, Raf-1"	ENSG00000132155	"Raf-1 proto-oncogene, serine/threonine kinase"	P04049	3	12582101-12664201	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Cardiomyopathy, Deafness, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 150.3"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 150.3"	"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002639, HPA002640, CAB019291, CAB080384"	Approved		Supported	"Plasma membrane,Cytosol"			NA	NA			"Cluster 35: Neutrophils - Protein binding"	"Cluster 19: Non-specific - Basic cellular processes"	"Cluster 25: Non-specific - Transcription"	"Cluster 8: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Transcription"	281	"Plasma membrane, Cytosol"		"CAB019291: , CAB080384: , HPA002639: , HPA002640: AB_1856047"	"unprognostic (9.22e-2)"	"unprognostic (2.30e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.44e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.23e-1)"	"potential prognostic favorable (3.08e-5)"	"unprognostic (1.08e-2)"	"potential prognostic unfavorable (4.06e-4)"	"potential prognostic favorable (2.76e-5)"	"unprognostic (8.03e-2)"	"unprognostic (1.57e-2)"	"unprognostic (5.91e-3)"	"unprognostic (5.31e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.58e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.75e-2)"	"unprognostic (5.12e-3)"	"unprognostic (8.51e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.24e-1)"
RAMP1		ENSG00000132329	"Receptor activity modifying protein 1"	O60894	2	237858893-237912106	"FDA approved drug targets, Predicted membrane proteins, Transporters"	Transport	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 682.4"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 207.0;Endometrial stromal cells: 600.5;Prostatic glandular cells: 186.9;Skeletal myocytes: 285.9;Smooth muscle cells: 208.5"	"Cell type enhanced"	"Detected in all"		"oligodendrocyte precursor cell: 172.9"	"Cancer enhanced"	"Detected in all"		"Glioblastoma Multiforme (TCGA): 334.5;Prostate Adenocarcinoma (TCGA): 361.9"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	18	"NK-cell: 70.4"	"Lineage enriched"	"Detected in many"	18	"NK-cells: 70.4"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 147.8"	"Adipose subcutaneous - Smooth muscle cells, Adrenal gland - Adrenal medulla cells, Lung - Smooth muscle cells, Thyroid gland - Smooth muscle cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057814			Approved	"Nucleoplasm,Nuclear membrane"			NA	NA			"Cluster 15: NK-cells - Unknown function"	"Cluster 64: Neuronal - Transcription"	"Cluster 39: Astrocytes - Mixed function"	"Cluster 60: Prostate cancer - Unknown function"	"Cluster 9: Endometrial stromal cells - Transcription"	7	"Nucleoplasm, Nuclear membrane"		"HPA057814: AB_2683536"	"unprognostic (1.79e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.89e-2)"	"unprognostic (3.84e-1)"	"unprognostic (2.35e-2)"	"unprognostic (9.64e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.04e-3)"	"unprognostic (4.77e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.21e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.47e-3)"	"unprognostic (2.80e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.42e-1)"	"unprognostic (7.22e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.01e-1)"	"potential prognostic unfavorable (3.38e-5)"	"unprognostic (2.78e-1)"	"unprognostic (3.64e-2)"	"unprognostic (5.08e-2)"
RAMP2		ENSG00000131477	"Receptor activity modifying protein 2"	O60895	17	42758447-42763041	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Adipocytes: 1017.0;Endothelial cells: 571.8;Lymphatic endothelial cells: 952.3"	"Cell type enriched"	"Detected in many"	7	"endothelial cell: 400.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	21	"plasmacytoid DC: 2.9"	"Lineage enriched"	"Detected in single"	21	"dendritic cells: 2.9"	"Cancer enhanced"	"Detected in many"		"Neuroblastoma: 25.4"	"Adrenal gland - Endothelial cells, Liver - Vascular Endothelial cells, Skin - Fibroblast_2, Thyroid gland - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052020			Approved	Vesicles			NA	NA				"Cluster 7: Adipose tissue - Mixed function"	"Cluster 42: Choroid plexus - Mitochondria"	"Cluster 18: Liver cancer - Metabolism"	"Cluster 54: Lymphatic endothelial cells - Lymph vessel development"	3	Vesicles		"HPA052020: AB_2681697"	"unprognostic (2.41e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.74e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.66e-1)"	"potential prognostic favorable (6.63e-4)"	"unprognostic (2.69e-1)"	"validated prognostic favorable (5.19e-5)"	"validated prognostic favorable (1.07e-5)"	"potential prognostic unfavorable (1.30e-4)"	"unprognostic (5.96e-2)"	"unprognostic (5.30e-3)"	"unprognostic (7.09e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.37e-2)"	"unprognostic (6.67e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.72e-2)"	"unprognostic (7.80e-2)"	"unprognostic (8.37e-3)"	"unprognostic (3.87e-3)"	"unprognostic (1.72e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.46e-2)"
RAMP3		ENSG00000122679	"Receptor activity modifying protein 3"	O60896	7	45157791-45186302	"FDA approved drug targets, Predicted membrane proteins, Transporters"	Transport	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Adipocytes: 313.9;Endothelial cells: 285.8"	"Cell type enriched"	"Detected in many"	6	"endothelial cell: 143.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Bone cancer: 12.3;breast cancer: 4.4"	"Adrenal gland - Endothelial cells, Breast - Endothelial cells, Colon - Endothelial cells, Heart muscle - Endothelial cells, Kidney - Endothelial cells, Liver - Sinusoid Endothelial cells, Minor Salivary Gland - Endothelial cells, Pituitary gland - Endothelial cells, Prostate - Endothelial cells, Skeletal muscle - Endothelial cells, Skin - Endothelial cells, Testis - Endothelial cells"	"Group enriched"	"Detected in all"	4	"cerebellum: 62.2;cerebral cortex: 49.2;thalamus: 175.0;white matter: 60.1"	"Low region specificity"	"Detected in all"			HPA075527			Supported	"Plasma membrane"			NA	NA				"Cluster 7: Adipose tissue - Mixed function"	"Cluster 30: White matter - Myelination"	"Cluster 12: Bone cancer - Neuronal signaling"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	107	"Plasma membrane"		"HPA075527: "	"unprognostic (1.46e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.01e-3)"	"unprognostic (8.51e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.32e-2)"	"unprognostic (3.35e-2)"	"potential prognostic favorable (3.96e-4)"	"unprognostic (8.54e-2)"	"validated prognostic favorable (1.47e-12)"	"validated prognostic favorable (5.33e-5)"	"unprognostic (2.21e-2)"	"validated prognostic favorable (3.56e-7)"	"validated prognostic favorable (3.93e-8)"	"unprognostic (9.46e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.18e-3)"	"unprognostic (5.93e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.90e-1)"
RARA	"NR1B1, RAR, RAR-alpha, RARalpha"	ENSG00000131759	"Retinoic acid receptor alpha"	P10276	17	40309180-40357643	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 105.0;monocytes: 161.7"	"Cell type enhanced"	"Detected in many"		"leukocyte: 42.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 52.8"	"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Spleen - Neutrophils"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058282, HPA071548"			Supported	"Nucleoplasm,Nucleoli,Actin filaments,Cytosol"			NA	NA			"Cluster 7: Non-specific - Innate immune response"	"Cluster 19: Non-specific - Basic cellular processes"	"Cluster 40: Astrocytes - Astrocyte-neuron interactions"	"Cluster 27: Breast cancer - Unknown function"	"Cluster 29: Monocytes - Innate immune response"	103	Nucleoplasm	"Nucleoli, Actin filaments, Cytosol"	"HPA058282: AB_2683666, HPA071548: "	"unprognostic (1.53e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.07e-2)"	"unprognostic (2.99e-3)"	"unprognostic (2.55e-1)"	"unprognostic (8.95e-2)"	"unprognostic (9.26e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.13e-2)"	"unprognostic (9.12e-2)"	"potential prognostic favorable (9.68e-4)"	"unprognostic (1.09e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.02e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.21e-1)"	"unprognostic (7.92e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.87e-1)"	"unprognostic (6.51e-3)"	"unprognostic (3.65e-2)"	"unprognostic (6.68e-2)"	"unprognostic (3.15e-3)"
RARB	"HAP, NR1B2, RAR-beta, RARbeta, RRB2"	ENSG00000077092	"Retinoic acid receptor beta"	P10826	3	24687887-25597932	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, Disease variant, FDA approved drug targets, Microphthalmia, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 39.3;Excitatory neurons: 64.5;Inhibitory neurons: 88.8"	"Cell type enhanced"	"Detected in all"		"eccentric medium spiny neuron: 647.3;medium spiny neuron: 638.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Lung - Fibroblast_1"	"Region enriched"	"Detected in all"	9	"basal ganglia: 109.3"	"Low region specificity"	"Detected in all"			"CAB002617, HPA004174"	Enhanced		Enhanced	Nucleoplasm			NA	NA				"Cluster 7: Adipose tissue - Mixed function"	"Cluster 53: Neurons - Mixed function"	"Cluster 72: Neuronal - Signal transduction"	"Cluster 69: Neurons - Neuronal signaling"	9	Nucleoplasm		"CAB002617: , HPA004174: AB_1079744"	"unprognostic (1.18e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.31e-1)"	"validated prognostic favorable (2.12e-9)"	"validated prognostic favorable (1.09e-4)"	"unprognostic (2.17e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.59e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.88e-2)"	"unprognostic (2.61e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.18e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.71e-2)"	"unprognostic (3.57e-2)"
RARG	"NR1B3, RAR-gamma, RARC, RARgamma"	ENSG00000172819	"Retinoic acid receptor gamma"	P13631	12	53210567-53232980	"Cancer-related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 137.7;skin 1: 118.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 41.4;Basal squamous epithelial cells: 45.7;Squamous epithelial cells: 73.3;Suprabasal keratinocytes: 71.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 18.9"	"Group enriched"	"Detected in all"	4	"dendritic cells: 6.7;T-cells: 18.9"	"Low cancer specificity"	"Detected in all"			"Skeletal muscle - Fibroblasts, Skin - Keratinocyte (other), Spleen - Fibroblast_1, Thyroid gland - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053883	Supported		Supported	Nucleoplasm			NA	NA			"Cluster 27: T-cells - Unknown function"	"Cluster 27: Squamous epithelium - Keratinization"	"Cluster 15: Non-specific - Transcription"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 12: Squamous epithelial cells - Keratinization"	12	Nucleoplasm		"HPA053883: AB_2682292"	"unprognostic (2.23e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.55e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.44e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.17e-1)"	"unprognostic (4.96e-2)"	"unprognostic (8.10e-2)"	"unprognostic (4.99e-3)"	"unprognostic (4.04e-3)"	"unprognostic (2.14e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.96e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.55e-2)"	"unprognostic (8.22e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.36e-1)"	"unprognostic (1.88e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.25e-3)"	"unprognostic (3.20e-1)"	"unprognostic (2.34e-2)"	"unprognostic (8.73e-2)"	"unprognostic (4.06e-2)"	"unprognostic (5.35e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.46e-1)"
REN		ENSG00000143839	Renin	P00797	1	204154819-204190324	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Aspartyl protease, Hydrolase, Protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"kidney: 157.7"	"Group enriched"	"Detected in some"	5	"Club cells: 33.8;Late spermatids: 27.8;Smooth muscle cells: 14.8"	"Cell type enhanced"	"Detected in some"		"choroid plexus epithelial cell: 16.8;ependymal cell: 7.2"	"Cancer enriched"	"Detected in many"	9	"Kidney Renal Clear Cell Carcinoma (TCGA): 94.7"	"Region enhanced"	"Detected in many"		"choroid plexus: 7.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"Bladder cancer: 22.1;colorectal cancer: 8.4"	"Lung - Alveolar cells type 2, Testis - Late spermatids"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA005131	Approved				"Secreted to blood"	Enzyme	NA	NA	692000	9600		"Cluster 52: Kidney - Transmembrane transport"	"Cluster 36: Choroid plexus - Mixed function"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 50: Connective tissue cells - ECM organization"	5			"HPA005131: AB_1079174"	"unprognostic (6.94e-2)"		"unprognostic (1.19e-2)"		"unprognostic (1.18e-1)"	"unprognostic (2.37e-1)"				"unprognostic (1.77e-1)"	"potential prognostic favorable (8.68e-6)"	"unprognostic (2.00e-2)"	"potential prognostic unfavorable (3.47e-5)"	"unprognostic (2.05e-2)"	"unprognostic (1.63e-1)"		"unprognostic (1.42e-1)"			"unprognostic (1.72e-2)"	"unprognostic (2.18e-2)"				"unprognostic (1.13e-1)"	"unprognostic (5.58e-3)"			"unprognostic (2.11e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.25e-1)"
RET	"CDHF12, CDHR16, HSCR1, MEN2A, MEN2B, MTC1, PTC, RET51"	ENSG00000165731	"Ret proto-oncogene"	P07949	10	43077064-43130351	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Hirschsprung disease, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 11.1;brain: 15.1;parathyroid gland: 19.3"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 47.2;Horizontal cells: 28.3;Lymphatic endothelial cells: 10.1"	"Cell type enhanced"	"Detected in many"		"lower rhombic lip: 23.0"	"Cancer enhanced"	"Detected in many"		"Breast Invasive Carcinoma (TCGA): 20.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Neuroblastoma: 97.7;thyroid cancer: 31.6"	"Adrenal gland - Adrenal medulla cells, Colon - Colon enteroendocrine cells, Pituitary gland - Corticotropes, Testis - Spermatogonia"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"midbrain: 86.5;spinal cord: 33.3"	"CAB002581, HPA008356, HPA008495"	Approved	Supported	Approved	"Golgi apparatus,Plasma membrane,Cytosol"			No	NA		18000000		"Cluster 24: Parathyroid gland - Vesicular transport"	"Cluster 41: Monoamines - Neurotransmitter signalling"	"Cluster 16: Thyroid cancer - Neuronal signaling"	"Cluster 53: Fibroblasts - ECM organization"	51	"Golgi apparatus, Cytosol"	"Plasma membrane"	"CAB002581: AB_563673, HPA008356: AB_1847232, HPA008495: "		"unprognostic (7.24e-2)"	"unprognostic (1.86e-1)"			"unprognostic (3.21e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.47e-2)"	"unprognostic (6.93e-3)"							"unprognostic (1.24e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.31e-2)"			"unprognostic (4.72e-1)"		"unprognostic (9.61e-2)"		"unprognostic (1.17e-3)"	"unprognostic (2.46e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.85e-1)"
RFK	"FLJ11149, RIFK"	ENSG00000135002	"Riboflavin kinase"	Q969G6	9	76385526-76394517	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 180.1;Extravillous trophoblasts: 392.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Testis - Spermatocytes, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023259, CAB033887, HPA057163"	Approved		Approved	"Golgi apparatus"			NA	NA			"Cluster 33: Non-specific - ATP binding"	"Cluster 25: Small intestine - Absorption"	"Cluster 1: Neurons - Mixed function"	"Cluster 43: Non-specific - Basic cellular processes"	"Cluster 4: Extravillous trophoblasts - Unknown function"	3	"Golgi apparatus"		"CAB033887: AB_2178617, HPA023259: AB_2671127, HPA057163: AB_2683357"	"unprognostic (7.01e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.64e-2)"	"unprognostic (4.73e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.57e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.07e-1)"	"potential prognostic favorable (6.31e-8)"	"unprognostic (1.35e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.46e-3)"	"unprognostic (6.90e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.32e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.17e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.07e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.14e-1)"	"unprognostic (5.57e-2)"
ROCK1	p160ROCK	ENSG00000067900	"Rho associated coiled-coil containing protein kinase 1"	Q13464	18	20946906-21111813	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004562, HPA007567, HPA045639"	Approved						NA	NA		41000	"Cluster 35: Neutrophils - Protein binding"	"Cluster 40: Non-specific - Transcription"	"Cluster 25: Non-specific - Transcription"	"Cluster 13: Non-specific - Mixed function"	"Cluster 32: Smooth muscle cells - Muscle contraction"	33			"CAB004562: AB_628223, HPA007567: AB_1856393, HPA045639: AB_2679401"	"unprognostic (4.11e-2)"	"unprognostic (2.17e-1)"	"unprognostic (9.76e-2)"	"unprognostic (2.55e-2)"	"unprognostic (4.10e-1)"	"unprognostic (2.55e-1)"	"unprognostic (4.06e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.51e-3)"	"unprognostic (1.47e-2)"	"unprognostic (3.14e-3)"	"unprognostic (7.39e-3)"	"unprognostic (1.81e-1)"	"unprognostic (9.38e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.97e-2)"	"unprognostic (7.53e-2)"	"unprognostic (2.50e-2)"	"unprognostic (5.24e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.98e-1)"	"unprognostic (8.79e-3)"	"unprognostic (3.71e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.64e-1)"
ROCK2		ENSG00000134318	"Rho associated coiled-coil containing protein kinase 2"	O75116	2	11179759-11348330	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms"	"Kinase, Serine/threonine-protein kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 271.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Prostate - Smooth muscle cells, Skin - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007459, CAB008666, HPA044109"	Approved		Supported	Cytosol			NA	NA		570000		"Cluster 62: Connective tissue - ECM organization"	"Cluster 34: Non-specific - Mixed function"	"Cluster 32: Non-specific - Cell proliferation"	"Cluster 32: Smooth muscle cells - Muscle contraction"	36	Cytosol		"CAB008666: AB_1622617, HPA007459: AB_1079828, HPA044109: AB_2678813"	"unprognostic (1.70e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.36e-1)"	"unprognostic (7.07e-2)"	"unprognostic (7.87e-2)"	"unprognostic (7.06e-3)"	"unprognostic (3.92e-1)"	"unprognostic (5.23e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.90e-2)"	"potential prognostic favorable (6.61e-5)"	"unprognostic (3.13e-3)"	"unprognostic (4.86e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.85e-1)"	"unprognostic (7.57e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.46e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.43e-2)"	"unprognostic (9.59e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.90e-2)"	"unprognostic (3.08e-2)"
ROS1	"c-ros-1, MCF3, ROS"	ENSG00000047936	"ROS proto-oncogene 1, receptor tyrosine kinase"	P08922	6	117287353-117425942	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	20	"epididymis: 57.2;lung: 30.7"	"Cell type enriched"	"Detected in some"	8	"Alveolar cells type 2: 148.5"	"Group enriched"	"Detected in some"	4	"deep-layer corticothalamic and 6b: 2.9;upper-layer intratelencephalic: 2.3"	"Cancer enriched"	"Detected in some"	4	"Lung Adenocarcinoma (TCGA): 24.7"	"Region enhanced"	"Detected in some"		"cerebral cortex: 7.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Bile duct cancer: 5.6;Bone cancer: 8.7;Brain cancer: 5.6"	"Lung - Alveolar cells type 2, Skin - Sebaceous gland cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA049098, HPA072424"	Uncertain		Approved	Vesicles			NA	NA				"Cluster 50: Epididymis - Male reproductive secretion"	"Cluster 53: Neurons - Mixed function"	"Cluster 72: Neuronal - Signal transduction"	"Cluster 72: Alveolar cells - Lung function"	12	Vesicles		"HPA049098: AB_2680628, HPA072424: AB_2686519"	"unprognostic (4.47e-2)"			"unprognostic (2.50e-2)"				"unprognostic (8.43e-3)"	"unprognostic (1.14e-1)"							"unprognostic (6.10e-2)"	"unprognostic (3.11e-1)"	"unprognostic (5.94e-3)"	"unprognostic (1.48e-1)"			"unprognostic (1.12e-1)"	"unprognostic (5.21e-2)"								
RPE65	"BCO3, LCA2, rd12, RP20"	ENSG00000116745	"Retinoid isomerohydrolase RPE65"	Q16518	1	68428822-68449954	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism, Sensory transduction, Vision"	"Hydrolase, Isomerase"	"Disease variant, FDA approved drug targets, Leber congenital amaurosis, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.4;choroid plexus: 3.6;retina: 8.1;seminal vesicle: 4.3"	"Group enriched"	"Detected in some"	4	"Cone photoreceptor cells: 18.7;Muller glia cells: 5.7;Rod photoreceptor cells: 11.7"	"Group enriched"	"Detected in some"	13	"astrocyte: 24.9;choroid plexus epithelial cell: 17.4;ependymal cell: 37.0"	"Cancer enriched"	"Detected in some"	8	"Glioblastoma Multiforme (TCGA): 9.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 3.2;Rhabdoid: 4.8"		"Group enriched"	"Detected in many"	4	"amygdala: 3.2;basal ganglia: 2.5;cerebral cortex: 3.9;hippocampal formation: 2.5"	"Low region specificity"	"Detected in many"										NA	NA				"Cluster 39: Retina & Testis - Cilium"	"Cluster 19: Astrocytes - Mixed function"	"Cluster 5: Rhabdoid - Unknown function"	"Cluster 66: Photoreceptor cells - Visual perception"	3										"unprognostic (7.29e-3)"	"unprognostic (1.25e-1)"	"unprognostic (7.42e-2)"																						
RPL3	L3	ENSG00000100316	"Ribosomal protein L3"	P39023	22	39312882-39320389	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adipose visceral - Adipose progenitor cells, Spleen - B-cells (Spleen)"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003365, HPA055361"	Uncertain		Supported	Nucleoli,Cytosol			NA	NA		1900000	"Cluster 43: Non-specific - Transcription & Translation"	"Cluster 18: Non-specific - Ribosome"	"Cluster 7: Non-specific - Ribosome"	"Cluster 25: Non-specific - Ribosome"	"Cluster 64: Non-specific - Ribosome"	341	"Nucleoli, Cytosol"		"HPA003365: AB_1079841, HPA055361: AB_2732594"	"unprognostic (1.16e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.28e-1)"	"unprognostic (5.06e-2)"	"unprognostic (2.68e-1)"	"unprognostic (6.50e-2)"	"unprognostic (2.96e-3)"	"unprognostic (2.54e-3)"	"unprognostic (5.02e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.25e-2)"	"unprognostic (5.58e-3)"	"unprognostic (4.60e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.64e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.17e-2)"	"unprognostic (2.54e-2)"	"unprognostic (8.33e-3)"	"unprognostic (7.53e-2)"	"unprognostic (5.36e-3)"	"unprognostic (2.99e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.02e-1)"	"unprognostic (8.87e-2)"	"unprognostic (5.20e-2)"
RRM1		ENSG00000167325	"Ribonucleotide reductase catalytic subunit M1"	P23921	11	4094707-4138932	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Deoxyribonucleotide synthesis"	"Allosteric enzyme, Oxidoreductase"	"FDA approved drug targets, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 114.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Adrenal cortex cells, Spleen - Mitotic cells (Spleen), Testis - Spermatocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022093, HPA057265, HPA064297"	Enhanced		Supported	"Plasma membrane,Centriolar satellite,Basal body,Cytosol"			NA	Yes		110000	"Cluster 9: T-regs - Cell cycle regulation"	"Cluster 71: Thymus - Adaptive immune response"	"Cluster 25: Non-specific - Transcription"	"Cluster 24: Non-specific - Unknown function"	"Cluster 52: Non-specific - Cell proliferation"	15	Cytosol	"Plasma membrane, Centriolar satellite, Basal body"	"CAB022093: , HPA057265: AB_2683386, HPA064297: AB_2685236"	"unprognostic (6.58e-3)"	"unprognostic (6.05e-2)"	"unprognostic (2.46e-2)"	"unprognostic (9.03e-2)"	"unprognostic (3.74e-3)"	"unprognostic (1.93e-1)"	"unprognostic (4.89e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.42e-1)"	"potential prognostic favorable (1.26e-7)"	"unprognostic (3.41e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.33e-2)"	"potential prognostic unfavorable (2.18e-4)"	"unprognostic (8.65e-3)"	"potential prognostic unfavorable (4.80e-6)"	"unprognostic (1.68e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.60e-1)"	"potential prognostic unfavorable (4.50e-5)"	"unprognostic (1.95e-1)"	"unprognostic (5.11e-2)"	"unprognostic (4.07e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.26e-2)"	"unprognostic (7.69e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.76e-2)"
RRM2	"C2orf48, FLJ25102"	ENSG00000171848	"Ribonucleotide reductase regulatory subunit M2"	P31350	2	10120698-10211725	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Deoxyribonucleotide synthesis"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 43.5;esophagus: 17.9;intestine: 19.0;lymphoid tissue: 56.6"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 172.9;Extravillous trophoblasts: 289.1;Plasma cells: 244.2;Undifferentiated cells: 79.5"	"Cell type enhanced"	"Detected in many"		"leukocyte: 13.3;upper-layer intratelencephalic: 6.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Mitotic cells (Adrenal gland), Colon - Mitotic cells (Colon), Heart muscle - Mitotic cells (Heart), Lung - Mitotic cells (Lung), Minor Salivary Gland - Mitotic cells (Minor salivary gland), Skin - Mitotic cells (Skin), Spleen - Mitotic cells (Spleen), Stomach - Mitotic cells (Stomach), Testis - Spermatocytes, Thyroid gland - Mitotic cells (Thyroid)"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA056994	Enhanced		Supported	Nucleoplasm,Cytosol			Yes	Yes		7200	"Cluster 15: NK-cells - Unknown function"	"Cluster 67: Lymphoid tissue & Bone marrow - Cell proliferation"	"Cluster 48: Non-specific - Mixed function"	"Cluster 22: Non-specific - mRNA splicing & Cell cycle"	"Cluster 61: Plasma cells - Immunoglobulins & histones"	21	Cytosol	Nucleoplasm	"HPA056994: AB_2683304"	"unprognostic (3.20e-1)"	"unprognostic (5.87e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.29e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.91e-1)"	"unprognostic (7.09e-2)"	"unprognostic (2.28e-1)"	"potential prognostic unfavorable (1.93e-4)"	"validated prognostic unfavorable (2.93e-7)"	"validated prognostic unfavorable (1.59e-7)"	"potential prognostic unfavorable (1.54e-11)"	"validated prognostic unfavorable (4.94e-7)"	"validated prognostic unfavorable (1.47e-8)"	"potential prognostic unfavorable (8.75e-8)"	"unprognostic (7.78e-3)"	"unprognostic (5.95e-3)"	"unprognostic (1.03e-1)"	"unprognostic (3.07e-2)"	"unprognostic (8.91e-2)"	"potential prognostic unfavorable (3.66e-5)"	"unprognostic (9.28e-3)"	"unprognostic (8.90e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.35e-3)"	"unprognostic (1.30e-2)"	"unprognostic (4.74e-1)"	"unprognostic (6.25e-2)"	"unprognostic (2.07e-1)"
RRM2B	p53R2	ENSG00000048392	"Ribonucleotide reductase regulatory TP53 inducible subunit M2B"	Q7LG56	8	102204502-102238961	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Deoxyribonucleotide synthesis, DNA damage, DNA repair"	Oxidoreductase	"Deafness, Disease variant, FDA approved drug targets, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006854, HPA028812"	Approved		Enhanced	Nucleoplasm,Cytosol			NA	NA			"Cluster 2: Dendritic cells - Unknown function"	"Cluster 35: Non-specific - Mitochondria"	"Cluster 21: Non-specific - Metabolism"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 74: Neutrophils - Degranulation"	6	Nucleoplasm	Cytosol	"CAB006854: , HPA028812: AB_10602246"	"potential prognostic favorable (7.15e-4)"	"unprognostic (1.08e-3)"	"unprognostic (8.69e-3)"	"unprognostic (1.46e-3)"	"unprognostic (3.92e-2)"	"unprognostic (6.02e-2)"	"unprognostic (3.33e-2)"	"potential prognostic unfavorable (1.71e-4)"	"unprognostic (7.61e-2)"	"unprognostic (1.36e-3)"	"validated prognostic favorable (2.67e-7)"	"validated prognostic favorable (6.06e-4)"	"unprognostic (1.47e-1)"	"unprognostic (8.63e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.94e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.03e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.02e-2)"	"potential prognostic unfavorable (3.33e-6)"	"unprognostic (3.50e-2)"	"unprognostic (2.84e-3)"	"unprognostic (8.56e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.21e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.83e-1)"
RXRA	"NR2B1, RXR-alpha, RXRalpha"	ENSG00000186350	"Retinoid X receptor alpha"	P19793	9	134317098-134440585	"Cancer-related genes, FDA approved drug targets, Metabolic proteins, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 102.7"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 194.8;Kupffer cells: 136.4;monocytes: 168.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 19.6"	"Group enriched"	"Detected in many"	5	"granulocytes: 19.6;monocytes: 12.9"	"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Adrenal gland - Adrenal cortex cells, Breast - Adipocytes (Breast), Skin - Keratinocyte (granular)"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004565, CAB005352"	Supported		Supported	"Nucleoplasm,Golgi apparatus"			NA	NA			"Cluster 37: Monocytes & Neutrophils - Innate immune response"	"Cluster 19: Non-specific - Basic cellular processes"	"Cluster 19: Astrocytes - Mixed function"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 29: Monocytes - Innate immune response"	72	Nucleoplasm	"Golgi apparatus"	"CAB004565: AB_2184877, CAB005352: AB_2184874"	"unprognostic (3.27e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.89e-1)"	"unprognostic (3.49e-1)"	"unprognostic (6.29e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.55e-3)"	"unprognostic (2.83e-2)"	"potential prognostic favorable (3.29e-6)"	"unprognostic (7.10e-3)"	"unprognostic (2.25e-2)"	"unprognostic (3.73e-1)"	"unprognostic (6.75e-2)"	"unprognostic (2.03e-2)"	"unprognostic (4.91e-3)"	"unprognostic (1.51e-2)"	"unprognostic (3.32e-1)"	"unprognostic (5.58e-3)"	"unprognostic (1.66e-2)"	"unprognostic (3.94e-3)"	"unprognostic (2.37e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.86e-2)"	"unprognostic (6.63e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.09e-1)"
RXRB	"H-2RIIBP, NR2B2, RCoR-1, RXR-beta, RXRbeta"	ENSG00000204231	"Retinoid X receptor beta"	P28702	6	33193588-33200665	"Cancer-related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002003, HPA071592, HPA075035"	Supported		Supported	Nucleoplasm,Nucleoli,Cytosol			NA	NA			"Cluster 45: Eosinophils - Unknown function"	"Cluster 66: Non-specific - Transcription"	"Cluster 27: Non-specific - Mixed function"	"Cluster 28: Non-specific - Nuclear processes"	"Cluster 80: Non-specific - Transcription"	27	Nucleoplasm	"Nucleoli, Cytosol"	"CAB002003: , HPA071592: , HPA075035: "	"unprognostic (2.84e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.82e-1)"	"unprognostic (3.31e-1)"	"unprognostic (2.01e-2)"	"potential prognostic favorable (4.82e-4)"	"unprognostic (1.68e-2)"	"unprognostic (3.32e-1)"	"unprognostic (3.83e-2)"		"unprognostic (7.15e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.81e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.78e-1)"	"potential prognostic unfavorable (2.82e-4)"	"unprognostic (1.01e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.65e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.09e-1)"
RXRG	"NR2B3, RXR-gamma, RXRgamma"	ENSG00000143171	"Retinoid X receptor gamma"	P48443	1	165400922-165445355	"Cancer-related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 29.1;retina: 23.5;skeletal muscle: 47.9"	"Group enriched"	"Detected in some"	4	"Cone photoreceptor cells: 86.7;Melanocytes: 42.9"	"Cell type enhanced"	"Detected in many"		"eccentric medium spiny neuron: 44.3;medium spiny neuron: 29.6"	"Group enriched"	"Detected in many"	16	"Skin Cuteneous Melanoma (TCGA): 55.9;Thyroid Carcinoma (TCGA): 68.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	5	"skin cancer: 29.7"	"Colon - Enteric glia cells, Minor Salivary Gland - Fibroblasts, Pancreas - Beta cells, Pituitary gland - Somatotropes, Skeletal muscle - Skeletal myocytes, Stomach - Fibroblasts, Thyroid gland - Fibroblasts"	"Region enriched"	"Detected in many"	5	"basal ganglia: 100.2"	"Low region specificity"	"Detected in many"			"CAB002615, HPA012933"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"			NA	NA				"Cluster 3: Non-specific - Unknown function"	"Cluster 49: Hindbrain - Mixed function"	"Cluster 1: Neuronal - Visual perception"	"Cluster 66: Photoreceptor cells - Visual perception"	28	"Nucleoplasm, Nuclear bodies"		"CAB002615: , HPA012933: AB_2732406"			"unprognostic (2.35e-1)"				"unprognostic (7.25e-2)"	"unprognostic (5.41e-2)"						"unprognostic (1.27e-1)"	"potential prognostic favorable (6.76e-4)"	"unprognostic (2.75e-3)"				"unprognostic (5.39e-2)"		"unprognostic (2.94e-2)"					"unprognostic (3.55e-1)"		"unprognostic (7.94e-2)"	"unprognostic (1.00e-3)"	"unprognostic (7.83e-2)"
RYR1	"CCO, MHS, MHS1, PPP1R137, RYR"	ENSG00000196218	"Ryanodine receptor 1"	P21817	19	38433691-38595273	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Developmental protein, Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	35	"skeletal muscle: 1097.4;tongue: 331.8"	"Cell type enriched"	"Detected in many"	9	"Skeletal myocytes: 445.9"	"Cell type enhanced"	"Detected in all"		"central nervous system macrophage: 353.0;cerebellar inhibitory: 239.5"	"Cancer enhanced"	"Detected in many"		"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA): 43.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"dendritic cells: 3.3;granulocytes: 3.3;monocytes: 4.3"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 21.0"	"Adrenal gland - Macrophages"	"Low region specificity"	"Detected in single"			"Region enhanced"	"Detected in many"		"basal ganglia: 12.6"	HPA056416	Enhanced		Approved	"Golgi apparatus,Vesicles,Cytosol"			NA	NA		620000	"Cluster 40: Monocytes - Innate immune response"	"Cluster 2: Skeletal muscle - Striated muscle contraction"	"Cluster 56: Hypothalamus - Neuropeptide signaling"	"Cluster 33: Sarcoma - Muscle contraction"	"Cluster 2: Skeletal myocytes - Muscle contraction"	10	"Golgi apparatus, Vesicles"	Cytosol	"HPA056416: AB_2683121"	"unprognostic (7.05e-2)"	"unprognostic (2.20e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.87e-1)"			"unprognostic (8.70e-2)"	"unprognostic (1.70e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.81e-1)"	"unprognostic (4.03e-1)"	"unprognostic (4.70e-2)"			"unprognostic (1.73e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.76e-3)"	"unprognostic (8.37e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.68e-3)"	"unprognostic (9.32e-2)"			"unprognostic (5.12e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.73e-3)"
RYR2	"ARVC2, ARVD2, VTSIP"	ENSG00000198626	"Ryanodine receptor 2"	Q92736	1	237042184-237833988	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Developmental protein, Ion channel, Ligand-gated ion channel, Receptor"	"Cardiomyopathy, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"heart muscle: 134.4"	"Group enriched"	"Detected in many"	12	"Cardiomyocytes: 2742.2;Excitatory neurons: 1274.9;Inhibitory neurons: 760.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"thyroid cancer: 4.1"	"Adipose subcutaneous - Smooth muscle cells, Adipose visceral - Smooth muscle cells, Heart muscle - Cardiomyocytes, Minor Salivary Gland - Minor salivary glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020028	Approved		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"			NA	NA				"Cluster 30: Heart muscle - Heart development"	"Cluster 34: Non-specific - Mixed function"	"Cluster 71: Lymphoma - Inflammatory response"	"Cluster 68: Cardiomyocytes - Muscle contraction"	12	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA020028: AB_1856528"			"unprognostic (9.88e-3)"			"unprognostic (6.89e-2)"		"unprognostic (1.35e-1)"									"unprognostic (7.28e-2)"		"unprognostic (3.20e-2)"				"unprognostic (9.99e-2)"	"unprognostic (1.57e-2)"		"unprognostic (6.17e-2)"		"unprognostic (2.35e-2)"	"unprognostic (1.73e-1)"		
S1PR1	"CD363, D1S3362, edg-1, EDG1"	ENSG00000170989	"Sphingosine-1-phosphate receptor 1"	P21453	1	101236865-101243713	"Cancer-related genes, CD markers, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Angiogenesis, Chemotaxis"	"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 257.8;Endothelial cells: 150.8;Lymphatic endothelial cells: 76.8;NK-cells: 57.4"	"Group enriched"	"Detected in some"	6	"astrocyte: 43.8;bergmann glia: 82.6;endothelial cell: 85.0;leukocyte: 21.3"	"Cancer enhanced"	"Detected in all"		"Kidney Renal Clear Cell Carcinoma (TCGA): 58.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 1252.2"	"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Adipose subcutaneous - Endothelial cells, Adipose visceral - Endothelial cells, Breast - Endothelial cells, Colon - Endothelial cells, Heart muscle - Endothelial cells, Kidney - Endothelial cells, Lung - Endothelial cells, Minor Salivary Gland - Endothelial cells, Pancreas - Endothelial cells, Pituitary gland - Endothelial cells, Prostate - Endothelial cells, Skeletal muscle - Endothelial cells, Skin - Endothelial cells, Stomach - Endothelial cells, Testis - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010104, HPA075568"	Supported		Supported	Vesicles			No	NA			"Cluster 5: Non-specific - Cell proliferation"	"Cluster 7: Adipose tissue - Mixed function"	"Cluster 19: Astrocytes - Mixed function"	"Cluster 48: Adipocytes & Endothelial cells - Angiogenesis"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	56	Vesicles		"CAB010104: AB_2238920, HPA075568: AB_2686758"	"unprognostic (1.40e-1)"	"unprognostic (2.82e-1)"	"unprognostic (7.69e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.32e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.97e-1)"	"unprognostic (4.16e-3)"	"unprognostic (1.27e-3)"	"unprognostic (1.87e-1)"	"validated prognostic favorable (1.94e-9)"	"validated prognostic favorable (6.68e-4)"	"unprognostic (1.38e-2)"	"unprognostic (4.46e-3)"	"unprognostic (1.04e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.68e-2)"	"unprognostic (9.71e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.40e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.56e-2)"	"unprognostic (4.92e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.28e-1)"
S1PR3	"bA791O21.3, C9orf108, C9orf47, EDG-3, EDG3, FLJ37523"	ENSG00000213694	"Sphingosine-1-phosphate receptor 3"	Q99500	9	88990863-89005155	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 66.0;Fibroblasts: 28.1;Sertoli cells: 40.8;Smooth muscle cells: 38.5"	"Group enriched"	"Detected in many"	4	"ependymal cell: 26.5;fibroblast: 31.0;pericyte: 89.9;vascular associated smooth muscle cell: 62.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	18	"classical monocyte: 7.0"	"Lineage enriched"	"Detected in single"	18	"monocytes: 7.0"	"Low cancer specificity"	"Detected in many"				"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"										NA	NA			"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 41: Smooth muscle tissue - ECM organization"	"Cluster 39: Astrocytes - Mixed function"	"Cluster 44: Connective tissue cells - ECM organization"	"Cluster 48: Smooth muscle cells - Signal transduction"	3				"unprognostic (1.95e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.18e-3)"	"unprognostic (3.46e-1)"	"unprognostic (5.54e-3)"	"unprognostic (2.07e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.24e-2)"	"unprognostic (9.79e-2)"	"unprognostic (3.84e-2)"	"unprognostic (9.13e-2)"	"potential prognostic favorable (6.05e-4)"	"unprognostic (3.90e-3)"	"unprognostic (4.40e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.89e-1)"	"potential prognostic unfavorable (6.85e-5)"	"unprognostic (5.59e-2)"	"unprognostic (1.15e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.91e-2)"	"unprognostic (7.97e-2)"	"unprognostic (2.26e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.96e-2)"	"unprognostic (8.90e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.05e-2)"	"unprognostic (3.70e-2)"	"unprognostic (8.47e-2)"
S1PR5	"Edg-8, EDG8"	ENSG00000180739	"Sphingosine-1-phosphate receptor 5"	Q9H228	19	10512742-10517931	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 15.6;brain: 33.3;skin 1: 14.1"	"Cell type enriched"	"Detected in some"	6	"NK-cells: 170.4"	"Group enriched"	"Detected in some"	6	"leukocyte: 42.3;oligodendrocyte: 33.9"	"Group enriched"	"Detected in many"	5	"Bladder Urothelial Carcinoma (TCGA): 14.6;Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA): 29.6;Head and Neck Squamous Cell Carcinoma (TCGA): 16.8;Lung Squamous Cell Carcinoma (TCGA): 15.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 300.0;MAIT T-cell: 185.0;memory CD8 T-cell: 144.8;naive CD8 T-cell: 109.2"	"Lineage enriched"	"Detected in many"	7	"T-cells: 300.0"	"Low cancer specificity"	"Detected in many"			"Adipose subcutaneous - T-cells, Liver - NK-cells (Liver), Lung - NK-cells (Lung), Skin - Keratinocyte (other), Testis - Late spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029683	Enhanced						NA	NA			"Cluster 1: T-cells - Unknown function"	"Cluster 9: Oligodendrocytes - Myelination"	"Cluster 11: White matter - Signal transduction"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 19: NK-cells - Adaptive immune response"	2			"HPA029683: AB_10603237"	"unprognostic (1.06e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.59e-1)"	"unprognostic (6.18e-2)"			"unprognostic (3.11e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.93e-3)"		"unprognostic (7.22e-3)"	"unprognostic (1.95e-3)"						"unprognostic (9.52e-2)"	"unprognostic (1.45e-1)"			"unprognostic (2.96e-1)"	"potential prognostic unfavorable (4.06e-4)"	"unprognostic (2.14e-1)"		"unprognostic (1.20e-1)"	"unprognostic (2.14e-2)"		"unprognostic (7.67e-2)"		"unprognostic (1.29e-3)"
SCN10A	"hPN3, Nav1.8, PN3, SNS"	ENSG00000185313	"Sodium voltage-gated channel alpha subunit 10"	Q9Y5Y9	3	38696802-38816286	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Testis - Early spermatids, Testis - Late spermatids"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA040337			Approved	"Connecting piece,Flagellar centriole"			NA	NA						"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 21: Early spermatids - Spermatogenesis"		"Connecting piece, Flagellar centriole"		"HPA040337: "																															
SCN11A	"NaN, Nav1.9, SCN12A, SNS-2"	ENSG00000168356	"Sodium voltage-gated channel alpha subunit 11"	Q9UI33	3	38845764-39052157	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease variant, FDA approved drug targets, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 2.9;placenta: 1.8"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 6.0;Astrocytes: 7.4;Early spermatids: 7.6;Late spermatids: 5.0;Spermatocytes: 18.4;Spermatogonia: 12.0"	"Cell type enhanced"	"Detected in all"		"bergmann glia: 60.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Colon - Colon enteroendocrine cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA036746, HPA036747"	Uncertain						NA	NA				"Cluster 47: Spleen - Immune response"	"Cluster 39: Astrocytes - Mixed function"	"Cluster 21: Lymphoma - Adaptive immune response"	"Cluster 67: Spermatogonia - Spermatogenesis"				"HPA036746: AB_10696785, HPA036747: AB_2675287"			"unprognostic (2.52e-1)"																												
SCN1A	"FEB3, GEFSP2, HBSCI, NAC1, Nav1.1, SCN1, SMEI"	ENSG00000144285	"Sodium voltage-gated channel alpha subunit 1"	P35498	2	165984641-166149214	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Autism, Autism spectrum disorder, Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 11.9;retina: 3.3"	"Group enriched"	"Detected in some"	10	"Excitatory neurons: 396.7;Inhibitory neurons: 474.6;Oligodendrocyte precursor cells: 649.5"	"Low cell type specificity"	"Detected in all"			"Cancer enriched"	"Detected in single"	7	"Glioblastoma Multiforme (TCGA): 2.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Colon - Colon enteroendocrine cells, Heart muscle - Cardiomyocytes, Lung - Alveolar cells type 2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078664			Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane"			NA	NA				"Cluster 22: Brain - Synaptic signal transduction"	"Cluster 52: Neurons & Synapses - Synaptic function"	"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 8: Neurons - Neuronal signaling"	1	"Nucleoplasm, Plasma membrane"	"Nuclear bodies"	"HPA078664: AB_2686888"							"unprognostic (4.38e-1)"	"unprognostic (7.03e-3)"																							
SCN1B		ENSG00000105711	"Sodium voltage-gated channel beta subunit 1"	Q07699	19	35030470-35040449	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Atrial fibrillation, Brugada syndrome, Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 278.8;skeletal muscle: 551.8;tongue: 218.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 65.8;Excitatory neurons: 48.8;Horizontal cells: 63.6;Inhibitory neurons: 46.5;Skeletal myocytes: 151.2"	"Cell type enhanced"	"Detected in all"		"cerebellar inhibitory: 205.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"thyroid cancer: 23.5"	"Minor Salivary Gland - Endothelial cells, Spleen - Macrophages"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebral cortex: 536.8"						"Secreted in other tissues"	Transport	NA	NA				"Cluster 79: Non-specific - Transcription"	"Cluster 52: Neurons & Synapses - Synaptic function"	"Cluster 72: Neuronal - Signal transduction"	"Cluster 57: Platelets - Hemostasis"	1				"unprognostic (2.34e-2)"	"unprognostic (1.81e-1)"	"unprognostic (8.87e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.72e-2)"	"unprognostic (3.28e-3)"	"unprognostic (1.84e-1)"	"unprognostic (4.04e-2)"	"unprognostic (6.10e-2)"	"unprognostic (3.26e-3)"	"unprognostic (4.37e-3)"	"potential prognostic favorable (1.85e-4)"	"unprognostic (8.76e-3)"	"unprognostic (1.06e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.24e-3)"	"unprognostic (2.22e-2)"	"potential prognostic favorable (3.80e-5)"	"unprognostic (1.91e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.24e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.72e-2)"	"unprognostic (7.88e-2)"
SCN2A	"HBSCI, HBSCII, Nav1.2, SCN2A1, SCN2A2"	ENSG00000136531	"Sodium voltage-gated channel alpha subunit 2"	Q99250	2	165194993-165392310	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"brain: 70.0"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 425.4;Inhibitory neurons: 349.2;Oligodendrocyte precursor cells: 231.1"	"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in some"		"Glioblastoma Multiforme (TCGA): 2.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Rhabdoid: 5.8"	"Adipose visceral - Mesothelial cells, Colon - Colon enteroendocrine cells, Pituitary gland - Lactotropes, Testis - Peritubular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022567	Enhanced						NA	NA				"Cluster 65: Cerebellum - Nervous system development"	"Cluster 14: Neurons - Synaptic function"	"Cluster 5: Rhabdoid - Unknown function"	"Cluster 69: Neurons - Neuronal signaling"	4			"CAB022567: "			"unprognostic (5.41e-1)"				"unprognostic (3.49e-1)"	"unprognostic (1.29e-3)"		"unprognostic (1.74e-1)"			"unprognostic (1.38e-1)"						"unprognostic (1.99e-1)"				"unprognostic (1.25e-1)"								
SCN2B		ENSG00000149575	"Sodium voltage-gated channel beta subunit 2"	O60939	11	118162806-118176639	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Atrial fibrillation, Brugada syndrome, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 42.8;heart muscle: 12.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 9.1;Cardiomyocytes: 15.0;Excitatory neurons: 21.2;Horizontal cells: 30.2;Inhibitory neurons: 30.6;Schwann cells: 10.3"	"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in some"		"Glioblastoma Multiforme (TCGA): 2.5;Thyroid Carcinoma (TCGA): 2.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Heart muscle - Cardiomyocytes, Minor Salivary Gland - Fibroblasts, Thyroid gland - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"										NA	NA				"Cluster 22: Brain - Synaptic signal transduction"	"Cluster 38: Sub-cortical - Mixed function"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 69: Neurons - Neuronal signaling"							"unprognostic (3.26e-1)"				"unprognostic (1.03e-1)"	"unprognostic (1.97e-1)"												"unprognostic (1.21e-1)"										"unprognostic (2.25e-1)"	
SCN3A	Nav1.3	ENSG00000153253	"Sodium voltage-gated channel alpha subunit 3"	Q9NY46	2	165087526-165204050	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 8.9;lymphoid tissue: 3.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 103.5;Excitatory neurons: 219.5;Inhibitory neurons: 161.8;Oligodendrocyte precursor cells: 336.3"	"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in single"		"Glioblastoma Multiforme (TCGA): 3.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	30	"memory B-cell: 13.3;naive B-cell: 15.4"	"Lineage enriched"	"Detected in single"	32	"B-cells: 15.4"	"Cancer enhanced"	"Detected in many"		"lung cancer: 9.7"	"Pituitary gland - Lactotropes, Spleen - B-cells (Spleen), Testis - Early spermatids, Testis - Late spermatids"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035396	Uncertain						NA	NA			"Cluster 34: B-cells - Unknown function"	"Cluster 61: Brain - Neuronal signaling"	"Cluster 1: Neurons - Mixed function"	"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 34: Neurons - Neuronal signaling"	1			"HPA035396: AB_2674607"			"unprognostic (5.07e-3)"			"unprognostic (3.91e-2)"	"unprognostic (1.28e-1)"	"potential prognostic favorable (3.01e-4)"									"unprognostic (1.31e-2)"									"unprognostic (4.18e-1)"					
SCN3B	"HSA243396, SCNB3"	ENSG00000166257	"Sodium voltage-gated channel beta subunit 3"	Q9NY72	11	123629187-123655244	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Atrial fibrillation, Brugada syndrome, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 75.8;pituitary gland: 27.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 56.6;Horizontal cells: 82.5;Inhibitory neurons: 34.0;Late spermatids: 33.0;Lymphatic endothelial cells: 73.2;Skeletal myocytes: 55.6"	"Low cell type specificity"	"Detected in many"			"Cancer enriched"	"Detected in some"	4	"Glioblastoma Multiforme (TCGA): 6.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	12	"Neuroblastoma: 18.0"	"Adrenal gland - Adrenal medulla cells, Pituitary gland - Lactotropes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078632			Approved	"Vesicles,Plasma membrane,Cytosol"			NA	NA		6100		"Cluster 61: Brain - Neuronal signaling"	"Cluster 51: Neurons - Mixed function"	"Cluster 17: Neuroblastoma - Neuronal signaling"	"Cluster 54: Lymphatic endothelial cells - Lymph vessel development"	127	"Plasma membrane, Cytosol"	Vesicles	"HPA078632: "			"unprognostic (7.64e-3)"				"unprognostic (3.89e-2)"	"unprognostic (1.77e-3)"				"unprognostic (3.80e-1)"								"unprognostic (4.31e-2)"		"unprognostic (1.94e-3)"							"unprognostic (2.30e-1)"	"unprognostic (4.97e-2)"	
SCN4A	"HYKPP, HYPP, Nav1.4, SkM1"	ENSG00000007314	"Sodium voltage-gated channel alpha subunit 4"	P35499	17	63938554-63972918	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Congenital myasthenic syndrome, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"skeletal muscle: 132.5;tongue: 51.9"	"Group enriched"	"Detected in some"	6	"Adipocytes: 40.2;Skeletal myocytes: 38.1"	"Cell type enriched"	"Detected in some"	27	"fibroblast: 36.6"	"Cancer enhanced"	"Detected in some"		"Thyroid Carcinoma (TCGA): 3.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Leukemia: 2.1;Sarcoma: 6.5"	"Pituitary gland - Somatotropes, Testis - Late spermatids"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"spinal cord: 1.3"	HPA070997			Uncertain	"Golgi apparatus"			NA	NA				"Cluster 2: Skeletal muscle - Striated muscle contraction"		"Cluster 33: Sarcoma - Muscle contraction"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"		"Golgi apparatus"		"HPA070997: "			"unprognostic (2.36e-3)"					"unprognostic (1.53e-1)"			"potential prognostic favorable (1.24e-7)"																		"unprognostic (3.10e-1)"	"unprognostic (3.59e-1)"	
SCN4B	LQT10	ENSG00000177098	"Sodium voltage-gated channel beta subunit 4"	Q8IWT1	11	118133377-118152888	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Atrial fibrillation, Disease variant, FDA approved drug targets, Long QT syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.0;tongue: 54.6"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 10.1;Excitatory neurons: 17.6;Inhibitory neurons: 7.9;Late spermatids: 8.7;Sertoli cells: 19.0;Smooth muscle cells: 23.5"	"Cell type enhanced"	"Detected in many"		"medium spiny neuron: 71.0"	"Cancer enhanced"	"Detected in many"		"Glioblastoma Multiforme (TCGA): 10.7;Kidney Renal Clear Cell Carcinoma (TCGA): 10.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Brain cancer: 2.1"	"Liver - Hepatic stellate cells, Minor Salivary Gland - Fibroblasts, Pituitary gland - Fibroblasts, Stomach - Fibroblasts, Thyroid gland - Fibroblasts"	"Region enriched"	"Detected in all"	11	"basal ganglia: 816.5"	"Region enriched"	"Detected in many"	4	"basal ganglia: 174.4"	HPA017293	Approved						NA	NA				"Cluster 14: Skeletal muscle - Muscle contraction"	"Cluster 52: Neurons & Synapses - Synaptic function"	"Cluster 65: Non-specific - Unknown function"	"Cluster 48: Smooth muscle cells - Signal transduction"	1			"HPA017293: AB_2184174"		"unprognostic (1.06e-1)"	"unprognostic (2.44e-1)"			"unprognostic (6.02e-2)"	"unprognostic (4.30e-1)"	"unprognostic (6.49e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.64e-1)"	"validated prognostic favorable (9.91e-8)"	"validated prognostic favorable (6.39e-5)"			"unprognostic (1.70e-1)"	"potential prognostic favorable (7.76e-4)"	"unprognostic (2.14e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.42e-1)"			"unprognostic (4.42e-3)"	"unprognostic (8.81e-2)"	"unprognostic (1.52e-1)"		"unprognostic (7.65e-2)"	"unprognostic (7.59e-2)"		"unprognostic (1.31e-1)"	"unprognostic (6.86e-2)"	
SCN5A	"CDCD2, CMD1E, CMPD2, HB1, HB2, HBBD, HH1, ICCD, IVF, LQT3, Nav1.5, PFHB1, SSS1"	ENSG00000183873	"Sodium voltage-gated channel alpha subunit 5"	Q14524	3	38548057-38649687	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Calmodulin-binding, Ion channel, Sodium channel, Voltage-gated channel"	"Atrial fibrillation, Brugada syndrome, Cardiomyopathy, Disease variant, FDA approved drug targets, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"heart muscle: 41.3"	"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 57.8;Cone photoreceptor cells: 34.0;Oocytes: 20.6"	"Cell type enhanced"	"Detected in many"		"eccentric medium spiny neuron: 37.8;fibroblast: 22.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Neuroblastoma: 5.5;Sarcoma: 4.2"	"Breast - Breast myoepithelial cells, Colon - Colon enteroendocrine cells, Heart muscle - Cardiomyocytes, Pituitary gland - Undifferentiated cells (Pituitary gland)"	"Group enriched"	"Detected in many"	5	"amygdala: 3.1;basal ganglia: 10.1;hypothalamus: 6.0"	"Region enhanced"	"Detected in many"		"basal ganglia: 6.6"	HPA063346			Supported	"Nucleoplasm,Nucleoli,Plasma membrane"			NA	NA				"Cluster 30: Heart muscle - Heart development"	"Cluster 56: Hypothalamus - Neuropeptide signaling"	"Cluster 33: Sarcoma - Muscle contraction"	"Cluster 68: Cardiomyocytes - Muscle contraction"	11	"Plasma membrane"	"Nucleoplasm, Nucleoli"	"HPA063346: "	"unprognostic (9.16e-2)"																												"unprognostic (1.53e-1)"		
SCN7A	"NaG, Nav2.1, Nav2.2, SCN6A"	ENSG00000136546	"Sodium voltage-gated channel alpha subunit 7"	Q01118	2	166403573-166611482	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 34.5;ovary: 38.5"	"Cell type enriched"	"Detected in many"	4	"Schwann cells: 709.4"	"Cell type enhanced"	"Detected in many"		"fibroblast: 109.9;splatter: 129.4;thalamic excitatory: 115.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	7	"Rhabdoid: 19.2"	"Colon - Enteric glia cells, Minor Salivary Gland - Minor salivary gland ductal cells, Prostate - Fibroblasts, Spleen - Fibroblast_2"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"spinal cord: 10.0"	HPA072715	Approved		Approved	"Plasma membrane"			NA	NA			"Cluster 41: Basophils - Unknown function"	"Cluster 41: Smooth muscle tissue - ECM organization"	"Cluster 56: Hypothalamus - Neuropeptide signaling"	"Cluster 5: Rhabdoid - Unknown function"	"Cluster 26: Schwann cells & Melanocytes - Mixed function"		"Plasma membrane"		"HPA072715: "		"unprognostic (1.60e-1)"	"unprognostic (3.05e-1)"		"unprognostic (4.85e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.11e-1)"		"unprognostic (2.54e-2)"						"unprognostic (1.85e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.02e-1)"			"unprognostic (6.16e-2)"	"unprognostic (2.71e-2)"	"unprognostic (3.82e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.27e-2)"		"unprognostic (3.98e-2)"	"unprognostic (4.69e-2)"		"unprognostic (8.06e-2)"
SCN8A	"CerIII, CIAT, MED, NaCh6, Nav1.6, PN4"	ENSG00000196876	"Sodium voltage-gated channel alpha subunit 8"	Q9UQD0	12	51590266-51812864	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets, Intellectual disability"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 17.5;pituitary gland: 6.5;retina: 7.6"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 325.4;Inhibitory neurons: 269.0;Oligodendrocyte precursor cells: 98.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Liver - Hepatocytes, Testis - Spermatogonia"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022169, HPA043937, HPA073590"			Approved	"Vesicles,Plasma membrane,Cell Junctions"			NA	NA				"Cluster 22: Brain - Synaptic signal transduction"	"Cluster 52: Neurons & Synapses - Synaptic function"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 8: Neurons - Neuronal signaling"	1	"Plasma membrane"	"Vesicles, Cell Junctions"	"CAB022169: , HPA043937: , HPA073590: "			"unprognostic (1.37e-1)"			"unprognostic (2.40e-1)"	"unprognostic (7.00e-2)"	"potential prognostic favorable (2.44e-4)"					"unprognostic (7.21e-2)"		"unprognostic (8.57e-3)"		"unprognostic (3.78e-1)"		"potential prognostic favorable (3.92e-4)"	"unprognostic (1.68e-2)"			"unprognostic (2.49e-1)"			"unprognostic (2.75e-1)"		"unprognostic (2.10e-1)"	"unprognostic (2.70e-1)"		
SCN9A	"ETHA, Nav1.7, NE-NA, NENA, PN1"	ENSG00000169432	"Sodium voltage-gated channel alpha subunit 9"	Q15858	2	166195185-166376001	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 6.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 110.7;Exocrine glandular cells: 52.7;Hofbauer cells: 65.0;Langerhans cells: 53.3;Lymphatic endothelial cells: 59.2;Oligodendrocyte precursor cells: 125.5;Schwann cells: 89.5;Sertoli cells: 73.4"	"Cell type enhanced"	"Detected in all"		"oligodendrocyte precursor cell: 408.5"	"Cancer enhanced"	"Detected in some"		"Lung Squamous Cell Carcinoma (TCGA): 4.4"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	16	"plasmacytoid DC: 23.6"	"Lineage enriched"	"Detected in single"	26	"dendritic cells: 23.6"	"Cancer enhanced"	"Detected in many"		"Rhabdoid: 44.7"	"Kidney - Proximal tubular cells, Testis - Sertoli cells"	"Region enriched"	"Detected in many"	5	"hypothalamus: 9.3"	"Low region specificity"	"Detected in many"			"CAB013679, HPA061843"	Uncertain		Approved	"Plasma membrane,Actin filaments,Focal adhesion sites"			NA	NA			"Cluster 8: Plasmacytoid DCs - Unknown function"	"Cluster 44: Testis - Spermatogenesis"	"Cluster 56: Hypothalamus - Neuropeptide signaling"	"Cluster 5: Rhabdoid - Unknown function"	"Cluster 58: Macrophages - Innate immune response"		"Plasma membrane, Actin filaments, Focal adhesion sites"		"CAB013679: , HPA061843: AB_2684625"			"unprognostic (3.00e-1)"			"unprognostic (1.04e-1)"		"unprognostic (5.89e-2)"	"unprognostic (1.14e-2)"		"unprognostic (2.70e-2)"	"unprognostic (7.62e-2)"			"unprognostic (2.59e-2)"	"unprognostic (4.04e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.96e-2)"			"unprognostic (1.02e-1)"	"unprognostic (7.58e-3)"			"unprognostic (1.78e-1)"					
SCNN1A	"ENaCalpha, SCNN1"	ENSG00000111319	"Sodium channel epithelial 1 subunit alpha"	P37088	12	6346843-6377730	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Sodium transport, Taste, Transport"	"Ion channel, Sodium channel"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 190.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 224.1;Alveolar cells type 2: 194.9;Distal enterocytes: 138.4;Glandular and luminal cells: 183.0;Intestinal goblet cells: 204.9;Salivary duct cells: 178.3"	"Cell type enriched"	"Detected in some"	51	"choroid plexus epithelial cell: 140.0"	"Cancer enhanced"	"Detected in many"		"Kidney Chromophobe (TCGA): 391.1"	"Region enriched"	"Detected in some"	18	"choroid plexus: 243.0"	"Immune cell enhanced"	"Detected in some"		"neutrophil: 1.5"	"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Adipose visceral - Mesothelial cells, Breast - Breast glandular cells, Colon - Colon enterocytes, Lung - Alveolar cells type 2, Minor Salivary Gland - Minor salivary glandular cells, Prostate - Prostate basal glandular cells, Stomach - Gastric mucous cells, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA012743	Enhanced		Uncertain	Vesicles,Acrosome,Annulus			NA	NA				"Cluster 52: Kidney - Transmembrane transport"	"Cluster 36: Choroid plexus - Mixed function"	"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 16: Intestinal goblet cells - Mucin production"	10	"Vesicles, Annulus"	Acrosome	"HPA012743: AB_1856627"	"unprognostic (2.62e-1)"	"unprognostic (2.33e-1)"	"unprognostic (7.00e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.49e-2)"	"unprognostic (3.20e-1)"			"unprognostic (1.75e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.10e-3)"	"unprognostic (2.15e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.93e-3)"	"unprognostic (1.62e-1)"	"validated prognostic unfavorable (2.14e-4)"	"validated prognostic unfavorable (6.66e-4)"	"unprognostic (1.51e-1)"	"unprognostic (1.33e-1)"	"unprognostic (7.18e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.11e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.42e-1)"
SCNN1B	ENaCbeta	ENSG00000168447	"Sodium channel epithelial 1 subunit beta"	P51168	16	23278231-23381294	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Sodium transport, Taste, Transport"	"Ion channel, Sodium channel"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 80.5;intestine: 91.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 93.7;Club cells: 56.9;Distal enterocytes: 242.3;Ionocytes: 48.6;Salivary duct cells: 76.9;Suprabasal keratinocytes: 51.4"	"Cell type enhanced"	"Detected in some"		"upper rhombic lip: 3.7"	"Cancer enhanced"	"Detected in many"		"Bladder Urothelial Carcinoma (TCGA): 54.0;Lung Adenocarcinoma (TCGA): 39.2"	"Region enriched"	"Detected in single"	9	"cerebellum: 2.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"Myeloma: 32.1;Sarcoma: 36.5;thyroid cancer: 9.6"	"Prostate - Prostate basal glandular cells, Stomach - Gastric mucous cells"	"Region enriched"	"Detected in single"	5	"cerebellum: 1.0"	"Low region specificity"	"Detected in many"			HPA015612	Uncertain						NA	NA				"Cluster 75: Epithelium - Extracellular exosomes"	"Cluster 35: Non-specific - DNA binding"	"Cluster 54: Non-specific - Transcription"	"Cluster 5: Enterocytes - Absorption"	11			"HPA015612: AB_1856629"	"unprognostic (7.74e-3)"	"unprognostic (1.12e-2)"	"unprognostic (7.36e-2)"	"potential prognostic favorable (8.52e-4)"	"unprognostic (1.33e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.07e-2)"	"unprognostic (8.17e-3)"	"unprognostic (1.70e-2)"	"unprognostic (6.87e-2)"	"potential prognostic unfavorable (8.64e-4)"	"unprognostic (1.82e-2)"	"unprognostic (1.60e-1)"			"potential prognostic favorable (3.14e-4)"	"unprognostic (3.88e-1)"	"unprognostic (4.16e-3)"	"unprognostic (9.89e-3)"	"unprognostic (2.15e-1)"	"unprognostic (2.34e-1)"	"unprognostic (3.00e-1)"		"unprognostic (3.14e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.10e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.48e-2)"
SCNN1D	"dNaCh, ENaCdelta"	ENSG00000162572	"Sodium channel epithelial 1 subunit delta"	P51172	1	1280436-1292029	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Sodium transport, Taste, Transport"	"Ion channel, Sodium channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.5;testis: 34.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 10.2;Early spermatids: 10.5;Horizontal cells: 8.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Liver - Hepatocytes, Skeletal muscle - Fibroblasts"					"Low region specificity"	"Detected in all"			HPA026884	Enhanced		Supported	"Plasma membrane,Actin filaments"			NA	NA				"Cluster 78: Testis - Transcription"	"Cluster 37: Neurons - Mixed function"	"Cluster 27: Breast cancer - Unknown function"	"Cluster 45: Non-specific - Mixed function"	3	"Plasma membrane, Actin filaments"		"HPA026884: AB_10601501"	"unprognostic (1.54e-3)"	"unprognostic (4.77e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.32e-1)"		"unprognostic (9.07e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.01e-1)"	"potential prognostic favorable (1.56e-4)"	"unprognostic (2.23e-2)"	"potential prognostic unfavorable (2.99e-5)"	"unprognostic (1.70e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.82e-1)"		"unprognostic (1.39e-1)"		"unprognostic (6.73e-2)"	"unprognostic (6.71e-2)"	"potential prognostic favorable (5.55e-4)"	"unprognostic (1.18e-3)"	"unprognostic (1.01e-1)"		"unprognostic (9.91e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.55e-1)"	"unprognostic (9.71e-3)"	"unprognostic (2.04e-1)"	"unprognostic (3.17e-1)"
SCNN1G	"ENaCgamma, SCNEG"	ENSG00000166828	"Sodium channel epithelial 1 subunit gamma"	P51170	16	23182745-23216883	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Sodium transport, Taste, Transport"	"Ion channel, Sodium channel"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 41.0"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 21.8;Basal squamous epithelial cells: 11.7;Club cells: 26.0;Collecting duct cells: 40.8;Gastric mucus-secreting cells: 14.7;Glandular and luminal cells: 16.5;Ionocytes: 17.7;Salivary duct cells: 26.8"	"Cell type enhanced"	"Detected in some"		"hippocampal dentate gyrus: 9.7;upper rhombic lip: 12.1"	"Cancer enhanced"	"Detected in many"		"Bladder Urothelial Carcinoma (TCGA): 15.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	5	"Bone cancer: 13.8"	"Lung - Alveolar cells type 1, Minor Salivary Gland - Minor salivary gland ductal cells, Pancreas - Ductal cells, Prostate - Prostate basal glandular cells"	"Region enriched"	"Detected in single"	13	"cerebellum: 2.5"	"Not detected"	"Not detected"			HPA071194			Approved	"Nucleoplasm,Plasma membrane,Primary cilium transition zone"			NA	NA				"Cluster 52: Kidney - Transmembrane transport"	"Cluster 35: Non-specific - DNA binding"	"Cluster 12: Bone cancer - Neuronal signaling"	"Cluster 35: Respiratory epithelial cells - Unknown function"	6	"Plasma membrane"	"Nucleoplasm, Primary cilium transition zone"	"HPA071194: AB_2686359"	"unprognostic (6.04e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.17e-3)"	"unprognostic (4.60e-3)"		"unprognostic (5.29e-2)"		"unprognostic (2.15e-2)"	"unprognostic (7.73e-3)"		"potential prognostic unfavorable (7.37e-6)"	"unprognostic (3.87e-2)"	"unprognostic (1.44e-1)"			"unprognostic (9.68e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.85e-2)"		"unprognostic (1.65e-1)"		"unprognostic (9.55e-2)"		"unprognostic (5.08e-2)"				"unprognostic (1.61e-1)"	"unprognostic (3.22e-1)"
SCTR		ENSG00000080293	"Secretin receptor"	P47872	2	119439843-119525301	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 25.8;pancreas: 66.0"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 2: 29.6;Ductal cells: 96.2;Exocrine glandular cells: 95.2;Pancreatic endocrine cells: 28.9"	"Cell type enhanced"	"Detected in some"		"CGE interneuron: 5.9;mammillary body: 8.3"	"Cancer enhanced"	"Detected in many"		"Lung Adenocarcinoma (TCGA): 14.5;Pancreatic Adenocarcinoma (TCGA): 31.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"liver cancer: 1.1"	"Pituitary gland - Thyrotropes"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA007269	Uncertain						NA	NA				"Cluster 15: Pancreas - Proteolysis"	"Cluster 37: Neurons - Mixed function"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 45: Non-specific - Mixed function"				"HPA007269: AB_1856640"				"unprognostic (4.62e-1)"						"unprognostic (3.18e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.70e-2)"		"unprognostic (3.04e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.29e-2)"	"unprognostic (8.25e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.28e-1)"			"unprognostic (1.18e-1)"	"unprognostic (2.19e-1)"			"unprognostic (3.40e-1)"		"unprognostic (7.57e-3)"			"unprognostic (3.76e-2)"
SDHA	"FP, SDH2, SDHF"	ENSG00000073578	"Succinate dehydrogenase complex flavoprotein subunit A"	P31040	5	218303-257082	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Electron transport, Transport, Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes, Cardiomyopathy, Disease variant, FDA approved drug targets, Leigh syndrome, Neurodegeneration, Primary mitochondrial disease, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 554.8;skeletal muscle: 459.9"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 453.4;Proximal enterocytes: 257.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adipose visceral - Adipocytes (Visceral), Adrenal gland - Adrenal cortex cells, Heart muscle - Cardiomyocytes, Liver - Hepatocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034929, HPA041981, HPA064582"	Enhanced		Supported	Nucleoli,Mitochondria			No	No		240000	"Cluster 9: T-regs - Cell cycle regulation"	"Cluster 23: Non-specific - Cellular respiration"	"Cluster 45: Non-specific - Mixed function"	"Cluster 7: Liver cancer - Metabolism"	"Cluster 68: Cardiomyocytes - Muscle contraction"	48	Mitochondria	Nucleoli	"CAB034929: AB_2183443, HPA041981: AB_2677779, HPA064582: AB_2685293"	"unprognostic (1.54e-2)"	"potential prognostic unfavorable (8.39e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.24e-3)"	"unprognostic (2.59e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.26e-2)"	"unprognostic (4.44e-1)"	"unprognostic (1.11e-2)"	"potential prognostic favorable (5.99e-4)"	"unprognostic (1.82e-1)"	"potential prognostic favorable (1.56e-4)"	"unprognostic (3.64e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.68e-1)"	"unprognostic (8.02e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.31e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.91e-1)"
SDHD	"cybS, PGL, PGL1"	ENSG00000204370	"Succinate dehydrogenase complex subunit D"	O14521	11	112086824-112120016	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Electron transport, Transport, Tricarboxylic acid cycle"		"Cancer-related genes, Disease variant, FDA approved drug targets, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 386.7;Distal tubular cells: 424.1"	"Cell type enhanced"	"Detected in some"		"pericyte: 2.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Adrenal cortex cells, Heart muscle - Cardiomyocytes, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA045727	Approved						NA	NA			"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 35: Non-specific - Mitochondria"	"Cluster 21: Non-specific - Metabolism"	"Cluster 24: Non-specific - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	4			"HPA045727: AB_10963114"	"unprognostic (2.24e-1)"	"unprognostic (4.41e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.50e-3)"	"unprognostic (1.14e-1)"	"unprognostic (8.03e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.86e-2)"	"unprognostic (6.14e-3)"	"potential prognostic favorable (3.67e-10)"	"unprognostic (9.48e-3)"	"unprognostic (5.23e-2)"	"unprognostic (2.47e-1)"	"unprognostic (8.49e-2)"	"unprognostic (8.25e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.58e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.08e-1)"	"potential prognostic unfavorable (6.51e-5)"	"unprognostic (3.75e-1)"	"unprognostic (9.94e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.69e-3)"	"unprognostic (2.37e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.80e-1)"
SELP	"CD62, CD62P, GMP140, GRMP, PADGEM, PSEL"	ENSG00000174175	"Selectin P"	P16109	1	169588849-169630193	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 24.6;Endothelial cells: 48.0;Smooth muscle cells: 9.4"	"Cell type enhanced"	"Detected in many"		"endothelial cell: 5.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"choroid plexus: 8.2"	"Immune cell enhanced"	"Detected in some"		"basophil: 8.2;T-reg: 8.8"	"Group enriched"	"Detected in many"	7	"granulocytes: 8.2;T-cells: 8.8"	"Cancer enriched"	"Detected in single"	5	"Leukemia: 2.9"	"Breast - Endothelial cells, Colon - Endothelial cells, Minor Salivary Gland - Endothelial cells, Prostate - Endothelial cells, Skin - Endothelial cells, Spleen - Platelets"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB002145, HPA002655, HPA005990"	Enhanced						NA	NA		300000000	"Cluster 35: Neutrophils - Protein binding"	"Cluster 62: Connective tissue - ECM organization"	"Cluster 23: Choroid plexus - Mixed function"	"Cluster 47: Leukemia - Hemostasis"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	2			"CAB002145: AB_563984, HPA002655: AB_1078480, HPA005990: AB_1078479"	"unprognostic (1.84e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.42e-3)"	"unprognostic (3.20e-1)"	"unprognostic (1.21e-1)"			"potential prognostic favorable (2.91e-4)"	"unprognostic (2.72e-1)"	"validated prognostic favorable (9.05e-7)"	"validated prognostic favorable (7.30e-5)"	"unprognostic (3.45e-2)"		"potential prognostic favorable (1.11e-4)"	"unprognostic (4.47e-3)"	"unprognostic (3.29e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.30e-1)"			"unprognostic (9.44e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.58e-2)"		"unprognostic (6.80e-2)"	"unprognostic (3.87e-2)"
SERPINB2	"HsT1201, PAI-2, PAI2, PLANH2"	ENSG00000197632	"Serpin family B member 2"	P05120	18	63871692-63903888	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Plasminogen activation"	"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 231.4;lymphoid tissue: 79.0;skin 1: 86.8"	"Group enriched"	"Detected in many"	8	"Basal keratinocytes: 1534.4;Suprabasal keratinocytes: 665.7;Syncytiotrophoblasts: 683.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"Bladder Urothelial Carcinoma (TCGA): 30.6;Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA): 43.2;Head and Neck Squamous Cell Carcinoma (TCGA): 69.1;Lung Squamous Cell Carcinoma (TCGA): 29.6"	"Region enhanced"	"Detected in some"		"cerebral cortex: 2.9;thalamus: 2.5"	"Immune cell enhanced"	"Detected in some"		"basophil: 22.1;eosinophil: 10.0"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 22.1"	"Cancer enhanced"	"Detected in many"		"Gallbladder cancer: 326.1"	"Pancreas - Ductal cells, Skin - Keratinocyte (other)"	"Region enriched"	"Detected in single"	15	"cerebellum: 2.6"	"Not detected"	"Not detected"			"HPA015480, HPA076596, HPA076608"	Enhanced				"Intracellular and membrane"	"Enzyme inhibitor"	NA	NA		1000000	"Cluster 22: Eosinophils - Transcription"	"Cluster 27: Squamous epithelium - Keratinization"	"Cluster 12: Non-specific - Vasculature"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 12: Squamous epithelial cells - Keratinization"	29			"HPA015480: AB_1855456, HPA076596: , HPA076608: "	"unprognostic (1.12e-1)"	"unprognostic (9.97e-2)"	"unprognostic (9.77e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.38e-1)"		"unprognostic (6.08e-2)"	"unprognostic (1.86e-2)"						"unprognostic (1.81e-1)"	"unprognostic (2.40e-1)"		"unprognostic (8.98e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.80e-3)"	"unprognostic (2.13e-1)"			"unprognostic (1.91e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.70e-2)"			
SERPINC1	"AT3, ATIII, MGC22579"	ENSG00000117601	"Serpin family C member 1"	P01008	1	173903800-173917327	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"	"Disease variant, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	1350	"liver: 4902.3"	"Cell type enriched"	"Detected in some"	36	"Hepatocytes: 2537.3"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	629	"Liver Hepatocellular Carcinoma (TCGA): 2227.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"Gastric cancer: 1.6;liver cancer: 5.7"	"Kidney - Proximal tubular cells, Liver - Hepatocytes"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA001816, CAB016790, HPA024007"	Supported				"Secreted to blood"	"Blood coagulation"	NA	NA		110000000000		"Cluster 31: Liver - Plasma proteins"		"Cluster 18: Liver cancer - Metabolism"	"Cluster 43: Hepatocytes - Metabolism"				"CAB016790: , HPA001816: AB_1079926, HPA024007: AB_1856732"			"unprognostic (4.53e-2)"								"unprognostic (4.40e-2)"			"validated prognostic favorable (3.41e-5)"	"validated prognostic favorable (4.37e-5)"														"unprognostic (6.24e-2)"		
SERPIND1	"D22S673, HC-II, HC2, HCF2, HLS2"	ENSG00000099937	"Serpin family D member 1"	P05546	22	20774113-20787720	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Chemotaxis, Hemostasis"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"	"Disease variant, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 1214.6"	"Cell type enriched"	"Detected in some"	13	"Hepatocytes: 238.0"	"Cell type enhanced"	"Detected in all"		"choroid plexus epithelial cell: 13.3"	"Cancer enriched"	"Detected in many"	44	"Liver Hepatocellular Carcinoma (TCGA): 487.1"	"Region enriched"	"Detected in all"	21	"choroid plexus: 191.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	15	"liver cancer: 30.6;ovarian cancer: 66.9"	"Liver - Hepatocytes, Thyroid gland - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"CAB008639, HPA055767"	Supported		Approved	Vesicles	"Secreted to blood"	"Blood coagulation"	NA	NA		40000000000	"Cluster 30: Non-specific - DNA binding"	"Cluster 31: Liver - Plasma proteins"	"Cluster 36: Choroid plexus - Mixed function"	"Cluster 66: Non-specific - Mitochondria"	"Cluster 62: Hepatocytes - Metabolism"	4	Vesicles		"CAB008639: AB_1618010, HPA055767: AB_2682912"					"unprognostic (1.60e-2)"	"unprognostic (5.58e-3)"					"potential prognostic unfavorable (8.85e-4)"			"unprognostic (1.08e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.09e-1)"	"potential prognostic unfavorable (2.39e-4)"	"unprognostic (2.85e-1)"			"unprognostic (2.59e-2)"	"unprognostic (8.58e-3)"		"unprognostic (2.06e-1)"	"unprognostic (1.45e-1)"		"unprognostic (1.19e-1)"	"unprognostic (5.35e-2)"		
SERPINE1	"PAI, PAI1, PLANH1"	ENSG00000106366	"Serpin family E member 1"	P05121	7	101127104-101139247	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"gallbladder: 348.4;placenta: 403.7"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 212.1;Ovarian stromal cells: 138.1;Pancreatic endocrine cells: 466.9;Syncytiotrophoblasts: 739.0"	"Group enriched"	"Detected in many"	4	"central nervous system macrophage: 99.2;endothelial cell: 130.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	25	"NK-cell: 9.5"	"Lineage enriched"	"Detected in single"	25	"NK-cells: 9.5"	"Cancer enhanced"	"Detected in all"		"Kidney cancer: 1620.4"	"Colon - Neutrophils"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB068501	Uncertain				"Secreted to blood"	"Enzyme inhibitor"	NA	No	142000000	20000000	"Cluster 14: Non-specific - Unknown function"	"Cluster 11: Liver - Plasma proteins"	"Cluster 12: Non-specific - Vasculature"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 45: Non-specific - Mixed function"	15			"CAB068501: AB_1642775"	"unprognostic (1.72e-2)"	"unprognostic (2.62e-2)"	"unprognostic (6.80e-2)"	"unprognostic (4.90e-3)"	"unprognostic (3.34e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.57e-2)"	"potential prognostic unfavorable (1.69e-4)"	"potential prognostic unfavorable (2.87e-5)"	"unprognostic (3.77e-3)"	"unprognostic (9.10e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.14e-3)"	"unprognostic (1.90e-3)"	"unprognostic (1.94e-1)"	"potential prognostic unfavorable (4.74e-4)"	"unprognostic (1.34e-3)"	"validated prognostic unfavorable (1.13e-4)"	"validated prognostic unfavorable (4.14e-5)"	"unprognostic (5.39e-2)"	"unprognostic (2.82e-1)"	"potential prognostic unfavorable (4.02e-4)"	"unprognostic (1.93e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.12e-1)"	"potential prognostic unfavorable (7.06e-6)"	"unprognostic (2.98e-1)"	"unprognostic (1.03e-2)"	"unprognostic (5.80e-3)"
SHBG	"ABP, MGC126834, MGC138391, TEBG"	ENSG00000129214	"Sex hormone binding globulin"	P04278	17	7613946-7633382	"Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 61.5"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 51.9;Late spermatids: 124.0;Proximal enterocytes: 28.6"	"Low cell type specificity"	"Detected in many"			"Cancer enriched"	"Detected in some"	16	"Liver Hepatocellular Carcinoma (TCGA): 29.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Kidney - Proximal tubular cells, Kidney - Proximal tubular cells, Testis - Late spermatids"	"Not detected"	"Not detected"												"Secreted to blood"	Transport	NA	NA		6100000000		"Cluster 83: Liver - Metabolism"	"Cluster 39: Astrocytes - Mixed function"	"Cluster 72: Neuronal - Signal transduction"	"Cluster 36: Late spermatids - Unknown function"							"unprognostic (7.32e-2)"				"unprognostic (2.94e-2)"	"unprognostic (5.73e-2)"					"unprognostic (4.41e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.20e-2)"												"unprognostic (3.24e-2)"		"unprognostic (2.77e-1)"		
SI		ENSG00000090402	Sucrase-isomaltase	P14410	3	164978898-165078496	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase, Multifunctional enzyme"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	150	"intestine: 530.0"	"Cell type enriched"	"Detected in some"	7	"Proximal enterocytes: 1115.4"	"Low cell type specificity"	"Detected in some"			"Cancer enhanced"	"Detected in some"		"Stomach Adenocarcinoma (TCGA): 9.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"colorectal cancer: 1.2;prostate cancer: 1.7"	"Colon - Colon enterocytes, Testis - Early spermatids, Testis - Late spermatids"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA011897	Enhanced						NA	NA				"Cluster 25: Small intestine - Absorption"		"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 22: Proximal enterocytes - Digestion"				"HPA011897: AB_1856840"					"unprognostic (1.05e-1)"	"unprognostic (1.09e-1)"																"unprognostic (1.56e-2)"	"unprognostic (4.22e-2)"	"unprognostic (3.71e-1)"	"unprognostic (5.71e-3)"	"unprognostic (4.83e-2)"		"unprognostic (1.04e-1)"			
SIGMAR1	"OPRS1, SR-BP1"	ENSG00000147955	"Sigma non-opioid intracellular receptor 1"	Q99720	9	34634722-34637844	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Receptor	"Amyotrophic lateral sclerosis, Disease variant, FDA approved drug targets, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 182.9"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 100.9;Hepatocytes: 85.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Skin - Keratinocyte (other)"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013470, HPA018002, HPA024071"	Enhanced						NA	NA			"Cluster 33: Non-specific - ATP binding"	"Cluster 83: Liver - Metabolism"	"Cluster 56: Hypothalamus - Neuropeptide signaling"	"Cluster 43: Non-specific - Basic cellular processes"	"Cluster 50: Connective tissue cells - ECM organization"	7			"CAB013470: AB_2533521, HPA018002: AB_1854802, HPA024071: AB_1854803"	"unprognostic (1.39e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.74e-1)"	"unprognostic (6.70e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.11e-2)"	"potential prognostic favorable (9.46e-4)"	"unprognostic (5.05e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.46e-3)"	"potential prognostic unfavorable (1.92e-5)"	"unprognostic (1.98e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.29e-3)"	"unprognostic (9.02e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.75e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.52e-2)"	"unprognostic (3.11e-1)"	"unprognostic (4.96e-2)"	"unprognostic (3.36e-1)"
SLAMF7	"19A, CD319, CRACC, CS1"	ENSG00000026751	"SLAM family member 7"	Q9NQ25	1	160739057-160754821	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity, Innate immunity"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 31.5;lymphoid tissue: 60.3;stomach 1: 33.2"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 79.8;monocytes: 69.2;NK-cells: 63.0;Plasma cells: 252.7;Schwann cells: 65.1"	"Cell type enriched"	"Detected in single"	239	"leukocyte: 94.0"	"Cancer enhanced"	"Detected in all"		"Testicular Germ Cell Tumor (TCGA): 43.5"	"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cancer enriched"	"Detected in many"	5	"Myeloma: 188.3"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Heart muscle - T-cells, Liver - T-cells, Lung - T-cells, Minor Salivary Gland - Plasma cells, Pituitary gland - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB015445, HPA055945, HPA061654"	Enhanced		Approved	Vesicles			NA	NA		570000	"Cluster 8: Plasmacytoid DCs - Unknown function"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 8: Immune cells - Immune response"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 77: Plasma cells - Protein processing"		Vesicles		"CAB015445: AB_1121905, HPA055945: AB_2682980, HPA061654: AB_2684576"	"unprognostic (9.26e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.60e-1)"	"unprognostic (9.09e-3)"	"unprognostic (3.40e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.35e-2)"	"unprognostic (7.07e-2)"	"unprognostic (2.84e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.78e-1)"	"potential prognostic favorable (8.21e-4)"	"unprognostic (4.02e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.27e-2)"	"unprognostic (3.85e-1)"	"unprognostic (3.75e-3)"	"unprognostic (3.29e-1)"	"unprognostic (5.58e-3)"	"unprognostic (3.98e-1)"	"unprognostic (3.98e-2)"	"unprognostic (7.90e-2)"	"unprognostic (2.00e-1)"
SLC10A1	"NTCP, NTCP1"	ENSG00000100652	"Solute carrier family 10 member 1"	Q14973	14	69775416-69797241	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction, Ion transport, Lipid transport, Sodium transport, Symport, Transport"	"Host cell receptor for virus entry, Receptor"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	1050	"liver: 413.9"	"Cell type enriched"	"Detected in some"	23	"Hepatocytes: 135.0"	"Low cell type specificity"	"Detected in all"			"Cancer enriched"	"Detected in single"	343	"Liver Hepatocellular Carcinoma (TCGA): 84.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Liver - Hepatocytes"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042727	Approved						NA	NA			"Cluster 45: Eosinophils - Unknown function"	"Cluster 31: Liver - Plasma proteins"	"Cluster 15: Non-specific - Transcription"	"Cluster 34: Testis cancer - Unknown function"	"Cluster 43: Hepatocytes - Metabolism"	80			"HPA042727: AB_10960691"														"validated prognostic favorable (3.68e-6)"	"validated prognostic favorable (1.61e-6)"											"potential prognostic unfavorable (3.28e-5)"					
SLC10A2	"ASBT, IBAT, ISBT, NTCP2"	ENSG00000125255	"Solute carrier family 10 member 2"	Q12908	13	103043998-103066417	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Lipid transport, Sodium transport, Symport, Transport"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 78.7"	"Cell type enriched"	"Detected in some"	20	"Proximal enterocytes: 348.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"Kidney Renal Clear Cell Carcinoma (TCGA): 9.4;Kidney Renal Papillary Cell Carcinoma (TCGA): 4.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	5	"ovarian cancer: 2.5"	"Kidney - Proximal tubular cells, Pituitary gland - Thyrotropes"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA004795	Approved						NA	NA				"Cluster 25: Small intestine - Absorption"	"Cluster 28: Oligodendrocytes - Mixed function"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 22: Proximal enterocytes - Digestion"	11			"HPA004795: AB_1856953"											"validated prognostic favorable (2.86e-11)"	"validated prognostic favorable (3.01e-5)"	"unprognostic (4.13e-2)"																		
SLC12A1	"BSC, BSC-1, BSC1, CCC2, NKCC2"	ENSG00000074803	"Solute carrier family 12 member 1"	Q13621	15	48178438-48304078	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Symport, Transport"		"Bartter syndrome, Disease variant, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	825	"kidney: 687.0"	"Group enriched"	"Detected in some"	4	"Collecting duct cells: 33.1;Distal tubular cells: 92.2"	"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"Kidney Chromophobe (TCGA): 4.8;Kidney Renal Clear Cell Carcinoma (TCGA): 2.9;Kidney Renal Papillary Cell Carcinoma (TCGA): 6.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Kidney - Ascending Loop of Henle cells, Testis - Early spermatids"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA014967, HPA018107"	Enhanced		Approved	Nucleoplasm,Vesicles			NA	NA				"Cluster 52: Kidney - Transmembrane transport"	"Cluster 1: Neurons - Mixed function"	"Cluster 27: Breast cancer - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"		Vesicles	Nucleoplasm	"HPA014967: AB_1854503, HPA018107: AB_1854504"			"unprognostic (2.19e-2)"							"unprognostic (3.67e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.49e-1)"	"unprognostic (5.54e-2)"		"unprognostic (4.81e-2)"																
SLC12A2	"BSC-2, BSC2, CCC1, NKCC1, PPP1R141"	ENSG00000064651	"Solute carrier family 12 member 2"	P55011	5	128083766-128189677	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Symport, Transport"		"Deafness, Disease variant, FDA approved drug targets, Intellectual disability, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 73.5"	"Cell type enhanced"	"Detected in many"		"Intestinal goblet cells: 371.8;Oligodendrocytes: 527.4;Undifferentiated cells: 348.4"	"Cell type enhanced"	"Detected in all"		"oligodendrocyte: 848.9;pericyte: 922.1"	"Cancer enhanced"	"Detected in all"		"Colon Adenocarcinoma (TCGA): 113.8;Rectum Adenocarcinoma (TCGA): 103.7"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 6.4"	"Low lineage specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"colorectal cancer: 106.3"	"Adipose visceral - Endothelial cells, Adrenal gland - Adrenal cortex cells, Minor Salivary Gland - Minor salivary glandular cells, Pancreas - Ductal cells, Skin - Eccrine sweat gland cells, Testis - Early spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020130, HPA063697"	Approved		Approved	"Vesicles,Plasma membrane,Basal body"			NA	NA			"Cluster 8: Plasmacytoid DCs - Unknown function"	"Cluster 45: Intestine - Digestion"	"Cluster 28: Oligodendrocytes - Mixed function"	"Cluster 57: Stomach & Colon cancer - Digestion"	"Cluster 16: Intestinal goblet cells - Mucin production"	17	"Vesicles, Plasma membrane"	"Basal body"	"HPA020130: AB_1854502, HPA063697: AB_2685094"	"unprognostic (5.65e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.40e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.45e-3)"	"unprognostic (5.04e-3)"	"unprognostic (1.94e-1)"	"unprognostic (7.94e-2)"	"unprognostic (5.03e-2)"	"unprognostic (9.07e-3)"	"validated prognostic favorable (2.01e-6)"	"validated prognostic favorable (8.73e-4)"	"unprognostic (1.69e-1)"	"potential prognostic unfavorable (8.52e-4)"	"unprognostic (1.96e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.96e-2)"	"unprognostic (5.57e-2)"	"unprognostic (5.83e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.45e-3)"	"unprognostic (9.92e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.70e-1)"	"potential prognostic favorable (2.68e-4)"
SLC12A3	"NCC, NCCT"	ENSG00000070915	"Solute carrier family 12 member 3"	P55017	16	56865207-56915850	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	118	"kidney: 98.9"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 5.8;dendritic cells: 20.8;Glandular and luminal cells: 4.2"	"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"Kidney Renal Clear Cell Carcinoma (TCGA): 5.8;Kidney Renal Papillary Cell Carcinoma (TCGA): 9.1"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	20	"plasmacytoid DC: 14.9"	"Lineage enriched"	"Detected in single"	20	"dendritic cells: 14.9"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 6.3;Uterine cancer: 6.7"	"Kidney - Intercalated cells, Spleen - B-cells (Spleen), Stomach - Parietal cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA028748	Enhanced						NA	NA			"Cluster 44: Plasmacytoid DCs - Plasma membrane proteins"	"Cluster 52: Kidney - Transmembrane transport"	"Cluster 51: Neurons - Mixed function"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 28: Dendritic cells - Antigen presentation"	4			"HPA028748: AB_10603886"	"unprognostic (3.28e-1)"									"unprognostic (1.58e-1)"	"unprognostic (4.10e-2)"		"unprognostic (1.12e-2)"																"unprognostic (1.27e-1)"		"unprognostic (9.87e-3)"
SLC12A4	KCC1	ENSG00000124067	"Solute carrier family 12 member 4"	Q9UP95	16	67943474-67969601	"FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Symport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 39.7;Syncytiotrophoblasts: 62.4"	"Cell type enhanced"	"Detected in many"		"bergmann glia: 43.6;pericyte: 29.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.7"	"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041138, HPA048239"	Approved		Approved	"Nucleoplasm,Cell Junctions,Cytokinetic bridge,Primary cilium"			Yes	NA			"Cluster 33: Non-specific - ATP binding"	"Cluster 60: Choroid plexus - Transmembrane transport"	"Cluster 42: Choroid plexus - Mitochondria"	"Cluster 68: Non-specific - Cell cycle regulation"	"Cluster 27: Syncytiotrophoblasts - Pregnancy"	12	"Nucleoplasm, Cell Junctions"	"Cytokinetic bridge, Primary cilium"	"HPA041138: AB_10794544, HPA048239: "	"unprognostic (2.43e-3)"	"unprognostic (5.42e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.54e-2)"	"potential prognostic favorable (2.11e-8)"	"unprognostic (1.23e-3)"	"potential prognostic favorable (1.47e-4)"	"unprognostic (1.13e-2)"	"unprognostic (6.31e-3)"	"unprognostic (9.70e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.60e-3)"	"unprognostic (3.01e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.85e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.69e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.29e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.14e-1)"
SLC12A5	"KCC2, KIAA1176"	ENSG00000124140	"Solute carrier family 12 member 5"	Q9H2X9	20	46021690-46060150	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Symport, Transport"		"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 198.0;retina: 114.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 209.0;Cone photoreceptor cells: 249.8;Excitatory neurons: 89.7;Horizontal cells: 129.7;Inhibitory neurons: 87.4;Rod photoreceptor cells: 192.2"	"Cell type enhanced"	"Detected in all"		"midbrain-derived inhibitory: 289.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 2.4"	"Low lineage specificity"	"Detected in single"			"Low cancer specificity"	"Detected in all"			"Pancreas - Alpha cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072058	Enhanced						NA	NA			"Cluster 43: Non-specific - Transcription & Translation"	"Cluster 17: Neuronal - Synaptic function"	"Cluster 40: Astrocytes - Astrocyte-neuron interactions"	"Cluster 62: Non-specific - Plasma proteins"	"Cluster 71: Horizontal & Bipolar cells - Neuronal signaling"				"HPA072058: AB_2686485"	"unprognostic (4.21e-2)"	"unprognostic (1.55e-1)"		"unprognostic (7.10e-2)"	"unprognostic (4.87e-3)"	"unprognostic (1.76e-1)"	"potential prognostic unfavorable (5.70e-5)"	"unprognostic (1.33e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.50e-1)"	"validated prognostic unfavorable (2.79e-10)"	"validated prognostic unfavorable (1.48e-4)"	"unprognostic (3.00e-1)"	"potential prognostic unfavorable (9.67e-4)"		"unprognostic (1.54e-2)"	"unprognostic (5.03e-2)"	"unprognostic (1.84e-1)"	"unprognostic (9.05e-2)"	"unprognostic (3.11e-1)"		"unprognostic (1.40e-3)"		"unprognostic (7.13e-3)"	"unprognostic (2.50e-1)"	"unprognostic (5.81e-2)"	"unprognostic (3.05e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.46e-1)"	"unprognostic (2.44e-1)"
SLC18A1	"CGAT, VAT1, VMAT1"	ENSG00000036565	"Solute carrier family 18 member A1"	P54219	8	20144855-20183206	"FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"adrenal gland: 24.3"	"Cell type enriched"	"Detected in some"	55	"Enteroendocrine cells: 99.9"	"Cell type enriched"	"Detected in some"	4	"central nervous system macrophage: 6.5"	"Cancer enhanced"	"Detected in some"		"Colon Adenocarcinoma (TCGA): 1.7;Stomach Adenocarcinoma (TCGA): 1.3"	"Region enriched"	"Detected in single"	20	"midbrain: 8.5"	"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 2.8"	"Lineage enriched"	"Detected in single"	19	"monocytes: 2.8"	"Cancer enriched"	"Detected in some"	10	"Neuroblastoma: 35.1"	"Adrenal gland - Adrenal medulla cells, Skin - Outer root sheath cells, Stomach - Gastric enteroendocrine cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA006877, HPA063797"	Enhanced						NA	NA			"Cluster 37: Monocytes & Neutrophils - Innate immune response"	"Cluster 26: Adrenal gland - Steroid metabolism"	"Cluster 41: Monoamines - Neurotransmitter signalling"	"Cluster 17: Neuroblastoma - Neuronal signaling"	"Cluster 20: Enteroendocrine cells - Hormone signaling"	1			"HPA006877: AB_2667690, HPA063797: AB_2685125"					"unprognostic (9.21e-3)"	"unprognostic (1.21e-2)"		"unprognostic (9.79e-3)"									"unprognostic (7.48e-2)"								"unprognostic (3.41e-1)"	"unprognostic (1.34e-1)"		"unprognostic (1.55e-1)"			
SLC18A2	"SVAT, SVMT, VMAT2"	ENSG00000165646	"Solute carrier family 18 member A2"	Q05940	10	117241093-117279430	"Disease related genes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"		"Disease variant, Dystonia, FDA approved drug targets, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.8;cervix: 28.9"	"Group enriched"	"Detected in many"	18	"Glandular and luminal cells: 120.8;granulocytes: 464.4"	"Cell type enhanced"	"Detected in many"		"cerebellar inhibitory: 32.5"	"Cancer enhanced"	"Detected in many"		"Uterine Corpus Endometrial Carcinoma (TCGA): 8.2"	"Group enriched"	"Detected in many"	12	"hypothalamus: 47.5;midbrain: 173.0;pons: 150.4"	"Immune cell enriched"	"Detected in some"	15	"basophil: 59.5"	"Lineage enriched"	"Detected in many"	15	"granulocytes: 59.5"	"Group enriched"	"Detected in some"	5	"Leukemia: 9.7;Neuroblastoma: 7.0"	"Adipose subcutaneous - Mast cells, Adipose visceral - Mast cells, Adrenal gland - Adrenal medulla cells, Colon - Mast cells, Lung - Mast cells, Skin - Langerhans cells, Testis - Spermatogonia"	"Region enhanced"	"Detected in many"		"midbrain: 62.8"	"Region enriched"	"Detected in all"	4	"midbrain: 145.2"	HPA073224	Enhanced		Approved	Vesicles,Centrosome			NA	NA			"Cluster 41: Basophils - Unknown function"	"Cluster 34: Non-specific - Mixed function"	"Cluster 41: Monoamines - Neurotransmitter signalling"	"Cluster 49: HMC-1 - Innate immune response"	"Cluster 30: Granulocytes - Unknown function"	9	"Vesicles, Centrosome"		"HPA073224: AB_2732222"		"unprognostic (1.02e-2)"	"unprognostic (3.81e-1)"			"unprognostic (1.96e-2)"				"unprognostic (8.09e-2)"	"potential prognostic favorable (8.93e-7)"	"unprognostic (1.12e-2)"	"unprognostic (2.97e-2)"		"unprognostic (1.24e-2)"	"potential prognostic favorable (6.60e-5)"	"unprognostic (2.19e-1)"		"unprognostic (2.10e-1)"		"unprognostic (1.69e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.41e-1)"		"unprognostic (2.57e-3)"		"unprognostic (4.07e-2)"			"unprognostic (9.69e-2)"
SLC1A5	"AAAT, ASCT2, M7V1, RDRC"	ENSG00000105281	"Solute carrier family 1 member 5"	Q15758	19	46774883-46788594	"FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Antiport, Host-virus interaction, Symport, Transport"	"Host cell receptor for virus entry, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"central nervous system macrophage: 30.1;leukocyte: 12.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 96.0"	"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Testis - Early spermatids"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA035239, HPA035240"	Enhanced		Supported	"Plasma membrane,Centriolar satellite,Basal body"			NA	NA		27000000	"Cluster 10: Non-specific - Membrane trafficking"	"Cluster 75: Epithelium - Extracellular exosomes"	"Cluster 49: Hindbrain - Mixed function"	"Cluster 32: Non-specific - Cell proliferation"	"Cluster 80: Non-specific - Transcription"	29	"Plasma membrane"	"Centriolar satellite, Basal body"	"HPA035239: AB_10670587, HPA035240: AB_10604092"	"unprognostic (1.16e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.79e-2)"	"unprognostic (9.91e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.88e-2)"	"unprognostic (6.83e-2)"	"unprognostic (2.76e-1)"	"potential prognostic unfavorable (2.20e-7)"	"unprognostic (1.12e-2)"	"unprognostic (1.24e-1)"	"potential prognostic unfavorable (2.14e-10)"	"unprognostic (4.21e-3)"	"unprognostic (1.46e-3)"	"unprognostic (1.06e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.07e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.04e-1)"	"unprognostic (8.69e-3)"	"unprognostic (1.52e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.91e-2)"	"unprognostic (3.88e-1)"
SLC22A11	OAT4	ENSG00000168065	"Solute carrier family 22 member 11"	Q9NSA0	11	64555690-64572875	"FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Antiport, Ion transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	71	"epididymis: 10.3;kidney: 30.8;placenta: 32.3"	"Group enriched"	"Detected in some"	33	"Cytotrophoblasts: 628.4;Syncytiotrophoblasts: 1718.7"	"Cell type enriched"	"Detected in single"	4	"fibroblast: 1.1"	"Group enriched"	"Detected in some"	5	"Kidney Renal Clear Cell Carcinoma (TCGA): 49.2;Kidney Renal Papillary Cell Carcinoma (TCGA): 46.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Kidney - Proximal tubular cells"					"Not detected"	"Not detected"			HPA026076	Enhanced						NA	NA				"Cluster 57: Lung - Lung function"		"Cluster 57: Stomach & Colon cancer - Digestion"	"Cluster 27: Syncytiotrophoblasts - Pregnancy"	1			"HPA026076: AB_1854756"	"unprognostic (1.52e-1)"				"unprognostic (3.03e-1)"	"unprognostic (3.70e-2)"					"validated prognostic favorable (2.59e-9)"	"validated prognostic favorable (6.99e-4)"	"potential prognostic favorable (2.66e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.43e-1)"										"unprognostic (1.37e-1)"	"unprognostic (1.47e-1)"					
SLC22A12	"OAT4L, RST, URAT1"	ENSG00000197891	"Solute carrier family 22 member 12"	Q96S37	11	64590641-64602353	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	205	"kidney: 106.4"	"Cell type enriched"	"Detected in some"	20	"Proximal tubular cells: 128.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"Kidney Renal Clear Cell Carcinoma (TCGA): 29.2;Kidney Renal Papillary Cell Carcinoma (TCGA): 36.5"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Kidney - Proximal tubular cells, Kidney - Proximal tubular cells"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA024575	Enhanced						NA	NA				"Cluster 52: Kidney - Transmembrane transport"	"Cluster 15: Non-specific - Transcription"	"Cluster 7: Liver cancer - Metabolism"	"Cluster 38: Proximal tubular cells - Transmembrane transport"	1			"HPA024575: AB_1858650"											"validated prognostic favorable (2.02e-6)"	"validated prognostic favorable (6.02e-4)"	"unprognostic (2.40e-2)"	"unprognostic (2.57e-1)"	"unprognostic (5.92e-2)"																
SLC22A6	"OAT1, PAHT, ROAT1"	ENSG00000197901	"Solute carrier family 22 member 6"	Q4U2R8	11	62936385-62984967	"FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	32	"kidney: 189.5"	"Cell type enriched"	"Detected in some"	36	"Proximal tubular cells: 170.6"	"Cell type enhanced"	"Detected in many"		"astrocyte: 31.6;fibroblast: 24.8;upper-layer intratelencephalic: 16.4"	"Group enriched"	"Detected in some"	120	"Kidney Renal Clear Cell Carcinoma (TCGA): 21.1;Kidney Renal Papillary Cell Carcinoma (TCGA): 54.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Kidney - Proximal tubular cells, Kidney - Proximal tubular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA074559, CAB075704"	Enhanced						NA	NA				"Cluster 52: Kidney - Transmembrane transport"	"Cluster 19: Astrocytes - Mixed function"		"Cluster 38: Proximal tubular cells - Transmembrane transport"	1			"CAB075704: , HPA074559: AB_2732260"											"validated prognostic favorable (1.68e-8)"	"validated prognostic favorable (9.01e-6)"	"unprognostic (1.18e-1)"																		
SLC22A8	OAT3	ENSG00000149452	"Solute carrier family 22 member 8"	Q8TCC7	11	62989154-63015841	"FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Detoxification, Ion transport, Lipid transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	203	"choroid plexus: 273.8;kidney: 322.8"	"Cell type enriched"	"Detected in some"	17	"Proximal tubular cells: 170.1"	"Cell type enriched"	"Detected in many"	6	"choroid plexus epithelial cell: 119.6"	"Cancer enhanced"	"Detected in some"		"Kidney Renal Clear Cell Carcinoma (TCGA): 3.0;Kidney Renal Papillary Cell Carcinoma (TCGA): 5.4"	"Region enriched"	"Detected in some"	31	"choroid plexus: 242.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Kidney - Proximal tubular cells, Kidney - Proximal tubular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA044174	Enhanced						NA	NA				"Cluster 52: Kidney - Transmembrane transport"	"Cluster 36: Choroid plexus - Mixed function"	"Cluster 1: Neuronal - Visual perception"	"Cluster 38: Proximal tubular cells - Transmembrane transport"				"HPA044174: AB_10963058"											"potential prognostic favorable (3.23e-9)"	"unprognostic (1.28e-2)"	"unprognostic (3.53e-2)"																"unprognostic (1.63e-1)"		
SLC25A4	"AAC1, ANT1, PEO2, PEO3, T1"	ENSG00000151729	"Solute carrier family 25 member 4"	P12235	4	185143266-185150382	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Antiport, Host-virus interaction, Transport"		"Cardiomyopathy, Disease variant, FDA approved drug targets, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"heart muscle: 237.2;skeletal muscle: 184.0;tongue: 333.2"	"Cell type enriched"	"Detected in all"	6	"Cardiomyocytes: 6374.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Smooth muscle cells, Colon - Smooth muscle cells, Heart muscle - Cardiomyocytes, Lung - Alveolar cells type 2, Prostate - Smooth muscle cells, Skeletal muscle - Skeletal myocytes, Testis - Sertoli cells, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046835, HPA071684"	Approved		Supported	Mitochondria			NA	NA		410000	"Cluster 24: Non-specific - Transcription"	"Cluster 12: Heart muscle - Cardiac muscle contraction"	"Cluster 37: Neurons - Mixed function"	"Cluster 69: Skin cancer - ECM organization"	"Cluster 68: Cardiomyocytes - Muscle contraction"	55	Mitochondria		"HPA046835: AB_2679831, HPA071684: AB_2686431"	"unprognostic (1.24e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.53e-2)"	"unprognostic (7.87e-3)"	"unprognostic (1.84e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.91e-3)"	"unprognostic (1.16e-1)"	"validated prognostic favorable (2.03e-7)"	"validated prognostic favorable (5.60e-5)"	"potential prognostic favorable (1.31e-6)"	"unprognostic (1.53e-1)"	"unprognostic (3.16e-1)"	"unprognostic (2.54e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.78e-3)"	"unprognostic (2.55e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.57e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.28e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.87e-2)"	"unprognostic (5.83e-2)"
SLC25A5	"2F1, ANT2, T2, T3"	ENSG00000005022	"Solute carrier family 25 member 5"	P05141	X	119468422-119471396	"FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Antiport, Chromosome partition, Host-virus interaction, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 2075.7;Proximal enterocytes: 2855.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Minor Salivary Gland - Minor salivary gland basal cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046835, HPA071684"	Approved		Supported	Mitochondria			NA	NA		780000	"Cluster 33: Non-specific - ATP binding"	"Cluster 48: Stomach - Proteolysis"	"Cluster 45: Non-specific - Mixed function"	"Cluster 36: Non-specific - mRNA processing"	"Cluster 5: Enterocytes - Absorption"	36	Mitochondria		"HPA046835: AB_2679831, HPA071684: AB_2686431"	"unprognostic (1.69e-3)"	"potential prognostic unfavorable (4.66e-4)"	"unprognostic (6.78e-3)"	"potential prognostic favorable (1.22e-4)"	"unprognostic (2.57e-2)"	"unprognostic (3.63e-3)"	"unprognostic (6.37e-2)"	"unprognostic (9.09e-2)"	"unprognostic (5.25e-3)"	"unprognostic (2.96e-1)"	"potential prognostic favorable (3.55e-5)"	"unprognostic (4.65e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.11e-2)"	"potential prognostic unfavorable (2.75e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.39e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.91e-3)"	"unprognostic (6.53e-2)"
SLC25A6	"ANT3, ANT3Y, MGC17525"	ENSG00000169100	"Solute carrier family 25 member 6"	P12236	X	1386152-1392113	"FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Antiport, Apoptosis, Host-virus interaction, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"								"Low region specificity"	"Detected in all"			"HPA046835, HPA071684"	Approved		Approved	Mitochondria			NA	NA			"Cluster 13: Non-specific - Mitochondria"	"Cluster 48: Stomach - Proteolysis"	"Cluster 23: Choroid plexus - Mixed function"	"Cluster 25: Non-specific - Ribosome"	"Cluster 64: Non-specific - Ribosome"	90	Mitochondria		"HPA046835: AB_2679831, HPA071684: AB_2686431"	"unprognostic (1.22e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.06e-2)"	"unprognostic (6.50e-3)"	"unprognostic (1.64e-1)"		"unprognostic (2.95e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.55e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.11e-3)"		"unprognostic (1.49e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.58e-1)"	"unprognostic (9.71e-2)"	"unprognostic (4.17e-2)"	"potential prognostic favorable (4.12e-4)"	"unprognostic (2.28e-2)"	"unprognostic (3.31e-1)"	"unprognostic (7.00e-3)"	"unprognostic (3.48e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.55e-2)"	"unprognostic (7.52e-2)"	"unprognostic (3.36e-3)"
SLC38A1	"ATA1, NAT2, SAT1"	ENSG00000111371	"Solute carrier family 38 member 1"	Q9H2H9	12	46183063-46270017	"FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Sodium transport, Symport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 368.3;Cardiomyocytes: 304.7"	"Cell type enhanced"	"Detected in all"		"bergmann glia: 889.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Smooth muscle cells, Breast - Breast glandular cells, Prostate - Smooth muscle cells, Spleen - B-cells (Spleen)"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039460, HPA052272"	Uncertain	Supported					NA	NA			"Cluster 24: Non-specific - Transcription"	"Cluster 19: Non-specific - Basic cellular processes"	"Cluster 25: Non-specific - Transcription"	"Cluster 38: Non-specific - Transcription"	"Cluster 78: NK-cells & T-cells - Immune system & Transcription"	39			"HPA039460: , HPA052272: AB_2681781"	"unprognostic (1.14e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.39e-2)"	"unprognostic (9.73e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.36e-3)"	"potential prognostic favorable (9.92e-5)"	"unprognostic (7.24e-2)"	"unprognostic (3.07e-1)"	"potential prognostic unfavorable (2.07e-7)"	"unprognostic (2.87e-3)"	"unprognostic (1.39e-3)"	"unprognostic (2.25e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.64e-2)"	"unprognostic (4.23e-3)"	"unprognostic (1.81e-2)"	"unprognostic (4.39e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.74e-2)"	"unprognostic (1.20e-2)"
SLC38A2	"ATA2, KIAA1382, SAT2, SNAT2"	ENSG00000134294	"Solute carrier family 38 member 2"	Q96QD8	12	46358188-46372773	"FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Sodium transport, Symport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 837.6;Suprabasal keratinocytes: 705.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035180, HPA069672"	Approved		Supported	"Plasma membrane"			NA	NA			"Cluster 30: Non-specific - DNA binding"	"Cluster 83: Liver - Metabolism"	"Cluster 28: Oligodendrocytes - Mixed function"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 12: Squamous epithelial cells - Keratinization"	9	"Plasma membrane"		"HPA035180: AB_10669901, HPA069672: "	"unprognostic (3.25e-1)"	"unprognostic (2.34e-3)"	"unprognostic (1.36e-2)"	"unprognostic (2.68e-3)"	"unprognostic (2.81e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.27e-1)"	"unprognostic (8.47e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.90e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.69e-1)"	"unprognostic (9.02e-2)"	"unprognostic (8.21e-2)"	"potential prognostic unfavorable (1.52e-4)"	"unprognostic (2.58e-2)"	"unprognostic (2.74e-1)"	"unprognostic (7.78e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.10e-2)"	"potential prognostic unfavorable (2.02e-4)"	"unprognostic (7.07e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.19e-2)"
SLC38A3	"G17, SN1"	ENSG00000188338	"Solute carrier family 38 member 3"	Q99624	3	50205246-50221486	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Antiport, Ion transport, Sodium transport, Symport, Transport"		"Disease variant, Epilepsy, FDA approved drug targets, Intellectual disability"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"liver: 321.4;retina: 167.5"	"Group enriched"	"Detected in many"	5	"Bipolar cells: 83.9;Cone photoreceptor cells: 144.4;Hepatocytes: 90.4;Muller glia cells: 67.7;Rod photoreceptor cells: 108.9"	"Cell type enhanced"	"Detected in many"		"endothelial cell: 71.9;ependymal cell: 40.9"	"Cancer enriched"	"Detected in many"	7	"Liver Hepatocellular Carcinoma (TCGA): 234.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.8"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 2.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 7.0"	"Adipose subcutaneous - Smooth muscle cells, Heart muscle - Cardiomyocytes, Liver - Hepatocytes, Skeletal muscle - Skeletal myocytes, Stomach - Gastric enteroendocrine cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031871			Approved	Microtubules,Cytosol			NA	NA			"Cluster 35: Neutrophils - Protein binding"	"Cluster 83: Liver - Metabolism"	"Cluster 19: Astrocytes - Mixed function"	"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 66: Photoreceptor cells - Visual perception"		Cytosol	Microtubules	"HPA031871: AB_2674080"		"unprognostic (4.38e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.56e-1)"		"unprognostic (8.55e-2)"	"unprognostic (3.91e-2)"	"unprognostic (4.34e-2)"		"unprognostic (1.05e-2)"	"potential prognostic unfavorable (1.59e-9)"		"unprognostic (4.32e-1)"	"unprognostic (3.06e-2)"	"unprognostic (3.60e-3)"	"potential prognostic favorable (8.05e-4)"				"unprognostic (2.81e-1)"		"unprognostic (1.36e-1)"	"potential prognostic unfavorable (5.35e-4)"		"unprognostic (9.85e-2)"	"unprognostic (7.94e-2)"		"unprognostic (3.85e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.09e-1)"
SLC38A4	"ATA3, NAT3, PAAT"	ENSG00000139209	"Solute carrier family 38 member 4"	Q969I6	12	46764761-46832408	"FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Sodium transport, Symport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	60	"liver: 591.5"	"Cell type enriched"	"Detected in some"	20	"Hepatocytes: 239.3"	"Cell type enhanced"	"Detected in many"		"fibroblast: 23.6"	"Cancer enriched"	"Detected in many"	12	"Liver Hepatocellular Carcinoma (TCGA): 81.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Sarcoma: 8.8"	"Liver - Hepatocytes, Liver - Hepatocytes"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"										NA	NA				"Cluster 31: Liver - Plasma proteins"	"Cluster 56: Hypothalamus - Neuropeptide signaling"	"Cluster 33: Sarcoma - Muscle contraction"	"Cluster 43: Hepatocytes - Metabolism"	1				"unprognostic (2.79e-1)"		"unprognostic (1.18e-2)"	"unprognostic (1.60e-2)"	"unprognostic (3.54e-2)"	"unprognostic (4.70e-3)"	"unprognostic (3.89e-1)"	"unprognostic (6.51e-2)"	"unprognostic (7.59e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.81e-2)"		"unprognostic (4.68e-2)"	"unprognostic (1.34e-3)"	"unprognostic (1.66e-3)"	"unprognostic (1.91e-1)"	"unprognostic (3.82e-1)"	"unprognostic (1.47e-3)"	"unprognostic (5.04e-1)"			"unprognostic (8.41e-2)"	"unprognostic (1.03e-2)"		"unprognostic (9.43e-2)"	"unprognostic (2.32e-1)"		"unprognostic (2.15e-2)"			
SLC52A2	"D15Ertd747e, FLJ11856, GPCR41, GPR172A, hRFT3, PAR1, RFVT2"	ENSG00000185803	"Solute carrier family 52 member 2"	Q9HAB3	8	144333957-144361286	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	"Host cell receptor for virus entry, Receptor"	"Deafness, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Adrenal cortex cells"									HPA063036	Approved						NA	NA			"Cluster 45: Eosinophils - Unknown function"	"Cluster 66: Non-specific - Transcription"	"Cluster 41: Monoamines - Neurotransmitter signalling"	"Cluster 40: Non-specific - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	4			"HPA063036: AB_2684928"	"unprognostic (1.20e-1)"	"unprognostic (5.02e-3)"		"unprognostic (1.81e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.27e-3)"	"unprognostic (3.74e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.66e-2)"	"validated prognostic unfavorable (3.27e-6)"	"validated prognostic unfavorable (2.06e-4)"	"unprognostic (1.02e-2)"	"potential prognostic unfavorable (3.01e-7)"		"unprognostic (1.97e-2)"	"unprognostic (5.70e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.02e-1)"	"unprognostic (7.43e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.65e-3)"	"unprognostic (3.96e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.21e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.16e-1)"
SLC5A1	"D22S675, NAGT, SGLT1"	ENSG00000100170	"Solute carrier family 5 member 1"	P13866	22	32043261-32113029	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Sugar transport, Symport, Transport"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"intestine: 513.5"	"Cell type enriched"	"Detected in many"	4	"Proximal enterocytes: 749.7"	"Low cell type specificity"	"Detected in some"			"Cancer enhanced"	"Detected in many"		"Rectum Adenocarcinoma (TCGA): 30.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"Bile duct cancer: 3.3;colorectal cancer: 8.3;Gastric cancer: 2.7"	"Colon - Colon enterocytes, Heart muscle - Cardiomyocytes, Kidney - Ascending Loop of Henle cells, Liver - Cholangiocyte, Lung - Alveolar cells type 1, Minor Salivary Gland - Minor salivary glandular cells, Testis - Early spermatids, Testis - Late spermatids"	"Region enriched"	"Detected in single"	26	"cerebellum: 7.6"	"Low region specificity"	"Detected in many"			"CAB015467, HPA051805, HPA055106"	Enhanced		Approved	"Nuclear membrane,Golgi apparatus,Plasma membrane"			NA	NA				"Cluster 25: Small intestine - Absorption"	"Cluster 9: Non-specific - Receptor signaling"	"Cluster 57: Stomach & Colon cancer - Digestion"	"Cluster 22: Proximal enterocytes - Digestion"	1	"Golgi apparatus, Plasma membrane"	"Nuclear membrane"	"CAB015467: , HPA051805: AB_2681618, HPA055106: AB_2682695"		"unprognostic (5.41e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.52e-2)"	"unprognostic (5.85e-2)"			"unprognostic (5.91e-2)"	"unprognostic (2.96e-1)"	"validated prognostic favorable (4.06e-9)"	"validated prognostic favorable (4.70e-4)"	"potential prognostic favorable (1.39e-4)"		"unprognostic (1.61e-2)"	"unprognostic (6.50e-2)"	"unprognostic (5.70e-3)"	"unprognostic (3.20e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.68e-2)"	"unprognostic (6.23e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.00e-3)"	"unprognostic (1.10e-1)"		"unprognostic (2.61e-3)"			"unprognostic (2.22e-3)"
SLC5A2	SGLT2	ENSG00000140675	"Solute carrier family 5 member 2"	P31639	16	31483002-31490860	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Sugar transport, Symport, Transport"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"kidney: 52.7"	"Group enriched"	"Detected in some"	4	"Early spermatids: 58.4;Late spermatids: 142.5;Proximal tubular cells: 113.0"	"Low cell type specificity"	"Detected in some"			"Cancer enhanced"	"Detected in some"		"Kidney Renal Papillary Cell Carcinoma (TCGA): 2.6"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Kidney - Proximal tubular cells, Testis - Early spermatids, Testis - Late spermatids"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA041603	Enhanced						NA	NA				"Cluster 52: Kidney - Transmembrane transport"	"Cluster 35: Non-specific - DNA binding"	"Cluster 57: Stomach & Colon cancer - Digestion"	"Cluster 38: Proximal tubular cells - Transmembrane transport"	2			"HPA041603: AB_10960540"						"unprognostic (5.46e-2)"					"unprognostic (8.18e-3)"	"unprognostic (3.07e-1)"	"potential prognostic unfavorable (2.25e-4)"		"unprognostic (8.87e-2)"						"unprognostic (7.17e-2)"		"unprognostic (1.40e-2)"			"unprognostic (2.96e-1)"					
SLC5A5	NIS	ENSG00000105641	"Solute carrier family 5 member 5"	Q92911	19	17871945-17895174	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Congenital hypothyroidism, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"choroid plexus: 138.0;salivary gland: 62.6;stomach 1: 57.3"	"Cell type enriched"	"Detected in some"	38	"Gastric mucus-secreting cells: 217.0"	"Cell type enriched"	"Detected in some"	12	"choroid plexus epithelial cell: 291.2"	"Cancer enhanced"	"Detected in many"		"Testicular Germ Cell Tumor (TCGA): 5.1;Thyroid Carcinoma (TCGA): 5.3"	"Region enriched"	"Detected in all"	15	"choroid plexus: 351.6"	"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in single"			"Lung - Respiratory ciliated cells, Stomach - Gastric mucous cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB022364, HPA049055"	Enhanced						NA	NA			"Cluster 31: T-cells - T-cell receptor"	"Cluster 60: Choroid plexus - Transmembrane transport"	"Cluster 36: Choroid plexus - Mixed function"	"Cluster 66: Non-specific - Mitochondria"	"Cluster 46: Gastric mucus-secreting cells - Digestion"	4			"CAB022364: , HPA049055: AB_2680614"	"unprognostic (3.43e-1)"		"unprognostic (9.56e-3)"	"unprognostic (2.14e-2)"												"unprognostic (2.00e-2)"	"unprognostic (5.27e-2)"											"unprognostic (1.59e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.81e-2)"
SLC6A1	"GABATHG, GABATR, GAT-1, GAT1, hGAT-1"	ENSG00000157103	"Solute carrier family 6 member 1"	P30531	3	10992186-11039247	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 107.9;liver: 85.4;retina: 36.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 209.6;Horizontal cells: 151.1;Inhibitory neurons: 317.1;Microglial cells: 103.8;Oligodendrocyte precursor cells: 122.2;Oligodendrocytes: 100.4"	"Cell type enhanced"	"Detected in all"		"pericyte: 2290.5"	"Group enriched"	"Detected in some"	10	"Glioblastoma Multiforme (TCGA): 24.4;Liver Hepatocellular Carcinoma (TCGA): 25.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Liver - Hepatocytes, Pituitary gland - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013341, CAB022293"	Enhanced						NA	NA				"Cluster 61: Brain - Neuronal signaling"	"Cluster 40: Astrocytes - Astrocyte-neuron interactions"	"Cluster 56: Non-specific - Sensory perception"	"Cluster 65: Neurons - Synaptic function"	5			"CAB022293: , HPA013341: AB_1849509"			"unprognostic (3.31e-1)"			"unprognostic (2.35e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.01e-1)"		"unprognostic (8.90e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.36e-3)"		"unprognostic (1.44e-3)"	"unprognostic (2.06e-3)"		"unprognostic (7.16e-2)"		"unprognostic (2.08e-1)"				"unprognostic (1.27e-1)"			"unprognostic (2.71e-1)"					
SLC6A2	"NAT1, NET, NET1, SLC6A5"	ENSG00000103546	"Solute carrier family 6 member 2"	P23975	16	55655988-55707645	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 10.1;placenta: 6.6;skin 1: 4.5;testis: 4.3"	"Group enriched"	"Detected in some"	6	"Early spermatids: 4.0;Extravillous trophoblasts: 9.4;Late spermatids: 4.7;Spermatocytes: 8.3;Syncytiotrophoblasts: 5.6"	"Cell type enriched"	"Detected in single"	4	"CGE interneuron: 3.5"	"Cancer enhanced"	"Detected in many"		"Liver Hepatocellular Carcinoma (TCGA): 6.2"	"Region enriched"	"Detected in some"	35	"pons: 192.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	50	"Neuroblastoma: 54.0"	"Adrenal gland - Adrenal medulla cells, Kidney - Intercalated cells, Minor Salivary Gland - Fibroblasts, Testis - Early spermatids"	"Region enriched"	"Detected in some"	4	"pons and medulla: 7.8"	"Region enriched"	"Detected in single"	19	"pons: 17.9"	"HPA004057, HPA076311, CAB078195"	Enhanced	Supported	Approved	Mitochondria,Cytosol			NA	NA				"Cluster 21: Testis - Unknown function"	"Cluster 41: Monoamines - Neurotransmitter signalling"	"Cluster 17: Neuroblastoma - Neuronal signaling"	"Cluster 31: Spermatocytes - Spermatogenesis"	2	Cytosol	Mitochondria	"CAB078195: AB_2665806, HPA004057: AB_1080012, HPA076311: AB_2732307"	"unprognostic (6.90e-2)"			"unprognostic (9.28e-2)"					"unprognostic (3.02e-1)"	"unprognostic (4.14e-2)"				"unprognostic (1.29e-1)"	"unprognostic (1.21e-1)"			"unprognostic (1.57e-1)"	"unprognostic (1.36e-2)"												"unprognostic (1.63e-2)"
SLC6A3	"DAT, DAT1"	ENSG00000142319	"Solute carrier family 6 member 3"	Q01959	5	1392794-1445440	"Disease related genes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease variant, Dystonia, FDA approved drug targets, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	119	"brain: 95.8"	"Cell type enhanced"	"Detected in some"		"granulocytes: 2.1;Lymphatic endothelial cells: 8.3;Oocytes: 8.8;Serous glandular cells: 2.2"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	16	"Kidney Renal Clear Cell Carcinoma (TCGA): 6.9"	"Region enriched"	"Detected in some"	28	"midbrain: 133.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	10	"Kidney cancer: 5.0"	"Adipose visceral - Mesothelial cells"	"Group enriched"	"Detected in many"	8	"midbrain: 80.6;thalamus: 29.0"	"Region enriched"	"Detected in some"	152	"midbrain: 393.2"	"HPA012763, HPA013602, CAB016249, CAB078172"	Enhanced	Supported	Approved	Vesicles			NA	NA				"Cluster 9: Oligodendrocytes - Myelination"	"Cluster 41: Monoamines - Neurotransmitter signalling"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 54: Lymphatic endothelial cells - Lymph vessel development"	14	Vesicles		"CAB016249: AB_627402, CAB078172: AB_2665810, HPA012763: AB_2732405, HPA013602: AB_1847484"											"potential prognostic favorable (8.63e-6)"	"unprognostic (2.08e-3)"																			
SLC6A4	"5-HTT, HTT, OCD1, SERT1"	ENSG00000108576	"Solute carrier family 6 member 4"	P31645	17	30194319-30236002	"FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Antiport, Neurotransmitter transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"intestine: 39.2;lung: 27.9;placenta: 17.8"	"Group enriched"	"Detected in many"	10	"Cytotrophoblasts: 119.5;Proximal enterocytes: 100.4;Syncytiotrophoblasts: 95.7"	"Cell type enhanced"	"Detected in many"		"splatter: 6.2"	"Cancer enhanced"	"Detected in some"		"Breast Invasive Carcinoma (TCGA): 4.6"	"Group enriched"	"Detected in many"	11	"midbrain: 507.8;pons: 183.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"colorectal cancer: 2.5;liver cancer: 1.4"	"Pancreas - Alpha cells"	"Region enriched"	"Detected in some"	4	"midbrain: 58.4"	"Group enriched"	"Detected in some"	8	"midbrain: 51.2;pons: 38.2"	"HPA054723, HPA071354, HPA074728"	Supported	Supported	Supported	"Golgi apparatus,Vesicles"			NA	NA				"Cluster 25: Small intestine - Absorption"	"Cluster 41: Monoamines - Neurotransmitter signalling"	"Cluster 57: Stomach & Colon cancer - Digestion"	"Cluster 24: Cytotrophoblasts - Mitochondria"	8	"Golgi apparatus, Vesicles"		"HPA054723: , HPA071354: , HPA074728: AB_2686708"		"unprognostic (1.47e-1)"	"unprognostic (1.51e-1)"		"unprognostic (1.81e-1)"	"unprognostic (3.90e-1)"				"unprognostic (6.77e-2)"							"potential prognostic favorable (6.64e-4)"					"unprognostic (3.99e-3)"			"unprognostic (8.98e-2)"	"unprognostic (2.54e-2)"					
SLC6A8	"CRT, CRT-1, CRT1, CRTR, CT1"	ENSG00000130821	"Solute carrier family 6 member 8"	P48029	X	153687926-153696588	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease variant, FDA approved drug targets, Intellectual disability"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 120.9;Cone photoreceptor cells: 125.7;Distal enterocytes: 164.4;Ionocytes: 118.2;Proximal enterocytes: 196.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Lung - Smooth muscle cells, Testis - Sertoli cells"																NA	NA				"Cluster 23: Non-specific - Cellular respiration"	"Cluster 11: White matter - Signal transduction"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 5: Enterocytes - Absorption"	13				"unprognostic (3.61e-3)"	"unprognostic (7.33e-2)"	"unprognostic (4.09e-2)"	"unprognostic (6.66e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.38e-2)"	"unprognostic (6.40e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.51e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.21e-2)"	"potential prognostic unfavorable (8.16e-4)"	"unprognostic (5.07e-3)"	"unprognostic (6.80e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.44e-1)"	"unprognostic (4.61e-1)"	"unprognostic (7.13e-2)"	"unprognostic (5.95e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.81e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.49e-1)"	"potential prognostic unfavorable (8.27e-5)"	"unprognostic (2.92e-1)"
SLC7A11	xCT	ENSG00000151012	"Solute carrier family 7 member 11"	Q9UPY5	4	138164097-138242349	"FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 349.6;dendritic cells: 75.1;Gastric mucus-secreting cells: 57.8;Langerhans cells: 69.4;Microglial cells: 142.2"	"Group enriched"	"Detected in all"	5	"astrocyte: 553.7;bergmann glia: 403.5;endothelial cell: 396.4;ependymal cell: 367.3;fibroblast: 1249.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in all"	4	"Gallbladder cancer: 158.2"	"Liver - Vascular Endothelial cells, Stomach - Gastric mucous cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064215			Approved	Vesicles			NA	NA			"Cluster 8: Plasmacytoid DCs - Unknown function"	"Cluster 33: Brain - Neuronal signaling"	"Cluster 39: Astrocytes - Mixed function"	"Cluster 7: Liver cancer - Metabolism"	"Cluster 47: Astrocytes - Unknown function"	26	Vesicles		"HPA064215: AB_2685213"	"unprognostic (9.99e-2)"	"unprognostic (9.72e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.54e-1)"	"potential prognostic unfavorable (4.09e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.47e-3)"			"potential prognostic unfavorable (2.10e-6)"	"validated prognostic unfavorable (1.97e-8)"	"validated prognostic unfavorable (5.22e-4)"	"unprognostic (3.44e-3)"	"unprognostic (2.12e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.19e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.98e-3)"	"unprognostic (7.07e-2)"
SLC7A3	"ATRC3, CAT-3, FLJ14541"	ENSG00000165349	"Solute carrier family 7 member 3"	Q8WY07	X	70925579-70931125	"FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 19.3"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 10.0"	"Cell type enhanced"	"Detected in some"		"LAMP5-LHX6 and Chandelier: 10.4"	"Cancer enriched"	"Detected in some"	9	"Testicular Germ Cell Tumor (TCGA): 60.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	17	"testis cancer: 142.1"	"Pituitary gland - Fibroblasts"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"										NA	NA				"Cluster 71: Thymus - Adaptive immune response"	"Cluster 38: Sub-cortical - Mixed function"	"Cluster 34: Testis cancer - Unknown function"	"Cluster 18: Early spermatids - Unknown function"	3						"unprognostic (3.35e-1)"				"unprognostic (1.07e-1)"	"unprognostic (2.49e-2)"												"unprognostic (1.75e-1)"				"unprognostic (1.77e-1)"					"unprognostic (2.41e-2)"		
SLC7A7	"LPI, y+LAT-1"	ENSG00000155465	"Solute carrier family 7 member 7"	Q9UM01	14	22773222-22829820	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Disease variant, FDA approved drug targets, Osteoporosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 117.6;kidney: 261.6"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 247.6;Kupffer cells: 327.7;Macrophages: 131.4;monocytes: 264.1;Proximal enterocytes: 399.8;Proximal tubular cells: 264.5"	"Group enriched"	"Detected in many"	12	"central nervous system macrophage: 102.4;leukocyte: 28.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 393.7;non-classical monocyte: 447.3"	"Lineage enriched"	"Detected in many"	5	"monocytes: 447.3"	"Low cancer specificity"	"Detected in many"			"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Colon - Macrophages, Heart muscle - Macrophages, Kidney - Proximal tubular cells, Kidney - Proximal tubular cells, Lung - Macrophages, Minor Salivary Gland - Macrophages, Pituitary gland - Macrophages, Prostate - Macrophages, Skeletal muscle - Macrophages, Stomach - Macrophages, Testis - Early spermatids, Testis - Late spermatids, Thyroid gland - Macrophages"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA036227	Enhanced						NA	NA			"Cluster 40: Monocytes - Innate immune response"	"Cluster 52: Kidney - Transmembrane transport"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 22: Proximal enterocytes - Digestion"				"HPA036227: AB_10696653"	"unprognostic (1.44e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.78e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.10e-2)"	"unprognostic (4.85e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.58e-1)"	"unprognostic (5.88e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.62e-3)"	"unprognostic (4.60e-1)"	"unprognostic (2.02e-3)"	"unprognostic (5.04e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.87e-3)"	"unprognostic (3.50e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.58e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.08e-1)"
SLC8A1	NCX1	ENSG00000183023	"Solute carrier family 8 member A1"	P32418	2	40097270-40611053	"FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Sodium transport, Transport"	Calmodulin-binding	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"heart muscle: 148.4"	"Group enriched"	"Detected in many"	8	"Cardiomyocytes: 942.4;Excitatory neurons: 1224.1;Inhibitory neurons: 602.1;Microglial cells: 548.4;Oligodendrocyte precursor cells: 706.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 39.9"	"Group enriched"	"Detected in many"	6	"granulocytes: 39.9;monocytes: 12.3"	"Low cancer specificity"	"Detected in many"			"Adipose subcutaneous - Smooth muscle cells, Colon - Smooth muscle cells, Kidney - Intercalated cells, Pituitary gland - Thyrotropes, Prostate - Smooth muscle cells, Spleen - Macrophages"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022694, HPA070007"	Uncertain		Supported	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	Transport	NA	NA			"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 30: Heart muscle - Heart development"	"Cluster 38: Sub-cortical - Mixed function"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 34: Neurons - Neuronal signaling"	3	"Nucleoplasm, Plasma membrane"		"CAB022694: , HPA070007: AB_2686227"	"unprognostic (2.25e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.84e-1)"		"unprognostic (7.73e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.60e-1)"		"unprognostic (1.89e-1)"	"potential prognostic favorable (3.46e-8)"	"unprognostic (1.15e-2)"	"unprognostic (3.74e-1)"		"unprognostic (1.25e-1)"	"unprognostic (6.08e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.10e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.49e-3)"	"unprognostic (5.72e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.00e-1)"	"unprognostic (8.96e-3)"		"unprognostic (1.65e-2)"	"unprognostic (3.68e-1)"		"unprognostic (8.56e-3)"
SLC9A3	"NHE-3, NHE3"	ENSG00000066230	"Solute carrier family 9 member A3"	P48764	5	470456-524449	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 43.9;intestine: 91.0;kidney: 60.4;stomach 1: 48.7"	"Group enriched"	"Detected in some"	4	"Basal squamous epithelial cells: 8.6;Squamous epithelial cells: 7.6"	"Cell type enhanced"	"Detected in some"		"mammillary body: 4.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Kidney - Ascending Loop of Henle cells, Stomach - Parietal cells"	"Region enriched"	"Detected in single"	14	"cerebellum: 4.1"	"Low region specificity"	"Detected in many"			"HPA036493, HPA036669"	Enhanced		Supported	"Plasma membrane"			NA	NA			"Cluster 43: Non-specific - Transcription & Translation"	"Cluster 55: Kidney & Intestine - Metabolism"	"Cluster 37: Neurons - Mixed function"	"Cluster 57: Stomach & Colon cancer - Digestion"	"Cluster 49: Non-specific - Transcription"	5	"Plasma membrane"		"HPA036493: AB_10673353, HPA036669: AB_10670843"	"unprognostic (2.49e-2)"	"unprognostic (2.24e-2)"		"unprognostic (8.23e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.80e-2)"		"unprognostic (3.33e-1)"	"unprognostic (1.06e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.77e-2)"	"unprognostic (7.25e-2)"	"potential prognostic favorable (7.69e-4)"	"unprognostic (2.50e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.45e-1)"		"unprognostic (1.14e-2)"	"unprognostic (2.60e-3)"	"unprognostic (2.51e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.28e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.75e-1)"	"unprognostic (5.21e-2)"	"unprognostic (7.49e-2)"
SMN1	"BCD541, GEMIN1, SMA, SMA@, SMA1, SMA2, SMA3, SMNT, TDRD16A"	ENSG00000172062	"Survival of motor neuron 1, telomeric"	Q16637	5	70925030-70953942	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Neurogenesis"	RNA-binding	"Disease variant, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"												"CAB016324, HPA045271, CAB069888, HPA073601"	Supported		Supported	"Nuclear bodies,Cytosol"			NA	NA			"Cluster 33: Non-specific - ATP binding"	"Cluster 66: Non-specific - Transcription"	"Cluster 31: Non-specific - Transcription"	"Cluster 38: Non-specific - Transcription"	"Cluster 39: Non-specific - Basic cellular processes"	162	"Nuclear bodies, Cytosol"		"CAB016324: AB_627931, CAB069888: AB_10001257, HPA045271: AB_2679280, HPA073601: "	"unprognostic (5.26e-2)"	"unprognostic (4.08e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.75e-1)"	"potential prognostic unfavorable (1.52e-4)"	"unprognostic (8.44e-2)"	"unprognostic (7.66e-2)"	"unprognostic (4.66e-3)"	"unprognostic (1.52e-1)"	"unprognostic (5.14e-2)"	"unprognostic (2.31e-2)"	"unprognostic (5.58e-3)"	"unprognostic (1.99e-2)"	"unprognostic (9.60e-3)"	"unprognostic (4.02e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.93e-2)"	"unprognostic (9.63e-2)"	"unprognostic (1.89e-1)"	"potential prognostic unfavorable (7.63e-4)"	"unprognostic (1.05e-1)"	"unprognostic (3.16e-1)"	"unprognostic (6.75e-3)"	"unprognostic (9.03e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.01e-2)"	"unprognostic (6.69e-3)"	"unprognostic (4.22e-2)"
SMN2	"BCD541, GEMIN1, SMNC, TDRD16B"	ENSG00000205571	"Survival of motor neuron 2, centromeric"	Q16637	5	70049638-70078522	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Neurogenesis"	RNA-binding	"Disease variant, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 12.1;Oocytes: 21.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"												"CAB009344, HPA045271, HPA073601"	Supported		Supported	"Nuclear bodies,Cytosol"			NA	NA			"Cluster 13: Non-specific - Mitochondria"	"Cluster 34: Non-specific - Mixed function"	"Cluster 27: Non-specific - Mixed function"	"Cluster 22: Non-specific - mRNA splicing & Cell cycle"	"Cluster 39: Non-specific - Basic cellular processes"	85	"Nuclear bodies, Cytosol"		"CAB009344: AB_2193083, HPA045271: AB_2679280, HPA073601: "	"unprognostic (1.68e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.25e-2)"	"potential prognostic favorable (7.02e-4)"	"unprognostic (3.02e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.84e-1)"	"unprognostic (9.87e-2)"	"unprognostic (3.11e-1)"	"unprognostic (8.62e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.39e-3)"	"unprognostic (5.58e-3)"	"unprognostic (1.17e-1)"	"unprognostic (8.50e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.76e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.55e-1)"	"potential prognostic unfavorable (2.50e-5)"	"unprognostic (7.77e-2)"	"unprognostic (2.08e-1)"	"unprognostic (6.85e-2)"	"unprognostic (3.07e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.97e-2)"
SMO	"FZD11, SMOH"	ENSG00000128602	"Smoothened, frizzled class receptor"	Q99835	7	129188633-129213545	"Cancer-related genes, Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transporters"		"Developmental protein, G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 26.0;Leydig cells: 19.9;Muller glia cells: 13.7;Peritubular cells: 21.9"	"Group enriched"	"Detected in many"	4	"astrocyte: 55.6;bergmann glia: 40.6;choroid plexus epithelial cell: 29.2;ependymal cell: 44.3;fibroblast: 22.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Adipose subcutaneous - Adipose progenitor cells, Liver - Hepatocytes, Lung - Fibroblast_2, Stomach - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB011446	Approved						NA	NA				"Cluster 53: Non-specific - Glycosylation"	"Cluster 42: Choroid plexus - Mitochondria"	"Cluster 5: Rhabdoid - Unknown function"	"Cluster 6: Ovarian stromal cells - Transcription"	3			"CAB011446: "	"unprognostic (2.73e-1)"	"unprognostic (3.93e-2)"	"unprognostic (5.42e-2)"	"unprognostic (5.91e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.09e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.32e-2)"	"unprognostic (7.30e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.58e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.69e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.14e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.09e-1)"	"potential prognostic unfavorable (9.61e-5)"	"unprognostic (1.48e-3)"	"unprognostic (5.21e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.76e-1)"
SNAP25	"bA416N4.2, dJ1068F16.2, RIC-4, RIC4, SEC9, SNAP, SNAP-25"	ENSG00000132639	"Synaptosome associated protein 25"	P60880	20	10172395-10308258	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Transporters"			"Congenital myasthenic syndrome, Disease variant, FDA approved drug targets, Intellectual disability"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 2378.1"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 458.9;Cone photoreceptor cells: 310.9;Excitatory neurons: 982.1;Horizontal cells: 236.1;Inhibitory neurons: 529.6"	"Low cell type specificity"	"Detected in all"			"Cancer enriched"	"Detected in many"	6	"Glioblastoma Multiforme (TCGA): 76.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Neuroblastoma: 52.2"	"Colon - Colon enteroendocrine cells, Pancreas - Alpha cells, Pancreas - Beta cells, Pituitary gland - Lactotropes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000360, HPA001830, HPA071013"	Enhanced	Supported	Approved	"Vesicles,Plasma membrane"			NA	NA		7100		"Cluster 22: Brain - Synaptic signal transduction"	"Cluster 52: Neurons & Synapses - Synaptic function"	"Cluster 16: Thyroid cancer - Neuronal signaling"	"Cluster 25: Bipolar cells - Visual perception"	22	"Plasma membrane"	Vesicles	"CAB000360: AB_2286342, HPA001830: AB_1080039, HPA071013: "	"unprognostic (1.42e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.69e-1)"				"unprognostic (6.81e-3)"	"unprognostic (5.79e-2)"		"unprognostic (2.24e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.53e-1)"	"potential prognostic favorable (5.15e-4)"	"unprognostic (1.37e-1)"	"unprognostic (4.42e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.34e-2)"	"potential prognostic unfavorable (3.07e-4)"	"unprognostic (2.21e-2)"	"unprognostic (7.48e-3)"	"unprognostic (8.10e-2)"	"unprognostic (1.90e-1)"			"unprognostic (1.32e-1)"	"unprognostic (6.10e-3)"	"unprognostic (2.32e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.27e-2)"
SOAT1	"ACAT, ACAT1, SOAT, STAT"	ENSG00000057252	"Sterol O-acyltransferase 1"	P35610	1	179293714-179358680	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Acyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"adrenal gland: 160.1"	"Cell type enhanced"	"Detected in many"		"monocytes: 99.3;Prostatic glandular cells: 94.3"	"Cell type enhanced"	"Detected in all"		"central nervous system macrophage: 178.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Macrophages, Prostate - Prostate glandular cells, Skin - Sebaceous gland cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009533, HPA047171"	Enhanced		Enhanced	"Endoplasmic reticulum"			NA	NA			"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 26: Adrenal gland - Steroid metabolism"	"Cluster 21: Non-specific - Metabolism"	"Cluster 9: Skin cancer - Melanin biosynthesis"	"Cluster 58: Macrophages - Innate immune response"	36	"Endoplasmic reticulum"		"CAB009533: AB_633499, HPA047171: AB_2679967"	"unprognostic (3.57e-1)"	"unprognostic (3.25e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.04e-2)"	"unprognostic (7.63e-2)"	"unprognostic (9.93e-3)"	"unprognostic (1.39e-1)"	"unprognostic (4.09e-2)"	"potential prognostic favorable (3.14e-4)"	"unprognostic (3.23e-1)"	"unprognostic (6.31e-2)"	"unprognostic (7.70e-3)"	"unprognostic (4.13e-3)"	"unprognostic (1.20e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.05e-2)"	"unprognostic (3.82e-3)"	"unprognostic (4.48e-2)"	"unprognostic (1.21e-3)"	"unprognostic (3.27e-1)"	"unprognostic (2.49e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.90e-1)"	"unprognostic (8.07e-2)"	"unprognostic (9.52e-3)"	"unprognostic (2.03e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.26e-1)"
SOST	"DAND6, VBCH"	ENSG00000167941	Sclerostin	Q9BQB4	17	43753738-43758791	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted secreted proteins"	"Wnt signaling pathway"	Heparin-binding	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"kidney: 13.0"	"Group enriched"	"Detected in some"	5	"B-cells: 1.6;Cholangiocytes: 1.9;Collecting duct cells: 5.8;Pancreatic endocrine cells: 1.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"Bladder Urothelial Carcinoma (TCGA): 7.8;Lung Squamous Cell Carcinoma (TCGA): 17.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Bladder cancer: 12.3;Rhabdoid: 19.6"		"Group enriched"	"Detected in some"	11	"basal ganglia: 1.7;cerebellum: 1.0"	"Not detected"	"Not detected"								"Secreted to extracellular matrix"	Other	NA	NA		350000		"Cluster 52: Kidney - Transmembrane transport"		"Cluster 7: Liver cancer - Metabolism"	"Cluster 73: B-cells - B-cell function"	17				"unprognostic (1.65e-1)"								"unprognostic (2.39e-1)"									"unprognostic (4.78e-2)"	"unprognostic (3.97e-1)"												
SQLE		ENSG00000104549	"Squalene epoxidase"	Q14534	8	124998497-125022283	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Suprabasal keratinocytes: 226.4;Syncytiotrophoblasts: 297.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Adrenal cortex cells, Lung - Alveolar cells type 2, Minor Salivary Gland - Minor salivary gland basal cells, Testis - Spermatocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018038, HPA020762"	Enhanced		Uncertain	Vesicles,Cytosol			NA	NA			"Cluster 23: B-cells - Immunoglobulins"	"Cluster 29: Squamous epithelium - Innate immune response"	"Cluster 43: Hindbrain - Mixed function"	"Cluster 40: Non-specific - Unknown function"	"Cluster 62: Hepatocytes - Metabolism"	7	"Vesicles, Cytosol"		"HPA018038: AB_2669753, HPA020762: AB_2670512"	"unprognostic (1.31e-1)"	"unprognostic (2.35e-2)"	"unprognostic (3.74e-1)"	"unprognostic (9.62e-3)"	"unprognostic (2.91e-2)"	"unprognostic (9.88e-3)"	"unprognostic (3.65e-1)"	"unprognostic (1.51e-2)"	"potential prognostic unfavorable (2.66e-4)"	"unprognostic (1.42e-2)"	"unprognostic (5.31e-2)"	"unprognostic (3.13e-3)"	"potential prognostic unfavorable (1.18e-5)"	"potential prognostic unfavorable (8.02e-4)"	"unprognostic (1.06e-2)"	"potential prognostic unfavorable (1.73e-4)"	"unprognostic (6.98e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.34e-1)"	"potential prognostic unfavorable (7.95e-4)"	"unprognostic (8.31e-3)"	"unprognostic (3.74e-2)"	"unprognostic (2.86e-1)"	"unprognostic (9.17e-2)"	"unprognostic (4.90e-3)"	"unprognostic (7.58e-2)"	"unprognostic (3.46e-2)"	"potential prognostic unfavorable (1.81e-4)"	"unprognostic (4.23e-2)"
SRC	"ASV, c-src, SRC1"	ENSG00000197122	"SRC proto-oncogene, non-receptor tyrosine kinase"	P12931	20	37344685-37406050	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell adhesion, Cell cycle, Host-virus interaction, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 41.9;Langerhans cells: 55.2;monocytes: 46.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 1.9"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.0;monocytes: 1.9"	"Low cancer specificity"	"Detected in all"			"Spleen - Macrophages, Testis - Sertoli cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004023, HPA030875"	Approved		Supported	"Vesicles,Plasma membrane,Cell Junctions"			NA	NA		2000000	"Cluster 10: Non-specific - Membrane trafficking"	"Cluster 41: Smooth muscle tissue - ECM organization"	"Cluster 29: Forebrain - Mixed function"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 16: Intestinal goblet cells - Mucin production"	218	"Plasma membrane, Cell Junctions"	Vesicles	"CAB004023: AB_2106059, HPA030875: AB_2673640"	"unprognostic (1.20e-1)"	"unprognostic (3.66e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.40e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.57e-1)"	"unprognostic (4.56e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.08e-2)"	"unprognostic (6.32e-3)"	"unprognostic (1.48e-1)"	"validated prognostic unfavorable (2.14e-4)"	"validated prognostic unfavorable (3.05e-5)"	"unprognostic (3.55e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.20e-2)"	"unprognostic (6.00e-2)"	"unprognostic (8.52e-3)"	"unprognostic (3.78e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.70e-2)"	"unprognostic (2.12e-2)"	"unprognostic (7.89e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.15e-3)"
SRD5A1		ENSG00000145545	"Steroid 5 alpha-reductase 1"	P18405	5	6633427-6674386	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins"	"Differentiation, Lipid metabolism, Sexual differentiation"	Oxidoreductase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 28.1"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 98.6;Hepatocytes: 96.7;Squamous epithelial cells: 139.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 3.4"	"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Liver - Hepatocytes, Skin - Sebaceous gland cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051402	Approved						NA	NA			"Cluster 41: Basophils - Unknown function"	"Cluster 37: Liver & Intestine - Lipid metabolism"	"Cluster 37: Neurons - Mixed function"	"Cluster 29: Non-specific - Unknown function"	"Cluster 12: Squamous epithelial cells - Keratinization"	1			"HPA051402: AB_2681470"	"unprognostic (1.50e-1)"	"unprognostic (2.98e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.23e-1)"	"unprognostic (9.67e-2)"	"unprognostic (9.82e-3)"	"unprognostic (3.14e-2)"	"unprognostic (2.37e-1)"	"potential prognostic favorable (7.35e-6)"	"unprognostic (4.90e-3)"	"unprognostic (1.99e-1)"	"unprognostic (5.41e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.23e-2)"	"unprognostic (8.32e-2)"	"unprognostic (1.58e-1)"	"unprognostic (9.71e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.19e-2)"	"potential prognostic unfavorable (1.06e-4)"	"unprognostic (1.01e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.25e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.99e-2)"	"unprognostic (9.38e-3)"
SRD5A2		ENSG00000277893	"Steroid 5 alpha-reductase 2"	P31213	2	31522480-31580938	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Differentiation, Lipid metabolism, Sexual differentiation"	Oxidoreductase	"Cancer-related genes, Disease variant, FDA approved drug targets, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"epididymis: 23.0;fallopian tube: 19.8;liver: 59.0;prostate: 16.2;seminal vesicle: 17.4"	"Group enriched"	"Detected in some"	10	"Ciliated cells: 27.8;Club cells: 20.7;Early spermatids: 59.2;Hepatocytes: 20.9;Late spermatids: 70.8"	"Group enriched"	"Detected in some"	4	"central nervous system macrophage: 1.2;cerebellar inhibitory: 4.6"	"Group enriched"	"Detected in some"	4	"Liver Hepatocellular Carcinoma (TCGA): 5.2;Prostate Adenocarcinoma (TCGA): 4.6"	"Region enriched"	"Detected in single"	13	"midbrain: 2.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Kidney - Proximal tubular cells, Liver - Hepatocytes, Lung - Respiratory ciliated cells, Testis - Early spermatids, Testis - Late spermatids"	"Not detected"	"Not detected"			"Not detected"	"Not detected"										NA	NA				"Cluster 53: Non-specific - Glycosylation"	"Cluster 46: Brainstem - Mixed function"	"Cluster 59: Leukemia - T-cell receptor"	"Cluster 11: Late spermatids - Unknown function"	5						"unprognostic (1.93e-1)"											"unprognostic (1.72e-3)"	"unprognostic (2.02e-2)"									"unprognostic (1.87e-3)"							"unprognostic (3.35e-2)"
SSTR1		ENSG00000139874	"Somatostatin receptor 1"	P30872	14	38207904-38213067	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 9.2;intestine: 13.4;stomach 1: 21.1"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 9.0;Enteroendocrine cells: 25.1;Gastric mucus-secreting cells: 18.3;Oligodendrocyte precursor cells: 22.6;Paneth cells: 11.1;Proximal enterocytes: 10.9"	"Cell type enhanced"	"Detected in many"		"oligodendrocyte precursor cell: 21.5"	"Cancer enhanced"	"Detected in many"		"Prostate Adenocarcinoma (TCGA): 7.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Minor Salivary Gland - Fibroblasts, Pancreas - Alpha cells, Pituitary gland - Lactotropes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA003207, HPA031506"	Approved		Uncertain	Vesicles			NA	NA				"Cluster 25: Small intestine - Absorption"	"Cluster 24: Neurons - Mixed function"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 20: Enteroendocrine cells - Hormone signaling"	9	Vesicles		"HPA003207: , HPA031506: AB_2673913"			"unprognostic (2.81e-1)"		"unprognostic (3.20e-1)"	"unprognostic (6.45e-3)"		"potential prognostic favorable (5.52e-6)"		"unprognostic (1.55e-1)"	"potential prognostic favorable (2.62e-9)"	"unprognostic (5.47e-3)"	"unprognostic (5.44e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.56e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.60e-3)"					"unprognostic (4.21e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.62e-3)"		"unprognostic (2.99e-1)"			
SSTR2		ENSG00000180616	"Somatostatin receptor 2"	P30874	17	73165010-73176633	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 37.4;Enteroendocrine cells: 46.9;Horizontal cells: 76.2;Mucus glandular cells: 26.7;Smooth muscle cells: 43.8"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.2"	"Cancer enhanced"	"Detected in some"		"Neuroblastoma: 18.2"	"Breast - Endothelial cells, Pancreas - Alpha cells, Pituitary gland - Thyrotropes"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA007264	Uncertain		Supported	Nucleoplasm,Cytosol			NA	NA				"Cluster 22: Brain - Synaptic signal transduction"	"Cluster 14: Neurons - Synaptic function"	"Cluster 1: Neuronal - Visual perception"	"Cluster 48: Smooth muscle cells - Signal transduction"	7	Cytosol	Nucleoplasm	"HPA007264: AB_1080053"	"unprognostic (2.27e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.54e-2)"		"unprognostic (8.31e-2)"	"unprognostic (3.66e-2)"	"potential prognostic favorable (4.25e-5)"		"unprognostic (1.06e-2)"	"unprognostic (2.45e-1)"	"potential prognostic favorable (4.22e-7)"	"unprognostic (8.38e-2)"	"unprognostic (8.71e-3)"	"unprognostic (1.25e-1)"		"unprognostic (8.47e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.04e-2)"			"unprognostic (4.43e-3)"	"unprognostic (3.89e-1)"			"potential prognostic favorable (1.02e-4)"		"unprognostic (9.48e-2)"	"unprognostic (2.46e-1)"		"unprognostic (8.81e-2)"
SSTR3		ENSG00000278195	"Somatostatin receptor 3"	P32745	22	37204237-37212477	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.8;lymphoid tissue: 10.8;testis: 7.6"	"Group enriched"	"Detected in some"	4	"Granulosa cells: 9.5;Sertoli cells: 10.9"	"Cell type enhanced"	"Detected in many"		"thalamic excitatory: 9.3"	"Cancer enhanced"	"Detected in single"		"Pancreatic Adenocarcinoma (TCGA): 2.8"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"naive CD4 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	10	"T-cells: 1.1"	"Cancer enriched"	"Detected in some"	5	"Myeloma: 23.4"	"Adipose visceral - Mesothelial cells, Breast - Plasma cells, Kidney - Podocytes, Minor Salivary Gland - Plasma cells, Pancreas - Alpha cells, Pancreas - Beta cells, Pituitary gland - Gonadotropes, Testis - Sertoli cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022647	Approved		Approved	"Primary cilium,Cytosol"			NA	NA			"Cluster 43: Non-specific - Transcription & Translation"	"Cluster 9: Oligodendrocytes - Myelination"	"Cluster 52: Neurons & Synapses - Synaptic function"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 7: T-cells - T-cell receptor"	5	"Primary cilium"	Cytosol	"CAB022647: "																						"unprognostic (1.89e-3)"									
SSTR4		ENSG00000132671	"Somatostatin receptor 4"	P31391	20	23035312-23039237	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Colon - Colon enteroendocrine cells"	"Low region specificity"	"Detected in many"							HPA064252	Uncertain						NA	NA					"Cluster 51: Neurons - Mixed function"	"Cluster 16: Thyroid cancer - Neuronal signaling"		1			"HPA064252: AB_2685227"																															
SSTR5		ENSG00000162009	"Somatostatin receptor 5"	P35346	16	1072747-1081454	"FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"adrenal gland: 2.4;heart muscle: 6.7;kidney: 2.8;pituitary gland: 7.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"hypothalamus: 2.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Gastric cancer: 5.6"	"Heart muscle - Cardiomyocytes, Pancreas - Beta cells"	"Group enriched"	"Detected in some"	5	"basal ganglia: 4.1;hypothalamus: 2.3"	"Low region specificity"	"Detected in many"			HPA066503			Supported	"Plasma membrane"			NA	NA				"Cluster 30: Heart muscle - Heart development"	"Cluster 56: Hypothalamus - Neuropeptide signaling"	"Cluster 2: Mucus-secreting cells - Unknown function"		4	"Plasma membrane"		"HPA066503: AB_2685679"				"unprognostic (2.15e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.25e-2)"				"unprognostic (4.57e-2)"			"unprognostic (2.19e-1)"	"unprognostic (3.40e-1)"	"unprognostic (9.68e-2)"										"unprognostic (4.65e-2)"	"unprognostic (2.12e-1)"		"unprognostic (3.16e-1)"			
SV2A	"KIAA0736, SV2"	ENSG00000159164	"Synaptic vesicle glycoprotein 2A"	Q7L0J3	1	149903318-149917844	"FDA approved drug targets, Predicted membrane proteins"	"Neurotransmitter transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 118.3;parathyroid gland: 46.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 85.7;Excitatory neurons: 61.3;Horizontal cells: 163.0;Inhibitory neurons: 102.7"	"Low cell type specificity"	"Detected in all"			"Cancer enriched"	"Detected in many"	6	"Glioblastoma Multiforme (TCGA): 49.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Neuroblastoma: 54.3"	"Adipose subcutaneous - Smooth muscle cells, Colon - Colon enteroendocrine cells, Pancreas - Alpha cells, Prostate - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002226, HPA007863"	Enhanced		Approved	Cytosol			NA	NA				"Cluster 22: Brain - Synaptic signal transduction"	"Cluster 52: Neurons & Synapses - Synaptic function"	"Cluster 16: Thyroid cancer - Neuronal signaling"	"Cluster 71: Horizontal & Bipolar cells - Neuronal signaling"		Cytosol		"CAB002226: AB_564144, HPA007863: AB_1080135"	"unprognostic (9.08e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.16e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.68e-1)"	"unprognostic (3.55e-1)"	"unprognostic (3.26e-3)"	"unprognostic (1.82e-1)"		"unprognostic (2.65e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.71e-1)"		"unprognostic (5.58e-3)"	"unprognostic (9.70e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.35e-3)"	"unprognostic (3.20e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.72e-3)"	"unprognostic (3.08e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.24e-2)"	"unprognostic (2.63e-1)"	"unprognostic (8.60e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.06e-1)"
SYK		ENSG00000165025	"Spleen associated tyrosine kinase"	P43405	9	90801787-90898549	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins"	"Adaptive immunity, Angiogenesis, Host-virus interaction, Immunity, Innate immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 71.8;parathyroid gland: 84.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 89.8;dendritic cells: 120.6;Hofbauer cells: 79.8;Kupffer cells: 86.8;Macrophages: 101.8;Microglial cells: 109.1;Plasma cells: 83.1"	"Cell type enriched"	"Detected in many"	9	"central nervous system macrophage: 863.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	13	"classical monocyte: 77.3;eosinophil: 83.6;intermediate monocyte: 64.0;memory B-cell: 74.7;myeloid DC: 85.1;naive B-cell: 58.6;neutrophil: 112.4;NK-cell: 30.2;non-classical monocyte: 60.5;plasmacytoid DC: 63.3"	"Low lineage specificity"	"Detected in many"			"Cancer enhanced"	"Detected in many"		"lymphoma: 87.6"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Heart muscle - Macrophages, Lung - Macrophages, Skeletal muscle - Macrophages, Spleen - B-cells (Spleen), Testis - Sertoli cells, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA001384, CAB007773"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"			No	NA		240000	"Cluster 2: Dendritic cells - Unknown function"	"Cluster 16: Non-specific - Transcription"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 55: Lymphoma - Immune response"	"Cluster 73: B-cells - B-cell function"	62	"Plasma membrane, Cytosol"	Vesicles	"CAB007773: AB_562232, HPA001384: AB_1080144"	"unprognostic (6.27e-2)"	"unprognostic (2.37e-2)"	"unprognostic (4.53e-1)"	"unprognostic (5.02e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.28e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.96e-1)"	"unprognostic (5.34e-3)"	"unprognostic (1.63e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.39e-2)"	"unprognostic (7.45e-2)"	"unprognostic (6.36e-2)"	"unprognostic (2.53e-1)"	"unprognostic (6.92e-2)"	"unprognostic (5.50e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.88e-3)"	"unprognostic (2.17e-1)"	"unprognostic (5.82e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.47e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.13e-2)"
SYT2		ENSG00000143858	"Synaptotagmin 2"	Q8N9I0	1	202590596-202710454	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins"	Differentiation		"Congenital myasthenic syndrome, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"brain: 41.3"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 22.5;Horizontal cells: 27.7;Inhibitory neurons: 21.8;Oocytes: 88.2"	"Cell type enhanced"	"Detected in all"		"cerebellar inhibitory: 284.7;lower rhombic lip: 132.9"	"Cancer enriched"	"Detected in some"	7	"Testicular Germ Cell Tumor (TCGA): 9.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	5	"thyroid cancer: 8.4"	"Heart muscle - Cardiomyocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA063655	Enhanced	Supported					NA	NA				"Cluster 65: Cerebellum - Nervous system development"	"Cluster 52: Neurons & Synapses - Synaptic function"	"Cluster 16: Thyroid cancer - Neuronal signaling"	"Cluster 44: Oocytes - Unknown function"	29			"HPA063655: AB_2685077"			"unprognostic (2.13e-1)"					"unprognostic (8.77e-3)"								"unprognostic (7.94e-3)"	"unprognostic (1.93e-2)"									"unprognostic (2.47e-2)"			"unprognostic (1.59e-1)"		"unprognostic (1.71e-1)"
TAAR1	"TA1, TAR1, TRAR1"	ENSG00000146399	"Trace amine associated receptor 1"	Q96RJ0	6	132643312-132659182	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	6	"stomach 1: 4.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA): 1.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	4	"pancreatic cancer: 2.1"		"Not detected"	"Not detected"							HPA055614	Approved						NA	NA				"Cluster 48: Stomach - Proteolysis"		"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 42: Ciliated cells - Cilium assembly"				"HPA055614: AB_2682862"				"unprognostic (2.97e-1)"																											
TACR1	"NK1R, NKIR, SPR, TAC1R"	ENSG00000115353	"Tachykinin receptor 1"	P25103	2	75046463-75199520	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 6.0"	"Cell type enriched"	"Detected in some"	4	"Inhibitory neurons: 79.8"	"Cell type enhanced"	"Detected in all"		"eccentric medium spiny neuron: 156.4;LAMP5-LHX6 and Chandelier: 305.0;splatter: 155.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	23	"basophil: 2.2"	"Lineage enriched"	"Detected in single"	23	"granulocytes: 2.2"	"Group enriched"	"Detected in some"	4	"Brain cancer: 2.9;ovarian cancer: 1.2"	"Kidney - Endothelial cells, Minor Salivary Gland - Endothelial cells, Prostate - Endothelial cells, Skin - Endothelial cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA055565, HPA074573"	Enhanced		Approved	"Plasma membrane,Centrosome,Basal body"			NA	NA				"Cluster 62: Connective tissue - ECM organization"	"Cluster 41: Monoamines - Neurotransmitter signalling"	"Cluster 72: Neuronal - Signal transduction"	"Cluster 65: Neurons - Synaptic function"	14	"Plasma membrane, Centrosome, Basal body"		"HPA055565: , HPA074573: AB_2686701"		"potential prognostic favorable (7.18e-4)"	"unprognostic (4.16e-2)"				"unprognostic (7.10e-2)"	"potential prognostic favorable (1.96e-4)"											"unprognostic (4.07e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.84e-3)"										
TACSTD2	"EGP-1, GA733-1, M1S1, TROP2"	ENSG00000184292	"Tumor associated calcium signal transducer 2"	P09758	1	58575433-58577252	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins"	"Sensory transduction, Vision"	"Tumor antigen"	"Amyloidosis, Corneal dystrophy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 961.9;salivary gland: 454.7;skin 1: 425.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 1666.8;Basal respiratory cells: 2850.6;Basal squamous epithelial cells: 1785.3;Club cells: 1989.2;Ductal cells: 1987.3;Ionocytes: 2021.5;Squamous epithelial cells: 2760.9;Suprabasal keratinocytes: 2420.8"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"choroid plexus: 3.9;white matter: 1.1"	"Immune cell enhanced"	"Detected in some"		"eosinophil: 15.1"	"Group enriched"	"Detected in many"	79	"dendritic cells: 4.3;granulocytes: 15.1;monocytes: 4.2"	"Cancer enhanced"	"Detected in many"		"Gallbladder cancer: 603.0;head and neck cancer: 792.6"	"Liver - Cholangiocyte, Pancreas - Ductal cells, Prostate - Prostate basal glandular cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA043104, HPA055067, CAB072852"	Enhanced		Supported	"Nucleoli,Vesicles,Plasma membrane"			NA	NA			"Cluster 7: Non-specific - Innate immune response"	"Cluster 27: Squamous epithelium - Keratinization"	"Cluster 36: Choroid plexus - Mixed function"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 35: Respiratory epithelial cells - Unknown function"	6	"Plasma membrane"	"Nucleoli, Vesicles"	"CAB072852: , HPA043104: AB_10960710, HPA055067: AB_2682687"	"unprognostic (1.45e-1)"	"unprognostic (5.10e-2)"	"unprognostic (7.09e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.24e-1)"			"unprognostic (6.81e-2)"	"potential prognostic favorable (7.73e-5)"	"unprognostic (8.69e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.21e-2)"	"unprognostic (5.84e-2)"	"unprognostic (2.56e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.61e-2)"	"unprognostic (9.31e-2)"	"unprognostic (1.34e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.51e-1)"	"unprognostic (4.11e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.49e-2)"	"unprognostic (8.16e-2)"
TEK	"CD202b, TIE-2, TIE2, VMCM, VMCM1"	ENSG00000120156	"TEK receptor tyrosine kinase"	Q02763	9	27109141-27230174	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Angiogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Glaucoma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 44.7"	"Group enriched"	"Detected in some"	6	"Adipocytes: 67.0;Endothelial cells: 74.2;Lymphatic endothelial cells: 34.9;Microglial cells: 36.7;Oligodendrocyte precursor cells: 129.2"	"Group enriched"	"Detected in all"	8	"endothelial cell: 417.7;oligodendrocyte precursor cell: 143.8"	"Cancer enhanced"	"Detected in all"		"Kidney Renal Clear Cell Carcinoma (TCGA): 13.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Rhabdoid: 17.5;testis cancer: 16.9"	"Adipose subcutaneous - Endothelial cells, Adipose visceral - Endothelial cells, Adrenal gland - Endothelial cells, Breast - Endothelial cells, Colon - Endothelial cells, Heart muscle - Endothelial cells, Kidney - Endothelial cells, Liver - Sinusoid Endothelial cells, Lung - Endothelial cells, Minor Salivary Gland - Endothelial cells, Pituitary gland - Endothelial cells, Prostate - Endothelial cells, Skeletal muscle - Endothelial cells, Stomach - Endothelial cells, Testis - Endothelial cells, Thyroid gland - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010359, HPA073265"	Approved		Supported	"Plasma membrane,Centrosome,Basal body"	"Secreted to blood"	Receptor	NA	NA	7750000	8000000		"Cluster 7: Adipose tissue - Mixed function"	"Cluster 47: Endothelial cells - Vasculature"	"Cluster 48: Adipocytes & Endothelial cells - Angiogenesis"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	14	"Plasma membrane"	"Centrosome, Basal body"	"CAB010359: AB_2203226, HPA073265: AB_2686592"	"unprognostic (2.08e-1)"	"unprognostic (3.02e-1)"	"unprognostic (7.64e-3)"	"unprognostic (4.21e-2)"	"unprognostic (3.16e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.56e-1)"	"unprognostic (8.83e-3)"	"unprognostic (4.71e-3)"	"unprognostic (3.04e-1)"	"validated prognostic favorable (3.45e-13)"	"validated prognostic favorable (5.48e-5)"	"unprognostic (4.39e-3)"	"validated prognostic favorable (1.01e-4)"	"validated prognostic favorable (8.49e-4)"	"unprognostic (2.27e-2)"	"unprognostic (3.43e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.82e-1)"		"unprognostic (7.71e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.60e-3)"	"unprognostic (3.71e-2)"	"unprognostic (5.25e-2)"	"unprognostic (6.63e-2)"
TFPI	"EPI, LACI, TFI, TFPI1"	ENSG00000003436	"Tissue factor pathway inhibitor"	P10646	2	187464230-187565760	"Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Protease inhibitor, Serine protease inhibitor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 263.9;placenta: 184.8"	"Group enriched"	"Detected in many"	4	"Extravillous trophoblasts: 2784.0;Lymphatic endothelial cells: 1775.9;Syncytiotrophoblasts: 976.8"	"Group enriched"	"Detected in many"	4	"fibroblast: 151.6;pericyte: 575.2;vascular associated smooth muscle cell: 159.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Endothelial cells, Breast - Fibroblasts"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA005575, CAB020842"	Supported				"Secreted to blood"	"Blood coagulation"	NA	NA	58100000	170000000	"Cluster 2: Dendritic cells - Unknown function"	"Cluster 11: Liver - Plasma proteins"	"Cluster 23: Choroid plexus - Mixed function"	"Cluster 48: Adipocytes & Endothelial cells - Angiogenesis"	"Cluster 4: Extravillous trophoblasts - Unknown function"	1			"CAB020842: , HPA005575: AB_1080290"	"unprognostic (1.88e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.60e-3)"	"unprognostic (4.89e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.44e-1)"	"unprognostic (6.68e-2)"	"unprognostic (8.07e-2)"	"unprognostic (3.54e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.25e-1)"	"unprognostic (8.07e-2)"	"unprognostic (2.15e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.89e-3)"	"unprognostic (2.86e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.40e-1)"	"unprognostic (5.08e-3)"	"unprognostic (6.37e-2)"	"unprognostic (6.57e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.11e-2)"	"unprognostic (7.48e-3)"	"unprognostic (1.32e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.38e-1)"
TFR2	"HFE3, TFRC2"	ENSG00000106327	"Transferrin receptor 2"	Q9UP52	7	100620416-100642779	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transporters"		Receptor	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"liver: 337.4"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 343.4"	"Low cell type specificity"	"Detected in many"			"Cancer enriched"	"Detected in some"	164	"Liver Hepatocellular Carcinoma (TCGA): 184.1"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	23	"basophil: 2.5;eosinophil: 1.9"	"Lineage enriched"	"Detected in single"	26	"granulocytes: 2.5"	"Cancer enriched"	"Detected in some"	7	"Leukemia: 23.6"	"Liver - Hepatocytes, Stomach - Parietal cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB016255, HPA017171, HPA073125"	Enhanced		Approved	"Golgi apparatus"			NA	NA		1100000	"Cluster 46: Basophils - Proteolysis"	"Cluster 83: Liver - Metabolism"	"Cluster 15: Non-specific - Transcription"	"Cluster 47: Leukemia - Hemostasis"	"Cluster 62: Hepatocytes - Metabolism"	4	"Golgi apparatus"		"CAB016255: AB_628395, HPA017171: , HPA073125: "			"unprognostic (1.14e-2)"					"unprognostic (4.07e-2)"						"unprognostic (2.15e-2)"	"unprognostic (4.51e-3)"						"unprognostic (1.07e-1)"		"unprognostic (3.31e-2)"					"unprognostic (4.06e-2)"			
TFRC	"CD71, p90, TFR1"	ENSG00000072274	"Transferrin receptor"	P02786	3	196012511-196082153	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Endocytosis, Host-virus interaction"	"Host cell receptor for virus entry, Receptor, Transducer"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 451.2;monocytes: 612.3;Syncytiotrophoblasts: 467.6"	"Cell type enriched"	"Detected in all"	6	"endothelial cell: 425.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 9.2"	"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Adrenal cortex cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000153, HPA028598"	Enhanced		Supported	Endosomes,Lysosomes	"Secreted to blood"	Receptor	NA	NA	1310000000	73000000	"Cluster 13: Non-specific - Mitochondria"	"Cluster 56: Non-specific - Unknown function"	"Cluster 52: Neurons & Synapses - Synaptic function"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 58: Macrophages - Innate immune response"	138	"Endosomes, Lysosomes"		"CAB000153: AB_2533029, HPA028598: AB_10601599"	"unprognostic (1.60e-2)"	"unprognostic (3.39e-2)"	"unprognostic (5.13e-2)"	"potential prognostic unfavorable (1.85e-4)"	"unprognostic (2.38e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.70e-2)"	"potential prognostic unfavorable (1.03e-4)"	"unprognostic (5.60e-2)"	"potential prognostic unfavorable (5.77e-4)"	"unprognostic (3.95e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.88e-2)"	"validated prognostic unfavorable (9.59e-6)"	"validated prognostic unfavorable (4.51e-6)"	"unprognostic (2.55e-2)"	"unprognostic (8.36e-3)"	"unprognostic (1.66e-2)"	"potential prognostic favorable (9.13e-4)"	"unprognostic (1.15e-2)"	"unprognostic (9.70e-3)"	"unprognostic (9.81e-3)"	"unprognostic (6.19e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.80e-2)"	"unprognostic (9.43e-3)"	"unprognostic (3.05e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.02e-3)"	"unprognostic (7.72e-2)"
TGFBR2	"MFS2, TBR-ii, TBRII"	ENSG00000163513	"Transforming growth factor beta receptor 2"	P37173	3	30606601-30694142	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Apoptosis, Differentiation, Growth regulation"	"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Aortic aneurysm, Cancer-related genes, Craniosynostosis, Disease variant, FDA approved drug targets, Hereditary nonpolyposis colorectal cancer"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 389.3;Endothelial cells: 383.4;Fibroblasts: 209.7;Lymphatic endothelial cells: 308.2"	"Group enriched"	"Detected in many"	9	"central nervous system macrophage: 646.8;choroid plexus epithelial cell: 610.3;endothelial cell: 572.4;fibroblast: 371.1;leukocyte: 407.5;pericyte: 296.7;vascular associated smooth muscle cell: 163.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Colon - Endothelial cells, Heart muscle - Macrophages, Kidney - Endothelial cells, Pituitary gland - Endothelial cells, Stomach - Endothelial cells, Testis - Endothelial cells, Thyroid gland - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB073537, HPA074821"			Supported	"Plasma membrane"	"Secreted to blood"	Receptor	NA	NA		520000	"Cluster 20: Non-specific - DNA binding"	"Cluster 7: Adipose tissue - Mixed function"	"Cluster 42: Choroid plexus - Mitochondria"	"Cluster 44: Connective tissue cells - ECM organization"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	94	"Plasma membrane"		"CAB073537: , HPA074821: "	"unprognostic (1.13e-1)"	"unprognostic (4.37e-1)"	"unprognostic (4.60e-2)"	"unprognostic (4.96e-3)"	"unprognostic (6.38e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.92e-3)"	"validated prognostic favorable (2.35e-7)"	"validated prognostic favorable (3.61e-4)"	"unprognostic (2.97e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.33e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.04e-2)"	"unprognostic (5.62e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.32e-3)"	"unprognostic (3.90e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.75e-3)"	"unprognostic (2.56e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.88e-1)"
TH	DYT5b	ENSG00000180176	"Tyrosine hydroxylase"	P07101	11	2163929-2171815	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Catecholamine biosynthesis, Neurotransmitter biosynthesis"	"Monooxygenase, Oxidoreductase"	"Disease variant, Dystonia, FDA approved drug targets, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	49	"adrenal gland: 190.6;brain: 130.3"	"Group enriched"	"Detected in some"	4	"Endometrial stromal cells: 9.4;Extravillous trophoblasts: 15.4;Oocytes: 12.5"	"Cell type enhanced"	"Detected in some"		"eccentric medium spiny neuron: 6.4;medium spiny neuron: 5.5"	"Group enriched"	"Detected in some"	4	"Bladder Urothelial Carcinoma (TCGA): 8.5;Head and Neck Squamous Cell Carcinoma (TCGA): 2.2"	"Group enriched"	"Detected in many"	5	"midbrain: 416.9;pons: 573.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"Brain cancer: 28.9;Neuroblastoma: 62.3"	"Adrenal gland - Adrenal medulla cells, Pancreas - Beta cells, Testis - Spermatogonia"	"Region enhanced"	"Detected in many"		"olfactory bulb: 178.8"	"Region enriched"	"Detected in many"	20	"midbrain: 999.2"	"CAB002522, HPA013768, HPA014010, HPA061003, CAB072340"	Enhanced	Supported	Approved	Cytosol			NA	NA				"Cluster 49: Pituitary gland - Hormone signaling"	"Cluster 41: Monoamines - Neurotransmitter signalling"	"Cluster 17: Neuroblastoma - Neuronal signaling"	"Cluster 4: Extravillous trophoblasts - Unknown function"	1	Cytosol		"CAB002522: AB_564047, CAB072340: , HPA013768: , HPA014010: , HPA061003: AB_2630374"	"unprognostic (1.68e-1)"		"unprognostic (3.76e-2)"	"unprognostic (1.22e-2)"					"unprognostic (9.59e-2)"													"unprognostic (4.74e-1)"			"unprognostic (2.10e-1)"						
THRA	"AR7, EAR-7.1/EAR-7.2, ERBA, ERBA1, NR1A1, THRA1, THRA2, THRA3, TRalpha"	ENSG00000126351	"Thyroid hormone receptor alpha"	P10827	17	40058290-40093867	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, Congenital hypothyroidism, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"brain: 402.5"	"Low cell type specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"Glioblastoma Multiforme (TCGA): 138.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Adrenal cortex cells, Kidney - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009654, CAB023349"	Approved		Uncertain	Cytosol			NA	NA			"Cluster 21: Neutrophils - Unknown function"	"Cluster 33: Brain - Neuronal signaling"	"Cluster 33: Neurons - Mixed function"	"Cluster 65: Non-specific - Unknown function"	"Cluster 6: Ovarian stromal cells - Transcription"	33	Cytosol		"CAB023349: AB_619577, HPA009654: AB_1854603"	"unprognostic (2.84e-1)"	"unprognostic (8.45e-2)"	"unprognostic (7.47e-2)"	"unprognostic (3.78e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.25e-3)"	"unprognostic (2.41e-1)"	"unprognostic (2.04e-1)"	"validated prognostic favorable (1.16e-7)"	"validated prognostic favorable (5.38e-4)"	"unprognostic (2.08e-3)"	"unprognostic (8.49e-3)"	"unprognostic (5.85e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.64e-1)"	"unprognostic (8.24e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.77e-3)"	"unprognostic (8.83e-2)"	"unprognostic (8.32e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.38e-1)"	"unprognostic (4.01e-2)"
THRB	"ERBA-BETA, ERBA2, GRTH, NR1A2, PRTH, THR1, THRB1, THRB2, TRbeta"	ENSG00000151090	"Thyroid hormone receptor beta"	P10828	3	24117153-24495756	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, Deafness, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 188.9;Excitatory neurons: 665.2;Inhibitory neurons: 603.8;Oligodendrocyte precursor cells: 308.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 7.2;naive B-cell: 2.3"	"Group enriched"	"Detected in many"	15	"B-cells: 2.3;granulocytes: 7.2"	"Cancer enhanced"	"Detected in many"		"Gallbladder cancer: 36.0"	"Liver - Hepatocytes, Pituitary gland - Lactotropes, Thyroid gland - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002008, CAB002009, HPA061035"	Approved		Supported	"Nuclear bodies"			NA	NA			"Cluster 20: Non-specific - DNA binding"	"Cluster 3: Non-specific - Unknown function"	"Cluster 53: Neurons - Mixed function"	"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 69: Neurons - Neuronal signaling"	18	"Nuclear bodies"		"CAB002008: , CAB002009: , HPA061035: AB_2684422"	"unprognostic (4.40e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.05e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.97e-1)"	"unprognostic (6.13e-2)"	"unprognostic (3.55e-2)"	"unprognostic (8.18e-2)"	"validated prognostic favorable (1.53e-10)"	"validated prognostic favorable (5.86e-4)"	"unprognostic (1.74e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.63e-2)"	"unprognostic (7.72e-2)"	"unprognostic (8.92e-3)"	"unprognostic (1.94e-1)"	"unprognostic (9.52e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.17e-1)"	"potential prognostic unfavorable (7.53e-4)"	"unprognostic (1.98e-1)"	"unprognostic (2.79e-3)"	"unprognostic (1.37e-3)"
TK2	SCA31	ENSG00000166548	"Thymidine kinase 2"	O00142	16	66508003-66552544	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"DNA synthesis"	"Kinase, Transferase"	"Disease variant, FDA approved drug targets, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Adrenal gland - Adrenal cortex cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041162	Uncertain						NA	NA			"Cluster 42: Non-specific - Vesicular transport"	"Cluster 26: Adrenal gland - Steroid metabolism"	"Cluster 19: Astrocytes - Mixed function"	"Cluster 68: Non-specific - Cell cycle regulation"	"Cluster 58: Macrophages - Innate immune response"				"HPA041162: AB_10961178"	"unprognostic (9.94e-3)"	"unprognostic (4.23e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.66e-2)"	"unprognostic (3.17e-1)"	"unprognostic (4.17e-2)"	"potential prognostic favorable (4.03e-4)"	"unprognostic (1.21e-1)"	"potential prognostic favorable (3.64e-7)"	"unprognostic (2.82e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.69e-2)"	"unprognostic (3.82e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.40e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.71e-1)"	"unprognostic (9.71e-2)"	"unprognostic (6.12e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.50e-3)"
TLR2	"CD282, TIL4"	ENSG00000137462	"Toll like receptor 2"	O60603	4	153684070-153706260	"CD markers, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 69.1;lymphoid tissue: 50.3"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 106.9;Macrophages: 117.2;monocytes: 342.1;Mucus glandular cells: 67.3"	"Cell type enriched"	"Detected in some"	5	"central nervous system macrophage: 299.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 200.3;intermediate monocyte: 179.4;myeloid DC: 121.5;neutrophil: 460.9;non-classical monocyte: 122.1"	"Group enriched"	"Detected in all"	48	"dendritic cells: 121.5;granulocytes: 460.9;monocytes: 200.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 11.0;Leukemia: 10.6"	"Adipose subcutaneous - Macrophages, Adrenal gland - Macrophages, Kidney - Macrophages, Liver - Neutrophils, Lung - Neutrophil_2, Minor Salivary Gland - Minor salivary glandular cells, Spleen - Neutrophils, Stomach - Macrophages"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA078321			Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"			NA	NA			"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 29: Monocytes - Innate immune response"	13	"Plasma membrane"	"Nucleoplasm, Vesicles, Cytosol"	"HPA078321: "	"unprognostic (1.11e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.84e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.22e-1)"	"unprognostic (6.40e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.77e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.05e-2)"	"unprognostic (3.58e-3)"	"potential prognostic favorable (5.70e-4)"	"unprognostic (6.79e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.61e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.39e-1)"	"unprognostic (4.22e-1)"	"unprognostic (4.37e-3)"	"unprognostic (3.10e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.14e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.27e-2)"	"unprognostic (7.73e-2)"	"unprognostic (9.89e-2)"	"unprognostic (4.35e-1)"
TLR4	"ARMD10, CD284, hToll, TLR-4"	ENSG00000136869	"Toll like receptor 4"	O00206	9	117704175-117724735	"CD markers, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"	Receptor	"Age-related macular degeneration, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 48.3;Hofbauer cells: 72.9;Kupffer cells: 156.6;Macrophages: 80.4;monocytes: 178.0"	"Cell type enhanced"	"Detected in single"		"central nervous system macrophage: 1.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 86.8"	"Group enriched"	"Detected in many"	33	"dendritic cells: 22.4;granulocytes: 86.8;monocytes: 65.9"	"Cancer enhanced"	"Detected in many"		"Brain cancer: 11.7"	"Heart muscle - Endothelial cells, Kidney - Endothelial cells, Lung - Neutrophil_2, Minor Salivary Gland - Macrophages"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB004025, HPA049174"	Approved		Approved	"Golgi apparatus,Plasma membrane"	"Intracellular and membrane"	Receptor	NA	NA			"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 39: Astrocytes - Mixed function"	"Cluster 72: Neuronal - Signal transduction"	"Cluster 74: Neutrophils - Degranulation"	25	"Golgi apparatus, Plasma membrane"		"CAB004025: , HPA049174: AB_2680662"	"unprognostic (1.71e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.44e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.10e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.14e-1)"	"potential prognostic favorable (1.51e-6)"	"unprognostic (1.28e-2)"	"unprognostic (9.68e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.14e-3)"	"unprognostic (2.99e-3)"	"unprognostic (5.26e-2)"	"unprognostic (4.44e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.26e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.94e-1)"	"unprognostic (8.41e-2)"	"unprognostic (8.50e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.27e-3)"	"unprognostic (4.00e-3)"	"unprognostic (5.86e-2)"
TLR7		ENSG00000196664	"Toll like receptor 7"	Q9NYK1	X	12867072-12890361	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	Receptor	"Disease variant, FDA approved drug targets, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 6.2"	"Cell type enhanced"	"Detected in some"		"B-cells: 9.5;dendritic cells: 37.2;Hofbauer cells: 23.3;Langerhans cells: 8.5;Macrophages: 23.2;Microglial cells: 13.4;monocytes: 7.4"	"Cell type enriched"	"Detected in some"	48	"central nervous system macrophage: 75.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 20.7"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"Leukemia: 1.5;lymphoma: 6.1;Myeloma: 5.5"	"Adrenal gland - Macrophages, Minor Salivary Gland - Macrophages, Thyroid gland - Macrophages"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA059613	Supported						NA	NA			"Cluster 10: Non-specific - Membrane trafficking"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 55: Lymphoma - Immune response"	"Cluster 58: Macrophages - Innate immune response"				"HPA059613: AB_2684083"	"unprognostic (2.56e-1)"	"unprognostic (6.14e-2)"	"unprognostic (3.30e-1)"			"unprognostic (5.71e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.08e-1)"			"unprognostic (1.15e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.63e-3)"			"potential prognostic favorable (2.51e-4)"	"unprognostic (8.69e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.79e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.19e-1)"			"unprognostic (3.14e-2)"		"unprognostic (9.96e-3)"	"unprognostic (8.94e-3)"		
TLR9	CD289	ENSG00000239732	"Toll like receptor 9"	Q9NR96	3	52221080-52225645	"CD markers, FDA approved drug targets, Human disease related genes, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 5.9"	"Cell type enhanced"	"Detected in some"		"B-cells: 3.4;Plasma cells: 3.2"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebral cortex: 10.3"	"Immune cell enriched"	"Detected in some"	7	"plasmacytoid DC: 167.1"	"Lineage enriched"	"Detected in many"	7	"dendritic cells: 167.1"	"Cancer enhanced"	"Detected in some"		"lymphoma: 16.6;Myeloma: 6.4"		"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"										NA	NA			"Cluster 44: Plasmacytoid DCs - Plasma membrane proteins"	"Cluster 16: Non-specific - Transcription"	"Cluster 15: Non-specific - Transcription"	"Cluster 55: Lymphoma - Immune response"	"Cluster 73: B-cells - B-cell function"	2						"unprognostic (2.51e-2)"			"unprognostic (3.30e-1)"										"unprognostic (8.91e-3)"				"unprognostic (1.04e-2)"						"unprognostic (7.34e-2)"		"unprognostic (1.46e-2)"			
TNF	"DIF, TNF-alpha, TNFA, TNFSF2"	ENSG00000232810	"Tumor necrosis factor"	P01375	6	31575565-31578336	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 20.9;lymphoid tissue: 6.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 100.4;Hofbauer cells: 84.3;Langerhans cells: 59.4;Macrophages: 158.2;monocytes: 97.8;Secretory cells: 58.0;T-cells: 93.4"	"Group enriched"	"Detected in some"	144	"central nervous system macrophage: 11.6;leukocyte: 17.3"	"Cancer enriched"	"Detected in single"	4	"Ovary Serous Cystadenocarcinoma (TCGA): 2.1"	"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 73.4"	"Group enriched"	"Detected in all"	6	"granulocytes: 22.7;monocytes: 73.4;T-cells: 41.4"	"Group enriched"	"Detected in many"	5	"Leukemia: 13.7;lymphoma: 34.9"	"Thyroid gland - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			CAB078469	Supported				"Secreted to blood"	Cytokine	NA	NA	10100		"Cluster 37: Monocytes & Neutrophils - Innate immune response"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 23: Choroid plexus - Mixed function"	"Cluster 55: Lymphoma - Immune response"	"Cluster 80: Non-specific - Transcription"	72			"CAB078469: AB_908070"			"unprognostic (4.29e-2)"					"unprognostic (3.12e-2)"							"unprognostic (2.61e-1)"					"unprognostic (1.68e-1)"	"unprognostic (2.63e-2)"		"unprognostic (1.56e-3)"								
TNFRSF17	"BCM, BCMA, CD269, TNFRSF13A"	ENSG00000048462	"TNF receptor superfamily member 17"	Q02223	16	11965210-11968068	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 28.2;lymphoid tissue: 46.5;stomach 1: 23.7"	"Cell type enriched"	"Detected in some"	15	"Plasma cells: 469.6"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	63	"memory B-cell: 125.4;naive B-cell: 109.1;plasmacytoid DC: 103.5"	"Group enriched"	"Detected in many"	64	"B-cells: 125.4;dendritic cells: 103.5"	"Cancer enriched"	"Detected in some"	9	"Myeloma: 608.0"	"Adipose visceral - Plasma cells, Breast - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Pancreas - Plasma cells, Prostate - Plasma cells, Stomach - Plasma cells, Testis - Early spermatids, Thyroid gland - Plasma cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA010569			Approved	"Golgi apparatus,Mitotic spindle"			Yes	NA		1200000	"Cluster 23: B-cells - Immunoglobulins"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 34: Non-specific - Mixed function"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 77: Plasma cells - Protein processing"	4	"Golgi apparatus"	"Mitotic spindle"	"HPA010569: AB_10602482"	"unprognostic (2.60e-1)"	"potential prognostic favorable (4.93e-6)"	"unprognostic (2.36e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.36e-2)"	"unprognostic (7.16e-2)"			"potential prognostic favorable (2.70e-6)"		"unprognostic (3.19e-3)"	"unprognostic (1.48e-1)"	"potential prognostic unfavorable (1.56e-4)"			"unprognostic (6.38e-3)"	"unprognostic (9.62e-3)"	"unprognostic (2.80e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.30e-2)"		"unprognostic (3.65e-1)"			"unprognostic (4.26e-3)"	"unprognostic (4.10e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.19e-1)"
TNFRSF1A	"CD120a, TNF-R, TNF-R-I, TNF-R55, TNFAR, TNFR1, TNFR60"	ENSG00000067182	"TNF receptor superfamily member 1A"	P19438	12	6328757-6342114	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Apoptosis, Host-virus interaction"	Receptor	"Amyloidosis, Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"central nervous system macrophage: 98.7;leukocyte: 78.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 454.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 116.0;granulocytes: 454.7;monocytes: 152.3"	"Low cancer specificity"	"Detected in all"			"Lung - Endothelial cells, Pituitary gland - Endothelial cells, Spleen - Fibroblast_1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004102, CAB010309"	Approved				"Secreted to blood"	Receptor	NA	NA	17700	650000	"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 41: Smooth muscle tissue - ECM organization"	"Cluster 39: Astrocytes - Mixed function"	"Cluster 7: Liver cancer - Metabolism"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	54			"CAB010309: AB_2206639, HPA004102: AB_1846232"	"unprognostic (1.10e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.45e-1)"	"unprognostic (7.41e-3)"	"unprognostic (2.64e-2)"	"unprognostic (5.28e-2)"	"unprognostic (4.83e-3)"	"potential prognostic unfavorable (1.94e-4)"	"unprognostic (2.80e-3)"	"unprognostic (1.03e-3)"	"unprognostic (5.66e-3)"	"unprognostic (3.12e-1)"	"unprognostic (5.44e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.09e-1)"	"potential prognostic unfavorable (1.81e-4)"	"unprognostic (1.10e-2)"	"unprognostic (5.05e-2)"	"potential prognostic unfavorable (7.43e-4)"	"unprognostic (1.10e-2)"	"unprognostic (4.00e-1)"	"unprognostic (1.85e-2)"	"potential prognostic unfavorable (5.97e-4)"	"unprognostic (3.29e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.87e-3)"	"unprognostic (3.77e-1)"	"unprognostic (4.75e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.45e-2)"	"unprognostic (4.70e-2)"
TNFRSF8	"CD30, D1S166E, KI-1"	ENSG00000120949	"TNF receptor superfamily member 8"	P28908	1	12063303-12144207	"Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 5.1"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 7.6;Kupffer cells: 4.8;Late spermatids: 10.1;Macrophages: 5.1;Mesothelial cells: 4.8;monocytes: 19.3"	"Cell type enhanced"	"Detected in some"		"leukocyte: 6.9;medium spiny neuron: 5.9"	"Cancer enriched"	"Detected in some"	10	"Testicular Germ Cell Tumor (TCGA): 11.6"	"Group enriched"	"Detected in some"	4	"basal ganglia: 4.8;thalamus: 1.5"	"Group enriched"	"Detected in many"	4	"intermediate monocyte: 59.4;non-classical monocyte: 97.0"	"Lineage enriched"	"Detected in many"	5	"monocytes: 97.0"	"Cancer enriched"	"Detected in some"	7	"lymphoma: 49.3"	"Breast - Endothelial cells, Colon - Endothelial cells, Minor Salivary Gland - Endothelial cells"	"Region enhanced"	"Detected in many"		"hypothalamus: 5.5"	"Low region specificity"	"Detected in all"			"CAB000016, HPA014823, HPA032081, HPA032082"	Approved		Supported	"Plasma membrane"			NA	NA		28000	"Cluster 37: Monocytes & Neutrophils - Innate immune response"	"Cluster 7: Adipose tissue - Mixed function"	"Cluster 33: Neurons - Mixed function"	"Cluster 21: Lymphoma - Adaptive immune response"	"Cluster 29: Monocytes - Innate immune response"	6	"Plasma membrane"		"CAB000016: AB_563546, HPA014823: , HPA032081: AB_2674141, HPA032082: AB_2674142"			"potential prognostic favorable (9.62e-4)"																	"unprognostic (1.65e-2)"									"unprognostic (6.89e-2)"		
TNFSF11	"CD254, ODF, OPGL, RANKL, TRANCE"	ENSG00000120659	"TNF superfamily member 11"	O14788	13	42562736-42608013	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Differentiation	"Cytokine, Developmental protein, Receptor"	"Cancer-related genes, Disease variant, FDA approved drug targets, Osteopetrosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"liver: 4.0;lymphoid tissue: 12.0"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 10.1;Ductal cells: 5.6;Early spermatids: 8.4;Late spermatids: 14.2;NK-cells: 3.9;Pancreatic endocrine cells: 3.4"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Pancreatic Adenocarcinoma (TCGA): 5.2"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in some"	8	"NK-cell: 9.9"	"Lineage enriched"	"Detected in many"	8	"NK-cells: 9.9"	"Cancer enhanced"	"Detected in some"		"Rhabdoid: 1.5;thyroid cancer: 1.7"	"Testis - Late spermatids"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB009193, HPA045142"	Enhanced				"Secreted to blood"	Cytokine	NA	NA	17200		"Cluster 15: NK-cells - Unknown function"	"Cluster 36: Lymphoid tissue - Cytokine signaling"	"Cluster 44: Non-specific - Mixed function"	"Cluster 55: Lymphoma - Immune response"	"Cluster 17: Breast glandular cells - Lactation"	4			"CAB009193: , HPA045142: AB_2679231"	"unprognostic (4.49e-2)"	"potential prognostic favorable (2.24e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.71e-2)"	"unprognostic (3.25e-2)"			"unprognostic (1.53e-1)"						"unprognostic (5.15e-2)"	"unprognostic (4.62e-3)"	"unprognostic (6.84e-2)"	"unprognostic (8.06e-2)"	"unprognostic (3.41e-2)"			"unprognostic (6.47e-3)"	"unprognostic (6.85e-2)"		"unprognostic (9.64e-2)"	"unprognostic (1.93e-1)"		"unprognostic (8.95e-2)"			
TNFSF13B	"BAFF, BLYS, CD257, TALL-1, TALL1, THANK, TNFSF20"	ENSG00000102524	"TNF superfamily member 13b"	Q9Y275	13	108251240-108308484	"Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Immunity	Cytokine	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 19.8;lymphoid tissue: 25.2"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 167.6;Kupffer cells: 106.6;Langerhans cells: 300.8;Macrophages: 143.4;monocytes: 542.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 509.3"	"Group enriched"	"Detected in all"	11	"dendritic cells: 207.0;granulocytes: 509.3;monocytes: 352.4"	"Cancer enriched"	"Detected in some"	10	"Leukemia: 21.6"		"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB009188, HPA030526"	Enhanced		Supported	"Vesicles,Plasma membrane,Focal adhesion sites"	"Secreted to blood"	Cytokine	NA	NA	393000	640000	"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 8: Immune cells - Immune response"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 29: Monocytes - Innate immune response"	26	"Plasma membrane"	"Vesicles, Focal adhesion sites"	"CAB009188: , HPA030526: "	"unprognostic (5.03e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.11e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.72e-2)"	"potential prognostic unfavorable (5.23e-4)"	"unprognostic (1.28e-1)"	"unprognostic (3.10e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.68e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.85e-2)"	"unprognostic (2.99e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.56e-2)"
TNNC1	TNNC	ENSG00000114854	"Troponin C1, slow skeletal and cardiac type"	P63316	3	52451100-52454041	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Muscle protein"	"Cardiomyopathy, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	36	"heart muscle: 8453.2;skeletal muscle: 20351.8;tongue: 11901.7"	"Group enriched"	"Detected in many"	4	"Cardiomyocytes: 986.3;Skeletal myocytes: 2797.6"	"Cell type enhanced"	"Detected in some"		"choroid plexus epithelial cell: 4.8;fibroblast: 4.7"	"Cancer enhanced"	"Detected in many"		"Head and Neck Squamous Cell Carcinoma (TCGA): 83.8"	"Group enriched"	"Detected in many"	6	"cerebellum: 5.0;choroid plexus: 15.5"	"Immune cell enhanced"	"Detected in single"		"MAIT T-cell: 1.2"	"Lineage enriched"	"Detected in single"	6	"T-cells: 1.2"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 94.2"	"Heart muscle - Cardiomyocytes, Lung - Alveolar cells type 1, Skeletal muscle - Skeletal myocytes, Skin - Keratinocyte (granular)"	"Region enriched"	"Detected in all"	4	"cerebral cortex: 87.0"	"Group enriched"	"Detected in some"	6	"midbrain: 10.1;spinal cord: 9.5"	"CAB002450, HPA044848, HPA056897"	Enhanced		Approved	"Nucleoplasm,Actin filaments,Mitochondria"			NA	NA		450000		"Cluster 14: Skeletal muscle - Muscle contraction"	"Cluster 5: Non-specific - Mixed function"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 2: Skeletal myocytes - Muscle contraction"	15	"Nucleoplasm, Actin filaments, Mitochondria"		"CAB002450: AB_564152, HPA044848: AB_2679110, HPA056897: AB_2683269"	"unprognostic (1.57e-1)"	"unprognostic (3.13e-2)"	"unprognostic (5.59e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.79e-2)"			"unprognostic (9.76e-3)"	"unprognostic (9.45e-2)"	"unprognostic (1.95e-1)"		"unprognostic (1.71e-2)"	"unprognostic (2.23e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.38e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.98e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.04e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.15e-3)"		"unprognostic (5.91e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.56e-1)"
TOP1		ENSG00000198900	"DNA topoisomerase I"	P11387	20	41028822-41124487	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Biological rhythms, Host-virus interaction"	"DNA-binding, Isomerase, Topoisomerase"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 896.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009058, HPA019039"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"			No	Yes		10000	"Cluster 29: Non-specific - Unknown function"	"Cluster 70: Lymphoid tissue - Immune response"	"Cluster 16: Non-specific - Transcription"	"Cluster 62: Non-specific - Plasma proteins"	"Cluster 39: Non-specific - Basic cellular processes"	415	"Nucleoplasm, Nucleoli fibrillar center"		"CAB009058: AB_2303554, HPA019039: AB_1858187"	"unprognostic (2.07e-2)"	"unprognostic (1.95e-2)"	"unprognostic (3.01e-1)"	"unprognostic (7.66e-2)"	"unprognostic (3.48e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.51e-3)"	"unprognostic (4.49e-3)"	"unprognostic (2.10e-3)"	"unprognostic (7.38e-2)"	"unprognostic (1.55e-2)"	"potential prognostic unfavorable (2.55e-4)"	"unprognostic (5.84e-3)"	"unprognostic (6.18e-3)"	"potential prognostic unfavorable (1.37e-4)"	"unprognostic (8.72e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.36e-3)"	"unprognostic (5.78e-3)"	"potential prognostic unfavorable (1.85e-5)"	"unprognostic (6.68e-2)"	"unprognostic (8.02e-2)"	"unprognostic (7.46e-2)"	"unprognostic (9.93e-2)"	"unprognostic (7.55e-2)"	"unprognostic (2.09e-1)"	"unprognostic (6.59e-2)"	"unprognostic (2.44e-1)"
TOP1MT		ENSG00000184428	"DNA topoisomerase I mitochondrial"	Q969P6	8	143304384-143359979	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"		"DNA-binding, Isomerase, Topoisomerase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oocytes: 54.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Testis - Early spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001915, HPA021542"	Approved		Supported	Mitochondria			NA	NA			"Cluster 18: Non-specific - Translation"	"Cluster 40: Non-specific - Transcription"	"Cluster 32: Cerebral cortex - Mixed function"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 1: Erythroid cells - Oxygen transport"		Mitochondria		"HPA001915: AB_1080331, HPA021542: AB_1858186"	"unprognostic (3.23e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.17e-1)"	"unprognostic (9.21e-3)"	"unprognostic (4.76e-2)"	"unprognostic (4.02e-1)"	"unprognostic (5.06e-2)"	"unprognostic (4.97e-2)"	"unprognostic (7.14e-3)"	"potential prognostic unfavorable (8.10e-4)"	"unprognostic (4.00e-1)"	"unprognostic (2.23e-1)"	"potential prognostic unfavorable (1.88e-4)"	"potential prognostic unfavorable (2.64e-4)"	"unprognostic (2.07e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.33e-2)"	"unprognostic (4.21e-2)"	"unprognostic (8.57e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.52e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.37e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.02e-1)"
TOP2A	"TOP2, TOP2alpha, TOPIIA"	ENSG00000131747	"DNA topoisomerase II alpha"	P11388	17	40388525-40417896	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms"	"DNA-binding, Isomerase, Topoisomerase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 124.5;testis: 63.8"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 179.4;Spermatocytes: 631.5;Spermatogonia: 154.1"	"Cell type enriched"	"Detected in single"	4	"leukocyte: 3.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"T-reg: 2.4"	"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Mitotic cells (Adrenal gland), Colon - Mitotic cells (Colon), Heart muscle - Mitotic cells (Heart), Lung - Mitotic cells (Lung), Minor Salivary Gland - Mitotic cells (Minor salivary gland), Skin - Mitotic cells (Skin), Spleen - Mitotic cells (Spleen), Stomach - Mitotic cells (Stomach), Testis - Spermatocytes, Thyroid gland - Mitotic cells (Thyroid)"	"Group enriched"	"Detected in many"	4	"basal ganglia: 4.2;white matter: 8.0"	"Low region specificity"	"Detected in many"			"CAB002448, HPA006458, HPA026773"	Enhanced	Approved	Supported	Nucleoplasm,Nucleoli			Yes	Yes		5400	"Cluster 9: T-regs - Cell cycle regulation"	"Cluster 67: Lymphoid tissue & Bone marrow - Cell proliferation"	"Cluster 12: Non-specific - Vasculature"	"Cluster 30: Non-specific - Gene expression regulation"	"Cluster 52: Non-specific - Cell proliferation"	232	Nucleoplasm	Nucleoli	"CAB002448: AB_564035, HPA006458: AB_1858189, HPA026773: AB_1858190"	"unprognostic (6.46e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.29e-3)"	"unprognostic (3.78e-2)"	"unprognostic (4.02e-3)"	"unprognostic (9.86e-2)"	"unprognostic (2.01e-2)"	"unprognostic (7.66e-2)"	"potential prognostic unfavorable (2.50e-6)"	"validated prognostic unfavorable (1.23e-10)"	"validated prognostic unfavorable (3.57e-6)"	"potential prognostic unfavorable (4.32e-8)"	"validated prognostic unfavorable (5.06e-5)"	"validated prognostic unfavorable (5.19e-7)"	"potential prognostic unfavorable (3.30e-5)"	"unprognostic (1.47e-3)"	"unprognostic (1.76e-3)"	"unprognostic (7.58e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.76e-3)"	"unprognostic (1.32e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.25e-1)"	"potential prognostic favorable (5.55e-4)"	"unprognostic (3.72e-3)"	"unprognostic (8.19e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.45e-2)"	"unprognostic (6.49e-2)"
TOP2B	"top2beta, TOPIIB"	ENSG00000077097	"DNA topoisomerase II beta"	Q02880	3	25597978-25664909	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Isomerase, Topoisomerase"	"Autism spectrum disorder, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 213.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004601, HPA024120, HPA050441"	Supported		Enhanced	Nucleoplasm			NA	NA			"Cluster 8: Plasmacytoid DCs - Unknown function"	"Cluster 16: Non-specific - Transcription"	"Cluster 31: Non-specific - Transcription"	"Cluster 6: Leukemia - Signal transduction"	"Cluster 68: Cardiomyocytes - Muscle contraction"	40	Nucleoplasm		"CAB004601: AB_628384, HPA024120: AB_1858191, HPA050441: AB_2681127"	"unprognostic (8.37e-3)"	"unprognostic (1.61e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.38e-2)"	"unprognostic (3.73e-3)"	"unprognostic (7.35e-3)"	"unprognostic (6.35e-3)"	"potential prognostic favorable (2.56e-5)"	"unprognostic (7.01e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.90e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.31e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.37e-2)"	"unprognostic (9.47e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.20e-1)"	"unprognostic (8.88e-2)"	"potential prognostic favorable (9.51e-5)"	"unprognostic (5.22e-2)"	"unprognostic (5.16e-2)"	"unprognostic (2.32e-1)"	"unprognostic (9.14e-2)"	"unprognostic (9.89e-2)"	"unprognostic (2.97e-1)"
TPH1	"TPH, TPRH"	ENSG00000129167	"Tryptophan hydroxylase 1"	P17752	11	18017555-18046269	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"Serotonin biosynthesis"	"Monooxygenase, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"choroid plexus: 6.6;intestine: 19.2;stomach 1: 14.9"	"Cell type enriched"	"Detected in many"	133	"Enteroendocrine cells: 1410.3"	"Cell type enhanced"	"Detected in all"		"committed oligodendrocyte precursor: 13.8"	"Cancer enhanced"	"Detected in many"		"Uterine Corpus Endometrial Carcinoma (TCGA): 5.1"	"Region enhanced"	"Detected in all"		"midbrain: 22.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	5	"pancreatic cancer: 15.3"	"Stomach - Gastric enteroendocrine cells"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB010767, HPA022483"	Uncertain		Approved	Cytosol			NA	NA				"Cluster 45: Intestine - Digestion"	"Cluster 44: Non-specific - Mixed function"	"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 20: Enteroendocrine cells - Hormone signaling"	4	Cytosol		"CAB010767: AB_261587, HPA022483: AB_1858378"		"unprognostic (5.29e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.05e-1)"		"unprognostic (8.69e-2)"		"unprognostic (3.64e-1)"									"unprognostic (1.55e-2)"	"unprognostic (3.65e-1)"	"unprognostic (5.33e-3)"				"unprognostic (1.21e-2)"		"unprognostic (2.14e-2)"	"unprognostic (8.71e-2)"		"unprognostic (2.24e-2)"	"unprognostic (1.58e-1)"		"unprognostic (8.52e-3)"
TPH2	"FLJ37295, NTPH"	ENSG00000139287	"Tryptophan hydroxylase 2"	Q8IWU9	12	71938845-72186618	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Serotonin biosynthesis"	"Monooxygenase, Oxidoreductase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"Early spermatids: 7.6;Inhibitory neurons: 3.1;Late spermatids: 6.8;Oocytes: 2.2;Spermatogonia: 2.8"	"Cell type enhanced"	"Detected in many"		"splatter: 28.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"midbrain: 631.8;pons: 271.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"head and neck cancer: 2.3"	"Testis - Early spermatids, Testis - Late spermatids"	"Group enriched"	"Detected in many"	31	"midbrain: 106.7;pons and medulla: 34.9"	"Group enriched"	"Detected in some"	5	"midbrain: 63.3;pons: 62.2"	CAB078198	Enhanced						NA	NA					"Cluster 41: Monoamines - Neurotransmitter signalling"	"Cluster 65: Non-specific - Unknown function"	"Cluster 11: Late spermatids - Unknown function"				"CAB078198: AB_2665804"																							"unprognostic (1.13e-2)"								
TPK1	"HTPK1, PP20"	ENSG00000196511	"Thiamin pyrophosphokinase 1"	Q9H3S4	7	144451941-144836395	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 13.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 76.4;Excitatory neurons: 79.8;Inhibitory neurons: 73.1;Late spermatids: 101.5;Microglial cells: 105.6"	"Low cell type specificity"	"Detected in all"			"Cancer enriched"	"Detected in all"	4	"Kidney Renal Papillary Cell Carcinoma (TCGA): 36.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"Kidney cancer: 15.0"	"Minor Salivary Gland - Minor salivary glandular cells, Testis - Early spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021545, HPA021849"	Approved		Approved	Vesicles			NA	NA		130000	"Cluster 33: Non-specific - ATP binding"	"Cluster 25: Small intestine - Absorption"	"Cluster 56: Hypothalamus - Neuropeptide signaling"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 24: Cytotrophoblasts - Mitochondria"	10	Vesicles		"HPA021545: AB_1858209, HPA021849: AB_1858210"	"potential prognostic favorable (8.65e-5)"	"unprognostic (2.78e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.54e-2)"	"unprognostic (4.49e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.78e-2)"	"potential prognostic favorable (2.79e-5)"	"unprognostic (1.59e-1)"	"unprognostic (1.05e-3)"	"unprognostic (2.06e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.11e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.79e-1)"	"unprognostic (9.98e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.41e-2)"
TPMT		ENSG00000137364	"Thiopurine S-methyltransferase"	P51580	6	18128311-18155077	"Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 73.7;liver: 66.7;thyroid gland: 74.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 140.5;Proximal tubular cells: 270.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Kidney - Proximal tubular cells, Kidney - Proximal tubular cells, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019851, HPA062364"	Enhanced						NA	NA		20000	"Cluster 37: Monocytes & Neutrophils - Innate immune response"	"Cluster 55: Kidney & Intestine - Metabolism"	"Cluster 14: Neurons - Synaptic function"	"Cluster 57: Stomach & Colon cancer - Digestion"	"Cluster 45: Non-specific - Mixed function"	1			"HPA019851: AB_1858213, HPA062364: "	"unprognostic (1.33e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.09e-2)"	"unprognostic (6.41e-3)"	"unprognostic (1.75e-2)"	"unprognostic (5.06e-2)"	"unprognostic (4.16e-1)"	"unprognostic (1.38e-3)"	"potential prognostic favorable (5.41e-9)"	"unprognostic (5.11e-3)"	"potential prognostic favorable (5.64e-5)"	"unprognostic (7.02e-2)"	"potential prognostic favorable (7.83e-5)"	"unprognostic (3.22e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.53e-1)"	"potential prognostic favorable (1.17e-4)"	"unprognostic (3.85e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.93e-2)"	"unprognostic (4.83e-2)"	"unprognostic (3.99e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.41e-1)"	"unprognostic (8.91e-2)"
TPO	TPX	ENSG00000115705	"Thyroid peroxidase"	P07202	2	1374066-1543711	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Hydrogen peroxide, Thyroid hormones biosynthesis"	"Oxidoreductase, Peroxidase"	"Congenital hypothyroidism, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	69	"thyroid gland: 1540.7"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 24.9;Endothelial cells: 14.3;Late spermatids: 7.3;Oocytes: 44.8"	"Cell type enhanced"	"Detected in many"		"endothelial cell: 6.8;lower rhombic lip: 6.6"	"Cancer enriched"	"Detected in some"	503	"Thyroid Carcinoma (TCGA): 512.0"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	12	"memory CD4 T-cell: 2.0;T-reg: 1.2"	"Lineage enriched"	"Detected in single"	20	"T-cells: 2.0"	"Group enriched"	"Detected in some"	6	"Myeloma: 4.7;thyroid cancer: 6.1"	"Pituitary gland - Corticotropes, Thyroid gland - Thyroid glandular cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA007987, CAB009587, HPA073226"	Enhanced				"Intracellular and membrane"	Enzyme	NA	NA			"Cluster 6: T-cells - T-cell receptor"	"Cluster 51: Thyroid gland - Unknown function"	"Cluster 53: Neurons - Mixed function"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"				"CAB009587: , HPA007987: AB_1080270, HPA073226: "			"unprognostic (4.43e-2)"																					"unprognostic (1.03e-1)"						"unprognostic (1.33e-2)"	
TRHR		ENSG00000174417	"Thyrotropin releasing hormone receptor"	P34981	8	109086585-109121565	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Congenital hypothyroidism, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"amygdala excitatory: 14.0;hippocampal dentate gyrus: 30.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"				"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA055162	Approved						NA	NA					"Cluster 29: Forebrain - Mixed function"	"Cluster 47: Leukemia - Hemostasis"	"Cluster 65: Neurons - Synaptic function"	16			"HPA055162: AB_2732592"																															
TRPA1	ANKTM1	ENSG00000104321	"Transient receptor potential cation channel subfamily A member 1"	O75762	8	72019917-72075584	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Sensory transduction, Transport"	"Calcium channel, Ion channel"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 8.9;stomach 1: 10.0;urinary bladder: 26.8"	"Group enriched"	"Detected in some"	4	"Early spermatids: 16.0;Intestinal goblet cells: 31.9"	"Cell type enhanced"	"Detected in many"		"hippocampal dentate gyrus: 14.5;pericyte: 10.3"	"Cancer enhanced"	"Detected in many"		"Breast Invasive Carcinoma (TCGA): 7.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Neuroblastoma: 7.2"	"Testis - Early spermatids, Testis - Late spermatids"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"										NA	NA				"Cluster 45: Intestine - Digestion"	"Cluster 51: Neurons - Mixed function"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 16: Intestinal goblet cells - Mucin production"					"unprognostic (8.87e-3)"	"unprognostic (2.34e-1)"	"unprognostic (3.65e-1)"		"unprognostic (7.23e-3)"	"unprognostic (1.02e-1)"					"potential prognostic favorable (2.64e-5)"	"unprognostic (6.68e-2)"	"unprognostic (2.66e-2)"					"unprognostic (1.74e-2)"	"unprognostic (3.60e-2)"			"unprognostic (6.90e-2)"	"unprognostic (1.92e-1)"		"unprognostic (3.17e-2)"	"unprognostic (4.17e-2)"		"unprognostic (4.47e-2)"	"unprognostic (3.27e-1)"		
TRPM7	"CHAK1, LTRPC7, TRP-PLIK"	ENSG00000092439	"Transient receptor potential cation channel subfamily M member 7"	Q96QT4	15	50552473-50686797	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Necrosis, Transport"	"Calcium channel, Ion channel, Kinase, Serine/threonine-protein kinase, Transferase"	"Amyotrophic lateral sclerosis, Disease variant, FDA approved drug targets, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"parathyroid gland: 105.5"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 118.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Adrenal cortex cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035522, HPA052173"	Enhanced		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"			NA	NA			"Cluster 24: Non-specific - Transcription"	"Cluster 24: Parathyroid gland - Vesicular transport"	"Cluster 31: Non-specific - Transcription"	"Cluster 58: Non-specific - Nuclear processes"	"Cluster 34: Neurons - Neuronal signaling"	11	"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA035522: , HPA052173: AB_2681749"	"unprognostic (5.36e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.12e-2)"	"unprognostic (5.77e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.28e-1)"	"unprognostic (5.51e-2)"	"unprognostic (2.17e-3)"	"potential prognostic favorable (4.75e-4)"	"unprognostic (2.20e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.72e-1)"	"unprognostic (8.81e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.20e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.79e-1)"	"unprognostic (9.83e-3)"	"unprognostic (4.01e-2)"	"unprognostic (2.38e-2)"	"unprognostic (4.12e-2)"	"unprognostic (5.89e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.17e-1)"	"unprognostic (4.70e-3)"	"unprognostic (1.20e-1)"
TRPM8		ENSG00000144481	"Transient receptor potential cation channel subfamily M member 8"	Q7Z2W7	2	233917373-234019522	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sensory transduction, Transport"	"Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	57	"liver: 30.5;prostate: 77.6"	"Group enriched"	"Detected in some"	12	"Hepatocytes: 37.5;Prostatic glandular cells: 87.1"	"Cell type enhanced"	"Detected in some"		"cerebellar inhibitory: 9.5"	"Cancer enriched"	"Detected in some"	35	"Prostate Adenocarcinoma (TCGA): 151.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"Kidney cancer: 6.3;Myeloma: 7.1;prostate cancer: 13.1;skin cancer: 15.8"	"Prostate - Prostate glandular cells, Testis - Early spermatids"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"										NA	NA				"Cluster 1: Liver & Kidney - Metabolism"	"Cluster 46: Brainstem - Mixed function"	"Cluster 69: Skin cancer - ECM organization"	"Cluster 40: Prostatic glandular cells - Transcription"	1										"unprognostic (1.09e-1)"	"unprognostic (3.28e-3)"					"unprognostic (5.52e-2)"	"validated prognostic favorable (3.92e-4)"	"validated prognostic favorable (6.18e-4)"	"unprognostic (1.40e-1)"	"unprognostic (8.13e-2)"						"potential prognostic unfavorable (8.66e-4)"	"unprognostic (2.98e-2)"			"unprognostic (5.16e-2)"				
TRPV1	VR1	ENSG00000196689	"Transient receptor potential cation channel subfamily V member 1"	Q8NER1	17	3565444-3609411	"FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 24.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 19.2;Oligodendrocytes: 17.5;Rod photoreceptor cells: 23.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"				"Not detected"	"Not detected"			"Not detected"	"Not detected"										NA	NA				"Cluster 69: Liver - Oxidoreductase activity"	"Cluster 11: White matter - Signal transduction"	"Cluster 42: Non-specific - Unknown function"	"Cluster 66: Photoreceptor cells - Visual perception"	5				"unprognostic (1.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.46e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.28e-1)"		"unprognostic (1.84e-3)"	"unprognostic (3.22e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.66e-3)"	"potential prognostic favorable (1.07e-5)"	"unprognostic (3.01e-1)"	"unprognostic (1.44e-2)"	"unprognostic (7.46e-2)"	"unprognostic (8.89e-3)"	"unprognostic (9.16e-2)"		"potential prognostic favorable (8.59e-5)"	"unprognostic (1.51e-2)"	"unprognostic (2.21e-3)"	"unprognostic (3.44e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.17e-3)"	"unprognostic (3.60e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.66e-1)"
TRPV3	VRL3	ENSG00000167723	"Transient receptor potential cation channel subfamily V member 3"	Q8NET8	17	3510502-3557812	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"	"Disease variant, FDA approved drug targets, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 5.1;skeletal muscle: 1.5;skin 1: 4.7"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 13.2;Plasma cells: 14.2;Proximal enterocytes: 21.8;Schwann cells: 15.1;Skeletal myocytes: 8.8;Suprabasal keratinocytes: 13.4"	"Cell type enhanced"	"Detected in many"		"astrocyte: 10.0"	"Cancer enhanced"	"Detected in single"		"Head and Neck Squamous Cell Carcinoma (TCGA): 2.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Myeloma: 3.0"		"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA069550			Approved	"Plasma membrane,Centrosome,Cytosol"			NA	NA				"Cluster 45: Intestine - Digestion"	"Cluster 34: Non-specific - Mixed function"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 77: Plasma cells - Protein processing"		"Plasma membrane"	"Centrosome, Cytosol"	"HPA069550: AB_2686149"			"unprognostic (2.35e-2)"			"unprognostic (1.01e-3)"		"unprognostic (1.03e-2)"	"unprognostic (5.07e-2)"														"unprognostic (1.70e-3)"			"unprognostic (3.99e-3)"					
TSHR	LGR3	ENSG00000165409	"Thyroid stimulating hormone receptor"	P16473	14	80954989-81146306	"Cancer-related genes, Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes, Congenital hypothyroidism, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"thyroid gland: 265.8"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 6.7;Inhibitory neurons: 11.8;Langerhans cells: 7.2;Microglial cells: 6.3;Oligodendrocytes: 8.8;Plasma cells: 14.3"	"Low cell type specificity"	"Detected in all"			"Cancer enriched"	"Detected in some"	107	"Thyroid Carcinoma (TCGA): 266.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"naive B-cell: 1.7;T-reg: 6.9"	"Group enriched"	"Detected in many"	5	"B-cells: 1.7;T-cells: 6.9"	"Cancer enhanced"	"Detected in some"		"Myeloma: 10.0"	"Minor Salivary Gland - Plasma cells, Testis - Late spermatids, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in some"			"Region enhanced"	"Detected in single"		"hypothalamus: 1.8"	CAB000473	Approved				"Intracellular and membrane"	Receptor	NA	NA			"Cluster 16: Non-specific - Cell proliferation"	"Cluster 51: Thyroid gland - Unknown function"	"Cluster 9: Non-specific - Receptor signaling"	"Cluster 59: Leukemia - T-cell receptor"	"Cluster 61: Plasma cells - Immunoglobulins & histones"	14			"CAB000473: AB_2303782"			"unprognostic (1.57e-2)"			"unprognostic (3.33e-2)"	"unprognostic (1.37e-2)"	"unprognostic (8.50e-3)"			"unprognostic (1.72e-1)"	"unprognostic (3.95e-2)"							"unprognostic (1.88e-2)"	"unprognostic (6.52e-2)"	"unprognostic (1.18e-1)"					"unprognostic (1.77e-3)"		"unprognostic (1.69e-1)"		"unprognostic (1.00e-1)"	
TSLP		ENSG00000145777	"Thymic stromal lymphopoietin"	Q969D9	5	111070062-111078026	"FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		Cytokine	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 11.2;urinary bladder: 11.5"	"Group enriched"	"Detected in many"	4	"Basal respiratory cells: 102.0;Basal squamous epithelial cells: 211.4"	"Cell type enhanced"	"Detected in some"		"bergmann glia: 2.3;fibroblast: 3.2;pericyte: 4.1;vascular associated smooth muscle cell: 2.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"thalamus: 2.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"				"Not detected"	"Not detected"							HPA056350			Uncertain	"Golgi apparatus,Vesicles"	"Secreted to blood"	Cytokine	NA	NA	38400			"Cluster 83: Liver - Metabolism"	"Cluster 39: Astrocytes - Mixed function"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 12: Squamous epithelial cells - Keratinization"		"Golgi apparatus, Vesicles"		"HPA056350: "	"unprognostic (2.00e-1)"		"unprognostic (3.84e-1)"	"unprognostic (2.14e-1)"				"unprognostic (6.83e-3)"	"unprognostic (1.34e-1)"				"unprognostic (4.59e-3)"		"potential prognostic favorable (1.34e-4)"			"unprognostic (9.35e-3)"	"unprognostic (1.67e-1)"				"unprognostic (8.36e-2)"	"unprognostic (5.25e-2)"						"unprognostic (9.30e-2)"	
TSPO	"BZRP, DBI, IBP, MBR, mDRC, PBR, pk18, PKBS, TSPO1"	ENSG00000100300	"Translocator protein"	P30536	22	43151547-43163242	"Cancer-related genes, FDA approved drug targets, Predicted membrane proteins"	"Lipid transport, Transport"	Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 670.8"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 1357.2;Suprabasal keratinocytes: 1573.5"	"Cell type enhanced"	"Detected in many"		"leukocyte: 74.0;vascular associated smooth muscle cell: 64.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Adipose visceral - Adipocytes (Visceral), Lung - Macrophages, Spleen - Neutrophils"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011232, HPA046260, HPA072304"	Uncertain		Supported	Vesicles,Mitochondria,Cytosol			NA	NA			"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 27: Squamous epithelium - Keratinization"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 66: Non-specific - Mitochondria"	"Cluster 58: Macrophages - Innate immune response"	18	Mitochondria	"Vesicles, Cytosol"	"CAB011232: , HPA046260: , HPA072304: "	"unprognostic (1.76e-1)"	"unprognostic (7.80e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.26e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.56e-1)"	"unprognostic (4.50e-2)"	"unprognostic (3.36e-2)"	"unprognostic (6.89e-2)"	"unprognostic (2.46e-3)"	"unprognostic (6.77e-3)"	"unprognostic (1.58e-2)"	"potential prognostic unfavorable (1.36e-5)"	"unprognostic (4.74e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.65e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.77e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.67e-2)"
TTR	"CTS, CTS1, HsT2651, PALB"	ENSG00000118271	Transthyretin	P02766	18	31557009-31598833	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Transport	"Hormone, Thyroid hormone"	"Amyloidosis, Cancer-related genes, Disease variant, FDA approved drug targets, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	34	"choroid plexus: 692067.5"	"Cell type enriched"	"Detected in many"	7	"Hepatocytes: 26585.9"	"Cell type enriched"	"Detected in many"	8	"choroid plexus epithelial cell: 40087.7"	"Group enriched"	"Detected in many"	21	"Liver Hepatocellular Carcinoma (TCGA): 5122.1;Pancreatic Adenocarcinoma (TCGA): 4235.1"	"Region enriched"	"Detected in all"	82	"choroid plexus: 302089.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"Gastric cancer: 130.8;liver cancer: 177.5"	"Liver - Hepatocytes, Pancreas - Alpha cells, Pituitary gland - Thyrotropes, Testis - Early spermatids"	"Group enriched"	"Detected in all"	5	"basal ganglia: 1538.8;hippocampal formation: 4894.4;pons and medulla: 5760.6;thalamus: 3403.0"	"Region enhanced"	"Detected in all"		"medulla oblongata: 1291.2"	"CAB002517, HPA002550, CAB062567, CAB073406"	Supported		Approved	"Golgi apparatus"	"Secreted to blood"	Hormone	NA	NA	345000000000	80000000000		"Cluster 60: Choroid plexus - Transmembrane transport"	"Cluster 36: Choroid plexus - Mixed function"	"Cluster 18: Liver cancer - Metabolism"	"Cluster 43: Hepatocytes - Metabolism"	82	"Golgi apparatus"		"CAB002517: AB_563965, CAB062567: AB_2665620, CAB073406: , HPA002550: AB_1080419"	"unprognostic (1.74e-2)"	"unprognostic (2.14e-3)"	"unprognostic (2.36e-1)"	"unprognostic (7.56e-2)"	"unprognostic (9.13e-3)"	"unprognostic (3.33e-1)"	"unprognostic (2.88e-2)"			"unprognostic (1.76e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.81e-2)"	"unprognostic (9.90e-2)"	"unprognostic (9.78e-3)"	"unprognostic (1.09e-3)"	"unprognostic (8.07e-2)"	"unprognostic (3.57e-2)"		"unprognostic (1.64e-1)"			"unprognostic (8.01e-3)"	"unprognostic (5.15e-2)"	"unprognostic (6.35e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.02e-3)"	"unprognostic (8.28e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.14e-2)"	
TUBA1A	"B-ALPHA-1, FLJ25113, TUBA3"	ENSG00000167552	"Tubulin alpha 1a"	Q71U36	12	49184686-49189080	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Transporters"		Hydrolase	"Cancer-related genes, Disease variant, FDA approved drug targets, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 2404.7"	"Cell type enhanced"	"Detected in all"		"Ciliated cells: 930.9;Ductal cells: 1004.7;Schwann cells: 1165.7"	"Cell type enhanced"	"Detected in all"		"oligodendrocyte: 786.8"	"Cancer enriched"	"Detected in all"	10	"Glioblastoma Multiforme (TCGA): 3672.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1667.7"	"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"Neuroblastoma: 1234.9"	"Adipose subcutaneous - Adipose progenitor cells, Colon - Smooth muscle cells, Prostate - Smooth muscle cells, Skeletal muscle - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008686, HPA039247, HPA043684, HPA063394"	Enhanced		Enhanced	"Microtubules,Primary cilium"			NA	NA			"Cluster 37: Monocytes & Neutrophils - Innate immune response"	"Cluster 9: Oligodendrocytes - Myelination"	"Cluster 30: White matter - Myelination"	"Cluster 17: Neuroblastoma - Neuronal signaling"	"Cluster 15: Non-specific - Mixed function"	231	Microtubules	"Primary cilium"	"CAB008686: AB_1624202, HPA039247: AB_2676410, HPA043684: AB_2678617, HPA063394: AB_2685003"	"unprognostic (1.72e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.92e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.90e-3)"	"unprognostic (1.29e-1)"	"unprognostic (4.65e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.96e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.48e-2)"	"unprognostic (9.56e-2)"	"unprognostic (4.82e-2)"	"unprognostic (5.32e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.14e-2)"	"unprognostic (4.00e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.50e-1)"
TUBA4A	"FLJ30169, H2-ALPHA, TUBA1"	ENSG00000127824	"Tubulin alpha 4a"	P68366	2	219249710-219277902	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		Hydrolase	"Amyotrophic lateral sclerosis, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 351.6;tongue: 256.2"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 899.2;Suprabasal keratinocytes: 645.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Adrenal gland - Adrenal cortex cells, Spleen - Neutrophils, Testis - Late spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004621, CAB005887, HPA039247, HPA043684, HPA063394"	Approved		Enhanced	"Microtubules,Primary cilium"			NA	NA		200000000	"Cluster 21: Neutrophils - Unknown function"	"Cluster 14: Skeletal muscle - Muscle contraction"	"Cluster 52: Neurons & Synapses - Synaptic function"	"Cluster 7: Liver cancer - Metabolism"	"Cluster 57: Platelets - Hemostasis"	90	Microtubules	"Primary cilium"	"CAB004621: AB_628411, CAB005887: AB_2288001, HPA039247: AB_2676410, HPA043684: AB_2678617, HPA063394: AB_2685003"	"unprognostic (4.77e-2)"	"unprognostic (7.92e-3)"	"unprognostic (2.82e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.70e-1)"	"unprognostic (9.98e-3)"	"unprognostic (2.11e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.01e-1)"	"potential prognostic unfavorable (3.27e-7)"	"unprognostic (7.47e-2)"	"potential prognostic unfavorable (1.22e-4)"	"unprognostic (1.12e-2)"	"unprognostic (2.43e-2)"	"unprognostic (7.50e-2)"	"unprognostic (2.22e-2)"	"unprognostic (4.32e-2)"	"unprognostic (5.33e-2)"	"unprognostic (5.69e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.40e-1)"	"unprognostic (2.56e-1)"	"unprognostic (6.02e-3)"	"unprognostic (1.33e-1)"
TUBB	"M40, MGC16435, OK/SW-cl.56, Tubb5"	ENSG00000196230	"Tubulin beta class I"	P07437	6	30717435-30725538	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 1298.7;Extravillous trophoblasts: 2539.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005417, CAB012406, HPA043640, HPA046280"	Enhanced		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle,Primary cilium,Basal body,Flagellar centriole,Principal piece,End piece"			Yes	Yes		160000000	"Cluster 33: Non-specific - ATP binding"	"Cluster 16: Non-specific - Transcription"	"Cluster 44: Non-specific - Mixed function"	"Cluster 28: Non-specific - Nuclear processes"	"Cluster 52: Non-specific - Cell proliferation"	203	"Microtubules, Cytokinetic bridge"	"Mitotic spindle, Primary cilium, Basal body, Flagellar centriole, Principal piece, End piece"	"CAB005417: AB_2241191, CAB012406: AB_2210370, HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (1.16e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.38e-1)"	"unprognostic (7.62e-2)"	"unprognostic (6.19e-2)"	"unprognostic (4.93e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.15e-1)"	"potential prognostic unfavorable (1.25e-4)"	"unprognostic (1.93e-2)"	"unprognostic (4.80e-2)"	"potential prognostic unfavorable (3.24e-4)"	"unprognostic (3.87e-3)"	"unprognostic (6.91e-3)"	"unprognostic (2.38e-3)"	"potential prognostic unfavorable (7.48e-7)"	"unprognostic (5.96e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.53e-1)"	"unprognostic (7.31e-3)"	"unprognostic (8.01e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.10e-1)"	"unprognostic (8.19e-2)"	"unprognostic (8.31e-2)"
TUBB1	dJ543J19.4	ENSG00000101162	"Tubulin beta 1 class VI"	Q9H4B7	20	59019429-59026654	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transporters"			"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 8.3;lymphoid tissue: 4.2"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 16.2;Erythroid cells: 13.5;Late spermatids: 8.7;NK-cells: 5.2;Rod photoreceptor cells: 4.0;Schwann cells: 4.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	17	"basophil: 63.2;neutrophil: 26.0"	"Lineage enriched"	"Detected in many"	24	"granulocytes: 63.2"	"Cancer enhanced"	"Detected in some"		"Leukemia: 2.6"	"Spleen - Platelets, Testis - Late spermatids"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB004286, HPA043640, HPA046280"	Approved		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle,Primary cilium,Basal body,Flagellar centriole,Principal piece,End piece"			Yes	NA		90000000	"Cluster 21: Neutrophils - Unknown function"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 6: Non-specific - Immune response"	"Cluster 47: Leukemia - Hemostasis"	"Cluster 57: Platelets - Hemostasis"	19	Microtubules	"Cytokinetic bridge, Mitotic spindle, Primary cilium, Basal body, Flagellar centriole, Principal piece, End piece"	"CAB004286: AB_2288090, HPA043640: AB_2678594, HPA046280: AB_2679612"			"unprognostic (8.33e-2)"			"unprognostic (8.05e-2)"		"unprognostic (5.68e-2)"																		"unprognostic (3.40e-2)"					
TUBB3	"beta-4, CFEOM3, CFEOM3A, FEOM3"	ENSG00000258947	"Tubulin beta 3 class III"	Q13509	16	89921392-89938761	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, FDA approved drug targets, Intellectual disability"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 330.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 19.2;Ductal cells: 21.1;Excitatory neurons: 36.7;Exocrine glandular cells: 26.2;Gastric mucus-secreting cells: 21.2;Inhibitory neurons: 43.2;Late spermatids: 18.5;Oligodendrocyte precursor cells: 15.1;Pancreatic endocrine cells: 23.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"naive B-cell: 2.5"	"Lineage enriched"	"Detected in single"	9	"B-cells: 2.5"	"Low cancer specificity"	"Detected in all"			"Colon - Colon enteroendocrine cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043640, HPA046280"	Approved		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle,Primary cilium,Basal body,Flagellar centriole,Principal piece,End piece"			Yes	NA		91000000		"Cluster 33: Brain - Neuronal signaling"	"Cluster 45: Non-specific - Mixed function"	"Cluster 17: Neuroblastoma - Neuronal signaling"	"Cluster 45: Non-specific - Mixed function"	54	Microtubules	"Cytokinetic bridge, Mitotic spindle, Primary cilium, Basal body, Flagellar centriole, Principal piece, End piece"	"HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (1.26e-1)"	"unprognostic (3.05e-2)"	"unprognostic (4.21e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.72e-1)"	"potential prognostic unfavorable (9.70e-4)"	"potential prognostic favorable (3.37e-4)"	"unprognostic (4.82e-2)"	"unprognostic (1.69e-1)"	"validated prognostic unfavorable (3.73e-7)"	"validated prognostic unfavorable (1.17e-6)"	"unprognostic (1.67e-2)"	"unprognostic (1.83e-3)"	"unprognostic (9.74e-2)"	"unprognostic (2.12e-3)"	"unprognostic (1.53e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.03e-3)"	"unprognostic (5.63e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.90e-2)"	"potential prognostic unfavorable (1.16e-5)"	"unprognostic (6.70e-3)"	"unprognostic (7.69e-2)"	"unprognostic (4.67e-2)"	"unprognostic (8.79e-2)"	"unprognostic (5.34e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.37e-1)"	"unprognostic (6.08e-2)"
TUBB4B	"Beta2, TUBB2C"	ENSG00000188229	"Tubulin beta 4B class IVb"	P68371	9	137241287-137243707	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Deafness, Disease variant, FDA approved drug targets, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Ciliated cells: 1765.7;Early spermatids: 2123.9;Late spermatids: 2919.7"	"Cell type enhanced"	"Detected in all"		"ependymal cell: 488.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adipose visceral - Adipocytes (Visceral), Testis - Early spermatids, Testis - Late spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010880, HPA043640, HPA046280"	Enhanced		Enhanced	"Microtubules,Cytokinetic bridge,Mitotic spindle,Primary cilium,Basal body,Principal piece,End piece"			Yes	Yes		120000000	"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 8: Ciliated cells - Cilium organization"	"Cluster 44: Non-specific - Mixed function"	"Cluster 43: Non-specific - Basic cellular processes"	"Cluster 42: Ciliated cells - Cilium assembly"	167	Microtubules	"Cytokinetic bridge, Mitotic spindle, Primary cilium, Basal body, Principal piece, End piece"	"CAB010880: AB_609915, HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (2.76e-2)"	"unprognostic (2.58e-1)"		"unprognostic (1.01e-2)"	"unprognostic (7.18e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.98e-1)"	"unprognostic (7.37e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.21e-1)"	"unprognostic (5.77e-2)"	"potential prognostic unfavorable (3.19e-4)"		"unprognostic (5.16e-3)"	"unprognostic (6.06e-3)"	"unprognostic (6.26e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.38e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.74e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.14e-2)"	"unprognostic (4.60e-2)"	"potential prognostic favorable (2.12e-4)"	"unprognostic (4.44e-2)"
TUBD1	"FLJ12709, TUBD"	ENSG00000108423	"Tubulin delta 1"	Q9UJT1	17	59859479-59892945	"FDA approved drug targets, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Developmental protein"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Testis - Spermatogonia"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004609, HPA023980, HPA027090"	Approved		Approved	Nucleoplasm,Cytosol			NA	Yes			"Cluster 3: Non-specific - Nuclear processes"	"Cluster 27: Squamous epithelium - Keratinization"	"Cluster 25: Non-specific - Transcription"	"Cluster 27: Breast cancer - Unknown function"	"Cluster 78: NK-cells & T-cells - Immune system & Transcription"	8	"Nucleoplasm, Cytosol"		"CAB004609: AB_628416, HPA023980: AB_1858456, HPA027090: AB_1858457"	"unprognostic (3.24e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.99e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.56e-3)"	"potential prognostic favorable (2.50e-4)"	"unprognostic (7.33e-2)"	"potential prognostic unfavorable (1.87e-5)"	"unprognostic (1.34e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.66e-3)"	"unprognostic (3.41e-2)"	"unprognostic (5.89e-3)"	"unprognostic (1.06e-2)"	"unprognostic (5.29e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.58e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.02e-2)"	"unprognostic (5.05e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.90e-2)"
TUBE1	"dJ142L7.2, FLJ22589, TUBE"	ENSG00000074935	"Tubulin epsilon 1"	Q9UJT0	6	112070663-112087529	"FDA approved drug targets, Predicted intracellular proteins"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 230.2;Spermatocytes: 84.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Liver - Hepatocytes, Testis - Early spermatids"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA032073, HPA032074"	Approved						NA	NA			"Cluster 43: Non-specific - Transcription & Translation"	"Cluster 78: Testis - Transcription"	"Cluster 55: Non-specific - Transcription"	"Cluster 13: Non-specific - Mixed function"	"Cluster 31: Spermatocytes - Spermatogenesis"	2			"HPA032073: AB_10601773, HPA032074: AB_10601216"	"unprognostic (3.82e-2)"	"unprognostic (4.19e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.23e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.49e-1)"	"unprognostic (8.25e-2)"	"unprognostic (2.92e-1)"	"unprognostic (5.38e-2)"	"unprognostic (5.58e-3)"	"unprognostic (6.95e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.00e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.78e-1)"	"potential prognostic favorable (4.26e-5)"	"unprognostic (8.42e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.30e-3)"	"unprognostic (3.09e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.59e-2)"
TUBG1	"TUBG, TUBGCP1"	ENSG00000131462	"Tubulin gamma 1"	P23258	17	42609641-42615238	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, FDA approved drug targets, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 169.0"	"Group enriched"	"Detected in all"	4	"Early spermatids: 472.1;Erythroid cells: 243.5;Late spermatids: 650.6;Spermatocytes: 344.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Testis - Early spermatids, Testis - Late spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004608, HPA043012"	Enhanced		Approved	"Principal piece"			NA	Yes			"Cluster 44: Plasmacytoid DCs - Plasma membrane proteins"	"Cluster 4: Testis - Basic cellular processes"	"Cluster 52: Neurons & Synapses - Synaptic function"	"Cluster 27: Breast cancer - Unknown function"	"Cluster 11: Late spermatids - Unknown function"	81	"Principal piece"		"CAB004608: AB_628417, HPA043012: "	"unprognostic (1.46e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.18e-3)"	"unprognostic (7.46e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.97e-2)"	"unprognostic (4.26e-1)"	"unprognostic (2.36e-3)"	"unprognostic (6.88e-2)"	"validated prognostic unfavorable (1.03e-10)"	"validated prognostic unfavorable (1.50e-6)"	"validated prognostic unfavorable (3.40e-4)"	"validated prognostic unfavorable (5.01e-4)"	"unprognostic (4.03e-2)"	"unprognostic (4.22e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.46e-3)"	"unprognostic (2.09e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.63e-2)"	"unprognostic (8.79e-2)"
TXNRD1	"GRIM-12, Trxr1, TXNR"	ENSG00000198431	"Thioredoxin reductase 1"	Q16881	12	104215779-104350307	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport"	Oxidoreductase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Alveolar cells type 1: 241.1;Alveolar cells type 2: 208.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Adrenal cortex cells, Prostate - Smooth muscle cells, Testis - Spermatogonia"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001395, CAB004607, CAB015834, HPA043871"	Approved		Supported	Nucleoplasm			NA	NA		6100000	"Cluster 35: Neutrophils - Protein binding"	"Cluster 41: Smooth muscle tissue - ECM organization"	"Cluster 21: Non-specific - Metabolism"	"Cluster 7: Liver cancer - Metabolism"	"Cluster 72: Alveolar cells - Lung function"	8	Nucleoplasm		"CAB004607: AB_628405, CAB015834: , HPA001395: AB_1858377, HPA043871: AB_2678709"	"unprognostic (3.36e-1)"	"unprognostic (2.63e-3)"	"unprognostic (2.09e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.41e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.69e-3)"	"potential prognostic favorable (2.34e-4)"	"unprognostic (7.08e-2)"	"potential prognostic unfavorable (3.04e-7)"	"potential prognostic unfavorable (1.74e-5)"	"unprognostic (2.00e-3)"	"potential prognostic unfavorable (7.64e-4)"	"unprognostic (3.56e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.15e-2)"	"unprognostic (8.52e-2)"	"unprognostic (5.83e-2)"	"unprognostic (6.11e-2)"	"unprognostic (1.84e-1)"	"unprognostic (5.13e-3)"	"unprognostic (1.99e-1)"	"unprognostic (9.68e-2)"	"unprognostic (8.17e-2)"	"unprognostic (1.63e-3)"	"unprognostic (2.60e-1)"
TYK2	JTK1	ENSG00000105397	"Tyrosine kinase 2"	P29597	19	10350533-10380608	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005157	Uncertain		Approved	Cytosol			NA	NA			"Cluster 26: Monocytes - Plasma membrane proteins"	"Cluster 43: Non-specific - Mitochondrial translation"	"Cluster 19: Astrocytes - Mixed function"	"Cluster 23: Non-specific - Transcription"	"Cluster 29: Monocytes - Innate immune response"	28	Cytosol		"HPA005157: AB_1858480"	"unprognostic (2.25e-1)"	"unprognostic (2.70e-2)"	"unprognostic (3.15e-2)"	"potential prognostic favorable (5.22e-5)"	"unprognostic (1.49e-1)"	"unprognostic (3.40e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.48e-3)"	"unprognostic (1.35e-1)"	"potential prognostic unfavorable (5.44e-11)"	"unprognostic (1.03e-1)"	"unprognostic (1.94e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.30e-2)"	"unprognostic (6.73e-3)"	"unprognostic (2.93e-2)"	"potential prognostic favorable (1.74e-4)"	"unprognostic (4.62e-3)"	"unprognostic (5.63e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.70e-2)"	"unprognostic (7.56e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.87e-2)"
TYMP	"ECGF1, MNGIE"	ENSG00000025708	"Thymidine phosphorylase"	P19971	22	50525752-50530032	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Angiogenesis, Chemotaxis, Differentiation"	"Developmental protein, Glycosyltransferase, Growth factor, Transferase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 428.8;Hofbauer cells: 667.1;Langerhans cells: 454.3;Macrophages: 541.4;monocytes: 866.8"	"Group enriched"	"Detected in many"	4	"central nervous system macrophage: 40.7;ependymal cell: 61.8;leukocyte: 74.7"	"Cancer enhanced"	"Detected in all"		"Head and Neck Squamous Cell Carcinoma (TCGA): 543.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 137.0;eosinophil: 75.1;intermediate monocyte: 98.9;myeloid DC: 39.6;neutrophil: 115.9;non-classical monocyte: 77.6"	"Group enriched"	"Detected in all"	10	"dendritic cells: 39.6;granulocytes: 115.9;monocytes: 137.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 86.4"	"Adrenal gland - Neutrophils"	"Not detected"	"Not detected"							"HPA000530, HPA001072, CAB002518"	Enhanced		Approved	"Nuclear bodies,Golgi apparatus,Cytosol"			NA	NA		12000000	"Cluster 25: Non-specific - Unknown function"	"Cluster 47: Spleen - Immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 14: Langerhans cells - Innate immune response"	24	"Nuclear bodies, Golgi apparatus"	Cytosol	"CAB002518: AB_563953, HPA000530: AB_2666017, HPA001072: AB_1080274"	"unprognostic (2.42e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.74e-2)"	"unprognostic (3.82e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.45e-1)"	"unprognostic (5.38e-2)"	"unprognostic (2.12e-1)"	"unprognostic (5.27e-3)"	"unprognostic (1.57e-3)"	"unprognostic (4.90e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.49e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.68e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.52e-1)"	"unprognostic (7.57e-3)"	"unprognostic (8.33e-2)"	"unprognostic (4.26e-3)"	"unprognostic (3.08e-1)"	"unprognostic (3.29e-2)"	"unprognostic (8.42e-2)"	"unprognostic (7.30e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.63e-2)"	"unprognostic (6.58e-3)"	"unprognostic (3.02e-1)"
TYMS	"HsT422, TMS, TS, Tsase"	ENSG00000176890	"Thymidylate synthetase"	P04818	18	657653-673578	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Nucleotide biosynthesis"	"Methyltransferase, Transferase"	"Cancer-related genes, Disease variant, Dyskeratosis congenita, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 87.4;lymphoid tissue: 110.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 111.0;Erythroid cells: 220.8;Extravillous trophoblasts: 117.6;Plasma cells: 120.6;Spermatocytes: 149.4;Undifferentiated cells: 121.4"	"Cell type enhanced"	"Detected in many"		"oligodendrocyte: 28.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 14.1"	"Group enriched"	"Detected in many"	6	"NK-cells: 6.8;T-cells: 14.1"	"Low cancer specificity"	"Detected in all"			"Adrenal gland - Mitotic cells (Adrenal gland), Colon - Mitotic cells (Colon), Lung - Mitotic cells (Lung), Minor Salivary Gland - Mitotic cells (Minor salivary gland), Skin - Mitotic cells (Skin), Spleen - Mitotic cells (Spleen), Stomach - Mitotic cells (Stomach), Testis - Early spermatids"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB002784, HPA074922"	Enhanced						NA	Yes		10000	"Cluster 12: Non-specific - Mitochondrial translation"	"Cluster 67: Lymphoid tissue & Bone marrow - Cell proliferation"	"Cluster 11: White matter - Signal transduction"	"Cluster 13: Non-specific - Mixed function"	"Cluster 52: Non-specific - Cell proliferation"	2			"CAB002784: , HPA074922: "	"unprognostic (1.25e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.75e-2)"	"unprognostic (2.51e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.29e-1)"	"unprognostic (2.47e-2)"	"unprognostic (4.16e-3)"	"potential prognostic favorable (8.73e-6)"	"unprognostic (1.24e-2)"	"unprognostic (1.49e-2)"	"validated prognostic unfavorable (8.34e-5)"	"validated prognostic unfavorable (9.99e-7)"	"potential prognostic unfavorable (1.45e-6)"	"unprognostic (5.67e-3)"	"unprognostic (1.17e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.29e-3)"	"validated prognostic unfavorable (1.81e-6)"	"validated prognostic unfavorable (9.64e-4)"	"unprognostic (9.74e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.60e-2)"	"unprognostic (7.34e-2)"	"unprognostic (3.62e-1)"	"unprognostic (3.53e-2)"	"unprognostic (9.65e-2)"
TYR	"OCA1, OCA1A, OCAIA"	ENSG00000077498	Tyrosinase	P14679	11	89177875-89295759	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Melanin biosynthesis"	"Monooxygenase, Oxidoreductase, Tumor antigen"	"Albinism, Deafness, Disease variant, FDA approved drug targets, Waardenburg syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	37	"skin 1: 30.7"	"Cell type enriched"	"Detected in some"	8	"Melanocytes: 295.5"	"Cell type enhanced"	"Detected in some"		"hippocampal CA1-3: 5.1;oligodendrocyte: 4.9"	"Cancer enriched"	"Detected in single"	1325	"Skin Cuteneous Melanoma (TCGA): 765.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	145	"skin cancer: 268.0"	"Skin - Melanocytes"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000079, HPA043241, HPA050889, HPA064583"	Enhanced		Enhanced	Vesicles			NA	NA				"Cluster 82: Skin - Keratinization"		"Cluster 9: Skin cancer - Melanin biosynthesis"	"Cluster 26: Schwann cells & Melanocytes - Mixed function"	1	Vesicles		"CAB000079: AB_564045, HPA043241: AB_2678383, HPA050889: AB_2681264, HPA064583: "																											"unprognostic (2.19e-1)"				
UGCG	GCS	ENSG00000148154	"UDP-glucose ceramide glucosyltransferase"	Q16739	9	111896814-111935369	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism"	"Glycosyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 111.7"	"Cell type enhanced"	"Detected in all"		"dendritic cells: 453.5;Glandular and luminal cells: 291.2"	"Cell type enhanced"	"Detected in all"		"central nervous system macrophage: 257.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	21	"plasmacytoid DC: 109.8"	"Lineage enriched"	"Detected in all"	21	"dendritic cells: 109.8"	"Low cancer specificity"	"Detected in all"			"Adrenal gland - Adrenal cortex cells, Colon - Neutrophils"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024124	Approved						NA	NA			"Cluster 44: Plasmacytoid DCs - Plasma membrane proteins"	"Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 21: Non-specific - Metabolism"	"Cluster 72: Neuronal - Signal transduction"	"Cluster 37: Glandular & Luminal cells - Unknown function"	2			"HPA024124: AB_1858595"	"unprognostic (7.42e-3)"	"unprognostic (2.98e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.61e-2)"	"unprognostic (5.82e-2)"	"unprognostic (7.20e-3)"	"unprognostic (5.29e-3)"	"potential prognostic unfavorable (2.77e-4)"	"unprognostic (5.56e-2)"	"unprognostic (1.80e-1)"	"unprognostic (6.09e-2)"	"unprognostic (5.48e-3)"	"unprognostic (2.20e-1)"	"unprognostic (6.47e-2)"	"unprognostic (4.64e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.48e-2)"	"unprognostic (7.23e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.02e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.93e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.88e-1)"	"unprognostic (3.85e-2)"	"unprognostic (8.79e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.92e-1)"
VAMP1	"SYB1, VAMP-1"	ENSG00000139190	"Vesicle associated membrane protein 1"	P23763	12	6462237-6470677	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"			"Congenital myasthenic syndrome, Disease variant, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 133.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 21.9;Inhibitory neurons: 24.0;Oligodendrocytes: 25.0"	"Cell type enhanced"	"Detected in all"		"lower rhombic lip: 72.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002779, CAB016119, CAB079000"	Approved	Supported					NA	NA			"Cluster 3: Non-specific - Nuclear processes"	"Cluster 9: Oligodendrocytes - Myelination"	"Cluster 45: Non-specific - Mixed function"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 78: NK-cells & T-cells - Immune system & Transcription"	9			"CAB002779: , CAB016119: AB_628309, CAB079000: "	"unprognostic (4.22e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.10e-1)"	"unprognostic (9.17e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.15e-2)"	"potential prognostic unfavorable (3.93e-8)"	"unprognostic (3.03e-2)"	"unprognostic (6.70e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.54e-1)"	"unprognostic (5.06e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.30e-2)"	"unprognostic (3.98e-2)"	"unprognostic (6.75e-2)"	"unprognostic (5.87e-2)"	"unprognostic (3.36e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.32e-2)"
VAMP2	"SYB2, VAMP-2"	ENSG00000220205	"Vesicle associated membrane protein 2"	P63027	17	8159149-8163546	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"			"Disease variant, FDA approved drug targets, Intellectual disability"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 470.8"	"Cell type enhanced"	"Detected in all"		"Bipolar cells: 1035.5;Cone photoreceptor cells: 1126.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB078785		Supported					NA	NA		5800000	"Cluster 42: Non-specific - Vesicular transport"	"Cluster 17: Neuronal - Synaptic function"	"Cluster 14: Neurons - Synaptic function"	"Cluster 42: Non-specific - Unknown function"	"Cluster 25: Bipolar cells - Visual perception"	81			"CAB078785: "	"potential prognostic favorable (4.21e-4)"	"unprognostic (7.77e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.75e-2)"	"unprognostic (5.81e-2)"	"unprognostic (6.25e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.30e-1)"	"unprognostic (8.18e-2)"	"unprognostic (6.82e-2)"	"validated prognostic favorable (1.13e-5)"	"validated prognostic favorable (2.06e-4)"	"potential prognostic favorable (6.92e-5)"	"unprognostic (6.73e-2)"	"potential prognostic favorable (4.83e-4)"	"unprognostic (5.39e-3)"	"unprognostic (2.94e-2)"	"unprognostic (7.98e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.73e-1)"	"unprognostic (4.49e-2)"	"potential prognostic favorable (1.84e-5)"	"unprognostic (1.12e-2)"	"unprognostic (8.93e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.82e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.26e-1)"	"unprognostic (8.32e-2)"	"potential prognostic favorable (7.84e-5)"
VDR	"NR1I1, PPP1R163"	ENSG00000111424	"Vitamin D receptor"	P11473	12	47841537-47943048	"Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors, Transporters"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"parathyroid gland: 228.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 125.5;monocytes: 89.1;Proximal enterocytes: 81.2;Schwann cells: 88.9;Undifferentiated cells: 56.2"	"Cell type enriched"	"Detected in some"	8	"leukocyte: 11.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"classical monocyte: 3.5;eosinophil: 1.9;intermediate monocyte: 6.5;myeloid DC: 5.1;neutrophil: 6.6;non-classical monocyte: 6.7"	"Group enriched"	"Detected in many"	8	"dendritic cells: 5.1;granulocytes: 6.6;monocytes: 6.7"	"Low cancer specificity"	"Detected in many"			"Adrenal gland - Adrenal cortex cells, Pituitary gland - Lactotropes, Prostate - Urothelial cells"	"Region enhanced"	"Detected in single"		"olfactory bulb: 2.1"	"Region enhanced"	"Detected in some"		"spinal cord: 5.8"	"CAB004617, HPA047740, HPA072102"			Supported	"Nucleoplasm,Intermediate filaments,Cytosol"			NA	NA			"Cluster 40: Monocytes - Innate immune response"	"Cluster 24: Parathyroid gland - Vesicular transport"	"Cluster 12: Non-specific - Vasculature"	"Cluster 57: Stomach & Colon cancer - Digestion"	"Cluster 28: Dendritic cells - Antigen presentation"	61	Nucleoplasm	"Intermediate filaments, Cytosol"	"CAB004617: AB_628040, HPA047740: AB_2680142, HPA072102: "	"potential prognostic favorable (6.06e-4)"	"unprognostic (3.22e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.04e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.67e-2)"	"potential prognostic unfavorable (4.25e-4)"	"unprognostic (1.57e-2)"	"unprognostic (8.25e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.54e-2)"	"unprognostic (9.02e-2)"	"unprognostic (1.68e-2)"	"unprognostic (4.41e-2)"	"unprognostic (6.06e-2)"	"unprognostic (3.23e-1)"	"potential prognostic unfavorable (2.06e-4)"	"unprognostic (8.72e-3)"	"unprognostic (1.36e-2)"	"unprognostic (7.09e-2)"	"unprognostic (1.40e-3)"	"unprognostic (9.50e-3)"	"unprognostic (9.44e-2)"	"unprognostic (3.30e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.41e-1)"
VEGFA	"VEGF, VEGF-A, VPF"	ENSG00000112715	"Vascular endothelial growth factor A"	P15692	6	43770184-43786487	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 241.3;granulocytes: 274.5;Langerhans cells: 272.3"	"Cell type enhanced"	"Detected in all"		"astrocyte: 127.8;oligodendrocyte precursor cell: 116.3"	"Cancer enhanced"	"Detected in all"		"Kidney Renal Clear Cell Carcinoma (TCGA): 667.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Adrenal cortex cells, Kidney - Podocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005429, CAB039240, HPA069116, CAB069907"	Supported				"Secreted to blood"	"Growth factor"	NA	NA	562000	20000		"Cluster 19: Non-specific - Basic cellular processes"	"Cluster 42: Choroid plexus - Mitochondria"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 29: Monocytes - Innate immune response"	24			"CAB005429: AB_2212984, CAB039240: , CAB069907: AB_10001947, HPA069116: AB_2686089"	"unprognostic (2.38e-1)"	"unprognostic (1.70e-2)"	"unprognostic (7.20e-2)"	"potential prognostic unfavorable (8.18e-4)"	"unprognostic (2.97e-3)"	"unprognostic (2.69e-1)"	"unprognostic (6.95e-3)"	"potential prognostic unfavorable (1.56e-4)"	"unprognostic (1.22e-1)"	"unprognostic (4.35e-2)"	"potential prognostic favorable (2.20e-4)"	"unprognostic (3.93e-3)"	"potential prognostic unfavorable (4.09e-5)"	"potential prognostic unfavorable (1.16e-4)"	"unprognostic (3.40e-3)"	"unprognostic (1.24e-2)"	"potential prognostic unfavorable (7.04e-4)"	"unprognostic (1.25e-1)"	"unprognostic (8.42e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.58e-3)"	"unprognostic (8.45e-3)"	"unprognostic (5.90e-3)"	"unprognostic (1.28e-1)"	"unprognostic (9.42e-2)"	"unprognostic (3.35e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.26e-2)"
VEGFB	"VEGFL, VRF"	ENSG00000173511	"Vascular endothelial growth factor B"	P49765	11	64234584-64239264	"Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 191.8;dendritic cells: 201.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	10	"plasmacytoid DC: 30.5"	"Lineage enriched"	"Detected in many"	10	"dendritic cells: 30.5"	"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Thyroid gland - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	"Growth factor"	NA	NA	186000		"Cluster 44: Plasmacytoid DCs - Plasma membrane proteins"	"Cluster 30: Heart muscle - Heart development"	"Cluster 19: Astrocytes - Mixed function"	"Cluster 24: Non-specific - Unknown function"	"Cluster 33: Non-specific - DNA binding"	3				"unprognostic (2.58e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.28e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.82e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.99e-2)"	"unprognostic (4.45e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.56e-1)"	"unprognostic (9.06e-3)"	"unprognostic (2.42e-1)"	"unprognostic (9.74e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.11e-3)"	"unprognostic (2.66e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.84e-3)"	"unprognostic (6.44e-2)"	"unprognostic (6.10e-3)"	"unprognostic (1.28e-1)"
VKORC1	VKCFD2	ENSG00000167397	"Vitamin K epoxide reductase complex subunit 1"	Q9BQB6	16	31090842-31095980	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 443.7"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 767.1;Oocytes: 587.4"	"Cell type enhanced"	"Detected in some"		"vascular associated smooth muscle cell: 1.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Adipose progenitor cells, Adipose visceral - Adipose progenitor cells, Breast - Fibroblasts, Spleen - Fibroblast_1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042720	Approved		Supported	"Endoplasmic reticulum"			NA	NA			"Cluster 29: Non-specific - Unknown function"	"Cluster 83: Liver - Metabolism"	"Cluster 28: Oligodendrocytes - Mixed function"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 43: Hepatocytes - Metabolism"	15	"Endoplasmic reticulum"		"HPA042720: AB_10961864"	"unprognostic (3.27e-2)"	"unprognostic (1.13e-2)"	"unprognostic (7.40e-2)"	"unprognostic (9.29e-2)"	"unprognostic (5.06e-3)"	"unprognostic (3.58e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.78e-1)"	"validated prognostic unfavorable (5.99e-5)"	"validated prognostic unfavorable (4.59e-5)"	"unprognostic (4.93e-3)"	"unprognostic (2.89e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.06e-1)"	"unprognostic (6.92e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.06e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.68e-2)"	"unprognostic (4.65e-1)"	"unprognostic (4.70e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.25e-1)"
VKORC1L1		ENSG00000196715	"Vitamin K epoxide reductase complex subunit 1 like 1"	Q8N0U8	7	65873074-65959563	"Enzymes, FDA approved drug targets, Predicted membrane proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Alveolar cells type 1: 93.9;Alveolar cells type 2: 96.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Liver - Hepatocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053954	Approved		Supported	"Endoplasmic reticulum"			NA	NA			"Cluster 5: Non-specific - Cell proliferation"	"Cluster 7: Adipose tissue - Mixed function"	"Cluster 14: Neurons - Synaptic function"	"Cluster 39: Non-specific - Transcription"	"Cluster 72: Alveolar cells - Lung function"	45	"Endoplasmic reticulum"		"HPA053954: AB_2682319"	"unprognostic (1.66e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.11e-2)"	"unprognostic (6.19e-3)"	"unprognostic (1.26e-1)"	"potential prognostic unfavorable (4.01e-4)"	"unprognostic (4.49e-3)"	"potential prognostic unfavorable (1.34e-4)"	"unprognostic (6.27e-2)"	"potential prognostic unfavorable (2.81e-7)"	"potential prognostic favorable (7.62e-5)"	"unprognostic (3.84e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.64e-3)"	"unprognostic (9.30e-3)"	"unprognostic (2.24e-1)"	"unprognostic (6.85e-2)"	"unprognostic (4.32e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.75e-2)"	"unprognostic (5.31e-3)"	"potential prognostic unfavorable (8.64e-5)"	"unprognostic (2.33e-1)"	"unprognostic (7.71e-2)"	"unprognostic (3.52e-1)"	"unprognostic (5.78e-2)"	"unprognostic (4.39e-2)"	"unprognostic (8.35e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.84e-1)"
VWF	F8VWF	ENSG00000110799	"Von Willebrand factor"	P04275	12	5948877-6124770	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Cell adhesion, Hemostasis"		"Cancer-related genes, Disease variant, FDA approved drug targets, von Willebrand disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"Adipocytes: 917.4;Endothelial cells: 827.6"	"Cell type enriched"	"Detected in many"	13	"endothelial cell: 1181.2"	"Cancer enriched"	"Detected in all"	4	"Kidney Renal Clear Cell Carcinoma (TCGA): 196.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Adipose subcutaneous - Endothelial cells, Adipose visceral - Endothelial cells, Breast - Endothelial cells, Colon - Endothelial cells, Minor Salivary Gland - Endothelial cells, Prostate - Endothelial cells, Skeletal muscle - Endothelial cells, Stomach - Endothelial cells, Testis - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001694, HPA001815, HPA002082, CAB072874, CAB072875"	Supported				"Secreted to blood"	"Blood coagulation"	NA	NA	28300000000	5000000000		"Cluster 7: Adipose tissue - Mixed function"	"Cluster 47: Endothelial cells - Vasculature"	"Cluster 48: Adipocytes & Endothelial cells - Angiogenesis"	"Cluster 41: Adipocytes & Endothelial cells - Mixed function"	12			"CAB001694: , CAB072874: AB_2665726, CAB072875: AB_2665727, HPA001815: AB_611880, HPA002082: AB_1080575"	"unprognostic (2.57e-1)"	"unprognostic (3.86e-1)"	"unprognostic (1.44e-3)"	"unprognostic (2.94e-1)"	"unprognostic (6.69e-2)"	"unprognostic (7.81e-3)"	"unprognostic (1.24e-1)"	"unprognostic (5.14e-2)"	"unprognostic (2.63e-2)"	"unprognostic (4.13e-2)"	"potential prognostic favorable (5.48e-9)"	"unprognostic (1.34e-3)"	"unprognostic (2.44e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.97e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.13e-2)"	"unprognostic (6.69e-2)"	"unprognostic (7.28e-2)"	"unprognostic (3.62e-2)"	"unprognostic (2.23e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.59e-1)"	"unprognostic (7.36e-2)"	"potential prognostic unfavorable (1.93e-4)"	"unprognostic (1.09e-1)"	"unprognostic (9.44e-2)"	"unprognostic (1.42e-3)"
XDH	"XO, XOR"	ENSG00000158125	"Xanthine dehydrogenase"	P47989	2	31334321-31414742	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"breast: 40.8;intestine: 48.1;liver: 66.4"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 252.4;Distal enterocytes: 68.7;Hepatocytes: 41.3;Proximal enterocytes: 98.2"	"Cell type enhanced"	"Detected in some"		"cerebellar inhibitory: 10.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"head and neck cancer: 13.0"	"Colon - Colon enterocytes, Liver - Hepatocytes, Pituitary gland - Corticotropes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA062641, HPA069323"	Supported		Uncertain	Nucleoplasm,Nucleoli	"Intracellular and membrane"	Enzyme	No	No		210000		"Cluster 37: Liver & Intestine - Lipid metabolism"	"Cluster 10: Cerebellum - Nucleic acid binding"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 17: Breast glandular cells - Lactation"	2	Nucleoplasm	Nucleoli	"HPA062641: AB_2684816, HPA069323: AB_2686121"	"unprognostic (3.87e-1)"	"unprognostic (4.92e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.12e-2)"	"unprognostic (6.42e-3)"	"unprognostic (3.77e-3)"			"unprognostic (2.49e-2)"				"unprognostic (9.47e-2)"	"unprognostic (2.78e-3)"	"potential prognostic favorable (8.04e-4)"	"unprognostic (4.76e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.79e-3)"	"unprognostic (4.89e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.76e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.37e-3)"	"unprognostic (7.79e-3)"		"unprognostic (9.32e-2)"	"unprognostic (1.99e-1)"		"unprognostic (1.10e-1)"
XIAP	"API3, BIRC4, hILP, ILP-1"	ENSG00000101966	"X-linked inhibitor of apoptosis"	P98170	X	123859712-123913972	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway, Wnt signaling pathway"	"Protease inhibitor, Thiol protease inhibitor, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009203, HPA042428"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"			NA	NA			"Cluster 30: Non-specific - DNA binding"	"Cluster 35: Non-specific - Mitochondria"	"Cluster 21: Non-specific - Metabolism"	"Cluster 36: Non-specific - mRNA processing"	"Cluster 33: Non-specific - DNA binding"	162	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB009203: AB_2257167, HPA042428: AB_2677993"	"unprognostic (1.22e-2)"	"unprognostic (1.08e-3)"	"unprognostic (3.90e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.69e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.84e-3)"	"potential prognostic favorable (3.93e-5)"	"unprognostic (3.06e-2)"	"unprognostic (3.44e-1)"	"unprognostic (4.87e-2)"	"unprognostic (3.53e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.86e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.63e-2)"	"unprognostic (6.41e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.81e-1)"	"unprognostic (5.03e-2)"	"unprognostic (8.21e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.40e-2)"	"unprognostic (5.67e-2)"
XPO1	"CRM-1, CRM1, emb"	ENSG00000082898	"Exportin 1"	O14980	2	61476032-61538741	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Transport"	RNA-binding	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010184, HPA042933"	Supported		Enhanced	"Nucleoplasm,Nuclear membrane,Vesicles,Cytosol"			NA	NA		300000	"Cluster 13: Non-specific - Mitochondria"	"Cluster 16: Non-specific - Transcription"	"Cluster 55: Non-specific - Transcription"	"Cluster 26: Non-specific - Mitochondria & RNA binding"	"Cluster 52: Non-specific - Cell proliferation"	192	"Nucleoplasm, Nuclear membrane"	"Vesicles, Cytosol"	"CAB010184: AB_2215817, HPA042933: AB_2678229"	"unprognostic (1.40e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.88e-2)"	"unprognostic (9.88e-2)"	"unprognostic (7.21e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.77e-2)"	"potential prognostic favorable (1.38e-4)"	"unprognostic (2.64e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.24e-3)"	"unprognostic (5.86e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.57e-3)"	"unprognostic (3.36e-1)"	"unprognostic (6.90e-3)"	"unprognostic (8.17e-3)"	"unprognostic (4.32e-1)"	"validated prognostic unfavorable (4.44e-5)"	"validated prognostic unfavorable (9.55e-4)"	"unprognostic (9.94e-2)"	"unprognostic (1.09e-3)"	"unprognostic (6.72e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.09e-2)"	"unprognostic (7.97e-3)"
YES1	"c-yes, HsT441, Yes"	ENSG00000176105	"YES proto-oncogene 1, Src family tyrosine kinase"	P07947	18	721588-812546	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"endothelial cell: 298.3;leukocyte: 168.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	9	"basophil: 20.1"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 20.1"	"Low cancer specificity"	"Detected in all"			"Adipose visceral - Endothelial cells, Heart muscle - Endothelial cells, Kidney - Endothelial cells, Lung - Endothelial cells, Skeletal muscle - Endothelial cells, Spleen - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004370, HPA026480"	Approved		Supported	"Plasma membrane,Cytosol"			NA	NA			"Cluster 41: Basophils - Unknown function"	"Cluster 11: Liver - Plasma proteins"	"Cluster 44: Non-specific - Mixed function"	"Cluster 13: Non-specific - Mixed function"	"Cluster 54: Lymphatic endothelial cells - Lymph vessel development"	112	"Plasma membrane, Cytosol"		"CAB004370: AB_627370, HPA026480: AB_1858921"	"unprognostic (4.13e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.76e-2)"	"unprognostic (4.79e-3)"	"unprognostic (6.11e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.79e-1)"	"unprognostic (1.26e-1)"	"potential prognostic unfavorable (2.71e-5)"	"potential prognostic favorable (5.57e-6)"	"unprognostic (1.27e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.57e-2)"	"unprognostic (5.31e-3)"	"unprognostic (2.17e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.85e-1)"	"unprognostic (3.43e-3)"	"unprognostic (3.58e-2)"	"potential prognostic unfavorable (2.08e-4)"	"unprognostic (4.71e-3)"	"unprognostic (2.65e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.98e-2)"	"unprognostic (3.24e-1)"
